<SEC-DOCUMENT>0001477932-25-003550.txt : 20250512
<SEC-HEADER>0001477932-25-003550.hdr.sgml : 20250512
<ACCEPTANCE-DATETIME>20250512160027
ACCESSION NUMBER:		0001477932-25-003550
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		65
CONFORMED PERIOD OF REPORT:	20250331
FILED AS OF DATE:		20250512
DATE AS OF CHANGE:		20250512

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LIGHTBRIDGE Corp
		CENTRAL INDEX KEY:			0001084554
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MANAGEMENT CONSULTING SERVICES [8742]
		ORGANIZATION NAME:           	07 Trade & Services
		EIN:				911975651
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34487
		FILM NUMBER:		25934568

	BUSINESS ADDRESS:	
		STREET 1:		11710 PLAZA AMERICA DRIVE
		STREET 2:		SUITE 2000
		CITY:			RESTON
		STATE:			VA
		ZIP:			20190
		BUSINESS PHONE:		571 730 1200

	MAIL ADDRESS:	
		STREET 1:		11710 PLAZA AMERICA DRIVE
		STREET 2:		SUITE 2000
		CITY:			RESTON
		STATE:			VA
		ZIP:			20190

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Thorium Power, Ltd
		DATE OF NAME CHANGE:	20061011

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NOVASTAR RESOURCES LTD.
		DATE OF NAME CHANGE:	20051011

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NOVASTAR RESOURCES LTD
		DATE OF NAME CHANGE:	20050829
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>ltbr_10q.htm
<DESCRIPTION>FORM 10-Q
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt="http://fasb.org/srt/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:ffd="http://xbrl.sec.gov/ffd/2024q2" xmlns:ltbr="http://ltbr.com/20250331"><head><title>ltbr_10q.htm</title><!--Document Created by XBRLMaster--><meta http-equiv="Content-Type" content="text/html"/></head><body style="text-align:justify;font:10pt times new roman"><div style="display:none;text-align:justify;font:10pt times new roman;margin-left:7%;margin-right:7%;" id="XBRLDIV"><ix:header><ix:hidden><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="From2025-01-01to2025-03-31" id="ixv-6861">0001084554</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" contextRef="From2025-01-01to2025-03-31" format="ixt:booleanfalse" id="ixv-6862">false</ix:nonNumeric><ix:nonNumeric name="dei:CurrentFiscalYearEndDate" contextRef="From2025-01-01to2025-03-31" id="ixv-6863">--12-31</ix:nonNumeric><ix:nonNumeric name="dei:DocumentFiscalPeriodFocus" contextRef="From2025-01-01to2025-03-31" id="ixv-6864">Q1</ix:nonNumeric><ix:nonNumeric name="dei:DocumentFiscalYearFocus" contextRef="From2025-01-01to2025-03-31" id="ixv-6865">2025</ix:nonNumeric><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-12-31" unitRef="USDPShares" decimals="INF" id="ixv-6866">0.001</ix:nonFraction><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2024-12-31" unitRef="Shares" decimals="0" id="ixv-6867">10000000</ix:nonFraction><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2024-12-31" unitRef="Shares" decimals="0" id="ixv-6868">1</ix:nonFraction><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2025-03-31" unitRef="Shares" decimals="0" id="ixv-6869">0</ix:nonFraction><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-12-31" unitRef="USDPShares" decimals="INF" id="ixv-6870">0.001</ix:nonFraction><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2024-12-31" unitRef="Shares" decimals="0" id="ixv-6871">25000000</ix:nonFraction><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2025-03-31" unitRef="Shares" decimals="0" id="ixv-6872">21557343</ix:nonFraction><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2025-03-31" unitRef="Shares" decimals="0" id="ixv-6873">18783912</ix:nonFraction><ix:nonNumeric name="ecd:Rule10b51ArrAdoptedFlag" contextRef="From2025-01-01to2025-03-31" id="ixv-6874">true</ix:nonNumeric><ix:nonNumeric name="ecd:Rule10b51ArrTrmntdFlag" contextRef="From2025-01-01to2025-03-31" id="ixv-6875">false</ix:nonNumeric><ix:nonNumeric name="ecd:NonRule10b51ArrAdoptedFlag" contextRef="From2025-01-01to2025-03-31" id="ixv-6876">false</ix:nonNumeric><ix:nonNumeric name="ecd:NonRule10b51ArrTrmntdFlag" contextRef="From2025-01-01to2025-03-31" id="ixv-6877">false</ix:nonNumeric><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2025-01-01to2025-03-31" unitRef="Pure" decimals="INF" id="ixv-6878">0</ix:nonFraction><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2024-01-01to2024-03-31" unitRef="Pure" decimals="INF" id="ixv-6879">0</ix:nonFraction><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" contextRef="From2024-01-01to2024-03-31" unitRef="USD" decimals="0" id="ixv-6880">60000</ix:nonFraction><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2025-02-27_ltbr_SeriesXPreferredStockMember" unitRef="USDPShares" decimals="INF" id="ixv-6881">0.001</ix:nonFraction><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2025-02-27_ltbr_SeriesXPreferredStockMember" unitRef="USD" decimals="0" id="ixv-6882">100</ix:nonFraction><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-03-31_ltbr_RestrictedStockAwardsSummaryMember" unitRef="Shares" decimals="0" id="ixv-6883">781864</ix:nonFraction><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2025-03-31_ltbr_RestrictedStockAwardsSummaryMember" unitRef="Shares" decimals="0" id="ixv-6884">743702</ix:nonFraction><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2024-01-01to2024-03-31_ltbr_CommonShareIssuancesMember" unitRef="USD" decimals="0" id="ixv-6885">15000</ix:nonFraction></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="ltbr-20250331.xsd"/></ix:references><ix:resources><xbrli:context id="From2025-01-01to2025-03-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-05-08_ltbr_TopMember_us-gaap_SubsequentEventMember_ltbr_TwentyTwentyPlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TopMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:TwentyTwentyPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-05-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-05-08_ltbr_BottomMember_us-gaap_SubsequentEventMember_ltbr_TwentyTwentyPlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:BottomMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:TwentyTwentyPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-05-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-05-08_ltbr_TopMember_us-gaap_SubsequentEventMember_ltbr_ArticlesOfIncorporationMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TopMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:ArticlesOfIncorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-05-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-05-08_ltbr_BottomMember_us-gaap_SubsequentEventMember_ltbr_ArticlesOfIncorporationMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:BottomMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:ArticlesOfIncorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-05-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-04-03_us-gaap_SubsequentEventMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-04-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2025-04-01to2025-04-03_us-gaap_SubsequentEventMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-04-01to2025-05-12_us-gaap_SubsequentEventMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-05-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_ltbr_CODMMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">ltbr:CODMMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_ltbr_CODMMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">ltbr:CODMMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-02-01to2025-02-26_ltbr_TwoThousandTwentyEquityIncentivePlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-01</xbrli:startDate><xbrli:endDate>2025-02-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_ltbr_AvailableForSaleSecuritiesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ltbr:AvailableForSaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_ltbr_AvailableForSaleSecuritiesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ltbr:AvailableForSaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-02-01to2024-02-27_ltbr_TwoThousandTwentyEquityIncentivePlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-01</xbrli:startDate><xbrli:endDate>2024-02-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-03-31_ltbr_TwoThousandTwentyEquityIncentivePlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_ltbr_TwoThousandTwentyEquityIncentivePlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-12-04_srt_BoardOfDirectorsChairmanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2024-03-01to2024-03-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-01</xbrli:startDate><xbrli:endDate>2024-03-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-11-01to2024-11-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-01</xbrli:startDate><xbrli:endDate>2024-11-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-03-01to2025-03-24_ltbr_TwentyTwentyFiveTransactionsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TwentyTwentyFiveTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-03-01</xbrli:startDate><xbrli:endDate>2025-03-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-03-01to2025-03-14_ltbr_TwentyTwentyFiveTransactionsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TwentyTwentyFiveTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-03-01</xbrli:startDate><xbrli:endDate>2025-03-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-03-31_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockUnitsRSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_ltbr_RestrictedStockAwardsSummaryMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:RestrictedStockAwardsSummaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_srt_BoardOfDirectorsChairmanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_srt_BoardOfDirectorsChairmanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2023-11-20_srt_BoardOfDirectorsChairmanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-08-19_srt_BoardOfDirectorsChairmanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2024-08-01to2024-08-19_srt_BoardOfDirectorsChairmanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-08-01</xbrli:startDate><xbrli:endDate>2024-08-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_ltbr_CommonShareIssuancesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">ltbr:CommonShareIssuancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_ltbr_CommonShareIssuancesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">ltbr:CommonShareIssuancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2019-05-01to2019-05-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-05-01</xbrli:startDate><xbrli:endDate>2019-05-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_ltbr_RestrictedStockAwardsSummaryMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:RestrictedStockAwardsSummaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-02-26_ltbr_BoardOfDirectorsMember_ltbr_BottomMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ltbr:BoardOfDirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:BottomMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-02-26_ltbr_BoardOfDirectorsMember_ltbr_TopMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ltbr:BoardOfDirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TopMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-03-31_ltbr_TwentyTwentyFiveTransactionsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TwentyTwentyFiveTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-03-31_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockUnitsRSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-12-31_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockUnitsRSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-03-31_ltbr_PrepaidExpenseAndOtherCurrentAssetMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">ltbr:PrepaidExpenseAndOtherCurrentAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_ltbr_PrepaidExpenseAndOtherCurrentAssetMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">ltbr:PrepaidExpenseAndOtherCurrentAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_ltbr_OptionsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:OptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-03-31_ltbr_RestrictedStockAwardsSummaryMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:RestrictedStockAwardsSummaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-03-31_ltbr_RestrictedStockAwardsSummaryMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:RestrictedStockAwardsSummaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2024-12-01to2024-12-04_srt_BoardOfDirectorsChairmanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-12-01</xbrli:startDate><xbrli:endDate>2024-12-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2023-11-01to2023-11-20_srt_BoardOfDirectorsChairmanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-01</xbrli:startDate><xbrli:endDate>2023-11-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-02-03to2025-02-27_ltbr_SeriesXPreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ltbr:SeriesXPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-03</xbrli:startDate><xbrli:endDate>2025-02-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-02-27_ltbr_SeriesXPreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ltbr:SeriesXPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-12-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_ltbr_TwentyTwentyFiveTransactionsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TwentyTwentyFiveTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-03-01to2025-03-12_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockUnitsRSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-03-01</xbrli:startDate><xbrli:endDate>2025-03-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockUnitsRSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_us-gaap_GeneralAndAdministrativeExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_us-gaap_GeneralAndAdministrativeExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_us-gaap_ResearchAndDevelopmentExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_us-gaap_ResearchAndDevelopmentExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-03-31_ltbr_RestrictedStockAwardMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockAwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_ltbr_RestrictedStockAwardMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockAwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-12-31_ltbr_RestrictedStockAwardMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockAwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_ltbr_FEEdMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:FEEdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_ltbr_FEEdMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:FEEdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-12-01to2024-12-31_ltbr_CANDUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:CANDUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-12-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2023-10-16_ltbr_CANDUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:CANDUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_ltbr_CANDUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:CANDUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_ltbr_CANDUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:CANDUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_ltbr_StrategicPartnershipProjectAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:StrategicPartnershipProjectAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_ltbr_CRADAMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:CRADAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_ltbr_INLMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:INLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-01-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-01-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_ltbr_BattelleEnergyAllianceLLCMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ltbr:BattelleEnergyAllianceLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2023-05-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_ltbr_MaxiimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:MaxiimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-12-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-03-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2023-05-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_ltbr_MiniimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:MiniimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2022-12-31_ltbr_BattelleEnergyAllianceLLCMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ltbr:BattelleEnergyAllianceLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_ltbr_INLMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:INLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-03-31_ltbr_TreasuryBillsLevelThreeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ltbr:TreasuryBillsLevelThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-12-31_ltbr_TreasuryBillsLevelThreeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ltbr:TreasuryBillsLevelThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-03-31_ltbr_TreasuryBillsLevelTwoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ltbr:TreasuryBillsLevelTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-12-31_ltbr_TreasuryBillsLevelTwoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ltbr:TreasuryBillsLevelTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-03-31_ltbr_TreasuryBillsLevelOneMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ltbr:TreasuryBillsLevelOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-12-31_ltbr_TreasuryBillsLevelOneMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ltbr:TreasuryBillsLevelOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-03-31_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-03-31_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-03-31_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-12-31_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-12-31_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-03-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-03-31_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-03-31_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-03-31_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2023-12-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2023-12-31_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2023-12-31_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-12-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-03-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-05-01"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-05-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="Shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="USDPShares"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="Pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit></ix:resources></ix:header></div><table style="font-size:1px;width:100%"><tbody><tr><td style="BORDER-BOTTOM: 5px solid;"/></tr><tr><td style="BORDER-BOTTOM: 2px solid;"/></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>UNITED STATES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>SECURITIES AND EXCHANGE COMMISSION </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>WASHINGTON, D.C. 20549</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="font-size:18pt">FORM <ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:DocumentType" id="ixv-7676">10-Q</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Mark One)</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="ixv-7677">&#9746;</ix:nonNumeric></p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">For the quarterly period ended: <strong><span style="text-decoration:underline"><ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:DocumentPeriodEndDate" format="ixt:datemonthdayyearen" id="ixv-7678">March 31, 2025</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="ixv-7679">&#9744;</ix:nonNumeric></p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">For the transition period from _____________ to _____________</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Commission File Number: <strong><span style="text-decoration:underline"><ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:EntityFileNumber" id="ixv-7680">001-34487</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:60%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="font-size:18pt"><ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:EntityRegistrantName" id="ixv-7681">LIGHTBRIDGE CORPORATION</ix:nonNumeric></span></strong></p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Exact name of registrant as specified in its charter)</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:85%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:45%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="ixv-7682">Nevada</ix:nonNumeric></strong></p></td><td style="width:10%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:45%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:EntityTaxIdentificationNumber" id="ixv-7683">91-1975651</ix:nonNumeric></strong></p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><em>(State or other jurisdiction of incorporation or organization)</em></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><em>(I.R.S. Employer Identification No.)</em></p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="text-decoration:underline"><ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:EntityAddressAddressLine1" id="ixv-7684">11710 Plaza America Drive</ix:nonNumeric>, <ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:EntityAddressAddressLine2" id="ixv-7685">Suite 2000</ix:nonNumeric> <ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:EntityAddressCityOrTown" id="ixv-7686">Reston</ix:nonNumeric>, <ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:EntityAddressStateOrProvince" id="ixv-7687">VA</ix:nonNumeric> <ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:EntityAddressPostalZipCode" id="ixv-7688">20190</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><em>(Address of principal executive offices, Zip Code)</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="text-decoration:underline">(<ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:CityAreaCode" id="ixv-7689">571</ix:nonNumeric>) <ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:LocalPhoneNumber" id="ixv-7690">730-1200</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><em>(Registrant&#8217;s telephone number, including area code)</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Securities registered pursuant to Section 12(b) of the Act:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:30%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Title of Each Class:</p></td><td style="width:5%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:30%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Trading Symbol(s):</p></td><td style="width:5%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:30%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Name of Each Exchange on Which Registered:</p></td></tr><tr style="height:15px"><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:Security12bTitle" id="ixv-7691">Common Stock, $0.001 par value</ix:nonNumeric></strong></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:TradingSymbol" id="ixv-7692">LTBR</ix:nonNumeric></strong></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>The <ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="ixv-7693">Nasdaq</ix:nonNumeric> Capital Market</strong></p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:EntityCurrentReportingStatus" id="ixv-7694">Yes</ix:nonNumeric> &#9746;&#160;&#160; &#160;No &#9744;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:EntityInteractiveDataCurrent" id="ixv-7695">Yes</ix:nonNumeric> &#9746;&#160;&#160; &#160;No &#9744;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:85%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:30%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Large Accelerated Filer</p></td><td style="width:20%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9744;</p></td><td style="width:30%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accelerated Filer</p></td><td style="width:20%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9744;</p></td></tr><tr style="height:15px"><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="ixv-7696">Non- accelerated Filer</ix:nonNumeric></p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9746;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Smaller reporting company</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="ixv-7697">&#9746;</ix:nonNumeric></p></td></tr><tr style="height:15px"><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Emerging growth company</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="ixv-7698">&#9744;</ix:nonNumeric></p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes <ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="ixv-7699">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;No &#9746;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The number of shares outstanding of the issuer&#8217;s common stock, as of May 1, 2025 is as follows: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Class of Securities</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Shares Outstanding</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:Security12bTitle" id="ixv-7700">Common Stock, $0.001 par value</ix:nonNumeric></strong></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonFraction contextRef="AsOf2025-05-01" name="dei:EntityCommonStockSharesOutstanding" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-7701">22,538,160</ix:nonFraction></p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="font-size:1px;width:100%"><tbody><tr><td style="BORDER-BOTTOM: 2px solid;"/></tr><tr><td style="BORDER-BOTTOM: 5px solid;"/></tr></tbody></table><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px;background-color:#ffffff"><td style="TEXT-INDENT: 0px;"/></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td>&#160;</td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="TOC">LIGHTBRIDGE CORPORATION</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>FORM 10-Q</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>MARCH 31, 2025</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:7%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:top;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Page</strong></p></td><td colspan="2" style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><a href="#p1">PART I - FINANCIAL INFORMATION</a></strong></p></td><td colspan="2"/><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="#i1">Item 1.</a></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="#i1">Condensed Consolidated Financial Statements (unaudited)</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">3</p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="#bs">Unaudited Condensed Consolidated Balance Sheets as of March 31, 2025 and December 31, 2024</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">3</p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="#ccso">Unaudited Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2025 and 2024</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">4</p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="#equity">Unaudited Condensed Consolidated Statements of Changes in Stockholders&#8217; Equity for the Three Months Ended March 31, 2025 and 2024</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">5</p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="#cf">Unaudited Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2025 and 2024</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">6</p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="#notes">Notes to Condensed Consolidated Financial Statements (unaudited)</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">7</p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="#forward">Forward-Looking Statements</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">17</p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="#i2">Item 2.</a></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="#i2">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">19</p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="#i3">Item 3.</a></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="#i3">Quantitative and Qualitative Disclosures About Market Risk</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">26</p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="#i4">Item 4.</a></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="#i4">Controls and Procedures</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">26</p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="#p2"><strong>PART II - OTHER INFORMATION</strong></a></p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="#p2i1">Item 1.</a></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="#p2i1">Legal Proceedings</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">27</p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="#p2i1a">Item 1A.</a></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="#p2i1a">Risk Factors</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">27</p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="#p2i2">Item 2.</a></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="#p2i2">Unregistered Sales of Equity Securities and Use of Proceeds</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">27</p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="#p2i3">Item 3.</a></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="#p2i3">Defaults Upon Senior Securities</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">27</p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="#p2i4">Item 4.</a></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="#p2i4">Mine Safety Disclosures</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">27</p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="#p2i5">Item 5.</a></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="#p2i5">Other Information</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">28</p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="#p2i6">Item 6.</a></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="#p2i6">Exhibits</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">29</p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#sig">SIGNATURES</a></p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">30</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">2</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOC">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="p1">PART I-FINANCIAL INFORMATION</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span class="atag" style="display: inline" id="i1"><strong>ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</strong></span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>LIGHTBRIDGE CORPORATION</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><span class="atag" style="display: inline" id="bs"><strong>UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS</strong></span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td colspan="8" style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>ASSETS</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Current Assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Cash and cash equivalents</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_2" contextRef="AsOf2025-03-31" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:numdotdecimal" decimals="0" unitRef="USD">56,929,988</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_3" contextRef="AsOf2024-12-31" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:numdotdecimal" decimals="0" unitRef="USD">39,990,827</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Prepaid expenses and other current assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_4" contextRef="AsOf2025-03-31" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:numdotdecimal" decimals="0" unitRef="USD">546,267</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_5" contextRef="AsOf2024-12-31" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:numdotdecimal" decimals="0" unitRef="USD">324,378</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 22.5pt">Total Current Assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_6" contextRef="AsOf2025-03-31" name="us-gaap:AssetsCurrent" format="ixt:numdotdecimal" decimals="0" unitRef="USD">57,476,255</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_7" contextRef="AsOf2024-12-31" name="us-gaap:AssetsCurrent" format="ixt:numdotdecimal" decimals="0" unitRef="USD">40,315,205</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Other Assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Prepaid project costs and other long-term assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_9" contextRef="AsOf2025-03-31" name="us-gaap:PrepaidExpenseAndOtherAssets" format="ixt:numdotdecimal" decimals="0" unitRef="USD">702,562</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_10" contextRef="AsOf2024-12-31" name="us-gaap:PrepaidExpenseAndOtherAssets" format="ixt:numdotdecimal" decimals="0" unitRef="USD">528,805</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Trademarks</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_11" contextRef="AsOf2025-03-31" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:numdotdecimal" decimals="0" unitRef="USD">108,865</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_12" contextRef="AsOf2024-12-31" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:numdotdecimal" decimals="0" unitRef="USD">108,865</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total Assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_13" contextRef="AsOf2025-03-31" name="us-gaap:Assets" format="ixt:numdotdecimal" decimals="0" unitRef="USD">58,287,682</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_14" contextRef="AsOf2024-12-31" name="us-gaap:Assets" format="ixt:numdotdecimal" decimals="0" unitRef="USD">40,952,875</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td colspan="9" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</strong></p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Current Liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Accounts payable and accrued liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_17" contextRef="AsOf2025-03-31" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:numdotdecimal" decimals="0" unitRef="USD">966,209</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_18" contextRef="AsOf2024-12-31" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:numdotdecimal" decimals="0" unitRef="USD">424,585</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 22.5pt">Total Current Liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_19" contextRef="AsOf2025-03-31" name="us-gaap:LiabilitiesCurrent" format="ixt:numdotdecimal" decimals="0" unitRef="USD">966,209</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_20" contextRef="AsOf2024-12-31" name="us-gaap:LiabilitiesCurrent" format="ixt:numdotdecimal" decimals="0" unitRef="USD">424,585</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Commitments and contingencies - Note 5</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Stockholders&#8217; Equity</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Preferred stock, $<ix:nonFraction id="fid_35" contextRef="AsOf2025-03-31" name="us-gaap:PreferredStockParOrStatedValuePerShare" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction> par value, <ix:nonFraction id="fid_37" contextRef="AsOf2025-03-31" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">10,000,000</ix:nonFraction> authorized shares, <ix:nonFraction id="fid_39" contextRef="AsOf2025-03-31" name="us-gaap:PreferredStockSharesIssued" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">1</ix:nonFraction> share and <ix:nonFraction id="fid_41" contextRef="AsOf2024-12-31" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_23" contextRef="AsOf2025-03-31" name="us-gaap:PreferredStockValue" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_24" contextRef="AsOf2024-12-31" name="us-gaap:PreferredStockValue" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Common stock, $<ix:nonFraction id="fid_43" contextRef="AsOf2025-03-31" name="us-gaap:CommonStockParOrStatedValuePerShare" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction> par value, <ix:nonFraction id="fid_45" contextRef="AsOf2025-03-31" name="us-gaap:CommonStockSharesAuthorized" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">25,000,000</ix:nonFraction> authorized, <ix:nonFraction id="fid_47" contextRef="AsOf2024-12-31" name="us-gaap:CommonStockSharesIssued" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">21,557,343</ix:nonFraction> shares and <ix:nonFraction id="fid_49" contextRef="AsOf2024-12-31" name="us-gaap:CommonStockSharesOutstanding" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">18,783,912</ix:nonFraction> shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_25" contextRef="AsOf2025-03-31" name="us-gaap:CommonStockValue" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,557</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_26" contextRef="AsOf2024-12-31" name="us-gaap:CommonStockValue" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,784</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Additional paid-in capital</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_27" contextRef="AsOf2025-03-31" name="us-gaap:AdditionalPaidInCapital" format="ixt:numdotdecimal" decimals="0" unitRef="USD">226,255,770</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_28" contextRef="AsOf2024-12-31" name="us-gaap:AdditionalPaidInCapital" format="ixt:numdotdecimal" decimals="0" unitRef="USD">204,694,348</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Accumulated deficit</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_29" contextRef="AsOf2025-03-31" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:numdotdecimal" decimals="0" unitRef="USD" sign="-">168,955,854</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_30" contextRef="AsOf2024-12-31" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:numdotdecimal" decimals="0" unitRef="USD" sign="-">164,184,842</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 22.5pt">Total Stockholders&#8217; Equity</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_31" contextRef="AsOf2025-03-31" name="us-gaap:StockholdersEquity" format="ixt:numdotdecimal" decimals="0" unitRef="USD">57,321,473</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_32" contextRef="AsOf2024-12-31" name="us-gaap:StockholdersEquity" format="ixt:numdotdecimal" decimals="0" unitRef="USD">40,528,290</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total Liabilities and Stockholders&#8217; Equity</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_33" contextRef="AsOf2025-03-31" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:numdotdecimal" decimals="0" unitRef="USD">58,287,682</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_34" contextRef="AsOf2024-12-31" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:numdotdecimal" decimals="0" unitRef="USD">40,952,875</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td colspan="9" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">3</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOC">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>LIGHTBRIDGE CORPORATION</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><span class="atag" style="display: inline" id="ccso"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</strong></span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"><strong>Three Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"><strong>March</strong><strong> 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_51" contextRef="From2025-01-01to2025-03-31" name="us-gaap:Revenues" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_52" contextRef="From2024-01-01to2024-03-31" name="us-gaap:Revenues" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Operating Expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">General and administrative</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_54" contextRef="From2025-01-01to2025-03-31" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,480,010</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_55" contextRef="From2024-01-01to2024-03-31" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,157,745</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Research and development</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_56" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,665,913</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_57" contextRef="From2024-01-01to2024-03-31" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,023,823</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total Operating Expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_58" contextRef="From2025-01-01to2025-03-31" name="us-gaap:OperatingExpenses" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,145,923</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_59" contextRef="From2024-01-01to2024-03-31" name="us-gaap:OperatingExpenses" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,181,568</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Operating Loss</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_60" contextRef="From2025-01-01to2025-03-31" name="us-gaap:OperatingIncomeLoss" format="ixt:numdotdecimal" decimals="0" unitRef="USD" sign="-">5,145,923</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_61" contextRef="From2024-01-01to2024-03-31" name="us-gaap:OperatingIncomeLoss" format="ixt:numdotdecimal" decimals="0" unitRef="USD" sign="-">3,181,568</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Other Income</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Interest income</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_63" contextRef="From2025-01-01to2025-03-31" name="us-gaap:InterestIncomeOther" format="ixt:numdotdecimal" decimals="0" unitRef="USD">374,911</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_64" contextRef="From2024-01-01to2024-03-31" name="us-gaap:InterestIncomeOther" format="ixt:numdotdecimal" decimals="0" unitRef="USD">361,984</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total Other Income</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_65" contextRef="From2025-01-01to2025-03-31" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:numdotdecimal" decimals="0" unitRef="USD">374,911</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_66" contextRef="From2024-01-01to2024-03-31" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:numdotdecimal" decimals="0" unitRef="USD">361,984</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Loss Before Income Taxes</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_67" contextRef="From2025-01-01to2025-03-31" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:numdotdecimal" decimals="0" unitRef="USD" sign="-">4,771,012</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_68" contextRef="From2024-01-01to2024-03-31" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:numdotdecimal" decimals="0" unitRef="USD" sign="-">2,819,584</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Income taxes</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_69" contextRef="From2025-01-01to2025-03-31" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_70" contextRef="From2024-01-01to2024-03-31" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Loss</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_71" contextRef="From2025-01-01to2025-03-31" name="us-gaap:NetIncomeLoss" format="ixt:numdotdecimal" decimals="0" unitRef="USD" sign="-">4,771,012</ix:nonFraction> </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_72" contextRef="From2024-01-01to2024-03-31" name="us-gaap:NetIncomeLoss" format="ixt:numdotdecimal" decimals="0" unitRef="USD" sign="-">2,819,584</ix:nonFraction> </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Loss Per Common Share</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Basic and diluted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_74" contextRef="From2025-01-01to2025-03-31" name="us-gaap:EarningsPerShareDiluted" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" sign="-">0.24</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_75" contextRef="From2024-01-01to2024-03-31" name="us-gaap:EarningsPerShareDiluted" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" sign="-">0.21</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Weighted Average Number of Common Shares Outstanding</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_76" contextRef="From2025-01-01to2025-03-31" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">19,547,312</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_77" contextRef="From2024-01-01to2024-03-31" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">13,491,954</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td colspan="9"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td colspan="9" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">4</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOC">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>LIGHTBRIDGE CORPORATION</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="equity">UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS&#8217; EQUITY&#160;</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>FOR THE THREE MONTHS ENDED MARCH 31, 2025 AND 2024</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Additional</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Total</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Common Stock</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Paid-in</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Accumulated</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Stockholders&#8217;</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Amount</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Capital</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Deficit</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Equity</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance - January 1, 2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_149" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" name="us-gaap:SharesIssued" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">13,698,274</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_79" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" name="us-gaap:StockholdersEquity" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,698</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_80" contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:StockholdersEquity" format="ixt:numdotdecimal" decimals="0" unitRef="USD">181,295,125</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_81" contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember" name="us-gaap:StockholdersEquity" format="ixt:numdotdecimal" decimals="0" unitRef="USD" sign="-">152,397,776</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_82" contextRef="AsOf2023-12-31" name="us-gaap:StockholdersEquity" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,911,047</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Shares issued - registered offerings - net of offering costs of $155,686</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_83" contextRef="From2024-01-01to2024-03-31_us-gaap_CommonStockMember" name="ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">427,300</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_84" contextRef="From2024-01-01to2024-03-31_us-gaap_CommonStockMember" name="ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" format="ixt:numdotdecimal" decimals="0" unitRef="USD">428</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_85" contextRef="From2024-01-01to2024-03-31_us-gaap_AdditionalPaidInCapitalMember" name="ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,221,554</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_86" contextRef="From2024-01-01to2024-03-31_us-gaap_RetainedEarningsMember" name="ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_87" contextRef="From2024-01-01to2024-03-31" name="ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,221,982</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Shares issued to consultant &amp; directors for services</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_88" contextRef="From2024-01-01to2024-03-31_us-gaap_CommonStockMember" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">64,206</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_89" contextRef="From2024-01-01to2024-03-31_us-gaap_CommonStockMember" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" format="ixt:numdotdecimal" decimals="0" unitRef="USD">64</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_90" contextRef="From2024-01-01to2024-03-31_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" format="ixt:numdotdecimal" decimals="0" unitRef="USD">254,936</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_91" contextRef="From2024-01-01to2024-03-31_us-gaap_RetainedEarningsMember" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_92" contextRef="From2024-01-01to2024-03-31" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" format="ixt:numdotdecimal" decimals="0" unitRef="USD">255,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Stock-based compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_93" contextRef="From2024-01-01to2024-03-31_us-gaap_CommonStockMember" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_94" contextRef="From2024-01-01to2024-03-31_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:numdotdecimal" decimals="0" unitRef="USD">456,904</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_95" contextRef="From2024-01-01to2024-03-31_us-gaap_RetainedEarningsMember" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_96" contextRef="From2024-01-01to2024-03-31" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:numdotdecimal" decimals="0" unitRef="USD">456,904</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net loss for the three months ended March 31, 2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_97" contextRef="From2024-01-01to2024-03-31_us-gaap_CommonStockMember" name="us-gaap:NetIncomeLoss" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_98" contextRef="From2024-01-01to2024-03-31_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:NetIncomeLoss" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_99" contextRef="From2024-01-01to2024-03-31_us-gaap_RetainedEarningsMember" name="us-gaap:NetIncomeLoss" format="ixt:numdotdecimal" decimals="0" unitRef="USD" sign="-">2,819,584</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_100" contextRef="From2024-01-01to2024-03-31" name="us-gaap:NetIncomeLoss" format="ixt:numdotdecimal" decimals="0" unitRef="USD" sign="-">2,819,584</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance - March 31, 2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_101" contextRef="AsOf2024-03-31_us-gaap_CommonStockMember" name="us-gaap:SharesIssued" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">14,189,780</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_102" contextRef="AsOf2024-03-31_us-gaap_CommonStockMember" name="us-gaap:StockholdersEquity" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,190</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_103" contextRef="AsOf2024-03-31_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:StockholdersEquity" format="ixt:numdotdecimal" decimals="0" unitRef="USD">183,228,519</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_104" contextRef="AsOf2024-03-31_us-gaap_RetainedEarningsMember" name="us-gaap:StockholdersEquity" format="ixt:numdotdecimal" decimals="0" unitRef="USD" sign="-">155,217,360</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_105" contextRef="AsOf2024-03-31" name="us-gaap:StockholdersEquity" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,025,349</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Additional</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Total</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Common Stock</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Paid-in</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Accumulated</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td/><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Stockholders&#8217;</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Amount</strong></p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Capital</strong></p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Deficit</strong></p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Equity</strong></p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance - January 1, 2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_106" contextRef="AsOf2024-12-31_us-gaap_CommonStockMember" name="us-gaap:SharesIssued" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">18,783,912</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_107" contextRef="AsOf2024-12-31_us-gaap_CommonStockMember" name="us-gaap:StockholdersEquity" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,784</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_108" contextRef="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:StockholdersEquity" format="ixt:numdotdecimal" decimals="0" unitRef="USD">204,694,348</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_109" contextRef="AsOf2024-12-31_us-gaap_RetainedEarningsMember" name="us-gaap:StockholdersEquity" format="ixt:numdotdecimal" decimals="0" unitRef="USD" sign="-">164,184,842</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_110" contextRef="AsOf2024-12-31" name="us-gaap:StockholdersEquity" format="ixt:numdotdecimal" decimals="0" unitRef="USD">40,528,290</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Restricted shares awards issued</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_111" contextRef="From2025-01-01to2025-03-31_us-gaap_CommonStockMember" name="ltbr:RestrictedSharesAwardsIssuedShares" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">57,940</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_112" contextRef="From2025-01-01to2025-03-31_us-gaap_CommonStockMember" name="ltbr:RestrictedSharesAwardsIssuedAmount" format="ixt:numdotdecimal" decimals="0" unitRef="USD">58</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_113" contextRef="From2025-01-01to2025-03-31_us-gaap_AdditionalPaidInCapitalMember" name="ltbr:RestrictedSharesAwardsIssuedAmount" format="ixt:numdotdecimal" decimals="0" unitRef="USD" sign="-">58</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_114" contextRef="From2025-01-01to2025-03-31_us-gaap_RetainedEarningsMember" name="ltbr:RestrictedSharesAwardsIssuedAmount" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_115" contextRef="From2025-01-01to2025-03-31" name="ltbr:RestrictedSharesAwardsIssuedAmount" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Share settlement for withholding taxes paid upon vesting of restricted stock awards</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_116" contextRef="From2025-01-01to2025-03-31_us-gaap_CommonStockMember" name="ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares" format="ixt:numdotdecimal" decimals="0" unitRef="Shares" sign="-">25,148</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_117" contextRef="From2025-01-01to2025-03-31_us-gaap_CommonStockMember" name="ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount" format="ixt:numdotdecimal" decimals="0" unitRef="USD" sign="-">25</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_118" contextRef="From2025-01-01to2025-03-31_us-gaap_AdditionalPaidInCapitalMember" name="ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount" format="ixt:numdotdecimal" decimals="0" unitRef="USD">194,853</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_119" contextRef="From2025-01-01to2025-03-31_us-gaap_RetainedEarningsMember" name="ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_120" contextRef="From2025-01-01to2025-03-31" name="ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount" format="ixt:numdotdecimal" decimals="0" unitRef="USD" sign="-">194,878</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Shares issued - registered offerings - net of offering costs of $657,914</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_121" contextRef="From2025-01-01to2025-03-31_us-gaap_CommonStockMember" name="ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">2,605,619</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_122" contextRef="From2025-01-01to2025-03-31_us-gaap_CommonStockMember" name="ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,605</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_123" contextRef="From2025-01-01to2025-03-31_us-gaap_AdditionalPaidInCapitalMember" name="ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,210,590</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_124" contextRef="From2025-01-01to2025-03-31_us-gaap_RetainedEarningsMember" name="ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_125" contextRef="From2025-01-01to2025-03-31" name="ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,213,195</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Shares issued to consultant &amp; directors for services</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_126" contextRef="From2025-01-01to2025-03-31_us-gaap_CommonStockMember" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">89,086</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_127" contextRef="From2025-01-01to2025-03-31_us-gaap_CommonStockMember" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" format="ixt:numdotdecimal" decimals="0" unitRef="USD">89</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_128" contextRef="From2025-01-01to2025-03-31_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,911</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_129" contextRef="From2025-01-01to2025-03-31_us-gaap_RetainedEarningsMember" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_130" contextRef="From2025-01-01to2025-03-31" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Shares issued through the exercise of options</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_131" contextRef="From2025-01-01to2025-03-31_us-gaap_CommonStockMember" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">45,934</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_132" contextRef="From2025-01-01to2025-03-31_us-gaap_CommonStockMember" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:numdotdecimal" decimals="0" unitRef="USD">46</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_133" contextRef="From2025-01-01to2025-03-31_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:numdotdecimal" decimals="0" unitRef="USD">220,651</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_134" contextRef="From2025-01-01to2025-03-31_us-gaap_RetainedEarningsMember" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_135" contextRef="From2025-01-01to2025-03-31" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:numdotdecimal" decimals="0" unitRef="USD">220,697</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Stock-based compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_136" contextRef="From2025-01-01to2025-03-31_us-gaap_CommonStockMember" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_137" contextRef="From2025-01-01to2025-03-31_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,295,181</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_138" contextRef="From2025-01-01to2025-03-31_us-gaap_RetainedEarningsMember" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_139" contextRef="From2025-01-01to2025-03-31" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,295,181</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net loss for the three months ended March 31, 2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_140" contextRef="From2025-01-01to2025-03-31_us-gaap_CommonStockMember" name="us-gaap:NetIncomeLoss" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_141" contextRef="From2025-01-01to2025-03-31_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:NetIncomeLoss" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_142" contextRef="From2025-01-01to2025-03-31_us-gaap_RetainedEarningsMember" name="us-gaap:NetIncomeLoss" format="ixt:numdotdecimal" decimals="0" unitRef="USD" sign="-">4,771,012</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_143" contextRef="From2025-01-01to2025-03-31" name="us-gaap:NetIncomeLoss" format="ixt:numdotdecimal" decimals="0" unitRef="USD" sign="-">4,771,012</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance - March 31, 2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_144" contextRef="AsOf2025-03-31_us-gaap_CommonStockMember" name="us-gaap:SharesIssued" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">21,557,343</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_145" contextRef="AsOf2025-03-31_us-gaap_CommonStockMember" name="us-gaap:StockholdersEquity" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,557</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_146" contextRef="AsOf2025-03-31_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:StockholdersEquity" format="ixt:numdotdecimal" decimals="0" unitRef="USD">226,255,770</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_147" contextRef="AsOf2025-03-31_us-gaap_RetainedEarningsMember" name="us-gaap:StockholdersEquity" format="ixt:numdotdecimal" decimals="0" unitRef="USD" sign="-">168,955,854</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_148" contextRef="AsOf2025-03-31" name="us-gaap:StockholdersEquity" format="ixt:numdotdecimal" decimals="0" unitRef="USD">57,321,473</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td colspan="21" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">5</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOC">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>LIGHTBRIDGE CORPORATION</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><span class="atag" style="display: inline" id="cf"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</strong></span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three Months Ended</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Operating Activities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Net Loss</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_151" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ProfitLoss" format="ixt:numdotdecimal" decimals="0" unitRef="USD" sign="-">4,771,012</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_152" contextRef="From2024-01-01to2024-03-31" name="us-gaap:ProfitLoss" format="ixt:numdotdecimal" decimals="0" unitRef="USD" sign="-">2,819,584</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Adjustments to reconcile net loss to net cash used in operating activities:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Stock-based compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_154" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ShareBasedCompensation" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,355,181</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_155" contextRef="From2024-01-01to2024-03-31" name="us-gaap:ShareBasedCompensation" format="ixt:numdotdecimal" decimals="0" unitRef="USD">456,904</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Changes in operating assets and liabilities:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Prepaid expenses and other current assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_157" contextRef="From2025-01-01to2025-03-31" name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" format="ixt:numdotdecimal" decimals="0" unitRef="USD">266,889</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_158" contextRef="From2024-01-01to2024-03-31" name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" format="ixt:numdotdecimal" decimals="0" unitRef="USD">194,796</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Prepaid project costs and other long-term assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_159" contextRef="From2025-01-01to2025-03-31" name="ltbr:IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets" format="ixt:numdotdecimal" decimals="0" unitRef="USD">173,757</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_160" contextRef="From2024-01-01to2024-03-31" name="ltbr:IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets" format="ixt:numdotdecimal" decimals="0" unitRef="USD" sign="-">3,375</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Accounts payable and accrued liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_161" contextRef="From2025-01-01to2025-03-31" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:numdotdecimal" decimals="0" unitRef="USD">556,624</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_162" contextRef="From2024-01-01to2024-03-31" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:numdotdecimal" decimals="0" unitRef="USD">676,095</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Cash Used in Operating Activities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_163" contextRef="From2025-01-01to2025-03-31" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:numdotdecimal" decimals="0" unitRef="USD" sign="-">3,299,853</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_164" contextRef="From2024-01-01to2024-03-31" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:numdotdecimal" decimals="0" unitRef="USD" sign="-">1,878,006</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Cash Used in Investing Activities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_165" contextRef="From2025-01-01to2025-03-31" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_166" contextRef="From2024-01-01to2024-03-31" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Financing Activities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Net proceeds from the issuances of common stock</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_168" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,213,195</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_169" contextRef="From2024-01-01to2024-03-31" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,221,982</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Net proceeds from the exercise of stock options</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_170" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:numdotdecimal" decimals="0" unitRef="USD">220,697</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_171" contextRef="From2024-01-01to2024-03-31" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Payments for taxes related to net share settlement of equity awards</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_172" contextRef="From2025-01-01to2025-03-31" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:numdotdecimal" decimals="0" unitRef="USD">194,878</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_173" contextRef="From2024-01-01to2024-03-31" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Cash Provided by Financing Activities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_174" contextRef="From2025-01-01to2025-03-31" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,239,014</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_175" contextRef="From2024-01-01to2024-03-31" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,221,982</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Increase (Decrease) in Cash and Cash Equivalents</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_176" contextRef="From2025-01-01to2025-03-31" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,939,161</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_177" contextRef="From2024-01-01to2024-03-31" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" format="ixt:numdotdecimal" decimals="0" unitRef="USD" sign="-">656,024</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash and Cash Equivalents, Beginning of Period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_178" contextRef="AsOf2024-12-31" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:numdotdecimal" decimals="0" unitRef="USD">39,990,827</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_179" contextRef="AsOf2023-12-31" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,598,445</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash and Cash Equivalents, End of Period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_180" contextRef="AsOf2025-03-31" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:numdotdecimal" decimals="0" unitRef="USD">56,929,988</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_181" contextRef="AsOf2024-03-31" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,942,421</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Supplemental Disclosure of Cash Flow Information</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash paid during the period:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Interest paid</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_184" contextRef="From2025-01-01to2025-03-31" name="us-gaap:InterestPaidNet" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_185" contextRef="From2024-01-01to2024-03-31" name="us-gaap:InterestPaidNet" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Income taxes paid</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_186" contextRef="From2025-01-01to2025-03-31" name="us-gaap:IncomeTaxesPaidNet" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_187" contextRef="From2024-01-01to2024-03-31" name="us-gaap:IncomeTaxesPaidNet" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Non-Cash Financing Activities:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Payment of accrued liabilities with common stock</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_189" contextRef="From2025-01-01to2025-03-31" name="ltbr:PaymentOfAccruedLiabilitiesWithCommonStock" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_190" contextRef="From2024-01-01to2024-03-31" name="ltbr:PaymentOfAccruedLiabilitiesWithCommonStock" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td colspan="9"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td colspan="9" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">6</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOC">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>LIGHTBRIDGE CORPORATION</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><span class="atag" style="display: inline" id="notes"><strong>NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</strong></span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><ix:nonNumeric id="fid_191" contextRef="From2025-01-01to2025-03-31" name="us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" escape="true" continuedAt="cont_2db4af"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 1. Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Nature of Operations and Basis of Presentation</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">When used in these notes, the terms &#8220;Lightbridge,&#8221; &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221; mean Lightbridge Corporation and all entities included in the condensed consolidated financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company was formed on October 6, 2006, when Thorium Power, Ltd., which was incorporated in the state of Nevada on February 2, 1999, merged with Thorium Power, Inc. (TPI), which was incorporated in the state of Delaware on January 8, 1992. On September 29, 2009, the Company changed its name from Thorium Power, Ltd. to Lightbridge Corporation and began its focus on developing and commercializing metallic nuclear fuels. The Company is a nuclear fuel technology company developing its nuclear fuel. The Company views its operations and manages its business as one business segment, which is the development and commercialization of its nuclear fuel. These unaudited condensed consolidated financial statements include the accounts of the Company, and the Company&#8217;s wholly-owned subsidiaries, TPI, a Delaware corporation, and Lightbridge International Holding LLC, a Delaware limited liability company. These wholly-owned subsidiaries are inactive, and all significant intercompany transactions and balances have been eliminated in consolidation.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The accompanying unaudited condensed consolidated financial statements of Lightbridge Corporation and its subsidiaries have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission, or the SEC, including the instructions to Form 10-Q and Regulation S-X. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America (GAAP), including a summary of the Company&#8217;s significant accounting policies, have been condensed or omitted from these statements pursuant to such rules and regulations and, accordingly, they do not include all the information and footnotes necessary for comprehensive condensed consolidated financial statements and should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2024, included in the Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on March 3, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In the opinion of the management of the Company, all adjustments, which are of a normal recurring nature, necessary for a fair statement of the results for the three-month period have been made. Results for the interim period presented are not necessarily indicative of the results that might be expected for the entire fiscal year.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Summary of Significant Accounting Policies</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Fair Value of Financial Instruments</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_202" contextRef="From2025-01-01to2025-03-31" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" escape="true" continuedAt="cont_b68976"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company determined fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between unaffiliated market participants at the measurement date.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounting Standards Codification (ASC), <em>Fair Value Measurement</em> (ASC 820), established a fair value hierarchy that prioritizes the inputs used to measure fair value. Assets and liabilities measured at fair value were categorized based on whether the inputs are observable in the market and the degree that the inputs are observable. The hierarchy gives the highest priority to active markets for identical assets and liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). The categorization of financial instruments within the valuation hierarchy was based on the lowest level of input that is significant to the fair value measurement. At the end of the reporting period, the Company reviews U.S. treasury instruments held to determine whether the securities are of the most recent issuance of that security with the same maturity (referred to as &#8220;on-the-run&#8221;, which is the most liquid version of the maturity band). If a U.S. treasury instrument held at the end of the reporting period was from the most recent issuance it is classified as level 1, otherwise it is referred to as &#8220;off-the-run&#8221; and is classified as level 2. The three levels of the fair value hierarchy were as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 1 - Observable inputs such as quoted prices in active markets for identical assets or liabilities;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 2 - Inputs other than quoted prices that were observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that were not active and inputs other than quoted prices that were observable for the asset or liability; and</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 3 - Unobservable inputs that reflect management&#8217;s assumptions.</p></ix:nonNumeric></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">7</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOC">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><ix:continuation id="cont_2db4af" continuedAt="cont_931318"><ix:continuation id="cont_b68976"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For disclosure purposes, assets and liabilities were classified in their entirety in the fair value hierarchy level based on the lowest level of input that was significant to the overall fair value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement required judgment and may have affected the placement within the fair value hierarchy levels.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company&#8217;s financial instruments consisted principally of cash and cash equivalents, accounts payable and accrued liabilities. The carrying amounts of cash, accounts payable and accrued liabilities are considered to be Level 1 measurements, because of the short-term nature of those instruments. Cash equivalents are primarily composed of US Treasury instruments having maturity dates of 30 to 90 days. The Company purchased $<ix:nonFraction id="fid_259" contextRef="From2025-01-01to2025-03-31" name="ltbr:InvestmentsInDebtSecuritiesPurchased" format="ixt:numdotdecimal" decimals="-6" unitRef="USD" scale="6">37</ix:nonFraction> million of US Treasury instruments for the three months ended March 31, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following table summarized the valuation of the Company&#8217;s financial instruments that fell within the fair value hierarchy (in millions) at March 31, 2025: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_213" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" escape="true" continuedAt="cont_435dde"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level I</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level II</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level III</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash and cash equivalents</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_245" contextRef="AsOf2025-03-31_ltbr_TreasuryBillsLevelOneMember" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">19.9</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_247" contextRef="AsOf2025-03-31_ltbr_TreasuryBillsLevelTwoMember" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">37.0</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_248" contextRef="AsOf2025-03-31_ltbr_TreasuryBillsLevelThreeMember" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:zerodash" decimals="-6" unitRef="USD" scale="6">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounts payable and accrued liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_251" contextRef="AsOf2025-03-31_ltbr_TreasuryBillsLevelOneMember" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">1.0</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_252" contextRef="AsOf2025-03-31_ltbr_TreasuryBillsLevelTwoMember" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" format="ixt:zerodash" decimals="-6" unitRef="USD" scale="6">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_253" contextRef="AsOf2025-03-31_ltbr_TreasuryBillsLevelThreeMember" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" format="ixt:zerodash" decimals="-6" unitRef="USD" scale="6">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following table summarized the valuation of the Company&#8217;s financial instruments that fell within the fair value hierarchy (in millions) at December 31, 2024: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:continuation id="cont_435dde"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level I</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level II</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level III</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash and cash equivalents</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_246" contextRef="AsOf2024-12-31_ltbr_TreasuryBillsLevelOneMember" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">40.0</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_249" contextRef="AsOf2024-12-31_ltbr_TreasuryBillsLevelTwoMember" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:zerodash" decimals="-6" unitRef="USD" scale="6">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_250" contextRef="AsOf2024-12-31_ltbr_TreasuryBillsLevelThreeMember" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:zerodash" decimals="-6" unitRef="USD" scale="6">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounts payable and accrued liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_254" contextRef="AsOf2024-12-31_ltbr_TreasuryBillsLevelOneMember" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.4</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_255" contextRef="AsOf2024-12-31_ltbr_TreasuryBillsLevelTwoMember" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" format="ixt:zerodash" decimals="-6" unitRef="USD" scale="6">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_256" contextRef="AsOf2024-12-31_ltbr_TreasuryBillsLevelThreeMember" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" format="ixt:zerodash" decimals="-6" unitRef="USD" scale="6">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:continuation></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Certain Risks and Uncertainties</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_203" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ConcentrationRiskCreditRisk" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company will need additional funding and/or in-kind support via a combination of strategic alliances, government grants, commercial loans, further offerings of equity securities, or an offering of debt securities in order to support its future research and development (R&amp;D) activities required to further enhance and complete the development and commercialization of its fuel products.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">There can be no assurance that the Company will be able to successfully continue to conduct its operations if there is a lack of financial resources available in the future to continue its fuel development activities, and a failure to do so would have a material adverse effect on the Company&#8217;s future R&amp;D activities, financial position, results of operations, and cash flows. Also, the success of the Company&#8217;s operations will be subject to other numerous contingencies, some of which are beyond management&#8217;s control. These contingencies include general and regional economic conditions, contingent liabilities, potential competition with other nuclear fuel developers, including those entities developing accident tolerant fuels (ATFs), changes in government regulations, risks related to the R&amp;D of the Lightbridge Fuel&#8482;, regulatory approval of the Company&#8217;s fuel, support for nuclear power, changes in accounting and taxation standards, inability to achieve overall short-term and long-term R&amp;D milestones toward commercialization, future impairment charges to the Company&#8217;s assets, and global or regional catastrophic events. The Company may also be subject to various additional political, economic, and other uncertainties.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company is engaged in significant research and development (R&amp;D) activities to advance its nuclear fuel technology at Idaho National Laboratory (INL). For the three months ended March 31, 2025, R&amp;D expenses associated with activities conducted at the INL accounted for approximately <ix:nonFraction id="fid_257" contextRef="From2025-01-01to2025-03-31_ltbr_INLMember" name="ltbr:ResearchAndDevelopmentPercentage" decimals="INF" unitRef="Pure" scale="-2">47</ix:nonFraction>% of the Company&#8217;s total R&amp;D expenditure. The Company currently relies on INL for developing, testing and evaluating its nuclear fuel. Any disruption in access to INL&#8217;s resources, including changes in government policies, facility downtime, regulatory constraints, or unforeseen operational challenges could have a material adverse effect on the Company&#8217;s current ability to advance its R&amp;D activities. </p></ix:nonNumeric></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">8</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOC">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><ix:continuation id="cont_931318"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Recent Accounting Pronouncements</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_212" contextRef="From2025-01-01to2025-03-31" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">ASU No. 2023-09, <em>Income Taxes (Topic 740): Improvements to Income Tax Disclosures</em>, was issued by the FASB in December 2023. This guidance enhances income tax disclosure requirements by mandating the disclosure of (1) specific categories in the rate reconciliation, (2) income or loss from continuing operations before income taxes, disaggregated between domestic and foreign, and (3) income tax expense or benefit from continuing operations, disaggregated by federal, state, and foreign. The ASU also requires disclosure of income tax payments to federal, state, local, and foreign jurisdictions, among other changes. The standard is effective for annual periods beginning after December 15, 2024, and will be adopted by the Company as permitted. The Company will apply the guidance on a prospective basis and the adoption is not expected to have a material impact on its condensed consolidated financial statements or related disclosures.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In November 2024, the FASB issued ASU No. 2024-03, <em>Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures</em> (Subtopic 220-40): <em>Disaggregation of Income Statement Expenses</em> (&#8220;ASU 2024-03&#8221;), which required disclosure of certain costs and expenses on an interim and annual basis in the notes to the consolidated financial statements. The guidance is effective for annual reporting periods beginning after December 15, 2026 and interim periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The guidance is to be applied either (1) prospectively to financial statements issued for reporting periods after the effective date or (2) retrospectively to any or all prior periods presented in the financial statements. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has evaluated other recently issued, but not yet effective, accounting standards that have been issued or proposed by the FASB or other standards-setting bodies through the filing date of these unaudited condensed consolidated financial statements and does not believe the future adoption of any such standards will have a material impact on the consolidated financial statements and related disclosures.</p></ix:nonNumeric></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_192" contextRef="From2025-01-01to2025-03-31" name="us-gaap:EarningsPerShareTextBlock" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 2. Net Loss Per Share</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Basic net loss per share is computed using the weighted-average number of common shares outstanding during the reporting period, except that it does not include unvested common shares subject to repurchase or cancellation. Diluted net loss per share is computed using the weighted-average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The outstanding securities noted below have been excluded from the computation of diluted weighted shares outstanding for the three months ended March 31, 2025 and 2024, as they would have been anti-dilutive due to the Company&#8217;s losses at March 31, 2025 and 2024 and also because the exercise price of certain of these outstanding securities was greater than the average closing price of the Company&#8217;s common stock.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_214" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three Months Ended</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Stock options outstanding</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_260" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">429,454</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_263" contextRef="From2024-01-01to2024-03-31" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">555,582</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Restricted stock awards outstanding</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_261" contextRef="From2025-01-01to2025-03-31" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">743,702</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_264" contextRef="From2024-01-01to2024-03-31" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">557,688</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_262" contextRef="From2025-01-01to2025-03-31" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">1,173,156</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_265" contextRef="From2024-01-01to2024-03-31" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">1,113,270</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:nonNumeric></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_193" contextRef="From2025-01-01to2025-03-31" name="ltbr:PrepaidProjectCostsDisclosureTextBlock" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 3. Prepaid Project Costs and Other Long-term Assets</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In 2022, the Company entered into two agreements with Idaho National Laboratory (INL), in collaboration with the Department of Energy (DOE), to support the development of Lightbridge Fuel&#8482;. At the time of signing, the Company made advance payments for future project work totaling $<ix:nonFraction id="fid_266" contextRef="AsOf2022-12-31_ltbr_BattelleEnergyAllianceLLCMember" name="us-gaap:PrepaidExpenseNoncurrent" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.4</ix:nonFraction> million to Battelle Energy Alliance, LLC (BEA), the DOE&#8217;s operating contractor for INL. In May 2023, the Company and INL modified the agreements to extend the contract term to May 2029, aligning it with the duration of the irradiation testing, and increasing the advance payments by $<ix:nonFraction id="fid_269" contextRef="AsOf2023-05-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_ltbr_MiniimumMember" name="us-gaap:PrepaidExpenseNoncurrent" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.1</ix:nonFraction> million to $<ix:nonFraction id="fid_268" contextRef="AsOf2023-05-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_ltbr_MaxiimumMember" name="ltbr:PrepaidProjectCostsAddition" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.5</ix:nonFraction> million. During the quarter ended March 31, 2025, the Company made additional advance payments of $<ix:nonFraction id="fid_271" contextRef="AsOf2025-03-31" name="ltbr:AdditionalPrepaidExpenseAndOtherAssetsCurrent" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.6</ix:nonFraction> million which subsequently offset $<ix:nonFraction id="fid_272" contextRef="From2025-01-01to2025-03-31" name="ltbr:OffsetOfProjectCosts" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.4</ix:nonFraction> million in project costs. As of March 31, 2025, and December 31, 2024, the Company&#8217;s prepaid project costs were $<ix:nonFraction id="fid_270" contextRef="AsOf2025-03-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" name="us-gaap:PrepaidExpenseNoncurrent" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.7</ix:nonFraction> million and $<ix:nonFraction id="fid_267" contextRef="AsOf2024-12-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" name="us-gaap:PrepaidExpenseNoncurrent" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.5</ix:nonFraction> million, respectively.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">9</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOC">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><ix:nonNumeric id="fid_194" contextRef="From2025-01-01to2025-03-31" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 4. Accounts Payable and Accrued Liabilities</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounts payable and accrued liabilities consist of the following (rounded in millions):</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_215" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Trade payables</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_273" contextRef="AsOf2025-03-31" name="us-gaap:AccountsPayableTradeCurrentAndNoncurrent" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.3</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_278" contextRef="AsOf2024-12-31" name="us-gaap:AccountsPayableTradeCurrentAndNoncurrent" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.2</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accrued research and development expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_274" contextRef="AsOf2025-03-31" name="ltbr:AccruedResearchAndDevelopmentExpensesCurrent" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.1</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_279" contextRef="AsOf2024-12-31" name="ltbr:AccruedResearchAndDevelopmentExpensesCurrent" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.1</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accrued bonus</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_275" contextRef="AsOf2025-03-31" name="us-gaap:AccruedBonusesCurrentAndNoncurrent" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.3</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_280" contextRef="AsOf2024-12-31" name="us-gaap:AccruedBonusesCurrentAndNoncurrent" format="ixt:zerodash" decimals="-6" unitRef="USD" scale="6">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accrued payroll taxes and professional fees </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_277" contextRef="AsOf2025-03-31" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.3</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_281" contextRef="AsOf2024-12-31" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.1</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_276" contextRef="AsOf2025-03-31" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">1.0</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_282" contextRef="AsOf2024-12-31" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.4</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:nonNumeric></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_195" contextRef="From2025-01-01to2025-03-31" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 5. Commitments and Contingencies</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Operating Leases</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company leased office space for a <ix:nonNumeric id="fid_287" contextRef="From2025-01-01to2025-03-31" name="ltbr:LesseeOperatingLeaseTerm" format="ixt-sec:durmonth">12</ix:nonNumeric>-month term from January 1, 2025 through December 31, 2025 with a monthly payment of approximately $<ix:nonFraction id="fid_285" contextRef="From2025-01-01to2025-03-31" name="us-gaap:OperatingLeasePayments" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,000</ix:nonFraction>. The future minimum lease payments required under the non-cancellable operating leases for 2025 total approximately $<ix:nonFraction id="fid_286" contextRef="From2025-01-01to2025-03-31" name="ltbr:LeasePaymentUnderNonCancellableOperatingLeases" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.1</ix:nonFraction> million. Total rent expense for the three months ended March 31, 2025 and 2024 was approximately $<ix:nonFraction id="fid_284" contextRef="From2025-01-01to2025-03-31" name="us-gaap:OperatingLeaseExpense" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction> and $<ix:nonFraction id="fid_283" contextRef="From2024-01-01to2024-03-31" name="us-gaap:OperatingLeaseExpense" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,000</ix:nonFraction>, respectively.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_196" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" escape="true" continuedAt="cont_d0d3d3"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 6. Research and Development Costs</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">INL Project</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In 2022, Lightbridge entered into agreements with BEA, to support the development of Lightbridge Fuel&#8482;. These framework agreements use an innovative structure that consists of an &#8220;umbrella&#8221; Strategic Partnership Project Agreement (SPPA) and an &#8220;umbrella&#8221; Cooperative Research and Development Agreement (CRADA), with an initial duration of seven years. Throughout the duration of these umbrella agreements, all R&amp;D work contracted with BEA is through the issuance of Project Task Statements (PTS). The initial phase of work under the two agreements is expected to culminate in future irradiation testing in the INL Advanced Test Reactor of fuel samples using enriched uranium supplied by the DOE. The initial phase of work aims to generate irradiation performance data for Lightbridge&#8217;s delta-phase uranium-zirconium alloy relating to various thermophysical properties. Data gathered during future post-irradiation examination work are expected to support fuel performance modeling and regulatory licensing efforts for the commercial deployment of Lightbridge Fuel&#8482;. For the three months ended March 31, 2025 and 2024, the Company recorded $<ix:nonFraction id="fid_289" contextRef="From2025-01-01to2025-03-31_ltbr_INLMember" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.8</ix:nonFraction> million and $<ix:nonFraction id="fid_290" contextRef="From2024-01-01to2024-03-31_ltbr_INLMember" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.4</ix:nonFraction> million in R&amp;D expenses associated with INL, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">INL Modifications to the CRADA and SPPA Project Task Statements</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On January 16, 2025, the Company and BEA entered into Modification No. 3 to the PTS No. 1 under the CRADA, dated September 27, 2022, as amended on May 22, 2023 and May 30, 2023, by and between the Company and BEA. Pursuant to the terms of Modification No. 3, the potential amounts payable by the Company to reimburse BEA for its expenses and employee time associated with R&amp;D activities were increased by approximately $<ix:nonFraction id="fid_291" contextRef="From2025-01-01to2025-03-31_ltbr_BattelleEnergyAllianceLLCMember" name="ltbr:ResearchAndDevelopmentArrangementExpense" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">1.6</ix:nonFraction> million, bringing the total estimated cost for the work to be performed under the &#8220;umbrella&#8221; CRADA to $<ix:nonFraction id="fid_292" contextRef="From2025-01-01to2025-03-31_ltbr_CRADAMember" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">4.2</ix:nonFraction> million. This modification also required that a $<ix:nonFraction id="fid_293" contextRef="AsOf2025-01-16" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:numdotdecimal" decimals="0" unitRef="USD">600,000</ix:nonFraction> advance payment be made, which was due and paid on January 16, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 18, 2025, the Company and BEA entered into Modification No. 4 to the PTS No. 1 under the SPPA, dated December 9, 2022, as amended on May 23, 2023, March 26, 2024 and October 24, 2024, by and between the Company and BEA. Pursuant to the terms of Modification No. 4, the potential amounts payable by the Company to reimburse BEA for its expenses and employee time were increased by approximately $<ix:nonFraction id="fid_295" contextRef="From2025-01-01to2025-03-31_ltbr_BattelleEnergyAllianceLLCMember" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.6</ix:nonFraction> million, bringing the total estimated cost for the work to be performed under the &#8220;umbrella&#8221; SPPA to $<ix:nonFraction id="fid_294" contextRef="From2025-01-01to2025-03-31_ltbr_StrategicPartnershipProjectAgreementMember" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">2.6</ix:nonFraction> million.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">After accounting for Modification No. 4, cash payments from Lightbridge to BEA under both CRADA and SPPA are estimated at approximately $<ix:nonFraction id="fid_288" contextRef="From2025-01-01to2025-03-31" name="us-gaap:OtherResearchAndDevelopmentExpense" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">6.8</ix:nonFraction> million on a cost reimbursable basis over the performance periods. These obligations are generally cancellable with 30 days&#8217; notice and, therefore, are not considered firm commitments. </p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">10</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOC">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><ix:continuation id="cont_d0d3d3"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline"></span></em>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Romania Feasibility Study</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On October 16, 2023, the Company engaged RATEN ICN in Romania to perform an engineering study to assess the compatibility and suitability of Lightbridge Fuel&#8482; for use in Canada Deuterium Uranium (CANDU) reactors. The total price of approximately $<ix:nonFraction id="fid_298" contextRef="AsOf2023-10-16_ltbr_CANDUMember" name="ltbr:ResearchAndDevelopmentExpensePayable" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.2</ix:nonFraction> million was payable in three installments, including an advance payment of $<ix:nonFraction id="fid_299" contextRef="AsOf2023-10-16_ltbr_CANDUMember" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.1</ix:nonFraction> million and an interim milestone payment and final payment totaling approximately $<ix:nonFraction id="fid_300" contextRef="From2024-12-01to2024-12-31_ltbr_CANDUMember" name="ltbr:PaymentsToResearchAndDevelopmentCost" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.1</ix:nonFraction> million. The Company made its final payment in December 2024 when the study was completed. The Company has no further obligations under the agreement. For the three months ended March 31, 2025 and 2024, the Company recorded $<ix:nonFraction id="fid_296" contextRef="From2025-01-01to2025-03-31_ltbr_CANDUMember" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:numdotdecimal" decimals="-6" unitRef="USD" scale="6">0</ix:nonFraction> million and $<ix:nonFraction id="fid_297" contextRef="From2024-01-01to2024-03-31_ltbr_CANDUMember" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.1</ix:nonFraction> million, respectively in R&amp;D expenses associated with RATEN ICN feasibility study.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">FEED Study with Centrus Energy for a Lightbridge Pilot Fuel Fabrication Facility</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On December 5, 2023, the Company entered into an agreement with Centrus Energy to conduct a front-end engineering and design (FEED) study to evaluate deployment of a Lightbridge Pilot Fuel Fabrication Facility (LPFFF) at the American Centrifuge Plant in Piketon, Ohio. The Company made its final payment in December 2024 for the study was completed in 2024 and has no further obligations under the agreement. For the three months ended March 31, 2025 and 2024, the Company recorded $<ix:nonFraction id="fid_301" contextRef="From2025-01-01to2025-03-31_ltbr_FEEdMember" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:numdotdecimal" decimals="-6" unitRef="USD" scale="6">0</ix:nonFraction> million and $<ix:nonFraction id="fid_302" contextRef="From2024-01-01to2024-03-31_ltbr_FEEdMember" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.2</ix:nonFraction> million, respectively, in R&amp;D expenses associated with this FEED study.</p></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_197" contextRef="From2025-01-01to2025-03-31" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" escape="true" continuedAt="cont_c61308"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 7. Stockholders&#8217; Equity and Stock-Based Compensation</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At March 31, 2025, the Company had <ix:nonFraction id="fid_370" contextRef="AsOf2025-03-31" name="ltbr:CommonStockShareOutstanding" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">21,557,343</ix:nonFraction> common shares outstanding (including outstanding restricted stock awards (RSAs) totaling <ix:nonFraction id="fid_397" contextRef="From2025-01-01to2025-03-31" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">743,702</ix:nonFraction> shares). Also outstanding were stock options relating to <ix:nonFraction id="fid_400" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">429,454</ix:nonFraction> shares of common stock (of which <ix:nonFraction id="fid_401" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">409,789</ix:nonFraction> stock options were vested), all totaling <ix:nonFraction id="fid_402" contextRef="AsOf2025-03-31" name="ltbr:CommonStockEquivalentsOutstandingShares" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">21,986,797</ix:nonFraction> shares of common stock and all common stock equivalents, outstanding as of March 31, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At December 31, 2024, the Company had <ix:nonFraction id="fid_371" contextRef="AsOf2024-12-31" name="ltbr:CommonStockShareOutstanding" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">18,783,912</ix:nonFraction> common shares outstanding (including outstanding RSAs totaling <ix:nonFraction id="fid_396" contextRef="From2024-01-01to2024-12-31" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">781,864</ix:nonFraction> shares). Also outstanding were stock options relating to <ix:nonFraction id="fid_373" contextRef="From2024-01-01to2024-12-31" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">464,940</ix:nonFraction> shares of common stock (of which <ix:nonFraction id="fid_379" contextRef="From2024-01-01to2024-12-31" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">445,275</ix:nonFraction> stock options were vested), all totaling <ix:nonFraction id="fid_372" contextRef="AsOf2024-12-31" name="ltbr:CommonStockEquivalentsOutstandingShares" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">19,248,852</ix:nonFraction> shares of common stock and all common stock equivalents, outstanding as of December 31, 2024.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Issuance of Series X Preferred Stock&#160;</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On February 27, 2025, the Company entered into a Subscription and Investment Representation Agreement with the chair of the Audit Committee and an independent member of the Board (the &#8220;Purchaser&#8221;), pursuant to which the Company agreed to issue and sell one <ix:nonNumeric id="fid_461" contextRef="From2025-02-03to2025-02-27_ltbr_SeriesXPreferredStockMember" name="ltbr:DescriptionOfSubscriptionAndInvestmentRepresentationAgreement">(1) share of the Company&#8217;s Series X Preferred Stock, par value $0.001 per share (the &#8220;Series X Preferred Stock&#8221;), to the Purchaser for $100 in cash. The sale closed on February 27, 2025 and the $100 was fully paid-up and recorded under current liabilities. The Company will redeem the Series X Preferred Stock for $100 cash after the Company&#8217;s annual 2025 shareholder meeting (the &#8220;Annual Meeting&#8221;).</ix:nonNumeric></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Series X Preferred Stock does not have any voting rights except with respect to any proposal to increase the number of authorized shares of common stock of the Company. Each share of Series X Preferred Stock will be entitled to <ix:nonFraction id="fid_462" contextRef="From2025-02-03to2025-02-27_ltbr_SeriesXPreferredStockMember" name="ltbr:PreferredStockVotingRightsShares" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">25,000,000</ix:nonFraction> votes on such proposal, voting together with the holders of the Company&#8217;s common stock. The votes by the holder of Series X Preferred Stock will be cast at the Annual Meeting automatically in the same &#8220;mirrored&#8221; proportion as the aggregate votes cast &#8220;for&#8221; and &#8220;against&#8221; the proposal by the holders of the common stock who vote on such proposal (excluding abstentions, broker non-votes and shares of common stock that are not voted &#8220;for&#8221; or &#8220;against&#8221; such proposal). The voting power attributable to the Series X Preferred Stock will be disregarded for purposes of determining whether a quorum is present at the Annual Meeting.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Pursuant to the terms of issuance, the Series X Preferred Stock will be redeemed at its original issuance price of $<ix:nonFraction id="fid_453" contextRef="AsOf2025-02-27_ltbr_SeriesXPreferredStockMember" name="us-gaap:PreferredStockRedemptionAmount" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100</ix:nonFraction> upon the earlier of (i) the order of the Board of Directors in its sole discretion, automatically and effective at such date and time as determined and specified by the Board of Directors in its sole discretion and (ii) automatically and effective immediately after the publishing or other public announcement by the Company of the final results of any stockholder vote on a proposal to increase the authorized common stock. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Common Stock Equity Offerings</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Increase in Authorized Common Shares </em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On February 26, 2025, the Company&#8217;s Board of Directors approved increasing the authorized common shares from <ix:nonFraction id="fid_452" contextRef="AsOf2025-02-26_ltbr_BoardOfDirectorsMember_ltbr_BottomMember" name="us-gaap:CommonStockSharesAuthorized" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">25,000,000</ix:nonFraction> shares to <ix:nonFraction id="fid_451" contextRef="AsOf2025-02-26_ltbr_BoardOfDirectorsMember_ltbr_TopMember" name="us-gaap:CommonStockSharesAuthorized" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">100,000,000</ix:nonFraction> shares. This change will take effect upon receiving majority shareholder approval at the 2025 shareholder annual meeting on May 8, 2025 and filing the amendment to the Company&#8217;s Articles of Incorporation with the Nevada Secretary of State (note 9).</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">11</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOC">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><ix:continuation id="cont_c61308" continuedAt="cont_c721a9"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>At-the-Market (ATM) Offerings</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On May 28, 2019, the Company entered into an at-the-market equity offering sales agreement with Stifel, Nicolaus &amp; Company, Incorporated (Stifel), which was amended on April 9, 2021 and May 8, 2024 (the ATM Agreement), pursuant to which the Company may issue and sell shares of its common stock from time to time through Stifel as the Company&#8217;s sales agent. <ix:nonNumeric id="fid_386" contextRef="From2019-05-01to2019-05-28" name="us-gaap:IntercompanyAgreementsDescription">Under this amended agreement, the Company pays Stifel a commission equal to 3.0% of the aggregate gross proceeds of any sales of common stock under the agreement. The offering of common stock pursuant to this agreement can be terminated with 10 days written notice by either party</ix:nonNumeric>. Sales of the Company&#8217;s common stock through Stifel, if any, will be made by any method that is deemed to be an &#8220;at-the-market&#8221; equity offering as defined in Rule 415 promulgated under the Securities Act of 1933.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><ix:nonNumeric id="fid_374" contextRef="From2024-03-01to2024-03-29" name="ltbr:MarketOfferingsDisclosureDescription">The Company filed a shelf registration statement on Form S-3 with the Securities and Exchange Commission (SEC) on March 29, 2024, registering the sale of up to $75.0 million of the Company&#8217;s securities that was declared effective on April 19, 2024. On May 10, 2024, the Company filed a prospectus supplement, which was further supplemented on July 19, 2024 and August 9, 2024 (collectively, the &#8220;First Prospectus Supplement&#8221;), pursuant to which the Company may offer and sell shares of common stock having an aggregate offering price of up to $12.6 million from time to time through the ATM. The Company exhausted all sales under the First Prospectus Supplement</ix:nonNumeric>. On November 22, 2024, the Company filed a prospectus supplement pursuant to which the Company may offer and sell shares of common stock having an aggregate offering price of up to $<ix:nonFraction id="fid_403" contextRef="From2024-11-01to2024-11-22" name="us-gaap:PaymentsForRepurchaseOfInitialPublicOffering" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">45.0</ix:nonFraction> million from time to time through the ATM.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company records its ATM sales on a settlement date basis. The Company sold <ix:nonFraction id="fid_398" contextRef="From2025-01-01to2025-03-31_ltbr_AvailableForSaleSecuritiesMember" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">2,605,619</ix:nonFraction> shares under the ATM for the three months ended March 31, 2025 resulting in net proceeds of $<ix:nonFraction id="fid_376" contextRef="From2025-01-01to2025-03-31_ltbr_AvailableForSaleSecuritiesMember" name="ltbr:ProceedsFromStockIssuances" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">20.2</ix:nonFraction> million (stock issuance costs were approximately $<ix:nonFraction id="fid_378" contextRef="From2025-01-01to2025-03-31_ltbr_AvailableForSaleSecuritiesMember" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.7</ix:nonFraction> million). The Company records its ATM sales on a settlement date basis. The Company sold <ix:nonFraction id="fid_399" contextRef="From2024-01-01to2024-03-31_ltbr_AvailableForSaleSecuritiesMember" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">427,300</ix:nonFraction> shares under the ATM for the three months ended March 31, 2024 resulting in net proceeds of $<ix:nonFraction id="fid_375" contextRef="From2024-01-01to2024-03-31_ltbr_AvailableForSaleSecuritiesMember" name="ltbr:ProceedsFromStockIssuances" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">1.2</ix:nonFraction> million (stock issuance costs were approximately $<ix:nonFraction id="fid_377" contextRef="From2024-01-01to2024-03-31_ltbr_AvailableForSaleSecuritiesMember" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.2</ix:nonFraction> million).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Stock-Based Compensation</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>&#160;2020 Omnibus Incentive Plan </em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 9, 2020, the Board of Directors adopted the Company&#8217;s 2020 Omnibus Incentive Plan (as subsequently amended, the &#8220;2020 Plan&#8221;). On September 3, 2020, the shareholders approved the 2020 Plan to authorize grants of the following types of awards: (a) Options, (b) Stock Appreciation Rights, (c) Restricted Stock Awards and Restricted Stock Units, and (d) Other Stock-Based and Cash-Based Awards. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On February 27, 2024, <ix:nonNumeric id="fid_383" contextRef="From2024-02-01to2024-02-27_ltbr_TwoThousandTwentyEquityIncentivePlanMember" name="ltbr:DescriptionOfEquityIncentivePlan">the Board of Directors approved an increase of 700,000 shares to the authorized number of shares under the 2020 Plan, increasing the total authorized number of shares from 1,800,000 shares to 2,500,000 shares</ix:nonNumeric>. This increase was approved by the stockholders at the shareholders&#8217; annual meeting on April 19, 2024. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The total number of shares of common stock available for issuance under the 2020 Plan was <ix:nonFraction id="fid_385" contextRef="AsOf2025-03-31_ltbr_TwoThousandTwentyEquityIncentivePlanMember" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">2,500,000</ix:nonFraction> shares with <ix:nonFraction id="fid_384" contextRef="From2025-01-01to2025-03-31_ltbr_TwoThousandTwentyEquityIncentivePlanMember" name="ltbr:FutureIssuanceOfShare" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">1,009,389</ix:nonFraction> shares available for future issuance at March 31, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On February 26, 2025, <ix:nonNumeric id="fid_404" contextRef="From2025-02-01to2025-02-26_ltbr_TwoThousandTwentyEquityIncentivePlanMember" name="ltbr:DescriptionOfEquityIncentivePlan">the Company&#8217;s Board of Directors approved an increase of 2,500,000 shares to the authorized number of shares under the 2020 Plan, increasing the total authorized number of shares from 2,500,000 to 5,000,000</ix:nonNumeric>. This change will take effect if approved by shareholders at the Company&#8217;s 2025 shareholder annual meeting on May 8, 2025 (note 9).</p></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">12</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOC">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><ix:continuation id="cont_c721a9" continuedAt="cont_09b002"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Stock Options</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Stock options issued to the Company&#8217;s employees, directors and consultants are summarized as follows for the three months ended March 31, 2025 and 2024:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_216" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Options </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted Average Exercise Price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted-Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Remaining</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Contractual</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Term (Years)</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Aggregate</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Intrinsic</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Outstanding, December 31, 2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_312" contextRef="AsOf2024-12-31" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">464,940</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_317" contextRef="AsOf2024-12-31" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">16.24</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonNumeric id="fid_322" contextRef="From2025-01-01to2025-03-31" name="ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm" format="ixt-sec:duryear">3.07</ix:nonNumeric></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_330" contextRef="AsOf2024-12-31" name="ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding" format="ixt:numdotdecimal" decimals="0" unitRef="USD">184,818</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_313" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">10,448</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_318" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.42</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_314" contextRef="From2025-01-01to2025-03-31" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">45,934</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_319" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.80</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_336" contextRef="From2025-01-01to2025-03-31" name="ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueExercised" format="ixt:numdotdecimal" decimals="0" unitRef="USD">310,093</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt">Forfeited</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_315" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:zerodash" decimals="0" unitRef="Shares">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_320" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" format="ixt:zerodash" decimals="INF" unitRef="USDPShares">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt">Expired</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_316" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" format="ixt:zerodash" decimals="0" unitRef="Shares">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_321" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" format="ixt:zerodash" decimals="INF" unitRef="USDPShares">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Outstanding, March 31, 2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_335" contextRef="AsOf2025-03-31" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">429,454</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_334" contextRef="AsOf2025-03-31" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">17.29</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonNumeric id="fid_323" contextRef="From2025-01-01to2025-03-31" name="ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermEndingFF" format="ixt-sec:duryear">2.53</ix:nonNumeric></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_333" contextRef="AsOf2025-03-31" name="ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding" format="ixt:numdotdecimal" decimals="0" unitRef="USD">469,719</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Vested and expected to vest, end of the period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_326" contextRef="AsOf2025-03-31" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">429,454</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_328" contextRef="AsOf2025-03-31" name="ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">17.29</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonNumeric id="fid_324" contextRef="From2025-01-01to2025-03-31" name="ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermVested" format="ixt-sec:duryear">2.53</ix:nonNumeric></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_331" contextRef="From2025-01-01to2025-03-31" name="ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueVestedAndExpectedToVest" format="ixt:numdotdecimal" decimals="0" unitRef="USD">469,719</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Options exercisable, end of the period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_327" contextRef="AsOf2025-03-31" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">409,789</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_329" contextRef="AsOf2025-03-31" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">17.97</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonNumeric id="fid_325" contextRef="From2025-01-01to2025-03-31" name="ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermOptionsExercisable" format="ixt-sec:duryear">2.22</ix:nonNumeric></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_332" contextRef="From2025-01-01to2025-03-31" name="ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueOptionsExercisable" format="ixt:numdotdecimal" decimals="0" unitRef="USD">387,153</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In the three months ended March 31, 2025 and 2024, the Company issued 10,448 and 58,309 stock options, respectively, to one consultant. The <ix:nonFraction id="fid_405" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">10,448</ix:nonFraction> stock options and the <ix:nonFraction id="fid_406" contextRef="From2024-01-01to2024-03-31" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">58,309</ix:nonFraction> stock options were assigned a fair value of $<ix:nonFraction id="fid_407" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.74</ix:nonFraction> per share and $<ix:nonFraction id="fid_408" contextRef="From2024-01-01to2024-03-31" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.03</ix:nonFraction> per share, respectively (total fair value of $<ix:nonFraction id="fid_409" contextRef="From2025-01-01to2025-03-31" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60,000</ix:nonFraction> for each grant). The weighted-average grant-date exercise price per share of the stock options granted for the three months ended March 31, 2025 and 2024, was $<ix:nonFraction id="fid_411" contextRef="From2025-01-01to2025-03-31" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.42</ix:nonFraction> and $<ix:nonFraction id="fid_412" contextRef="From2024-01-01to2024-03-31" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.62</ix:nonFraction>, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The fair value was determined using the Black-Scholes pricing model. For expected volatility, the Company concluded that the historical volatility over the option&#8217;s expected holding term provided the most reasonable basis for this estimate. For the risk-free interest rate, the Company used U.S. Treasury Note rates, which mature at approximately the same time as the option&#8217;s expected holding term or option life determined by using the simplified method. The Company recognized forfeitures of equity-based awards as a reduction to compensation costs in the period in which they occur. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following assumptions were used in the Black-Scholes pricing model to determine the fair value of stock options granted for the three months ended March 31, 2025 and 2024:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_217" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected volatility</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_339" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" decimals="INF" unitRef="Pure" scale="-2">117.44</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_340" contextRef="From2024-01-01to2024-03-31" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" decimals="INF" unitRef="Pure" scale="-2">75.36</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Risk free interest rate </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_341" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" decimals="INF" unitRef="Pure" scale="-2">3.95</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_342" contextRef="From2024-01-01to2024-03-31" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" decimals="INF" unitRef="Pure" scale="-2">4.54</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Dividend yield rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected life</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><ix:nonNumeric id="fid_345" contextRef="From2025-01-01to2025-03-31" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear">2</ix:nonNumeric> years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><ix:nonNumeric id="fid_346" contextRef="From2024-01-01to2024-03-31" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear">2</ix:nonNumeric> years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Closing price per share - common stock </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_343" contextRef="AsOf2025-03-31" name="us-gaap:SharePrice" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.42</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_344" contextRef="AsOf2024-03-31" name="us-gaap:SharePrice" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.62</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The intrinsic value is calculated as the difference between the fair value of the Company&#8217;s common stock and the exercise price of the stock options. The fair value of the Company&#8217;s common stock was $<ix:nonFraction id="fid_414" contextRef="AsOf2025-03-31" name="ltbr:ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.46</ix:nonFraction> per share and $<ix:nonFraction id="fid_413" contextRef="AsOf2024-03-31" name="ltbr:ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.95</ix:nonFraction> per share at March 31, 2025 and 2024, respectively. As of March 31, 2025, total unrecognized compensation cost related to option awards was $<ix:nonFraction id="fid_415" contextRef="AsOf2025-03-31" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,388</ix:nonFraction>, which is expected to be recognized over a remaining weighted-average vesting period of <ix:nonNumeric id="fid_416" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear">1.9</ix:nonNumeric> years. As of March 31, 2024, total unrecognized compensation cost related to option awards was $<ix:nonFraction id="fid_417" contextRef="AsOf2024-03-31" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,384</ix:nonFraction>, which is expected to be recognized over a remaining weighted-average vesting period of <ix:nonNumeric id="fid_418" contextRef="From2024-01-01to2024-03-31" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear">1.9</ix:nonNumeric> years.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Exercise of Options</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For the three months ended March 31, 2025, the Company received approximately $<ix:nonFraction id="fid_394" contextRef="From2025-01-01to2025-03-31_ltbr_OptionsMember" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.2</ix:nonFraction> million of net proceeds from the exercise of <ix:nonFraction id="fid_395" contextRef="From2025-01-01to2025-03-31_ltbr_OptionsMember" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">45,934</ix:nonFraction> stock options from employees and consultants. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Common Stock</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Consultants&#8217; Stock Issuances</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For the three months ended March 31, 2025 and 2024, the Company issued <ix:nonFraction id="fid_419" contextRef="From2025-01-01to2025-03-31_ltbr_CommonShareIssuancesMember" name="us-gaap:StockIssuedDuringPeriodSharesOther" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">3,171</ix:nonFraction> shares (with stock prices of $<ix:nonFraction id="fid_421" contextRef="From2025-01-01to2025-03-31_ltbr_CommonShareIssuancesMember" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.73</ix:nonFraction> per share) and <ix:nonFraction id="fid_420" contextRef="From2024-01-01to2024-03-31_ltbr_CommonShareIssuancesMember" name="us-gaap:StockIssuedDuringPeriodSharesOther" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">3,750</ix:nonFraction> shares (with stock prices of $<ix:nonFraction id="fid_422" contextRef="From2024-01-01to2024-03-31_ltbr_CommonShareIssuancesMember" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.00</ix:nonFraction> per share) of common stock, respectively, to its investor relations firm for services provided during the period, recorded to general and administrative expenses. These shares vested immediately upon issuance. The expense recorded for these share issuances was $<ix:nonFraction id="fid_423" contextRef="From2025-01-01to2025-03-31_ltbr_CommonShareIssuancesMember" name="us-gaap:ShareBasedCompensation" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,000</ix:nonFraction> for each quarter. The shares were valued based on the closing market price of the Company&#8217;s common stock on the date of grant. </p></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">13</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOC">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><ix:continuation id="cont_09b002" continuedAt="cont_b161ad"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On August 19, 2024, the Board of Directors approved an equity grant valued at $<ix:nonFraction id="fid_392" contextRef="From2024-08-01to2024-08-19_srt_BoardOfDirectorsChairmanMember" name="ltbr:CommonSharesIssuancesEquityGrant" format="ixt:numdotdecimal" decimals="0" unitRef="USD">180,000</ix:nonFraction> to a consulting and investment research firm, for corporate advisory services to be provided over a twelve-month period, and preparation and dissemination of a report regarding the Company, which resulted in issuing the consultant <ix:nonFraction id="fid_389" contextRef="AsOf2024-08-19_srt_BoardOfDirectorsChairmanMember" name="ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">71,713</ix:nonFraction> shares of common stock on the grant date, valued at $<ix:nonFraction id="fid_387" contextRef="From2024-08-01to2024-08-19_srt_BoardOfDirectorsChairmanMember" name="ltbr:CommonStockValuedGrantDatePricePerShare" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.51</ix:nonFraction> per share. These shares vested immediately upon issuance and are not forfeitable. The compensation cost of $<ix:nonFraction id="fid_388" contextRef="From2024-08-01to2024-08-19_srt_BoardOfDirectorsChairmanMember" name="us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense" format="ixt:numdotdecimal" decimals="0" unitRef="USD">180,000</ix:nonFraction> began to be recognized on a straight-line basis over the requisite service period. Approximately $<ix:nonFraction id="fid_425" contextRef="From2025-01-01to2025-03-31_srt_BoardOfDirectorsChairmanMember" name="us-gaap:OperatingExpenses" format="ixt:numdotdecimal" decimals="0" unitRef="USD">45,000</ix:nonFraction> and $<ix:nonFraction id="fid_426" contextRef="From2024-01-01to2024-03-31_srt_BoardOfDirectorsChairmanMember" name="us-gaap:OperatingExpenses" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction> were recorded as consulting expenses for the three months ended March 31, 2025, and 2024, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of March 31, 2025, the unrecognized compensation cost of approximately $<ix:nonFraction id="fid_428" contextRef="AsOf2025-03-31_ltbr_PrepaidExpenseAndOtherCurrentAssetMember" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:numdotdecimal" decimals="0" unitRef="USD">69,000</ix:nonFraction> was recorded under prepaid expenses and other current assets on the accompanying condensed consolidated balance sheet, which is expected to be recognized over a remaining service period of <ix:nonNumeric id="fid_427" contextRef="From2025-01-01to2025-03-31_ltbr_PrepaidExpenseAndOtherCurrentAssetMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear">0.4</ix:nonNumeric> years.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Director Compensation - Equity-Settled Awards</span></em>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On December 4, 2024, the Board of Directors approved an equity grant valued at $<ix:nonFraction id="fid_380" contextRef="From2024-12-01to2024-12-04_srt_BoardOfDirectorsChairmanMember" name="ltbr:CommonSharesIssuancesEquityGrant" format="ixt:numdotdecimal" decimals="0" unitRef="USD">500,000</ix:nonFraction> in total to its five directors for the service period and year ended December 31, 2024, which resulted in granting a total of <ix:nonFraction id="fid_382" contextRef="AsOf2024-12-04_srt_BoardOfDirectorsChairmanMember" name="ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">85,915</ix:nonFraction> shares of common stock, valued on the grant date at $<ix:nonFraction id="fid_381" contextRef="From2024-12-01to2024-12-04_srt_BoardOfDirectorsChairmanMember" name="ltbr:CommonSharesEquityGrantPricePerShares" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.82</ix:nonFraction> per share on December 4, 2024, which shares vested on January 2, 2025. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On November 20, 2023, the Board of Directors approved an equity grant valued at $<ix:nonFraction id="fid_368" contextRef="From2023-11-01to2023-11-20_srt_BoardOfDirectorsChairmanMember" name="ltbr:CommonSharesIssuancesEquityGrant" format="ixt:numdotdecimal" decimals="0" unitRef="USD">240,000</ix:nonFraction> in total to its six directors for the service period and year ended December 31, 2023, which resulted in granting a total of <ix:nonFraction id="fid_390" contextRef="AsOf2023-11-20_srt_BoardOfDirectorsChairmanMember" name="ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">60,456</ix:nonFraction> shares of common stock, valued on the grant date at $<ix:nonFraction id="fid_391" contextRef="From2023-11-01to2023-11-20_srt_BoardOfDirectorsChairmanMember" name="ltbr:CommonSharesEquityGrantPricePerShares" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.97</ix:nonFraction> per share on November 20, 2023, which shares vested on January 2, 2024.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As a result, the fair value of the stock awards was measured on the grant date and recorded as an increase to stock-based compensation expense and additional paid-in capital in 2025 and 2024. The fair value of the shares granted was determined based on the closing market price of the Company&#8217;s common stock on the grant date. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Restricted Stock Awards</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following summarizes the Company&#8217;s restricted stock award activity and the RSA outstanding: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_218" contextRef="From2025-01-01to2025-03-31" name="ltbr:ScheduleOfOutstandingRSATableTextBlock" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted- </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Grant Date</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Fair Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Aggregate </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Fair</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Outstanding, December 31, 2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_358" contextRef="AsOf2024-12-31_ltbr_RestrictedStockAwardMember" name="ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">781,864</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_359" contextRef="AsOf2024-12-31_ltbr_RestrictedStockAwardMember" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.19</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_360" contextRef="AsOf2024-12-31_ltbr_RestrictedStockAwardMember" name="ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,698,217</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Awards granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_347" contextRef="From2025-01-01to2025-03-31_ltbr_RestrictedStockAwardMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">57,940</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_350" contextRef="From2025-01-01to2025-03-31_ltbr_RestrictedStockAwardMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.63</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_354" contextRef="From2025-01-01to2025-03-31_ltbr_RestrictedStockAwardMember" name="ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted" format="ixt:numdotdecimal" decimals="0" unitRef="USD">500,022</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Awards vested</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_348" contextRef="From2025-01-01to2025-03-31_ltbr_RestrictedStockAwardMember" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">96,102</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_351" contextRef="From2025-01-01to2025-03-31_ltbr_RestrictedStockAwardMember" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.67</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_355" contextRef="From2025-01-01to2025-03-31_ltbr_RestrictedStockAwardMember" name="ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueVested" format="ixt:numdotdecimal" decimals="0" unitRef="USD">737,535</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Awards forfeited</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_349" contextRef="From2025-01-01to2025-03-31_ltbr_RestrictedStockAwardMember" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" format="ixt:zerodash" decimals="0" unitRef="Shares">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_352" contextRef="From2025-01-01to2025-03-31_ltbr_RestrictedStockAwardMember" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" format="ixt:zerodash" decimals="INF" unitRef="USDPShares">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_356" contextRef="From2025-01-01to2025-03-31_ltbr_RestrictedStockAwardMember" name="ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Outstanding, March 31, 2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_361" contextRef="AsOf2025-03-31_ltbr_RestrictedStockAwardMember" name="ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">743,702</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_353" contextRef="AsOf2025-03-31_ltbr_RestrictedStockAwardMember" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.40</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;">$</td><td style="BORDER-BOTTOM: black 3px double;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;<ix:nonFraction id="fid_357" contextRef="AsOf2025-03-31_ltbr_RestrictedStockAwardMember" name="ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,548,017</ix:nonFraction> </p></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 12, 2025, the Board of Directors approved a grant of restricted stock awards (RSAs) totaling $<ix:nonFraction id="fid_369" contextRef="From2025-03-01to2025-03-12_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember" name="ltbr:EquityGrantValue" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.5</ix:nonFraction> million to its five directors for the service year ending December 31, 2025. This grant comprised <ix:nonFraction id="fid_430" contextRef="From2025-01-01to2025-03-31_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">57,940</ix:nonFraction> RSAs, valued at $<ix:nonFraction id="fid_429" contextRef="From2025-01-01to2025-03-31_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.63</ix:nonFraction> per share on the grant date, with vesting scheduled in four quarterly installments. The first installment, consisting of <ix:nonFraction id="fid_432" contextRef="From2025-03-01to2025-03-12_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">14,485</ix:nonFraction> RSAs, vested on March 31, 2025. This resulted in the recognition of $<ix:nonFraction id="fid_431" contextRef="From2025-01-01to2025-03-31_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember" name="us-gaap:ShareBasedCompensation" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.1</ix:nonFraction> million in stock-based compensation expense for the quarter ended March 31, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The aggregate fair value was calculated as the fair value of the Company&#8217;s common stock. The fair value of the Company&#8217;s common stock was $<ix:nonFraction id="fid_435" contextRef="AsOf2025-03-31_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.46</ix:nonFraction> and $<ix:nonFraction id="fid_436" contextRef="AsOf2024-03-31_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.95</ix:nonFraction> per share at March 31, 2025 and 2024, respectively. The fair value of the RSAs vested for the three months ended March 31, 2025 and 2024 was $<ix:nonFraction id="fid_433" contextRef="From2025-01-01to2025-03-31_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:numdotdecimal" decimals="-5" unitRef="Shares" scale="6">0.7</ix:nonFraction> million and $<ix:nonFraction id="fid_434" contextRef="From2024-01-01to2024-12-31_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:numdotdecimal" decimals="-6" unitRef="Shares" scale="6">0</ix:nonFraction> million, respectively. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of March 31, 2025, all the outstanding shares of RSAs are unvested. As of March 31, 2025, total unrecognized compensation cost related to RSAs was $<ix:nonFraction id="fid_437" contextRef="AsOf2025-03-31_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">3.5</ix:nonFraction> million, which is expected to be recognized over a remaining weighted-average vesting period of <ix:nonNumeric id="fid_438" contextRef="From2025-01-01to2025-03-31_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear">2.14</ix:nonNumeric> years.</p></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">14</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOC">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><ix:continuation id="cont_b161ad"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><em><span style="text-decoration:underline"></span></em>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><em><span style="text-decoration:underline">Restricted Stock Awards Modification and Net Share Settlements for Payments of Withholding Taxes</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On March 24, 2025, the Company entered into a separation agreement with a former employee. As part of the agreement, the Board of Directors approved the accelerated vesting of <ix:nonFraction id="fid_443" contextRef="From2025-01-01to2025-03-31_ltbr_TwentyTwentyFiveTransactionsMember" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">70,710</ix:nonFraction> RSAs, which would have otherwise been forfeited upon termination. In accordance with ASC 718, this was treated as a modification, leading to the recognition of $<ix:nonFraction id="fid_440" contextRef="From2025-01-01to2025-03-31_ltbr_TwentyTwentyFiveTransactionsMember" name="us-gaap:ShareBasedCompensation" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.5</ix:nonFraction> million in stock-based compensation expense for the quarter ended March 31, 2025. This expense included $<ix:nonFraction id="fid_441" contextRef="AsOf2025-03-31_ltbr_TwentyTwentyFiveTransactionsMember" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.2</ix:nonFraction> million of previously unrecognized compensation cost and $<ix:nonFraction id="fid_442" contextRef="From2025-01-01to2025-03-31_ltbr_TwentyTwentyFiveTransactionsMember" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.3</ix:nonFraction> million of incremental fair value from the modification of the RSAs awarded.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">To satisfy <ix:nonNumeric id="fid_439" contextRef="From2025-03-01to2025-03-24_ltbr_TwentyTwentyFiveTransactionsMember" name="ltbr:DescriptionOfRSAsModificationAndNetShareSettlementsForPaymentsOfWithholdingTaxes">approximately $0.2 million in payroll withholding taxes associated with the accelerated RSAs vesting, the Company withheld 21,285 shares, resulting in the issuance of 49,425 net shares to the former employee</ix:nonNumeric>. These withheld shares were returned to the 2020 Plan share reserve for potential future issuance.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On March 14, 2025, <ix:nonNumeric id="fid_393" contextRef="From2025-03-01to2025-03-14_ltbr_TwentyTwentyFiveTransactionsMember" name="ltbr:DescriptionOfRSAsModificationAndNetShareSettlementsForPaymentsOfWithholdingTaxes">10,907 RSAs vested to the former employee based on his service to the Company. To satisfy approximately $36,000 in payroll withholding taxes, the Company withheld 3,863 shares, resulting in the issuance of 7,044 net shares to the former employee</ix:nonNumeric>. These withheld shares were returned to the 2020 Plan share reserve for potential future issuance.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">RSA Summary - 2025 and 2024</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of March 31, 2025 and December 31, 2024, there were <ix:nonFraction id="fid_444" contextRef="AsOf2025-03-31_ltbr_RestrictedStockAwardsSummaryMember" name="ltbr:CommonStockShareOutstanding" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">743,702</ix:nonFraction> shares and <ix:nonFraction id="fid_445" contextRef="AsOf2024-03-31_ltbr_RestrictedStockAwardsSummaryMember" name="ltbr:CommonStockShareOutstanding" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">781,864</ix:nonFraction> shares of RSAs included in the total issued and outstanding common stock, respectively. Compensation expense for RSAs issued to employees and consultants are generally recognized straight line over the three-year vesting period. A total of $<ix:nonFraction id="fid_448" contextRef="From2025-01-01to2025-03-31_ltbr_RestrictedStockAwardsSummaryMember" name="us-gaap:ShareBasedCompensation" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">1.3</ix:nonFraction> million (including the $<ix:nonFraction id="fid_450" contextRef="From2025-01-01to2025-03-31_ltbr_RestrictedStockAwardsSummaryMember" name="ltbr:RSAFairValue" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.5</ix:nonFraction> million accelerated RSAs vesting for the former employee) and $<ix:nonFraction id="fid_449" contextRef="From2024-01-01to2024-03-31_ltbr_RestrictedStockAwardsSummaryMember" name="us-gaap:ShareBasedCompensation" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.4</ix:nonFraction> million of stock-based compensation expense was recorded for the three months ended March 31, 2025 and 2024, respectively, for the RSAs.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Stock-Based Compensation Expense</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Total non-cash stock-based compensation expense recorded related to options granted and restricted stock awards included in the Company&#8217;s unaudited condensed consolidated statements of operations for the three months ended March 31, 2025 and 2024 are as follows (rounded in millions):</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_219" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Research and development expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_362" contextRef="From2025-01-01to2025-03-31_us-gaap_ResearchAndDevelopmentExpenseMember" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.2</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_363" contextRef="From2024-01-01to2024-03-31_us-gaap_ResearchAndDevelopmentExpenseMember" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.1</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">General and administrative expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_364" contextRef="From2025-01-01to2025-03-31_us-gaap_GeneralAndAdministrativeExpenseMember" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">1.1</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_365" contextRef="From2024-01-01to2024-03-31_us-gaap_GeneralAndAdministrativeExpenseMember" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.4</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total stock-based compensation expense </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_366" contextRef="From2025-01-01to2025-03-31" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">1.3</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_367" contextRef="From2024-01-01to2024-03-31" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.5</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:nonNumeric></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_198" contextRef="From2025-01-01to2025-03-31" name="us-gaap:SegmentReportingDisclosureTextBlock" escape="true" continuedAt="cont_f30a34"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 8. Segment Reporting</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Operating segments are defined as components of an enterprise about which separate discrete information is available for evaluation by the chief operating decision maker, or decision-making group, in deciding how to allocate resources in assessing performance. The Company has one reportable business segment: nuclear fuel technology. This segment consists of the research and development and commercialization of its nuclear fuel. The Company&#8217;s chief operating decision maker (&#8220;CODM&#8221;) is the chief executive officer.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The accounting policies of the segment are the same as those described in the summary of significant accounting policies. The CODM assesses performance for the segment based on net loss as reported on the condensed consolidated statement of operations. The Company expects to continue to incur significant expenses and operating losses for the foreseeable future as it advances its nuclear fuel through all the stages of its development and commercialization. In addition, the measure of segment assets is reported on the condensed consolidated balance sheet as total assets.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The CODM uses segment net loss to allocate resources predominantly in the annual budget and forecasting process and uses that measure as a basis for evaluating progress toward R&amp;D milestones. The CODM uses cash forecast models in deciding how to invest into the segment. Research and development expenses, general and administrative expenses are included in segment net loss and used to monitor budget versus actual results. Monitoring budgeted versus actual results is used in assessing performance of the segment, while research and development milestones scorecard results and scorecard general and administrative budgeted results are used in establishing management&#8217;s incentive compensation.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">15</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOC">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><ix:continuation id="cont_f30a34"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The table below summarizes the significant expense categories regularly provided to the CODM for the three months ended March 31, 2025 and 2024 (rounded in millions):</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_220" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_223" contextRef="From2025-01-01to2025-03-31_ltbr_CODMMember" name="us-gaap:Revenues" format="ixt:zerodash" decimals="-6" unitRef="USD" scale="6">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_224" contextRef="From2024-01-01to2024-03-31_ltbr_CODMMember" name="us-gaap:Revenues" format="ixt:zerodash" decimals="-6" unitRef="USD" scale="6">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">General and administrative </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_225" contextRef="From2025-01-01to2025-03-31_ltbr_CODMMember" name="us-gaap:OtherGeneralAndAdministrativeExpense" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">3.5</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_226" contextRef="From2024-01-01to2024-03-31_ltbr_CODMMember" name="us-gaap:OtherGeneralAndAdministrativeExpense" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">2.2</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Research and development:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 11.25pt; text-align:justify;">INL Project</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_227" contextRef="From2025-01-01to2025-03-31_ltbr_CODMMember" name="ltbr:InlProject" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.8</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_228" contextRef="From2024-01-01to2024-03-31_ltbr_CODMMember" name="ltbr:InlProject" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.4</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 11.25pt; text-align:justify;">Romania feasibility study</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_229" contextRef="From2025-01-01to2025-03-31_ltbr_CODMMember" name="ltbr:RomaniaFeasibilityStudy" format="ixt:zerodash" decimals="-6" unitRef="USD" scale="6">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_230" contextRef="From2024-01-01to2024-03-31_ltbr_CODMMember" name="ltbr:RomaniaFeasibilityStudy" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.1</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 11.25pt; text-align:justify;">Centrus Energy FEED study</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_231" contextRef="From2025-01-01to2025-03-31_ltbr_CODMMember" name="ltbr:CentrusEnergyFeedStudy" format="ixt:zerodash" decimals="-6" unitRef="USD" scale="6">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_232" contextRef="From2024-01-01to2024-03-31_ltbr_CODMMember" name="ltbr:CentrusEnergyFeedStudy" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.2</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Allocated employee compensation and stock-based compensation </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_235" contextRef="From2025-01-01to2025-03-31_ltbr_CODMMember" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.8</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_236" contextRef="From2024-01-01to2024-03-31_ltbr_CODMMember" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.2</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 11.25pt; text-align:justify;">Other outside R&amp;D expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_237" contextRef="From2025-01-01to2025-03-31_ltbr_CODMMember" name="us-gaap:OtherExpenses" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.1</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_238" contextRef="From2024-01-01to2024-03-31_ltbr_CODMMember" name="us-gaap:OtherExpenses" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">0.1</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Total research and development</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_239" contextRef="From2025-01-01to2025-03-31_ltbr_CODMMember" name="ltbr:ResearchAndDevelopmentExpenseNet" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">1.7</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_240" contextRef="From2024-01-01to2024-03-31_ltbr_CODMMember" name="ltbr:ResearchAndDevelopmentExpenseNet" format="ixt:numdotdecimal" decimals="-6" unitRef="USD" scale="6">1</ix:nonFraction>.0</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Other segments items<sup style="vertical-align:super">(1)</sup></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_241" contextRef="From2025-01-01to2025-03-31_ltbr_CODMMember" name="ltbr:OtherSegmentsItem" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" sign="-" scale="6">0.4</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_242" contextRef="From2024-01-01to2024-03-31_ltbr_CODMMember" name="ltbr:OtherSegmentsItem" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" sign="-" scale="6">0.4</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Net loss</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_243" contextRef="From2025-01-01to2025-03-31_ltbr_CODMMember" name="ltbr:OperatingNetIncomeLossFromSegmentsToConsolidated" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" sign="-" scale="6">4.8</ix:nonFraction> </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_244" contextRef="From2024-01-01to2024-03-31_ltbr_CODMMember" name="ltbr:OperatingNetIncomeLossFromSegmentsToConsolidated" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" sign="-" scale="6">2.8</ix:nonFraction> </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr></tbody></table></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; text-align:justify;">(1) Other segment items include interest income.</p></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_199" contextRef="From2025-01-01to2025-03-31" name="us-gaap:SubsequentEventsTextBlock" escape="true" continuedAt="cont_2f2ca1"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 9. Subsequent Events</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>ATM Sales</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Sales of common stock under the Company&#8217;s ATM from April 1, 2025 to May 12, 2025 amounted to <ix:nonFraction id="fid_303" contextRef="From2025-04-01to2025-05-12_us-gaap_SubsequentEventMember" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">677,300</ix:nonFraction> shares, which resulted in total net proceeds of approximately $<ix:nonFraction id="fid_304" contextRef="From2025-04-01to2025-05-12_us-gaap_SubsequentEventMember" name="ltbr:ProceedsFromStockIssuances" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">5.0</ix:nonFraction> million. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Issuance of Performance-Based RSAs</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On April 3, 2025, the Company&#8217;s Compensation Committee and Board approved the grant of performance-based RSAs to certain executives, key employees and certain consultants under the 2020 Plan. The awards are subject to both service and performance-based vesting conditions, including achievement of one specific R&amp;D fuel milestone, the insertion of the Company&#8217;s coupon fuel samples into the ATR reactor at INL for irradiation testing by December 31, 2026. The service requirement for vesting is a three-year period from the grant date.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company will recognize stock-based compensation expense for these awards beginning on the grant date, with the amount and timing of expense recognition dependent on the probability of achieving the above performance condition. These <ix:nonFraction id="fid_305" contextRef="From2025-04-01to2025-04-03_us-gaap_SubsequentEventMember" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">300,000</ix:nonFraction> performance-based restricted stock awards were valued at $<ix:nonFraction id="fid_306" contextRef="From2025-04-01to2025-04-03_us-gaap_SubsequentEventMember" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" format="ixt:numdotdecimal" decimals="-5" unitRef="USD" scale="6">2.1</ix:nonFraction> million, based on the April 7, 2025 closing stock price of $<ix:nonFraction id="fid_307" contextRef="AsOf2025-04-03_us-gaap_SubsequentEventMember" name="us-gaap:SaleOfStockPricePerShare" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.99</ix:nonFraction> per share</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>2025 Annual Shareholder Meeting Voting Results</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At the Company&#8217;s Annual Meeting of Shareholders held on May 8, 2025, shareholders approved the following proposals:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">1.</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Amendment to the Articles of Incorporation to increase the number of authorized shares of common stock from <ix:nonFraction id="fid_308" contextRef="AsOf2025-05-08_ltbr_BottomMember_us-gaap_SubsequentEventMember_ltbr_ArticlesOfIncorporationMember" name="us-gaap:CommonStockSharesAuthorized" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">25,000,000</ix:nonFraction> shares to <ix:nonFraction id="fid_309" contextRef="AsOf2025-05-08_ltbr_TopMember_us-gaap_SubsequentEventMember_ltbr_ArticlesOfIncorporationMember" name="us-gaap:CommonStockSharesAuthorized" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">100,000,000</ix:nonFraction> shares.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2.</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Amendment to the 2020 Plan to increase the number of shares authorized for issuance under the plan from <ix:nonFraction id="fid_310" contextRef="AsOf2025-05-08_ltbr_BottomMember_us-gaap_SubsequentEventMember_ltbr_TwentyTwentyPlanMember" name="us-gaap:CommonStockSharesAuthorized" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">2,500,000</ix:nonFraction> shares to <ix:nonFraction id="fid_311" contextRef="AsOf2025-05-08_ltbr_TopMember_us-gaap_SubsequentEventMember_ltbr_TwentyTwentyPlanMember" name="us-gaap:CommonStockSharesAuthorized" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">5,000,000</ix:nonFraction> shares.</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The approved proposal to the Amendment to the Articles of Incorporation became effective upon the filing of the Amended and Restated Certificate of Incorporation with the Secretary of State of Nevada.The Series X Preferred Stock (note 7) was redeemed and the Certificate of Withdrawal was filed with the Secretary of State of Nevada. </p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">16</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOC">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><ix:continuation id="cont_2f2ca1" continuedAt="cont_5e9f7f"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span class="atag" style="display: inline" id="forward">FORWARD-LOOKING STATEMENTS </span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In addition to historical information, this Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. We use words such as &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;project,&#8221; &#8220;target,&#8221; &#8220;plan,&#8221; &#8220;optimistic,&#8221; &#8220;intend,&#8221; &#8220;aim,&#8221; &#8220;will,&#8221; &#8220;may,&#8221; or similar expressions, which are intended to identify forward-looking statements. Such statements include, among others:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">those concerning market and business segment growth, demand, and acceptance of our nuclear fuel technology and other steps toward the commercialization of Lightbridge Fuel&#8482;;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">any projections of sales, earnings, revenue, margins, or other financial items;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">any statements of the plans, strategies, and objectives of management for future operations and the timing and outcome of the development of our nuclear fuel technology;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">any statements regarding future economic conditions or performance;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">any statements about future financings and liquidity;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">the Company&#8217;s anticipated financial resources and position; and</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">all assumptions, expectations, predictions, intentions, or beliefs about future events and other statements that are not historical facts.</td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">You are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, as well as assumptions that if they were to ever materialize or prove incorrect, could cause the results of the Company to differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties, among others, include:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">our ability to commercialize our nuclear fuel technology, including risks related to the design and testing of nuclear fuel incorporating our technology and the degree of market adoption of the Company&#8217;s product and service offerings;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">dependence on strategic partners;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">any adverse changes to our agreements or relationship with the U.S. government and its national laboratories;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">our ability to fund our future operations, including general corporate overhead and outside research and development (R&amp;D) expenses, and continue as a going concern;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">the future market and demand for our fuel for nuclear reactors and our ability to attract customers;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">our ability to manage the business effectively in a rapidly evolving market;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">our ability to employ and retain qualified employees and consultants that have experience in the nuclear industry;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">competition and competitive factors in the markets in which we compete, including from accident tolerant fuels (ATFs);</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">access to and availability of nuclear test reactors and the risks associated with unexpected changes in our nuclear fuel development timeline;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">access to and availability of adequate resources and manufacturing capabilities at national laboratories that affect our nuclear fuel development timeline and project costs;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">the increased costs associated with metallization of our nuclear fuel;</td></tr></tbody></table></ix:continuation><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">17</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOC">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><ix:continuation id="cont_5e9f7f"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">uncertainties related to conducting business in foreign countries;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">public perception of nuclear energy generally;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">changes in laws, rules, and regulations governing our business;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">changes in the political environment;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">development and utilization of, and challenges to, our intellectual property domestically and abroad;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">the trading price of our securities is likely to be volatile, and purchasers of our securities could incur substantial losses; and</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">the other risks and uncertainties identified in Item 1A. Risk Factors included in our Annual Report on Form 10-K for the year ended December 31, 2024.</td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Most of these factors are beyond our ability to predict or control and you should not put undue reliance on any forward-looking statement. Future events and actual results could differ materially from those set forth in, contemplated by or underlying the forward-looking statements. Forward-looking statements speak only as of the date on which they are made. The Company assumes no obligation and does not intend to update these forward-looking statements for any reason after the date of the filing of this report, to conform these statements to actual results or to changes in our expectations, except as required by law.</p></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">18</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOC">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span class="atag" style="display: inline" id="i2"><strong>ITEM 2. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</strong></span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations, or MD&amp;A, is intended to help the reader understand Lightbridge Corporation, our operations, and our present business environment. MD&amp;A is provided as a supplement to, and should be read in conjunction with, our unaudited condensed consolidated financial statements and the accompanying notes thereto contained in Part I, Item 1 of this report, as well as those included in our Annual Report on Form 10-K for the year ended December 31, 2024. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">This MD&amp;A consists of the following sections:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">Overview of Our Business and Recent Developments of Lightbridge Fuel&#8482; - a general overview of our business and updates;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">Critical Accounting Estimates;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">Operations Review - an analysis of our condensed consolidated results of operations for the periods presented in our condensed consolidated financial statements; and</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">Liquidity, Capital Resources, and Financial Position - an analysis of our cash flows and an overview of our financial position.</td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As discussed in more detail under &#8220;Forward-Looking Statements&#8221; preceding this MD&amp;A, the following discussion contains forward-looking statements that are based on our management&#8217;s current expectations, estimates, and projections, which are subject to a number of risks and uncertainties. Our actual results may differ materially from those discussed in these forward-looking statements because of the risks and uncertainties inherent in future event<em>s, </em>including those set forth under &#8220;Forward-Looking Statements&#8221; and Part II. Item 1A. Risk Factors included herein.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span style="text-decoration:underline">OVERVIEW OF OUR BUSINESS AND DEVELOPMENT OF LIGHTBRIDGE FUEL</span></strong><strong><span style="text-decoration:underline"><sup style="vertical-align:super">TM</sup></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">When used in this Quarterly Report on Form 10-Q, the terms &#8220;Lightbridge,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; and &#8220;us&#8221; refer to Lightbridge Corporation together with its wholly-owned subsidiaries Lightbridge International Holding LLC and Thorium Power Inc. Lightbridge&#8217;s principal executive offices are located at 11710 Plaza America Drive, Suite 2000, Reston, Virginia, 20190, USA.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Our Business</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At Lightbridge, we are developing next generation nuclear fuel for water-cooled reactors that could significantly improve the economics and safety of existing and new nuclear power plants, large and small, and enhance proliferation resistance of spent nuclear fuel while supplying clean energy to the electric grid or to &#8220;behind the meter&#8221; customers for electric power, including data centers. We believe that the world&#8217;s energy and climate needs can only be met if nuclear power&#8217;s share of the energy-generating mix grows substantially in the coming decades. We believe Lightbridge can benefit from a growing nuclear power industry, and that our nuclear fuel can help enable that growth to happen. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We believe our metallic fuel will offer significant economic and safety benefits over traditional nuclear fuel, primarily because of the superior heat transfer properties and the resulting lower operating temperature of all-metal fuel.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Technology industry companies believe that nuclear energy can offer a strategic, sustainable, and reliable solution for powering data centers. Advances in reactor technology, combined with growing corporate and governmental support for clean energy, can position nuclear power as a cornerstone of future energy strategies for data-intensive industries. We believe that by integrating nuclear power, the data center sector can achieve operational efficiency, energy security, and sustainability. We believe uses of our fuel could include providing additional power via power uprates of existing reactors, which may be willing to pay a premium for reliable, clean, and sustainable baseload electricity. Oil and gas producing companies are investing in low-emission energy technologies to reduce fossil fuel emissions from oil and gas production. Advances in nuclear reactor and fuel technology can position nuclear power as a key energy source for this purpose.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Emerging nuclear technologies include small modular reactors (SMRs), which are now in the development and licensing phases. We expect that Lightbridge Fuel&#8482; can provide water-cooled SMRs with the same benefits our technology brings to large reactors, with such benefits being even more meaningful to the economic case for deployment of SMRs, including potential load following capability when included on a virtually zero-carbon electric grid with renewable energy sources. We expect Lightbridge Fuel&#8482; to enable power uprates in SMRs.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We have built a significant portfolio of patents, and we anticipate testing our nuclear fuel through third-party vendors and others, including the United States Department of Energy&#8217;s (DOE) national laboratories. Currently, we are performing the majority of our R&amp;D activities within and in collaboration with the DOE&#8217;s national laboratories. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">19</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOC">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Recent Developments of Lightbridge Fuel&#8482;</em></strong>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Memorandum of Understanding with Oklo, Inc.</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In January 2025, we signed a memorandum of understanding (MOU) with Oklo, Inc. Oklo is developing advanced micro-reactors to provide clean, reliable, and affordable energy at scale. The scope of the MOU includes the following areas: (1) to conduct a preliminary evaluation of feasibility of co-locating a Lightbridge Commercial-scale Fuel Fabrication Facility at Oklo&#8217;s proposed commercial fuel fabrication facility, (2) to explore opportunities for collaboration on reprocessing and recycling of spent uranium zirconium fuel, and (3) to explore any other areas of collaboration that may be of mutual interest. We believe there may be some potential synergies in co-locating our commercial scale fuel fabrication facility at Oklo&#8217;s proposed site. We also believe recycling and reprocessing spent uranium-zirconium fuel represents another area of potential synergies. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Idaho National Laboratory Agreements </span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In December 2022, Lightbridge entered into agreements with Battelle Energy Alliance, LLC (BEA), the DOE&#8217;s operating contractor for Idaho National Laboratory (INL), to support the development of Lightbridge Fuel&#8482;. The framework agreements use an innovative structure that consists of an &#8220;umbrella&#8221; Strategic Partnership Project Agreement (SPPA) and an &#8220;umbrella&#8221; Cooperative Research and Development Agreement (CRADA), each with BEA, with an initial duration of seven years. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We anticipate that the initial phase of work under the two agreements that has been released will culminate in casting and extrusion of unclad fuel material samples using enriched uranium supplied by the DOE that will subsequently be inserted for irradiation testing in the Advanced Test Reactor (ATR) at INL. The initial phase of work aims to generate irradiation performance data for Lightbridge&#8217;s delta-phase uranium-zirconium alloy relating to various thermophysical properties. The data will support fuel performance modeling and regulatory licensing efforts for commercial deployment of Lightbridge Fuel&#8482;. We use a rolling wave planning approach for project management purposes on the released scopes of work. It is an iterative planning technique in which the work to be accomplished in the near term is planned in detail, while work further in the future is planned at a higher level. As such, periodic revisions to the scope and/or cost estimates are anticipated. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 26, 2024 and October 24, 2024, the Company and BEA entered into Modifications No. 2 and No. 3 respectively, to PTS No. 1 under the SPPA, dated December 9, 2022, as amended on May 23, 2023, by and between the Company and BEA. Pursuant to the terms of Modifications No. 2 and No. 3, the potential amounts payable by the Company to reimburse BEA for its expenses and employee time were increased by approximately $0.6 million and $0.3 million, respectively, bringing the total estimated cost for the work to be performed under the &#8220;umbrella&#8221; SPPA to approximately $2.0 million. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 18, 2025, the Company and BEA entered into Modification No. 4 to the PTS No. 1 under the SPPA, dated December 9, 2022, as amended on May 23, 2023, March 26, 2024 and October 24, 2024, by and between the Company and BEA. Pursuant to the terms of Modification No. 4, the potential amounts payable by the Company to reimburse BEA for its expenses and employee time were increased by approximately $0.6 million, bringing the total estimated cost for the work to be performed under the &#8220;umbrella&#8221; SPPA to $2.6 million.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On January 16, 2025 the Company and BEA entered into Modification No. 3 to PTS No. 1 under the CRADA, dated September 27, 2022, as amended on May 22, 2023, May 30, 2023, by and between the Company and BEA. Pursuant to the terms of Modification No. 3, the potential amounts payable by the Company to reimburse BEA for its expenses and employee time were increased from $2.6 million by approximately $1.6 million, bringing the total estimated cost for the work to be performed under the &#8220;umbrella&#8221; CRADA to $4.2 million. This modification also required that a $0.6 million advance payment be made, which was paid on January 16, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">After accounting for all modifications, cash payments from Lightbridge to Battelle under both CRADA and SPPA are estimated at approximately $6.8 million on a cost reimbursable basis over the performance periods.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company anticipates entering into additional modifications to the Project Task Statements (PTS) under the SPPA and/or CRADA with INL to expand the scope of work, including performing additional extrusions, updating the experiment design for irradiation testing of coupon samples in the ATR, and other potential activities. The successful execution of this project is subject to risks, including potential delays, cost overruns, regulatory challenges, and changes in funding availability, and if the project scope does increase, then the project will be successfully executed or completed. Regardless of whether further project modifications occur, INL has indicated to the Company that due to resource and manufacturing equipment constraints, INL may not be able to meet the Company&#8217;s preferred project timeline, and that the total project cost will exceed the current budget.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We anticipate that subsequent phases of work under the two umbrella agreements that have not yet been released may include post-irradiation examination of the irradiated fuel material coupons, loop irradiation testing in the ATR, and post-irradiation examination of one or more uranium-zirconium fuel rodlets, as well as transient experiments in the Transient Reactor Test Facility at INL.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">20</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOC">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Romania Feasibility Study of Lightbridge Fuel&#8482; for use in CANDU reactors</span>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On October 16, 2023, we engaged Institutul de Cercet&#259;ri Nucleare Pite&#537;ti, a subsidiary of Regia Autonoma Tehnologii pentru Energia Nucleara (RATEN ICN) in Romania to perform an engineering study to assess the compatibility and suitability of Lightbridge Fuel&#8482; for use in CANDU reactors. This assessment covers key areas including mechanical design, neutronics analysis, and thermal and thermal-hydraulic evaluations. The findings from this engineering study will play an important role in guiding future economic evaluations and navigating potential regulatory licensing-related issues for potential use of Lightbridge Fuel&#8482; in CANDU reactors. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The results of this Feasibility Study indicated that Lightbridge Fuel&#8482; can double the discharged burnup in a CANDU reactor at U-235 enrichment levels of less than 3% compared to conventional uranium dioxide fuel. Based on these favorable initial results, we plan to continue further evaluation of Lightbridge Fuel&#8482; in CANDU reactors.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Nuclear Energy University Program Awards </span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Texas A&amp;M University (TAMU), NuScale Power, and Structural Integrity Associates are working on a 3-year study of our nuclear fuel, led by TAMU. The TAMU study is expected to be completed in 2026. In mid-2023, TAMU was awarded $1.0 million by the DOE&#8217;s Nuclear Energy University Program (NEUP) R&amp;D Awards to conduct this study. The project entails a characterization of the performance of the Lightbridge Fuel&#8482; Helical Cruciform advanced fuel design, which will generate sets of experimental data on friction factor, flow, and heat transfer behavior under NuScale&#8217;s SMR simulated normal and off-normal conditions. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We previously announced the ongoing NEUP project with the Massachusetts Institute of Technology (MIT). The study led by MIT and funded by DOE relates to evaluation of accident tolerant fuels (ATFs) in various SMRs. The project aims to simulate the fuel and safety performance of Lightbridge Fuel&#8482; for the NuScale SMR and provide scoping analysis to improve the safety and economics of water-cooled SMRs. In October 2024, MIT presented a technical paper with preliminary safety evaluation results at the TopFuel 2024 Conference in Grenoble, France. According to MIT, the results have shown promising safety and performance benefits for Lightbridge Fuel&#8482;. Compared to conventional fuel, Lightbridge Fuel&#8482; demonstrated improved thermal-hydraulic margins, lower operating temperatures, and greater potential for power uprates, which contributes to enhancing reactor economics.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We do not have any performance obligations with the collaboration teams working on the above-mentioned projects and will not receive any revenue or record any economic benefits from these awards.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Future Steps Toward Our Fuel Development and Timeline For The Commercialization of Our Nuclear Fuel Assemblies</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We anticipate fuel development milestones for Lightbridge Fuel&#8482; over the next 2-3 years will consist of the following:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>INL:</strong> To produce samples, coupons, and rodlets necessary for testing to be performed under our INL agreements. We will continue to execute the SPPA/CRADA work at INL leading to casting and extrusion of fuel material samples using enriched uranium and their subsequent insertion for irradiation testing in the ATR.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 30px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Modeling:</strong> Continue development and/or validation (benchmarking) of Lightbridge-specific methods and modifications to existing modeling codes to accurately predict Lightbridge Fuel&#8482; performance over the full domain of operating conditions for which Lightbridge Fuel&#8482; will be licensed.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 30px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Fuel Qualification Plan:</strong> Develop a Fuel Qualification Plan that describes our approach to characterizing and validating the performance our fuel rods, assemblies, and assembly components in relevant operation scenarios, and validation of the modeling tools that accurately describe the performance of Lightbridge Fuel&#8482; in the relevant conditions.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 30px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NRC Engagement Plan</strong>: Prepare and submit the Nuclear Regulatory Commission (NRC) Engagement Plan that outlines how and when Lightbridge will engage the NRC regarding submission of relevant information and supporting documentation for license applications.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 30px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Fabrication:</strong> Continue manufacturing efforts relating to establishing a manufacturing process for the co-extrusion of cladded rodlets for loop irradiation testing and other fuel testing. In addition, we plan to complete site selection and begin deployment of a Lightbridge Pilot Fuel Fabrication Facility (LPFFF) with capacity to produce fuel samples, fuel coupons, fuel rodlets, and full-length fuel rods for lead test rods and lead test assemblies for demonstration of our fuel in commercial reactors.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 30px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Thermal-Hydraulic Analysis and Experiments:</strong> Perform thermal-hydraulic modeling of Lightbridge Fuel&#8482; to prepare for a series of thermal-hydraulic experiments to confirm pressure drop, critical heat flux performance, and other thermal-hydraulic parameters of Lightbridge Fuel&#8482; under various operating conditions in different types of reactors.</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">21</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOC">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The long-term milestones towards development and commercialization of nuclear fuel assemblies include, among other things, irradiating nuclear material samples and prototype fuel rods with enriched uranium in test reactors, conducting post-irradiation examination of irradiated material samples and/or prototype fuel rods, performing thermal-hydraulic experiments, performing seismic and other out-of-reactor experiments, performing advanced computer modeling and simulations to support fuel qualification, designing a lead test assembly (LTA), entering into a lead test rod/assembly agreement(s) with a host reactor(s), demonstrating the production process of lead test rods and/or lead test assemblies at a pilot-scale fuel fabrication facility and demonstrating the operation of lead test rods and/or lead test assemblies in commercial reactors.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The above future steps describe our current proposed approach to deploying Lightbridge Fuel&#8482; in CANDU and/or U.S. pressurized water reactors (PWRs).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">There are inherent uncertainties in the cost and outcomes of the many steps needed for successful deployment of our fuel in commercial nuclear reactors, which makes it difficult to accurately predict the timing of the commercialization of our nuclear fuel technology. However, based on our best estimate and assuming adequate R&amp;D funding levels, we expect to begin demonstration of lead test rods and/or possibly LTAs with our metallic fuel in commercial reactors in the 2030s and begin receiving purchase orders for initial fuel reload batches from utilities 15-20 years from now, with deployment of our nuclear fuel in the first reload batch in a commercial reactor taking place approximately two years thereafter. We are exploring ways of shortening this timeframe that may include securing access to expanded irradiation test loop capacity in existing or new research reactor facilities. Lightbridge aims to engage early with relevant nuclear regulators to inform our future R&amp;D activities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span style="text-decoration:underline">CRITICAL ACCOUNTING ESTIMATES</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make a variety of estimates and assumptions that affect (i) the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and (ii) the reported amounts of revenues and expenses during the reporting periods covered by the financial statements. For a discussion of the accounting judgments and estimates that we have identified as critical in the preparation of our financial statements, please see &#8220;Critical Accounting Estimates&#8221; under Item 7, &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in our Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on March 3, 2025. There have been no significant changes in our critical accounting policies and estimates during the three months ended March 31, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our management expects to make judgments and estimates about the effect of matters that are inherently uncertain. As the number of variables and assumptions affecting the future resolution of the uncertainties increase, these judgments become even more subjective and complex. Although we believe that our estimates and assumptions are reasonable, actual results may differ significantly from these estimates. Changes in estimates and assumptions based upon actual results may have a material impact on our results of operations and/or financial condition.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span style="text-decoration:underline">OPERATIONS REVIEW</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Financial information is included in Part I, Item 1 of this Quarterly Report on Form 10-Q. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Condensed Consolidated Results of Operations - Three Months Ended March 31, 2025 and 2024</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following table presents our historical operating results and the change in amounts for the periods indicated (rounded to millions):</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three Months Ended </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Increase</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Increase</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>(Decrease)</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>(Decrease)</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Change $</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Change %</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Operating Expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:7.3pt">General and administrative</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.5</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.3</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">59</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:7.3pt">Research and development</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1.7</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1.0</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.7</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">70</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total Operating Expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.0</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">63</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Operating Loss</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(5.2 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(3.2 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.0</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">63</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt">Other Income</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.4</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.4</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;" colspan="2">&#8212;%</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net loss before Income Taxes</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(4.8 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2.8 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.0</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">71</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Loss</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(4.8 </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(2.8 </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">2.0</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">71</td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">22</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOC">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Operating Expenses</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">General and Administrative </span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">General and administrative expenses consist mostly of compensation and related costs for personnel and facilities, stock-based compensation, finance, human resources, information technology, fees for consulting and other professional services. Professional services are principally comprised of legal, audit, strategic advisory services, and outsourcing services.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">General and administrative expenses increased by $1.3 million for the three months ended March 31, 2025, as compared to the three months ended March 31, 2024. The increase primarily consisted of an increase in employee compensation and employee benefits of $0.2 million, an increase in consulting fees of $0.1 million, an increase in professional fees of $0.4 million, and an increase in stock-based compensation of $0.7 million primarily due to the accelerated vesting of RSAs issued to a former employee of $0.5 million, partially offset by a decrease in information technology and recruitment expenses of $0.1 million. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Total stock-based compensation included in general and administrative expenses was $1.1 million and $0.4 million for three months ended March 31, 2025 and March 31, 2024, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Research and Development</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">R&amp;D expenses consist primarily of costs associated with our CRADA and SPPA agreements with INL, employee compensation and related fringe benefits including stock-based compensation and other R&amp;D costs for the development of our Lightbridge Fuel&#8482;. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following table presents our total R&amp;D expenses, including internal costs and other outside R&amp;D costs, for the three months ended March 31, 2025 and 2024 (rounded to millions):</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">INL Project</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.8</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.4</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Romania Feasibility Study</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Centrus Energy FEED Study</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Allocated employee compensation and stock-based compensation expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.8</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Other outside R&amp;D expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">1.7</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">1.0</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">R&amp;D expenses increased by $0.7 million for the three months ended March 31, 2025, as compared to the three months ended March 31, 2024, due to the increase in R&amp;D activities related to the development of Lightbridge Fuel&#8482;. This increase primarily consisted of an increase in INL project labor costs of $0.4 million, and an increase in allocated employee compensation and employee benefits and stock-based compensation expenses of $0.6 million, partially offset by a decrease in R&amp;D expenses of $0.3 million due to two completed R&amp;D studies in 2024.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Total stock-based compensation included in research and development expenses was $0.2 million and $0.1 million for the three months ended March 31, 2025 and 2024, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We currently anticipate investing approximately $17.0 million in the R&amp;D of our nuclear fuel for the full year 2025. This future budgeted R&amp;D spending for the next 12 months is uncertain and actual spending may differ.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Due to the nature of our R&amp;D expenditures, future costs and schedule estimates are inherently uncertain and can vary significantly as new information and the outcome of these R&amp;D activities become available. Our future business operations are dependent on budgetary constraints due primarily to market conditions and the uncertainty of future liquidity and capital resources available to us to conduct our future R&amp;D activities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">23</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOC">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Other Income </span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company&#8217;s other income, consisting of interest income earned from the purchase of treasury bills and from our bank savings account for the three months ended March 31, 2025, was relatively constant, as compared to the three months ended March 31, 2024.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span style="text-decoration:underline">LIQUIDITY, CAPITAL RESOURCES AND FINANCIAL POSITION</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Liquidity Outlook </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We measure liquidity in terms of our ability to fund the cash requirements of our R&amp;D activities and our general and administrative expenses, including our contractual obligations and other commitments. We believe that based on our current level of operating expenses and currently available cash resources, we will have sufficient funds available to cover our business activities and operating cash needs for the next 12 months. In order to meet these long-term cash requirements for future planned operations to develop and commercialize our nuclear fuel, including any additional expenditures that may result from unexpected developments, it will be necessary for our project to receive direct or indirect funding and/or in-kind support from government and/or strategic partners and/or other third-party sources.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At March 31, 2025, we had cash and cash equivalents of $56.9 million, as compared to $40.0 million at December 31, 2024, an increase of $16.9 million. We raised net proceeds of $20.2 million from the sale of approximately 2.6 million shares of common stock for the three months ended March 31, 2025. Our net cash used in operating activities for the three months ended March 31, 2025, was $3.3 million and our cash flow projections indicate that we will have continued negative cash flows for the foreseeable future. We currently do not anticipate any incoming cash flows, other than the sale of common stock through our at-the-market (ATM) offering. We are not profitable, and we cannot provide any assurance that we will become profitable in the future. We will continue to incur losses because we are in the early R&amp;D development stage of our nuclear fuel.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">To complete the development and commercial deployment of Lightbridge Fuel&#8482; we currently estimate a total R&amp;D, including capital expenditures investment in the range of $200 million to $300 million or approximately $20.0 million per year over the next 10-15 years. We plan to raise this capital through a combination of strategic and financial investors, as well as potentially receiving grants from the DOE and/or other government sources.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Sufficient funding is needed to continue our nuclear fuel development project and to achieve our future R&amp;D milestones leading to the commercialization of our nuclear fuel. The actual amount of cash we will need to reach the commercialization of our nuclear fuel is subject to many factors, including, but not limited to, the timing, design and conduct of the R&amp;D work at the DOE&#8217;s national laboratories for our fuel along with other costs to commercialize our nuclear fuel. Accordingly, there is high potential for budget variances in the current above cost projections and fuel development timelines of our current planned operations over the above cited fuel development period. Currently, we plan to continue to utilize our ATM to finance our future R&amp;D and general and administrative activities. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We will also need to receive substantial funding and in-kind support from government, strategic partners and/or other third-party sources throughout our nuclear fuel R&amp;D development period in order to fund our ongoing R&amp;D efforts in the future. If we are unable to obtain such funding and/or in-kind support that meets our future R&amp;D cash requirements, we will need to seek other funding, which may include the issuance of additional shares of the Company&#8217;s common stock, if available. This will result in dilution to our existing stockholders. If we can raise additional funds through the issuance of preferred stock, other equity or convertible securities, these securities could have rights or preferences senior to those of our common stock and could contain covenants that restrict our operations in the future. There can be no assurance that we will be able to obtain additional equity or debt financing on terms acceptable to us, if at all.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We have approximately $61 million of working capital as of the date of this filing and this amount exceeds our anticipated cash requirements for the next 12 months. We currently project a negative cash flow from our operations from both our general and administrative and R&amp;D expenses, resulting in total expected expenditures of approximately $25.0 million for the full year 2025. Our R&amp;D expenses are expected to increase over the next 12 months as we continue advancing our nuclear fuel development program. There are inherent uncertainties in forecasting the R&amp;D and other expenditures that will be required in the future. We may also be unsuccessful in raising the capital necessary in the future to continue the R&amp;D development of our fuel. Once other anticipated agreements are finalized or other future R&amp;D agreements are entered into and the future R&amp;D expenses are known, we expect to incur a significantly higher level of future required R&amp;D expenses to further develop our fuel, resulting in higher negative monthly cash flows from operations in future periods.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">24</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOC">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our current source of cash available to us for the next 12 months, in addition to cash and cash equivalents on hand, is the potential funding from equity issuances pursuant to the at-the-market equity offering sales agreement, as amended, with Stifel, Nicolaus &amp; Company, Incorporated. We filed a shelf registration statement on Form S-3 with the Securities and Exchange Commission (SEC) on March 29, 2024, registering the sale of up to $75.0 million of the Company&#8217;s securities that was declared effective on April 19, 2024. On May 10, 2024, we filed a prospectus supplement, which was further supplemented on July 19, 2024 and August 9, 2024 (collectively, the &#8220;First Prospectus Supplement&#8221;) pursuant to which we may offer and sell shares of common stock having an aggregate offering price of up to $12.6 million from time to time, through the ATM. The Company exhausted all sales under the First Prospectus Supplement. On November 22, 2024, we filed a prospectus supplement pursuant to which we may offer and sell shares of common stock having an aggregate offering price of up to $45.0 million from time to time through the ATM. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Although we expect this ATM offering to continue to be our primary source of working capital for the Company in 2025, there is no assurance that an ATM financing arrangement will be available to us in the future. See Note 7. Stockholders&#8217; Equity and Stock-Based Compensation of the Notes to our Unaudited Condensed Consolidated Financial Statements included in Part I. Item 1. <em>Financial Statements,</em> of this Quarterly Report on Form 10-Q for information regarding our prior equity financings.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We have no debt or lines of credit, and we have financed our operations to date through the sale of our preferred stock and common stock. Management believes that public or private equity investments may be available in the future; however, adverse market conditions, in our common stock price and trading volume, as well as other factors could substantially impair our ability to raise capital in the future and continue developing our nuclear fuel.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Short-Term and Long-Term Liquidity Sources</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Currently, our primary source of liquidity is cash raised from our ATM offering.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As discussed above, we will seek new financing in order to bring us additional sources of capital, depending on the capital market conditions of our common stock. There can be no assurance that these additional sources of capital will be made available on terms acceptable to us, or at all. The primary potential sources of cash that may be available to us are as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">equity or debt investment from third-party investors in Lightbridge;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">collaboration with potential industry partners; and</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">strategic investment and/or government funding to support the remaining R&amp;D activities required to continue the development of our fuel products and move them to a commercial stage.</td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In support of our long-term business with respect to our fuel technology business, we endeavor to create strategic alliances with other parties to support the remaining R&amp;D activities that are required to further enhance and complete the development of our fuel products to a commercial stage. We may be unable to form such strategic alliances on terms acceptable to us or at all.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">See Note 7. Stockholders&#8217; Equity and Stock-Based Compensation of the Notes to our Unaudited Condensed Consolidated Financial Statements included in Part I. Item 1. <em>Financial Statements,</em> of this Quarterly Report on Form 10-Q for information regarding our prior equity financings.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Cash Flow</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following table provides detailed information about our net cash flows for the three months ended March 31, 2025 and 2024 (rounded in millions):</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Cash Used in Operating Activities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(3.3 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(1.9 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Cash Used in Investing Activities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Cash Provided by Financing Activities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">20.2</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1.2</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Cash Inflow (Outflow)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">16.9</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(0.7 </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">25</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOC">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Operating Activities</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Cash used in operating activities increased by $1.4 million for the three months ended March 31, 2025 as compared to the three months ended March 31, 2024. This increase was primarily due to increased spending on R&amp;D and general and administrative expenses.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Financing Activities</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Cash provided by financing activities increased by $19.0 million for the three months ended March 31, 2025 as compared to the three months ended March 31, 2024. This increase was primarily due to an increase in the net proceeds received from the issuance of common stock under our ATM offering of $19.0 million and net proceeds from the exercise of stock options of 0.2 million, partially offset by an increase in net share settlement of equity awards for the payment of withholding taxes of $0.2 million.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Cash provided by our ATM offering was $20.2 million (sale of approximately 2.6 million common shares) and $1.2 million (sale of approximately 0.4 million common shares) for the three months ended March 31, 2025 and 2024, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Inflation</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our business, revenues, and operating results have not been affected in any material way by inflation.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="i3">ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company is not required to provide the information required by this Item as it is a &#8220;smaller reporting company,&#8221; as defined in Rule 12b-2 of the Exchange Act.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span class="atag" style="display: inline" id="i4"><strong>ITEM 4. CONTROLS AND PROCEDURES</strong></span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Evaluation of Disclosure Controls and Procedures</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company maintains disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the Exchange Act)) that are designed to provide reasonable assurance that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is (a) recorded, processed, summarized and reported, within the time periods specified in the SEC&#8217;s rules and forms, and (b) accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating such controls and procedures, the Company recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our management, under the supervision and with the participation of our principal executive officer and principal financial officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of March 31, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Changes in Internal Control Over Financial Reporting</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">There were no changes in the Company&#8217;s internal control over financial reporting during the first quarter of 2025 that have materially affected, or are reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">26</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOC">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span class="atag" style="display: inline" id="p2"><strong>PART II-OTHER INFORMATION</strong></span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span class="atag" style="display: inline" id="p2i1"><strong>ITEM 1. LEGAL PROCEEDINGS</strong></span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">From time to time, we may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. We are currently not aware of any such legal proceedings or claims that we believe, either individually or in the aggregate, will have a material adverse effect on our business, financial condition, or results of operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span class="atag" style="display: inline" id="p2i1a"><strong>ITEM 1A. RISK FACTORS</strong></span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">There have been no material changes to our risk factors from the risk factors disclosed in our Annual Report on Form 10-K for the year ended December 31, 2024.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="p2i2">ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES OR USE OF PROCEEDS</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">None.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span class="atag" style="display: inline" id="p2i3"><strong>ITEM 3. DEFAULTS UPON SENIOR SECURITIES</strong></span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Not Applicable</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span class="atag" style="display: inline" id="p2i4"><strong>ITEM 4. MINE SAFETY DISCLOSURES</strong></span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Not Applicable</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">27</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOC">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="p2i5">ITEM 5. OTHER INFORMATION</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Trading Arrangements</em> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The adoption or termination of contracts, instructions or written plans for the purchase or sale of our securities by our Section 16 officers and directors for the three months ended March 31, 2025, each of which is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (a &#8220;Rule 10b5-1 Plan&#8221;) and was adopted during an open trading window, with no sales commencing under the plan until completion of the required cooling off period under Rule 10b5-1, were as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:19%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Name</strong></p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:17%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Title</strong></p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:12%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Action</strong></p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:14%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Date Adopted</strong></p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:14%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Expiration Date</strong></p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:19%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Aggregate # of</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Securities to be</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Purchased/Sold</strong></p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric id="fid_463" contextRef="From2025-01-01to2025-03-31" name="ltbr:TrdArrIndNameOne">Jesse Funches</ix:nonNumeric><sup style="vertical-align:super">(1)</sup></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric id="fid_467" contextRef="From2025-01-01to2025-03-31" name="ltbr:TrdArrIndTitleOne">Director</ix:nonNumeric></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric id="fid_471" contextRef="From2025-01-01to2025-03-31" name="ltbr:Rule10b51ArrAdoptedOneFlag" format="ixt:booleantrue">Adoption</ix:nonNumeric></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric id="fid_475" contextRef="From2025-01-01to2025-03-31" name="ltbr:TrdArrAdoptionDateFirst">1/9/2025</ix:nonNumeric></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric id="fid_479" contextRef="From2025-01-01to2025-03-31" name="ltbr:TrdArrExpirationDateOne">4/9/2026</ix:nonNumeric></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonFraction id="fid_483" contextRef="AsOf2025-03-31" name="ltbr:TrdArrSecuritiesAggAvailAmtOne" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">6,250</ix:nonFraction></p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric id="fid_464" contextRef="From2025-01-01to2025-03-31" name="ltbr:TrdArrIndNameTwo">Mark Tobin</ix:nonNumeric><sup style="vertical-align:super">(2)</sup></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric id="fid_468" contextRef="From2025-01-01to2025-03-31" name="ltbr:TrdArrIndTitleTwo">Director</ix:nonNumeric></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric id="fid_472" contextRef="From2025-01-01to2025-03-31" name="ltbr:Rule10b51ArrAdoptedTwoFlag" format="ixt:booleantrue">Adoption</ix:nonNumeric></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric id="fid_476" contextRef="From2025-01-01to2025-03-31" name="ltbr:TrdArrAdoptionDateSecond">1/13/2025</ix:nonNumeric></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric id="fid_480" contextRef="From2025-01-01to2025-03-31" name="ltbr:TrdArrExpirationDateTwo">6/1/2026</ix:nonNumeric></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonFraction id="fid_484" contextRef="AsOf2025-03-31" name="ltbr:TrdArrSecuritiesAggAvailAmtTwo" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">6,000</ix:nonFraction></p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric id="fid_465" contextRef="From2025-01-01to2025-03-31" name="ltbr:TrdArrIndNameThird">Sherri Goodman</ix:nonNumeric><sup style="vertical-align:super">(3)</sup></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric id="fid_469" contextRef="From2025-01-01to2025-03-31" name="ltbr:TrdArrIndTitleThree">Director</ix:nonNumeric></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric id="fid_473" contextRef="From2025-01-01to2025-03-31" name="ltbr:Rule10b51ArrAdoptedThreeFlag" format="ixt:booleantrue">Adoption</ix:nonNumeric></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric id="fid_477" contextRef="From2025-01-01to2025-03-31" name="ltbr:TrdArrAdoptionDateThird">1/24/2025</ix:nonNumeric></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric id="fid_481" contextRef="From2025-01-01to2025-03-31" name="ltbr:TrdArrExpirationDateThree">4/24/2026</ix:nonNumeric></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonFraction id="fid_485" contextRef="AsOf2025-03-31" name="ltbr:TrdArrSecuritiesAggAvailAmtThree" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">7,000</ix:nonFraction></p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric id="fid_466" contextRef="From2025-01-01to2025-03-31" name="ltbr:TrdArrIndNameFourth">Larry Goldman</ix:nonNumeric><sup style="vertical-align:super">(4)</sup></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric id="fid_470" contextRef="From2025-01-01to2025-03-31" name="ltbr:TrdArrIndTitleFour">Chief Financial Officer</ix:nonNumeric></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric id="fid_474" contextRef="From2025-01-01to2025-03-31" name="ltbr:Rule10b51ArrAdoptedFourFlag" format="ixt:booleantrue">Adoption</ix:nonNumeric></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric id="fid_478" contextRef="From2025-01-01to2025-03-31" name="ltbr:TrdArrAdoptionDateFourth">3/7/2025</ix:nonNumeric></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric id="fid_482" contextRef="From2025-01-01to2025-03-31" name="ltbr:TrdArrExpirationDateFour">6/8/2026</ix:nonNumeric></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Indeterminable<sup style="vertical-align:super">(4)</sup></p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(1)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Jesse Funches, Director, entered into a pre-arranged stock trading plan pursuant to Rule 10b5-1 on January 9, 2025. Mr. Funches&#8217;s plan provides for the sale, subject to certain price limits, of up to 6,250 shares of the Company&#8217;s common stock in the aggregate. The plan terminates on April 9, 2026, unless terminated sooner in accordance with its terms.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 30px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(2)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Mark Tobin, Director, entered into a pre-arranged stock trading plan pursuant to Rule 10b5-1 on January 13, 2025. Mr. Tobin&#8217;s plan provides for the sale at market price, of up to 6,000 shares of the Company&#8217;s common stock in the aggregate. The plan terminates on June 1, 2026, unless terminated sooner in accordance with its terms.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 30px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(3)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Sherri Goodman, Director, entered into a pre-arranged stock trading plan pursuant to Rule 10b5-1 on January 24, 2025. Ms. Goodman&#8217;s plan provides for the sale at market price, of up to 7,000 shares of the Company&#8217;s common stock in the aggregate. The plan terminates on April 24, 2026, unless terminated sooner in accordance with its terms.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 30px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(4)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Larry Goldman, Chief Financial Officer, entered into a pre-arranged stock trading plan pursuant to Rule 10b5-1 on March 7, 2025. Mr. Goldman&#8217;s plan covers sales of 140,349 shares of common stock at certain price limits, which includes 54,912 shares subject to future vesting under restricted stock awards and net of any shares withheld to satisfy tax withholding obligations upon vesting. The plan terminates on June 8, 2026, unless terminated sooner in accordance with its terms.</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For the three months ended March 31, 2025, no other director or officer of the Company adopted, modified or&#160;terminated&#160;a &#8220;Rule 10b5-1 trading arrangement&#8221; or &#8220;non-Rule 10b5-1 trading arrangement,&#8221; as each term is defined in Item 408(a) of Regulation S-K.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">28</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOC">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="p2i6">ITEM 6. EXHIBITS</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>EXHIBIT INDEX - </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;width:8%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;<strong>Exhibit</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Number</strong></p></td><td style="width:2%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Description </strong></p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="http://www.sec.gov/Archives/edgar/data/1084554/000147793225001398/ltbr_ex31.htm">3.1</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="http://www.sec.gov/Archives/edgar/data/1084554/000147793225001398/ltbr_ex31.htm">Certificate of Designation of Series X Preferred Stock (incorporated by reference to Exhibit 3.1 to the Form 8-K filed by the Company on March 3, 2025).</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="http://www.sec.gov/Archives/edgar/data/1084554/000147793225003492/ltbr_ex31.htm">3.2</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="http://www.sec.gov/Archives/edgar/data/1084554/000147793225003492/ltbr_ex31.htm">Certificate of Withdrawal of Series X Preferred Stock (incorporated by reference to Exhibit 3.1 to the Form 8-K filed by the Company on May 9, 2025).</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="ltbr_ex33.htm">3.3*</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="ltbr_ex33.htm">Articles of Incorporation of the Company, as amended through May 8, 2025.</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="http://www.sec.gov/Archives/edgar/data/1084554/000147793225000327/ltbr_ex101.htm">10.1&#9650;</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="http://www.sec.gov/Archives/edgar/data/1084554/000147793225000327/ltbr_ex101.htm">Modification No. 3 to the Project Task Statement, dated January 16, 2025, under the Cooperative Research and Development Agreement, dated December 9, 2022, by and between Lightbridge Corporation and Battelle Energy Alliance, LLC (incorporated by reference to Exhibit 10.1 to the Form 8-K filed by the Company on January 17, 2025).</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="ltbr_ex102.htm">10.2*&#9650;</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="ltbr_ex102.htm">Modification No. 4 to the Project Task Statement, dated March 18, 2025, under the Strategic Partnership Project Agreement, dated December 9, 2022, as amended on May 23, 2023, March 26, 2024 and October 24, 2024, by and between Lightbridge Corporation and Battelle Energy Alliance, LLC. </a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="http://www.sec.gov/Archives/edgar/data/1084554/000147793225001398/ltbr_ex101.htm">10.3</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="http://www.sec.gov/Archives/edgar/data/1084554/000147793225001398/ltbr_ex101.htm">Subscription and Investor Representation Agreement, dated February 27, 2025, by and between the Company and the Purchaser (incorporated by reference to Exhibit 10.1 to the Form 8-K filed by the Company on March 3, 2025).</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="ltbr_ex104.htm">10.4*&#8224;</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="ltbr_ex104.htm">Form of Performance-Based Restricted Stock Award Agreement.</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="ltbr_ex311.htm">31.1*</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="ltbr_ex311.htm">Rule 13a-14(a)/15d-14(a) Certification - Principal Executive Officer.</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="ltbr_ex312.htm">31.2*</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="ltbr_ex312.htm">Rule 13a-14(a)/15d-14(a) Certification - Principal Financial Officer.</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="ltbr_ex32.htm">32*</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="ltbr_ex32.htm">Section 1350 Certifications.</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">101</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Interactive data files pursuant to Rule 405 of Regulation S-T.</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">101.INS</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">101.SCH</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Inline XBRL Taxonomy Extension Schema Document.</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">101.CAL</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Inline XBRL Taxonomy Extension Calculation Linkbase Document.</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">101.DEF</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Inline XBRL Taxonomy Extension Definition Linkbase Document.</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">101.LAB</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Inline XBRL Taxonomy Extension Labels Linkbase Document.</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">101.PRE</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Inline XBRL Taxonomy Extension Presentation Linkbase Document.</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">104</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">* Filed or furnished herewith </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9650; Certain portions of this Exhibit have been redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K. The Company agrees to furnish supplementally an unredacted copy of this Exhibit to the SEC upon request.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#8224; Management contracts or compensation plans or arrangements in which directors or executive officers participate.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">29</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOC">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="sig">SIGNATURES</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>LIGHTBRIDGE CORPORATION </strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="width:50%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:5%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:35%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:10%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Date: May 12, 2025</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">By: </p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>/s/ Seth Grae</em></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Name: </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Seth Grae </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Title: </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">President, Chief Executive Officer, and Director </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(Principal Executive Officer) </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">By: </p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>/s/ Larry Goldman </em></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Name:</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Larry Goldman </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Title: </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Chief Financial Officer </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(Principal Financial Officer and Principal Accounting Officer) </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">30</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.3
<SEQUENCE>2
<FILENAME>ltbr_ex33.htm
<DESCRIPTION>ARTICLES OF INCORPORATION
<TEXT>
<html><head><title>ltbr_ex33.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman; MARGIN-LEFT: 7%; MARGIN-RIGHT: 7%"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT 3.3</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>ARTICLES OF INCORPORATION</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>OF</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>LIGHTBRIDGE CORPORATION</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">As amended through May 8, 2025</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">1. <strong>Name of Corporation.</strong> The name of this corporation is Lightbridge Corporation.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">2. <strong>Resident Agent.</strong> The resident agent of this corporation in Nevada is CSC Services Of Nevada, Inc. whose address is 2215-B Renaissance Drive, Las Vegas, Clark County, Nevada 89119.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">3. <strong>Purposes; Powers.</strong> The purposes for which the corporation is formed and its powers are:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">3.1 To conduct such business as is lawful.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">3.2 To purchase, acquire, hold, mortgage, sell, let, lease or otherwise dispose of or deal in real or personal property of every kind, character and description, and to erect, manage, care for, maintain, extend or alter buildings or structures of any kind or character on real property.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">3.3 To purchase or otherwise acquire, hold and/or reissue the shares of its capital stock.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">3.4 To raise, borrow and secure the payment of money in any lawful manner, including the issue and sale or other disposition of bonds, warrants, debentures, obligations, negotiable and transferable instruments and evidences of indebtedness of all kinds, whether secured by mortgage, pledge, deed of trust, or otherwise, and incur debt in the purchase or acquisition of property, businesses, rights or franchises, or for additional working capital or for any other object connected with its business or affairs, without limit as to amount.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">3.5 To enter into, make, perform and carry out contracts of every sort and kind with any person, firm, association, corporation, private, public or municipal or body politic.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">3.6 To guarantee any dividends or bonds or contracts or other obligations.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">3.7 To have one or more offices or agencies and keep such books of the company outside of Nevada as are not required by law to be kept in Nevada.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">4. <strong>Authorized Capital.</strong> The aggregate number of shares that the corporation will have authority to issue is one hundred and ten million (110,000,000), of which one hundred million (100,000,000) shares will be common stock, with a par value of $0.001 per share, and ten million (10,000,000) shares will be preferred stock, with a par value of $0.001 per share. This preferred stock may be divided into and issued in series, each of which shall be so designated as to distinguish the shares thereof from the shares of all other series and classes. The board of directors of the corporation is authorized, within any limitations prescribed by law, to fix and determine the designations, qualifications, preferences, limitations and terms of the shares of any series of preferred stock.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">5. <strong>Stock Nonassessable.</strong> The capital stock of this corporation shall not be subject to assessment to pay the debts of the corporation, and in this particular the Articles of Incorporation shall not be subject to amendment.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">1</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">6. <strong>Board of Directors.</strong> The members of the governing board shall be styled &#8220;Directors&#8221; and their number shall not be less than one (1) nor more than fifteen (15).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">7. <strong>Liability of Directors and Officers.</strong> No director or officer shall have personal liability to the corporation or its shareholders for damages for breach of fiduciary duty as a director or officer, but nothing herein shall eliminate or limit the liability of a director or officer for: 7.1 Acts or omissions not in good faith; 7.2 Acts or omissions which involve intentional misconduct, fraud or violation of law; 7.3 Acts or omissions in breach of the director&#8217;s or officer&#8217;s duty of loyalty to the corporation or its shareholders; 7.4 Acts or omissions from which the director or officer derived an improper personal benefit; or 7.5 Payment of dividends in violation of law.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">8. <strong>Indemnification.</strong> The corporation shall indemnify, to the full extent and in the manner permitted under the laws of Nevada and any other applicable laws, any person made or threatened to be made a party to an action or proceeding, whether criminal, civil, administrative or investigative, by reason of the fact that he is or was a director or officer of this corporation or served any other enterprise as a director or officer at the request of this corporation; such right of indemnification shall also be applicable to the executors, administrators and other similar legal representative of any such director or officer. The provisions of this Section shall be deemed to be a contract between the corporation and each director and officer who serves in such capacity at any time while this Section is in effect, and any repeal or modification of this Section shall not affect any rights or obligations then existing with respect to any state of facts then existing or any action, suit or proceeding brought based in whole or in part upon any such state of facts. The foregoing rights of indemnification shall not be deemed exclusive of any other rights to which any director or officer or his legal representative may be entitled apart from the provisions of this Section.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">9. <strong>Perpetual Existence.</strong> This corporation shall have perpetual existence.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">10. <strong>By-Laws. </strong>The Board of Directors is expressly authorized and empowered to adopt, amend or repeal the By-Laws of this corporation.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">2</td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ltbr_ex102.htm
<DESCRIPTION>MODIFICATION
<TEXT>
<html><head><title>ltbr_ex102.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman; MARGIN-LEFT: 7%; MARGIN-RIGHT: 7%"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT 10.2</strong></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="ltbr_ex32img1.jpg">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;">&nbsp;</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="ltbr_ex32img2.jpg">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;">&nbsp;</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="ltbr_ex32img3.jpg">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;">&nbsp;</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="ltbr_ex32img4.jpg">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;">&nbsp;</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="ltbr_ex32img5.jpg">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;">&nbsp;</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="ltbr_ex32img6.jpg">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;">&nbsp;</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="ltbr_ex32img7.jpg">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;">&nbsp;</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="ltbr_ex32img8.jpg">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;">&nbsp;</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="ltbr_ex32img9.jpg">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;">&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>4
<FILENAME>ltbr_ex104.htm
<DESCRIPTION>MODIFICATION
<TEXT>
<html><head><title>ltbr_ex104.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman; MARGIN-LEFT: 7%; MARGIN-RIGHT: 7%"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT 10.4<br>&nbsp;</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>LIGHTBRIDGE CORPORATION</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020 OMNIBUS INCENTIVE PLAN</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>PERFORMANCE-BASED RESTRICTED STOCK AWARD AGREEMENT</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The Compensation Committee of the Board of Directors (the &#8220;<strong>Board</strong>&#8221;) of Lightbridge Corporation, a Nevada corporation (the &#8220;<strong>Company</strong>&#8221;), granted an award of shares of Performance-Based Restricted Stock Awards (the &#8220;<strong>Shares</strong>&#8221;), under the Lightbridge Corporation 2020 Omnibus Incentive Plan (the &#8220;<strong>Plan</strong>&#8221;), to the Grantee named below. This Performance-Based Restricted Stock Award Agreement (the &#8220;<strong>Agreement</strong>&#8221;) evidences the terms of the Company&#8217;s grant of the Shares on the terms and subject to the conditions set forth herein and in the Plan. Any capitalized term in this Agreement shall have the meaning assigned to it in this Agreement or in the Plan, as applicable.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>A. NOTICE OF GRANT</strong></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Name of Grantee:</strong><u id="del_u0137010d-17bf-4e78-937f-95b02a3770a8"></u></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Number of Shares of Performance-Based Restricted Stock Awards: </strong></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Grant Date:</strong></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Vesting Condition: </strong>Except as provided otherwise in this Agreement or the Plan (including but not limited to Section 10(c) of the Plan which provides for accelerated vesting upon certain terminations in connection with a Change of Control), and subject to Grantee&#8217;s continuous Service (as defined below), the Shares shall vest, and the forfeiture provisions set forth in this Agreement shall lapse as follows:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">[<em>Insert Vesting Schedule</em>]</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>B.</strong> <strong>PERFORMANCE-BASED RESTRICTED STOCK AWARD AGREEMENT</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;"><strong>1.</strong> <strong>Grant of Restricted Stock. </strong>Subject to the terms and conditions of this Agreement and the Plan, the Company granted to Grantee the number of Shares set forth in the Notice of Grant, effective on the Grant Date set forth in the Notice of Grant, and subject to the terms and conditions of the Plan, which is incorporated herein by reference.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The Shares will be issued by the Company in book entry form only, in the name of the Grantee. The Grantee agrees that the Shares shall be subject to the restrictions on transfer set forth in Section 2 of this Agreement and the forfeiture provisions set forth in Section 4 of this Agreement. In the event of a conflict between the terms and conditions of the Plan and this Agreement, the terms and conditions of the Plan shall govern.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;"><strong>2. Transfer Restrictions<em>.</em></strong> Grantee shall not sell, transfer, assign, pledge or otherwise encumber or dispose of, by operation of law or otherwise, the Shares, or any interest therein, until such Shares have vested.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;"><strong>3. Vesting; Lapse of Restrictions<em>. </em></strong>Except as provided otherwise in this Agreement and the Plan (including but not limited to Section 10(c) of the Plan which provides for accelerated vesting upon certain terminations in connection with a Change of Control), provided the Compensation Committee determines that the Vesting Condition described in the Notice of Grant has been satisfied, if Grantee has been in continuous service to the Company or another entity the service providers of which are eligible to receive Awards under the Plan from the Grant Date through the third anniversary of the [Grant Date] (the &#8220;<strong>Vesting Date</strong>&#8221;) as an employee, director, consultant and/or advisor (herein referred to as &#8220;<strong>Service</strong>&#8221;), the Shares shall vest on the Vesting Date. For the avoidance of doubt, the change in Grantee&#8217;s status from one type of service to another, such as from employee to consultant, shall not by itself cause Grantee&#8217;s Service to terminate. If the Shares have vested, as soon as practicable after the Vesting Date, the Company will cause the restrictive legends, as set forth in Section 6 of this Agreement, to be removed. Only following the removal of such restrictive legends may the Grantee transfer the Shares (subject to applicable securities law requirements and the Company&#8217;s policies and procedures).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">1</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;"><strong>4. Termination of Service. </strong>If Grantee terminates Service prior to the Vesting Date for any reason, or the Compensation Committee determines that the Vesting Condition has not been satisfied, Grantee shall not be entitled to any Shares, Grantee shall forfeit all of Grantee&#8217;s right, title and interest in and to the unvested Shares as of the earlier of the date of termination or the date of such determination, and such unvested Shares shall revert to the Company without further consideration or any act or action by Grantee. Section 10(c) of the Plan provides for accelerated vesting with respect to certain terminations in connection with a Change of Control.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;"><strong>5. Leave of Absence. </strong>For purposes of the Shares, Service does not terminate when Grantee goes on a <em>bona fide </em>employee leave of absence that was approved by the Company or an Affiliate in writing, if the terms of the leave provide for continued Service crediting, or when continued Service crediting is required by applicable law. However, Service will be treated as terminating 90 days after Grantee went on the approved leave, unless Grantee&#8217;s right to return to active work is guaranteed by law or by a contract. Service terminates in any event when the approved leave ends unless Grantee immediately returns to active Service. The Compensation Committee determines, in its sole discretion, which leaves of absence count for this purpose, and when Service terminates for all purposes under the Plan.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;"><strong>6. Restrictive Legends. </strong>The book entry account reflecting the issuance of the Shares in the name of the Grantee shall bear a legend or other notation upon substantially the following terms:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">&#8220;These shares of stock are subject to forfeiture provisions and restrictions on transfer set forth in a certain Performance-Based Restricted Stock Award Agreement between the corporation and the registered owner of these shares (or his or her predecessor in interest), and such Agreement is available for inspection without charge at the office of the Secretary of the corporation.&#8221;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;"><strong>7. Rights as Shareholder.</strong> Except as otherwise provided in this Agreement, for so long as Grantee is the registered owner of the Shares, Grantee shall have all rights as a shareholder with respect to the Shares, whether vested or unvested, including, without limitation, rights to vote the Shares and act in respect of the Shares at any meeting of shareholders; provided that any dividends (whether paid in cash, stock or property) declared and paid by the Company with respect to unvested Shares shall be paid to Grantee only if and when such Shares vest as provided in Section 7(c)(1) of the Plan. If Grantee forfeits any rights he or she may have to the Shares in accordance with Section 4, Grantee shall no longer have any rights as a shareholder with respect to the unvested Shares or any interest therein and Grantee shall no longer be entitled to receive any Unvested Dividends relating to such Shares.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;"><strong>8. Payment of Taxes.</strong> No later than 30 days after the Grant Date, Grantee may make an election to be taxed upon such award under Section 83(b) of the Code. Grantee will, no later than the date as of which any amount related to the Shares first becomes includable in Grantee&#8217;s gross income for federal income tax purposes, pay to the Company, or make other arrangements satisfactory to the Board regarding payment of, any federal, state and local or other income and employment taxes of any kind required by law to be withheld with respect to such amount. The obligations of the Company under this Agreement will be conditional on such payment or arrangements, and the Company, and, where applicable, its Affiliates will, to the extent permitted by law, have the right to deduct any such taxes from any payment of any kind otherwise due to Grantee. The withholding requirement may be satisfied, in whole or in part, at the election of the Company, by allowing Grantee to surrender to the Company a number of Shares from this award having a fair market value (valued in the manner determined by (or in a manner approved by) the Company) on the date of withholding equal to the Company&#8217;s minimum statutory withholding obligations (based on minimum statutory withholding rates for federal and state tax purposes, including payroll taxes, that are applicable to such supplemental taxable income), except that, to the extent that the Company is able to retain Shares having a fair market value (determined by, or in a manner approved by, the Company) that exceeds the statutory minimum applicable withholding tax without financial accounting implications or the Company is withholding in a jurisdiction that does not have a statutory minimum withholding tax, the Company may retain such number of Shares (up to the number of Shares having a fair market value equal to the maximum individual statutory rate of tax (determined by, or in a manner approved by, the Company)) as the Company shall determine in its sole discretion to satisfy the applicable tax liability.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">2</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;"><strong>9. Effect of Prohibited Transfer.</strong> If any transfer of Shares is made or attempted to be made contrary to the terms of this Agreement, the Company shall have the right to disregard such transfer and to terminate this award of Shares as a result of such prohibited transfer. In addition to any other legal or equitable remedies it may have, the Company may enforce its rights to specific performance to the extent permitted by law and may exercise such other equitable remedies then available. The Company may refuse for any purpose to recognize any transferee who receives Shares contrary to the provisions of this Agreement as a holder of the Shares.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;"><strong>10. Investment Representations.</strong> The Compensation Committee may require Grantee (or Grantee&#8217;s estate or heirs) to represent and warrant in writing that the individual is acquiring the Shares for investment purposes and without any present intention to sell or distribute such Shares and to make such other representations as are deemed necessary or appropriate by the Company and its counsel.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;"><strong>11. Continued Service. </strong>Neither the grant of the Shares nor this Agreement gives Grantee the right to continue Service with the Company or its Affiliates in any capacity. The Company and its Affiliates reserve the right to terminate Grantee&#8217;s Service at any time and for any reason not prohibited by law.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;"><strong>12. Governing Law.</strong> The validity and construction of this Agreement and the Plan shall be construed in accordance with and governed by the laws of the State of Nevada other than any conflicts or choice of law rule or principle that might otherwise refer construction or interpretation of the Plan and this Agreement to the substantive laws of any other jurisdiction.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;"><strong>13.</strong> <strong>Binding Effect.</strong> This Agreement shall be binding upon and inure to the benefit of the Company and Grantee and their respective heirs, executors, administrators, legal representatives, successors and assigns.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;"><strong>14.</strong> <strong>Tax Treatment<em>. </em></strong>Grantee may incur tax liability as a result of the grant of the Shares, the payment of dividend equivalents or the disposition of the Shares upon the vesting of the Shares. Grantee should consult his or her own tax adviser for tax advice.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;"><strong>15.</strong> <strong>Amendment.</strong> The terms and conditions set forth in this Agreement may only be amended by the written consent of the Company and Grantee, except to the extent set forth in the Plan.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;"><strong>16.</strong> <strong>2020 Omnibus Incentive Plan. </strong>The Shares and payment of dividend equivalents granted hereunder shall be subject to such additional terms and conditions as may be imposed under the terms of the Plan, a copy of which has been provided to Grantee. A copy of the Prospectus for the 2020 Omnibus Incentive Plan shall also be provided to Grantee.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr"></td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">3</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td></td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td></td> <td colspan="2"> <p style="margin:0px"><strong>LIGHTBRIDGE CORPORATION</strong></p></td> <td></td></tr> <tr style="height:15px"> <td style="width:50%;"></td> <td style="width:5%;"></td> <td style="width:35%;"></td> <td style="width:10%;"></td></tr> <tr style="height:15px"> <td></td> <td> <p style="margin:0px">By:</p></td> <td style="BORDER-BOTTOM: 1px solid;"></td> <td></td></tr> <tr style="height:15px"> <td></td> <td> <p style="margin:0px">Name:</p></td> <td></td> <td></td></tr> <tr style="height:15px"> <td></td> <td> <p style="margin:0px">Title:</p></td> <td></td> <td></td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">4</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>ltbr_ex311.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<html><head><title>ltbr_ex311.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman; MARGIN-LEFT: 7%; MARGIN-RIGHT: 7%"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT 31.1</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Certification of Principal Executive Officer</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">I, Seth Grae, certify that: </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">1.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">I have reviewed this Quarterly Report on Form 10-Q of Lightbridge Corporation;</p></td></tr> <tr style="height:15px"> <td></td> <td></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">2.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</p></td></tr> <tr style="height:15px"> <td></td> <td></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">3.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</p></td></tr> <tr style="height:15px"> <td></td> <td></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">4.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"></td> <td style="width:4%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">a.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p></td></tr> <tr style="height:15px"> <td></td> <td></td> <td></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">b.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p></td></tr> <tr style="height:15px"> <td></td> <td></td> <td></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">c.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</p></td></tr> <tr style="height:15px"> <td></td> <td></td> <td></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">d.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">5.</p></td> <td colspan="2" style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"></td> <td style="width:4%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">a.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</p></td></tr> <tr style="height:15px"> <td></td> <td></td> <td></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">b.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:50%;"> <p style="MARGIN: 0px; text-align:justify;">Date: May 12, 2025</p></td> <td style="width:3%;"> <p style="MARGIN: 0px; text-align:justify;">By:</p></td> <td style="BORDER-BOTTOM: 1px solid;width:35%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;"><em>/s/ Seth Grae </em></p></td> <td style="width:12%;"></td></tr> <tr style="height:15px"> <td></td> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Seth Grae</p></td> <td></td></tr> <tr style="height:15px"> <td></td> <td></td> <td> <p style="MARGIN: 0px; text-align:justify;">Principal Executive Officer </p></td> <td></td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>ltbr_ex312.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<html><head><title>ltbr_ex312.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman; MARGIN-LEFT: 7%; MARGIN-RIGHT: 7%"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT 31.2</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Certification of Principal Financial Officer</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">I, Larry Goldman, certify that: </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">1.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">I have reviewed this Quarterly Report on Form 10-Q of Lightbridge Corporation;</p></td></tr> <tr style="height:15px"> <td></td> <td></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">2.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</p></td></tr> <tr style="height:15px"> <td></td> <td></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">3.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</p></td></tr> <tr style="height:15px"> <td></td> <td></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">4.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"></td> <td style="width:4%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">a.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p></td></tr> <tr style="height:15px"> <td></td> <td></td> <td></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">b.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p></td></tr> <tr style="height:15px"> <td></td> <td></td> <td></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">c.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</p></td></tr> <tr style="height:15px"> <td></td> <td></td> <td></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">d.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">5.</p></td> <td colspan="2" style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"></td> <td style="width:4%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">a.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</p></td></tr> <tr style="height:15px"> <td></td> <td></td> <td></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">b.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:50%;"> <p style="MARGIN: 0px; text-align:justify;">Date: May 12, 2025</p></td> <td style="width:3%;"> <p style="MARGIN: 0px; text-align:justify;">By:</p></td> <td style="BORDER-BOTTOM: 1px solid;width:35%;"> <p style="MARGIN: 0px; text-align:justify;"><em>/s/ Larry Goldman </em></p></td> <td style="width:12%;"></td></tr> <tr style="height:15px"> <td></td> <td></td> <td> <p style="MARGIN: 0px; text-align:justify;">Larry Goldman</p></td> <td></td></tr> <tr style="height:15px"> <td></td> <td></td> <td> <p style="MARGIN: 0px; text-align:justify;">Chief Financial Officer </p></td> <td></td></tr> <tr style="height:15px"> <td></td> <td></td> <td> <p style="margin:0px">(Principal Financial and Principal Accounting Officer)</p></td> <td></td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>7
<FILENAME>ltbr_ex32.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<html><head><title>ltbr_ex32.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman; MARGIN-LEFT: 7%; MARGIN-RIGHT: 7%"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT 32</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Section 1350 Certifications</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>STATEMENT FURNISHED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The undersigned, the Chief Executive Officer and Chief Financial Officer of Lightbridge Corporation, each hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge on the date hereof: </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"></td> <td style="width:4%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">1. </p></td> <td> <p style="MARGIN: 0px; text-align:justify;">The Quarterly Report on Form 10-Q of Lightbridge Corporation for the quarter ended March 31, 2025, filed on the date hereof with the Securities and Exchange Commission (the Report), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</p></td></tr> <tr style="height:15px"> <td></td> <td></td> <td></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">2. </p></td> <td> <p style="MARGIN: 0px; text-align:justify;">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Lightbridge Corporation.</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:50%;"> <p style="MARGIN: 0px; text-align:justify;">Date: May 12, 2025</p></td> <td style="width:5%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">By:</p></td> <td style="BORDER-BOTTOM: 1px solid;width:35%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;"><em>/s/ Seth Grae</em></p></td> <td style="width:10%;"></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Name: </p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Seth Grae</p></td> <td></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Title: </p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">President, Chief Executive Officer and Director</p></td> <td></td></tr> <tr style="height:15px"> <td></td> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">(Principal Executive Officer)</p></td> <td></td></tr> <tr style="height:15px"> <td></td> <td></td> <td></td> <td></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">By:</p></td> <td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;"><em>/s/ Larry Goldman</em></p></td> <td></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Name: </p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Larry Goldman</p></td> <td></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Title: </p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Chief Financial Officer</p></td> <td></td></tr> <tr style="height:15px"> <td></td> <td></td> <td style="vertical-align:top;"> <p style="margin:0px">(Principal Financial Officer and Principal Accounting Officer)</p></td> <td></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>ltbr-20250331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 05/12/2025-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2025 I-NET Business Solutions, Inc. All Rights Reserved.-->
<schema xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:us-gaap-att="http://fasb.org/us-gaap/attributes" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:naics="http://xbrl.sec.gov/naics/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt-roles="http://fasb.org/srt-roles/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:srt="http://fasb.org/srt/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:ltbr="http://ltbr.com/20250331" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://ltbr.com/20250331">
  <annotation>
    <appinfo>
      <link:roleType roleURI="http://ltbr.com/role/Cover" id="Cover">
        <link:definition>000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/ConsolidatedBalanceSheets" id="ConsolidatedBalanceSheets">
        <link:definition>110200 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/ConsolidatedBalanceSheetsParenthetical" id="ConsolidatedBalanceSheetsParenthetical">
        <link:definition>110201 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/ConsolidatedStatementsOfOperations" id="ConsolidatedStatementsOfOperations">
        <link:definition>124100 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" id="ConsolidatedStatementsOfChangesInStockholdersEquity">
        <link:definition>148600 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/ConsolidatedStatementsOfCashFlows" id="ConsolidatedStatementsOfCashFlows">
        <link:definition>170000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/InsiderTradingArragements" id="InsiderTradingArragements">
        <link:definition>995445 - Disclosure - Insider Trading Arragements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements" id="NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements">
        <link:definition>995446 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/NetLossPerShare" id="NetLossPerShare">
        <link:definition>995447 - Disclosure - Net Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongtermAssets" id="PrepaidProjectCostsAndOtherLongtermAssets">
        <link:definition>995448 - Disclosure - Prepaid Project Costs and Other Longterm Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/AccountsPayableAndAccruedLiabilities" id="AccountsPayableAndAccruedLiabilities">
        <link:definition>995449 - Disclosure - Accounts Payable and Accrued Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
        <link:definition>995450 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/ResearchAndDevelopmentCosts" id="ResearchAndDevelopmentCosts">
        <link:definition>995451 - Disclosure - Research and Development Costs</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensation" id="StockholdersEquityAndStockbasedCompensation">
        <link:definition>995452 - Disclosure - Stockholders Equity and StockBased Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/SegmentReporting" id="SegmentReporting">
        <link:definition>995453 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/SubsequentEvents" id="SubsequentEvents">
        <link:definition>995454 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperationsPolicies" id="BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperationsPolicies">
        <link:definition>995455 - Disclosure - Basis of Presentation Summary of Significant Accounting Policies and Nature of Operations (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperationsTables" id="BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperationsTables">
        <link:definition>995456 - Disclosure - Basis of Presentation Summary of Significant Accounting Policies and Nature of Operations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/NetLossPerShareTables" id="NetLossPerShareTables">
        <link:definition>995457 - Disclosure - Net Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesTables" id="AccountsPayableAndAccruedLiabilitiesTables">
        <link:definition>995458 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables" id="StockholdersEquityAndStockbasedCompensationTables">
        <link:definition>995459 - Disclosure - Stockholders Equity and StockBased Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/SegmentReportingTables" id="SegmentReportingTables">
        <link:definition>995460 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails" id="NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails">
        <link:definition>995461 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative" id="NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative">
        <link:definition>995462 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/NetLossPerShareDetails" id="NetLossPerShareDetails">
        <link:definition>995463 - Disclosure - Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative" id="PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative">
        <link:definition>995464 - Disclosure - Prepaid Project Costs and Other Long-term Assets (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails" id="AccountsPayableAndAccruedLiabilitiesDetails">
        <link:definition>995465 - Disclosure - Accounts Payable and Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
        <link:definition>995466 - Disclosure - Commitments and Contingencies (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/ResearchAndDevelopmentCostDetailsNarrative" id="ResearchAndDevelopmentCostDetailsNarrative">
        <link:definition>995467 - Disclosure - Research and Development Cost (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails" id="StockholdersEquityAndStockbasedCompensationDetails">
        <link:definition>995468 - Disclosure - Stockholders Equity and StockBased Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1" id="StockholdersEquityAndStockbasedCompensationDetails1">
        <link:definition>995469 - Disclosure - Stockholders Equity and StockBased Compensation (Details 1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2" id="StockholdersEquityAndStockbasedCompensationDetails2">
        <link:definition>995470 - Disclosure - Stockholders Equity and StockBased Compensation (Details 2)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails3" id="StockholdersEquityAndStockbasedCompensationDetails3">
        <link:definition>995471 - Disclosure - Stockholders Equity and StockBased Compensation (Details 3)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative" id="StockholdersEquityAndStockbasedCompensationDetailsNarrative">
        <link:definition>995472 - Disclosure - Stockholders Equity and StockBased Compensation (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/SegmentReportingDetails" id="SegmentReportingDetails">
        <link:definition>995473 - Disclosure - Segment Reporting (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
        <link:definition>995474 - Disclosure - Subsequent Events (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="ltbr-20250331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="ltbr-20250331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="ltbr-20250331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="ltbr-20250331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
    </appinfo>
  </annotation>
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
  <import namespace="http://xbrl.sec.gov/currency/2024" schemaLocation="https://xbrl.sec.gov/currency/2024/currency-2024.xsd" />
  <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
  <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <import namespace="http://xbrl.sec.gov/exch/2024" schemaLocation="https://xbrl.sec.gov/exch/2024/exch-2024.xsd" />
  <import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <import namespace="http://xbrl.sec.gov/naics/2024" schemaLocation="https://xbrl.sec.gov/naics/2024/naics-2024.xsd" />
  <import namespace="http://xbrl.sec.gov/sic/2024" schemaLocation="https://xbrl.sec.gov/sic/2024/sic-2024.xsd" />
  <import namespace="http://fasb.org/srt-roles/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd" />
  <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
  <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
  <import namespace="http://xbrl.sec.gov/stpr/2024" schemaLocation="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" />
  <import namespace="http://fasb.org/us-roles/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd" />
  <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
  <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
  <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
  <import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd" />
  <element id="ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares" name="SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" name="SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_RestrictedSharesAwardsIssuedShares" name="RestrictedSharesAwardsIssuedShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_RestrictedSharesAwardsIssuedAmount" name="RestrictedSharesAwardsIssuedAmount" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares" name="SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount" name="SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets" name="IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_CashPaidDuringThePeriodAbstract" name="CashPaidDuringThePeriodAbstract" nillable="true" xbrli:balance="credit" abstract="true" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_PaymentOfAccruedLiabilitiesWithCommonStock" name="PaymentOfAccruedLiabilitiesWithCommonStock" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_TrdArrIndNameOne" name="TrdArrIndNameOne" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_TrdArrIndNameTwo" name="TrdArrIndNameTwo" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_TrdArrIndNameThird" name="TrdArrIndNameThird" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_TrdArrIndNameFourth" name="TrdArrIndNameFourth" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_TrdArrIndTitleOne" name="TrdArrIndTitleOne" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_TrdArrIndTitleTwo" name="TrdArrIndTitleTwo" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_TrdArrIndTitleThree" name="TrdArrIndTitleThree" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_TrdArrIndTitleFour" name="TrdArrIndTitleFour" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_Rule10b51ArrAdoptedOneFlag" name="Rule10b51ArrAdoptedOneFlag" nillable="true" xbrli:periodType="duration" type="xbrli:booleanItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_Rule10b51ArrAdoptedTwoFlag" name="Rule10b51ArrAdoptedTwoFlag" nillable="true" xbrli:periodType="duration" type="xbrli:booleanItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_Rule10b51ArrAdoptedThreeFlag" name="Rule10b51ArrAdoptedThreeFlag" nillable="true" xbrli:periodType="duration" type="xbrli:booleanItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_Rule10b51ArrAdoptedFourFlag" name="Rule10b51ArrAdoptedFourFlag" nillable="true" xbrli:periodType="duration" type="xbrli:booleanItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_TrdArrAdoptionDateFirst" name="TrdArrAdoptionDateFirst" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_TrdArrAdoptionDateSecond" name="TrdArrAdoptionDateSecond" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_TrdArrAdoptionDateThird" name="TrdArrAdoptionDateThird" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_TrdArrAdoptionDateFourth" name="TrdArrAdoptionDateFourth" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_TrdArrExpirationDateOne" name="TrdArrExpirationDateOne" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_TrdArrExpirationDateTwo" name="TrdArrExpirationDateTwo" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_TrdArrExpirationDateThree" name="TrdArrExpirationDateThree" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_TrdArrExpirationDateFour" name="TrdArrExpirationDateFour" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_TrdArrSecuritiesAggAvailAmtOne" name="TrdArrSecuritiesAggAvailAmtOne" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_TrdArrSecuritiesAggAvailAmtTwo" name="TrdArrSecuritiesAggAvailAmtTwo" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_TrdArrSecuritiesAggAvailAmtThree" name="TrdArrSecuritiesAggAvailAmtThree" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_PrepaidProjectCostsDisclosureTextBlock" name="PrepaidProjectCostsDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_ScheduleOfOutstandingRSATableTextBlock" name="ScheduleOfOutstandingRSATableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_InvestmentsInDebtSecuritiesPurchased" name="InvestmentsInDebtSecuritiesPurchased" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_ResearchAndDevelopmentPercentage" name="ResearchAndDevelopmentPercentage" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_AdditionalPrepaidExpenseAndOtherAssetsCurrent" name="AdditionalPrepaidExpenseAndOtherAssetsCurrent" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_OffsetOfProjectCosts" name="OffsetOfProjectCosts" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_PrepaidProjectCostsAddition" name="PrepaidProjectCostsAddition" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_AccruedResearchAndDevelopmentExpensesCurrent" name="AccruedResearchAndDevelopmentExpensesCurrent" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_LeasePaymentUnderNonCancellableOperatingLeases" name="LeasePaymentUnderNonCancellableOperatingLeases" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_LesseeOperatingLeaseTerm" name="LesseeOperatingLeaseTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_ResearchAndDevelopmentArrangementExpense" name="ResearchAndDevelopmentArrangementExpense" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_ResearchAndDevelopmentExpensePayable" name="ResearchAndDevelopmentExpensePayable" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_PaymentsToResearchAndDevelopmentCost" name="PaymentsToResearchAndDevelopmentCost" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm" name="SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermEndingFF" name="SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermEndingFF" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermVested" name="SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermVested" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermOptionsExercisable" name="SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermOptionsExercisable" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding" name="SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueExercised" name="SharebasedCompensationSharesOptionsAggregateIntrinsicValueExercised" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding" name="SharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVestedAndExpectedToVest" name="SharebasedCompensationSharesOptionsAggregateIntrinsicValueVestedAndExpectedToVest" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOptionsExercisable" name="SharebasedCompensationSharesOptionsAggregateIntrinsicValueOptionsExercisable" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted" name="SharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVested" name="SharebasedCompensationSharesOptionsAggregateIntrinsicValueVested" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited" name="SharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings" name="SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_DescriptionOfSubscriptionAndInvestmentRepresentationAgreement" name="DescriptionOfSubscriptionAndInvestmentRepresentationAgreement" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_PreferredStockVotingRightsShares" name="PreferredStockVotingRightsShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_CommonSharesIssuancesEquityGrant" name="CommonSharesIssuancesEquityGrant" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_EquityGrantValue" name="EquityGrantValue" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_CommonStockShareOutstanding" name="CommonStockShareOutstanding" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_RSAFairValue" name="RSAFairValue" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_CommonSharesEquityGrantPricePerShares" name="CommonSharesEquityGrantPricePerShares" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_CommonStockValuedGrantDatePricePerShare" name="CommonStockValuedGrantDatePricePerShare" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_DescriptionOfRSAsModificationAndNetShareSettlementsForPaymentsOfWithholdingTaxes" name="DescriptionOfRSAsModificationAndNetShareSettlementsForPaymentsOfWithholdingTaxes" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_CommonStockEquivalentsOutstandingShares" name="CommonStockEquivalentsOutstandingShares" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_MarketOfferingsDisclosureDescription" name="MarketOfferingsDisclosureDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_FutureIssuanceOfShare" name="FutureIssuanceOfShare" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_DescriptionOfEquityIncentivePlan" name="DescriptionOfEquityIncentivePlan" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_ProceedsFromStockIssuances" name="ProceedsFromStockIssuances" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_InlProject" name="InlProject" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_RomaniaFeasibilityStudy" name="RomaniaFeasibilityStudy" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_CentrusEnergyFeedStudy" name="CentrusEnergyFeedStudy" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_ResearchAndDevelopmentExpenseNet" name="ResearchAndDevelopmentExpenseNet" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_OtherSegmentsItem" name="OtherSegmentsItem" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_OperatingNetIncomeLossFromSegmentsToConsolidated" name="OperatingNetIncomeLossFromSegmentsToConsolidated" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_PrepaidExpensesCurrentAndLongTermAssetsAbstract" name="PrepaidExpensesCurrentAndLongTermAssetsAbstract" nillable="true" abstract="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_CommitmentsAndContingenciesAbstract" name="CommitmentsAndContingenciesAbstract" nillable="true" abstract="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations" name="BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations" nillable="true" abstract="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_ResearchAndDevelopmentCostAbstract" name="ResearchAndDevelopmentCostAbstract" nillable="true" abstract="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element name="CODMMember" id="ltbr_CODMMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="TreasuryBillsLevelTwoMember" id="ltbr_TreasuryBillsLevelTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="TreasuryBillsLevelThreeMember" id="ltbr_TreasuryBillsLevelThreeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="INLMember" id="ltbr_INLMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="BattelleEnergyAllianceLLCMember" id="ltbr_BattelleEnergyAllianceLLCMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="MaxiimumMember" id="ltbr_MaxiimumMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="MiniimumMember" id="ltbr_MiniimumMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="CRADAMember" id="ltbr_CRADAMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="StrategicPartnershipProjectAgreementMember" id="ltbr_StrategicPartnershipProjectAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="CANDUMember" id="ltbr_CANDUMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="FEEdMember" id="ltbr_FEEdMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="BottomMember" id="ltbr_BottomMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="ArticlesOfIncorporationMember" id="ltbr_ArticlesOfIncorporationMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="TopMember" id="ltbr_TopMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="TwentyTwentyPlanMember" id="ltbr_TwentyTwentyPlanMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="RestrictedStockAwardMember" id="ltbr_RestrictedStockAwardMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="RestrictedStockUnitsRSAMember" id="ltbr_RestrictedStockUnitsRSAMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="AvailableForSaleSecuritiesMember" id="ltbr_AvailableForSaleSecuritiesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="TwoThousandTwentyEquityIncentivePlanMember" id="ltbr_TwoThousandTwentyEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="TwentyTwentyFiveTransactionsMember" id="ltbr_TwentyTwentyFiveTransactionsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="OptionsMember" id="ltbr_OptionsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="CommonShareIssuancesMember" id="ltbr_CommonShareIssuancesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="PrepaidExpenseAndOtherCurrentAssetMember" id="ltbr_PrepaidExpenseAndOtherCurrentAssetMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="RestrictedStockAwardsSummaryMember" id="ltbr_RestrictedStockAwardsSummaryMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="BoardOfDirectorsMember" id="ltbr_BoardOfDirectorsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="SeriesXPreferredStockMember" id="ltbr_SeriesXPreferredStockMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="TreasuryBillsLevelOneMember" id="ltbr_TreasuryBillsLevelOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>ltbr-20250331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 05/12/2025-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2025 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
  <link:roleRef xlink:type="simple" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address Address Line 1</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address Address Line 2</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address City Or Town</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address State Or Province</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Security 12b Title</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl_7a0557" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl_7a0557" xml:lang="en-US">CONSOLIDATED BALANCE SHEETS</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="ecd_NonRule10b51ArrTrmntdFlag" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrTrmntdFlag" xlink:to="ecd_NonRule10b51ArrTrmntdFlag_lbl_153c10" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrTrmntdFlag_lbl_153c10" xml:lang="en-US">ASSETS</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl_44b797" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl_44b797" xml:lang="en-US">Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl_a45072" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl_a45072" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl_57fd00" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl_57fd00" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl_db2c5f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl_db2c5f" xml:lang="en-US">Total Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl_6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl_6" xml:lang="en-US">[Assets, Current]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsAbstract" xlink:label="us-gaap_OtherAssetsAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_OtherAssetsAbstract_lbl_ba22eb" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsAbstract_lbl_ba22eb" xml:lang="en-US">Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssets" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssets" xlink:to="us-gaap_PrepaidExpenseAndOtherAssets_lbl_630eeb" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets_lbl_630eeb" xml:lang="en-US">Prepaid project costs and other long-term assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl_177c70" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl_177c70" xml:lang="en-US">Trademarks</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl_81d938" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl_81d938" xml:lang="en-US">Total Assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl_10" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl_10" xml:lang="en-US">[Assets]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl_aa869d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl_aa869d" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl_e696f3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl_e696f3" xml:lang="en-US">Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl_1faffc" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl_1faffc" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl_af9a9b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl_af9a9b" xml:lang="en-US">Total Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl_14" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl_14" xml:lang="en-US">[Liabilities, Current]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl_c167b1" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl_c167b1" xml:lang="en-US">Commitments and contingencies - Note 5</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl_52b518" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl_52b518" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl_0de3e2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl_0de3e2" xml:lang="en-US">Preferred stock, $0.001 par value, 10,000,000 authorized shares, 1 share and 0 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl_6d6748" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl_6d6748" xml:lang="en-US">Common stock, $0.001 par value, 25,000,000 authorized, 21,557,343 shares and 18,783,912 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl_02092f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl_02092f" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl_de03b0" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl_de03b0" xml:lang="en-US">Accumulated deficit</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl_2ab679" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl_2ab679" xml:lang="en-US">Total Stockholders' Equity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl_21" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl_21" xml:lang="en-US">[Equity, Attributable to Parent]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl_d7b661" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl_d7b661" xml:lang="en-US">Total Liabilities and Stockholders' Equity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl_22" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl_22" xml:lang="en-US">[Liabilities and Equity]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl_aab315" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl_aab315" xml:lang="en-US">Preferred Stock, Shares Par Value</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl_19c4fb" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl_19c4fb" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl_757289" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl_757289" xml:lang="en-US">Preferred Stock, Shares issued</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl_8d71da" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl_8d71da" xml:lang="en-US">Preferred Stock, Shares outstanding</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl_90224f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl_90224f" xml:lang="en-US">Common Stock, Shares Par Value</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl_56db09" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl_56db09" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl_caca4f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl_caca4f" xml:lang="en-US">Common Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl_d42eeb" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl_d42eeb" xml:lang="en-US">Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl_5f748b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl_5f748b" xml:lang="en-US">CONSOLIDATED STATEMENTS OF OPERATIONS</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl_986809" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl_986809" xml:lang="en-US">Revenue</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl_a5699e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl_a5699e" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl_d732f1" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl_d732f1" xml:lang="en-US">General and administrative</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl_b110eb" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl_b110eb" xml:lang="en-US">Research and development</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl_4ffa66" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl_4ffa66" xml:lang="en-US">Total Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl_6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_lbl_6" xml:lang="en-US">[Operating Expenses]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl_c88c14" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl_c88c14" xml:lang="en-US">Operating Loss</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl_7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl_7" xml:lang="en-US">[Operating Income (Loss)]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl_932c7b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl_932c7b" xml:lang="en-US">Other Income</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeOther" xlink:label="us-gaap_InterestIncomeOther" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeOther" xlink:to="us-gaap_InterestIncomeOther_lbl_98b3bd" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestIncomeOther_lbl_98b3bd" xml:lang="en-US">Interest income</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl_fcd681" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl_fcd681" xml:lang="en-US">Total Other Income</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl_10" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl_10" xml:lang="en-US">[Other Nonoperating Income (Expense)]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl_3ef31c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl_3ef31c" xml:lang="en-US">Net Loss Before Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl_11" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl_11" xml:lang="en-US">[Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl_56256c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl_56256c" xml:lang="en-US">Income taxes</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl_198994" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl_198994" xml:lang="en-US">Net Loss</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl_13" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl_13" xml:lang="en-US">[Net Income (Loss) Attributable to Parent]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl_8a80c0" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl_8a80c0" xml:lang="en-US">Net Loss Per Common Share</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl_8b972c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl_8b972c" xml:lang="en-US">Basic and diluted</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl_e8a59f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl_e8a59f" xml:lang="en-US">Weighted Average Number of Common Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl_6b3dee" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl_6b3dee" xml:lang="en-US">CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl_526ae1" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl_526ae1" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl_1f37f3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl_1f37f3" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl_7548b4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl_7548b4" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl_185d1b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl_185d1b" xml:lang="en-US">Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl_a62dc1" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl_a62dc1" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl_d95c7f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl_d95c7f" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl_955b13" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesIssued_lbl_955b13" xml:lang="en-US">Balance, shares</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssued_lbl_2" xml:lang="en-US">[Shares, Issued]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl_8dcaff" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_lbl_8dcaff" xml:lang="en-US">Balance, amount</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares" xlink:label="ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares" xlink:to="ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares_lbl_2e7303" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares_lbl_2e7303" xml:lang="en-US">Shares issued - registered offerings - net of offering costs of $155,686, shares</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" xlink:label="ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" xlink:to="ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount_lbl_ffed90" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount_lbl_ffed90" xml:lang="en-US">Shares issued - registered offerings - net of offering costs of $155,686, amount</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl_8a8d61" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl_8a8d61" xml:lang="en-US">Shares issued to consultant &amp; directors for services, shares</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl_ef89c6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl_ef89c6" xml:lang="en-US">Shares issued to consultant &amp; directors for services, amount</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl_9730bc" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl_9730bc" xml:lang="en-US">Stock-based compensation</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl_3e9583" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl_3e9583" xml:lang="en-US">Net loss for the three months ended March 31, 2024</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_RestrictedSharesAwardsIssuedShares" xlink:label="ltbr_RestrictedSharesAwardsIssuedShares" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_RestrictedSharesAwardsIssuedShares" xlink:to="ltbr_RestrictedSharesAwardsIssuedShares_lbl_e8445d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_RestrictedSharesAwardsIssuedShares_lbl_e8445d" xml:lang="en-US">Restricted shares awards issued, shares</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_RestrictedSharesAwardsIssuedAmount" xlink:label="ltbr_RestrictedSharesAwardsIssuedAmount" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_RestrictedSharesAwardsIssuedAmount" xlink:to="ltbr_RestrictedSharesAwardsIssuedAmount_lbl_3058ca" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_RestrictedSharesAwardsIssuedAmount_lbl_3058ca" xml:lang="en-US">Restricted shares awards issued, amount</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares" xlink:label="ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares" xlink:to="ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares_lbl_3d6d85" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares_lbl_3d6d85" xml:lang="en-US">Share settlement for withholding taxes paid upon vesting of restricted stock awards, shares</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount" xlink:label="ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount" xlink:to="ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount_lbl_9fd45a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount_lbl_9fd45a" xml:lang="en-US">Share settlement for withholding taxes paid upon vesting of restricted stock awards, amount</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl_90ae84" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl_90ae84" xml:lang="en-US">Shares issued through the exercise of options, shares</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl_76d7f9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl_76d7f9" xml:lang="en-US">Shares issued through the exercise of options, amount</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl_936a39" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesIssued_lbl_936a39" xml:lang="en-US">Balance, shares</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl_32ed05" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_lbl_32ed05" xml:lang="en-US">Balance, amount</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl_9cfa69" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl_9cfa69" xml:lang="en-US">CONSOLIDATED STATEMENTS OF CASH FLOWS</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl_447b0b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl_447b0b" xml:lang="en-US">Operating Activities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl_1a1a00" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProfitLoss_lbl_1a1a00" xml:lang="en-US">Net Loss</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl_3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_lbl_3" xml:lang="en-US">[Net Income (Loss), Including Portion Attributable to Noncontrolling Interest]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl_59ccdd" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl_59ccdd" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl_29d330" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl_29d330" xml:lang="en-US">Stock-based compensation</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl_5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl_5" xml:lang="en-US">[Share-Based Payment Arrangement, Noncash Expense]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl_5c924c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl_5c924c" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl_a6efbe" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl_a6efbe" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl_7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl_7" xml:lang="en-US">[Increase (Decrease) in Prepaid Expenses, Other]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets" xlink:to="ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets_lbl_749e5b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets_lbl_749e5b" xml:lang="en-US">Prepaid project costs and other long-term assets</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets" xlink:label="ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets" xlink:to="ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets_lbl_8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets_lbl_8" xml:lang="en-US">[Prepaid project costs and other long-term assets]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl_5d5175" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl_5d5175" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl_9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl_9" xml:lang="en-US">[Increase (Decrease) in Accounts Payable and Accrued Liabilities]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl_ae58e4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl_ae58e4" xml:lang="en-US">Net Cash Used in Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl_10" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl_10" xml:lang="en-US">[Net Cash Provided by (Used in) Operating Activities]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl_eae992" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl_eae992" xml:lang="en-US">Net Cash Used in Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl_05ac19" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl_05ac19" xml:lang="en-US">Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl_6e46c7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl_6e46c7" xml:lang="en-US">Net proceeds from the issuances of common stock</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl_331f63" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl_331f63" xml:lang="en-US">Net proceeds from the exercise of stock options</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl_44d026" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl_44d026" xml:lang="en-US">Payments for taxes related to net share settlement of equity awards</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl_15" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl_15" xml:lang="en-US">[Payment, Tax Withholding, Share-Based Payment Arrangement]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl_c9cab7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl_c9cab7" xml:lang="en-US">Net Cash Provided by Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl_16" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl_16" xml:lang="en-US">[Net Cash Provided by (Used in) Financing Activities]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl_59b85f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl_59b85f" xml:lang="en-US">Net Increase (Decrease) in Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl_17" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl_17" xml:lang="en-US">[Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl_977bbf" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl_977bbf" xml:lang="en-US">Cash and Cash Equivalents, Beginning of Period</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl_601b09" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl_601b09" xml:lang="en-US">Cash and Cash Equivalents, End of Period</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl_cac1cf" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl_cac1cf" xml:lang="en-US">Supplemental Disclosure of Cash Flow Information</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_CashPaidDuringThePeriodAbstract" xlink:label="ltbr_CashPaidDuringThePeriodAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_CashPaidDuringThePeriodAbstract" xlink:to="ltbr_CashPaidDuringThePeriodAbstract_lbl_bf0d2f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_CashPaidDuringThePeriodAbstract_lbl_bf0d2f" xml:lang="en-US">Cash paid during the period:</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl_4776e0" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl_4776e0" xml:lang="en-US">Interest paid</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl_80de5f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl_80de5f" xml:lang="en-US">Income taxes paid</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl_d3235d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl_d3235d" xml:lang="en-US">Non-Cash Financing Activities:</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_PaymentOfAccruedLiabilitiesWithCommonStock" xlink:label="ltbr_PaymentOfAccruedLiabilitiesWithCommonStock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_PaymentOfAccruedLiabilitiesWithCommonStock" xlink:to="ltbr_PaymentOfAccruedLiabilitiesWithCommonStock_lbl_df8f15" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_PaymentOfAccruedLiabilitiesWithCommonStock_lbl_df8f15" xml:lang="en-US">Payment of accrued liabilities with common stock</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems" xlink:label="ecd_InsiderTradingArrLineItems" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTradingArrLineItems" xlink:to="ecd_InsiderTradingArrLineItems_lbl_44889f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTradingArrLineItems_lbl_44889f" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="ecd_Rule10b51ArrAdoptedFlag" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrAdoptedFlag" xlink:to="ecd_Rule10b51ArrAdoptedFlag_lbl_e961ba" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrAdoptedFlag_lbl_e961ba" xml:lang="en-US">Rule 10b5-1 Arragement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="ecd_Rule10b51ArrTrmntdFlag" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrTrmntdFlag" xlink:to="ecd_Rule10b51ArrTrmntdFlag_lbl_90b8b8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrTrmntdFlag_lbl_90b8b8" xml:lang="en-US">Rule 10b5-1 Arragement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="ecd_NonRule10b51ArrAdoptedFlag" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrAdoptedFlag" xlink:to="ecd_NonRule10b51ArrAdoptedFlag_lbl_e0cef3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrAdoptedFlag_lbl_e0cef3" xml:lang="en-US">Non Rule 10b5-1 Arragement Adopted [Flag]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrTrmntdFlag" xlink:to="ecd_NonRule10b51ArrTrmntdFlag_lbl_33dd94" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_NonRule10b51ArrTrmntdFlag_lbl_33dd94" xml:lang="en-US">Non Rule 10b5-1 Arragement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TrdArrIndNameOne" xlink:label="ltbr_TrdArrIndNameOne" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TrdArrIndNameOne" xlink:to="ltbr_TrdArrIndNameOne_lbl_87f644" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TrdArrIndNameOne_lbl_87f644" xml:lang="en-US">First Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TrdArrIndNameTwo" xlink:label="ltbr_TrdArrIndNameTwo" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TrdArrIndNameTwo" xlink:to="ltbr_TrdArrIndNameTwo_lbl_7d5cde" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TrdArrIndNameTwo_lbl_7d5cde" xml:lang="en-US">Second Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TrdArrIndNameThird" xlink:label="ltbr_TrdArrIndNameThird" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TrdArrIndNameThird" xlink:to="ltbr_TrdArrIndNameThird_lbl_4b005b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TrdArrIndNameThird_lbl_4b005b" xml:lang="en-US">Third Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TrdArrIndNameFourth" xlink:label="ltbr_TrdArrIndNameFourth" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TrdArrIndNameFourth" xlink:to="ltbr_TrdArrIndNameFourth_lbl_77b115" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TrdArrIndNameFourth_lbl_77b115" xml:lang="en-US">Fourth Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TrdArrIndTitleOne" xlink:label="ltbr_TrdArrIndTitleOne" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TrdArrIndTitleOne" xlink:to="ltbr_TrdArrIndTitleOne_lbl_7216af" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TrdArrIndTitleOne_lbl_7216af" xml:lang="en-US">First Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TrdArrIndTitleTwo" xlink:label="ltbr_TrdArrIndTitleTwo" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TrdArrIndTitleTwo" xlink:to="ltbr_TrdArrIndTitleTwo_lbl_4ba979" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TrdArrIndTitleTwo_lbl_4ba979" xml:lang="en-US">Second Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TrdArrIndTitleThree" xlink:label="ltbr_TrdArrIndTitleThree" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TrdArrIndTitleThree" xlink:to="ltbr_TrdArrIndTitleThree_lbl_12a05d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TrdArrIndTitleThree_lbl_12a05d" xml:lang="en-US">Third Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TrdArrIndTitleFour" xlink:label="ltbr_TrdArrIndTitleFour" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TrdArrIndTitleFour" xlink:to="ltbr_TrdArrIndTitleFour_lbl_03b59c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TrdArrIndTitleFour_lbl_03b59c" xml:lang="en-US">Fourth Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_Rule10b51ArrAdoptedOneFlag" xlink:label="ltbr_Rule10b51ArrAdoptedOneFlag" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_Rule10b51ArrAdoptedOneFlag" xlink:to="ltbr_Rule10b51ArrAdoptedOneFlag_lbl_2856de" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_Rule10b51ArrAdoptedOneFlag_lbl_2856de" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted One [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_Rule10b51ArrAdoptedTwoFlag" xlink:label="ltbr_Rule10b51ArrAdoptedTwoFlag" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_Rule10b51ArrAdoptedTwoFlag" xlink:to="ltbr_Rule10b51ArrAdoptedTwoFlag_lbl_ce25f9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_Rule10b51ArrAdoptedTwoFlag_lbl_ce25f9" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted Two [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_Rule10b51ArrAdoptedThreeFlag" xlink:label="ltbr_Rule10b51ArrAdoptedThreeFlag" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_Rule10b51ArrAdoptedThreeFlag" xlink:to="ltbr_Rule10b51ArrAdoptedThreeFlag_lbl_108631" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_Rule10b51ArrAdoptedThreeFlag_lbl_108631" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted Three [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_Rule10b51ArrAdoptedFourFlag" xlink:label="ltbr_Rule10b51ArrAdoptedFourFlag" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_Rule10b51ArrAdoptedFourFlag" xlink:to="ltbr_Rule10b51ArrAdoptedFourFlag_lbl_4b38de" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_Rule10b51ArrAdoptedFourFlag_lbl_4b38de" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted Four [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TrdArrAdoptionDateFirst" xlink:label="ltbr_TrdArrAdoptionDateFirst" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TrdArrAdoptionDateFirst" xlink:to="ltbr_TrdArrAdoptionDateFirst_lbl_2fdf23" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TrdArrAdoptionDateFirst_lbl_2fdf23" xml:lang="en-US">Trading Arrangement Adoption Date, First</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TrdArrAdoptionDateSecond" xlink:label="ltbr_TrdArrAdoptionDateSecond" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TrdArrAdoptionDateSecond" xlink:to="ltbr_TrdArrAdoptionDateSecond_lbl_63ce71" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TrdArrAdoptionDateSecond_lbl_63ce71" xml:lang="en-US">Trading Arrangement Adoption Date, Second</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TrdArrAdoptionDateThird" xlink:label="ltbr_TrdArrAdoptionDateThird" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TrdArrAdoptionDateThird" xlink:to="ltbr_TrdArrAdoptionDateThird_lbl_8c6319" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TrdArrAdoptionDateThird_lbl_8c6319" xml:lang="en-US">Trading Arrangement Adoption Date, Third</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TrdArrAdoptionDateFourth" xlink:label="ltbr_TrdArrAdoptionDateFourth" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TrdArrAdoptionDateFourth" xlink:to="ltbr_TrdArrAdoptionDateFourth_lbl_7ba8c2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TrdArrAdoptionDateFourth_lbl_7ba8c2" xml:lang="en-US">Trading Arrangement Adoption Date, Fourth</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TrdArrExpirationDateOne" xlink:label="ltbr_TrdArrExpirationDateOne" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TrdArrExpirationDateOne" xlink:to="ltbr_TrdArrExpirationDateOne_lbl_ad0ece" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TrdArrExpirationDateOne_lbl_ad0ece" xml:lang="en-US">Trading Arrangement Expiration Date, First</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TrdArrExpirationDateTwo" xlink:label="ltbr_TrdArrExpirationDateTwo" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TrdArrExpirationDateTwo" xlink:to="ltbr_TrdArrExpirationDateTwo_lbl_e01676" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TrdArrExpirationDateTwo_lbl_e01676" xml:lang="en-US">Trading Arrangement Expiration Date, Second</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TrdArrExpirationDateThree" xlink:label="ltbr_TrdArrExpirationDateThree" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TrdArrExpirationDateThree" xlink:to="ltbr_TrdArrExpirationDateThree_lbl_deef0d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TrdArrExpirationDateThree_lbl_deef0d" xml:lang="en-US">Trading Arrangement Expiration Date, Third</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TrdArrExpirationDateFour" xlink:label="ltbr_TrdArrExpirationDateFour" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TrdArrExpirationDateFour" xlink:to="ltbr_TrdArrExpirationDateFour_lbl_ed14b0" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TrdArrExpirationDateFour_lbl_ed14b0" xml:lang="en-US">Trading Arrangement Expiration Date, Fourth</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TrdArrSecuritiesAggAvailAmtOne" xlink:label="ltbr_TrdArrSecuritiesAggAvailAmtOne" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TrdArrSecuritiesAggAvailAmtOne" xlink:to="ltbr_TrdArrSecuritiesAggAvailAmtOne_lbl_adeb83" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TrdArrSecuritiesAggAvailAmtOne_lbl_adeb83" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount, First</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TrdArrSecuritiesAggAvailAmtTwo" xlink:label="ltbr_TrdArrSecuritiesAggAvailAmtTwo" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TrdArrSecuritiesAggAvailAmtTwo" xlink:to="ltbr_TrdArrSecuritiesAggAvailAmtTwo_lbl_e80639" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TrdArrSecuritiesAggAvailAmtTwo_lbl_e80639" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount, Second</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TrdArrSecuritiesAggAvailAmtThree" xlink:label="ltbr_TrdArrSecuritiesAggAvailAmtThree" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TrdArrSecuritiesAggAvailAmtThree" xlink:to="ltbr_TrdArrSecuritiesAggAvailAmtThree_lbl_777e47" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TrdArrSecuritiesAggAvailAmtThree_lbl_777e47" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount, Third</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl_b6b895" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl_b6b895" xml:lang="en-US">Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_lbl_b53189" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_lbl_b53189" xml:lang="en-US">Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_lbl_2" xml:lang="en-US">Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl_4e737e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl_4e737e" xml:lang="en-US">Net Loss Per Share</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl_2" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_PrepaidExpensesCurrentAndLongTermAssetsAbstract" xlink:label="ltbr_PrepaidExpensesCurrentAndLongTermAssetsAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_PrepaidExpensesCurrentAndLongTermAssetsAbstract" xlink:to="ltbr_PrepaidExpensesCurrentAndLongTermAssetsAbstract_lbl_f56404" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_PrepaidExpensesCurrentAndLongTermAssetsAbstract_lbl_f56404" xml:lang="en-US">Prepaid Project Costs and Other Longterm Assets</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_PrepaidProjectCostsDisclosureTextBlock" xlink:label="ltbr_PrepaidProjectCostsDisclosureTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_PrepaidProjectCostsDisclosureTextBlock" xlink:to="ltbr_PrepaidProjectCostsDisclosureTextBlock_lbl_582047" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_PrepaidProjectCostsDisclosureTextBlock_lbl_582047" xml:lang="en-US">Prepaid Project Costs and Other Long-term Assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_lbl_bb3531" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_lbl_bb3531" xml:lang="en-US">Accounts Payable and Accrued Liabilities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl_52e5e7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl_52e5e7" xml:lang="en-US">Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl_2" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_CommitmentsAndContingenciesAbstract" xlink:label="ltbr_CommitmentsAndContingenciesAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_CommitmentsAndContingenciesAbstract" xlink:to="ltbr_CommitmentsAndContingenciesAbstract_lbl_e2983c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_CommitmentsAndContingenciesAbstract_lbl_e2983c" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl_8c112e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl_8c112e" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl_2" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="us-gaap_ResearchAndDevelopmentAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentAbstract" xlink:to="us-gaap_ResearchAndDevelopmentAbstract_lbl_7bca71" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentAbstract_lbl_7bca71" xml:lang="en-US">Research and Development Costs</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:to="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_lbl_8e5520" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_lbl_8e5520" xml:lang="en-US">Research and Development Costs</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:to="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_lbl_2" xml:lang="en-US">Research, Development, and Computer Software Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl_28cd5d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl_28cd5d" xml:lang="en-US">Stockholders Equity and StockBased Compensation</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl_df9e26" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl_df9e26" xml:lang="en-US">Stockholders' Equity and Stock-Based Compensation</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl_e60389" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAbstract_lbl_e60389" xml:lang="en-US">Segment Reporting</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl_13cdda" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl_13cdda" xml:lang="en-US">Segment Reporting</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl_2" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl_8f17c3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl_8f17c3" xml:lang="en-US">Subsequent Events</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl_5ddf5e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl_5ddf5e" xml:lang="en-US">Subsequent Events</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl_2" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations" xlink:label="ltbr_BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations" xlink:to="ltbr_BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations_lbl_4f62b3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations_lbl_4f62b3" xml:lang="en-US">Basis of Presentation Summary of Significant Accounting Policies and Nature of Operations (Policies)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl_e75ec9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl_e75ec9" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl_2acf57" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl_2acf57" xml:lang="en-US">Certain Risks and Uncertainties</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl_4d1861" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl_4d1861" xml:lang="en-US">Recent Adopted Pronouncements</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:label="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_lbl_6ba289" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_lbl_6ba289" xml:lang="en-US">Schedule of fair value of financial instruments</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl_d1e5d6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl_d1e5d6" xml:lang="en-US">Summary of outstanding securities excluded from diluted weighted shares outstanding</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl_dab73e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl_dab73e" xml:lang="en-US">Schedule of accounts payable and accrued liabilities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:to="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_lbl_2f6eba" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_lbl_2f6eba" xml:lang="en-US">Schedule Of stock option</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl_903c2f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl_903c2f" xml:lang="en-US">Schedule Of Share-based Compensation, Stock Options, Activity</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_ScheduleOfOutstandingRSATableTextBlock" xlink:label="ltbr_ScheduleOfOutstandingRSATableTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ScheduleOfOutstandingRSATableTextBlock" xlink:to="ltbr_ScheduleOfOutstandingRSATableTextBlock_lbl_fe9a43" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ScheduleOfOutstandingRSATableTextBlock_lbl_fe9a43" xml:lang="en-US">Schedule Of outstanding RSA</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl_5cbe05" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl_5cbe05" xml:lang="en-US">Schedule of stock based compensation expense</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl_3f55ae" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl_3f55ae" xml:lang="en-US">Schedule of summarizes the expense categories Segment Reporting</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl_bcdd42" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl_bcdd42" xml:lang="en-US">Statement Class Of Stock Axis</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TreasuryBillsLevelTwoMember" xlink:label="ltbr_TreasuryBillsLevelTwoMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TreasuryBillsLevelTwoMember" xlink:to="ltbr_TreasuryBillsLevelTwoMember_lbl_7ab3f2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TreasuryBillsLevelTwoMember_lbl_7ab3f2" xml:lang="en-US">Level II</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TreasuryBillsLevelThreeMember" xlink:label="ltbr_TreasuryBillsLevelThreeMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TreasuryBillsLevelThreeMember" xlink:to="ltbr_TreasuryBillsLevelThreeMember_lbl_9609fa" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TreasuryBillsLevelThreeMember_lbl_9609fa" xml:lang="en-US">Level III</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TreasuryBillsLevelOneMember" xlink:label="ltbr_TreasuryBillsLevelOneMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TreasuryBillsLevelOneMember" xlink:to="ltbr_TreasuryBillsLevelOneMember_lbl_a21cbf" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TreasuryBillsLevelOneMember_lbl_a21cbf" xml:lang="en-US">Level I</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl_d60047" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl_d60047" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl_5d7512" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl_5d7512" xml:lang="en-US">Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl_3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl_3" xml:lang="en-US">[Accounts Payable and Accrued Liabilities]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl_828b9c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl_828b9c" xml:lang="en-US">Product Or Service Axis</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_INLMember" xlink:label="ltbr_INLMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_INLMember" xlink:to="ltbr_INLMember_lbl_f806c4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_INLMember_lbl_f806c4" xml:lang="en-US">Idaho National Laboratory (INL)</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_InvestmentsInDebtSecuritiesPurchased" xlink:label="ltbr_InvestmentsInDebtSecuritiesPurchased" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_InvestmentsInDebtSecuritiesPurchased" xlink:to="ltbr_InvestmentsInDebtSecuritiesPurchased_lbl_03b478" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_InvestmentsInDebtSecuritiesPurchased_lbl_03b478" xml:lang="en-US">US Treasury instruments purchased</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_ResearchAndDevelopmentPercentage" xlink:label="ltbr_ResearchAndDevelopmentPercentage" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ResearchAndDevelopmentPercentage" xlink:to="ltbr_ResearchAndDevelopmentPercentage_lbl_2cc051" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ResearchAndDevelopmentPercentage_lbl_2cc051" xml:lang="en-US">Percentage of research and development expense</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease_lbl_940faa" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease_lbl_940faa" xml:lang="en-US">Stock options outstanding</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:label="us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:to="us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_lbl_06df55" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_lbl_06df55" xml:lang="en-US">Restricted stock awards outstanding</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl_8cc8e1" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl_8cc8e1" xml:lang="en-US">Total</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl_4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl_4" xml:lang="en-US">[Weighted Average Number of Shares Outstanding, Diluted, Adjustment]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl_04c416" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl_04c416" xml:lang="en-US">Related Party Transactions By Related Party Axis</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationAxis_lbl_3bfb92" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl_3bfb92" xml:lang="en-US">Balance Sheet Location Axis</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl_0d5e23" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl_0d5e23" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_BattelleEnergyAllianceLLCMember" xlink:label="ltbr_BattelleEnergyAllianceLLCMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_BattelleEnergyAllianceLLCMember" xlink:to="ltbr_BattelleEnergyAllianceLLCMember_lbl_07aba0" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_BattelleEnergyAllianceLLCMember_lbl_07aba0" xml:lang="en-US">Battelle Energy Alliance, LLC (BEA) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:label="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_lbl_0d147f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_lbl_0d147f" xml:lang="en-US">Prepaid Expenses And Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_MaxiimumMember" xlink:label="ltbr_MaxiimumMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_MaxiimumMember" xlink:to="ltbr_MaxiimumMember_lbl_d5103c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_MaxiimumMember_lbl_d5103c" xml:lang="en-US">Maxiimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_MiniimumMember" xlink:label="ltbr_MiniimumMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_MiniimumMember" xlink:to="ltbr_MiniimumMember_lbl_4a8420" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_MiniimumMember_lbl_4a8420" xml:lang="en-US">Miniimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_AdditionalPrepaidExpenseAndOtherAssetsCurrent" xlink:label="ltbr_AdditionalPrepaidExpenseAndOtherAssetsCurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_AdditionalPrepaidExpenseAndOtherAssetsCurrent" xlink:to="ltbr_AdditionalPrepaidExpenseAndOtherAssetsCurrent_lbl_714d5e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_AdditionalPrepaidExpenseAndOtherAssetsCurrent_lbl_714d5e" xml:lang="en-US">Aditional advance payments</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_OffsetOfProjectCosts" xlink:label="ltbr_OffsetOfProjectCosts" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_OffsetOfProjectCosts" xlink:to="ltbr_OffsetOfProjectCosts_lbl_68a72d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_OffsetOfProjectCosts_lbl_68a72d" xml:lang="en-US">Offset of Project Costs</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseNoncurrent" xlink:label="us-gaap_PrepaidExpenseNoncurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseNoncurrent" xlink:to="us-gaap_PrepaidExpenseNoncurrent_lbl_6bb997" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseNoncurrent_lbl_6bb997" xml:lang="en-US">Prepaid project costs</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_PrepaidProjectCostsAddition" xlink:label="ltbr_PrepaidProjectCostsAddition" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_PrepaidProjectCostsAddition" xlink:to="ltbr_PrepaidProjectCostsAddition_lbl_6f7fae" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_PrepaidProjectCostsAddition_lbl_6f7fae" xml:lang="en-US">Prepaid project costs- addition</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableTradeCurrentAndNoncurrent" xlink:label="us-gaap_AccountsPayableTradeCurrentAndNoncurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableTradeCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableTradeCurrentAndNoncurrent_lbl_475be1" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableTradeCurrentAndNoncurrent_lbl_475be1" xml:lang="en-US">Trade payables</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_AccruedResearchAndDevelopmentExpensesCurrent" xlink:label="ltbr_AccruedResearchAndDevelopmentExpensesCurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_AccruedResearchAndDevelopmentExpensesCurrent" xlink:to="ltbr_AccruedResearchAndDevelopmentExpensesCurrent_lbl_c9dbcf" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_AccruedResearchAndDevelopmentExpensesCurrent_lbl_c9dbcf" xml:lang="en-US">Accrued research and development expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedBonusesCurrentAndNoncurrent" xlink:label="us-gaap_AccruedBonusesCurrentAndNoncurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedBonusesCurrentAndNoncurrent" xlink:to="us-gaap_AccruedBonusesCurrentAndNoncurrent_lbl_e46b48" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedBonusesCurrentAndNoncurrent_lbl_e46b48" xml:lang="en-US">Accrued bonus</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl_50d9f9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl_50d9f9" xml:lang="en-US">Accrued payroll taxes and professional fees</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl_d5cdc9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl_d5cdc9" xml:lang="en-US">Total</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl_f1f37a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseExpense_lbl_f1f37a" xml:lang="en-US">Total Rent Expense</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl_c1fc53" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasePayments_lbl_c1fc53" xml:lang="en-US">Operating Lease Monthly Payment</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_LeasePaymentUnderNonCancellableOperatingLeases" xlink:label="ltbr_LeasePaymentUnderNonCancellableOperatingLeases" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_LeasePaymentUnderNonCancellableOperatingLeases" xlink:to="ltbr_LeasePaymentUnderNonCancellableOperatingLeases_lbl_453e51" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_LeasePaymentUnderNonCancellableOperatingLeases_lbl_453e51" xml:lang="en-US">Future minimum lease payments required under the non-cancellable operating leases</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_LesseeOperatingLeaseTerm" xlink:label="ltbr_LesseeOperatingLeaseTerm" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_LesseeOperatingLeaseTerm" xlink:to="ltbr_LesseeOperatingLeaseTerm_lbl_2a6fc0" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_LesseeOperatingLeaseTerm_lbl_2a6fc0" xml:lang="en-US">Operating Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_ResearchAndDevelopmentCostAbstract" xlink:label="ltbr_ResearchAndDevelopmentCostAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ResearchAndDevelopmentCostAbstract" xlink:to="ltbr_ResearchAndDevelopmentCostAbstract_lbl_b0d251" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ResearchAndDevelopmentCostAbstract_lbl_b0d251" xml:lang="en-US">Research and Development Cost (Details Narrative)</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_CRADAMember" xlink:label="ltbr_CRADAMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_CRADAMember" xlink:to="ltbr_CRADAMember_lbl_c2b24e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_CRADAMember_lbl_c2b24e" xml:lang="en-US">CRADA</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_StrategicPartnershipProjectAgreementMember" xlink:label="ltbr_StrategicPartnershipProjectAgreementMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_StrategicPartnershipProjectAgreementMember" xlink:to="ltbr_StrategicPartnershipProjectAgreementMember_lbl_1b9076" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_StrategicPartnershipProjectAgreementMember_lbl_1b9076" xml:lang="en-US">Strategic Partnership Project Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_CANDUMember" xlink:label="ltbr_CANDUMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_CANDUMember" xlink:to="ltbr_CANDUMember_lbl_7ed978" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_CANDUMember_lbl_7ed978" xml:lang="en-US">Canada Deuterium Uranium (CANDU)</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_FEEdMember" xlink:label="ltbr_FEEdMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_FEEdMember" xlink:to="ltbr_FEEdMember_lbl_c578d4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_FEEdMember_lbl_c578d4" xml:lang="en-US">Front-end engineering and design (FEED)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherResearchAndDevelopmentExpense" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherResearchAndDevelopmentExpense" xlink:to="us-gaap_OtherResearchAndDevelopmentExpense_lbl_1ed757" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense_lbl_1ed757" xml:lang="en-US">Other research and development expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_ResearchAndDevelopmentArrangementExpense" xlink:label="ltbr_ResearchAndDevelopmentArrangementExpense" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ResearchAndDevelopmentArrangementExpense" xlink:to="ltbr_ResearchAndDevelopmentArrangementExpense_lbl_a70a6f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ResearchAndDevelopmentArrangementExpense_lbl_a70a6f" xml:lang="en-US">Increase in Estimated Cost Under R&amp;D Agreement</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl_e2f1db" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl_e2f1db" xml:lang="en-US">Advance Payment Made</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl_66fc99" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl_66fc99" xml:lang="en-US">Research and development expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_ResearchAndDevelopmentExpensePayable" xlink:label="ltbr_ResearchAndDevelopmentExpensePayable" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ResearchAndDevelopmentExpensePayable" xlink:to="ltbr_ResearchAndDevelopmentExpensePayable_lbl_28e20a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ResearchAndDevelopmentExpensePayable_lbl_28e20a" xml:lang="en-US">Payable amount</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_PaymentsToResearchAndDevelopmentCost" xlink:label="ltbr_PaymentsToResearchAndDevelopmentCost" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_PaymentsToResearchAndDevelopmentCost" xlink:to="ltbr_PaymentsToResearchAndDevelopmentCost_lbl_29ba00" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_PaymentsToResearchAndDevelopmentCost_lbl_29ba00" xml:lang="en-US">Final payment</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl_12062d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl_12062d" xml:lang="en-US">Options outstanding, Beginning of the period</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl_2" xml:lang="en-US">[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl_0a627e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl_0a627e" xml:lang="en-US">Options outstanding, Granted</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl_c54293" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl_c54293" xml:lang="en-US">Options outstanding, Exercised</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl_4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl_4" xml:lang="en-US">[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl_c4beb5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl_c4beb5" xml:lang="en-US">Options outstanding, Forfeited</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl_d6de0c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl_d6de0c" xml:lang="en-US">Options outstanding, Expired</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl_b9a026" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl_b9a026" xml:lang="en-US">Options outstanding, End of the period</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl_dd1265" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl_dd1265" xml:lang="en-US">Options vested and expected to vest, End of the period</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl_8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl_8" xml:lang="en-US">[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl_c9077d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl_c9077d" xml:lang="en-US">Options outstanding options, exercisable</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl_9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl_9" xml:lang="en-US">[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl_355b49" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl_355b49" xml:lang="en-US">Weighted Average Exercise Price, Beginning of the period</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl_10" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl_10" xml:lang="en-US">[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl_d5daf3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl_d5daf3" xml:lang="en-US">Weighted Average Exercise Price Stock Options, Granted</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl_3f819b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl_3f819b" xml:lang="en-US">Weighted Average Exercise Price Stock Options, Exercised</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl_f7caec" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl_f7caec" xml:lang="en-US">Weighted Average Exercise Price Stock Options, Forfeited</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl_c012c6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl_c012c6" xml:lang="en-US">Weighted Average Exercise Price Stock Options, Expired</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl_055a00" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl_055a00" xml:lang="en-US">Weighted Average Exercise Price, End of the period</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice" xlink:to="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice_lbl_1f8463" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice_lbl_1f8463" xml:lang="en-US">Weighted Average Exercise Price, vested and expected to vest, End of the period</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice" xlink:label="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice" xlink:to="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice_lbl_16" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice_lbl_16" xml:lang="en-US">[Weighted Average Exercise Price, vested and expected to vest, End of the period]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl_f03350" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl_f03350" xml:lang="en-US">Weighted Average Exercise Price Options, exercisable</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl_17" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl_17" xml:lang="en-US">[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm" xlink:label="ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm" xlink:to="ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm_lbl_78d5e8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm_lbl_78d5e8" xml:lang="en-US">Weighted Average Remaining Contractual Life - Years Beginning</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermEndingFF" xlink:label="ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermEndingFF" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermEndingFF" xlink:to="ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermEndingFF_lbl_6bce72" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermEndingFF_lbl_6bce72" xml:lang="en-US">Weighted Average Remaining Contractual Life - Years Ending</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermVested" xlink:label="ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermVested" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermVested" xlink:to="ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermVested_lbl_f0321b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermVested_lbl_f0321b" xml:lang="en-US">Weighted Average Remaining Contractual Life - (Years) Vested and expected to vest</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermOptionsExercisable" xlink:label="ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermOptionsExercisable" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermOptionsExercisable" xlink:to="ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermOptionsExercisable_lbl_5bcfff" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermOptionsExercisable_lbl_5bcfff" xml:lang="en-US">Weighted Average Remaining Contractual Life - (Years) exercisable</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding" xlink:to="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding_lbl_7352ca" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding_lbl_7352ca" xml:lang="en-US">Options aggregate intrinsic value, Outstanding beginning</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding" xlink:to="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding_lbl_22" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding_lbl_22" xml:lang="en-US">[Options aggregate intrinsic value, Outstanding beginning]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueExercised" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueExercised" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueExercised" xlink:to="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueExercised_lbl_34d7f5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueExercised_lbl_34d7f5" xml:lang="en-US">Options aggregate intrinsic value, Outstanding exercised</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding" xlink:to="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding_lbl_9b6809" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding_lbl_9b6809" xml:lang="en-US">Options aggregate intrinsic value, Outstanding ending</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding" xlink:to="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding_lbl_24" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding_lbl_24" xml:lang="en-US">[Options aggregate intrinsic value, Outstanding ending]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVestedAndExpectedToVest" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVestedAndExpectedToVest" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVestedAndExpectedToVest" xlink:to="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVestedAndExpectedToVest_lbl_e184a6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVestedAndExpectedToVest_lbl_e184a6" xml:lang="en-US">Options aggregate intrinsic value, Vested and expected to vest</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOptionsExercisable" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOptionsExercisable" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOptionsExercisable" xlink:to="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOptionsExercisable_lbl_6fd04c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOptionsExercisable_lbl_6fd04c" xml:lang="en-US">Options aggregate intrinsic value, Options exercisable</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl_5ef97d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl_5ef97d" xml:lang="en-US">Expected volatility</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl_4c1ee8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl_4c1ee8" xml:lang="en-US">Risk free interest rate</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl_169a75" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl_169a75" xml:lang="en-US">Dividend yield rate</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl_b0a134" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl_b0a134" xml:lang="en-US">Closing price per share - common stock</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl_9c69b2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl_9c69b2" xml:lang="en-US">Expected Life</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl_5887fe" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl_5887fe" xml:lang="en-US">Award Type Axis</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_RestrictedStockAwardMember" xlink:label="ltbr_RestrictedStockAwardMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_RestrictedStockAwardMember" xlink:to="ltbr_RestrictedStockAwardMember_lbl_086055" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_RestrictedStockAwardMember_lbl_086055" xml:lang="en-US">Restricted Stock Award [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding" xlink:to="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding_lbl_83fd55" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding_lbl_83fd55" xml:lang="en-US">Outstanding at beginning of period</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding" xlink:label="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding" xlink:to="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding_lbl_2" xml:lang="en-US">[Outstanding at beginning of period]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl_384d53" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl_384d53" xml:lang="en-US">Shares, Granted</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl_175e4e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl_175e4e" xml:lang="en-US">Shares, vested</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl_4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl_4" xml:lang="en-US">[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_lbl_e9983b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_lbl_e9983b" xml:lang="en-US">Shares, forfieted</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94" xlink:to="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94_lbl_4f7ff3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94_lbl_4f7ff3" xml:lang="en-US">Outstanding at end of period</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94" xlink:label="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94" xlink:to="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94_lbl_6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94_lbl_6" xml:lang="en-US">[Outstanding at end of period]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl_73605a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl_73605a" xml:lang="en-US">Weighted average fair value grant date, beginning</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl_7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl_7" xml:lang="en-US">[Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl_766bba" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl_766bba" xml:lang="en-US">Weighted average fair value grant date, granted</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl_c653c7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl_c653c7" xml:lang="en-US">Weighted average fair value grant date, vested</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_lbl_819c10" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_lbl_819c10" xml:lang="en-US">Weighted average fair value grant date, forfeited</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl_9d6709" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl_9d6709" xml:lang="en-US">Weighted average fair value grant date, ending</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted" xlink:to="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted_lbl_845f60" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted_lbl_845f60" xml:lang="en-US">Options aggregate intrinsic value, granted</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVested" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVested" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVested" xlink:to="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVested_lbl_97bd97" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVested_lbl_97bd97" xml:lang="en-US">Options aggregate intrinsic value, vested</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited" xlink:to="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited_lbl_025d27" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited_lbl_025d27" xml:lang="en-US">Options aggregate intrinsic value, forfeited</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings" xlink:to="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings_lbl_d2c6f1" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings_lbl_d2c6f1" xml:lang="en-US">Options aggregate intrinsic value, Outstanding ending</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings" xlink:to="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings_lbl_16" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings_lbl_16" xml:lang="en-US">[Options aggregate intrinsic value, Outstanding ending 1]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl_ab877a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl_ab877a" xml:lang="en-US">Income Statement Location Axis</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl_bd9478" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl_bd9478" xml:lang="en-US">Research And Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl_467964" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl_467964" xml:lang="en-US">General And Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl_60b74e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl_60b74e" xml:lang="en-US">Total stock-based compensation expense</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl_0ac72c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentAxis_lbl_0ac72c" xml:lang="en-US">Financial Instrument Axis</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingAxis_lbl_0dde8e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VestingAxis_lbl_0dde8e" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_lbl_65c866" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_lbl_65c866" xml:lang="en-US">Equity Interest Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="srt_BoardOfDirectorsChairmanMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_BoardOfDirectorsChairmanMember" xlink:to="srt_BoardOfDirectorsChairmanMember_lbl_bc4883" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_BoardOfDirectorsChairmanMember_lbl_bc4883" xml:lang="en-US">Board of Directors Chairman [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_RestrictedStockUnitsRSAMember" xlink:label="ltbr_RestrictedStockUnitsRSAMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_RestrictedStockUnitsRSAMember" xlink:to="ltbr_RestrictedStockUnitsRSAMember_lbl_02b782" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_RestrictedStockUnitsRSAMember_lbl_02b782" xml:lang="en-US">Restricted Stock Units R S A [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_AvailableForSaleSecuritiesMember" xlink:label="ltbr_AvailableForSaleSecuritiesMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_AvailableForSaleSecuritiesMember" xlink:to="ltbr_AvailableForSaleSecuritiesMember_lbl_e5cae6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_AvailableForSaleSecuritiesMember_lbl_e5cae6" xml:lang="en-US">Available for sale Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TwoThousandTwentyEquityIncentivePlanMember" xlink:label="ltbr_TwoThousandTwentyEquityIncentivePlanMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TwoThousandTwentyEquityIncentivePlanMember" xlink:to="ltbr_TwoThousandTwentyEquityIncentivePlanMember_lbl_361b32" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TwoThousandTwentyEquityIncentivePlanMember_lbl_361b32" xml:lang="en-US">2020 Equity Incentive Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TwentyTwentyFiveTransactionsMember" xlink:label="ltbr_TwentyTwentyFiveTransactionsMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TwentyTwentyFiveTransactionsMember" xlink:to="ltbr_TwentyTwentyFiveTransactionsMember_lbl_ff20c1" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TwentyTwentyFiveTransactionsMember_lbl_ff20c1" xml:lang="en-US">2025 Transactions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_OptionsMember" xlink:label="ltbr_OptionsMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_OptionsMember" xlink:to="ltbr_OptionsMember_lbl_b00931" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_OptionsMember_lbl_b00931" xml:lang="en-US">Options [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_CommonShareIssuancesMember" xlink:label="ltbr_CommonShareIssuancesMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_CommonShareIssuancesMember" xlink:to="ltbr_CommonShareIssuancesMember_lbl_6f4da0" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_CommonShareIssuancesMember_lbl_6f4da0" xml:lang="en-US">Common Share Issuances [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_PrepaidExpenseAndOtherCurrentAssetMember" xlink:to="ltbr_PrepaidExpenseAndOtherCurrentAssetMember_lbl_1ced20" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ltbr_PrepaidExpenseAndOtherCurrentAssetMember_lbl_1ced20" xml:lang="en-US">Prepaid Expenses And Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_PrepaidExpenseAndOtherCurrentAssetMember" xlink:label="ltbr_PrepaidExpenseAndOtherCurrentAssetMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_PrepaidExpenseAndOtherCurrentAssetMember" xlink:to="ltbr_PrepaidExpenseAndOtherCurrentAssetMember_lbl_109" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_PrepaidExpenseAndOtherCurrentAssetMember_lbl_109" xml:lang="en-US">[Prepaid Expenses And Other Current Assets [Member]]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_RestrictedStockAwardsSummaryMember" xlink:label="ltbr_RestrictedStockAwardsSummaryMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_RestrictedStockAwardsSummaryMember" xlink:to="ltbr_RestrictedStockAwardsSummaryMember_lbl_df86fb" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_RestrictedStockAwardsSummaryMember_lbl_df86fb" xml:lang="en-US">RSA Summary 2025 and 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_BoardOfDirectorsMember" xlink:label="ltbr_BoardOfDirectorsMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_BoardOfDirectorsMember" xlink:to="ltbr_BoardOfDirectorsMember_lbl_9a8b53" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_BoardOfDirectorsMember_lbl_9a8b53" xml:lang="en-US">Board of Directors [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TopMember" xlink:label="ltbr_TopMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TopMember" xlink:to="ltbr_TopMember_lbl_ed99ec" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TopMember_lbl_ed99ec" xml:lang="en-US">Maximum</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_BottomMember" xlink:label="ltbr_BottomMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_BottomMember" xlink:to="ltbr_BottomMember_lbl_432a2c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_BottomMember_lbl_432a2c" xml:lang="en-US">Minimum</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SeriesXPreferredStockMember" xlink:label="ltbr_SeriesXPreferredStockMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SeriesXPreferredStockMember" xlink:to="ltbr_SeriesXPreferredStockMember_lbl_9c0343" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SeriesXPreferredStockMember_lbl_9c0343" xml:lang="en-US">Series X Preferred Stock [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl_5dd06c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl_5dd06c" xml:lang="en-US">Options outstanding, Granted</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_lbl_0aa662" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_lbl_0aa662" xml:lang="en-US">Exercise price lower range limit</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl_a1957c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl_a1957c" xml:lang="en-US">Total fair value</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl_ea630c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl_ea630c" xml:lang="en-US">Shares, Granted</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl_d3953d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl_d3953d" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl_fc3b60" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl_fc3b60" xml:lang="en-US">Shares, vested</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl_ac5284" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl_ac5284" xml:lang="en-US">Weighted average fair value grant date, granted</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:to="us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_lbl_469511" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_lbl_469511" xml:lang="en-US">Outstanding restricted stock awards</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockRedemptionAmount" xlink:label="us-gaap_PreferredStockRedemptionAmount" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockRedemptionAmount" xlink:to="us-gaap_PreferredStockRedemptionAmount_lbl_845801" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockRedemptionAmount_lbl_845801" xml:lang="en-US">Redemption Price of Preferred Stock</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl_5fbd22" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl_5fbd22" xml:lang="en-US">Preferred Stock, par value</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl_e9c17d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl_e9c17d" xml:lang="en-US">Cash</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_DescriptionOfSubscriptionAndInvestmentRepresentationAgreement" xlink:label="ltbr_DescriptionOfSubscriptionAndInvestmentRepresentationAgreement" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_DescriptionOfSubscriptionAndInvestmentRepresentationAgreement" xlink:to="ltbr_DescriptionOfSubscriptionAndInvestmentRepresentationAgreement_lbl_da8f3d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_DescriptionOfSubscriptionAndInvestmentRepresentationAgreement_lbl_da8f3d" xml:lang="en-US">Description of subscription and investment representation agreement</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_PreferredStockVotingRightsShares" xlink:label="ltbr_PreferredStockVotingRightsShares" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_PreferredStockVotingRightsShares" xlink:to="ltbr_PreferredStockVotingRightsShares_lbl_955907" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_PreferredStockVotingRightsShares_lbl_955907" xml:lang="en-US">Preferred stock voting rights shares</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_CommonSharesIssuancesEquityGrant" xlink:label="ltbr_CommonSharesIssuancesEquityGrant" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_CommonSharesIssuancesEquityGrant" xlink:to="ltbr_CommonSharesIssuancesEquityGrant_lbl_048098" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_CommonSharesIssuancesEquityGrant_lbl_048098" xml:lang="en-US">Common shares issuances equity grant value</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_EquityGrantValue" xlink:label="ltbr_EquityGrantValue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_EquityGrantValue" xlink:to="ltbr_EquityGrantValue_lbl_eef224" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_EquityGrantValue_lbl_eef224" xml:lang="en-US">Equity grant approved by board of directors</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl_ae984c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesIssued_lbl_ae984c" xml:lang="en-US">Common Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl_345c75" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl_345c75" xml:lang="en-US">Stock options vested</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl_b122e7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl_b122e7" xml:lang="en-US">Proceeds from stock option exercise</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl_3fa12b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl_3fa12b" xml:lang="en-US">Proceeds from Stock options, shares</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl_2607b7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl_2607b7" xml:lang="en-US">Unrecognized compensation cost related to option awards</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl_2a64a6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl_2a64a6" xml:lang="en-US">Unrecognized compensation cost related to option awards vesting period</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_CommonStockShareOutstanding" xlink:to="ltbr_CommonStockShareOutstanding_lbl_0c143e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ltbr_CommonStockShareOutstanding_lbl_0c143e" xml:lang="en-US">Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_CommonStockShareOutstanding" xlink:label="ltbr_CommonStockShareOutstanding" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_CommonStockShareOutstanding" xlink:to="ltbr_CommonStockShareOutstanding_lbl_23" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_CommonStockShareOutstanding_lbl_23" xml:lang="en-US">[Common Stock, Shares Outstanding]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl_bb3548" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl_bb3548" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_RSAFairValue" xlink:label="ltbr_RSAFairValue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_RSAFairValue" xlink:to="ltbr_RSAFairValue_lbl_a87e9e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_RSAFairValue_lbl_a87e9e" xml:lang="en-US">Fair value of the RSAs vested</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntercompanyAgreementsDescription" xlink:label="us-gaap_IntercompanyAgreementsDescription" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntercompanyAgreementsDescription" xlink:to="us-gaap_IntercompanyAgreementsDescription_lbl_0cbff9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntercompanyAgreementsDescription_lbl_0cbff9" xml:lang="en-US">ATM Agreement amendment, description</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl_62bf05" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl_62bf05" xml:lang="en-US">Shares of common stock issued</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_CommonSharesEquityGrantPricePerShares" xlink:label="ltbr_CommonSharesEquityGrantPricePerShares" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_CommonSharesEquityGrantPricePerShares" xlink:to="ltbr_CommonSharesEquityGrantPricePerShares_lbl_42d1a1" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_CommonSharesEquityGrantPricePerShares_lbl_42d1a1" xml:lang="en-US">Common shares equity grant price per shares</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted" xlink:label="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted" xlink:to="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted_lbl_09940f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted_lbl_09940f" xml:lang="en-US">Number of shares granted</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense_lbl_626470" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense_lbl_626470" xml:lang="en-US">Compensation cost recognized</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl_d4c7f6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingExpenses_lbl_d4c7f6" xml:lang="en-US">Consulting expense</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_CommonStockValuedGrantDatePricePerShare" xlink:label="ltbr_CommonStockValuedGrantDatePricePerShare" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_CommonStockValuedGrantDatePricePerShare" xlink:to="ltbr_CommonStockValuedGrantDatePricePerShare_lbl_1c277c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_CommonStockValuedGrantDatePricePerShare_lbl_1c277c" xml:lang="en-US">Common stock, valued grant date price per share</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl_334256" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl_334256" xml:lang="en-US">Weighted average grant date fair value</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice_lbl_08e4ec" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice_lbl_08e4ec" xml:lang="en-US">Fair value of the Company's common stock per share</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl_be8e6e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl_be8e6e" xml:lang="en-US">Fair value of the Company's common stock per share</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_DescriptionOfRSAsModificationAndNetShareSettlementsForPaymentsOfWithholdingTaxes" xlink:label="ltbr_DescriptionOfRSAsModificationAndNetShareSettlementsForPaymentsOfWithholdingTaxes" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_DescriptionOfRSAsModificationAndNetShareSettlementsForPaymentsOfWithholdingTaxes" xlink:to="ltbr_DescriptionOfRSAsModificationAndNetShareSettlementsForPaymentsOfWithholdingTaxes_lbl_97537d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_DescriptionOfRSAsModificationAndNetShareSettlementsForPaymentsOfWithholdingTaxes_lbl_97537d" xml:lang="en-US">RSAs Modification and Net Share Settlements for Payments of Withholding Taxes, Description</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_CommonStockEquivalentsOutstandingShares" xlink:label="ltbr_CommonStockEquivalentsOutstandingShares" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_CommonStockEquivalentsOutstandingShares" xlink:to="ltbr_CommonStockEquivalentsOutstandingShares_lbl_cdb53c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_CommonStockEquivalentsOutstandingShares_lbl_cdb53c" xml:lang="en-US">Outstanding shares of common stock and ommon stock equivalents</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease_lbl_dc594f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease_lbl_dc594f" xml:lang="en-US">Stock options outstanding</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfInitialPublicOffering" xlink:label="us-gaap_PaymentsForRepurchaseOfInitialPublicOffering" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfInitialPublicOffering" xlink:to="us-gaap_PaymentsForRepurchaseOfInitialPublicOffering_lbl_136fae" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRepurchaseOfInitialPublicOffering_lbl_136fae" xml:lang="en-US">Offering price, ATM</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_MarketOfferingsDisclosureDescription" xlink:label="ltbr_MarketOfferingsDisclosureDescription" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_MarketOfferingsDisclosureDescription" xlink:to="ltbr_MarketOfferingsDisclosureDescription_lbl_c82b7f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_MarketOfferingsDisclosureDescription_lbl_c82b7f" xml:lang="en-US">Description related to ATM offerings</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_FutureIssuanceOfShare" xlink:label="ltbr_FutureIssuanceOfShare" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_FutureIssuanceOfShare" xlink:to="ltbr_FutureIssuanceOfShare_lbl_7fc8e5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_FutureIssuanceOfShare_lbl_7fc8e5" xml:lang="en-US">Common stock available for future issuance</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl_ae12d0" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl_ae12d0" xml:lang="en-US">Total number of common stock available for future issuance</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_DescriptionOfEquityIncentivePlan" xlink:label="ltbr_DescriptionOfEquityIncentivePlan" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_DescriptionOfEquityIncentivePlan" xlink:to="ltbr_DescriptionOfEquityIncentivePlan_lbl_88b4f4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_DescriptionOfEquityIncentivePlan_lbl_88b4f4" xml:lang="en-US">Description of Equity incentive plan</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl_1f3bd9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl_1f3bd9" xml:lang="en-US">Proceeds from sale of common stock, shares</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_ProceedsFromStockIssuances" xlink:label="ltbr_ProceedsFromStockIssuances" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ProceedsFromStockIssuances" xlink:to="ltbr_ProceedsFromStockIssuances_lbl_3c7979" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ProceedsFromStockIssuances_lbl_3c7979" xml:lang="en-US">Net proceeds from stock issuance under ATM</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl_2c4b17" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl_2c4b17" xml:lang="en-US">Stock issuence cost</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReportingUnitAxis" xlink:label="us-gaap_ReportingUnitAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReportingUnitAxis" xlink:to="us-gaap_ReportingUnitAxis_lbl_3cefde" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReportingUnitAxis_lbl_3cefde" xml:lang="en-US">Reporting Unit Axis</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_CODMMember" xlink:label="ltbr_CODMMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_CODMMember" xlink:to="ltbr_CODMMember_lbl_59d9e0" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_CODMMember_lbl_59d9e0" xml:lang="en-US">CODM</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl_4c7f46" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Revenues_lbl_4c7f46" xml:lang="en-US">Revenue</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherGeneralAndAdministrativeExpense" xlink:to="us-gaap_OtherGeneralAndAdministrativeExpense_lbl_d7c0e4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherGeneralAndAdministrativeExpense_lbl_d7c0e4" xml:lang="en-US">General and administrative</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherGeneralAndAdministrativeExpense" xlink:label="us-gaap_OtherGeneralAndAdministrativeExpense" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherGeneralAndAdministrativeExpense" xlink:to="us-gaap_OtherGeneralAndAdministrativeExpense_lbl_3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherGeneralAndAdministrativeExpense_lbl_3" xml:lang="en-US">[Other General and Administrative Expense]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_InlProject" xlink:label="ltbr_InlProject" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_InlProject" xlink:to="ltbr_InlProject_lbl_148731" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_InlProject_lbl_148731" xml:lang="en-US">INL Project</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_RomaniaFeasibilityStudy" xlink:label="ltbr_RomaniaFeasibilityStudy" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_RomaniaFeasibilityStudy" xlink:to="ltbr_RomaniaFeasibilityStudy_lbl_2b9f28" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_RomaniaFeasibilityStudy_lbl_2b9f28" xml:lang="en-US">Romania feasibility study</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_CentrusEnergyFeedStudy" xlink:label="ltbr_CentrusEnergyFeedStudy" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_CentrusEnergyFeedStudy" xlink:to="ltbr_CentrusEnergyFeedStudy_lbl_aaee30" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_CentrusEnergyFeedStudy_lbl_aaee30" xml:lang="en-US">Centrus Energy FEED study</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl_237ba5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl_237ba5" xml:lang="en-US">Allocated employee compensation and stock-based compensation</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherExpenses" xlink:label="us-gaap_OtherExpenses" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherExpenses" xlink:to="us-gaap_OtherExpenses_lbl_4ed6fa" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherExpenses_lbl_4ed6fa" xml:lang="en-US">Other outside R&amp;D expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_ResearchAndDevelopmentExpenseNet" xlink:label="ltbr_ResearchAndDevelopmentExpenseNet" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ResearchAndDevelopmentExpenseNet" xlink:to="ltbr_ResearchAndDevelopmentExpenseNet_lbl_845aa7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ResearchAndDevelopmentExpenseNet_lbl_845aa7" xml:lang="en-US">Total research and development</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_OtherSegmentsItem" xlink:label="ltbr_OtherSegmentsItem" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_OtherSegmentsItem" xlink:to="ltbr_OtherSegmentsItem_lbl_241b0e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_OtherSegmentsItem_lbl_241b0e" xml:lang="en-US">Other segments item (1)</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_OperatingNetIncomeLossFromSegmentsToConsolidated" xlink:label="ltbr_OperatingNetIncomeLossFromSegmentsToConsolidated" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_OperatingNetIncomeLossFromSegmentsToConsolidated" xlink:to="ltbr_OperatingNetIncomeLossFromSegmentsToConsolidated_lbl_14f71f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_OperatingNetIncomeLossFromSegmentsToConsolidated_lbl_14f71f" xml:lang="en-US">Net loss</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl_350c1c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl_350c1c" xml:lang="en-US">Subsequent Event Type Axis</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl_c4a912" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl_c4a912" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_BottomMember" xlink:to="ltbr_BottomMember_lbl_509340" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ltbr_BottomMember_lbl_509340" xml:lang="en-US">Bottom</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_ArticlesOfIncorporationMember" xlink:label="ltbr_ArticlesOfIncorporationMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ArticlesOfIncorporationMember" xlink:to="ltbr_ArticlesOfIncorporationMember_lbl_1e61c0" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ArticlesOfIncorporationMember_lbl_1e61c0" xml:lang="en-US">Articles of Incorporation [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TopMember" xlink:to="ltbr_TopMember_lbl_300f7c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ltbr_TopMember_lbl_300f7c" xml:lang="en-US">Top</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TwentyTwentyPlanMember" xlink:label="ltbr_TwentyTwentyPlanMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TwentyTwentyPlanMember" xlink:to="ltbr_TwentyTwentyPlanMember_lbl_d98913" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TwentyTwentyPlanMember_lbl_d98913" xml:lang="en-US">2020 Plan [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl_ee8413" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl_ee8413" xml:lang="en-US">Proceeds from sale of common stock, shares</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ProceedsFromStockIssuances" xlink:to="ltbr_ProceedsFromStockIssuances_lbl_1f83c2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ltbr_ProceedsFromStockIssuances_lbl_1f83c2" xml:lang="en-US">Net proceeds from stock issuance under ATM</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl_17f255" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl_17f255" xml:lang="en-US">Restricted stock awards shares</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl_e73bfa" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl_e73bfa" xml:lang="en-US">Restricted stock awards shares value</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl_7160ad" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl_7160ad" xml:lang="en-US">Stock price per share</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl_7e5374" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl_7e5374" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>ltbr-20250331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 05/12/2025-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2025 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://ltbr.com/role/Cover" xlink:href="ltbr-20250331.xsd#Cover" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/ConsolidatedBalanceSheets" xlink:href="ltbr-20250331.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="ltbr-20250331.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/ConsolidatedStatementsOfOperations" xlink:href="ltbr-20250331.xsd#ConsolidatedStatementsOfOperations" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" xlink:href="ltbr-20250331.xsd#ConsolidatedStatementsOfChangesInStockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="ltbr-20250331.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements" xlink:href="ltbr-20250331.xsd#NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NetLossPerShare" xlink:href="ltbr-20250331.xsd#NetLossPerShare" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongtermAssets" xlink:href="ltbr-20250331.xsd#PrepaidProjectCostsAndOtherLongtermAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="ltbr-20250331.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/CommitmentsAndContingencies" xlink:href="ltbr-20250331.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/ResearchAndDevelopmentCosts" xlink:href="ltbr-20250331.xsd#ResearchAndDevelopmentCosts" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensation" xlink:href="ltbr-20250331.xsd#StockholdersEquityAndStockbasedCompensation" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/SegmentReporting" xlink:href="ltbr-20250331.xsd#SegmentReporting" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/SubsequentEvents" xlink:href="ltbr-20250331.xsd#SubsequentEvents" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperationsPolicies" xlink:href="ltbr-20250331.xsd#BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperationsPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperationsTables" xlink:href="ltbr-20250331.xsd#BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperationsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NetLossPerShareTables" xlink:href="ltbr-20250331.xsd#NetLossPerShareTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="ltbr-20250331.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables" xlink:href="ltbr-20250331.xsd#StockholdersEquityAndStockbasedCompensationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/SegmentReportingTables" xlink:href="ltbr-20250331.xsd#SegmentReportingTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails" xlink:href="ltbr-20250331.xsd#NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative" xlink:href="ltbr-20250331.xsd#NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NetLossPerShareDetails" xlink:href="ltbr-20250331.xsd#NetLossPerShareDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative" xlink:href="ltbr-20250331.xsd#PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:href="ltbr-20250331.xsd#AccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="ltbr-20250331.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/ResearchAndDevelopmentCostDetailsNarrative" xlink:href="ltbr-20250331.xsd#ResearchAndDevelopmentCostDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails" xlink:href="ltbr-20250331.xsd#StockholdersEquityAndStockbasedCompensationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1" xlink:href="ltbr-20250331.xsd#StockholdersEquityAndStockbasedCompensationDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2" xlink:href="ltbr-20250331.xsd#StockholdersEquityAndStockbasedCompensationDetails2" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails3" xlink:href="ltbr-20250331.xsd#StockholdersEquityAndStockbasedCompensationDetails3" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative" xlink:href="ltbr-20250331.xsd#StockholdersEquityAndStockbasedCompensationDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/SegmentReportingDetails" xlink:href="ltbr-20250331.xsd#SegmentReportingDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/SubsequentEventsDetailsNarrative" xlink:href="ltbr-20250331.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/Cover" xlink:title="00000001 - Document - Document and Entity Information" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/ConsolidatedBalanceSheets" xlink:title="110200 - Statement - CONSOLIDATED BALANCE SHEETS">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
    <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
    <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssets" />
    <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssets" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
    <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
    <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
    <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
    <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
    <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
    <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
    <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
    <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="110201 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/ConsolidatedStatementsOfOperations" xlink:title="124100 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
    <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
    <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
    <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" />
    <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeOther" xlink:label="loc_us-gaapInterestIncomeOther" />
    <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestIncomeOther" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
    <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
    <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
    <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" xlink:title="148600 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="170000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
    <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
    <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" />
    <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets" xlink:label="loc_ltbrIncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets" />
    <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ltbrIncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
    <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
    <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="loc_us-gaapPaymentsRelatedToTaxWithholdingForShareBasedCompensation" />
    <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
    <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
    <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
    <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements" xlink:title="995446 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NetLossPerShare" xlink:title="995447 - Disclosure - Net Loss Per Share" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongtermAssets" xlink:title="995448 - Disclosure - Prepaid Project Costs and Other Longterm Assets" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="995449 - Disclosure - Accounts Payable and Accrued Liabilities" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/CommitmentsAndContingencies" xlink:title="995450 - Disclosure - Commitments and Contingencies" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/ResearchAndDevelopmentCosts" xlink:title="995451 - Disclosure - Research and Development Costs" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensation" xlink:title="995452 - Disclosure - Stockholders Equity and StockBased Compensation" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/SegmentReporting" xlink:title="995453 - Disclosure - Segment Reporting" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/SubsequentEvents" xlink:title="995454 - Disclosure - Subsequent Events" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperationsPolicies" xlink:title="995455 - Disclosure - Basis of Presentation Summary of Significant Accounting Policies and Nature of Operations (Policies)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperationsTables" xlink:title="995456 - Disclosure - Basis of Presentation Summary of Significant Accounting Policies and Nature of Operations (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NetLossPerShareTables" xlink:title="995457 - Disclosure - Net Loss Per Share (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="995458 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables" xlink:title="995459 - Disclosure - Stockholders Equity and StockBased Compensation (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/SegmentReportingTables" xlink:title="995460 - Disclosure - Segment Reporting (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails" xlink:title="995461 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative" xlink:title="995462 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NetLossPerShareDetails" xlink:title="995463 - Disclosure - Net Loss Per Share (Details)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative" xlink:title="995464 - Disclosure - Prepaid Project Costs and Other Long-term Assets (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:title="995465 - Disclosure - Accounts Payable and Accrued Liabilities (Details)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="995466 - Disclosure - Commitments and Contingencies (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/ResearchAndDevelopmentCostDetailsNarrative" xlink:title="995467 - Disclosure - Research and Development Cost (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails" xlink:title="995468 - Disclosure - Stockholders Equity and StockBased Compensation (Details)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1" xlink:title="995469 - Disclosure - Stockholders Equity and StockBased Compensation (Details 1)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2" xlink:title="995470 - Disclosure - Stockholders Equity and StockBased Compensation (Details 2)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails3" xlink:title="995471 - Disclosure - Stockholders Equity and StockBased Compensation (Details 3)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative" xlink:title="995472 - Disclosure - Stockholders Equity and StockBased Compensation (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/SegmentReportingDetails" xlink:title="995473 - Disclosure - Segment Reporting (Details)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/SubsequentEventsDetailsNarrative" xlink:title="995474 - Disclosure - Subsequent Events (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>ltbr-20250331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 05/12/2025-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2025 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://ltbr.com/role/Cover" xlink:href="ltbr-20250331.xsd#Cover" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/ConsolidatedBalanceSheets" xlink:href="ltbr-20250331.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="ltbr-20250331.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/ConsolidatedStatementsOfOperations" xlink:href="ltbr-20250331.xsd#ConsolidatedStatementsOfOperations" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" xlink:href="ltbr-20250331.xsd#ConsolidatedStatementsOfChangesInStockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="ltbr-20250331.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements" xlink:href="ltbr-20250331.xsd#NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NetLossPerShare" xlink:href="ltbr-20250331.xsd#NetLossPerShare" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongtermAssets" xlink:href="ltbr-20250331.xsd#PrepaidProjectCostsAndOtherLongtermAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="ltbr-20250331.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/CommitmentsAndContingencies" xlink:href="ltbr-20250331.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/ResearchAndDevelopmentCosts" xlink:href="ltbr-20250331.xsd#ResearchAndDevelopmentCosts" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensation" xlink:href="ltbr-20250331.xsd#StockholdersEquityAndStockbasedCompensation" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/SegmentReporting" xlink:href="ltbr-20250331.xsd#SegmentReporting" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/SubsequentEvents" xlink:href="ltbr-20250331.xsd#SubsequentEvents" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperationsPolicies" xlink:href="ltbr-20250331.xsd#BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperationsPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperationsTables" xlink:href="ltbr-20250331.xsd#BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperationsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NetLossPerShareTables" xlink:href="ltbr-20250331.xsd#NetLossPerShareTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="ltbr-20250331.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables" xlink:href="ltbr-20250331.xsd#StockholdersEquityAndStockbasedCompensationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/SegmentReportingTables" xlink:href="ltbr-20250331.xsd#SegmentReportingTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails" xlink:href="ltbr-20250331.xsd#NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative" xlink:href="ltbr-20250331.xsd#NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NetLossPerShareDetails" xlink:href="ltbr-20250331.xsd#NetLossPerShareDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative" xlink:href="ltbr-20250331.xsd#PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:href="ltbr-20250331.xsd#AccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="ltbr-20250331.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/ResearchAndDevelopmentCostDetailsNarrative" xlink:href="ltbr-20250331.xsd#ResearchAndDevelopmentCostDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails" xlink:href="ltbr-20250331.xsd#StockholdersEquityAndStockbasedCompensationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1" xlink:href="ltbr-20250331.xsd#StockholdersEquityAndStockbasedCompensationDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2" xlink:href="ltbr-20250331.xsd#StockholdersEquityAndStockbasedCompensationDetails2" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails3" xlink:href="ltbr-20250331.xsd#StockholdersEquityAndStockbasedCompensationDetails3" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative" xlink:href="ltbr-20250331.xsd#StockholdersEquityAndStockbasedCompensationDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/SegmentReportingDetails" xlink:href="ltbr-20250331.xsd#SegmentReportingDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/SubsequentEventsDetailsNarrative" xlink:href="ltbr-20250331.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/Cover" xlink:title="00000001 - Document - Cover Page Information">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
    <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/ConsolidatedBalanceSheets" xlink:title="110200 - Statement - CONSOLIDATED BALANCE SHEETS">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract_71cfae" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="loc_ecdNonRule10b51ArrTrmntdFlag_f5bb46" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract_c13d3a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_71cfae" xlink:to="loc_us-gaapAssetsCurrentAbstract_c13d3a" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_05f395" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_71cfae" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_05f395" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_29340d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_71cfae" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_29340d" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_4d7e29" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_71cfae" xlink:to="loc_us-gaapAssetsCurrent_4d7e29" order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsAbstract" xlink:label="loc_us-gaapOtherAssetsAbstract_5cd660" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_71cfae" xlink:to="loc_us-gaapOtherAssetsAbstract_5cd660" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssets_2a05bd" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_71cfae" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssets_2a05bd" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet_cba57c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_71cfae" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet_cba57c" order="8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_f4d36a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_71cfae" xlink:to="loc_us-gaapAssets_f4d36a" order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_3eb113" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_71cfae" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_3eb113" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract_c5dde0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_71cfae" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract_c5dde0" order="11" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent_9b14c1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_c5dde0" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent_9b14c1" order="12" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_dff682" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_c5dde0" xlink:to="loc_us-gaapLiabilitiesCurrent_dff682" order="13" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract_a406d0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_71cfae" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract_a406d0" order="14" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract_fc6f19" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_71cfae" xlink:to="loc_us-gaapStockholdersEquityAbstract_fc6f19" order="15" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue_12af26" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract_fc6f19" xlink:to="loc_us-gaapPreferredStockValue_12af26" order="16" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_018af1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract_fc6f19" xlink:to="loc_us-gaapCommonStockValue_018af1" order="17" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_0e1a85" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract_fc6f19" xlink:to="loc_us-gaapAdditionalPaidInCapital_0e1a85" order="18" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_42407c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract_fc6f19" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_42407c" order="19" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_3c280c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract_fc6f19" xlink:to="loc_us-gaapStockholdersEquity_3c280c" order="20" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_4c919b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_71cfae" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_4c919b" order="21" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="110201 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract_2aae8a" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_1c0106" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_2aae8a" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_1c0106" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_c51db1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_2aae8a" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_c51db1" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_c7b99c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_2aae8a" xlink:to="loc_us-gaapPreferredStockSharesIssued_c7b99c" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_35695b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_2aae8a" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_35695b" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_8f384f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_2aae8a" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_8f384f" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_0fa050" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_2aae8a" xlink:to="loc_us-gaapCommonStockSharesAuthorized_0fa050" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_761e9f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_2aae8a" xlink:to="loc_us-gaapCommonStockSharesIssued_761e9f" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_d0727f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_2aae8a" xlink:to="loc_us-gaapCommonStockSharesOutstanding_d0727f" order="8" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/ConsolidatedStatementsOfOperations" xlink:title="124100 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract_76c062" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_5845ba" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract_76c062" xlink:to="loc_us-gaapRevenues_5845ba" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract_a13d85" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract_76c062" xlink:to="loc_us-gaapOperatingExpensesAbstract_a13d85" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense_1c3d8c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract_a13d85" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense_1c3d8c" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_847373" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract_a13d85" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_847373" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses_8d7c9d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract_a13d85" xlink:to="loc_us-gaapOperatingExpenses_8d7c9d" order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss_2c570c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract_a13d85" xlink:to="loc_us-gaapOperatingIncomeLoss_2c570c" order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract_764976" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract_a13d85" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract_764976" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeOther" xlink:label="loc_us-gaapInterestIncomeOther_873b16" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract_76c062" xlink:to="loc_us-gaapInterestIncomeOther_873b16" order="8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense_fe599d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract_76c062" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense_fe599d" order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3bc924" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract_76c062" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3bc924" order="10" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_3e416a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract_76c062" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_3e416a" order="11" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_4fb1d2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract_76c062" xlink:to="loc_us-gaapNetIncomeLoss_4fb1d2" order="12" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract_ed3881" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract_76c062" xlink:to="loc_us-gaapEarningsPerShareAbstract_ed3881" order="13" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_908e2c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract_ed3881" xlink:to="loc_us-gaapEarningsPerShareDiluted_908e2c" order="14" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_43ea48" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract_76c062" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_43ea48" order="15" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" xlink:title="148600 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract_274233" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_aa159d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract_274233" xlink:to="loc_us-gaapStatementTable_aa159d" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_4038a6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_aa159d" xlink:to="loc_us-gaapStatementLineItems_4038a6" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis_5115c6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_aa159d" xlink:to="loc_us-gaapStatementEquityComponentsAxis_5115c6" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_34d6ef" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis_5115c6" xlink:to="loc_us-gaapEquityComponentDomain_34d6ef" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_207ea3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain_34d6ef" xlink:to="loc_us-gaapCommonStockMember_207ea3" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_64f102" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain_34d6ef" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_64f102" order="22" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_06afda" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain_34d6ef" xlink:to="loc_us-gaapRetainedEarningsMember_06afda" order="23" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued_b01fc5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_4038a6" xlink:to="loc_us-gaapSharesIssued_b01fc5" order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_e56f8e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_4038a6" xlink:to="loc_us-gaapStockholdersEquity_e56f8e" order="2" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares" xlink:label="loc_ltbrSharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares_b2b623" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_4038a6" xlink:to="loc_ltbrSharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares_b2b623" order="3" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" xlink:label="loc_ltbrSharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount_7d5f64" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_4038a6" xlink:to="loc_ltbrSharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount_7d5f64" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_7752b0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_4038a6" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_7752b0" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_da1236" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_4038a6" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_da1236" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_bf39cc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_4038a6" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_bf39cc" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_212400" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_4038a6" xlink:to="loc_us-gaapNetIncomeLoss_212400" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_RestrictedSharesAwardsIssuedShares" xlink:label="loc_ltbrRestrictedSharesAwardsIssuedShares_5a9e4a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_4038a6" xlink:to="loc_ltbrRestrictedSharesAwardsIssuedShares_5a9e4a" order="9" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_RestrictedSharesAwardsIssuedAmount" xlink:label="loc_ltbrRestrictedSharesAwardsIssuedAmount_e6a7a2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_4038a6" xlink:to="loc_ltbrRestrictedSharesAwardsIssuedAmount_e6a7a2" order="10" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares" xlink:label="loc_ltbrSharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares_dca836" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_4038a6" xlink:to="loc_ltbrSharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares_dca836" order="11" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount" xlink:label="loc_ltbrSharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount_5ea2de" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_4038a6" xlink:to="loc_ltbrSharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount_5ea2de" order="12" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation_9da3da" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_4038a6" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation_9da3da" order="13" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation_e0cf33" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_4038a6" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation_e0cf33" order="14" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued_4d9006" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_4038a6" xlink:to="loc_us-gaapSharesIssued_4d9006" order="15" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_a65ad6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_4038a6" xlink:to="loc_us-gaapStockholdersEquity_a65ad6" order="16" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="170000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract_1e19d2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_fc2932" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_1e19d2" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_fc2932" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss_fd6d4f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_fc2932" xlink:to="loc_us-gaapProfitLoss_fd6d4f" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_54cf56" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_fc2932" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_54cf56" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_ca8d0b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_54cf56" xlink:to="loc_us-gaapShareBasedCompensation_ca8d0b" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_ce1c5e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_54cf56" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_ce1c5e" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther_eef354" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_ce1c5e" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther_eef354" order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets" xlink:label="loc_ltbrIncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets_0cbdcf" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_ce1c5e" xlink:to="loc_ltbrIncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets_0cbdcf" order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities_b8fe12" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_ce1c5e" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities_b8fe12" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities_e59a18" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_ce1c5e" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities_e59a18" order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities_a845e3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_ce1c5e" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities_a845e3" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_e81d5d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_1e19d2" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_e81d5d" order="11" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock_6063a5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_e81d5d" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock_6063a5" order="12" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised_8cd9e2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_e81d5d" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised_8cd9e2" order="13" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="loc_us-gaapPaymentsRelatedToTaxWithholdingForShareBasedCompensation_6ba4dd" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_e81d5d" xlink:to="loc_us-gaapPaymentsRelatedToTaxWithholdingForShareBasedCompensation_6ba4dd" order="14" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities_9452c1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_e81d5d" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities_9452c1" order="15" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2fdf23" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_1e19d2" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2fdf23" order="16" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3df048" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_1e19d2" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3df048" order="17" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_744474" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_1e19d2" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_744474" order="18" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract_2e5b5c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_1e19d2" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract_2e5b5c" order="19" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_CashPaidDuringThePeriodAbstract" xlink:label="loc_ltbrCashPaidDuringThePeriodAbstract_11d09a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract_2e5b5c" xlink:to="loc_ltbrCashPaidDuringThePeriodAbstract_11d09a" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet_0b707e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ltbrCashPaidDuringThePeriodAbstract_11d09a" xlink:to="loc_us-gaapInterestPaidNet_0b707e" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaapIncomeTaxesPaidNet_d4eafe" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_1e19d2" xlink:to="loc_us-gaapIncomeTaxesPaidNet_d4eafe" order="22" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract_3852d1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_1e19d2" xlink:to="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract_3852d1" order="23" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_PaymentOfAccruedLiabilitiesWithCommonStock" xlink:label="loc_ltbrPaymentOfAccruedLiabilitiesWithCommonStock_594be5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract_3852d1" xlink:to="loc_ltbrPaymentOfAccruedLiabilitiesWithCommonStock_594be5" order="24" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:title="995445 - Disclosure - Insider Trading Arragements">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems" xlink:label="loc_ecdInsiderTradingArrLineItems_3e6f25" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="loc_ecdRule10b51ArrAdoptedFlag_5f6ec1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_3e6f25" xlink:to="loc_ecdRule10b51ArrAdoptedFlag_5f6ec1" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="loc_ecdRule10b51ArrTrmntdFlag_94dbe0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_3e6f25" xlink:to="loc_ecdRule10b51ArrTrmntdFlag_94dbe0" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="loc_ecdNonRule10b51ArrAdoptedFlag_60228e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_3e6f25" xlink:to="loc_ecdNonRule10b51ArrAdoptedFlag_60228e" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="loc_ecdNonRule10b51ArrTrmntdFlag_df728e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_3e6f25" xlink:to="loc_ecdNonRule10b51ArrTrmntdFlag_df728e" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TrdArrIndNameOne" xlink:label="loc_ltbrTrdArrIndNameOne_4e6e56" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_3e6f25" xlink:to="loc_ltbrTrdArrIndNameOne_4e6e56" order="6" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TrdArrIndNameTwo" xlink:label="loc_ltbrTrdArrIndNameTwo_a41be9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_3e6f25" xlink:to="loc_ltbrTrdArrIndNameTwo_a41be9" order="7" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TrdArrIndNameThird" xlink:label="loc_ltbrTrdArrIndNameThird_2e9382" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_3e6f25" xlink:to="loc_ltbrTrdArrIndNameThird_2e9382" order="8" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TrdArrIndNameFourth" xlink:label="loc_ltbrTrdArrIndNameFourth_6dfbff" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_3e6f25" xlink:to="loc_ltbrTrdArrIndNameFourth_6dfbff" order="9" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TrdArrIndTitleOne" xlink:label="loc_ltbrTrdArrIndTitleOne_93cf58" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_3e6f25" xlink:to="loc_ltbrTrdArrIndTitleOne_93cf58" order="10" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TrdArrIndTitleTwo" xlink:label="loc_ltbrTrdArrIndTitleTwo_4c3308" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_3e6f25" xlink:to="loc_ltbrTrdArrIndTitleTwo_4c3308" order="11" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TrdArrIndTitleThree" xlink:label="loc_ltbrTrdArrIndTitleThree_cd3fe7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_3e6f25" xlink:to="loc_ltbrTrdArrIndTitleThree_cd3fe7" order="12" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TrdArrIndTitleFour" xlink:label="loc_ltbrTrdArrIndTitleFour_c9dba6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_3e6f25" xlink:to="loc_ltbrTrdArrIndTitleFour_c9dba6" order="13" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_Rule10b51ArrAdoptedOneFlag" xlink:label="loc_ltbrRule10b51ArrAdoptedOneFlag_c5f2a8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_3e6f25" xlink:to="loc_ltbrRule10b51ArrAdoptedOneFlag_c5f2a8" order="14" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_Rule10b51ArrAdoptedTwoFlag" xlink:label="loc_ltbrRule10b51ArrAdoptedTwoFlag_3ad175" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_3e6f25" xlink:to="loc_ltbrRule10b51ArrAdoptedTwoFlag_3ad175" order="15" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_Rule10b51ArrAdoptedThreeFlag" xlink:label="loc_ltbrRule10b51ArrAdoptedThreeFlag_743e1e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_3e6f25" xlink:to="loc_ltbrRule10b51ArrAdoptedThreeFlag_743e1e" order="16" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_Rule10b51ArrAdoptedFourFlag" xlink:label="loc_ltbrRule10b51ArrAdoptedFourFlag_a3bf32" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_3e6f25" xlink:to="loc_ltbrRule10b51ArrAdoptedFourFlag_a3bf32" order="17" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TrdArrAdoptionDateFirst" xlink:label="loc_ltbrTrdArrAdoptionDateFirst_bf1c3b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_3e6f25" xlink:to="loc_ltbrTrdArrAdoptionDateFirst_bf1c3b" order="18" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TrdArrAdoptionDateSecond" xlink:label="loc_ltbrTrdArrAdoptionDateSecond_76d1c7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_3e6f25" xlink:to="loc_ltbrTrdArrAdoptionDateSecond_76d1c7" order="19" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TrdArrAdoptionDateThird" xlink:label="loc_ltbrTrdArrAdoptionDateThird_55748c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_3e6f25" xlink:to="loc_ltbrTrdArrAdoptionDateThird_55748c" order="20" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TrdArrAdoptionDateFourth" xlink:label="loc_ltbrTrdArrAdoptionDateFourth_9869b8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_3e6f25" xlink:to="loc_ltbrTrdArrAdoptionDateFourth_9869b8" order="21" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TrdArrExpirationDateOne" xlink:label="loc_ltbrTrdArrExpirationDateOne_61accf" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_3e6f25" xlink:to="loc_ltbrTrdArrExpirationDateOne_61accf" order="22" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TrdArrExpirationDateTwo" xlink:label="loc_ltbrTrdArrExpirationDateTwo_28a522" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_3e6f25" xlink:to="loc_ltbrTrdArrExpirationDateTwo_28a522" order="23" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TrdArrExpirationDateThree" xlink:label="loc_ltbrTrdArrExpirationDateThree_76e04b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_3e6f25" xlink:to="loc_ltbrTrdArrExpirationDateThree_76e04b" order="24" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TrdArrExpirationDateFour" xlink:label="loc_ltbrTrdArrExpirationDateFour_4c105c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_3e6f25" xlink:to="loc_ltbrTrdArrExpirationDateFour_4c105c" order="25" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TrdArrSecuritiesAggAvailAmtOne" xlink:label="loc_ltbrTrdArrSecuritiesAggAvailAmtOne_6ca046" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_3e6f25" xlink:to="loc_ltbrTrdArrSecuritiesAggAvailAmtOne_6ca046" order="26" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TrdArrSecuritiesAggAvailAmtTwo" xlink:label="loc_ltbrTrdArrSecuritiesAggAvailAmtTwo_92d03c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_3e6f25" xlink:to="loc_ltbrTrdArrSecuritiesAggAvailAmtTwo_92d03c" order="27" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TrdArrSecuritiesAggAvailAmtThree" xlink:label="loc_ltbrTrdArrSecuritiesAggAvailAmtThree_091a8c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_3e6f25" xlink:to="loc_ltbrTrdArrSecuritiesAggAvailAmtThree_091a8c" order="28" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements" xlink:title="995446 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract_a8a2c6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="loc_us-gaapOrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_22c59f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_a8a2c6" xlink:to="loc_us-gaapOrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_22c59f" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NetLossPerShare" xlink:title="995447 - Disclosure - Net Loss Per Share">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract_80fefe" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaapEarningsPerShareTextBlock_4eba05" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract_80fefe" xlink:to="loc_us-gaapEarningsPerShareTextBlock_4eba05" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongtermAssets" xlink:title="995448 - Disclosure - Prepaid Project Costs and Other Longterm Assets">
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_PrepaidExpensesCurrentAndLongTermAssetsAbstract" xlink:label="loc_ltbrPrepaidExpensesCurrentAndLongTermAssetsAbstract_364c88" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_PrepaidProjectCostsDisclosureTextBlock" xlink:label="loc_ltbrPrepaidProjectCostsDisclosureTextBlock_42a18d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ltbrPrepaidExpensesCurrentAndLongTermAssetsAbstract_364c88" xlink:to="loc_ltbrPrepaidProjectCostsDisclosureTextBlock_42a18d" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="995449 - Disclosure - Accounts Payable and Accrued Liabilities">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_9880a3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_b7720b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_9880a3" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_b7720b" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/CommitmentsAndContingencies" xlink:title="995450 - Disclosure - Commitments and Contingencies">
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_CommitmentsAndContingenciesAbstract" xlink:label="loc_ltbrCommitmentsAndContingenciesAbstract_bcedbd" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock_c83510" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ltbrCommitmentsAndContingenciesAbstract_bcedbd" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock_c83510" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/ResearchAndDevelopmentCosts" xlink:title="995451 - Disclosure - Research and Development Costs">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="loc_us-gaapResearchAndDevelopmentAbstract_31eee0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:label="loc_us-gaapResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_6c815f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapResearchAndDevelopmentAbstract_31eee0" xlink:to="loc_us-gaapResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_6c815f" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensation" xlink:title="995452 - Disclosure - Stockholders Equity and StockBased Compensation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract_dbbe60" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock_4c764b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_dbbe60" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock_4c764b" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/SegmentReporting" xlink:title="995453 - Disclosure - Segment Reporting">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract_b9bda8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaapSegmentReportingDisclosureTextBlock_ca07bb" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract_b9bda8" xlink:to="loc_us-gaapSegmentReportingDisclosureTextBlock_ca07bb" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/SubsequentEvents" xlink:title="995454 - Disclosure - Subsequent Events">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract_b5a02d" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock_e01fe2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract_b5a02d" xlink:to="loc_us-gaapSubsequentEventsTextBlock_e01fe2" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperationsPolicies" xlink:title="995455 - Disclosure - Basis of Presentation Summary of Significant Accounting Policies and Nature of Operations (Policies)">
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations" xlink:label="loc_ltbrBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations_cda1bd" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy_76c56c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ltbrBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations_cda1bd" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy_76c56c" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk_ec8e5a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ltbrBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations_cda1bd" xlink:to="loc_us-gaapConcentrationRiskCreditRisk_ec8e5a" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock_a611af" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ltbrBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations_cda1bd" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock_a611af" order="3" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperationsTables" xlink:title="995456 - Disclosure - Basis of Presentation Summary of Significant Accounting Policies and Nature of Operations (Tables)">
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations" xlink:label="loc_ltbrBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations_b692e3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:label="loc_us-gaapScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_b794da" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ltbrBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations_b692e3" xlink:to="loc_us-gaapScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_b794da" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NetLossPerShareTables" xlink:title="995457 - Disclosure - Net Loss Per Share (Tables)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract_a05731" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_e66179" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract_a05731" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_e66179" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="995458 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_d51e5f" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_da5363" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_d51e5f" xlink:to="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_da5363" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables" xlink:title="995459 - Disclosure - Stockholders Equity and StockBased Compensation (Tables)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract_3bc649" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:label="loc_us-gaapScheduleOfStockOptionsRollForwardTableTextBlock_1d1f13" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_3bc649" xlink:to="loc_us-gaapScheduleOfStockOptionsRollForwardTableTextBlock_1d1f13" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_9d24e6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_3bc649" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_9d24e6" order="2" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_ScheduleOfOutstandingRSATableTextBlock" xlink:label="loc_ltbrScheduleOfOutstandingRSATableTextBlock_69f451" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_3bc649" xlink:to="loc_ltbrScheduleOfOutstandingRSATableTextBlock_69f451" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationActivityTableTextBlock_3758b9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_3bc649" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationActivityTableTextBlock_3758b9" order="4" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/SegmentReportingTables" xlink:title="995460 - Disclosure - Segment Reporting (Tables)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract_17eb20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock_a5a8d9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract_17eb20" xlink:to="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock_a5a8d9" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails" xlink:title="995461 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract_5b2f94" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_22382f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_5b2f94" xlink:to="loc_us-gaapStatementTable_22382f" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_15df5f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_22382f" xlink:to="loc_us-gaapStatementLineItems_15df5f" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis_91f1bc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_22382f" xlink:to="loc_us-gaapStatementClassOfStockAxis_91f1bc" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_58bed9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis_91f1bc" xlink:to="loc_us-gaapClassOfStockDomain_58bed9" order="20" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TreasuryBillsLevelTwoMember" xlink:label="loc_ltbrTreasuryBillsLevelTwoMember_3b1add" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain_58bed9" xlink:to="loc_ltbrTreasuryBillsLevelTwoMember_3b1add" order="21" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TreasuryBillsLevelThreeMember" xlink:label="loc_ltbrTreasuryBillsLevelThreeMember_d92e77" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain_58bed9" xlink:to="loc_ltbrTreasuryBillsLevelThreeMember_d92e77" order="22" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TreasuryBillsLevelOneMember" xlink:label="loc_ltbrTreasuryBillsLevelOneMember_8155fc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain_58bed9" xlink:to="loc_ltbrTreasuryBillsLevelOneMember_8155fc" order="23" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_463895" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_15df5f" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_463895" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_ca753d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_15df5f" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_ca753d" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative" xlink:title="995462 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract_edd8e1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_f9adc9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_edd8e1" xlink:to="loc_us-gaapStatementTable_f9adc9" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_d1eba1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_f9adc9" xlink:to="loc_us-gaapStatementLineItems_d1eba1" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis_9efec3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_f9adc9" xlink:to="loc_srtProductOrServiceAxis_9efec3" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_0a89f1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis_9efec3" xlink:to="loc_srtProductsAndServicesDomain_0a89f1" order="20" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_INLMember" xlink:label="loc_ltbrINLMember_0aa05d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain_0a89f1" xlink:to="loc_ltbrINLMember_0aa05d" order="21" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_InvestmentsInDebtSecuritiesPurchased" xlink:label="loc_ltbrInvestmentsInDebtSecuritiesPurchased_b5686d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_d1eba1" xlink:to="loc_ltbrInvestmentsInDebtSecuritiesPurchased_b5686d" order="1" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_ResearchAndDevelopmentPercentage" xlink:label="loc_ltbrResearchAndDevelopmentPercentage_f96a5c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_d1eba1" xlink:to="loc_ltbrResearchAndDevelopmentPercentage_f96a5c" order="2" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NetLossPerShareDetails" xlink:title="995463 - Disclosure - Net Loss Per Share (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract_46c086" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease_417c0c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract_46c086" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease_417c0c" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:label="loc_us-gaapRestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_8cbe5c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract_46c086" xlink:to="loc_us-gaapRestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_8cbe5c" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment_b4f5c3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract_46c086" xlink:to="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment_b4f5c3" order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative" xlink:title="995464 - Disclosure - Prepaid Project Costs and Other Long-term Assets (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_PrepaidExpensesCurrentAndLongTermAssetsAbstract" xlink:label="loc_ltbrPrepaidExpensesCurrentAndLongTermAssetsAbstract_e53b29" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_068912" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ltbrPrepaidExpensesCurrentAndLongTermAssetsAbstract_e53b29" xlink:to="loc_us-gaapStatementTable_068912" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_6abe64" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_068912" xlink:to="loc_us-gaapStatementLineItems_6abe64" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_70e57e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_068912" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_70e57e" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_ccf078" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_70e57e" xlink:to="loc_us-gaapRelatedPartyDomain_ccf078" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaapBalanceSheetLocationAxis_456931" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_068912" xlink:to="loc_us-gaapBalanceSheetLocationAxis_456931" order="40" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain_469ab0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationAxis_456931" xlink:to="loc_us-gaapBalanceSheetLocationDomain_469ab0" order="40" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis_129499" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_068912" xlink:to="loc_us-gaapPlanNameAxis_129499" order="60" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_e81382" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis_129499" xlink:to="loc_us-gaapPlanNameDomain_e81382" order="60" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_BattelleEnergyAllianceLLCMember" xlink:label="loc_ltbrBattelleEnergyAllianceLLCMember_1c58c8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain_ccf078" xlink:to="loc_ltbrBattelleEnergyAllianceLLCMember_1c58c8" order="61" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:label="loc_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember_eab14f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain_469ab0" xlink:to="loc_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember_eab14f" order="62" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_MaxiimumMember" xlink:label="loc_ltbrMaxiimumMember_c8f46a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain_e81382" xlink:to="loc_ltbrMaxiimumMember_c8f46a" order="63" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_MiniimumMember" xlink:label="loc_ltbrMiniimumMember_8ad2b3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain_e81382" xlink:to="loc_ltbrMiniimumMember_8ad2b3" order="64" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_AdditionalPrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_ltbrAdditionalPrepaidExpenseAndOtherAssetsCurrent_c419dc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_6abe64" xlink:to="loc_ltbrAdditionalPrepaidExpenseAndOtherAssetsCurrent_c419dc" order="1" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_OffsetOfProjectCosts" xlink:label="loc_ltbrOffsetOfProjectCosts_0a8e3a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_6abe64" xlink:to="loc_ltbrOffsetOfProjectCosts_0a8e3a" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseNoncurrent" xlink:label="loc_us-gaapPrepaidExpenseNoncurrent_088450" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_6abe64" xlink:to="loc_us-gaapPrepaidExpenseNoncurrent_088450" order="3" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_PrepaidProjectCostsAddition" xlink:label="loc_ltbrPrepaidProjectCostsAddition_8e8ed4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_6abe64" xlink:to="loc_ltbrPrepaidProjectCostsAddition_8e8ed4" order="4" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:title="995465 - Disclosure - Accounts Payable and Accrued Liabilities (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_d4a397" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableTradeCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableTradeCurrentAndNoncurrent_ef0c0c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_d4a397" xlink:to="loc_us-gaapAccountsPayableTradeCurrentAndNoncurrent_ef0c0c" order="1" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_AccruedResearchAndDevelopmentExpensesCurrent" xlink:label="loc_ltbrAccruedResearchAndDevelopmentExpensesCurrent_d68d2b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_d4a397" xlink:to="loc_ltbrAccruedResearchAndDevelopmentExpensesCurrent_d68d2b" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedBonusesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedBonusesCurrentAndNoncurrent_8965f9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_d4a397" xlink:to="loc_us-gaapAccruedBonusesCurrentAndNoncurrent_8965f9" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="loc_us-gaapAccruedLiabilitiesAndOtherLiabilities_7de785" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_d4a397" xlink:to="loc_us-gaapAccruedLiabilitiesAndOtherLiabilities_7de785" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_1b2b12" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_d4a397" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_1b2b12" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="995466 - Disclosure - Commitments and Contingencies (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_CommitmentsAndContingenciesAbstract" xlink:label="loc_ltbrCommitmentsAndContingenciesAbstract_b6c331" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaapOperatingLeaseExpense_787bd5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ltbrCommitmentsAndContingenciesAbstract_b6c331" xlink:to="loc_us-gaapOperatingLeaseExpense_787bd5" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaapOperatingLeasePayments_2b54b6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ltbrCommitmentsAndContingenciesAbstract_b6c331" xlink:to="loc_us-gaapOperatingLeasePayments_2b54b6" order="2" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_LeasePaymentUnderNonCancellableOperatingLeases" xlink:label="loc_ltbrLeasePaymentUnderNonCancellableOperatingLeases_394dc0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ltbrCommitmentsAndContingenciesAbstract_b6c331" xlink:to="loc_ltbrLeasePaymentUnderNonCancellableOperatingLeases_394dc0" order="3" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_LesseeOperatingLeaseTerm" xlink:label="loc_ltbrLesseeOperatingLeaseTerm_c14a40" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ltbrCommitmentsAndContingenciesAbstract_b6c331" xlink:to="loc_ltbrLesseeOperatingLeaseTerm_c14a40" order="4" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/ResearchAndDevelopmentCostDetailsNarrative" xlink:title="995467 - Disclosure - Research and Development Cost (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_ResearchAndDevelopmentCostAbstract" xlink:label="loc_ltbrResearchAndDevelopmentCostAbstract_1ffb66" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_9ea979" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ltbrResearchAndDevelopmentCostAbstract_1ffb66" xlink:to="loc_us-gaapStatementTable_9ea979" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_873e50" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_9ea979" xlink:to="loc_us-gaapStatementLineItems_873e50" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis_fe04bb" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_9ea979" xlink:to="loc_srtProductOrServiceAxis_fe04bb" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_f0aca2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis_fe04bb" xlink:to="loc_srtProductsAndServicesDomain_f0aca2" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_22b576" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_9ea979" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_22b576" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_3dff2a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_22b576" xlink:to="loc_us-gaapRelatedPartyDomain_3dff2a" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis_508caa" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_9ea979" xlink:to="loc_us-gaapPlanNameAxis_508caa" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_d5946a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis_508caa" xlink:to="loc_us-gaapPlanNameDomain_d5946a" order="30" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_INLMember" xlink:label="loc_ltbrINLMember_c02b4b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain_f0aca2" xlink:to="loc_ltbrINLMember_c02b4b" order="31" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_BattelleEnergyAllianceLLCMember" xlink:label="loc_ltbrBattelleEnergyAllianceLLCMember_f45ad3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain_3dff2a" xlink:to="loc_ltbrBattelleEnergyAllianceLLCMember_f45ad3" order="32" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_CRADAMember" xlink:label="loc_ltbrCRADAMember_ba0e8e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain_f0aca2" xlink:to="loc_ltbrCRADAMember_ba0e8e" order="33" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_StrategicPartnershipProjectAgreementMember" xlink:label="loc_ltbrStrategicPartnershipProjectAgreementMember_e85857" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain_d5946a" xlink:to="loc_ltbrStrategicPartnershipProjectAgreementMember_e85857" order="34" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_CANDUMember" xlink:label="loc_ltbrCANDUMember_67e2e5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain_f0aca2" xlink:to="loc_ltbrCANDUMember_67e2e5" order="35" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_FEEdMember" xlink:label="loc_ltbrFEEdMember_64223b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain_f0aca2" xlink:to="loc_ltbrFEEdMember_64223b" order="36" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherResearchAndDevelopmentExpense" xlink:label="loc_us-gaapOtherResearchAndDevelopmentExpense_b5e1d4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_873e50" xlink:to="loc_us-gaapOtherResearchAndDevelopmentExpense_b5e1d4" order="1" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_ResearchAndDevelopmentArrangementExpense" xlink:label="loc_ltbrResearchAndDevelopmentArrangementExpense_498071" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_873e50" xlink:to="loc_ltbrResearchAndDevelopmentArrangementExpense_498071" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_1b2dfc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_873e50" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_1b2dfc" order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_0f1ff8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_873e50" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_0f1ff8" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_ResearchAndDevelopmentExpensePayable" xlink:label="loc_ltbrResearchAndDevelopmentExpensePayable_02fcf1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_873e50" xlink:to="loc_ltbrResearchAndDevelopmentExpensePayable_02fcf1" order="5" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_PaymentsToResearchAndDevelopmentCost" xlink:label="loc_ltbrPaymentsToResearchAndDevelopmentCost_0f4080" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_873e50" xlink:to="loc_ltbrPaymentsToResearchAndDevelopmentCost_0f4080" order="6" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails" xlink:title="995468 - Disclosure - Stockholders Equity and StockBased Compensation (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract_c5cbb3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_82f901" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_c5cbb3" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_82f901" order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_9056b6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_c5cbb3" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_9056b6" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_7fa1a2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_c5cbb3" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_7fa1a2" order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_8f33bb" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_c5cbb3" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_8f33bb" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2d1ba8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_c5cbb3" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2d1ba8" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_595e20" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_c5cbb3" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_595e20" order="6" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_6087de" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_c5cbb3" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_6087de" order="7" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_fc8242" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_c5cbb3" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_fc8242" order="8" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_302af3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_c5cbb3" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_302af3" order="9" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_86c4ab" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_c5cbb3" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_86c4ab" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_40b44b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_c5cbb3" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_40b44b" order="11" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_5d4366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_c5cbb3" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_5d4366" order="12" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_aa0fd6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_c5cbb3" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_aa0fd6" order="13" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_d2b9b1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_c5cbb3" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_d2b9b1" order="14" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice" xlink:label="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice_64e7e8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_c5cbb3" xlink:to="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice_64e7e8" order="15" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_a67dcb" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_c5cbb3" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_a67dcb" order="16" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm" xlink:label="loc_ltbrSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm_2dae7b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_c5cbb3" xlink:to="loc_ltbrSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm_2dae7b" order="17" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermEndingFF" xlink:label="loc_ltbrSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermEndingFF_ac5b0e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_c5cbb3" xlink:to="loc_ltbrSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermEndingFF_ac5b0e" order="18" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermVested" xlink:label="loc_ltbrSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermVested_95e61b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_c5cbb3" xlink:to="loc_ltbrSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermVested_95e61b" order="19" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermOptionsExercisable" xlink:label="loc_ltbrSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermOptionsExercisable_bfeb0a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_c5cbb3" xlink:to="loc_ltbrSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermOptionsExercisable_bfeb0a" order="20" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding" xlink:label="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding_4b12ca" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_c5cbb3" xlink:to="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding_4b12ca" order="21" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueExercised" xlink:label="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueExercised_2ce39a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_c5cbb3" xlink:to="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueExercised_2ce39a" order="22" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding" xlink:label="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding_5127fa" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_c5cbb3" xlink:to="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding_5127fa" order="23" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVestedAndExpectedToVest" xlink:label="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueVestedAndExpectedToVest_f28c03" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_c5cbb3" xlink:to="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueVestedAndExpectedToVest_f28c03" order="24" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOptionsExercisable" xlink:label="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueOptionsExercisable_3701e1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_c5cbb3" xlink:to="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueOptionsExercisable_3701e1" order="25" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1" xlink:title="995469 - Disclosure - Stockholders Equity and StockBased Compensation (Details 1)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract_2ff884" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_36e0a1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_2ff884" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_36e0a1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_b438ef" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_2ff884" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_b438ef" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_7a65ba" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_2ff884" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_7a65ba" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_615a94" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_2ff884" xlink:to="loc_us-gaapSharePrice_615a94" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_850d39" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_2ff884" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_850d39" order="5" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2" xlink:title="995470 - Disclosure - Stockholders Equity and StockBased Compensation (Details 2)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract_0bebd4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_568c23" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_0bebd4" xlink:to="loc_us-gaapStatementTable_568c23" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_642e75" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_568c23" xlink:to="loc_us-gaapStatementLineItems_642e75" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis_13ff93" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_568c23" xlink:to="loc_us-gaapAwardTypeAxis_13ff93" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_813d0a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis_13ff93" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_813d0a" order="20" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_RestrictedStockAwardMember" xlink:label="loc_ltbrRestrictedStockAwardMember_b6f35f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_813d0a" xlink:to="loc_ltbrRestrictedStockAwardMember_b6f35f" order="21" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding" xlink:label="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding_60f885" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_642e75" xlink:to="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding_60f885" order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_359bb7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_642e75" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_359bb7" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_096297" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_642e75" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_096297" order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_50aa91" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_642e75" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_50aa91" order="4" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94" xlink:label="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94_d91e41" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_642e75" xlink:to="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94_d91e41" order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_586a7c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_642e75" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_586a7c" order="6" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_775f88" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_642e75" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_775f88" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_36eaed" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_642e75" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_36eaed" order="8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_98c48e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_642e75" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_98c48e" order="9" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_9c3f7c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_642e75" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_9c3f7c" order="10" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding" xlink:label="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding_aa7d0b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_642e75" xlink:to="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding_aa7d0b" order="11" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted" xlink:label="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted_cde8c9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_642e75" xlink:to="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted_cde8c9" order="12" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVested" xlink:label="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueVested_be4a98" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_642e75" xlink:to="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueVested_be4a98" order="13" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited" xlink:label="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited_5cf9d9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_642e75" xlink:to="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited_5cf9d9" order="14" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings" xlink:label="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings_8fb277" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_642e75" xlink:to="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings_8fb277" order="15" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails3" xlink:title="995471 - Disclosure - Stockholders Equity and StockBased Compensation (Details 3)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract_a21baa" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_ad1c69" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_a21baa" xlink:to="loc_us-gaapStatementTable_ad1c69" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_08ceaa" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_ad1c69" xlink:to="loc_us-gaapStatementLineItems_08ceaa" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis_634f36" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_ad1c69" xlink:to="loc_us-gaapIncomeStatementLocationAxis_634f36" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_5eda82" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis_634f36" xlink:to="loc_us-gaapIncomeStatementLocationDomain_5eda82" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaapResearchAndDevelopmentExpenseMember_bab18a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain_5eda82" xlink:to="loc_us-gaapResearchAndDevelopmentExpenseMember_bab18a" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaapGeneralAndAdministrativeExpenseMember_d65450" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain_5eda82" xlink:to="loc_us-gaapGeneralAndAdministrativeExpenseMember_d65450" order="22" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense_521d75" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_08ceaa" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense_521d75" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative" xlink:title="995472 - Disclosure - Stockholders Equity and StockBased Compensation (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract_fa46ed" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_8057bb" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_fa46ed" xlink:to="loc_us-gaapStatementTable_8057bb" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_119bee" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_8057bb" xlink:to="loc_us-gaapStatementLineItems_119bee" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_21486b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_8057bb" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_21486b" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_aafb78" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_21486b" xlink:to="loc_us-gaapRelatedPartyDomain_aafb78" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis_fe0864" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_8057bb" xlink:to="loc_us-gaapAwardTypeAxis_fe0864" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_74f7ce" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis_fe0864" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_74f7ce" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis_86d7f8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_8057bb" xlink:to="loc_us-gaapFinancialInstrumentAxis_86d7f8" order="40" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f7eb60" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis_86d7f8" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f7eb60" order="40" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis_3ea01b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_8057bb" xlink:to="loc_us-gaapPlanNameAxis_3ea01b" order="50" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_f3d209" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis_3ea01b" xlink:to="loc_us-gaapPlanNameDomain_f3d209" order="50" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaapVestingAxis_4a0820" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_8057bb" xlink:to="loc_us-gaapVestingAxis_4a0820" order="70" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain_e7c89a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingAxis_4a0820" xlink:to="loc_us-gaapVestingDomain_e7c89a" order="70" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:label="loc_us-gaapEquityInterestIssuedOrIssuableByTypeAxis_092b26" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_8057bb" xlink:to="loc_us-gaapEquityInterestIssuedOrIssuableByTypeAxis_092b26" order="90" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:label="loc_us-gaapEquityInterestIssuedOrIssuableTypeDomain_ce32f5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityInterestIssuedOrIssuableByTypeAxis_092b26" xlink:to="loc_us-gaapEquityInterestIssuedOrIssuableTypeDomain_ce32f5" order="90" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis_8ea966" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_8057bb" xlink:to="loc_us-gaapStatementClassOfStockAxis_8ea966" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_016dce" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis_8ea966" xlink:to="loc_us-gaapClassOfStockDomain_016dce" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="loc_srtBoardOfDirectorsChairmanMember_2a8e5a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain_aafb78" xlink:to="loc_srtBoardOfDirectorsChairmanMember_2a8e5a" order="101" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_RestrictedStockUnitsRSAMember" xlink:label="loc_ltbrRestrictedStockUnitsRSAMember_60e6e4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_74f7ce" xlink:to="loc_ltbrRestrictedStockUnitsRSAMember_60e6e4" order="102" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_AvailableForSaleSecuritiesMember" xlink:label="loc_ltbrAvailableForSaleSecuritiesMember_18da2f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f7eb60" xlink:to="loc_ltbrAvailableForSaleSecuritiesMember_18da2f" order="103" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TwoThousandTwentyEquityIncentivePlanMember" xlink:label="loc_ltbrTwoThousandTwentyEquityIncentivePlanMember_bf986d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain_f3d209" xlink:to="loc_ltbrTwoThousandTwentyEquityIncentivePlanMember_bf986d" order="104" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TwentyTwentyFiveTransactionsMember" xlink:label="loc_ltbrTwentyTwentyFiveTransactionsMember_a2a795" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain_f3d209" xlink:to="loc_ltbrTwentyTwentyFiveTransactionsMember_a2a795" order="105" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_OptionsMember" xlink:label="loc_ltbrOptionsMember_50c900" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_74f7ce" xlink:to="loc_ltbrOptionsMember_50c900" order="106" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_CommonShareIssuancesMember" xlink:label="loc_ltbrCommonShareIssuancesMember_3176dc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingDomain_e7c89a" xlink:to="loc_ltbrCommonShareIssuancesMember_3176dc" order="107" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_PrepaidExpenseAndOtherCurrentAssetMember" xlink:label="loc_ltbrPrepaidExpenseAndOtherCurrentAssetMember_d2af90" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityInterestIssuedOrIssuableTypeDomain_ce32f5" xlink:to="loc_ltbrPrepaidExpenseAndOtherCurrentAssetMember_d2af90" order="108" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_RestrictedStockAwardsSummaryMember" xlink:label="loc_ltbrRestrictedStockAwardsSummaryMember_94cc07" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain_f3d209" xlink:to="loc_ltbrRestrictedStockAwardsSummaryMember_94cc07" order="109" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_BoardOfDirectorsMember" xlink:label="loc_ltbrBoardOfDirectorsMember_4baad7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain_aafb78" xlink:to="loc_ltbrBoardOfDirectorsMember_4baad7" order="110" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TopMember" xlink:label="loc_ltbrTopMember_cbb0a2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain_f3d209" xlink:to="loc_ltbrTopMember_cbb0a2" order="111" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_BottomMember" xlink:label="loc_ltbrBottomMember_debe33" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain_f3d209" xlink:to="loc_ltbrBottomMember_debe33" order="112" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SeriesXPreferredStockMember" xlink:label="loc_ltbrSeriesXPreferredStockMember_56faba" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain_016dce" xlink:to="loc_ltbrSeriesXPreferredStockMember_56faba" order="113" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_2a581c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_2a581c" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_b74dd9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_b74dd9" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_0fd658" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_0fd658" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_152107" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_152107" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_9b721e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_us-gaapShareBasedCompensation_9b721e" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_ad8907" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_ad8907" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8b49b6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8b49b6" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:label="loc_us-gaapRestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_1de2dc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_us-gaapRestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_1de2dc" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockRedemptionAmount" xlink:label="loc_us-gaapPreferredStockRedemptionAmount_edd8e1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_us-gaapPreferredStockRedemptionAmount_edd8e1" order="9" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_ec9e5f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_ec9e5f" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash_2ede65" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_us-gaapCash_2ede65" order="11" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_DescriptionOfSubscriptionAndInvestmentRepresentationAgreement" xlink:label="loc_ltbrDescriptionOfSubscriptionAndInvestmentRepresentationAgreement_e58f43" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_ltbrDescriptionOfSubscriptionAndInvestmentRepresentationAgreement_e58f43" order="12" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_PreferredStockVotingRightsShares" xlink:label="loc_ltbrPreferredStockVotingRightsShares_ce5b60" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_ltbrPreferredStockVotingRightsShares_ce5b60" order="13" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_CommonSharesIssuancesEquityGrant" xlink:label="loc_ltbrCommonSharesIssuancesEquityGrant_9a3826" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_ltbrCommonSharesIssuancesEquityGrant_9a3826" order="14" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_EquityGrantValue" xlink:label="loc_ltbrEquityGrantValue_8fc91c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_ltbrEquityGrantValue_8fc91c" order="15" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_47926e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_us-gaapCommonStockSharesIssued_47926e" order="16" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_974ef7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_974ef7" order="17" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised_0c65b5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised_0c65b5" order="18" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation_5cfbc7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation_5cfbc7" order="19" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0459f4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0459f4" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d1658f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d1658f" order="21" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_CommonStockShareOutstanding" xlink:label="loc_ltbrCommonStockShareOutstanding_c2865e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_ltbrCommonStockShareOutstanding_c2865e" order="22" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_e28da3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_us-gaapCommonStockSharesAuthorized_e28da3" order="23" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_RSAFairValue" xlink:label="loc_ltbrRSAFairValue_769f94" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_ltbrRSAFairValue_769f94" order="24" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntercompanyAgreementsDescription" xlink:label="loc_us-gaapIntercompanyAgreementsDescription_2d2de8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_us-gaapIntercompanyAgreementsDescription_2d2de8" order="25" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther_49dae3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther_49dae3" order="26" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_CommonSharesEquityGrantPricePerShares" xlink:label="loc_ltbrCommonSharesEquityGrantPricePerShares_b4293d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_ltbrCommonSharesEquityGrantPricePerShares_b4293d" order="27" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted" xlink:label="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted_e9b7f8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted_e9b7f8" order="28" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense" xlink:label="loc_us-gaapEmployeeStockOwnershipPlanESOPCompensationExpense_c40367" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_us-gaapEmployeeStockOwnershipPlanESOPCompensationExpense_c40367" order="29" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses_149111" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_us-gaapOperatingExpenses_149111" order="30" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_CommonStockValuedGrantDatePricePerShare" xlink:label="loc_ltbrCommonStockValuedGrantDatePricePerShare_b63997" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_ltbrCommonStockValuedGrantDatePricePerShare_b63997" order="31" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_646cfa" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_646cfa" order="32" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice_487e13" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice_487e13" order="33" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_9f6645" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_9f6645" order="34" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_DescriptionOfRSAsModificationAndNetShareSettlementsForPaymentsOfWithholdingTaxes" xlink:label="loc_ltbrDescriptionOfRSAsModificationAndNetShareSettlementsForPaymentsOfWithholdingTaxes_32efe5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_ltbrDescriptionOfRSAsModificationAndNetShareSettlementsForPaymentsOfWithholdingTaxes_32efe5" order="35" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_CommonStockEquivalentsOutstandingShares" xlink:label="loc_ltbrCommonStockEquivalentsOutstandingShares_584206" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_ltbrCommonStockEquivalentsOutstandingShares_584206" order="36" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease_75df72" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease_75df72" order="37" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfInitialPublicOffering" xlink:label="loc_us-gaapPaymentsForRepurchaseOfInitialPublicOffering_af4760" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_us-gaapPaymentsForRepurchaseOfInitialPublicOffering_af4760" order="38" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_MarketOfferingsDisclosureDescription" xlink:label="loc_ltbrMarketOfferingsDisclosureDescription_e67e14" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_ltbrMarketOfferingsDisclosureDescription_e67e14" order="39" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_FutureIssuanceOfShare" xlink:label="loc_ltbrFutureIssuanceOfShare_d2aa7f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_ltbrFutureIssuanceOfShare_d2aa7f" order="40" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_279109" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_279109" order="41" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_DescriptionOfEquityIncentivePlan" xlink:label="loc_ltbrDescriptionOfEquityIncentivePlan_aad944" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_ltbrDescriptionOfEquityIncentivePlan_aad944" order="42" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_8ca944" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_8ca944" order="43" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_ProceedsFromStockIssuances" xlink:label="loc_ltbrProceedsFromStockIssuances_04d63e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_ltbrProceedsFromStockIssuances_04d63e" order="44" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_87c26b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_119bee" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_87c26b" order="45" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/SegmentReportingDetails" xlink:title="995473 - Disclosure - Segment Reporting (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract_f37c5a" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_b6ba6e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract_f37c5a" xlink:to="loc_us-gaapStatementTable_b6ba6e" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_ed1712" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_b6ba6e" xlink:to="loc_us-gaapStatementLineItems_ed1712" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReportingUnitAxis" xlink:label="loc_us-gaapReportingUnitAxis_bd0791" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_b6ba6e" xlink:to="loc_us-gaapReportingUnitAxis_bd0791" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReportingUnitDomain" xlink:label="loc_us-gaapReportingUnitDomain_61beca" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReportingUnitAxis_bd0791" xlink:to="loc_us-gaapReportingUnitDomain_61beca" order="20" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_CODMMember" xlink:label="loc_ltbrCODMMember_436e9e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReportingUnitDomain_61beca" xlink:to="loc_ltbrCODMMember_436e9e" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_d3c179" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_ed1712" xlink:to="loc_us-gaapRevenues_d3c179" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapOtherGeneralAndAdministrativeExpense_b76519" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_ed1712" xlink:to="loc_us-gaapOtherGeneralAndAdministrativeExpense_b76519" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_InlProject" xlink:label="loc_ltbrInlProject_871ac5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_ed1712" xlink:to="loc_ltbrInlProject_871ac5" order="3" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_RomaniaFeasibilityStudy" xlink:label="loc_ltbrRomaniaFeasibilityStudy_1fb084" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_ed1712" xlink:to="loc_ltbrRomaniaFeasibilityStudy_1fb084" order="4" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_CentrusEnergyFeedStudy" xlink:label="loc_ltbrCentrusEnergyFeedStudy_ca282b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_ed1712" xlink:to="loc_ltbrCentrusEnergyFeedStudy_ca282b" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense_dafc1a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_ed1712" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense_dafc1a" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherExpenses" xlink:label="loc_us-gaapOtherExpenses_46b90f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_ed1712" xlink:to="loc_us-gaapOtherExpenses_46b90f" order="7" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_ResearchAndDevelopmentExpenseNet" xlink:label="loc_ltbrResearchAndDevelopmentExpenseNet_a1efaf" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_ed1712" xlink:to="loc_ltbrResearchAndDevelopmentExpenseNet_a1efaf" order="8" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_OtherSegmentsItem" xlink:label="loc_ltbrOtherSegmentsItem_387fb9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_ed1712" xlink:to="loc_ltbrOtherSegmentsItem_387fb9" order="9" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_OperatingNetIncomeLossFromSegmentsToConsolidated" xlink:label="loc_ltbrOperatingNetIncomeLossFromSegmentsToConsolidated_8bf6a5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_ed1712" xlink:to="loc_ltbrOperatingNetIncomeLossFromSegmentsToConsolidated_8bf6a5" order="10" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/SubsequentEventsDetailsNarrative" xlink:title="995474 - Disclosure - Subsequent Events (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract_166c31" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_24be9f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract_166c31" xlink:to="loc_us-gaapStatementTable_24be9f" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_1039e4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_24be9f" xlink:to="loc_us-gaapStatementLineItems_1039e4" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis_4d61a9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_24be9f" xlink:to="loc_us-gaapSubsequentEventTypeAxis_4d61a9" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_6b0da4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis_4d61a9" xlink:to="loc_us-gaapSubsequentEventTypeDomain_6b0da4" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis_3fcf11" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_24be9f" xlink:to="loc_us-gaapPlanNameAxis_3fcf11" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_a453d5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis_3fcf11" xlink:to="loc_us-gaapPlanNameDomain_a453d5" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis_05d081" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_24be9f" xlink:to="loc_us-gaapAwardTypeAxis_05d081" order="40" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cf7fe1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis_05d081" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cf7fe1" order="40" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_94e114" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain_6b0da4" xlink:to="loc_us-gaapSubsequentEventMember_94e114" order="41" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_BottomMember" xlink:label="loc_ltbrBottomMember_3b9cb0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain_a453d5" xlink:to="loc_ltbrBottomMember_3b9cb0" order="42" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_ArticlesOfIncorporationMember" xlink:label="loc_ltbrArticlesOfIncorporationMember_bdda32" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cf7fe1" xlink:to="loc_ltbrArticlesOfIncorporationMember_bdda32" order="43" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TopMember" xlink:label="loc_ltbrTopMember_136c77" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain_a453d5" xlink:to="loc_ltbrTopMember_136c77" order="44" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TwentyTwentyPlanMember" xlink:label="loc_ltbrTwentyTwentyPlanMember_83c205" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cf7fe1" xlink:to="loc_ltbrTwentyTwentyPlanMember_83c205" order="45" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_d3850a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_1039e4" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_d3850a" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_ProceedsFromStockIssuances" xlink:label="loc_ltbrProceedsFromStockIssuances_88e0da" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_1039e4" xlink:to="loc_ltbrProceedsFromStockIssuances_88e0da" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_0ab278" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_1039e4" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_0ab278" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross_c3e938" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_1039e4" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross_c3e938" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_f5ae9c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_1039e4" xlink:to="loc_us-gaapSaleOfStockPricePerShare_f5ae9c" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_0c32ee" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_1039e4" xlink:to="loc_us-gaapCommonStockSharesAuthorized_0c32ee" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>ltbr-20250331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 05/12/2025-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2025 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://ltbr.com/role/Cover" xlink:href="ltbr-20250331.xsd#Cover" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/ConsolidatedBalanceSheets" xlink:href="ltbr-20250331.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="ltbr-20250331.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/ConsolidatedStatementsOfOperations" xlink:href="ltbr-20250331.xsd#ConsolidatedStatementsOfOperations" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" xlink:href="ltbr-20250331.xsd#ConsolidatedStatementsOfChangesInStockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="ltbr-20250331.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements" xlink:href="ltbr-20250331.xsd#NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NetLossPerShare" xlink:href="ltbr-20250331.xsd#NetLossPerShare" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongtermAssets" xlink:href="ltbr-20250331.xsd#PrepaidProjectCostsAndOtherLongtermAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="ltbr-20250331.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/CommitmentsAndContingencies" xlink:href="ltbr-20250331.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/ResearchAndDevelopmentCosts" xlink:href="ltbr-20250331.xsd#ResearchAndDevelopmentCosts" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensation" xlink:href="ltbr-20250331.xsd#StockholdersEquityAndStockbasedCompensation" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/SegmentReporting" xlink:href="ltbr-20250331.xsd#SegmentReporting" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/SubsequentEvents" xlink:href="ltbr-20250331.xsd#SubsequentEvents" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperationsPolicies" xlink:href="ltbr-20250331.xsd#BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperationsPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperationsTables" xlink:href="ltbr-20250331.xsd#BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperationsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NetLossPerShareTables" xlink:href="ltbr-20250331.xsd#NetLossPerShareTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="ltbr-20250331.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables" xlink:href="ltbr-20250331.xsd#StockholdersEquityAndStockbasedCompensationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/SegmentReportingTables" xlink:href="ltbr-20250331.xsd#SegmentReportingTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails" xlink:href="ltbr-20250331.xsd#NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative" xlink:href="ltbr-20250331.xsd#NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NetLossPerShareDetails" xlink:href="ltbr-20250331.xsd#NetLossPerShareDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative" xlink:href="ltbr-20250331.xsd#PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:href="ltbr-20250331.xsd#AccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="ltbr-20250331.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/ResearchAndDevelopmentCostDetailsNarrative" xlink:href="ltbr-20250331.xsd#ResearchAndDevelopmentCostDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails" xlink:href="ltbr-20250331.xsd#StockholdersEquityAndStockbasedCompensationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1" xlink:href="ltbr-20250331.xsd#StockholdersEquityAndStockbasedCompensationDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2" xlink:href="ltbr-20250331.xsd#StockholdersEquityAndStockbasedCompensationDetails2" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails3" xlink:href="ltbr-20250331.xsd#StockholdersEquityAndStockbasedCompensationDetails3" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative" xlink:href="ltbr-20250331.xsd#StockholdersEquityAndStockbasedCompensationDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/SegmentReportingDetails" xlink:href="ltbr-20250331.xsd#SegmentReportingDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/SubsequentEventsDetailsNarrative" xlink:href="ltbr-20250331.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/Cover" xlink:title="00000001 - Document - Cover Page Information">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCover" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/ConsolidatedBalanceSheets" xlink:title="110200 - Statement - CONSOLIDATED BALANCE SHEETS" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="110201 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/ConsolidatedStatementsOfOperations" xlink:title="124100 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" xlink:title="148600 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" order="40" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" order="22" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember" order="23" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssued" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" order="2" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares" xlink:label="loc_ltbrSharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrSharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares" order="3" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" xlink:label="loc_ltbrSharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrSharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" order="8" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_RestrictedSharesAwardsIssuedShares" xlink:label="loc_ltbrRestrictedSharesAwardsIssuedShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrRestrictedSharesAwardsIssuedShares" order="9" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_RestrictedSharesAwardsIssuedAmount" xlink:label="loc_ltbrRestrictedSharesAwardsIssuedAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrRestrictedSharesAwardsIssuedAmount" order="10" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares" xlink:label="loc_ltbrSharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrSharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares" order="11" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount" xlink:label="loc_ltbrSharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrSharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount" order="12" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" order="13" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" order="14" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="170000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements" xlink:title="995446 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/NetLossPerShare" xlink:title="995447 - Disclosure - Net Loss Per Share" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongtermAssets" xlink:title="995448 - Disclosure - Prepaid Project Costs and Other Longterm Assets" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="995449 - Disclosure - Accounts Payable and Accrued Liabilities" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/CommitmentsAndContingencies" xlink:title="995450 - Disclosure - Commitments and Contingencies" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/ResearchAndDevelopmentCosts" xlink:title="995451 - Disclosure - Research and Development Costs" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensation" xlink:title="995452 - Disclosure - Stockholders Equity and StockBased Compensation" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/SegmentReporting" xlink:title="995453 - Disclosure - Segment Reporting" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/SubsequentEvents" xlink:title="995454 - Disclosure - Subsequent Events" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperationsPolicies" xlink:title="995455 - Disclosure - Basis of Presentation Summary of Significant Accounting Policies and Nature of Operations (Policies)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperationsTables" xlink:title="995456 - Disclosure - Basis of Presentation Summary of Significant Accounting Policies and Nature of Operations (Tables)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/NetLossPerShareTables" xlink:title="995457 - Disclosure - Net Loss Per Share (Tables)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="995458 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables" xlink:title="995459 - Disclosure - Stockholders Equity and StockBased Compensation (Tables)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/SegmentReportingTables" xlink:title="995460 - Disclosure - Segment Reporting (Tables)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails" xlink:title="995461 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" order="40" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TreasuryBillsLevelTwoMember" xlink:label="loc_ltbrTreasuryBillsLevelTwoMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ltbrTreasuryBillsLevelTwoMember" order="21" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TreasuryBillsLevelThreeMember" xlink:label="loc_ltbrTreasuryBillsLevelThreeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ltbrTreasuryBillsLevelThreeMember" order="22" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TreasuryBillsLevelOneMember" xlink:label="loc_ltbrTreasuryBillsLevelOneMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ltbrTreasuryBillsLevelOneMember" order="23" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" order="2" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative" xlink:title="995462 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" order="40" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_INLMember" xlink:label="loc_ltbrINLMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ltbrINLMember" order="21" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_InvestmentsInDebtSecuritiesPurchased" xlink:label="loc_ltbrInvestmentsInDebtSecuritiesPurchased" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrInvestmentsInDebtSecuritiesPurchased" order="1" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_ResearchAndDevelopmentPercentage" xlink:label="loc_ltbrResearchAndDevelopmentPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrResearchAndDevelopmentPercentage" order="2" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/NetLossPerShareDetails" xlink:title="995463 - Disclosure - Net Loss Per Share (Details)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative" xlink:title="995464 - Disclosure - Prepaid Project Costs and Other Long-term Assets (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" order="40" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaapBalanceSheetLocationAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBalanceSheetLocationAxis" order="40" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain" order="50" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain_10" order="60" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="60" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="70" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" order="80" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_BattelleEnergyAllianceLLCMember" xlink:label="loc_ltbrBattelleEnergyAllianceLLCMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ltbrBattelleEnergyAllianceLLCMember" order="61" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:label="loc_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember" order="62" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_MaxiimumMember" xlink:label="loc_ltbrMaxiimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ltbrMaxiimumMember" order="63" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_MiniimumMember" xlink:label="loc_ltbrMiniimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ltbrMiniimumMember" order="64" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_AdditionalPrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_ltbrAdditionalPrepaidExpenseAndOtherAssetsCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrAdditionalPrepaidExpenseAndOtherAssetsCurrent" order="1" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_OffsetOfProjectCosts" xlink:label="loc_ltbrOffsetOfProjectCosts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrOffsetOfProjectCosts" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseNoncurrent" xlink:label="loc_us-gaapPrepaidExpenseNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPrepaidExpenseNoncurrent" order="3" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_PrepaidProjectCostsAddition" xlink:label="loc_ltbrPrepaidProjectCostsAddition" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrPrepaidProjectCostsAddition" order="4" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:title="995465 - Disclosure - Accounts Payable and Accrued Liabilities (Details)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="995466 - Disclosure - Commitments and Contingencies (Details Narrative)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/ResearchAndDevelopmentCostDetailsNarrative" xlink:title="995467 - Disclosure - Research and Development Cost (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" order="30" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" order="40" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="40" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" order="50" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_INLMember" xlink:label="loc_ltbrINLMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ltbrINLMember" order="31" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_BattelleEnergyAllianceLLCMember" xlink:label="loc_ltbrBattelleEnergyAllianceLLCMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ltbrBattelleEnergyAllianceLLCMember" order="32" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_CRADAMember" xlink:label="loc_ltbrCRADAMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ltbrCRADAMember" order="33" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_StrategicPartnershipProjectAgreementMember" xlink:label="loc_ltbrStrategicPartnershipProjectAgreementMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ltbrStrategicPartnershipProjectAgreementMember" order="34" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_CANDUMember" xlink:label="loc_ltbrCANDUMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ltbrCANDUMember" order="35" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_FEEdMember" xlink:label="loc_ltbrFEEdMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ltbrFEEdMember" order="36" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherResearchAndDevelopmentExpense" xlink:label="loc_us-gaapOtherResearchAndDevelopmentExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherResearchAndDevelopmentExpense" order="1" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_ResearchAndDevelopmentArrangementExpense" xlink:label="loc_ltbrResearchAndDevelopmentArrangementExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrResearchAndDevelopmentArrangementExpense" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" order="4" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_ResearchAndDevelopmentExpensePayable" xlink:label="loc_ltbrResearchAndDevelopmentExpensePayable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrResearchAndDevelopmentExpensePayable" order="5" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_PaymentsToResearchAndDevelopmentCost" xlink:label="loc_ltbrPaymentsToResearchAndDevelopmentCost" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrPaymentsToResearchAndDevelopmentCost" order="6" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails" xlink:title="995468 - Disclosure - Stockholders Equity and StockBased Compensation (Details)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1" xlink:title="995469 - Disclosure - Stockholders Equity and StockBased Compensation (Details 1)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2" xlink:title="995470 - Disclosure - Stockholders Equity and StockBased Compensation (Details 2)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" order="40" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_RestrictedStockAwardMember" xlink:label="loc_ltbrRestrictedStockAwardMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ltbrRestrictedStockAwardMember" order="21" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding" xlink:label="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" order="4" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94" xlink:label="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" order="8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" order="9" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding" xlink:label="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding" order="11" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted" xlink:label="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted" order="12" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVested" xlink:label="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueVested" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueVested" order="13" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited" xlink:label="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited" order="14" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings" xlink:label="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings" order="15" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails3" xlink:title="995471 - Disclosure - Stockholders Equity and StockBased Compensation (Details 3)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" order="40" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaapResearchAndDevelopmentExpenseMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapResearchAndDevelopmentExpenseMember" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaapGeneralAndAdministrativeExpenseMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapGeneralAndAdministrativeExpenseMember" order="22" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense" order="1" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative" xlink:title="995472 - Disclosure - Stockholders Equity and StockBased Compensation (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" order="30" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" order="40" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="40" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="50" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" order="60" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="50" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="60" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" order="70" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaapVestingAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapVestingAxis" order="70" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain" order="80" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain_10" order="90" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:label="loc_us-gaapEquityInterestIssuedOrIssuableByTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapEquityInterestIssuedOrIssuableByTypeAxis" order="90" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:label="loc_us-gaapEquityInterestIssuedOrIssuableTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapEquityInterestIssuedOrIssuableByTypeAxis" xlink:to="loc_us-gaapEquityInterestIssuedOrIssuableTypeDomain" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:label="loc_us-gaapEquityInterestIssuedOrIssuableTypeDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapEquityInterestIssuedOrIssuableByTypeAxis" xlink:to="loc_us-gaapEquityInterestIssuedOrIssuableTypeDomain_10" order="110" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="110" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" order="120" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="loc_srtBoardOfDirectorsChairmanMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_srtBoardOfDirectorsChairmanMember" order="101" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_RestrictedStockUnitsRSAMember" xlink:label="loc_ltbrRestrictedStockUnitsRSAMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ltbrRestrictedStockUnitsRSAMember" order="102" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_AvailableForSaleSecuritiesMember" xlink:label="loc_ltbrAvailableForSaleSecuritiesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ltbrAvailableForSaleSecuritiesMember" order="103" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TwoThousandTwentyEquityIncentivePlanMember" xlink:label="loc_ltbrTwoThousandTwentyEquityIncentivePlanMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ltbrTwoThousandTwentyEquityIncentivePlanMember" order="104" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TwentyTwentyFiveTransactionsMember" xlink:label="loc_ltbrTwentyTwentyFiveTransactionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ltbrTwentyTwentyFiveTransactionsMember" order="105" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_OptionsMember" xlink:label="loc_ltbrOptionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ltbrOptionsMember" order="106" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_CommonShareIssuancesMember" xlink:label="loc_ltbrCommonShareIssuancesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_ltbrCommonShareIssuancesMember" order="107" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_PrepaidExpenseAndOtherCurrentAssetMember" xlink:label="loc_ltbrPrepaidExpenseAndOtherCurrentAssetMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityInterestIssuedOrIssuableTypeDomain" xlink:to="loc_ltbrPrepaidExpenseAndOtherCurrentAssetMember" order="108" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_RestrictedStockAwardsSummaryMember" xlink:label="loc_ltbrRestrictedStockAwardsSummaryMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ltbrRestrictedStockAwardsSummaryMember" order="109" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_BoardOfDirectorsMember" xlink:label="loc_ltbrBoardOfDirectorsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ltbrBoardOfDirectorsMember" order="110" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TopMember" xlink:label="loc_ltbrTopMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ltbrTopMember" order="111" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_BottomMember" xlink:label="loc_ltbrBottomMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ltbrBottomMember" order="112" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_SeriesXPreferredStockMember" xlink:label="loc_ltbrSeriesXPreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ltbrSeriesXPreferredStockMember" order="113" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensation" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:label="loc_us-gaapRestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" order="8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockRedemptionAmount" xlink:label="loc_us-gaapPreferredStockRedemptionAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockRedemptionAmount" order="9" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCash" order="11" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_DescriptionOfSubscriptionAndInvestmentRepresentationAgreement" xlink:label="loc_ltbrDescriptionOfSubscriptionAndInvestmentRepresentationAgreement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrDescriptionOfSubscriptionAndInvestmentRepresentationAgreement" order="12" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_PreferredStockVotingRightsShares" xlink:label="loc_ltbrPreferredStockVotingRightsShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrPreferredStockVotingRightsShares" order="13" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_CommonSharesIssuancesEquityGrant" xlink:label="loc_ltbrCommonSharesIssuancesEquityGrant" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrCommonSharesIssuancesEquityGrant" order="14" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_EquityGrantValue" xlink:label="loc_ltbrEquityGrantValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrEquityGrantValue" order="15" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" order="16" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="17" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" order="18" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" order="19" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="21" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_CommonStockShareOutstanding" xlink:label="loc_ltbrCommonStockShareOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrCommonStockShareOutstanding" order="22" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" order="23" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_RSAFairValue" xlink:label="loc_ltbrRSAFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrRSAFairValue" order="24" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntercompanyAgreementsDescription" xlink:label="loc_us-gaapIntercompanyAgreementsDescription" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIntercompanyAgreementsDescription" order="25" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther" order="26" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_CommonSharesEquityGrantPricePerShares" xlink:label="loc_ltbrCommonSharesEquityGrantPricePerShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrCommonSharesEquityGrantPricePerShares" order="27" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted" xlink:label="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted" order="28" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense" xlink:label="loc_us-gaapEmployeeStockOwnershipPlanESOPCompensationExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEmployeeStockOwnershipPlanESOPCompensationExpense" order="29" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingExpenses" order="30" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_CommonStockValuedGrantDatePricePerShare" xlink:label="loc_ltbrCommonStockValuedGrantDatePricePerShare" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrCommonStockValuedGrantDatePricePerShare" order="31" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" order="32" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice" order="33" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="34" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_DescriptionOfRSAsModificationAndNetShareSettlementsForPaymentsOfWithholdingTaxes" xlink:label="loc_ltbrDescriptionOfRSAsModificationAndNetShareSettlementsForPaymentsOfWithholdingTaxes" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrDescriptionOfRSAsModificationAndNetShareSettlementsForPaymentsOfWithholdingTaxes" order="35" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_CommonStockEquivalentsOutstandingShares" xlink:label="loc_ltbrCommonStockEquivalentsOutstandingShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrCommonStockEquivalentsOutstandingShares" order="36" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" order="37" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfInitialPublicOffering" xlink:label="loc_us-gaapPaymentsForRepurchaseOfInitialPublicOffering" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsForRepurchaseOfInitialPublicOffering" order="38" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_MarketOfferingsDisclosureDescription" xlink:label="loc_ltbrMarketOfferingsDisclosureDescription" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrMarketOfferingsDisclosureDescription" order="39" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_FutureIssuanceOfShare" xlink:label="loc_ltbrFutureIssuanceOfShare" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrFutureIssuanceOfShare" order="40" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" order="41" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_DescriptionOfEquityIncentivePlan" xlink:label="loc_ltbrDescriptionOfEquityIncentivePlan" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrDescriptionOfEquityIncentivePlan" order="42" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" order="43" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_ProceedsFromStockIssuances" xlink:label="loc_ltbrProceedsFromStockIssuances" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrProceedsFromStockIssuances" order="44" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" order="45" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/SegmentReportingDetails" xlink:title="995473 - Disclosure - Segment Reporting (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReportingUnitAxis" xlink:label="loc_us-gaapReportingUnitAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapReportingUnitAxis" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReportingUnitDomain" xlink:label="loc_us-gaapReportingUnitDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapReportingUnitAxis" xlink:to="loc_us-gaapReportingUnitDomain" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReportingUnitDomain" xlink:label="loc_us-gaapReportingUnitDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapReportingUnitAxis" xlink:to="loc_us-gaapReportingUnitDomain_10" order="40" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_CODMMember" xlink:label="loc_ltbrCODMMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReportingUnitDomain" xlink:to="loc_ltbrCODMMember" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapOtherGeneralAndAdministrativeExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherGeneralAndAdministrativeExpense" order="2" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_InlProject" xlink:label="loc_ltbrInlProject" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrInlProject" order="3" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_RomaniaFeasibilityStudy" xlink:label="loc_ltbrRomaniaFeasibilityStudy" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrRomaniaFeasibilityStudy" order="4" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_CentrusEnergyFeedStudy" xlink:label="loc_ltbrCentrusEnergyFeedStudy" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrCentrusEnergyFeedStudy" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherExpenses" xlink:label="loc_us-gaapOtherExpenses" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherExpenses" order="7" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_ResearchAndDevelopmentExpenseNet" xlink:label="loc_ltbrResearchAndDevelopmentExpenseNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrResearchAndDevelopmentExpenseNet" order="8" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_OtherSegmentsItem" xlink:label="loc_ltbrOtherSegmentsItem" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrOtherSegmentsItem" order="9" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_OperatingNetIncomeLossFromSegmentsToConsolidated" xlink:label="loc_ltbrOperatingNetIncomeLossFromSegmentsToConsolidated" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrOperatingNetIncomeLossFromSegmentsToConsolidated" order="10" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/SubsequentEventsDetailsNarrative" xlink:title="995474 - Disclosure - Subsequent Events (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" order="40" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="40" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" order="50" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="40" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="50" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" order="60" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" order="41" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_BottomMember" xlink:label="loc_ltbrBottomMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ltbrBottomMember" order="42" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_ArticlesOfIncorporationMember" xlink:label="loc_ltbrArticlesOfIncorporationMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ltbrArticlesOfIncorporationMember" order="43" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TopMember" xlink:label="loc_ltbrTopMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ltbrTopMember" order="44" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_TwentyTwentyPlanMember" xlink:label="loc_ltbrTwentyTwentyPlanMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ltbrTwentyTwentyPlanMember" order="45" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" order="1" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250331.xsd#ltbr_ProceedsFromStockIssuances" xlink:label="loc_ltbrProceedsFromStockIssuances" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrProceedsFromStockIssuances" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" order="6" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>ltbr_ex32img5.jpg
<TEXT>
begin 644 ltbr_ex32img5.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" 2D Y8# 2(  A$! Q$!_\0
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M#U_Y3+/_ .,T ?IC17YG?\-1_'7_ *'K_P IEG_\9H_X:C^.O_0]?^4RS_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1/+GCD.0.>0A'XU\K_\ #$/BK_H=]*_\!Y*H1\F45]9_\,0^*O\ H=]*_P#
M>2C_ (8A\5?]#OI7_@/)0!\F45]9_P##$/BK_H=]*_\  >2C_AB'Q5_T.^E?
M^ \E 'R917UG_P ,0^*O^AWTK_P'DH_X8A\5?]#OI7_@/)0![7^SQK%CH_[-
M?@C[?]H"W,US;H\-K+,JLUY,!O**1&N>-SX7IS6Y\>;#4-4^%IT[3+/4;JZE
MU"R=1IUJ]Q+&J7",S@(K8VJ"<D8X[]*V/A?\/W\"?"[0O!VJW$&J7&E/+)YR
M(1&S-</*I"GNN\8ST(R*]$J;ZI]F#U.*\-^$;/0=2OO$<^K:KKNK:C$B27VJ
M[#-'"N2L*)''&L:Y)8J$!+'G)QC#^%*W$=UXX6ZTW4+,W/B2[NX3=V,UN)H7
M"!74R* P.#TKU&CWJKDM7L?.]]H>H1WFE>/O .CZ[X;\874UN-2T'[)+'I]V
M&<"<S@J(P0FYO,# \#C<:]DL+?Q?#K$\VK:YI-WI7SF.VM=)EAG7GY<RFY<-
M@=<1C)Z8Z5TU%%]+(IZNYY9\-YI;*'QM<7ECJ=JC:]>7L8FT^=&EA;:5:-2F
M7SM. H)/IR*[3^V+.Z\-G6;4SSVDT6]/+MI6D(/&/+"[\YZC;D<YZ5KL@=&!
MSAA@X.#^8J*&"&UMX[>WB2&&)0B1HH554#   Z 4I+F5F*/N_>>(Z5H6M6>N
MZ19Z;X;N/[ \7Z3;PZY(\+PFQGMD <NC $&6,F+IDE5/8YS+C1_$5]X(\;V^
MBZ3JD#CQ<NJ?8Y+&:W.H62O"72/>J[@RHWRC.=N,<U]&\T9ICZW/FOXE>&?%
MVO\ B+Q7XD\*Z;J,FCW.D:?;SV/DO;2ZE(EX))0(Y K$B %22.0VT9Y ]"T-
MHY?C5>:K:Z/J%M9WN@VL*SRZ;/ AD2:9BC%D 5@C)P<=@*]1HHOLNQ+5[^=O
MP/&OB]X7\3:AX.\4WEC>?VF]W%;P6NG0Z?))+#&LR,RIMDY+-EF;;R%4?P@U
MZ[;_ &I84%U)'+*!\[QQE%)]E))'YFK5%)*Q;=PHHHIB"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^&HO@5_T/7_E,O/_ (S1_P -1? K_H>O_*9>?_&: /9Z*\8_X:B^!7_0]?\
ME,O/_C-'_#47P*_Z'K_RF7G_ ,9H ]GHKQC_ (:B^!7_ $/7_E,O/_C-'_#4
M7P*_Z'K_ ,IEY_\ &: /9Z*\8_X:B^!7_0]?^4R\_P#C-'_#47P*_P"AZ_\
M*9>?_&: /9Z*\8_X:B^!7_0]?^4R\_\ C-'_  U%\"O^AZ_\IEY_\9H ]GHK
MQC_AJ+X%?]#U_P"4R\_^,T?\-1? K_H>O_*9>?\ QF@#V>BO&/\ AJ+X%?\
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M'K_RF7G_ ,9H ]GHKQC_ (:B^!7_ $/7_E,O/_C-'_#47P*_Z'K_ ,IEY_\
M&: /9Z*\8_X:B^!7_0]?^4R\_P#C-'_#47P*_P"AZ_\ *9>?_&: /9Z*\8_X
M:B^!7_0]?^4R\_\ C-'_  U%\"O^AZ_\IEY_\9H ]GHKQC_AJ+X%?]#U_P"4
MR\_^,T?\-1? K_H>O_*9>?\ QF@#V>BO&/\ AJ+X%?\ 0]?^4R\_^,T?\-1?
M K_H>O\ RF7G_P 9H ]GHKQC_AJ+X%?]#U_Y3+S_ .,T?\-1? K_ *'K_P I
MEY_\9H ]GHKQC_AJ+X%?]#U_Y3+S_P",T?\ #47P*_Z'K_RF7G_QF@#V>BO&
M/^&HO@5_T/7_ )3+S_XS1_PU%\"O^AZ_\IEY_P#&: /9Z*\8_P"&HO@5_P!#
MU_Y3+S_XS1_PU%\"O^AZ_P#*9>?_ !F@#V>BO&/^&HO@5_T/7_E,O/\ XS1_
MPU%\"O\ H>O_ "F7G_QF@#V>BO&/^&HO@5_T/7_E,O/_ (S71>#?C)\.OB%K
M<VA^$?$7]IW\,#74D7V.XAVQ!E4MF2-1U=1C.>: /1:*** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH \8_:C_ .39/%W_ &Y_^ED-?F=7
MZ8_M1_\ )LGB[_MS_P#2R&OS.H **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ KZ:_8K_P"2VZS_ -B_-_Z4V]?,
MM?37[%?_ "6W6?\ L7YO_2FWH ^_J*** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_ 6Y_P#C]'_#:GQ2_P"@!X5_\!;G_P"/T ?,M%?37_#:GQ2_Z 'A7_P%N?\
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M_ 6Y_P#C]'_#:GQ2_P"@!X5_\!;G_P"/T ?,M%?37_#:GQ2_Z 'A7_P%N?\
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M_ 6Y_P#C]'_#:GQ2_P"@!X5_\!;G_P"/T ?,M%?37_#:GQ2_Z 'A7_P%N?\
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M /&**]G_ .&7/CK_ -"+_P"5.S_^/4?\,N?'7_H1?_*G9_\ QZ@#QBBO9_\
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M^&7/CK_T(O\ Y4[/_P"/4?\ #+GQU_Z$7_RIV?\ \>H \8HKV?\ X9<^.O\
MT(O_ )4[/_X]1_PRY\=?^A%_\J=G_P#'J /&**]G_P"&7/CK_P!"+_Y4[/\
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M^A4\?_\ ?R#_ ./4?VQ^R1_T*GC_ /[^0?\ QZOG^B@#Z _MC]DC_H5/'_\
MW\@_^/4?VQ^R1_T*GC__ +^0?_'J^?Z* /H#^V/V2/\ H5/'_P#W\@_^/4?V
MQ^R1_P!"IX__ ._D'_QZOG^B@#Z _MC]DC_H5/'_ /W\@_\ CU']L?LD?]"I
MX_\ ^_D'_P >KY_HH ^@/[8_9(_Z%3Q__P!_(/\ X]1_;'[)'_0J>/\ _OY!
M_P#'J^?Z* /H#^V/V2/^A4\?_P#?R#_X]1_;'[)'_0J>/_\ OY!_\>KY_HH
M^@/[8_9(_P"A4\?_ /?R#_X]1_;'[)'_ $*GC_\ [^0?_'J^?Z* /H#^V/V2
M/^A4\?\ _?R#_P"/4?VQ^R1_T*GC_P#[^0?_ !ZOG^B@#Z _MC]DC_H5/'__
M '\@_P#CU']L?LD?]"IX_P#^_D'_ ,>KY_HH ^@/[8_9(_Z%3Q__ -_(/_CU
M']L?LD?]"IX__P"_D'_QZOG^B@#Z _MC]DC_ *%3Q_\ ]_(/_CU']L?LD?\
M0J>/_P#OY!_\>KY_HH ^@/[8_9(_Z%3Q_P#]_(/_ (]1_;'[)'_0J>/_ /OY
M!_\ 'J^?Z* /H#^V/V2/^A4\?_\ ?R#_ ./4?VQ^R1_T*GC_ /[^0?\ QZOG
M^B@#Z _MC]DC_H5/'_\ W\@_^/4?VQ^R1_T*GC__ +^0?_'J^?Z* /H#^V/V
M2/\ H5/'_P#W\@_^/4?VQ^R1_P!"IX__ ._D'_QZOG^B@#Z _MC]DC_H5/'_
M /W\@_\ CU']L?LD?]"IX_\ ^_D'_P >KY_HH ^@/[8_9(_Z%3Q__P!_(/\
MX]1_;'[)'_0J>/\ _OY!_P#'J^?Z* /H#^V/V2/^A4\?_P#?R#_X]1_;'[)'
M_0J>/_\ OY!_\>KY_HH ^@/[8_9(_P"A4\?_ /?R#_X]1_;'[)'_ $*GC_\
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M *)IXJ_\$US_ /$5]E_\-J_"W_H >*O_  %MO_C]'_#:OPM_Z 'BK_P%MO\
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M%MO_ (_0!\:?\*G^*7_1-/%7_@FN?_B*)/A9\3HUWS?#KQ/&N0,MH]P!D_\
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M ,)FV_\ D^C^S_A9_P!#EXJ_\)FV_P#D^@#BZ*[3^S_A9_T.7BK_ ,)FV_\
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MRV\;.;B A0SJ 3A6..N ?2OMZB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** /&/VH_^39/%W_;G_Z60U^9U?IC^U'_ ,FR>+O^W/\ ]+(:
M_,Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_3']ES_DV
M3PC_ -OG_I9-7YG5^F/[+G_)LGA'_M\_]+)J /9Z*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /*_V@M>U
MCPS\!/$NN:#J$NGZE;?9O)N(3ATW742-CZJQ'XU\$_\ "_OC)_T4+5?^^U_P
MK[C_ &H_^39/%W_;G_Z60U^9U 'IW_"_OC)_T4+5?^^U_P */^%_?&3_ **%
MJO\ WVO^%>8T4 >G?\+^^,G_ $4+5?\ OM?\*/\ A?WQD_Z*%JO_ 'VO^%>8
MT4 >G?\ "_OC)_T4+5?^^U_PH_X7]\9/^BA:K_WVO^%>8T4 >G?\+^^,G_10
MM5_[[7_"C_A?WQD_Z*%JO_?:_P"%>8T4 >G?\+^^,G_10M5_[[7_  H_X7]\
M9/\ HH6J_P#?:_X5YC10!Z=_PO[XR?\ 10M5_P"^U_PH_P"%_?&3_HH6J_\
M?:_X5YC10!Z=_P +^^,G_10M5_[[7_"C_A?WQD_Z*%JO_?:_X5YC10!Z=_PO
M[XR?]%"U7_OM?\*/^%_?&3_HH6J_]]K_ (5YC10!Z=_PO[XR?]%"U7_OM?\
M"C_A?WQD_P"BA:K_ -]K_A7F-% 'IW_"_OC)_P!%"U7_ +[7_"C_ (7]\9/^
MBA:K_P!]K_A7F-% 'IW_  O[XR?]%"U7_OM?\*/^%_?&3_HH6J_]]K_A7F-%
M 'IW_"_OC)_T4+5?^^U_PH_X7]\9/^BA:K_WVO\ A7F-% 'IW_"_OC)_T4+5
M?^^U_P */^%_?&3_ **%JO\ WVO^%>8T4 >G?\+^^,G_ $4+5?\ OM?\*/\
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M%_?&3_HH6J_]]K_A7F-% 'IW_"_OC)_T4+5?^^U_PH_X7]\9/^BA:K_WVO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&\_^*KQFB@#V;_A7GP)_Z.*_\M&\_P#BJ/\ A7GP)_Z.*_\ +1O/_BJ\9HH
M]F_X5Y\"?^CBO_+1O/\ XJC_ (5Y\"?^CBO_ "T;S_XJO&:* /9O^%>? G_H
MXK_RT;S_ .*H_P"%>? G_HXK_P M&\_^*KQFB@#V;_A7GP)_Z.*_\M&\_P#B
MJ/\ A7GP)_Z.*_\ +1O/_BJ\9HH ]F_X5Y\"?^CBO_+1O/\ XJC_ (5Y\"?^
MCBO_ "T;S_XJO&:* /9O^%>? G_HXK_RT;S_ .*H_P"%>? G_HXK_P M&\_^
M*KQFB@#V;_A7GP)_Z.*_\M&\_P#BJ/\ A7GP)_Z.*_\ +1O/_BJ\9HH ]F_X
M5Y\"?^CBO_+1O/\ XJC_ (5Y\"?^CBO_ "T;S_XJO&:* /9O^%>? G_HXK_R
MT;S_ .*H_P"%>? G_HXK_P M&\_^*KQFB@#V;_A7GP)_Z.*_\M&\_P#BJ/\
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M7G_QFOS.HH _3'_AJ+X%?]#U_P"4R\_^,T?\-1? K_H>O_*9>?\ QFOS.HH
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M7_807_T$U^I5?EK\ O\ DX7P5_V$%_\ 037ZE4 %%%% !1110 4444 %%%%
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MI\4O^@!X5_\  6Y_^/U\RT4 ?37_  VI\4O^@!X5_P# 6Y_^/T?\-J?%+_H
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MI\4O^@!X5_\  6Y_^/U\RT4 ?37_  VI\4O^@!X5_P# 6Y_^/T?\-J?%+_H
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MI\4O^@!X5_\  6Y_^/U\RT4 ?37_  VI\4O^@!X5_P# 6Y_^/T?\-J?%+_H
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M*ZNHH'9+6X#!6<*<9G//-?=U?D%X3_Y'?0?^PA;_ /HQ:_7V@ HHHH ****
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M>8T4 >G?\*)^)G_0+TK_ ,*#3_\ X_1_PHGXF?\ 0+TK_P *#3__ (_7F-%
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M>8T4 >G?\*)^)G_0+TK_ ,*#3_\ X_1_PHGXF?\ 0+TK_P *#3__ (_7F-%
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M>8T4 >G?\*)^)G_0+TK_ ,*#3_\ X_1_PHGXF?\ 0+TK_P *#3__ (_7F-%
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MP*_2*QU;2]4:3^S=2M;XQ8W_ &>99-F<XSM)QG!_*OQZK[,_89_YJ#_W#O\
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M $!O'_\ X,[+_P"1Z /,J*]-^T_ /_H#>/\ _P &=E_\CT?:?@'_ - ;Q_\
M^#.R_P#D>@#S*BO3?M/P#_Z WC__ ,&=E_\ (]'VGX!_] ;Q_P#^#.R_^1Z
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M17W_ /\ #%7PM_Z#_BK_ ,"K;_XQ1_PQ5\+?^@_XJ_\  JV_^,4 ? %%??\
M_P ,5?"W_H/^*O\ P*MO_C%'_#%7PM_Z#_BK_P "K;_XQ0!\ 45]_P#_  Q5
M\+?^@_XJ_P# JV_^,4?\,5?"W_H/^*O_  *MO_C% 'P!17W_ /\ #%7PM_Z#
M_BK_ ,"K;_XQ1_PQ5\+?^@_XJ_\  JV_^,4 ? %%??\ _P ,5?"W_H/^*O\
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MX6^$']K_ /"-:AJEV-6\GS_[1EC?;Y6_;MV1IC_6-G.>@Z4 >I4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'C'[4?\
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MJ_\ !-<__$4?\*G^*7_1-/%7_@FN?_B* .+HKM/^%3_%+_HFGBK_ ,$US_\
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M-J_"W_H >*O_  %MO_C]'_#:OPM_Z 'BK_P%MO\ X_0!],T5\S?\-J_"W_H
M>*O_  %MO_C]'_#:OPM_Z 'BK_P%MO\ X_0!],T5\S?\-J_"W_H >*O_  %M
MO_C]'_#:OPM_Z 'BK_P%MO\ X_0!],T5\S?\-J_"W_H >*O_  %MO_C]'_#:
MOPM_Z 'BK_P%MO\ X_0!],T5\S?\-J_"W_H >*O_  %MO_C]'_#:OPM_Z 'B
MK_P%MO\ X_0!],T5\S?\-J_"W_H >*O_  %MO_C]'_#:OPM_Z 'BK_P%MO\
MX_0!],T5\S?\-J_"W_H >*O_  %MO_C]'_#:OPM_Z 'BK_P%MO\ X_0!],T5
M\S?\-J_"W_H >*O_  %MO_C]'_#:OPM_Z 'BK_P%MO\ X_0!],T5\S?\-J_"
MW_H >*O_  %MO_C]'_#:OPM_Z 'BK_P%MO\ X_0!],T5\S?\-J_"W_H >*O_
M  %MO_C]'_#:OPM_Z 'BK_P%MO\ X_0!],T5\S?\-J_"W_H >*O_  %MO_C]
M'_#:OPM_Z 'BK_P%MO\ X_0!],T5\S?\-J_"W_H >*O_  %MO_C]'_#:OPM_
MZ 'BK_P%MO\ X_0!],T5\S?\-J_"W_H >*O_  %MO_C]'_#:OPM_Z 'BK_P%
MMO\ X_0!],T5\S?\-J_"W_H >*O_  %MO_C]'_#:OPM_Z 'BK_P%MO\ X_0!
M],T5\S?\-J_"W_H >*O_  %MO_C]'_#:OPM_Z 'BK_P%MO\ X_0!],T5\S?\
M-J_"W_H >*O_  %MO_C]'_#:OPM_Z 'BK_P%MO\ X_0!],T5\S?\-J_"W_H
M>*O_  %MO_C]'_#:OPM_Z 'BK_P%MO\ X_0!],T5\S?\-J_"W_H >*O_  %M
MO_C]'_#:OPM_Z 'BK_P%MO\ X_0!],T5\S?\-J_"W_H >*O_  %MO_C]'_#:
MOPM_Z 'BK_P%MO\ X_0!],T5\S?\-J_"W_H >*O_  %MO_C]'_#:OPM_Z 'B
MK_P%MO\ X_0!],T5\S?\-J_"W_H >*O_  %MO_C]'_#:OPM_Z 'BK_P%MO\
MX_0!],T5\S?\-J_"W_H >*O_  %MO_C]>R_#GX@:/\3/"$?BC0;6]MK&29X0
MEZB))N0X/",PQ^- ':4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MXI_Z%G5?_ .3_P")H_X1/Q3_ -"SJO\ X!R?_$T 8E%;?_")^*?^A9U7_P
MY/\ XFC_ (1/Q3_T+.J_^ <G_P 30!B45M_\(GXI_P"A9U7_ , Y/_B:/^$3
M\4_]"SJO_@')_P#$T 8E%;?_  B?BG_H6=5_\ Y/_B:/^$3\4_\ 0LZK_P"
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M."".#U%:E !16,GB+0)?$,GAV/7-/?68H_-DT];E#<(G'S&/.X#D<X[BMF@
MHKEX_&W@^?Q#_P ([#XMT>36P[1G3DOXFN0Z@DKY8;=D $D8[5J:IJVE:'IS
MZCK&I6NF6,>-]Q=S+#&F>!EF( HZ7#K8U**HV=Y::A8PWEA<Q7=M,@DCGA<.
MDBGD,K#@@^HJMK&NZ+X>L/MWB#6+'2;+<$^T7UPD$>X]%W.0,G!XH U^U%9]
MGJ%CJ6GP:EI]Y!>V4Z"2*Y@D62.13T96!P1[BLW1?&'A/Q+-/#X<\4:3K$L
M#3)87L5PT0/ +!&..AZT=; =%116'J/B/0=)U.QTS5-<T^PO[]MEI;7-TD4M
MRV0,1JQ!<Y(&!GDB@#<HHHH **I7=U:V=I->7EQ';V\"F22:1PB1J!DLQ/
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M[CO+5(+J1&\U"2&=LY<DLQ))R2<YS70^(M"@\2:'/I-U=W=M;SX\Q[23RY"
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M![/17C'_  U%\"O^AZ_\IEY_\9H_X:B^!7_0]?\ E,O/_C- 'L]%>,?\-1?
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M44 >,?M1_P#)LGB[_MS_ /2R&OS.K],?VH_^39/%W_;G_P"ED-?F=0 4444
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MBZ* .T_X67XB_P"@;X5_\)/2O_D:C_A9?B+_ *!OA7_PD]*_^1JXNB@#M/\
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MBZ* .T_X67XB_P"@;X5_\)/2O_D:C_A9?B+_ *!OA7_PD]*_^1JXNB@#M/\
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MBZ* .T_X67XB_P"@;X5_\)/2O_D:C_A9?B+_ *!OA7_PD]*_^1JXNB@#M/\
MA9?B+_H&^%?_  D]*_\ D:C_ (67XB_Z!OA7_P )/2O_ )&KBZ* .T_X67XB
M_P"@;X5_\)/2O_D:C_A9?B+_ *!OA7_PD]*_^1JXNB@#M/\ A9?B+_H&^%?_
M  D]*_\ D:C_ (67XB_Z!OA7_P )/2O_ )&KBZ* .T_X67XB_P"@;X5_\)/2
MO_D:C_A9?B+_ *!OA7_PD]*_^1JXNB@#M/\ A9?B+_H&^%?_  D]*_\ D:C_
M (67XB_Z!OA7_P )/2O_ )&KBZ* .T_X67XB_P"@;X5_\)/2O_D:C_A9?B+_
M *!OA7_PD]*_^1JXNB@#M/\ A9?B+_H&^%?_  D]*_\ D:C_ (67XB_Z!OA7
M_P )/2O_ )&KBZ* .T_X67XB_P"@;X5_\)/2O_D:C_A9?B+_ *!OA7_PD]*_
M^1JXNB@#M/\ A9?B+_H&^%?_  D]*_\ D:C_ (67XB_Z!OA7_P )/2O_ )&K
MBZ* .T_X67XB_P"@;X5_\)/2O_D:O3/@7XBE\:?'+P]X:\2:!X7O=)O/M/G6
MX\,Z=%OV6TKK\R0!AAE4\'M7S_7L_P"RW_R<WX1_[?/_ $CFH ^_O^%3_"S_
M *)IX5_\$UM_\16IH7A/PSX7>X_X1GPSI6B"YV^?_9UG';^;MSMW;%&[&YL9
MZ9/K6_10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 >3_M :7'K'P#\2Z=-K%AHZ2_9LWNH.Z018NHF^8HK,,XP,*>2/K7P=
M_P *GT__ *+!\/\ _P #;K_Y&K[B_:C_ .39/%W_ &Y_^ED-?F=0!Z?_ ,*G
MT_\ Z+!\/_\ P-NO_D:C_A4^G_\ 18/A_P#^!MU_\C5YA10!Z?\ \*GT_P#Z
M+!\/_P#P-NO_ )&H_P"%3Z?_ -%@^'__ (&W7_R-7F%% 'I__"I]/_Z+!\/_
M /P-NO\ Y&H_X5/I_P#T6#X?_P#@;=?_ "-7F%% 'I__  J?3_\ HL'P_P#_
M  -NO_D:C_A4^G_]%@^'_P#X&W7_ ,C5YA10!Z?_ ,*GT_\ Z+!\/_\ P-NO
M_D:C_A4^G_\ 18/A_P#^!MU_\C5YA10!Z?\ \*GT_P#Z+!\/_P#P-NO_ )&H
M_P"%3Z?_ -%@^'__ (&W7_R-7F%% 'I__"I]/_Z+!\/_ /P-NO\ Y&H_X5/I
M_P#T6#X?_P#@;=?_ "-7F%% 'I__  J?3_\ HL'P_P#_  -NO_D:C_A4^G_]
M%@^'_P#X&W7_ ,C5YA10!Z?_ ,*GT_\ Z+!\/_\ P-NO_D:C_A4^G_\ 18/A
M_P#^!MU_\C5YA10!Z?\ \*GT_P#Z+!\/_P#P-NO_ )&H_P"%3Z?_ -%@^'__
M (&W7_R-7F%% 'I__"I]/_Z+!\/_ /P-NO\ Y&H_X5/I_P#T6#X?_P#@;=?_
M "-7F%% 'I__  J?3_\ HL'P_P#_  -NO_D:C_A4^G_]%@^'_P#X&W7_ ,C5
MYA10!Z?_ ,*GT_\ Z+!\/_\ P-NO_D:C_A4^G_\ 18/A_P#^!MU_\C5YA10!
MZ?\ \*GT_P#Z+!\/_P#P-NO_ )&H_P"%3Z?_ -%@^'__ (&W7_R-7F%% 'I_
M_"I]/_Z+!\/_ /P-NO\ Y&H_X5/I_P#T6#X?_P#@;=?_ "-7F%% 'I__  J?
M3_\ HL'P_P#_  -NO_D:C_A4^G_]%@^'_P#X&W7_ ,C5YA10!Z?_ ,*GT_\
MZ+!\/_\ P-NO_D:C_A4^G_\ 18/A_P#^!MU_\C5YA10!Z?\ \*GT_P#Z+!\/
M_P#P-NO_ )&H_P"%3Z?_ -%@^'__ (&W7_R-7F%% 'I__"I]/_Z+!\/_ /P-
MNO\ Y&H_X5/I_P#T6#X?_P#@;=?_ "-7F%% 'I__  J?3_\ HL'P_P#_  -N
MO_D:C_A4^G_]%@^'_P#X&W7_ ,C5YA10!Z?_ ,*GT_\ Z+!\/_\ P-NO_D:C
M_A4^G_\ 18/A_P#^!MU_\C5YA10!Z?\ \*GT_P#Z+!\/_P#P-NO_ )&H_P"%
M3Z?_ -%@^'__ (&W7_R-7F%% 'I__"I]/_Z+!\/_ /P-NO\ Y&H_X5/I_P#T
M6#X?_P#@;=?_ "-7F%% 'I__  J?3_\ HL'P_P#_  -NO_D:C_A4^G_]%@^'
M_P#X&W7_ ,C5YA10!Z?_ ,*GT_\ Z+!\/_\ P-NO_D:C_A4^G_\ 18/A_P#^
M!MU_\C5YA10!Z?\ \*GT_P#Z+!\/_P#P-NO_ )&H_P"%3Z?_ -%@^'__ (&W
M7_R-7F%% 'I__"I]/_Z+!\/_ /P-NO\ Y&H_X5/I_P#T6#X?_P#@;=?_ "-7
MF%% 'I__  J?3_\ HL'P_P#_  -NO_D:C_A4^G_]%@^'_P#X&W7_ ,C5YA10
M!Z?_ ,*GT_\ Z+!\/_\ P-NO_D:C_A4^G_\ 18/A_P#^!MU_\C5YA10!Z?\
M\*GT_P#Z+!\/_P#P-NO_ )&H_P"%3Z?_ -%@^'__ (&W7_R-7F%% 'I__"I]
M/_Z+!\/_ /P-NO\ Y&H_X5/I_P#T6#X?_P#@;=?_ "-7F%% 'I__  J?3_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P#CM 'F5%>F_P#"=_#/_HAVE?\ @\U#_P".T?\ "=_#/_HAVE?^#S4/_CM
M'F5%>F_\)W\,_P#HAVE?^#S4/_CM'_"=_#/_ *(=I7_@\U#_ ..T >945Z;_
M ,)W\,_^B':5_P"#S4/_ ([1_P )W\,_^B':5_X/-0_^.T >945Z;_PG?PS_
M .B':5_X/-0_^.T?\)W\,_\ HAVE?^#S4/\ X[0!YE17IO\ PG?PS_Z(=I7_
M (/-0_\ CM'_  G?PS_Z(=I7_@\U#_X[0!YE17IO_"=_#/\ Z(=I7_@\U#_X
M[1_PG?PS_P"B':5_X/-0_P#CM 'F5%>F_P#"=_#/_HAVE?\ @\U#_P".T?\
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M_P#CM 'F5%>F_P#"=_#/_HAVE?\ @\U#_P".T?\ "=_#/_HAVE?^#S4/_CM
M'F5%>F_\)W\,_P#HAVE?^#S4/_CM'_"=_#/_ *(=I7_@\U#_ ..T >945Z;_
M ,)W\,_^B':5_P"#S4/_ ([1_P )W\,_^B':5_X/-0_^.T >945Z;_PG?PS_
M .B':5_X/-0_^.T?\)W\,_\ HAVE?^#S4/\ X[0!YE17IO\ PG?PS_Z(=I7_
M (/-0_\ CM'_  G?PS_Z(=I7_@\U#_X[0!YE17IO_"=_#/\ Z(=I7_@\U#_X
M[1_PG?PS_P"B':5_X/-0_P#CM 'F5%>F_P#"=_#/_HAVE?\ @\U#_P".T?\
M"=_#/_HAVE?^#S4/_CM 'F5%>F_\)W\,_P#HAVE?^#S4/_CM'_"=_#/_ *(=
MI7_@\U#_ ..T 8_PI_Y+?X#_ .Q@L/\ TI2OUCK\Q-)^)W@70]:L-:TOX-Z5
M;W]C<1W5M+_:]^WERHP9&PTI!P0#@@BO5O\ AM[Q5_T)&E?^!$E 'W+17Q1H
MW[9?B?5->T[39/!NEQI=W,<#.MQ(2H9@N?UK[7H **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#QC]J/_DV3Q=_VY_\
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M /&**]G_ .&7/CK_ -"+_P"5.S_^/4?\,N?'7_H1?_*G9_\ QZ@#QBBO9_\
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M^&7/CK_T(O\ Y4[/_P"/4?\ #+GQU_Z$7_RIV?\ \>H \8HKV?\ X9<^.O\
MT(O_ )4[/_X]1_PRY\=?^A%_\J=G_P#'J /&**]G_P"&7/CK_P!"+_Y4[/\
M^/4?\,N?'7_H1?\ RIV?_P >H \8HKV?_AESXZ_]"+_Y4[/_ ./4?\,N?'7_
M *$7_P J=G_\>H \8HKV?_AESXZ_]"+_ .5.S_\ CU'_  RY\=?^A%_\J=G_
M /'J /,_"?\ R.^@_P#80M__ $8M?K[7YQ^'_P!FOXV6/BC2;V[\$^7;V]Y#
M+(_]HVAVJK@DX$N3P*_1R@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?_(U'_"5?!O_ *)#JO\ X53?_(U>944 >F_\)5\&_P#HD.J_^%4W_P C4?\
M"5?!O_HD.J_^%4W_ ,C5YE10!Z;_ ,)5\&_^B0ZK_P"%4W_R-1_PE7P;_P"B
M0ZK_ .%4W_R-7F5% 'IO_"5?!O\ Z)#JO_A5-_\ (U'_  E7P;_Z)#JO_A5-
M_P#(U>944 >F_P#"5?!O_HD.J_\ A5-_\C4?\)5\&_\ HD.J_P#A5-_\C5YE
M10!Z;_PE7P;_ .B0ZK_X53?_ "-1_P )5\&_^B0ZK_X53?\ R-7F5% 'IO\
MPE7P;_Z)#JO_ (53?_(U'_"5?!O_ *)#JO\ X53?_(U>944 >F_\)5\&_P#H
MD.J_^%4W_P C4?\ "5?!O_HD.J_^%4W_ ,C5YE10!Z;_ ,)5\&_^B0ZK_P"%
M4W_R-1_PE7P;_P"B0ZK_ .%4W_R-7F5% 'IO_"5?!O\ Z)#JO_A5-_\ (U'_
M  E7P;_Z)#JO_A5-_P#(U>944 >F_P#"5?!O_HD.J_\ A5-_\C4?\)5\&_\
MHD.J_P#A5-_\C5YE10!Z;_PE7P;_ .B0ZK_X53?_ "-1_P )5\&_^B0ZK_X5
M3?\ R-7F5% 'IO\ PE7P;_Z)#JO_ (53?_(U'_"5?!O_ *)#JO\ X53?_(U>
M944 >F_\)5\&_P#HD.J_^%4W_P C4?\ "5?!O_HD.J_^%4W_ ,C5YE10!Z;_
M ,)5\&_^B0ZK_P"%4W_R-1_PE7P;_P"B0ZK_ .%4W_R-7F5% 'IO_"5?!O\
MZ)#JO_A5-_\ (U'_  E7P;_Z)#JO_A5-_P#(U>944 >F_P#"5?!O_HD.J_\
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MR-YC(B'D]L(O%=I10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!X[^TE:75]^S?XJM;.VENIW^R;8H4+LV+N$G ')X!-?G)_PB?BG
M_H6=5_\  .3_ .)K]%OVH_\ DV3Q=_VY_P#I9#7YG4 ;?_")^*?^A9U7_P
MY/\ XFC_ (1/Q3_T+.J_^ <G_P 36)10!M_\(GXI_P"A9U7_ , Y/_B:/^$3
M\4_]"SJO_@')_P#$UB44 ;?_  B?BG_H6=5_\ Y/_B:/^$3\4_\ 0LZK_P"
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M+Q5_X3-M_P#)]']G_"S_ *'+Q5_X3-M_\GT <717:?V?\+/^AR\5?^$S;?\
MR?1_9_PL_P"AR\5?^$S;?_)] '%T5VG]G_"S_H<O%7_A,VW_ ,GT?V?\+/\
MH<O%7_A,VW_R?0!Q=%=I_9_PL_Z'+Q5_X3-M_P#)]']G_"S_ *'+Q5_X3-M_
M\GT <717:?V?\+/^AR\5?^$S;?\ R?1_9_PL_P"AR\5?^$S;?_)] '%T5VG]
MG_"S_H<O%7_A,VW_ ,GT?V?\+/\ H<O%7_A,VW_R?0!Q=%=I_9_PL_Z'+Q5_
MX3-M_P#)]']G_"S_ *'+Q5_X3-M_\GT <717:?V?\+/^AR\5?^$S;?\ R?1_
M9_PL_P"AR\5?^$S;?_)] '%T5VG]G_"S_H<O%7_A,VW_ ,GT?V?\+/\ H<O%
M7_A,VW_R?0!Q=%=I_9_PL_Z'+Q5_X3-M_P#)]']G_"S_ *'+Q5_X3-M_\GT
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P#?:_X4?\+^^,G_ $4+5?\ OM?\*\QHH ]._P"%_?&3_HH6J_\ ?:_X4?\
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M[)XY#N*S,>B'& ><5\?444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 ?9_PR_:H^'O@WX6^'O"VJ:-XA
MDO--M1!+);6\#1LP)/REI@2.>X%?2OPY^(&C_$SPA'XHT&UO;:QDF>$)>HB2
M;D.#PC,,?C7Y-U^C/[(?_)O-K_V$+G_T(4 >_P!%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !7Y:_'W_DX7QK_P!A!O\ T$5^I5?EK\??^3A?&O\
MV$&_]!% 'F-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !7Z,_LA_\F\VO_80N?_0A7YS5^C/[(?\
MR;S:_P#80N?_ $(4 >_T444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%?EK\??^3A?&O_80;_T$5^I5?EK\??\ DX7QK_V$&_\ 010!YC1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 5^C/[(?\ R;S:_P#80N?_ $(5^<U?HS^R'_R;S:_]A"Y_]"% 'O\
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 5R.H?#GX?:MJ$^H:IX$
M\/7]Y<-OEN+G2X)))&]69E))^M==10!\X_M$?#_P'H?[/?BC5-'\$Z!IE_;_
M &7R[JSTR&&6/-U"IVNJ@C()!P>A(K\]:_3']J/_ )-D\7?]N?\ Z60U^9U
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5]$_LF>']!\2_%S5;'Q!HNGZQ:QZ'-,L%_;)<1JXN( &"N" <,PSUP3ZU\
M[5]-?L5_\EMUG_L7YO\ TIMZ /LO_A4_PL_Z)IX5_P#!-;?_ !%'_"I_A9_T
M33PK_P"":V_^(KLZ* .,_P"%3_"S_HFGA7_P36W_ ,16YH^AZ+X>L1I^@Z/9
M:39ABXM[*W2",,>IVH ,FM>B@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** /*/V@+K2;/X">);C7M'EUC35^S>=9PW7V5Y<W407$FUMN&(/
MW3G&.^:^"_\ A*O@W_T2'5?_  JF_P#D:ON3]J/_ )-D\7?]N?\ Z60U^9U
M'IO_  E7P;_Z)#JO_A5-_P#(U'_"5?!O_HD.J_\ A5-_\C5YE10!Z;_PE7P;
M_P"B0ZK_ .%4W_R-1_PE7P;_ .B0ZK_X53?_ "-7F5% 'IO_  E7P;_Z)#JO
M_A5-_P#(U'_"5?!O_HD.J_\ A5-_\C5YE10!Z;_PE7P;_P"B0ZK_ .%4W_R-
M1_PE7P;_ .B0ZK_X53?_ "-7F5% 'IO_  E7P;_Z)#JO_A5-_P#(U'_"5?!O
M_HD.J_\ A5-_\C5YE10!Z;_PE7P;_P"B0ZK_ .%4W_R-1_PE7P;_ .B0ZK_X
M53?_ "-7F5% 'IO_  E7P;_Z)#JO_A5-_P#(U'_"5?!O_HD.J_\ A5-_\C5Y
ME10!Z;_PE7P;_P"B0ZK_ .%4W_R-1_PE7P;_ .B0ZK_X53?_ "-7F5% 'IO_
M  E7P;_Z)#JO_A5-_P#(U'_"5?!O_HD.J_\ A5-_\C5YE10!Z;_PE7P;_P"B
M0ZK_ .%4W_R-1_PE7P;_ .B0ZK_X53?_ "-7F5% 'IO_  E7P;_Z)#JO_A5-
M_P#(U'_"5?!O_HD.J_\ A5-_\C5YE10!Z;_PE7P;_P"B0ZK_ .%4W_R-1_PE
M7P;_ .B0ZK_X53?_ "-7F5% 'IO_  E7P;_Z)#JO_A5-_P#(U'_"5?!O_HD.
MJ_\ A5-_\C5YE10!Z;_PE7P;_P"B0ZK_ .%4W_R-1_PE7P;_ .B0ZK_X53?_
M "-7F5% 'IO_  E7P;_Z)#JO_A5-_P#(U'_"5?!O_HD.J_\ A5-_\C5YE10!
MZ;_PE7P;_P"B0ZK_ .%4W_R-1_PE7P;_ .B0ZK_X53?_ "-7F5% 'IO_  E7
MP;_Z)#JO_A5-_P#(U'_"5?!O_HD.J_\ A5-_\C5YE10!Z;_PE7P;_P"B0ZK_
M .%4W_R-1_PE7P;_ .B0ZK_X53?_ "-7F5% 'IO_  E7P;_Z)#JO_A5-_P#(
MU'_"5?!O_HD.J_\ A5-_\C5YE10!Z;_PE7P;_P"B0ZK_ .%4W_R-1_PE7P;_
M .B0ZK_X53?_ "-7F5% 'IO_  E7P;_Z)#JO_A5-_P#(U'_"5?!O_HD.J_\
MA5-_\C5YE10!Z;_PE7P;_P"B0ZK_ .%4W_R-1_PE7P;_ .B0ZK_X53?_ "-7
MF5% 'IO_  E7P;_Z)#JO_A5-_P#(U'_"5?!O_HD.J_\ A5-_\C5YE10!Z;_P
ME7P;_P"B0ZK_ .%4W_R-1_PE7P;_ .B0ZK_X53?_ "-7F5% 'IO_  E7P;_Z
M)#JO_A5-_P#(U'_"5?!O_HD.J_\ A5-_\C5YE10!Z;_PE7P;_P"B0ZK_ .%4
MW_R-1_PE7P;_ .B0ZK_X53?_ "-7F5% 'IO_  E7P;_Z)#JO_A5-_P#(U'_"
M5?!O_HD.J_\ A5-_\C5YE10!Z;_PE7P;_P"B0ZK_ .%4W_R-1_PE7P;_ .B0
MZK_X53?_ "-7F5% 'IO_  E7P;_Z)#JO_A5-_P#(U'_"5?!O_HD.J_\ A5-_
M\C5YE10!Z;_PE7P;_P"B0ZK_ .%4W_R-1_PE7P;_ .B0ZK_X53?_ "-7F5%
M'IO_  E7P;_Z)#JO_A5-_P#(U'_"5?!O_HD.J_\ A5-_\C5YE10!Z;_PE7P;
M_P"B0ZK_ .%4W_R-1_PE7P;_ .B0ZK_X53?_ "-7F5% 'IO_  E7P;_Z)#JO
M_A5-_P#(U'_"5?!O_HD.J_\ A5-_\C5YE10!Z;_PE7P;_P"B0ZK_ .%4W_R-
M1_PE7P;_ .B0ZK_X53?_ "-7F5% 'U_\%?A3\'_C)HNK:G_PA^J:'_9UPD'E
M_P!M-<^9N7=G/EIC]:^A/A_\#? ?PT\17&O>%8;V.]N+5K-S<7)D7RV='/!'
M7*+S7D7[$/\ R)'BW_L(1?\ HNOK*@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH \B_:'TG5-<_9[\4:7H^F76IW\_V7R[6S
MA::63%U"QVHH). "3@= 37Y\?\*G^*7_ $33Q5_X)KG_ .(K[]_:C_Y-D\7?
M]N?_ *60U^9U ':?\*G^*7_1-/%7_@FN?_B*/^%3_%+_ *)IXJ_\$US_ /$5
MQ=% ':?\*G^*7_1-/%7_ ()KG_XBC_A4_P 4O^B:>*O_  37/_Q%<710!VG_
M  J?XI?]$T\5?^":Y_\ B*/^%3_%+_HFGBK_ ,$US_\ $5Q=% ':?\*G^*7_
M $33Q5_X)KG_ .(H_P"%3_%+_HFGBK_P37/_ ,17%T4 =I_PJ?XI?]$T\5?^
M":Y_^(H_X5/\4O\ HFGBK_P37/\ \17%T4 =I_PJ?XI?]$T\5?\ @FN?_B*/
M^%3_ !2_Z)IXJ_\ !-<__$5Q=% ':?\ "I_BE_T33Q5_X)KG_P"(H_X5/\4O
M^B:>*O\ P37/_P 17%T4 =I_PJ?XI?\ 1-/%7_@FN?\ XBC_ (5/\4O^B:>*
MO_!-<_\ Q%<710!VG_"I_BE_T33Q5_X)KG_XBC_A4_Q2_P"B:>*O_!-<_P#Q
M%<710!VG_"I_BE_T33Q5_P"":Y_^(H_X5/\ %+_HFGBK_P $US_\17%T4 =I
M_P *G^*7_1-/%7_@FN?_ (BC_A4_Q2_Z)IXJ_P#!-<__ !%<710!VG_"I_BE
M_P!$T\5?^":Y_P#B*/\ A4_Q2_Z)IXJ_\$US_P#$5Q=% ':?\*G^*7_1-/%7
M_@FN?_B*/^%3_%+_ *)IXJ_\$US_ /$5Q=% ':?\*G^*7_1-/%7_ ()KG_XB
MC_A4_P 4O^B:>*O_  37/_Q%<710!VG_  J?XI?]$T\5?^":Y_\ B*/^%3_%
M+_HFGBK_ ,$US_\ $5Q=% ':?\*G^*7_ $33Q5_X)KG_ .(H_P"%3_%+_HFG
MBK_P37/_ ,17%T4 =I_PJ?XI?]$T\5?^":Y_^(H_X5/\4O\ HFGBK_P37/\
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M'VGX!_\ 0&\?_P#@SLO_ )'H \RHKTW[3\ _^@-X_P#_  9V7_R/1]I^ ?\
MT!O'_P#X,[+_ .1Z /,J*]-^T_ /_H#>/_\ P9V7_P CT?:?@'_T!O'_ /X,
M[+_Y'H \RHKTW[3\ _\ H#>/_P#P9V7_ ,CT?:?@'_T!O'__ (,[+_Y'H \R
MHKTW[3\ _P#H#>/_ /P9V7_R/1]I^ ?_ $!O'_\ X,[+_P"1Z /,J*]-^T_
M/_H#>/\ _P &=E_\CT?:?@'_ - ;Q_\ ^#.R_P#D>@#S*BO3?M/P#_Z WC__
M ,&=E_\ (]'VGX!_] ;Q_P#^#.R_^1Z /,J*]-^T_ /_ * WC_\ \&=E_P#(
M]'VGX!_] ;Q__P"#.R_^1Z /,J*]-^T_ /\ Z WC_P#\&=E_\CT?:?@'_P!
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M7/\ \10!Q=%=I_PJ?XI?]$T\5?\ @FN?_B*/^%3_ !2_Z)IXJ_\ !-<__$4
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M?]$T\5?^":Y_^(H_X5/\4O\ HFGBK_P37/\ \10!Q=%=I_PJ?XI?]$T\5?\
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M ()KG_XBC_A4_P 4O^B:>*O_  37/_Q% '%T5VG_  J?XI?]$T\5?^":Y_\
MB*/^%3_%+_HFGBK_ ,$US_\ $4 <717:?\*G^*7_ $33Q5_X)KG_ .(H_P"%
M3_%+_HFGBK_P37/_ ,10!Q=%=I_PJ?XI?]$T\5?^":Y_^(H_X5/\4O\ HFGB
MK_P37/\ \10!Q==K\*?^2W^ _P#L8+#_ -*4I/\ A4_Q2_Z)IXJ_\$US_P#$
M5V'PW^&?Q&L/BSX,OKWX?^([6VMM:LIIIIM)N$CB1;A"S,Q3   ))/ % 'Z:
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Y%^T/JVJ
M:'^SWXHU31]3NM,OX/LOEW5G,T,L>;J%3M=2",@D'!Z$BOSX_P"%L?%+_HI?
MBK_P<W/_ ,77W[^U'_R;)XN_[<__ $LAK\SJ .T_X6Q\4O\ HI?BK_P<W/\
M\71_PMCXI?\ 12_%7_@YN?\ XNN+HH [3_A;'Q2_Z*7XJ_\ !S<__%T?\+8^
M*7_12_%7_@YN?_BZXNB@#M/^%L?%+_HI?BK_ ,'-S_\ %T?\+8^*7_12_%7_
M (.;G_XNN+HH [3_ (6Q\4O^BE^*O_!S<_\ Q='_  MCXI?]%+\5?^#FY_\
MBZXNB@#M/^%L?%+_ **7XJ_\'-S_ /%T?\+8^*7_ $4OQ5_X.;G_ .+KBZ*
M.T_X6Q\4O^BE^*O_  <W/_Q='_"V/BE_T4OQ5_X.;G_XNN+HH [3_A;'Q2_Z
M*7XJ_P#!S<__ !='_"V/BE_T4OQ5_P"#FY_^+KBZ* .T_P"%L?%+_HI?BK_P
M<W/_ ,71_P +8^*7_12_%7_@YN?_ (NN+HH [3_A;'Q2_P"BE^*O_!S<_P#Q
M='_"V/BE_P!%+\5?^#FY_P#BZXNB@#M/^%L?%+_HI?BK_P '-S_\71_PMCXI
M?]%+\5?^#FY_^+KBZ* .T_X6Q\4O^BE^*O\ P<W/_P 71_PMCXI?]%+\5?\
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M5XS10![-_P *\^!/_1Q7_EHWG_Q5'_"O/@3_ -'%?^6C>?\ Q5>,T4 >S?\
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M>?\ Q5>,T4 >S?\ "O/@3_T<5_Y:-Y_\51_PKSX$_P#1Q7_EHWG_ ,57C-%
M'LW_  KSX$_]'%?^6C>?_%4?\*\^!/\ T<5_Y:-Y_P#%5XS10![-_P *\^!/
M_1Q7_EHWG_Q5'_"O/@3_ -'%?^6C>?\ Q5>,T4 ?IC_PU%\"O^AZ_P#*9>?_
M !FM3P_^T!\)/%'B"RT#0_%GVO4;V3RK>'^S[I-[>FYH@H_$BORZKT[X!?\
M)PO@K_L(+_Z": /U*HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBOB']K/QKXR\-?%O2K'P_XNUK1[1]%AF:"QU"6WC9S<3@L51@"<*HSU
MP!Z4 >[_ +4?_)LGB[_MS_\ 2R&OS.KM+CXF_$:ZMWM;[X@>([JW?&Z*;5KA
MT;!R,@O@\@&L;_A+/%/_ $,VJ_\ @9)_\50!B45M_P#"6>*?^AFU7_P,D_\
MBJ/^$L\4_P#0S:K_ .!DG_Q5 &)16W_PEGBG_H9M5_\  R3_ .*H_P"$L\4_
M]#-JO_@9)_\ %4 8E%;?_"6>*?\ H9M5_P# R3_XJC_A+/%/_0S:K_X&2?\
MQ5 &)16W_P )9XI_Z&;5?_ R3_XJC_A+/%/_ $,VJ_\ @9)_\50!B45M_P#"
M6>*?^AFU7_P,D_\ BJ/^$L\4_P#0S:K_ .!DG_Q5 &)16W_PEGBG_H9M5_\
M R3_ .*H_P"$L\4_]#-JO_@9)_\ %4 8E%;?_"6>*?\ H9M5_P# R3_XJC_A
M+/%/_0S:K_X&2?\ Q5 &)16W_P )9XI_Z&;5?_ R3_XJC_A+/%/_ $,VJ_\
M@9)_\50!B45M_P#"6>*?^AFU7_P,D_\ BJ/^$L\4_P#0S:K_ .!DG_Q5 &)1
M6W_PEGBG_H9M5_\  R3_ .*H_P"$L\4_]#-JO_@9)_\ %4 8E%;?_"6>*?\
MH9M5_P# R3_XJC_A+/%/_0S:K_X&2?\ Q5 &)16W_P )9XI_Z&;5?_ R3_XJ
MC_A+/%/_ $,VJ_\ @9)_\50!B45M_P#"6>*?^AFU7_P,D_\ BJ/^$L\4_P#0
MS:K_ .!DG_Q5 &)16W_PEGBG_H9M5_\  R3_ .*H_P"$L\4_]#-JO_@9)_\
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M3QA:7"7-KXLUB":,Y22*_E5E/J"&R* /UUHK\F_^%L?%+_HI?BK_ ,'-S_\
M%U]Y?LOZUK'B#X'VVIZ]J][JUZU]<(;B]N'GD*AA@;G).!0![E1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 5\ _MJ?\ );=&_P"Q?A_]*;BOOZO@
M']M3_DMNC?\ 8OP_^E-Q0!\RT444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %?HS^R'_P F\VO_ &$+
MG_T(5^<U?HS^R'_R;S:_]A"Y_P#0A0![_1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 5\ _MJ?\EMT;_L7X?_ $IN*^_J^ ?VU/\ DMNC?]B_#_Z4
MW% 'S+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 5^C/[(?\ R;S:_P#80N?_ $(5^<U?HS^R'_R;
MS:_]A"Y_]"% 'O\ 1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\
M_MJ?\EMT;_L7X?\ TIN*^_J^ ?VU/^2VZ-_V+\/_ *4W% 'S+1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5^C/[(?_)O-K_V$+G_ -"%?G-7Z,_LA_\ )O-K_P!A"Y_]"% 'O]%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !7P#^VI_R6W1O^Q?A_]*;B
MOOZOEO\ : _9_P#&7Q6^(MAXB\.ZGH]M:6^EQV3)?S2I(7665R0$B88Q(O?.
M<\4 ?!=%>\>./V9?'GP[\$:CXPUK5M GL+$1^;':7$S2MOD6,;0T*CJXSDCC
M->#T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 445ZU\+_ (%^+OBUI6H:CX;U'2;:&PF6"07\TJ,6*[AMV1OQ
M]<4 >2U^C/[(?_)O-K_V$+G_ -"%> ?\,5_%+_H/^%?_  *N?_C%?57P+\ :
MU\,_AA#X5U^ZLKF]CNIIS)9.[Q[7((Y=5.?PH ]4HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ_\ EW7G_P 31_PL/X$_]&Z_^7=>?_$T >,T5[-_PL/X$_\ 1NO_ )=UY_\
M$T?\+#^!/_1NO_EW7G_Q- 'C-%>S?\+#^!/_ $;K_P"7=>?_ !-'_"P_@3_T
M;K_Y=UY_\30!XS17LW_"P_@3_P!&Z_\ EW7G_P 31_PL/X$_]&Z_^7=>?_$T
M >,T5[-_PL/X$_\ 1NO_ )=UY_\ $T?\+#^!/_1NO_EW7G_Q- 'C-%>S?\+#
M^!/_ $;K_P"7=>?_ !-'_"P_@3_T;K_Y=UY_\30!XS17LW_"P_@3_P!&Z_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7/\ \10!Q=%=I_PJ?XI?]$T\5?\ @FN?_B*/^%3_ !2_Z)IXJ_\ !-<__$4
M<717:?\ "I_BE_T33Q5_X)KG_P"(H_X5/\4O^B:>*O\ P37/_P 10!Q=%=I_
MPJ?XI?\ 1-/%7_@FN?\ XBC_ (5/\4O^B:>*O_!-<_\ Q% '%T5VG_"I_BE_
MT33Q5_X)KG_XBC_A4_Q2_P"B:>*O_!-<_P#Q% '%T5VG_"I_BE_T33Q5_P""
M:Y_^(H_X5/\ %+_HFGBK_P $US_\10!Q=%=I_P *G^*7_1-/%7_@FN?_ (BC
M_A4_Q2_Z)IXJ_P#!-<__ !% '%T5VG_"I_BE_P!$T\5?^":Y_P#B*/\ A4_Q
M2_Z)IXJ_\$US_P#$4 <717:?\*G^*7_1-/%7_@FN?_B*/^%3_%+_ *)IXJ_\
M$US_ /$4 <717:?\*G^*7_1-/%7_ ()KG_XBC_A4_P 4O^B:>*O_  37/_Q%
M '%T5VG_  J?XI?]$T\5?^":Y_\ B*/^%3_%+_HFGBK_ ,$US_\ $4 <717:
M?\*G^*7_ $33Q5_X)KG_ .(H_P"%3_%+_HFGBK_P37/_ ,10!Q=%=I_PJ?XI
M?]$T\5?^":Y_^(H_X5/\4O\ HFGBK_P37/\ \10!Q=%=I_PJ?XI?]$T\5?\
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M_P""RR_^2*\RHH ]-^S? /\ Z#/C_P#\%EE_\D4?9O@'_P!!GQ__ ."RR_\
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M'_T&?'__ (+++_Y(KS*B@#TW[-\ _P#H,^/_ /P667_R11]F^ ?_ $&?'_\
MX+++_P"2*\RHH ]-^S? /_H,^/\ _P %EE_\D4?9O@'_ -!GQ_\ ^"RR_P#D
MBO,J* /3?LWP#_Z#/C__ ,%EE_\ )%'V;X!_]!GQ_P#^"RR_^2*\RHH ]-^S
M? /_ *#/C_\ \%EE_P#)%'V;X!_]!GQ__P""RR_^2*\RHH ]-^S? /\ Z#/C
M_P#\%EE_\D4?9O@'_P!!GQ__ ."RR_\ DBO,J* /3?LWP#_Z#/C_ /\ !99?
M_)%'V;X!_P#09\?_ /@LLO\ Y(KS*B@#TW[-\ _^@SX__P#!99?_ "11]F^
M?_09\?\ _@LLO_DBO,J* /3?LWP#_P"@SX__ /!99?\ R11]F^ ?_09\?_\
M@LLO_DBO,J* /3?LWP#_ .@SX_\ _!99?_)%?0WP[_:8^$?PX^'FE^#+/3_%
M]];Z?YNV>:SM59_,E>0Y GQP7(_"OBRB@#[_ /\ AM7X6_\ 0 \5?^ MM_\
M'Z/^&U?A;_T /%7_ ("VW_Q^O@"B@#[_ /\ AM7X6_\ 0 \5?^ MM_\ 'Z/^
M&U?A;_T /%7_ ("VW_Q^O@"B@#]??#NM6OB3PUI7B*QCFBM=5M(;V%)@ X21
M ZA@"0#AAG!(SW-;=<7\*?\ DB'@/_L7[#_TF2NTH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@#QC]J/\ Y-D\7?\ ;G_Z60U^9U?HQ^U7
MXH\1^%?@[9W/AW6[K2+F\U>&UEN+.0QRF+RII-JN/F7+1IDJ02 1T)!^&_\
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M_P"#FY_^+H_X6Q\4O^BE^*O_  <W/_Q= '%T5VG_  MCXI?]%+\5?^#FY_\
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M9H \8HKV?_AJ/XZ_]#U_Y3+/_P",T?\ #4?QU_Z'K_RF6?\ \9H \8HKV?\
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M9H \8HKV?_AJ/XZ_]#U_Y3+/_P",T?\ #4?QU_Z'K_RF6?\ \9H \8HKV?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% 'U?^Q*KGQ[XJ<280:;&"F.I,HP?PP?SK[IKX:_8
MB_Y'CQ9_V#XO_1E?<M !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 ?,O[:O_)$=&_[&"'_TFN*^ :^_OVU?^2(Z-_V,$/\ Z37%? - !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% 'UG^Q%_R/'BS_L'Q?^C*^Y:^&OV(O^1X\6?]@^+_ -&5]RT %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\R_MJ_P#)$=&_[&"'
M_P!)KBO@&OO[]M7_ )(CHW_8P0_^DUQ7P#0 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/P__ /!M!_\ '*/^$:_9(_Y^?A__ .#:#_XY7YST4 ?HQ_PC7[)'_/S\/_\
MP;0?_'*/^$:_9(_Y^?A__P"#:#_XY7YST4 ?HQ_PC7[)'_/S\/\ _P &T'_Q
MRC_A&OV2/^?GX?\ _@V@_P#CE?G/10!^C'_"-?LD?\_/P_\ _!M!_P#'*YRZ
M\"_LXR>-;?5H/&'P_AT6* PR:0;F!A*203(9?M (<8P., $\$G-?!5% 'Z,?
M\(U^R1_S\_#_ /\ !M!_\<H_X1K]DC_GY^'_ /X-H/\ XY7YST4 ?HQ_PC7[
M)'_/S\/_ /P;0?\ QRC_ (1K]DC_ )^?A_\ ^#:#_P".5^<]% 'Z,?\ "-?L
MD?\ /S\/_P#P;0?_ !RC_A&OV2/^?GX?_P#@V@_^.5^<]% 'Z,?\(U^R1_S\
M_#__ ,&T'_QRC_A&OV2/^?GX?_\ @V@_^.5^<]% 'Z,?\(U^R1_S\_#_ /\
M!M!_\<H_X1K]DC_GY^'_ /X-H/\ XY7YST4 ?HQ_PC7[)'_/S\/_ /P;0?\
MQRO)OC#\+_A+XF_L,_"WQQ\-_#OV?S_M_P!HUU(_/W>7Y>-N_.-LG7'WN_;Y
M HH ]G_X4%_U6GX5?^%'_P#:Z/\ A07_ %6GX5?^%'_]KKQBB@#V?_A07_5:
M?A5_X4?_ -KH_P"%!?\ 5:?A5_X4?_VNO&** /9_^%!?]5I^%7_A1_\ VNC_
M (4%_P!5I^%7_A1__:Z\8HH ]G_X4%_U6GX5?^%'_P#:Z/\ A07_ %6GX5?^
M%'_]KKQBB@#V?_A07_5:?A5_X4?_ -KH_P"%!?\ 5:?A5_X4?_VNO&** /9_
M^%!?]5I^%7_A1_\ VNC_ (4%_P!5I^%7_A1__:Z\8HH ]G_X4%_U6GX5?^%'
M_P#:Z/\ A07_ %6GX5?^%'_]KKQBB@#V?_A07_5:?A5_X4?_ -KH_P"%!?\
M5:?A5_X4?_VNO&** /9_^%!?]5I^%7_A1_\ VNC_ (4%_P!5I^%7_A1__:Z\
M8HH ]G_X4%_U6GX5?^%'_P#:Z/\ A07_ %6GX5?^%'_]KKQBB@#V?_A07_5:
M?A5_X4?_ -KH_P"%!?\ 5:?A5_X4?_VNO&** /9_^%!?]5I^%7_A1_\ VNC_
M (4%_P!5I^%7_A1__:Z\8HH ]G_X4%_U6GX5?^%'_P#:Z/\ A07_ %6GX5?^
M%'_]KKQBB@#V?_A07_5:?A5_X4?_ -KH_P"%!?\ 5:?A5_X4?_VNO&** /9_
M^%!?]5I^%7_A1_\ VNC_ (4%_P!5I^%7_A1__:Z\8HH ]G_X4%_U6GX5?^%'
M_P#:Z/\ A07_ %6GX5?^%'_]KKQBB@#V?_A07_5:?A5_X4?_ -KH_P"%!?\
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M /\  *Z_^2: /,**]/\ ^%L:?_T1_P"'_P#X!77_ ,DT?\+8T_\ Z(_\/_\
MP"NO_DF@#S"BO3_^%L:?_P!$?^'_ /X!77_R31_PMC3_ /HC_P /_P#P"NO_
M ))H \PHKT__ (6QI_\ T1_X?_\ @%=?_)-'_"V-/_Z(_P##_P#\ KK_ .2:
M /,**]/_ .%L:?\ ]$?^'_\ X!77_P DT?\ "V-/_P"B/_#_ /\  *Z_^2:
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M?_\ @%=?_)-'_"V-/_Z(_P##_P#\ KK_ .2: /,**]/_ .%L:?\ ]$?^'_\
MX!77_P DT?\ "V-/_P"B/_#_ /\  *Z_^2: /,**]/\ ^%L:?_T1_P"'_P#X
M!77_ ,DT?\+8T_\ Z(_\/_\ P"NO_DF@#S"BO3_^%L:?_P!$?^'_ /X!77_R
M31_PMC3_ /HC_P /_P#P"NO_ ))H \PHKT__ (6QI_\ T1_X?_\ @%=?_)-'
M_"V-/_Z(_P##_P#\ KK_ .2: /,**]/_ .%L:?\ ]$?^'_\ X!77_P DT?\
M"V-/_P"B/_#_ /\  *Z_^2: /,**]/\ ^%L:?_T1_P"'_P#X!77_ ,DT?\+8
MT_\ Z(_\/_\ P"NO_DF@#S"BO3_^%L:?_P!$?^'_ /X!77_R31_PMC3_ /HC
M_P /_P#P"NO_ ))H \PHKT__ (6QI_\ T1_X?_\ @%=?_)-'_"V-/_Z(_P##
M_P#\ KK_ .2: /,**]/_ .%L:?\ ]$?^'_\ X!77_P DT?\ "V-/_P"B/_#_
M /\  *Z_^2: /,**]/\ ^%L:?_T1_P"'_P#X!77_ ,DT?\+8T_\ Z(_\/_\
MP"NO_DF@#S"BO3_^%L:?_P!$?^'_ /X!77_R31_PMC3_ /HC_P /_P#P"NO_
M ))H \PHKT__ (6QI_\ T1_X?_\ @%=?_)-'_"V-/_Z(_P##_P#\ KK_ .2:
M /,**]/_ .%L:?\ ]$?^'_\ X!77_P DT?\ "V-/_P"B/_#_ /\  *Z_^2:
M/,**]/\ ^%L:?_T1_P"'_P#X!77_ ,DT?\+8T_\ Z(_\/_\ P"NO_DF@#S"B
MO3_^%L:?_P!$?^'_ /X!77_R31_PMC3_ /HC_P /_P#P"NO_ ))H \PHKT__
M (6QI_\ T1_X?_\ @%=?_)-'_"V-/_Z(_P##_P#\ KK_ .2: /,**]/_ .%L
M:?\ ]$?^'_\ X!77_P DT?\ "V-/_P"B/_#_ /\  *Z_^2: /,**]/\ ^%L:
M?_T1_P"'_P#X!77_ ,DT?\+8T_\ Z(_\/_\ P"NO_DF@#S"BO3_^%L:?_P!$
M?^'_ /X!77_R31_PMC3_ /HC_P /_P#P"NO_ ))H \PHKT__ (6QI_\ T1_X
M?_\ @%=?_)-'_"V-/_Z(_P##_P#\ KK_ .2: /,**]/_ .%L:?\ ]$?^'_\
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M3W5?^^%_QH_X4#\9/^B>ZK_WPO\ C0!YC17IW_"@?C)_T3W5?^^%_P :/^%
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M?C)_T3W5?^^%_P :/^% _&3_ *)[JO\ WPO^- 'F-%>G?\*!^,G_ $3W5?\
MOA?\:/\ A0/QD_Z)[JO_ 'PO^- 'F-%>G?\ "@?C)_T3W5?^^%_QH_X4#\9/
M^B>ZK_WPO^- 'F-%>G?\*!^,G_1/=5_[X7_&C_A0/QD_Z)[JO_?"_P"- 'F-
M%>G?\*!^,G_1/=5_[X7_ !H_X4#\9/\ HGNJ_P#?"_XT >8T5Z=_PH'XR?\
M1/=5_P"^%_QH_P"% _&3_HGNJ_\ ?"_XT >8T5Z=_P *!^,G_1/=5_[X7_&C
M_A0/QD_Z)[JO_?"_XT >8T5Z=_PH'XR?]$]U7_OA?\:/^% _&3_HGNJ_]\+_
M (T >8T5Z=_PH'XR?]$]U7_OA?\ &C_A0/QD_P"B>ZK_ -\+_C0!YC17IW_"
M@?C)_P!$]U7_ +X7_&C_ (4#\9/^B>ZK_P!\+_C0!YC17IW_  H'XR?]$]U7
M_OA?\:/^% _&3_HGNJ_]\+_C0!YC7Z8_LN?\FR>$?^WS_P!+)J^'/^% _&3_
M *)[JO\ WPO^-?>W[/N@ZQX9^ GAK0]>T^73]2MOM/G6\PPZ;KJ5US]58'\:
M /5**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \8_:C
M_P"39/%W_;G_ .ED-?F=7Z8_M1_\FR>+O^W/_P!+(:_,Z@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P#0?\5?^!5M_P#&*/\ ABKX6_\ 0?\ %7_@5;?_ !BOIFB@#YF_X8J^%O\
MT'_%7_@5;?\ QBC_ (8J^%O_ $'_ !5_X%6W_P 8KZ9HH ^9O^&*OA;_ -!_
MQ5_X%6W_ ,8H_P"&*OA;_P!!_P 5?^!5M_\ &*^F:* /F;_ABKX6_P#0?\5?
M^!5M_P#&*/\ ABKX6_\ 0?\ %7_@5;?_ !BOIFB@#YF_X8J^%O\ T'_%7_@5
M;?\ QBC_ (8J^%O_ $'_ !5_X%6W_P 8KZ9HH ^9O^&*OA;_ -!_Q5_X%6W_
M ,8H_P"&*OA;_P!!_P 5?^!5M_\ &*^F:* /F;_ABKX6_P#0?\5?^!5M_P#&
M*/\ ABKX6_\ 0?\ %7_@5;?_ !BOIFB@#YF_X8J^%O\ T'_%7_@5;?\ QBC_
M (8K^%O_ $'O%7_@5;?_ !BOIFB@#Y,\3_LH_#'POX9OM>>X\:ZE!91---#9
MW5CY@C499AYD:*< $XSGT!/%8.C?L\_"'5-;TS1]2C^(&@7>KP-<:<-1GL"E
MXJJ'8(\"2*&"G.UBIQVKZ=^)5U;V?PH\5R75Q'"ATJZ0-(P4%C"P Y[DUP.@
MZ!>W.B:-\0_$/BY=<L=!T21M/L]#L?($;-!MDDW>;(9)=F5&"H!["E>R;[!U
M2[G+_P##%?PM_P"@_P"*O_ JV_\ C%'_  Q7\+?^@_XJ_P# JV_^,56T^>PT
MF'Q2NBZI::!9W_@=;^.326$D_G+YN9Y&4IYUSCEF 4\]>]6O#XL[70=?U'P1
MXE\/-JD7A9@-(\-:R+EY[Q4)>[>)0H\WD ,0Q+$9/2GLKBO=V#_ABOX6_P#0
M?\5?^!5M_P#&*Y?Q1^S'\+?#,EM;0IX_\07MP&?[)H[V<LD<8P#(^^-%"Y(
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M_BK_ ,"K;_XQ1_PQ5\+?^@_XJ_\  JV_^,5],T4 ?,W_  Q5\+?^@_XJ_P#
MJV_^,4?\,5?"W_H/^*O_  *MO_C%?3-% 'S-_P ,5?"W_H/^*O\ P*MO_C%'
M_#%7PM_Z#_BK_P "K;_XQ7TS10!\S?\ #%7PM_Z#_BK_ ,"K;_XQ1_PQ5\+?
M^@_XJ_\  JV_^,5],T4 ?,W_  Q5\+?^@_XJ_P# JV_^,4?\,5?"W_H/^*O_
M  *MO_C%?3-% 'S-_P ,5?"W_H/^*O\ P*MO_C%'_#%7PM_Z#_BK_P "K;_X
MQ7TS10!\S?\ #%7PM_Z#_BK_ ,"K;_XQ1_PQ5\+?^@_XJ_\  JV_^,5],T4
M?,W_  Q5\+?^@_XJ_P# JV_^,4?\,5?"W_H/^*O_  *MO_C%?3-% 'S-_P ,
M5?"W_H/^*O\ P*MO_C%'_#%7PM_Z#_BK_P "K;_XQ7TS10!\S?\ #%7PM_Z#
M_BK_ ,"K;_XQ1_PQ5\+?^@_XJ_\  JV_^,5],T4 ?,W_  Q5\+?^@_XJ_P#
MJV_^,4?\,5?"W_H/^*O_  *MO_C%?3-% 'S-_P ,5?"W_H/^*O\ P*MO_C%'
M_#%7PM_Z#_BK_P "K;_XQ7TS10!\S?\ #%7PM_Z#_BK_ ,"K;_XQ1_PQ5\+?
M^@_XJ_\  JV_^,5],T4 ?,W_  Q5\+?^@_XJ_P# JV_^,4?\,5?"W_H/^*O_
M  *MO_C%?3-% 'S-_P ,5?"W_H/^*O\ P*MO_C%'_#%7PM_Z#_BK_P "K;_X
MQ7TS10!\S?\ #%7PM_Z#_BK_ ,"K;_XQ1_PQ5\+?^@_XJ_\  JV_^,5],T4
M?,W_  Q5\+?^@_XJ_P# JV_^,5[]X=T6U\-^&M*\.V,DTMKI5I#90O,07*1H
M$4L0 "<*,X &>PK;HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'VK@A53H>H)Z' ]F[4E+K?J'D>,Q_"/Q5;^'M,BTWXC#2O$.EW-U);ZM8Z2
MK07$OFRP2PR2NL@\S!!R,;1P3DG5F^'OB3_A/-&\50^-(9Y])TZ>Q47^F&9Y
MWFY:5VCFC7[X4A%10%!4=01ZE11I8=SQ[PK\)=6\,WOA*ZD\8073^'8[NU_=
MZ:8A<V\[JY0YF;:X=?OC.0<;01NKV'BCBEIMM[DI6"BBB@84444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
0 !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>ltbr_ex32img3.jpg
<TEXT>
begin 644 ltbr_ex32img3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" 2D Y8# 2(  A$! Q$!_\0
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M#U_Y3+/_ .,T ?IC17YG?\-1_'7_ *'K_P IEG_\9H_X:C^.O_0]?^4RS_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1/+GCD.0.>0A'XU\K_\ #$/BK_H=]*_\!Y*H1\F45]9_\,0^*O\ H=]*_P#
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MZ[;_ &I84%U)'+*!\[QQE%)]E))'YFK5%)*Q;=PHHHIB"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^&HO@5_T/7_E,O/_ (S1_P -1? K_H>O_*9>?_&: /9Z*\8_X:B^!7_0]?\
ME,O/_C-'_#47P*_Z'K_RF7G_ ,9H ]GHKQC_ (:B^!7_ $/7_E,O/_C-'_#4
M7P*_Z'K_ ,IEY_\ &: /9Z*\8_X:B^!7_0]?^4R\_P#C-'_#47P*_P"AZ_\
M*9>?_&: /9Z*\8_X:B^!7_0]?^4R\_\ C-'_  U%\"O^AZ_\IEY_\9H ]GHK
MQC_AJ+X%?]#U_P"4R\_^,T?\-1? K_H>O_*9>?\ QF@#V>BO&/\ AJ+X%?\
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M'K_RF7G_ ,9H ]GHKQC_ (:B^!7_ $/7_E,O/_C-'_#47P*_Z'K_ ,IEY_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% 'C'[4?_)LGB[_MS_\ 2R&OS.K],?VH_P#D
MV3Q=_P!N?_I9#7YG4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% 'W]^Q5_R1'6?^Q@F_])K>OIJOF7]BK_DB.L_]C!-_
MZ36]?35 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M *'K_P IEG_\9KQBB@#V?_AJ/XZ_]#U_Y3+/_P",T?\ #4?QU_Z'K_RF6?\
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M8/A__P"!MU_\C5YA10!Z?_PJ?3_^BP?#_P#\#;K_ .1J/^%3Z?\ ]%@^'_\
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MI]/_ .BP?#__ ,#;K_Y&H_X5/I__ $6#X?\ _@;=?_(U>844 >G_ /"I]/\
M^BP?#_\ \#;K_P"1J/\ A4^G_P#18/A__P"!MU_\C5YA10!Z?_PJ?3_^BP?#
M_P#\#;K_ .1J/^%3Z?\ ]%@^'_\ X&W7_P C5YA10!Z?_P *GT__ *+!\/\
M_P #;K_Y&H_X5/I__18/A_\ ^!MU_P#(U>844 >G_P#"I]/_ .BP?#__ ,#;
MK_Y&H_X5/I__ $6#X?\ _@;=?_(U>844 >G_ /"I]/\ ^BP?#_\ \#;K_P"1
MJ/\ A4^G_P#18/A__P"!MU_\C5YA10!Z?_PJ?3_^BP?#_P#\#;K_ .1J/^%3
MZ?\ ]%@^'_\ X&W7_P C5YA10!Z?_P *GT__ *+!\/\ _P #;K_Y&H_X5/I_
M_18/A_\ ^!MU_P#(U>844 >G_P#"I]/_ .BP?#__ ,#;K_Y&H_X5/I__ $6#
MX?\ _@;=?_(U>844 >G_ /"I]/\ ^BP?#_\ \#;K_P"1J/\ A4^G_P#18/A_
M_P"!MU_\C5YA10!Z?_PJ?3_^BP?#_P#\#;K_ .1J/^%3Z?\ ]%@^'_\ X&W7
M_P C5YA10!Z?_P *GT__ *+!\/\ _P #;K_Y&H_X5/I__18/A_\ ^!MU_P#(
MU>844 >G_P#"I]/_ .BP?#__ ,#;K_Y&H_X5/I__ $6#X?\ _@;=?_(U>844
M >G_ /"I]/\ ^BP?#_\ \#;K_P"1J/\ A4^G_P#18/A__P"!MU_\C5YA10!Z
M?_PJ?3_^BP?#_P#\#;K_ .1J/^%3Z?\ ]%@^'_\ X&W7_P C5YA10!Z?_P *
MGT__ *+!\/\ _P #;K_Y&H_X5/I__18/A_\ ^!MU_P#(U>844 >G_P#"I]/_
M .BP?#__ ,#;K_Y&H_X5/I__ $6#X?\ _@;=?_(U>844 >G_ /"I]/\ ^BP?
M#_\ \#;K_P"1J/\ A4^G_P#18/A__P"!MU_\C5YA10!Z?_PJ?3_^BP?#_P#\
M#;K_ .1J/^%3Z?\ ]%@^'_\ X&W7_P C5YA10!Z?_P *GT__ *+!\/\ _P #
M;K_Y&H_X5/I__18/A_\ ^!MU_P#(U>844 ?K'\,4MX?A)X1M;74+?48K72;6
MV^U6C%H9C'$J,R%@"5)4XR ?85VM>9? /_DWOP5_V#U_]"->FT %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\)EX=_Z)/X5_\"=5_P#DVC_A,O#O_1)_"O\ X$ZK_P#)M '&45V?_"9>'?\
MHD_A7_P)U7_Y-H_X3+P[_P!$G\*_^!.J_P#R;0!QE%=G_P )EX=_Z)/X5_\
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MD_A7_P "=5_^3:/^$R\._P#1)_"O_@3JO_R;0!QE%=G_ ,)EX=_Z)/X5_P#
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MSX%_]"-_Y4[S_P"/4 ?F=17Z8_\ #+GP+_Z$;_RIWG_QZC_AESX%_P#0C?\
ME3O/_CU 'YG45^F/_#+GP+_Z$;_RIWG_ ,>H_P"&7/@7_P!"-_Y4[S_X]0!^
M9U%?IC_PRY\"_P#H1O\ RIWG_P >H_X9<^!?_0C?^5.\_P#CU &U\ _^3>_!
M7_8/7_T(UZ;6-H/A_2?"^@67A_0[7[)IMC'Y5O!YC/L7TW,2QZ]R:V: "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@#QBBO9_^&7/CK_T(O\ Y4[/_P"/4?\ #+GQU_Z$7_RIV?\ \>H \8HKV?\
MX9<^.O\ T(O_ )4[/_X]1_PRY\=?^A%_\J=G_P#'J /&**]G_P"&7/CK_P!"
M+_Y4[/\ ^/4?\,N?'7_H1?\ RIV?_P >H \8HKV?_AESXZ_]"+_Y4[/_ ./4
M?\,N?'7_ *$7_P J=G_\>H \8HKV?_AESXZ_]"+_ .5.S_\ CU'_  RY\=?^
MA%_\J=G_ /'J /&**]G_ .&7/CK_ -"+_P"5.S_^/4?\,N?'7_H1?_*G9_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M>,?M1_\ )LGB[_MS_P#2R&OS.K],?VH_^39/%W_;G_Z60U^9U !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M2'5?_"J;_P"1J/\ A*O@W_T2'5?_  JF_P#D:O,J* /3?^$J^#?_ $2'5?\
MPJF_^1J/^$J^#?\ T2'5?_"J;_Y&KS*B@#TW_A*O@W_T2'5?_"J;_P"1J/\
MA*O@W_T2'5?_  JF_P#D:O,J* /3?^$J^#?_ $2'5?\ PJF_^1J/^$J^#?\
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MZ)IXJ_\ !-<__$5Q=% ':?\ "I_BE_T33Q5_X)KG_P"(H_X5/\4O^B:>*O\
MP37/_P 17%T4 =I_PJ?XI?\ 1-/%7_@FN?\ XBC_ (5/\4O^B:>*O_!-<_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!XQ^U'_P FR>+O^W/_ -+(:_,ZOT\_:*BTR7]GOQ/'K5Y=V5@?
MLOFSV=LMQ*G^E0XVQM)&&R< Y<8!)YQ@_GO_ &?\+/\ H<O%7_A,VW_R?0!Q
M=%=I_9_PL_Z'+Q5_X3-M_P#)]']G_"S_ *'+Q5_X3-M_\GT <717:?V?\+/^
MAR\5?^$S;?\ R?1_9_PL_P"AR\5?^$S;?_)] '%T5VG]G_"S_H<O%7_A,VW_
M ,GT?V?\+/\ H<O%7_A,VW_R?0!Q=%=I_9_PL_Z'+Q5_X3-M_P#)]']G_"S_
M *'+Q5_X3-M_\GT <717:?V?\+/^AR\5?^$S;?\ R?1_9_PL_P"AR\5?^$S;
M?_)] '%T5VG]G_"S_H<O%7_A,VW_ ,GT?V?\+/\ H<O%7_A,VW_R?0!Q=%=I
M_9_PL_Z'+Q5_X3-M_P#)]']G_"S_ *'+Q5_X3-M_\GT <717:?V?\+/^AR\5
M?^$S;?\ R?1_9_PL_P"AR\5?^$S;?_)] '%T5VG]G_"S_H<O%7_A,VW_ ,GT
M?V?\+/\ H<O%7_A,VW_R?0!Q=%=I_9_PL_Z'+Q5_X3-M_P#)]']G_"S_ *'+
MQ5_X3-M_\GT <717:?V?\+/^AR\5?^$S;?\ R?1_9_PL_P"AR\5?^$S;?_)]
M '%T5VG]G_"S_H<O%7_A,VW_ ,GT?V?\+/\ H<O%7_A,VW_R?0!Q=%=I_9_P
ML_Z'+Q5_X3-M_P#)]']G_"S_ *'+Q5_X3-M_\GT <717:?V?\+/^AR\5?^$S
M;?\ R?1_9_PL_P"AR\5?^$S;?_)] '%T5VG]G_"S_H<O%7_A,VW_ ,GT?V?\
M+/\ H<O%7_A,VW_R?0!Q=%=I_9_PL_Z'+Q5_X3-M_P#)]']G_"S_ *'+Q5_X
M3-M_\GT <717:?V?\+/^AR\5?^$S;?\ R?1_9_PL_P"AR\5?^$S;?_)] '%T
M5VG]G_"S_H<O%7_A,VW_ ,GT?V?\+/\ H<O%7_A,VW_R?0!Q=%=I_9_PL_Z'
M+Q5_X3-M_P#)]']G_"S_ *'+Q5_X3-M_\GT <717:?V?\+/^AR\5?^$S;?\
MR?1_9_PL_P"AR\5?^$S;?_)] '%T5VG]G_"S_H<O%7_A,VW_ ,GT?V?\+/\
MH<O%7_A,VW_R?0!Q=%=I_9_PL_Z'+Q5_X3-M_P#)]']G_"S_ *'+Q5_X3-M_
M\GT <717:?V?\+/^AR\5?^$S;?\ R?1_9_PL_P"AR\5?^$S;?_)] '%T5VG]
MG_"S_H<O%7_A,VW_ ,GT?V?\+/\ H<O%7_A,VW_R?0!Q=%=I_9_PL_Z'+Q5_
MX3-M_P#)]']G_"S_ *'+Q5_X3-M_\GT <717:?V?\+/^AR\5?^$S;?\ R?1_
M9_PL_P"AR\5?^$S;?_)] '%T5VG]G_"S_H<O%7_A,VW_ ,GT?V?\+/\ H<O%
M7_A,VW_R?0!Q=%=I_9_PL_Z'+Q5_X3-M_P#)]']G_"S_ *'+Q5_X3-M_\GT
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M\+?^@!XJ_P# 6V_^/T ?3-%?,W_#:OPM_P"@!XJ_\!;;_P"/T?\ #:OPM_Z
M'BK_ ,!;;_X_0!],T5\S?\-J_"W_ * 'BK_P%MO_ (_1_P -J_"W_H >*O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%_?&3_HH6J_]]K_A7F-% 'IW_"_OC)_T4+5?^^U_PH_X7]\9/^BA:K_WVO\
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M9/\ HH6J_P#?:_X5YC10!Z=_PO[XR?\ 10M5_P"^U_PH_P"%_?&3_HH6J_\
M?:_X5YC10!Z=_P +^^,G_10M5_[[7_"C_A?WQD_Z*%JO_?:_X5YC10!Z=_PO
M[XR?]%"U7_OM?\*/^%_?&3_HH6J_]]K_ (5YC10!Z=_PO[XR?]%"U7_OM?\
M"C_A?WQD_P"BA:K_ -]K_A7F-% 'IW_"_OC)_P!%"U7_ +[7_"C_ (7]\9/^
MBA:K_P!]K_A7F-% 'IW_  O[XR?]%"U7_OM?\*/^%_?&3_HH6J_]]K_A7F-%
M 'IW_"_OC)_T4+5?^^U_PH_X7]\9/^BA:K_WVO\ A7F-% 'IW_"_OC)_T4+5
M?^^U_P */^%_?&3_ **%JO\ WVO^%>8T4 >G?\+^^,G_ $4+5?\ OM?\*/\
MA?WQD_Z*%JO_ 'VO^%>8T4 >G?\ "_OC)_T4+5?^^U_PH_X7]\9/^BA:K_WV
MO^%>8T4 >G?\+^^,G_10M5_[[7_"C_A?WQD_Z*%JO_?:_P"%>8T4 >G?\+^^
M,G_10M5_[[7_  H_X7]\9/\ HH6J_P#?:_X5YC10!Z=_PO[XR?\ 10M5_P"^
MU_PH_P"%_?&3_HH6J_\ ?:_X5YC10!^HG[/NO:QXF^ GAK7->U"74-2N?M/G
M7$QR[[;J5%S]%4#\*]4KQC]ES_DV3PC_ -OG_I9-7L] !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'E_QXT_0
M]4^!WB#3_$GB'_A'-)E^S>?J7V-[OR,7,17]TA#-E@J\=-V>U?#O_"O/@3_T
M<5_Y:-Y_\57V7^U'_P FR>+O^W/_ -+(:_,Z@#V;_A7GP)_Z.*_\M&\_^*H_
MX5Y\"?\ HXK_ ,M&\_\ BJ\9HH ]F_X5Y\"?^CBO_+1O/_BJ/^%>? G_ *.*
M_P#+1O/_ (JO&:* /9O^%>? G_HXK_RT;S_XJC_A7GP)_P"CBO\ RT;S_P"*
MKQFB@#V;_A7GP)_Z.*_\M&\_^*H_X5Y\"?\ HXK_ ,M&\_\ BJ\9HH ]F_X5
MY\"?^CBO_+1O/_BJ/^%>? G_ *.*_P#+1O/_ (JO&:* /9O^%>? G_HXK_RT
M;S_XJC_A7GP)_P"CBO\ RT;S_P"*KQFB@#V;_A7GP)_Z.*_\M&\_^*H_X5Y\
M"?\ HXK_ ,M&\_\ BJ\9HH ]F_X5Y\"?^CBO_+1O/_BJ/^%>? G_ *.*_P#+
M1O/_ (JO&:* /9O^%>? G_HXK_RT;S_XJC_A7GP)_P"CBO\ RT;S_P"*KQFB
M@#V;_A7GP)_Z.*_\M&\_^*H_X5Y\"?\ HXK_ ,M&\_\ BJ\9HH ]F_X5Y\"?
M^CBO_+1O/_BJ/^%>? G_ *.*_P#+1O/_ (JO&:* /9O^%>? G_HXK_RT;S_X
MJC_A7GP)_P"CBO\ RT;S_P"*KQFB@#V;_A7GP)_Z.*_\M&\_^*H_X5Y\"?\
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M\_\ BJ\9HH ]F_X5Y\"?^CBO_+1O/_BJ/^%>? G_ *.*_P#+1O/_ (JO&:*
M/9O^%>? G_HXK_RT;S_XJC_A7GP)_P"CBO\ RT;S_P"*KQFB@#V;_A7GP)_Z
M.*_\M&\_^*H_X5Y\"?\ HXK_ ,M&\_\ BJ\9HH ]F_X5Y\"?^CBO_+1O/_BJ
M/^%>? G_ *.*_P#+1O/_ (JO&:* /9O^%>? G_HXK_RT;S_XJC_A7GP)_P"C
MBO\ RT;S_P"*KQFB@#V;_A7GP)_Z.*_\M&\_^*H_X5Y\"?\ HXK_ ,M&\_\
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MG/\ [91_POW_ *HM\*O_  G/_ME 'C%%>S_\+]_ZHM\*O_"<_P#ME'_"_?\
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MG/\ [91_POW_ *HM\*O_  G/_ME 'C%%>S_\+]_ZHM\*O_"<_P#ME'_"_?\
MJBWPJ_\ "<_^V4 >,45[/_POW_JBWPJ_\)S_ .V4?\+]_P"J+?"K_P )S_[9
M0!XQ17L__"_?^J+?"K_PG/\ [91_POW_ *HM\*O_  G/_ME 'C%%>S_\+]_Z
MHM\*O_"<_P#ME'_"_?\ JBWPJ_\ "<_^V4 >,45[/_POW_JBWPJ_\)S_ .V4
M?\+]_P"J+?"K_P )S_[90!XQ17L__"_?^J+?"K_PG/\ [91_POW_ *HM\*O_
M  G/_ME 'C%%>S_\+]_ZHM\*O_"<_P#ME'_"_?\ JBWPJ_\ "<_^V4 >,45[
M/_POW_JBWPJ_\)S_ .V4?\+]_P"J+?"K_P )S_[90!XQ17L__"_?^J+?"K_P
MG/\ [91_POW_ *HM\*O_  G/_ME 'C%%>S_\+]_ZHM\*O_"<_P#ME'_"_?\
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M ,^6E?\ @>O^% 'S_17T!_PR'\9?^?+2O_ ]?\*/^&0_C+_SY:5_X'K_ (4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBOAGXZ?'7XJ>"_CCXB\,^&?%1L-)
MM/LWDV_V&VDV;[:)V^9XRQRS,>3WH ^YJ*_,[_AJ/XZ_]#U_Y3+/_P",T?\
M#4?QU_Z'K_RF6?\ \9H _3&BOS._X:C^.O\ T/7_ )3+/_XS1_PU'\=?^AZ_
M\IEG_P#&: /TQHK\SO\ AJ/XZ_\ 0]?^4RS_ /C-'_#4?QU_Z'K_ ,IEG_\
M&: /TQHK\SO^&H_CK_T/7_E,L_\ XS1_PU'\=?\ H>O_ "F6?_QF@#],:*_,
M[_AJ/XZ_]#U_Y3+/_P",T?\ #4?QU_Z'K_RF6?\ \9H _3&BOS._X:C^.O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %?F=^U)_P G-^+O^W/_ -(X:_3&OGCXB?LOZ!\1
M_B'JGC.\\4:A8W&H>5N@AA1E3RXDC&">>0@/XT ?G=17W-_PQ#X5_P"AWU7_
M ,!XZ/\ AB'PK_T.^J_^ \= 'PS17W-_PQ#X5_Z'?5?_  'CH_X8A\*_]#OJ
MO_@/'0!\,T5]S?\ #$/A7_H=]5_\!XZ/^&(?"O\ T.^J_P#@/'0!\,T5]S?\
M,0^%?^AWU7_P'CH_X8A\*_\ 0[ZK_P" \= 'PS17W-_PQ#X5_P"AWU7_ ,!X
MZ/\ AB'PK_T.^J_^ \= 'PS17W-_PQ#X5_Z'?5?_  'CH_X8A\*_]#OJO_@/
M'0!\,T5]S?\ #$/A7_H=]5_\!XZ/^&(?"O\ T.^J_P#@/'0!\,T5]S?\,0^%
M?^AWU7_P'CH_X8A\*_\ 0[ZK_P" \= 'PS17W-_PQ#X5_P"AWU7_ ,!XZ/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_ G5?_DV@#]9:*_)K_A,O#O_ $2?PK_X$ZK_ /)M'_"9>'?^B3^%?_ G5?\
MY-H _66BOR:_X3+P[_T2?PK_ .!.J_\ R;1_PF7AW_HD_A7_ ,"=5_\ DV@#
M]9:*^=_!/[/OP7\2_#SPWKU[X$BCNM5TRUO9DAU&]$:O)$KL%!G) RQQDDX[
MFMV;]F'X&QVTLB^!\,J$@_VG>=<?]=J /:Z*^1])^"OPGC_9FB\>W7@V*^UN
M+PR^JLTU]=K'-.EN9/F5)E&"PY"XXZ8KY2_X3+P[_P!$G\*_^!.J_P#R;0!^
MLM%?DU_PF7AW_HD_A7_P)U7_ .3:/^$R\._]$G\*_P#@3JO_ ,FT ?K+17Y-
M?\)EX=_Z)/X5_P# G5?_ )-H_P"$R\._]$G\*_\ @3JO_P FT ?K+17Y-?\
M"9>'?^B3^%?_  )U7_Y-H_X3+P[_ -$G\*_^!.J__)M 'ZRT5^37_"9>'?\
MHD_A7_P)U7_Y-KZ_^#OP3^$?Q"^$>B>+];\ VL%_?^?YL=GJ%\L2[)Y(QM#7
M#'H@SDGG- 'U-17C'_#+GP+_ .A&_P#*G>?_ !ZN0\3?L]_!_3_%_@33;7P>
M(K75=2GM[R/^T+H^:BV-Q*HR9<C#QH<C!XQT)% 'TM17Y]_M Z'X!^%/Q%L/
M#OAWX:Z-=6EQID=ZS7]YJ+R!VEE0@%+I1C$:]LYSS7CW_"9>'?\ HD_A7_P)
MU7_Y-H _66BOR:_X3+P[_P!$G\*_^!.J_P#R;1_PF7AW_HD_A7_P)U7_ .3:
M /UEHK\FO^$R\._]$G\*_P#@3JO_ ,FT?\)EX=_Z)/X5_P# G5?_ )-H _66
MBOR:_P"$R\._]$G\*_\ @3JO_P FU] ?LY^!_AK\7O\ A)_^$F^'.EVG]D?9
M?)_L^^U!-WF^=NW;[E\_ZM<8QU/6@#[EHKQC_AESX%_]"-_Y4[S_ ./4?\,N
M? O_ *$;_P J=Y_\>H ]GHKYG^)W[//PA\._"?Q5KFC^$/LNHV&FS7%O-_:%
MT_ENJ$@[6E(//8@BN4_: ^%WPM^%/P[L/$?AWX?:?=7=SJD=FR7]]?O&$:*5
MR0$N%.<QKWQC/% 'V'17Y-?\)EX=_P"B3^%?_ G5?_DVC_A,O#O_ $2?PK_X
M$ZK_ /)M 'ZRT5^37_"9>'?^B3^%?_ G5?\ Y-H_X3+P[_T2?PK_ .!.J_\
MR;0!^LM%?DU_PF7AW_HD_A7_ ,"=5_\ DVM71?$7A?4O$6G:;-\*_#2175U%
M [)<:H&"LX4XS>GGF@#]4**\8_X9<^!?_0C?^5.\_P#CU'_#+GP+_P"A&_\
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M ,"=5_\ DV@#]9:*_)K_ (3+P[_T2?PK_P"!.J__ ";1_P )EX=_Z)/X5_\
M G5?_DV@#]9:*_)K_A,O#O\ T2?PK_X$ZK_\FT?\)EX=_P"B3^%?_ G5?_DV
M@#]9:*_)K_A,O#O_ $2?PK_X$ZK_ /)M'_"9>'?^B3^%?_ G5?\ Y-H _66B
MOG?P3^S[\%_$OP\\-Z]>^!(H[K5=,M;V9(=1O1&KR1*[!09R0,L<9)..YJ+1
M_P!G7X.W?CGQ3IEQX-WVEA]E^SQ_VA=#9OB+-R)<G)]<T ?1M%?F;\3+KP;X
M-^*/B'PKI?PO\/2V6G71@BDN;O4VD90 ?F*W@!//8"N,_P"$R\._]$G\*_\
M@3JO_P FT ?K+17Y-?\ "9>'?^B3^%?_  )U7_Y-H_X3+P[_ -$G\*_^!.J_
M_)M 'ZRT5^37_"9>'?\ HD_A7_P)U7_Y-H_X3+P[_P!$G\*_^!.J_P#R;0!^
MLM%?DU_PF7AW_HD_A7_P)U7_ .3:/^$R\._]$G\*_P#@3JO_ ,FT ?K+17Y-
M?\)EX=_Z)/X5_P# G5?_ )-H_P"$R\._]$G\*_\ @3JO_P FT ?K+17Y-?\
M"9>'?^B3^%?_  )U7_Y-H_X3+P[_ -$G\*_^!.J__)M 'ZRT5^37_"9>'?\
MHD_A7_P)U7_Y-H_X3+P[_P!$G\*_^!.J_P#R;0!^LM%?DU_PF7AW_HD_A7_P
M)U7_ .3:/^$R\._]$G\*_P#@3JO_ ,FT ?K+17Y-?\)EX=_Z)/X5_P# G5?_
M )-KT'X.IX)^(7Q>T3PCK7PST"WL+_S_ #9+.[U)95V022#:6NV'5!G(/&:
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MN?'7_H1?_*G9_P#QZ@#QBOO[]BK_ )(CK/\ V,$W_I-;U\T?\,N?'7_H1?\
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M $_2+2UN8MRMY<J0HKKE20<$$9!(KI;S_CRN/^N;?RH \3TS_DQ>3_L1Y_\
MTC:OS;K]+?#.FW^L?L<6FBZ7!]IO]0\(O:VT6Y5\R5[5E1<L0!DD#)(%?'/_
M  RY\=?^A%_\J=G_ /'J /&**]G_ .&7/CK_ -"+_P"5.S_^/4?\,N?'7_H1
M?_*G9_\ QZ@#QBBO9_\ AESXZ_\ 0B_^5.S_ /CU'_#+GQU_Z$7_ ,J=G_\
M'J /&**]G_X9<^.O_0B_^5.S_P#CU'_#+GQU_P"A%_\ *G9__'J /&*_3']E
MS_DV3PC_ -OG_I9-7QK_ ,,N?'7_ *$7_P J=G_\>K[A^ _AO7/!_P #O#_A
MKQ'8_8=5L_M/GV_F))LWW,KK\R$J<JRG@]Z /4*\_P#&W_)2?A?_ -AB[_\
M39=UZ!7G_C;_ )*3\+_^PQ=_^FR[H ^0?VU/^2VZ-_V+\/\ Z4W%?,M?37[:
MG_);=&_[%^'_ -*;BOF6@ HHHH **** "OLS]AG_ )J#_P!P[_VYKXSKZ:_9
M7^*'@7X;_P#"7?\ ":ZY_97]H?8_LW^BS3>9Y?G[_P#5HV,;UZXZ\=Z /OZB
MO&/^&HO@5_T/7_E,O/\ XS7L] 'G_P :_P#D@OCC_L#W/_H!KR7]M7_DB.C?
M]C!#_P"DUQ7K7QK_ .2"^./^P/<_^@&O)?VU?^2(Z-_V,$/_ *37% 'P#111
M0 4444 %;?A/_D=]!_["%O\ ^C%K2\%^ _%7Q UR;1?!^E_VG?PV[7,D7GQ1
M8B#*I;,C*.KJ,9SS7I_A_P#9K^-ECXHTF]N_!/EV]O>0RR/_ &C:':JN"3@2
MY/ H _1RBBB@#Q.V_P"3'&_[$-__ $@-?FG7Z66W_)CC?]B&_P#Z0&OS3H *
M*]&\&_!OXB_$+0Y=<\(^'?[3T^&=K627[9;P[90JL5Q)(IZ.ISC'-=#_ ,,N
M?'7_ *$7_P J=G_\>H ^LOV0_P#DWFU_["%S_P"A"O?Z\<_9U\'^(O ?P=M_
M#WBK3_[/U);R>5H?-CEPK$8.Z-F7]:]CH *\Y^#'_)/+C_L.:O\ ^G">O1J\
MY^#'_)/+C_L.:O\ ^G">@#\K:*** "BBM72=+OM<UJPT72X/M%_?7$=K;1;E
M7S)78*BY8@#)(&20* ,JBO9_^&7/CK_T(O\ Y4[/_P"/4?\ #+GQU_Z$7_RI
MV?\ \>H \8HKV?\ X9<^.O\ T(O_ )4[/_X]1_PRY\=?^A%_\J=G_P#'J /O
MWX4_\D0\!_\ 8OV'_I,E+X=_Y*?XW_[<?_1)J;X>Z;?Z/\,?">BZG!]FO]/T
MBTM;F+<K>7*D**ZY4D'!!&02*A\._P#)3_&__;C_ .B30!^='Q]_Y.%\:_\
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M $(O_E3L_P#X]1_PRY\=?^A%_P#*G9__ !Z@#QBBO9_^&7/CK_T(O_E3L_\
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M_P#V [G_ -*(*ZZN1F_Y+%I__8#N?_2B"@#KJ*** "BBB@ KB_%7_(^^ /\
ML(77_I#/7:5Q?BK_ )'WP!_V$+K_ -(9Z .THHHH **** "BBB@ HHHH ***
M* "J]Y_QY7'_ %S;^56*KWG_ !Y7'_7-OY4 </\ !3_D@O@?_L#VW_H KT"O
M/_@I_P D%\#_ /8'MO\ T 5Z!0 4444 %%%% !1110 4444 %>?^-O\ DI/P
MO_[#%W_Z;+NO0*\_\;?\E)^%_P#V&+O_ --EW0!\@_MJ?\EMT;_L7X?_ $IN
M*^9:^FOVU/\ DMNC?]B_#_Z4W%?,M !1110 4444 %%%% !7[,5^,]?LQ0!Y
M_P#&O_D@OCC_ + ]S_Z :\E_;5_Y(CHW_8P0_P#I-<5ZU\:_^2"^./\ L#W/
M_H!KR7]M7_DB.C?]C!#_ .DUQ0!\ T444 %%%% 'TU^Q7_R6W6?^Q?F_]*;>
MOOZO@']BO_DMNL_]B_-_Z4V]??U !1110!XG;?\ )CC?]B&__I :_-.OTLMO
M^3'&_P"Q#?\ ](#7YIT ??W[%7_)$=9_[&";_P!)K>OIJOF7]BK_ )(CK/\
MV,$W_I-;U]-4 %%%% !7G/P8_P"2>7'_ &'-7_\ 3A/7HU><_!C_ ))Y<?\
M8<U?_P!.$] 'Y6T444 %=K\*?^2W^ _^Q@L/_2E*XJNU^%/_ "6_P'_V,%A_
MZ4I0!^L=%%% !1110 5QGAW_ )*?XW_[<?\ T2:[.N,\._\ )3_&_P#VX_\
MHDT =G1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!X
MS\ O^:J_]E U;_VE7LU>,_ +_FJO_90-6_\ :5>S4 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<C-_R6+3_ /L!
MW/\ Z405UU<C-_R6+3_^P'<_^E$% '74444 %%%% !7%^*O^1]\ ?]A"Z_\
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M_P"A@U7_ ,I__P A4?M>?\G#7?\ V#[;_P!!-?/] 'T!_P -6?$S_H8-5_\
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MJQP&01"1XF;'RXW')[\UX'_PU9\3/^A@U7_RG_\ R%7U)IG_ "8O)_V(\_\
MZ1M7YMT ?0'_  U9\3/^A@U7_P I_P#\A4?\-6?$S_H8-5_\I_\ \A5\_P!%
M 'T!_P -6?$S_H8-5_\ *?\ _(5'_#5GQ,_Z&#5?_*?_ /(5?/\ 10!] ?\
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M]C!8?^E*5^L= 'F7_""?$S_HN.J_^"/3_P#XU1_P@GQ,_P"BXZK_ ."/3_\
MXU7IM% 'F7_""?$S_HN.J_\ @CT__P"-4?\ ""?$S_HN.J_^"/3_ /XU7IM%
M 'RW#X5\<']DTZFOQ0OUTO\ X0]Y_P"RO[+L_+\K[&3Y'F>7YF-OR[L[N^<U
M\%U^EEM_R8XW_8AO_P"D!K\TZ "OLS_AAC_JJ/\ Y1/_ +HKXSK]F* /C/\
MX88_ZJC_ .43_P"Z*]?\'?!OQQX+\(V7AG1_C-J%M96?F>7'#HEGM7?(SG'F
M*[=6/5C[8& /;:* /,O^$$^)G_1<=5_\$>G_ /QJN%^%W@_Q]=>#)I+'XN:C
MIT/]JZDAACTBQD!=;V96?+QDY9@6(Z#=@8 %?0]><_!C_DGEQ_V'-7_].$]
M'Y6T444 %%%% !7NFA_M(^/M!\.:9HMEKFI16^G6L5I"B?8=JI&@50-UFS8P
M!U8GU)ZUX710!] ?\-6?$S_H8-5_\I__ ,A5>TK]ICXDZGKMAIO_  DFJ0B[
MN(X/,VZ>VS<P7./L0SC-?.-;?A/_ )'?0?\ L(6__HQ: /TP_P"$$^)G_1<=
M5_\ !'I__P :KDM$\&?$"3QYXMAB^+VI0W$7V/S9QH]B3/F(E<@Q8&!QQC/>
MO>JXSP[_ ,E/\;_]N/\ Z)- 'R#X]^/GQ,\$?$/6O"7_  F&JZ@-+N#!]I\G
M3XO-P <[?L;8Z],FN8_X:L^)G_0P:K_Y3_\ Y"KC?C[_ ,G"^-?^P@W_ *"*
M\QH ^@/^&K/B9_T,&J_^4_\ ^0J/^&K/B9_T,&J_^4__ .0J^?Z* /H#_AJS
MXF?]#!JO_E/_ /D*C_AJSXF?]#!JO_E/_P#D*OG^B@#Z _X:L^)G_0P:K_Y3
M_P#Y"H_X:L^)G_0P:K_Y3_\ Y"KY_HH ^@/^&K/B9_T,&J_^4_\ ^0J/^&K/
MB9_T,&J_^4__ .0J^?Z* /H#_AJSXF?]#!JO_E/_ /D*C_AJSXF?]#!JO_E/
M_P#D*OG^B@#Z _X:L^)G_0P:K_Y3_P#Y"KZ+^$M[\2OBG\/HO%G_  M?5=(\
MRXE@^S?V9I\^-AQG=]G7KZ8K\]*_1G]D/_DWFU_["%S_ .A"@#LO^$$^)G_1
M<=5_\$>G_P#QJC_A!/B9_P!%QU7_ ,$>G_\ QJO3:* /,O\ A!/B9_T7'5?_
M  1Z?_\ &J/^$$^)G_1<=5_\$>G_ /QJO3:* /,O^$$^)G_1<=5_\$>G_P#Q
MJC_A!/B9_P!%QU7_ ,$>G_\ QJO3:* /#/V>8+JUTSXC6M[>/?74/CC4HYKM
MT5&G<+"&D*J JECDX  &>*]SKQGX!?\ -5?^R@:M_P"TJ]FH **** "BBB@
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MXST5^S%% '%_"G_DB'@/_L7[#_TF2NLO/^/*X_ZYM_*K%5[S_CRN/^N;?RH
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MKT:O.?@Q_P D\N/^PYJ__IPGH _*VBBB@ HKZ _9#_Y.&M/^P?<_^@BOT8H
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M;_DL6G_]@.Y_]*(* .NHHHH **** "N+\5?\C[X _P"PA=?^D,]=I7%^*O\
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M'\&_^?+5?_ ]O\*/^&0_@W_SY:K_ .![?X4 ?G-17Z,_\,A_!O\ Y\M5_P#
M]O\ "C_AD/X-_P#/EJO_ ('M_A0!^<U%?HS_ ,,A_!O_ )\M5_\  ]O\*/\
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M+5?_ )54 ?3-%?,W_#6GAW_GOX5_\&6J_P#RJH_X:T\._P#/?PK_ .#+5?\
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MFM-US6K+1]+_ .$6N+_4+B.UMHO[5U-?,E=@J+EM+ &20,D@5ZS_ &C\4_\
MH3?"O_A37/\ \@4 =I17%_VC\4_^A-\*_P#A37/_ ,@4?VC\4_\ H3?"O_A3
M7/\ \@4 =I17%_VC\4_^A-\*_P#A37/_ ,@4?VC\4_\ H3?"O_A37/\ \@4
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M\S?\-:>'?^>_A7_P9:K_ /*JC_AK3P[_ ,]_"O\ X,M5_P#E50!],T5\S?\
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M_7T!^UY_R<-=_P#8/MO_ $$U\_T %%%% 'V9^PS_ ,U!_P"X=_[<U],>*O\
MD?? '_80NO\ TAGKYG_89_YJ#_W#O_;FOICQ5_R/O@#_ +"%U_Z0ST ?&O[:
MG_);=&_[%^'_ -*;BOF6OIK]M3_DMNC?]B_#_P"E-Q7S+0 4444 %%%% !11
M10 4444 ?K)\*?\ DB'@/_L7[#_TF2NLO/\ CRN/^N;?RKD_A3_R1#P'_P!B
M_8?^DR5UEY_QY7'_ %S;^5 'B>F?\F+R?]B//_Z1M7YMU^DFF?\ )B\G_8CS
M_P#I&U?FW0 4444 %%%% !1110 4444 ?IC^RY_R;)X1_P"WS_TLFKI_&W_)
M2?A?_P!AB[_]-EW7,?LN?\FR>$?^WS_TLFKI_&W_ "4GX7_]AB[_ /39=T ?
M(/[:G_);=&_[%^'_ -*;BOF6OIK]M3_DMNC?]B_#_P"E-Q7S+0 4444 %%%%
M !1110 5[/\ LM_\G-^$?^WS_P!(YJ\8KV?]EO\ Y.;\(_\ ;Y_Z1S4 ?>/Q
MK_Y(+XX_[ ]S_P"@&O)?VU?^2(Z-_P!C!#_Z37%>M?&O_D@OCC_L#W/_ * :
M\E_;5_Y(CHW_ &,$/_I-<4 ? -%%% ':_"G_ )+?X#_[&"P_]*4K]8Z_)SX4
M_P#);_ ?_8P6'_I2E?K'0 4444 %%%% 'B=M_P F.-_V(;_^D!K\TZ_2RV_Y
M,<;_ +$-_P#T@-?FG0 5^S%?C/7[,4 %%%% !7G/P8_Y)Y<?]AS5_P#TX3UZ
M-7G/P8_Y)Y<?]AS5_P#TX3T ?E;1110 4444 %%%% !6WX3_ .1WT'_L(6__
M *,6L2MOPG_R.^@_]A"W_P#1BT ?K[7&>'?^2G^-_P#MQ_\ 1)KLZXSP[_R4
M_P ;_P#;C_Z)- 'YT?'W_DX7QK_V$&_]!%>8UZ=\??\ DX7QK_V$&_\ 017F
M- !1110 4444 %%%% !1110 4444 %%%% !1110 5]-?L5_\EMUG_L7YO_2F
MWKYEKZ:_8K_Y+;K/_8OS?^E-O0!]_4444 >,_ +_ )JK_P!E U;_ -I5[-7C
M/P"_YJK_ -E U;_VE7LU !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !7(S?\ )8M/_P"P'<_^E$%==7(S?\EBT_\
M[ =S_P"E$% %7Q%\+/AWXLUEM9\2^$['4]09%C,\ZDL57H.#VK*_X4#\&_\
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M*;>OOZ@#S+_A0/P;_P"B>Z5_WPW^-'_"@?@W_P!$]TK_ +X;_&O3:* /,O\
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MTK[B_P"% _!O_HGNE?\ ?#?XU\:?LA_\G#6G_8/N?_017Z,4 >9?\*!^#?\
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MJ\-M91R1)<,"$8R8)&!Z5]=U\-?L1?\ (\>+/^P?%_Z,K[EH \9^ 7_-5?\
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M7'_7-OY4 </\%/\ D@O@?_L#VW_H KT"O/\ X*?\D%\#_P#8'MO_ $ 5Z!0
M4444 %%%% !1110 4444 %>?^-O^2D_"_P#[#%W_ .FR[KT"O/\ QM_R4GX7
M_P#88N__ $V7= 'GWQH_9T_X6YXWL_$O_"8?V+]GL$L?L_\ 9_VC=MDD??N\
MU,?ZS&,=NO->:?\ ##'_ %5'_P HG_W17V910!\9_P###'_54?\ RB?_ '11
M_P ,,?\ 54?_ "B?_=%?9E% 'QG_ ,,,?]51_P#*)_\ =%'_  PQ_P!51_\
M*)_]T5]F44 ?&?\ PPQ_U5'_ ,HG_P!T4?\ ##'_ %5'_P HG_W17V910!\_
M?!?]G3_A4?C>\\2_\)A_;7VBP>Q^S_V?]GV[I(WW[O-?/^KQC'?KQ7T#110!
MY_\ &O\ Y(+XX_[ ]S_Z :] KS_XU_\ )!?''_8'N?\ T UZ!0 4444 %%%%
M !1110 4444 <-\'?^2%^!?^P'9_^B5KN:X;X._\D+\"_P#8#L__ $2M=S0
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MSCJ*Y^NU^%/_ "6_P'_V,%A_Z4I0!]+_ /##'_54?_*)_P#=%'_##'_54?\
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MBB@ JO>?\>5Q_P!<V_E5BJ]Y_P >5Q_US;^5 '#_  4_Y(+X'_[ ]M_Z *]
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M,Q3   ))/ %>-T4 ?LQ17XSU]-?L5_\ );=9_P"Q?F_]*;>@#[^HHHH \9^
M7_-5?^R@:M_[2KV:O&?@%_S57_LH&K?^TJ]FH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y&;_DL6G_ /8#N?\
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M *)- 'Y-45VOQ+\+Z?X+^)_B'PKI<UQ-9:==&"*2Y96D90 ?F*@ GGL!7%4
M%%%% !1110 4444 %%%% !1110 4444 %%%>Z?L\_"7PU\6O$.MZ9XBO-1M(
MK"U2>(Z?)&C,Q?:=V]'X^F* /"Z^B/V0;R_@^/9AL]/-U#=:5<0W4@./LT0:
M-Q)_WVD:?\#KW?\ X8J^%O\ T'_%7_@5;?\ QBNW^&O[/_@WX4^)KGQ%X=U+
M6;JZN;1K)DOIHGCV,Z.2 D2G.8U[XQGB@#V*BBB@#QGX!?\ -5?^R@:M_P"T
MJ]FKQGX!?\U5_P"R@:M_[2KV:@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ KD9O^2Q:?_P!@.Y_]*(*ZZN1F_P"2
MQ:?_ -@.Y_\ 2B"@#KJ*** "BBB@ KB_%7_(^^ /^PA=?^D,]=I7%^*O^1]\
M ?\ 80NO_2&>@#M**** "BBB@ HHHH **** "BBB@ JO>?\ 'E<?]<V_E5BJ
M]Y_QY7'_ %S;^5 '#_!3_D@O@?\ [ ]M_P"@"O0*\_\ @I_R07P/_P!@>V_]
M %>@4 %%%% !1110 4444 %%%% !7G_C;_DI/PO_ .PQ=_\ ILNZ] KS_P ;
M?\E)^%__ &&+O_TV7= 'H%%%% !1110 4444 %%%% !1110!Y_\ &O\ Y(+X
MX_[ ]S_Z :] KS_XU_\ )!?''_8'N?\ T UZ!0 4444 %%%% !1110 4444
M<-\'?^2%^!?^P'9_^B5KN:X;X._\D+\"_P#8#L__ $2M=S0 4444 %%%% !7
MG/P8_P"2>7'_ &'-7_\ 3A/7HU><_!C_ ))Y<?\ 8<U?_P!.$] 'HU%%% !1
M110 4444 %%%% !7&>'?^2G^-_\ MQ_]$FNSKC/#O_)3_&__ &X_^B30!^='
MQ]_Y.%\:_P#80;_T$5YC7IWQ]_Y.%\:_]A!O_017F- !1110 45Z!\,OACKW
MQ4\3W/A_P[>:?;7=O9M>N]](Z1E%=$(!1&.<R+VQC/->M?\ #%?Q2_Z#_A7_
M ,"KG_XQ0!\RT5]-?\,5_%+_ *#_ (5_\"KG_P",4?\ #%?Q2_Z#_A7_ ,"K
MG_XQ0!\RT5]-?\,5_%+_ *#_ (5_\"KG_P",4?\ #%?Q2_Z#_A7_ ,"KG_XQ
M0!\RT5]-?\,5_%+_ *#_ (5_\"KG_P",4?\ #%?Q2_Z#_A7_ ,"KG_XQ0!\R
MT5]-?\,5_%+_ *#_ (5_\"KG_P",4?\ #%?Q2_Z#_A7_ ,"KG_XQ0!\RU]9_
ML1?\CQXL_P"P?%_Z,K&_X8K^*7_0?\*_^!5S_P#&*]L_9Y^!?B[X3>(];U+Q
M)?Z5=QW]JD$0L)I796#[CNWQIQ],T ?25%%% !1110!XS\ O^:J_]E U;_VE
M7LU>,_ +_FJO_90-6_\ :5>S4 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %<C-_R6+3_ /L!W/\ Z405UU>=>(-=
ML?#_ ,5M+N+ZWU*99=&N446&FW%ZP/GP'E8(W91[D 4 >BT5QG_"R_#O_0-\
M5?\ A)ZK_P#(U'_"R_#O_0-\5?\ A)ZK_P#(U '9T5QG_"R_#O\ T#?%7_A)
MZK_\C4?\++\._P#0-\5?^$GJO_R-0!V=<7XJ_P"1]\ ?]A"Z_P#2&>E_X67X
M=_Z!OBK_ ,)/5?\ Y&KC/$/C_19O&O@F;[#XE*6]_<LX?PSJ2,0;.9?E4VX+
MG)Z*"0,D\ F@#V:BN,_X67X=_P"@;XJ_\)/5?_D:C_A9?AW_ *!OBK_PD]5_
M^1J .SHKC/\ A9?AW_H&^*O_  D]5_\ D:C_ (67X=_Z!OBK_P )/5?_ )&H
M [.BN,_X67X=_P"@;XJ_\)/5?_D:C_A9?AW_ *!OBK_PD]5_^1J .SHKC/\
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M,%AXB26;2KB-6N/#>I01@E#]Z1X JCW8@#UKN_\ A9?AW_H&^*O_  D]5_\
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M_%GBKQ1_PF__  DGB;5=;^S?8?)_M"\DN/*W?:-VW>QVYVKG'7 ]*]^\5?\
M(^^ /^PA=?\ I#/7S/\ L,_\U!_[AW_MS7TQXJ_Y'WP!_P!A"Z_](9Z /E7]
MK/QKXR\-?%O2K'P_XNUK1[1]%AF:"QU"6WC9S<3@L51@"<*HSUP!Z5\\_P#"
MV/BE_P!%+\5?^#FY_P#BZ]F_;4_Y+;HW_8OP_P#I3<5\RT =I_PMCXI?]%+\
M5?\ @YN?_BZ/^%L?%+_HI?BK_P '-S_\77%T4 =I_P +8^*7_12_%7_@YN?_
M (NC_A;'Q2_Z*7XJ_P#!S<__ !=<710!VG_"V/BE_P!%+\5?^#FY_P#BZ/\
MA;'Q2_Z*7XJ_\'-S_P#%UQ=% ':?\+8^*7_12_%7_@YN?_BZ]P_9?\=>./$/
MQQMM-U[QCKFK61L;AS;WNHS3QE@HP=KL1D5\MU] ?LA_\G#6G_8/N?\ T$4
M?HQ5>\_X\KC_ *YM_*K%5[S_ (\KC_KFW\J /%]!N[NQ_8NBOK.YEM;FW\&R
M2PSPN4>)UM&*LK#D$$ @CD&O@O\ X6Q\4O\ HI?BK_P<W/\ \77WAIG_ "8O
M)_V(\_\ Z1M7YMT =I_PMCXI?]%+\5?^#FY_^+H_X6Q\4O\ HI?BK_P<W/\
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M+KBZ* .T_P"%L?%+_HI?BK_P<W/_ ,71_P +8^*7_12_%7_@YN?_ (NN+HH
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M@/JO_@SC_P#D>NX^&/Q-T/X8^.8O%=CX5OM1FCADA\F?5452'&"<BWS7EE%
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MD_VEI][<2_V'#AK>[2%0OVBXXP8GYZ\Y_"OG'[1X5_Z ^J_^#./_ .1Z]_\
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MAWU7_P !XZ]+^$'P'TCX/ZQJ>I:?K]YJCZA L#)<1*@0*V[(Q7L]% !1110
M5YS\&/\ DGEQ_P!AS5__ $X3UZ-7G/P8_P"2>7'_ &'-7_\ 3A/0!^9'VCPK
M_P! ?5?_  9Q_P#R/1]H\*_] ?5?_!G'_P#(]8E% &W]H\*_] ?5?_!G'_\
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M 4444 %%%% !1110 5R,W_)8M/\ ^P'<_P#I1!775R,W_)8M/_[ =S_Z404
M==1110 4444 %<7XJ_Y'WP!_V$+K_P!(9Z[2N+\5?\C[X _["%U_Z0ST ?&O
M[:G_ "6W1O\ L7X?_2FXKYEKZ:_;4_Y+;HW_ &+\/_I3<5\RT %%%% &WHOA
M[7/$M\]AX=T._P!8NHXS,T-A;/<2*@(!8J@) RRC/3)'K6S_ ,*G^*7_ $33
MQ5_X)KG_ .(KV;]BO_DMNL_]B_-_Z4V]??U 'Y-_\*G^*7_1-/%7_@FN?_B*
M/^%3_%+_ *)IXJ_\$US_ /$5^LE% 'Y-_P#"I_BE_P!$T\5?^":Y_P#B*/\
MA4_Q2_Z)IXJ_\$US_P#$5^LE% '&_#>UNK#X3>#+&]M9K6YM]%LH9H)D*21.
MMN@964\@@@@@\@UU5Y_QY7'_ %S;^56*KWG_ !Y7'_7-OY4 </\ !3_D@O@?
M_L#VW_H KT"O/_@I_P D%\#_ /8'MO\ T 5Z!0 4444 %%%% !1110 4444
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MHH **** "BBB@ HHHH X;X._\D+\"_\ 8#L__1*UW-<-\'?^2%^!?^P'9_\
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M HHHH **** "BBB@ KD9O^2Q:?\ ]@.Y_P#2B"NNKD9O^2Q:?_V [G_TH@H
MZZBBB@ HHHH *XOQ5_R/O@#_ +"%U_Z0SUVE<7XJ_P"1]\ ?]A"Z_P#2&>@#
MM**** "BBB@ HHHH **** "BBB@ JO>?\>5Q_P!<V_E5BJ]Y_P >5Q_US;^5
M '#_  4_Y(+X'_[ ]M_Z *] KS_X*?\ )!? _P#V![;_ - %>@4 %%%% !11
M10 4444 %%%% !7G_C;_ )*3\+_^PQ=_^FR[KT"O/_&W_)2?A?\ ]AB[_P#3
M9=T >@4444 %%%% !1110 4444 %%%% 'G_QK_Y(+XX_[ ]S_P"@&O0*\_\
MC7_R07QQ_P!@>Y_] ->@4 %%%% !1110 4444 %%%% '#?!W_DA?@7_L!V?_
M *)6NYKAO@[_ ,D+\"_]@.S_ /1*UW- !1110 4444 %><_!C_DGEQ_V'-7_
M /3A/7HU><_!C_DGEQ_V'-7_ /3A/0!Z-1110 4444 %%%% !1110 5QGAW_
M )*?XW_[<?\ T2:[.N,\._\ )3_&_P#VX_\ HDT ?G1\??\ DX7QK_V$&_\
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MB@ KSGX,?\D\N/\ L.:O_P"G">O1J\Y^#'_)/+C_ +#FK_\ IPGH ]&HHHH
M**** "BBB@ HHHH *XSP[_R4_P ;_P#;C_Z)-=G7&>'?^2G^-_\ MQ_]$F@#
M\Z/C[_R<+XU_["#?^@BO,:^\O'W[)/\ PF_Q"UKQ;_PL#^S_ .U+@S_9O[)\
MWRL@#&[SESTZX%<S_P ,,?\ 54?_ "B?_=% 'QG17V9_PPQ_U5'_ ,HG_P!T
M4?\ ##'_ %5'_P HG_W10!\9T5]F?\,,?]51_P#*)_\ =%'_  PQ_P!51_\
M*)_]T4 ?&=%?9G_##'_54?\ RB?_ '11_P ,,?\ 54?_ "B?_=% 'QG17V9_
MPPQ_U5'_ ,HG_P!T4?\ ##'_ %5'_P HG_W10!\9T5]F?\,,?]51_P#*)_\
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M%%% !1110 4444 %%%% !1110 5R,W_)8M/_ .P'<_\ I1!775R,W_)8M/\
M^P'<_P#I1!0!UU%%% !1110 5Q?BK_D?? '_ &$+K_TAGKM*XOQ5_P C[X _
M["%U_P"D,] ':4444 %%%% !1110 4444 %%%% !5>\_X\KC_KFW\JL57O/^
M/*X_ZYM_*@#A_@I_R07P/_V![;_T 5Z!7G_P4_Y(+X'_ .P/;?\ H KT"@ H
MHHH **** "BBB@ HHHH *\_\;?\ )2?A?_V&+O\ ]-EW7H%>?^-O^2D_"_\
M[#%W_P"FR[H ] HHHH **** "BBB@ HHHH **** //\ XU_\D%\<?]@>Y_\
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M **** "BBB@ HHHH \9^ 7_-5?\ LH&K?^TJ]FKQGX!?\U5_[*!JW_M*O9J
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "O*_&WA/0_&'Q9\+:;KUO<36RZ-JL^+>[FM6+K/8*N6B=6( D?@G'/2O
M5*XS4O\ DM_A?_L7]7_]*=-H ^2/C1XB\(_"_P")<WA.Q\#S:C!';13^=/XE
MU16)<$D8$^*\W_X7/X=_Z)G_ .71JO\ \?K:_:\_Y.&N_P#L'VW_ *":^?Z
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MS!5'R@?*!7SI_P +G\._]$S_ /+HU7_X_7UEX9_Y,+G_ .Q/OO\ T1+7YST
M>S?\+G\._P#1,_\ RZ-5_P#C]?<O_"B/AG_T"]5_\*#4/_C]?EI7[,4 >9?\
M*(^&?_0+U7_PH-0_^/T?\*(^&?\ T"]5_P#"@U#_ ./UZ;10!YE_PHCX9_\
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M!VN:K9&QMT%Q9:=-/&6"G(W(I&17A_\ PJ?XI?\ 1-/%7_@FN?\ XBOUDHH
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M "BBB@ HHHH *XS4O^2W^%_^Q?U?_P!*=-KLZXS4O^2W^%_^Q?U?_P!*=-H
M[.BBB@ HHHH *\R\=?\ )9?A+_V$-1_]-\U>FUYEXZ_Y++\)?^PAJ/\ Z;YJ
M /D[]M3_ )+;HW_8OP_^E-Q7S+7TU^VI_P EMT;_ +%^'_TIN*^9: "BBB@
MHHHH **** "OLS]AG_FH/_<._P#;FJG[,OP>^'/Q"^%M_K7BWP[_ &G?V^KR
MVL<OVRXAVQ"&%@N(Y%'5V.<9YKZ>\#?#'P)\-WU!?!>A'2_[1\O[3_I4TWF>
M7NV?ZQVQC>W3'7GM0!W-%%% 'C'[+G_)LGA'_M\_]+)J]GKQC]ES_DV3PC_V
M^?\ I9-7L] !1110 4444 %%%% !1110 5YEXZ_Y++\)?^PAJ/\ Z;YJ]-KS
M+QU_R67X2_\ 80U'_P!-\U 'R=^VI_R6W1O^Q?A_]*;BOF6OU3\9?!OX=?$+
M6X=<\7>'?[3OX8%M8Y?MEQ#MB#,P7$<BCJ['.,\USO\ PRY\"_\ H1O_ "IW
MG_QZ@#\SJ*_3'_AESX%_]"-_Y4[S_P"/4?\ #+GP+_Z$;_RIWG_QZ@#YH_8K
M_P"2VZS_ -B_-_Z4V]??U>=>#?@W\.OA[K<VN>$?#O\ 9E_- UK)+]LN)MT1
M96*XDD8=44YQGBO1: "BBB@ HHHH \R^/G_)O?C7_L'M_P"A"O3:\R^/G_)O
M?C7_ +![?^A"O3: "BBB@ HHHH **** "BBB@#S+X!_\F]^"O^P>O_H1KTVO
M,O@'_P F]^"O^P>O_H1KTV@ HHHH **** "O /V0_P#DWFU_["%S_P"A"O?Z
M\ _9#_Y-YM?^PA<_^A"@#\YJ*** /H#]D/\ Y.&M/^P?<_\ H(K]&*_(OPCX
MT\1>!?$":YX7U#[!J*1M$LWDQRX5NHVR*R_I7H?_  U'\=?^AZ_\IEG_ /&:
M /TQHK\SO^&H_CK_ -#U_P"4RS_^,UZ7\"_CK\5/&GQQ\.^&?$WBHW^DW?VG
MSK?[#;1[]EM*Z_,D88895/![4 ?<U%%% !7F7@7_ )++\6O^PAIW_IOAKTVO
M,O O_)9?BU_V$-._]-\- 'P%\??^3A?&O_80;_T$5YC7IWQ]_P"3A?&O_80;
M_P!!%>8T %%%% !1110 4444 %%%?37[*_PO\"_$C_A+O^$UT/\ M7^S_L?V
M;_2IH?+\SS]_^K=<YV+USTX[T ?,M%?IC_PRY\"_^A&_\J=Y_P#'J/\ AESX
M%_\ 0C?^5.\_^/4 ?F=17Z8_\,N? O\ Z$;_ ,J=Y_\ 'J/^&7/@7_T(W_E3
MO/\ X]0!^9U%?IC_ ,,N? O_ *$;_P J=Y_\>H_X9<^!?_0C?^5.\_\ CU '
MYG5]S?L0_P#(D>+?^PA%_P"BZ]+_ .&7/@7_ -"-_P"5.\_^/5VW@KX<>#?A
MS87=EX,T;^R[>[D$LR?:)9M[ 8!S(S$<>E '8T444 >,_ +_ )JK_P!E U;_
M -I5[-7C/P"_YJK_ -E U;_VE7LU !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !7&:E_R6_PO_P!B_J__ *4Z;79U
MQFI?\EO\+_\ 8OZO_P"E.FT =G1110 4444 %>9>.O\ DLOPE_["&H_^F^:O
M3:\R\=?\EE^$O_80U'_TWS4 ?)W[:G_);=&_[%^'_P!*;BOF6OT&^.G[.^L_
M%KQ]9>(M-\166F16VFQV)BN(G=F9997W9';]X!^%>6?\,0^*O^AWTK_P'DH
M^3**^L_^&(?%7_0[Z5_X#R4?\,0^*O\ H=]*_P# >2@#Y,HKZS_X8A\5?]#O
MI7_@/)1_PQ#XJ_Z'?2O_  'DH ^3**^L_P#AB'Q5_P!#OI7_ (#R4?\ #$/B
MK_H=]*_\!Y* /2_V*O\ DB.L_P#8P3?^DUO7TU7DWP+^%^H?"7P)?>&]2U2W
MU.:XU*2^$MNC(JJT42;<'O\ NR?QKUF@ HHHH \8_9<_Y-D\(_\ ;Y_Z635[
M/7C'[+G_ ";)X1_[?/\ TLFKV>@ HHHH **** "BBB@ HHHH *\R\=?\EE^$
MO_80U'_TWS5Z;7F7CK_DLOPE_P"PAJ/_ *;YJ /3:*** "BBB@ HHHH ****
M "BBB@#S+X^?\F]^-?\ L'M_Z$*]-KS+X^?\F]^-?^P>W_H0KTV@ HHHH **
M** "BBB@ HHHH \R^ ?_ ";WX*_[!Z_^A&O3:\R^ ?\ R;WX*_[!Z_\ H1KT
MV@ HHHH **** "O /V0_^3>;7_L(7/\ Z$*]_KP#]D/_ )-YM?\ L(7/_H0H
M _.:BOK/_AB'Q5_T.^E?^ \E'_#$/BK_ *'?2O\ P'DH ^3**^L_^&(?%7_0
M[Z5_X#R4?\,0^*O^AWTK_P !Y* /DRO9_P!EO_DYOPC_ -OG_I'-7IG_  Q#
MXJ_Z'?2O_ >2NX^$_P"RYX@^'?Q5T7QE>>*-/OK?3_/W00PNKOYD$D8P3QP7
M!_"@#ZMHHHH *\R\"_\ )9?BU_V$-._]-\->FUYEX%_Y++\6O^PAIW_IOAH
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M^F^:O3:\R\=?\EE^$O\ V$-1_P#3?-0!Z;1110 4444 %%%% !1110 4444
M%%%% 'C'[+G_ ";)X1_[?/\ TLFKV>O&/V7/^39/"/\ V^?^EDU>ST %%%%
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M!O\ T$5YC7IWQ]_Y.%\:_P#80;_T$5YC0 4444 %%%% !1110 4444 %%%%
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M_P!!%>8UZ=\??^3A?&O_ &$&_P#017F- !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 ?LQ1110!XS\ O^:J_P#90-6_]I5[-7C/P"_YJK_V4#5O
M_:5>S4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %<9J7_);_  O_ -B_J_\ Z4Z;79UQFI?\EO\ "_\ V+^K_P#I
M3IM '9T444 %%%% !7F7CK_DLOPE_P"PAJ/_ *;YJ]-KS+QU_P EE^$O_80U
M'_TWS4 >FT444 %%%% !1110 4444 %%%% !1110!XQ^RY_R;)X1_P"WS_TL
MFKV>O&/V7/\ DV3PC_V^?^EDU>ST %%%% !1110 4444 %%%% !7F7CK_DLO
MPE_["&H_^F^:O3:\R\=?\EE^$O\ V$-1_P#3?-0!Z;1110 4444 %%%% !11
M10 4444 >9?'S_DWOQK_ -@]O_0A7IM>9?'S_DWOQK_V#V_]"%>FT %%%% !
M1110 4444 %%%% 'F7P#_P"3>_!7_8/7_P!"->FUYE\ _P#DWOP5_P!@]?\
MT(UZ;0 4444 %%%% !7@'[(?_)O-K_V$+G_T(5[_ %X!^R'_ ,F\VO\ V$+G
M_P!"% 'O]%%% !1110 4444 %%%% !7F7@7_ )++\6O^PAIW_IOAKTVO,O O
M_)9?BU_V$-._]-\- 'P%\??^3A?&O_80;_T$5YC7IWQ]_P"3A?&O_80;_P!!
M%>8T %%%% !1110 4444 %%%% !1110 5Z)\'/!NE?$+XO:)X2UJ:YM["_\
M/\V2S95E79!)(-I96'5!G(/&:\[KV?\ 9;_Y.;\(_P#;Y_Z1S4 ?3'_#%7PM
M_P"@_P"*O_ JV_\ C%'_  Q5\+?^@_XJ_P# JV_^,5],T4 ?,W_#%7PM_P"@
M_P"*O_ JV_\ C%'_  Q5\+?^@_XJ_P# JV_^,5],T4 %%%% 'C/P"_YJK_V4
M#5O_ &E7LU>,_ +_ )JK_P!E U;_ -I5[-0 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 5QFI?\EO\+_]B_J__I3I
MM=G7&:E_R6_PO_V+^K_^E.FT =G1110 4444 %>9>.O^2R_"7_L(:C_Z;YJ]
M-KS+QU_R67X2_P#80U'_ --\U 'IM%%% !1110 4444 %%%% !1110 4444
M>,?LN?\ )LGA'_M\_P#2R:O9Z\8_9<_Y-D\(_P#;Y_Z635[/0 4444 %%%%
M!1110 4444 %>9>.O^2R_"7_ +"&H_\ IOFKTVO,O'7_ "67X2_]A#4?_3?-
M0!Z;1110 4444 %%%% !1110 4444 >9?'S_ )-[\:_]@]O_ $(5Z;7F7Q\_
MY-[\:_\ 8/;_ -"%>FT %%%% !1110 4444 %%%% 'F7P#_Y-[\%?]@]?_0C
M7IM>9? /_DWOP5_V#U_]"->FT %%%% !1110 5X!^R'_ ,F\VO\ V$+G_P!"
M%>_UX!^R'_R;S:_]A"Y_]"% 'O\ 1110 4444 %%%% !1110 5YEX%_Y++\6
MO^PAIW_IOAKTVO,O O\ R67XM?\ 80T[_P!-\- 'P%\??^3A?&O_ &$&_P#0
M17F->G?'W_DX7QK_ -A!O_017F- !1110 4444 %%%% !1110 4444 %>E?!
M'Q=H_@7XSZ!XJUYY4TZQ^T><T,>]QOMY(UP._P SBO-:* /T9_X:\^#?_/[J
MO_@ W^-'_#7GP;_Y_=5_\ &_QK\YJ* /T9_X:\^#?_/[JO\ X -_C1_PUY\&
M_P#G]U7_ , &_P :_.:B@#]&?^&O/@W_ ,_NJ_\ @ W^->TZ'K%GX@\.Z9KV
MFL[66I6L5Y 77:QCD0.N1V.".*_'VOUD^%/_ "1#P'_V+]A_Z3)0!QOP"_YJ
MK_V4#5O_ &E7LU>,_ +_ )JK_P!E U;_ -I5[-0 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5QFI?\EO\+_]B_J_
M_I3IM=G7&:E_R6_PO_V+^K_^E.FT =G1110 4444 %>9>.O^2R_"7_L(:C_Z
M;YJ]-KS+QU_R67X2_P#80U'_ --\U 'IM%%% !1110 4444 %%%% !1110 4
M444 >,?LN?\ )LGA'_M\_P#2R:O9Z\8_9<_Y-D\(_P#;Y_Z635[/0 4444 %
M%%% !1110 4444 %>9>.O^2R_"7_ +"&H_\ IOFKTVO,O'7_ "67X2_]A#4?
M_3?-0!Z;1110 4444 %%%% !1110 4444 >9?'S_ )-[\:_]@]O_ $(5Z;7F
M7Q\_Y-[\:_\ 8/;_ -"%>FT %%%% !1110 4444 %%%% 'F7P#_Y-[\%?]@]
M?_0C7IM>9? /_DWOP5_V#U_]"->FT %%%% !1110 5X!^R'_ ,F\VO\ V$+G
M_P!"%>_UX!^R'_R;S:_]A"Y_]"% 'O\ 1110 4444 %%%% !1110 5YEX%_Y
M++\6O^PAIW_IOAKTVO,O O\ R67XM?\ 80T[_P!-\- 'P%\??^3A?&O_ &$&
M_P#017F->G?'W_DX7QK_ -A!O_017F- !1110 4444 %%%% !1110 4444 %
M%%% !1110 445]S?L0_\B1XM_P"PA%_Z+H ^&:_63X4_\D0\!_\ 8OV'_I,E
M=I10!XS\ O\ FJO_ &4#5O\ VE7LU>,_ +_FJO\ V4#5O_:5>S4 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<9J
M7_);_"__ &+^K_\ I3IM=G7G_CKX<VWCJ_TJ^?Q1XD\.W6FQSPQSZ!?"T>1)
MC&75VV,2,PH<<#(YSQ@ ] HKQG_A09_Z+5\5/_"C_P#M='_"@S_T6KXJ?^%'
M_P#:Z /9J*\9_P"%!G_HM7Q4_P#"C_\ M='_  H,_P#1:OBI_P"%'_\ :Z /
M9J\R\=?\EE^$O_80U'_TWS5C?\*#/_1:OBI_X4?_ -KJC<?L[V=U>VEY=?%C
MXDSW5HS/;32:\K/ S*58HQBRI*D@XQD$B@#W2BO&?^%!G_HM7Q4_\*/_ .UT
M?\*#/_1:OBI_X4?_ -KH ]FHKQG_ (4&?^BU?%3_ ,*/_P"UT?\ "@S_ -%J
M^*G_ (4?_P!KH ]FHKQG_A09_P"BU?%3_P */_[71_PH,_\ 1:OBI_X4?_VN
M@#V:BO&?^%!G_HM7Q4_\*/\ ^UT?\*#/_1:OBI_X4?\ ]KH ]FHKQG_A09_Z
M+5\5/_"C_P#M='_"@S_T6KXJ?^%'_P#:Z /9J*\9_P"%!G_HM7Q4_P#"C_\
MM='_  H,_P#1:OBI_P"%'_\ :Z $_9<_Y-D\(_\ ;Y_Z635[/7A&F?LYZ;H>
MF0Z7H_Q4^(^F6$)/E6MGKBPQ1Y8L=J+$ ,DDG ZDFM'_ (4&?^BU?%3_ ,*/
M_P"UT >S45XS_P *#/\ T6KXJ?\ A1__ &NC_A09_P"BU?%3_P */_[70![-
M17C/_"@S_P!%J^*G_A1__:Z/^%!G_HM7Q4_\*/\ ^UT >S45XS_PH,_]%J^*
MG_A1_P#VNC_A09_Z+5\5/_"C_P#M= 'LU%>,_P#"@S_T6KXJ?^%'_P#:Z/\
MA09_Z+5\5/\ PH__ +70![-7F7CK_DLOPE_["&H_^F^:L;_A09_Z+5\5/_"C
M_P#M=4;C]G>SNKVTO+KXL?$F>ZM&9[::37E9X&92K%&,65)4D'&,@D4 >Z45
MXS_PH,_]%J^*G_A1_P#VNC_A09_Z+5\5/_"C_P#M= 'LU%>,_P#"@S_T6KXJ
M?^%'_P#:Z/\ A09_Z+5\5/\ PH__ +70![-17C/_  H,_P#1:OBI_P"%'_\
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M /M= 'LU%>,_\*#/_1:OBI_X4?\ ]KH_X4&?^BU?%3_PH_\ [70![-17C/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BN2\>>,M+\ ^!=0\8:
MW;W4UAIYC,D=HBM*V^58QM#,HZN,Y(XS7B?_  VK\+?^@!XJ_P# 6V_^/T ?
M3-%?,W_#:OPM_P"@!XJ_\!;;_P"/T?\ #:OPM_Z 'BK_ ,!;;_X_0!],T5\S
M?\-J_"W_ * 'BK_P%MO_ (_1_P -J_"W_H >*O\ P%MO_C] 'TS17S-_PVK\
M+?\ H >*O_ 6V_\ C]'_  VK\+?^@!XJ_P# 6V_^/T ?3-%?,W_#:OPM_P"@
M!XJ_\!;;_P"/T?\ #:OPM_Z 'BK_ ,!;;_X_0!],T5\S?\-J_"W_ * 'BK_P
M%MO_ (_1_P -J_"W_H >*O\ P%MO_C] 'TS17S-_PVK\+?\ H >*O_ 6V_\
MC]'_  VK\+?^@!XJ_P# 6V_^/T ?3-%?,W_#:OPM_P"@!XJ_\!;;_P"/T?\
M#:OPM_Z 'BK_ ,!;;_X_0!],T5\S?\-J_"W_ * 'BK_P%MO_ (_1_P -J_"W
M_H >*O\ P%MO_C] 'TS17S-_PVK\+?\ H >*O_ 6V_\ C]'_  VK\+?^@!XJ
M_P# 6V_^/T ?3-%?,W_#:OPM_P"@!XJ_\!;;_P"/T?\ #:OPM_Z 'BK_ ,!;
M;_X_0!],T5\S?\-J_"W_ * 'BK_P%MO_ (_1_P -J_"W_H >*O\ P%MO_C]
M'TS17S-_PVK\+?\ H >*O_ 6V_\ C]'_  VK\+?^@!XJ_P# 6V_^/T ?3-%?
M,W_#:OPM_P"@!XJ_\!;;_P"/T?\ #:OPM_Z 'BK_ ,!;;_X_0!],T5\S?\-J
M_"W_ * 'BK_P%MO_ (_1_P -J_"W_H >*O\ P%MO_C] 'TS17S-_PVK\+?\
MH >*O_ 6V_\ C]'_  VK\+?^@!XJ_P# 6V_^/T ?3-%?,W_#:OPM_P"@!XJ_
M\!;;_P"/T?\ #:OPM_Z 'BK_ ,!;;_X_0!],T5\S?\-J_"W_ * 'BK_P%MO_
M (_1_P -J_"W_H >*O\ P%MO_C] 'TS17S-_PVK\+?\ H >*O_ 6V_\ C]'_
M  VK\+?^@!XJ_P# 6V_^/T ?3-%?,W_#:OPM_P"@!XJ_\!;;_P"/T?\ #:OP
MM_Z 'BK_ ,!;;_X_0!],T5\S?\-J_"W_ * 'BK_P%MO_ (_1_P -J_"W_H >
M*O\ P%MO_C] 'TS17S-_PVK\+?\ H >*O_ 6V_\ C]'_  VK\+?^@!XJ_P#
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M%G5?_ .3_P")H Q**V_^$3\4_P#0LZK_ . <G_Q-'_")^*?^A9U7_P  Y/\
MXF@#$HK;_P"$3\4_]"SJO_@')_\ $T?\(GXI_P"A9U7_ , Y/_B: ,2BMO\
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MLZK_ . <G_Q-'_")^*?^A9U7_P  Y/\ XF@#$HK;_P"$3\4_]"SJO_@')_\
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MXI_Z%G5?_ .3_P")H Q**V_^$3\4_P#0LZK_ . <G_Q-'_")^*?^A9U7_P
MY/\ XF@#]%OV7/\ DV3PC_V^?^EDU>SUX[^S;:75C^S?X5M;RVEM9T^U[HID
M*,N;N8C(/(X(->Q4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MRK&3@ YSC!Q5KQ)K-YJ7P>\$R3:#;Z3J^G_$&"RN;**8BU^T1!U(B;+[(N
M!D+@A1@ 4_M)>:_$6RN?8O>O-?%7Q>\-^#?%FG:!J^GZXJWUREF-333W^PQ3
M/]U#,V QYZ)NQ@YQ@US'P'N_#U]%XMN8M)31_&3:O*GB*TCQB.<,P7R\?\L_
MO$?[1<G/6N2^-'BSPSXNN(;+PSXPV>,_".N0+:Z!<P!H[ZZ\S8,1LN9",G#
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M/)P!VKWS]J21$_9RUY&D"EY;55!.-Q^T1G _ '\JAW27>]A[RMTL>KZ!JO\
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MAFTK_P #(_\ XJC_ (2SPO\ ]#-I7_@9'_\ %4 ;=%8G_"6>%_\ H9M*_P#
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M_P #(_\ XJC_ (2SPO\ ]#-I7_@9'_\ %4 ;=%8G_"6>%_\ H9M*_P# R/\
M^*H_X2SPO_T,VE?^!D?_ ,50!MT5B?\ "6>%_P#H9M*_\#(__BJ/^$L\+_\
M0S:5_P"!D?\ \50!MT5D6>O:'J%P+;3]8L;N<@GRX+A'; ZG .:UZ "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** /QGHHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M#Z _9#_Y.&M/^P?<_P#H(K]&*_.?]D/_ ).&M/\ L'W/_H(K]&* "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** /S-_X6'\"?\ HW7_ ,NZ\_\ B:/^%A_
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MV;_A8?P)_P"C=?\ R[KS_P")H_X6'\"?^C=?_+NO/_B:\9HH ]F_X6'\"?\
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M=?\ R[KS_P")H_X6'\"?^C=?_+NO/_B:\9HH ]F_X6'\"?\ HW7_ ,NZ\_\
MB:/^%A_ G_HW7_R[KS_XFO&:* /9O^%A_ G_ *-U_P#+NO/_ (FC_A8?P)_Z
M-U_\NZ\_^)KQFB@#V;_A8?P)_P"C=?\ R[KS_P")H_X6'\"?^C=?_+NO/_B:
M\9HH ]F_X6'\"?\ HW7_ ,NZ\_\ B:/^%A_ G_HW7_R[KS_XFO&:* /9O^%A
M_ G_ *-U_P#+NO/_ (FC_A8?P)_Z-U_\NZ\_^)KQFB@#V;_A8?P)_P"C=?\
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M?C)_T3W5?^^%_P :/^% _&3_ *)[JO\ WPO^->8T4 >G?\*!^,G_ $3W5?\
MOA?\:/\ A0/QD_Z)[JO_ 'PO^->8T4 >G?\ "@?C)_T3W5?^^%_QH_X4#\9/
M^B>ZK_WPO^->8T4 >G?\*!^,G_1/=5_[X7_&C_A0/QD_Z)[JO_?"_P"->8T4
M >G?\*!^,G_1/=5_[X7_ !H_X4#\9/\ HGNJ_P#?"_XUYC10!Z=_PH'XR?\
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M3W5?^^%_QH_X4#\9/^B>ZK_WPO\ C7F-% 'IW_"@?C)_T3W5?^^%_P :/^%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M_&>BO3?LWP#_ .@SX_\ _!99?_)%'V;X!_\ 09\?_P#@LLO_ )(H \RHKTW[
M-\ _^@SX_P#_  667_R11]F^ ?\ T&?'_P#X+++_ .2* /,J*]-^S? /_H,^
M/_\ P667_P D4?9O@'_T&?'_ /X+++_Y(H \RHKTW[-\ _\ H,^/_P#P667_
M ,D4?9O@'_T&?'__ (+++_Y(H \RHKTW[-\ _P#H,^/_ /P667_R11]F^ ?_
M $&?'_\ X+++_P"2* /,J*]-^S? /_H,^/\ _P %EE_\D4?9O@'_ -!GQ_\
M^"RR_P#DB@#S*BO3?LWP#_Z#/C__ ,%EE_\ )%'V;X!_]!GQ_P#^"RR_^2*
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M'V;X!_\ 09\?_P#@LLO_ )(H \RHKTW[-\ _^@SX_P#_  667_R11]F^ ?\
MT&?'_P#X+++_ .2* /,J*]-^S? /_H,^/_\ P667_P D4?9O@'_T&?'_ /X+
M++_Y(H \RHKTW[-\ _\ H,^/_P#P667_ ,D4?9O@'_T&?'__ (+++_Y(H \R
MHKTW[-\ _P#H,^/_ /P667_R11]F^ ?_ $&?'_\ X+++_P"2* /,J*]-^S?
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M%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^,]%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %>S_ ++?_)S?A'_M\_\ 2.:O&*]G_9;_ .3F_"/_ &^?^D<U
M 'Z8T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110!^3?_  MCXI?]%+\5?^#F
MY_\ BZ/^%L?%+_HI?BK_ ,'-S_\ %UQ=% ':?\+8^*7_ $4OQ5_X.;G_ .+H
M_P"%L?%+_HI?BK_P<W/_ ,77%T4 =I_PMCXI?]%+\5?^#FY_^+H_X6Q\4O\
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M (NC_A;'Q2_Z*7XJ_P#!S<__ !=<710!VG_"V/BE_P!%+\5?^#FY_P#BZ/\
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M_P"#FY_^+H_X6Q\4O^BE^*O_  <W/_Q=<710!VG_  MCXI?]%+\5?^#FY_\
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M_P!%"TK_ +[;_"@#P#_AAC_JJ/\ Y1/_ +HH_P"&&/\ JJ/_ )1/_NBO?_\
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MX4?\+^^#?_10M*_[[;_"@#P#_AAC_JJ/_E$_^Z*/^&&/^JH_^43_ .Z*]_\
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MLWNHM)A^S3'4& W1QR0R(SNK%"H5<;LD'=TI]5<:U,I/V8_@3)&LB>!\JP#
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^[M/+9R98GCC9=VX< LVWCCJ0>,>T]ZIQ:W)3N.HHHI#"BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
AHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>ltbr_ex32img2.jpg
<TEXT>
begin 644 ltbr_ex32img2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" 2D Y8# 2(  A$! Q$!_\0
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M#U_Y3+/_ .,T ?IC17YG?\-1_'7_ *'K_P IEG_\9H_X:C^.O_0]?^4RS_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *XOQQ#IE_I5GHVN>%Y-<TG49S;W2QVS3FU7RG(EVJ"PP
MP50R\@L".E=I12]0/GNST7Q%X?\  _Q&\+VLWB'7O#']E.ND/J=M-+>_:)8I
M%>W0; [QCY,';@%B,G!KIO!G@73[?2_#OC3Q#>:]K6K:3I:P6<6IVX5M-S&!
M(L4$<,;%CC;N96<@#FO7**35[^:L'8\%^$_PYAU+P)X2O/%USKUQ)H<KW-MH
M>J6ZVUO97&]BL@3R4DD(!RI=G W'%>F>*;E+>_\ #OF6=Y<1KJ!DD^S64MP$
M3[/,N6\M6P,LHY]:["DJP>M_,^>]/^'_ (@\%?&WPW9Z&EU>>!;N_N]452A9
M='N&M9T,0QPL3^8"N0 ",=3S#)X=\2:AX'\(^&VTV_\ ^$KT;Q0EU<Z@]K(B
M;%N9'EN5G(V,KQ-G 8D[MN,@@?15%1O9]AWW\SPW]I*^AO/V9O&311SH(I;6
M%O.MY(266\@!(#J-R^C#*GL37YM5^K?Q9\$W7Q%^%FL^#;&^BLKC4?(VSS*6
M1/+GCD.0.>0A'XU\K_\ #$/BK_H=]*_\!Y*H1\F45]9_\,0^*O\ H=]*_P#
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MZ[;_ &I84%U)'+*!\[QQE%)]E))'YFK5%)*Q;=PHHHIB"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ME0U[;_Z0Z*%Y5-NV3GJ=W3@5!X@^%NK:R_CP?\)3:V\?C"U@M7 TUF-J(D*
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M1=%()VCD9+<XQ6+'JFN:3\:];US5/#%PU^OA7[0NFZ=?27QN,3X58PRH$<X
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M\"N8LO@PUG\!H_A5-XH$I@N!<0ZBECLP1<_: &B\P[ANR#AAQZ5<;)^]M?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ML7]E=:?=ZY!%!=:"FBRFRL/)?<CEUN ?-;#[B"<@YQUJOM>5OQ(=^73>_P"
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MX5\*Z;:^'H].,YM=0UJ6)[=0V$B0BWE,K,>!G') &<UT>B>!=5T;7/&&K?\
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M*R*0=Y'+<<\,T_X6W&CZYX<U2QUZ+&D75_?3)+8EFNIKLL9#N$H"*-V%&#@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6O+:?4;B^TW4M+L9KV&>.5]PCD\M289%)P=^%[ANM>X44)V \A\5:I-#\6?
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#PS=:MXFT/6K74HK5M-$\,T4MMYPN(9@H=1\Z[&^1<-\PZY4UUE%,#R[P_\
M"U-"LM*\._VL+WPKHEX+_3+&:V(N890S,JO/OPZ*SL5'EJ>%!9@#GIO%OA>3
MQ-#H[6^H?8+K2=2BU&"5HO-4L@92K+N7(*NPZ\'!YQ@]32]J3UW#;8\.U+X.
M^*+VR\1V*^-]-CAUS7(M<<MH;L\3QLA5 1= $?NH\G _BZ9&.KT_P%K6C^+;
MZ]TKQ=)::!J<[7U[I"6:%FN6 \QXIV8M&CD E<$@YVLN<CT:D%/8'J<+X\\(
MZWXJ.A?V7KUEI0TG48]3Q<Z<]WYTL9R@^6:/:O+9')/&",<YUU\.M2@\?7GB
M[POXLFT2;6/)76;9[-;F.[\I0J/'N8>2^W(S\PZ?+D<^FT4+38=SY^^-V@R>
M&_A=\0M4M]>MK71]:A62?3KF#=))>%8XPT4QD&-RQIE"C$D$@C-;<_PY_P"$
MQ\,ZI-I/BJ&VTGQ?H]K#=%+07#;HX]J212"0*%*D J5;.,AA7L9Z4HXI)(5W
MH>-ZE\)_%%_K&OZ@OCBQ!UC04T!O.T5G9(AG,F5N%!<[W_A &5XX.=O4?A_K
M=YX=\-_9_%D.G>*O#NY+35[;3LPM&R['C>W>5MP9 N?GSN4,,=*])/6EI@>5
M7WP_\57'CK0?%D'C2V:^TJPGM2+W23*L\DP&]\)/&$4;4P@'&#EF+9K(L/@_
MXDL],\'6#>,M-E3POJ,U_&W]BN#<"3=E&_THX_UDG(]5X^4[O;.])2[>0=&N
MYYEX1^'FM>!1+H_A_P 82'PS")7TW2KNQ$IM)')8!I@ZM)$&+$)\IZ OZX&D
M?!OQ'IH\$PS^--/N+?PEJ$]]"$T5XWN!*6WHS?:2!]]\$#NN0<'/MM&:8'G-
MMX!U:Q\%S^%[77[&6S>2X58K_2O/B:"60OLD42J78;F&X,H/'R\<ZVG>!]'L
M?AG#\/KAI]0TE+#^SG-P^7EB*[3DC&#@\8Z<8Z5U]%*RLUT#KS=3S.Q^'>I1
MWFBZAJGB*WU*^\-6\UOH$S:>T:V_F1B/?<J)?W[A0H^4Q _-P"01K> ?"^M>
M#]!DT?5]>L=6A6:6:![;3WM'0R2O+(&S-(&&Y^,!< <[NM=QVHI >0>*/A+J
M.O:3JVFZ?XJ@T^UU'6HM: FTTSM&Z[&*$B9-P+QJ0>, L.20P)_A3K5_?^)[
M_4O%ULMUK%S:WUI-8:6T+Z?=6P AD&^>0.,+AE(&[)Y&<5Z]0*:5DEV"^_F<
M[X;TS7=-TT+XB\1-KNHL )+E;5;6+C.-L2D[>O)+$D^@P!SECX%UC2?&.H7F
MC>,)K'P[J=RU]=Z,+-'<W#C]XT=P3NC5B 2NT\[MI7/'HU%'6X=+'D=U\,?$
MK>)M)\8?\)M8P^(-/N;B6XO_ .RI-MU:R!0+5D^TX6-0OOR PVMN+<G\/;&S
M^(?_  FNF6GC*QNO#Y\4W%Y=65BJ23S+YRR1,)@Y"PN4_N$L%.UQS7T-2TTQ
M;GF^D?#[6/#_ (GOYM%\72VGAN^N9+^31S9J[+<N=SE)]VY8V;DIC/)PPSQS
M2_!O7T^$WB#P')XRL776KZ2\>[&CN#$))/,D4)]I.?FQ@YX&00V<CVS-&:%H
MM >KNSR2[^&?BV\UOQ!K$WC'2?/UK1$T5T70Y D2KG,@_P!*R2=\G!/&5Z[3
MNI1?!O4[N]T)?$7BC3]2TO3-"E\/RVD&E26[7-O(H4MYGVEMCX1.0".&XY&/
M::6E9;#6AY--\-?%EU\.-9\&ZG\0CJ$5Y9MIUI/+I:K]F@8;3YBI(#-)LX#9
M49Y*FJMK\)_$$=Q;1WWC"PN+*+PV_AEHH-'>*1H611YF\W+ /N53]TC&1CN/
M8J*-P6AS%GH$DW@H>&M>O(M3$EJ;.YD@@-NDJ%=APF]BOR_[1YS]!P4WP=U#
M5-5\,2^(/%D>H:=X>M[JQ@MHM.\E[BVGA$)263S6!;8""RJN<Y 4]?8Z*.K?
M<%HDD>=^#_ _B#PGI;Z(/'$]]I%I!]GTB![%$ELD (3S) ?W^T8 RJCCD$XQ
MS7B;X,WOB?PCXGTB3Q)96%]XEO+:YO;BUTEE@Q 05VP^?Q(Q5=TA<[@/NC@C
MVOO24[ZW \"\71_VG\4%CNO&V@Z%K&EP6\5G!K/A^.[ENIL,YFL \H?!+;<(
M7;<N#T7.G'\-?&VKW'B#Q!J_BS2K;4O$FA1Z/<0IH\C);@9!<?Z2"6(>3C P
M2O\ =(;VJC/%3;N.YQOA/0/$>A66G6.I^([34+"RT^.R6&#3S;EI$.!+N,KD
M?(%4KZ@MD9VCLNU%+5-MLE*P4444#"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 1.K%"$8*V.#C(!^E<-\.? 7_"O=*U'38]6;
M48;Z_EU LT'ELDDARXX8@KP,#&1SR>W?4G>EL M%%%, HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MMKZQN8%N95@N(IGE=&20Q95E,I!&SD=^*^C:*?0+GS58? ;Q1H=I\-8=-O\
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ME5+?+.[,B@$E>  >.]>TZWX;\/\ B2UBM?$6AV&LVT;^8D-]:I.BO@C<%<$
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M%\*^%_#9G/AWPWI>C&?!E^P6<=OYF.F[8!G\:W?6FWL M%%% !1110 4444
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M_#;WBK_H2-*_\")*/^&WO%7_ $)&E?\ @1)7R910!]9_\-O>*O\ H2-*_P#
MB2C_ (;>\5?]"1I7_@1)7R910!]9_P##;WBK_H2-*_\  B2C_AM[Q5_T)&E?
M^!$E?)E% 'UG_P -O>*O^A(TK_P(DH_X;>\5?]"1I7_@1)7R910!]9_\-O>*
MO^A(TK_P(DH_X;>\5?\ 0D:5_P"!$E?)E% 'UG_PV]XJ_P"A(TK_ ,")*/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M $(O_E3L_P#X]1_PRY\=?^A%_P#*G9__ !ZO&** /9_^&7/CK_T(O_E3L_\
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MGQU_Z$7_ ,J=G_\ 'J\8HH ]G_X9<^.O_0B_^5.S_P#CU'_#+GQU_P"A%_\
M*G9__'J\8HH ]G_X9<^.O_0B_P#E3L__ (]1_P ,N?'7_H1?_*G9_P#QZO&*
M* /9_P#AESXZ_P#0B_\ E3L__CU'_#+GQU_Z$7_RIV?_ ,>KQBB@#V?_ (9<
M^.O_ $(O_E3L_P#X]1_PRY\=?^A%_P#*G9__ !ZO&** /9_^&7/CK_T(O_E3
ML_\ X]1_PRY\=?\ H1?_ "IV?_QZO&** /9_^&7/CK_T(O\ Y4[/_P"/4?\
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M2'5?_"J;_P"1J /,J*]-_P"$J^#?_1(=5_\ "J;_ .1J/^$J^#?_ $2'5?\
MPJF_^1J /,J*]-_X2KX-_P#1(=5_\*IO_D:C_A*O@W_T2'5?_"J;_P"1J /,
MJ*]-_P"$J^#?_1(=5_\ "J;_ .1J/^$J^#?_ $2'5?\ PJF_^1J /,J*]-_X
M2KX-_P#1(=5_\*IO_D:C_A*O@W_T2'5?_"J;_P"1J /,J*]-_P"$J^#?_1(=
M5_\ "J;_ .1J/^$J^#?_ $2'5?\ PJF_^1J /,J*]-_X2KX-_P#1(=5_\*IO
M_D:C_A*O@W_T2'5?_"J;_P"1J /,J*]-_P"$J^#?_1(=5_\ "J;_ .1J/^$J
M^#?_ $2'5?\ PJF_^1J /,J*]-_X2KX-_P#1(=5_\*IO_D:C_A*O@W_T2'5?
M_"J;_P"1J /,J*]-_P"$J^#?_1(=5_\ "J;_ .1J/^$J^#?_ $2'5?\ PJF_
M^1J /,J*]-_X2KX-_P#1(=5_\*IO_D:C_A*O@W_T2'5?_"J;_P"1J /,J*]-
M_P"$J^#?_1(=5_\ "J;_ .1J/^$J^#?_ $2'5?\ PJF_^1J /,J*]-_X2KX-
M_P#1(=5_\*IO_D:C_A*O@W_T2'5?_"J;_P"1J /,J*]-_P"$J^#?_1(=5_\
M"J;_ .1J/^$J^#?_ $2'5?\ PJF_^1J /,J*]-_X2KX-_P#1(=5_\*IO_D:C
M_A*O@W_T2'5?_"J;_P"1J /,J*]-_P"$J^#?_1(=5_\ "J;_ .1J/^$J^#?_
M $2'5?\ PJF_^1J /,J*]-_X2KX-_P#1(=5_\*IO_D:C_A*O@W_T2'5?_"J;
M_P"1J /,J*]-_P"$J^#?_1(=5_\ "J;_ .1J/^$J^#?_ $2'5?\ PJF_^1J
M/,J*]-_X2KX-_P#1(=5_\*IO_D:C_A*O@W_T2'5?_"J;_P"1J /,J*]-_P"$
MJ^#?_1(=5_\ "J;_ .1J/^$J^#?_ $2'5?\ PJF_^1J /,J*]-_X2KX-_P#1
M(=5_\*IO_D:C_A*O@W_T2'5?_"J;_P"1J /,J*]-_P"$J^#?_1(=5_\ "J;_
M .1J/^$J^#?_ $2'5?\ PJF_^1J /,J*]-_X2KX-_P#1(=5_\*IO_D:C_A*O
M@W_T2'5?_"J;_P"1J /,J*]-_P"$J^#?_1(=5_\ "J;_ .1J/^$J^#?_ $2'
M5?\ PJF_^1J /,J*]-_X2KX-_P#1(=5_\*IO_D:C_A*O@W_T2'5?_"J;_P"1
MJ /,J*]-_P"$J^#?_1(=5_\ "J;_ .1J/^$J^#?_ $2'5?\ PJF_^1J /,J*
M]-_X2KX-_P#1(=5_\*IO_D:C_A*O@W_T2'5?_"J;_P"1J /,J*]-_P"$J^#?
M_1(=5_\ "J;_ .1J/^$J^#?_ $2'5?\ PJF_^1J /,J*]-_X2KX-_P#1(=5_
M\*IO_D:C_A*O@W_T2'5?_"J;_P"1J /,J*]-_P"$J^#?_1(=5_\ "J;_ .1J
M/^$J^#?_ $2'5?\ PJF_^1J /,J*]-_X2KX-_P#1(=5_\*IO_D:C_A*O@W_T
M2'5?_"J;_P"1J /,J*]-_P"$J^#?_1(=5_\ "J;_ .1J/^$J^#?_ $2'5?\
MPJF_^1J /,J*^C/A'H7P=^*GQ!B\)+\.]5T?S+>2?[3_ ,) T^-@SC;Y*]?K
M7T;_ ,,A_!O_ )\M5_\  ]O\* /,OV&?^:@_]P[_ -N:^S*\]^'/PB\'_"UM
M4_X1*&ZB_M/ROM'VB<RY\O?MQGI_K&KT*@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M**V_^$3\4_\ 0LZK_P" <G_Q-'_")^*?^A9U7_P#D_\ B: ,2BMO_A$_%/\
MT+.J_P#@')_\31_PB?BG_H6=5_\  .3_ .)H Q**V_\ A$_%/_0LZK_X!R?_
M !-'_")^*?\ H6=5_P# .3_XF@#$HK;_ .$3\4_]"SJO_@')_P#$T?\ ")^*
M?^A9U7_P#D_^)H Q**V_^$3\4_\ 0LZK_P" <G_Q-'_")^*?^A9U7_P#D_\
MB: ,2BMO_A$_%/\ T+.J_P#@')_\31_PB?BG_H6=5_\  .3_ .)H Q**V_\
MA$_%/_0LZK_X!R?_ !-'_")^*?\ H6=5_P# .3_XF@#$HK;_ .$3\4_]"SJO
M_@')_P#$T?\ ")^*?^A9U7_P#D_^)H Q**V_^$3\4_\ 0LZK_P" <G_Q-'_"
M)^*?^A9U7_P#D_\ B: ,2BMO_A$_%/\ T+.J_P#@')_\31_PB?BG_H6=5_\
M .3_ .)H Q**V_\ A$_%/_0LZK_X!R?_ !-'_")^*?\ H6=5_P# .3_XF@#$
MHK;_ .$3\4_]"SJO_@')_P#$T?\ ")^*?^A9U7_P#D_^)H Q**V_^$3\4_\
M0LZK_P" <G_Q-'_")^*?^A9U7_P#D_\ B: ,2BMO_A$_%/\ T+.J_P#@')_\
M31_PB?BG_H6=5_\  .3_ .)H Q**V_\ A$_%/_0LZK_X!R?_ !-'_")^*?\
MH6=5_P# .3_XF@#$HK;_ .$3\4_]"SJO_@')_P#$T?\ ")^*?^A9U7_P#D_^
M)H Q**V_^$3\4_\ 0LZK_P" <G_Q-'_")^*?^A9U7_P#D_\ B: ,2BMO_A$_
M%/\ T+.J_P#@')_\31_PB?BG_H6=5_\  .3_ .)H Q**V_\ A$_%/_0LZK_X
M!R?_ !-'_")^*?\ H6=5_P# .3_XF@#$HK;_ .$3\4_]"SJO_@')_P#$T?\
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M?]%+\5?^#FY_^+KBZ* .T_X6Q\4O^BE^*O\ P<W/_P 71_PMCXI?]%+\5?\
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M ,'-S_\ %T?\+8^*7_12_%7_ (.;G_XNN+HH [3_ (6Q\4O^BE^*O_!S<_\
MQ='_  MCXI?]%+\5?^#FY_\ BZXNB@#M/^%L?%+_ **7XJ_\'-S_ /%T?\+8
M^*7_ $4OQ5_X.;G_ .+KBZ* .T_X6Q\4O^BE^*O_  <W/_Q='_"V/BE_T4OQ
M5_X.;G_XNN+HH [3_A;'Q2_Z*7XJ_P#!S<__ !='_"V/BE_T4OQ5_P"#FY_^
M+KBZ* .T_P"%L?%+_HI?BK_P<W/_ ,71_P +8^*7_12_%7_@YN?_ (NN+HH
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MEXJ_\)FV_P#D^C^S_A9_T.7BK_PF;;_Y/KBZ* .T_L_X6?\ 0Y>*O_"9MO\
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M [3^S_A9_P!#EXJ_\)FV_P#D^C^S_A9_T.7BK_PF;;_Y/KBZ* .T_L_X6?\
M0Y>*O_"9MO\ Y/H_L_X6?]#EXJ_\)FV_^3ZXNB@#VGX8^*/A;\-_B=I'C/\
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M7]\9/^BA:K_WVO\ A1_PO[XR?]%"U7_OM?\ "@#S&BO3O^%_?&3_ **%JO\
MWVO^%'_"_OC)_P!%"U7_ +[7_"@#S&BO3O\ A?WQD_Z*%JO_ 'VO^%'_  O[
MXR?]%"U7_OM?\* /,:*]._X7]\9/^BA:K_WVO^%'_"_OC)_T4+5?^^U_PH \
MQHKT[_A?WQD_Z*%JO_?:_P"%'_"_OC)_T4+5?^^U_P * /,:*]._X7]\9/\
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M10 4444 %%%% !1110 4444 %%%% !1110!^,]%>G_\ "I]/_P"BP?#_ /\
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M /X&W7_R-0!YA17I_P#PJ?3_ /HL'P__ / VZ_\ D:C_ (5/I_\ T6#X?_\
M@;=?_(U 'F%%>G_\*GT__HL'P_\ _ VZ_P#D:C_A4^G_ /18/A__ .!MU_\
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M_P!%@^'_ /X&W7_R-0!YA17I_P#PJ?3_ /HL'P__ / VZ_\ D:C_ (5/I_\
MT6#X?_\ @;=?_(U 'F%%>G_\*GT__HL'P_\ _ VZ_P#D:C_A4^G_ /18/A__
M .!MU_\ (U 'F%%>G_\ "I]/_P"BP?#_ /\  VZ_^1J/^%3Z?_T6#X?_ /@;
M=?\ R-0!YA17I_\ PJ?3_P#HL'P__P# VZ_^1J/^%3Z?_P!%@^'_ /X&W7_R
M-0!YA17I_P#PJ?3_ /HL'P__ / VZ_\ D:C_ (5/I_\ T6#X?_\ @;=?_(U
M'ZDT5YE_PO[X-_\ 10M*_P"^V_PH_P"%_?!O_HH6E?\ ?;?X4 >FT5RGA7Q]
MX-\<_;/^$1\06NL"RV?:/LY)\K?NVYR.^UORKJZ "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HK*U35=-T/2YM4UG4K73;"$CS;J[G6&*/+!1N=B ,D@#)ZD"L'_A;'
MPL_Z*7X5_P#!S;?_ != 'Y-4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?9G[
M#/\ S4'_ +AW_MS7V97QG^PS_P U!_[AW_MS7V90 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 >,?M1_\FR>+O\ MS_]+(:_,ZOTQ_:C_P"39/%W_;G_ .ED-?F=0 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5JZ3J"Z3K-AJGV&TO_ +'<)<?9;V/S()]C!MDB9&Y#C!&>02*RJ* /9_\
MA?O_ %1;X5?^$Y_]LH_X7[_U1;X5?^$Y_P#;*\8HH ]G_P"%^_\ 5%OA5_X3
MG_VRC_A?O_5%OA5_X3G_ -LKQBB@#V?_ (7[_P!46^%7_A.?_;*/^%^_]46^
M%7_A.?\ VRO&** /9_\ A?O_ %1;X5?^$Y_]LH_X7[_U1;X5?^$Y_P#;*\8H
MH ]G_P"%^_\ 5%OA5_X3G_VRC_A?O_5%OA5_X3G_ -LKQBB@#V?_ (7[_P!4
M6^%7_A.?_;*/^%^_]46^%7_A.?\ VRO&** /9_\ A?O_ %1;X5?^$Y_]LH_X
M7[_U1;X5?^$Y_P#;*\8HH ]G_P"%^_\ 5%OA5_X3G_VRC_A?O_5%OA5_X3G_
M -LKQBB@#V?_ (7[_P!46^%7_A.?_;*/^%^_]46^%7_A.?\ VRO&** /9_\
MA?O_ %1;X5?^$Y_]LH_X7[_U1;X5?^$Y_P#;*\8HH ]G_P"%^_\ 5%OA5_X3
MG_VRC_A?O_5%OA5_X3G_ -LKQBB@#V?_ (7[_P!46^%7_A.?_;*/^%^_]46^
M%7_A.?\ VRO&** /9_\ A?O_ %1;X5?^$Y_]LH_X7[_U1;X5?^$Y_P#;*\8H
MH ]G_P"%^_\ 5%OA5_X3G_VRC_A?O_5%OA5_X3G_ -LKQBB@#V?_ (7[_P!4
M6^%7_A.?_;*/^%^_]46^%7_A.?\ VRO&** /9_\ A?O_ %1;X5?^$Y_]LH_X
M7[_U1;X5?^$Y_P#;*\8HH ]G_P"%^_\ 5%OA5_X3G_VRC_A?O_5%OA5_X3G_
M -LKQBB@#V?_ (7[_P!46^%7_A.?_;*/^%^_]46^%7_A.?\ VRO&** /9_\
MA?O_ %1;X5?^$Y_]LH_X7[_U1;X5?^$Y_P#;*\8HH ]G_P"%^_\ 5%OA5_X3
MG_VRC_A?O_5%OA5_X3G_ -LKQBB@#V?_ (7[_P!46^%7_A.?_;*/^%^_]46^
M%7_A.?\ VRO&** /9_\ A?O_ %1;X5?^$Y_]LH_X7[_U1;X5?^$Y_P#;*\8H
MH ]G_P"%^_\ 5%OA5_X3G_VRC_A?O_5%OA5_X3G_ -LKQBB@#V?_ (7[_P!4
M6^%7_A.?_;*/^%^_]46^%7_A.?\ VRO&** /9_\ A?O_ %1;X5?^$Y_]LH_X
M7[_U1;X5?^$Y_P#;*\8HH ]G_P"%^_\ 5%OA5_X3G_VRO7/V?O%F@_%;XB7_
M (=\1?"3X?6UI;Z9)>JUAH*)(766) "79AC$C=LYQS7QY7TU^Q7_ ,EMUG_L
M7YO_ $IMZ /LO_A4_P +/^B:>%?_  36W_Q%'_"I_A9_T33PK_X)K;_XBNSH
MH P-"\)^&?"[W'_",^&=*T07.WS_ .SK..W\W;G;NV*-V-S8STR?6M^BB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH \8_:C_Y-D\7?]N?_ *60U^9U?KSXH\+Z'XP\
M-7?AOQ%8_;M+O-GG6_FO'OV.KK\R$,,,JG@]J\W_ .&7/@7_ -"-_P"5.\_^
M/4 ?F=17Z8_\,N? O_H1O_*G>?\ QZC_ (9<^!?_ $(W_E3O/_CU 'YG45^F
M/_#+GP+_ .A&_P#*G>?_ !ZC_AESX%_]"-_Y4[S_ ./4 ?F=17Z8_P##+GP+
M_P"A&_\ *G>?_'J/^&7/@7_T(W_E3O/_ (]0!^9U%?IC_P ,N? O_H1O_*G>
M?_'J/^&7/@7_ -"-_P"5.\_^/4 ?F=17Z8_\,N? O_H1O_*G>?\ QZC_ (9<
M^!?_ $(W_E3O/_CU 'YG45^F/_#+GP+_ .A&_P#*G>?_ !ZC_AESX%_]"-_Y
M4[S_ ./4 ?F=17Z8_P##+GP+_P"A&_\ *G>?_'J/^&7/@7_T(W_E3O/_ (]0
M!^9U%?IC_P ,N? O_H1O_*G>?_'J/^&7/@7_ -"-_P"5.\_^/4 ?F=17Z8_\
M,N? O_H1O_*G>?\ QZC_ (9<^!?_ $(W_E3O/_CU 'YG45^F/_#+GP+_ .A&
M_P#*G>?_ !ZC_AESX%_]"-_Y4[S_ ./4 ?F=17Z8_P##+GP+_P"A&_\ *G>?
M_'J/^&7/@7_T(W_E3O/_ (]0!^9U%?IC_P ,N? O_H1O_*G>?_'J/^&7/@7_
M -"-_P"5.\_^/4 ?F=6MH>CWGB#Q%IF@Z:J->ZE=16< =MJF21PBY/89(YK]
M&_\ AESX%_\ 0C?^5.\_^/5;TG]G7X/Z'K=AK6E^#?L]_I]Q'=6\O]H73^7*
MC!D;#2D'! .""* /D/\ X9#^,O\ SY:5_P"!Z_X4?\,A_&7_ )\M*_\  ]?\
M*_1BB@#\Y_\ AD/XR_\ /EI7_@>O^%'_  R'\9?^?+2O_ ]?\*_1BB@#\Y_^
M&0_C+_SY:5_X'K_A1_PR'\9?^?+2O_ ]?\*_1BB@#\Y_^&0_C+_SY:5_X'K_
M (4?\,A_&7_GRTK_ ,#U_P *_1BB@#\Y_P#AD/XR_P#/EI7_ ('K_A1_PR'\
M9?\ GRTK_P #U_PK]&** /SG_P"&0_C+_P ^6E?^!Z_X4?\ #(?QE_Y\M*_\
M#U_PK]&** /SG_X9#^,O_/EI7_@>O^%'_#(?QE_Y\M*_\#U_PK]&** /SG_X
M9#^,O_/EI7_@>O\ A1_PR'\9?^?+2O\ P/7_  K]&** /SG_ .&0_C+_ ,^6
ME?\ @>O^%'_#(?QE_P"?+2O_  /7_"OT8HH _.?_ (9#^,O_ #Y:5_X'K_A1
M_P ,A_&7_GRTK_P/7_"OT8HH _.?_AD/XR_\^6E?^!Z_X4?\,A_&7_GRTK_P
M/7_"OT8HH _.?_AD/XR_\^6E?^!Z_P"%'_#(?QE_Y\M*_P# ]?\ "OT8HH _
M.?\ X9#^,O\ SY:5_P"!Z_X4?\,A_&7_ )\M*_\  ]?\*_1BB@#\Y_\ AD/X
MR_\ /EI7_@>O^%'_  R'\9?^?+2O_ ]?\*_1BB@#\Y_^&0_C+_SY:5_X'K_A
M1_PR'\9?^?+2O_ ]?\*_1BB@#\Y_^&0_C+_SY:5_X'K_ (4?\,A_&7_GRTK_
M ,#U_P *_1BB@#\Y_P#AD/XR_P#/EI7_ ('K_A1_PR'\9?\ GRTK_P #U_PK
M]&** /SG_P"&0_C+_P ^6E?^!Z_X4?\ #(?QE_Y\M*_\#U_PK]&** /SG_X9
M#^,O_/EI7_@>O^%'_#(?QE_Y\M*_\#U_PK]&** /SG_X9#^,O_/EI7_@>O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?HS^R'
M_P F\VO_ &$+G_T(5^<U?HS^R'_R;S:_]A"Y_P#0A0![_1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 ?EI]F^ ?_ $&?'_\ X+++_P"2*/LW
MP#_Z#/C_ /\ !99?_)%>944 >F_9O@'_ -!GQ_\ ^"RR_P#DBC[-\ _^@SX_
M_P#!99?_ "17F5% 'IOV;X!_]!GQ_P#^"RR_^2*/LWP#_P"@SX__ /!99?\
MR17F5% 'IOV;X!_]!GQ__P""RR_^2*/LWP#_ .@SX_\ _!99?_)%>944 >F_
M9O@'_P!!GQ__ ."RR_\ DBC[-\ _^@SX_P#_  667_R17F5% 'IOV;X!_P#0
M9\?_ /@LLO\ Y(H^S? /_H,^/_\ P667_P D5YE10!Z;]F^ ?_09\?\ _@LL
MO_DBC[-\ _\ H,^/_P#P667_ ,D5YE10!Z;]F^ ?_09\?_\ @LLO_DBC[-\
M_P#H,^/_ /P667_R17F5% 'IOV;X!_\ 09\?_P#@LLO_ )(H^S? /_H,^/\
M_P %EE_\D5YE10!Z;]F^ ?\ T&?'_P#X+++_ .2*/LWP#_Z#/C__ ,%EE_\
M)%>944 >F_9O@'_T&?'_ /X+++_Y(H^S? /_ *#/C_\ \%EE_P#)%>944 >F
M_9O@'_T&?'__ (+++_Y(H^S? /\ Z#/C_P#\%EE_\D5YE10!Z;]F^ ?_ $&?
M'_\ X+++_P"2*/LWP#_Z#/C_ /\ !99?_)%>944 >F_9O@'_ -!GQ_\ ^"RR
M_P#DBC[-\ _^@SX__P#!99?_ "17F5% 'IOV;X!_]!GQ_P#^"RR_^2*/LWP#
M_P"@SX__ /!99?\ R17F5% 'IOV;X!_]!GQ__P""RR_^2*/LWP#_ .@SX_\
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M#_Z#/C__ ,%EE_\ )%>944 >F_9O@'_T&?'_ /X+++_Y(H^S? /_ *#/C_\
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M^@SX_P#_  667_R17F5% 'IOV;X!_P#09\?_ /@LLO\ Y(H^S? /_H,^/_\
MP667_P D5YE10!Z;]F^ ?_09\?\ _@LLO_DBC[-\ _\ H,^/_P#P667_ ,D5
MYE10!Z;]F^ ?_09\?_\ @LLO_DBC[-\ _P#H,^/_ /P667_R17F5% 'IOV;X
M!_\ 09\?_P#@LLO_ )(H^S? /_H,^/\ _P %EE_\D5YE10!Z;]F^ ?\ T&?'
M_P#X+++_ .2*/LWP#_Z#/C__ ,%EE_\ )%>944 >F_9O@'_T&?'_ /X+++_Y
M(H^S? /_ *#/C_\ \%EE_P#)%>944 >F_9O@'_T&?'__ (+++_Y(H^S? /\
MZ#/C_P#\%EE_\D5YE10!Z;]F^ ?_ $&?'_\ X+++_P"2*].^%/P1^&/Q>_MC
M_A&O%/BFT_LGR?/_ +1L;9-WF[]NW9(^?]6V<XZCK7S)7V9^PS_S4'_N'?\
MMS0!M?\ #$/A7_H=]5_\!XZ]X^&/P[L_ACX'B\*6.I3ZC#'/)/YTZ!6)<Y(P
M.*[JB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /QGHKM/
M^%L?%+_HI?BK_P '-S_\71_PMCXI?]%+\5?^#FY_^+H XNBNT_X6Q\4O^BE^
M*O\ P<W/_P 71_PMCXI?]%+\5?\ @YN?_BZ .+HKM/\ A;'Q2_Z*7XJ_\'-S
M_P#%T?\ "V/BE_T4OQ5_X.;G_P"+H XNBNT_X6Q\4O\ HI?BK_P<W/\ \71_
MPMCXI?\ 12_%7_@YN?\ XN@#BZ*[3_A;'Q2_Z*7XJ_\ !S<__%T?\+8^*7_1
M2_%7_@YN?_BZ .+HKM/^%L?%+_HI?BK_ ,'-S_\ %T?\+8^*7_12_%7_ (.;
MG_XN@#BZ*[3_ (6Q\4O^BE^*O_!S<_\ Q='_  MCXI?]%+\5?^#FY_\ BZ .
M+HKM/^%L?%+_ **7XJ_\'-S_ /%T?\+8^*7_ $4OQ5_X.;G_ .+H XNBNT_X
M6Q\4O^BE^*O_  <W/_Q='_"V/BE_T4OQ5_X.;G_XN@#BZ*[3_A;'Q2_Z*7XJ
M_P#!S<__ !='_"V/BE_T4OQ5_P"#FY_^+H XNBNT_P"%L?%+_HI?BK_P<W/_
M ,71_P +8^*7_12_%7_@YN?_ (N@#BZ*[3_A;'Q2_P"BE^*O_!S<_P#Q='_"
MV/BE_P!%+\5?^#FY_P#BZ .+HKM/^%L?%+_HI?BK_P '-S_\71_PMCXI?]%+
M\5?^#FY_^+H XNBNT_X6Q\4O^BE^*O\ P<W/_P 71_PMCXI?]%+\5?\ @YN?
M_BZ .+HKM/\ A;'Q2_Z*7XJ_\'-S_P#%T?\ "V/BE_T4OQ5_X.;G_P"+H XN
MBNT_X6Q\4O\ HI?BK_P<W/\ \71_PMCXI?\ 12_%7_@YN?\ XN@#BZ*[3_A;
M'Q2_Z*7XJ_\ !S<__%T?\+8^*7_12_%7_@YN?_BZ .+HKM/^%L?%+_HI?BK_
M ,'-S_\ %T?\+8^*7_12_%7_ (.;G_XN@#BZ*[3_ (6Q\4O^BE^*O_!S<_\
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M%+_HI?BK_P '-S_\71_PMCXI?]%+\5?^#FY_^+H XNBNT_X6Q\4O^BE^*O\
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M>WD _P!F2.-74^ZD&@#].:*_)O\ X6Q\4O\ HI?BK_P<W/\ \71_PMCXI?\
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M_P (K\&_^BO:K_X2K?\ R31_PBOP;_Z*]JO_ (2K?_)- 'F5%>F_\(K\&_\
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M_P#A*M_\DT?\(K\&_P#HKVJ_^$JW_P DT >945Z;_P (K\&_^BO:K_X2K?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#M?A3_ ,EO\!_]C!8?^E*5^L=?DY\*?^2W
M^ _^Q@L/_2E*_6.@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH X7Q1\3O!O@U[G_ (22\O[&*UV>?<KI-W-;Q%\;0TT<31@G(XW9Y%:?AWQA
MHOBP3'1_MY\J..8_;--N;/<DF[8R^?&F]3M/*Y'%>9_M5?\ )MVO?]=[3_TH
M2M/Q9KT'AW]G6VU2;Q!=:&%T^R1;NTA$TQ+>6-B+N7YG&5SN7;G=D8I='ZV#
MJD>N'I7->(_&?A_PB^E1^(;Z2R&JW2V5HWV:619)F^ZA9%(0GMN(S@^AKYU\
M-Z[\3-<T_P"+?@[0]<FL]0TJ]M4TFWU+4FGFB$C2&2V%TQ\PNRIM!WY4_=8?
M>J'QAXL'BKX3^ =2_L[5+6_L_'EI97>GWUP9Y8)XE<-$LCD%ATP7.<D[CG)H
MZI=V@Z7]3ZW/6N&U;XI?#_1?&5KX/U3Q796NN7+!4M&8DJS8VJ[ %8R<C 8@
MG(Q7,_!/7+/Q%I?B/6O[2U>34Y-7GAOM-U*\EF&E.K';!&KNP50#DE>"<] H
M5<#XRQ^ ]<UGP[X0U7Q#HNAMIVJ1Z]J#75U'#-Y8#_)&"07DE;TS@#)_A!>T
MDGU%T9[Y7&>*OB3X0\$ZCIUCXDO;NTGU)A'9K%IUS<"=R<!%,4; OG^'.[D<
M<U)%:Z7_ ,+/GO5\97KZJ=.5&\/'4$,"1;^+@6^-P8GC?G':O*?VC%N9-8^%
M:V<T4%R?%%OY3S1F14?<N"RAE+ 'J PSZCK2?3S8UK]Q[#H?C30O$&ISZ;IZ
MZE%>01"9X;_2KJR;83C(\^--W/IFG>*_%V@^!_#DWB+Q)>O9:7$RI)<+!),$
M+'"Y$:L0"2!G&,D>M<#XXUC6O"?P=OKSQ=XN&E:LUX\*ZCI5GO:1'G.R*&-G
MRA:, ?ZS*'G=QFO$/%^N:]>?!+XU>'=7NKB2VT74[!;6"YU![^2U#SQEHO/D
M^=P"O<G!R 32[VZ#72_4^Q+&Z@O["WOK>3S()XUEB?!&Y6&0<'D<'O46I:A9
MZ/I-YJNI3>39V4+W$\N"=D:*69L#). #TYKYLO=2\0Z)KC^'=%UC5GT>^^'K
MZQ<[KZ9S9W"1N(Y87W9@R0HVH0I]*N:$=:U#]DN3QS>^*O$;ZS'X;NRLBZG,
M@\Q)&=)<JP8R#8!NW<J2IR. WIJ+JEW/H;2=2L]:TBTU?3+C[197D*SP38(W
MHPRIP<$<'OS6I7RIX8\0>(O&WCOP=X UGQ9K>F:=/X*MM3CN=/O6@NKB\95S
M*TW+/QO^5LJ2"2":M_&[Q=J6CS:Y'X<\6:Q/JF@:/:7@$%R;6&Q8SJOG2F-@
MMR\H91Y31E0,G*YP:DK.PD[JY](27]G'J%M8R7"+=7*N\41/S.J8W$#T&X<^
MX]:S/#7BK1/&&F/JGAW4A?V:SR6YE6-T'F(=K## '@]^A[5X%9V:>*OVC/#%
M]JUQJ2S:CX%BU&9[34;FU_?%USM,4B[%]47"D\D$\UR_P]\9>,-9^&WP[TG4
M/$&KW%MK_B:XM-1U(W\WV@Q1@.D"S[O,0-@\J0<*1D9-3UL/2S9]D45\9ZGX
MS\8ZA\#M?OI/$NKPW7A_QA_9%AJ%O>RPRR6V]%V2E&'FD _>?<>?7)KU;X0Z
MYKD_QE^*WAF]UB]O]+TB]MVLH[N=IV@\P/N57<EMORCY<X'8"G8D]"?XB>$H
M_B!'X!FU22#Q%*I>*UELYHQ*H7<2DC((W& ?NL>A'44OBKXA>$_!-YIEIXDU
M.6UNM4D\JSAALY[EYGR!M"PHQR21@'KSC.#7E?Q_T74KC1]0\9>'X\:]X1DL
MM6M95&65%,OFCW7&&([A*Y[XB:M-XFU/X/>,)X3;Q:SXGL9;.%AAEMAM*EO=
MF=V_W64=12[>NI7GY/\  ^FK>XCNH8KB-9%21 ZB6-HW /(RK ,I]00".]7J
M^0?'7C[QK#KWQ;UB/Q#?V%SX+N]-BT6SMYFC@*RRX?S(E.V;>O/[P-C/&*]
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M:J***!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M 9&L>']#\160LO$&B6&KVP;<(;ZV2= ?7:X(S4,OAGPW-H/_  C\OA_37T<8
MQ8-:QFW&#D?N\;>" >E;M% '.Q^$/"D<UW-'X6TE);QD:YD6QB#3E/N%SM^8
MKVST[4R?P9X0N+."PN?">D36EM,;B&"2PB:.*4G)D52N Q/<<UTM% &'IOAG
MP_HNH7=_H^@Z;IUY?-NNKBUM8XI+@YSEV4 L<DGG-9UW\/? 6I:K)JVH^!]
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/P7X9@CBCBTN-+:&87$5H7<VT4@;>'2$GRU8-\P(48/-=1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% 'CO[25W=6/[-_BJZL[F6UG3[)MEA<HRY
MNX0<$<C@D5^<G_"6>*?^AFU7_P #)/\ XJOT6_:C_P"39/%W_;G_ .ED-?F=
M0!M_\)9XI_Z&;5?_  ,D_P#BJ/\ A+/%/_0S:K_X&2?_ !58E% &W_PEGBG_
M *&;5?\ P,D_^*H_X2SQ3_T,VJ_^!DG_ ,56)10!M_\ "6>*?^AFU7_P,D_^
M*H_X2SQ3_P!#-JO_ (&2?_%5B44 ;?\ PEGBG_H9M5_\#)/_ (JC_A+/%/\
MT,VJ_P#@9)_\56)10!M_\)9XI_Z&;5?_  ,D_P#BJ/\ A+/%/_0S:K_X&2?_
M !58E% &W_PEGBG_ *&;5?\ P,D_^*H_X2SQ3_T,VJ_^!DG_ ,56)10!M_\
M"6>*?^AFU7_P,D_^*H_X2SQ3_P!#-JO_ (&2?_%5B44 ;?\ PEGBG_H9M5_\
M#)/_ (JC_A+/%/\ T,VJ_P#@9)_\56)10!M_\)9XI_Z&;5?_  ,D_P#BJ/\
MA+/%/_0S:K_X&2?_ !58E% &W_PEGBG_ *&;5?\ P,D_^*H_X2SQ3_T,VJ_^
M!DG_ ,56)10!M_\ "6>*?^AFU7_P,D_^*H_X2SQ3_P!#-JO_ (&2?_%5B44
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1/\ [HH_X88_ZJC_ .43_P"Z*^S** /C/_AAC_JJ/_E$_P#NBC_AAC_JJ/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!,5Q/BKX?Z7XLU:
MRU:XU*_T^^M(F@CEMQ#,A1B"08KB.6+.0/FV!NV<<5VU%*PSF_"GA/1/!>CO
MI>AVWE1S3O=7$C8WSS/R\C8 &3@<        5TM%%/<04444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 >7_ !X\2:YX/^!WB#Q+X<OOL.JV?V;R+CRTDV;[F)&^5P5.59AR.]?#
MW_#4?QU_Z'K_ ,IEG_\ &:^ROVH_^39/%W_;G_Z60U^9U 'L_P#PU'\=?^AZ
M_P#*99__ !FC_AJ/XZ_]#U_Y3+/_ .,UXQ10![/_ ,-1_'7_ *'K_P IEG_\
M9H_X:C^.O_0]?^4RS_\ C->,44 >S_\ #4?QU_Z'K_RF6?\ \9H_X:C^.O\
MT/7_ )3+/_XS7C%% 'L__#4?QU_Z'K_RF6?_ ,9H_P"&H_CK_P!#U_Y3+/\
M^,UXQ10![/\ \-1_'7_H>O\ RF6?_P 9H_X:C^.O_0]?^4RS_P#C->,44 >S
M_P##4?QU_P"AZ_\ *99__&:/^&H_CK_T/7_E,L__ (S7C%% 'L__  U'\=?^
MAZ_\IEG_ /&:/^&H_CK_ -#U_P"4RS_^,UXQ10![/_PU'\=?^AZ_\IEG_P#&
M:/\ AJ/XZ_\ 0]?^4RS_ /C->,44 >S_ /#4?QU_Z'K_ ,IEG_\ &:/^&H_C
MK_T/7_E,L_\ XS7C%% 'L_\ PU'\=?\ H>O_ "F6?_QFC_AJ/XZ_]#U_Y3+/
M_P",UXQ10![/_P -1_'7_H>O_*99_P#QFC_AJ/XZ_P#0]?\ E,L__C->,44
M>S_\-1_'7_H>O_*99_\ QFC_ (:C^.O_ $/7_E,L_P#XS7C%% 'L_P#PU'\=
M?^AZ_P#*99__ !FC_AJ/XZ_]#U_Y3+/_ .,UXQ10![/_ ,-1_'7_ *'K_P I
MEG_\9H_X:C^.O_0]?^4RS_\ C->,44 >S_\ #4?QU_Z'K_RF6?\ \9H_X:C^
M.O\ T/7_ )3+/_XS7C%% 'L__#4?QU_Z'K_RF6?_ ,9H_P"&H_CK_P!#U_Y3
M+/\ ^,UXQ10![/\ \-1_'7_H>O\ RF6?_P 9H_X:C^.O_0]?^4RS_P#C->,4
M4 >S_P##4?QU_P"AZ_\ *99__&:/^&H_CK_T/7_E,L__ (S7C%% 'L__  U'
M\=?^AZ_\IEG_ /&:/^&H_CK_ -#U_P"4RS_^,UXQ10![/_PU'\=?^AZ_\IEG
M_P#&:/\ AJ/XZ_\ 0]?^4RS_ /C->,44 >S_ /#4?QU_Z'K_ ,IEG_\ &:/^
M&H_CK_T/7_E,L_\ XS7C%% 'L_\ PU'\=?\ H>O_ "F6?_QFC_AJ/XZ_]#U_
MY3+/_P",UXQ10![/_P -1_'7_H>O_*99_P#QFC_AJ/XZ_P#0]?\ E,L__C->
M,44 >S_\-1_'7_H>O_*99_\ QFC_ (:C^.O_ $/7_E,L_P#XS7C%% 'L_P#P
MU'\=?^AZ_P#*99__ !FC_AJ/XZ_]#U_Y3+/_ .,UXQ10![/_ ,-1_'7_ *'K
M_P IEG_\9H_X:C^.O_0]?^4RS_\ C->,44 >S_\ #4?QU_Z'K_RF6?\ \9H_
MX:C^.O\ T/7_ )3+/_XS7C%% 'L__#4?QU_Z'K_RF6?_ ,9H_P"&H_CK_P!#
MU_Y3+/\ ^,UXQ10![/\ \-1_'7_H>O\ RF6?_P 9H_X:C^.O_0]?^4RS_P#C
M->,44 >S_P##4?QU_P"AZ_\ *99__&:/^&H_CK_T/7_E,L__ (S7C%% 'L__
M  U'\=?^AZ_\IEG_ /&:/^&H_CK_ -#U_P"4RS_^,UXQ10![/_PU'\=?^AZ_
M\IEG_P#&:/\ AJ/XZ_\ 0]?^4RS_ /C->,44 >S_ /#4?QU_Z'K_ ,IEG_\
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MJ'_QJO,J* /3?^$$^&?_ $7'2O\ P1ZA_P#&J/\ A!/AG_T7'2O_  1ZA_\
M&J\RHH ]-_X03X9_]%QTK_P1ZA_\:H_X03X9_P#1<=*_\$>H?_&J\RHH ]-_
MX03X9_\ 1<=*_P#!'J'_ ,:H_P"$$^&?_1<=*_\ !'J'_P :KS*B@#TW_A!/
MAG_T7'2O_!'J'_QJC_A!/AG_ -%QTK_P1ZA_\:KS*B@#TW_A!/AG_P!%QTK_
M ,$>H?\ QJC_ (03X9_]%QTK_P $>H?_ !JO,J* /3?^$$^&?_1<=*_\$>H?
M_&J/^$$^&?\ T7'2O_!'J'_QJO,J* /3?^$$^&?_ $7'2O\ P1ZA_P#&J/\
MA!/AG_T7'2O_  1ZA_\ &J\RHH ]-_X03X9_]%QTK_P1ZA_\:H_X03X9_P#1
M<=*_\$>H?_&J\RHH ]-_X03X9_\ 1<=*_P#!'J'_ ,:H_P"$$^&?_1<=*_\
M!'J'_P :KS*B@#TW_A!/AG_T7'2O_!'J'_QJC_A!/AG_ -%QTK_P1ZA_\:KS
M*B@#TW_A!/AG_P!%QTK_ ,$>H?\ QJC_ (03X9_]%QTK_P $>H?_ !JO,J*
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MJ'_QJO,J* /3?^$$^&?_ $7'2O\ P1ZA_P#&J/\ A!/AG_T7'2O_  1ZA_\
M&J\RHH ]-_X03X9_]%QTK_P1ZA_\:H_X03X9_P#1<=*_\$>H?_&J\RHH ]-_
MX03X9_\ 1<=*_P#!'J'_ ,:H_P"$$^&?_1<=*_\ !'J'_P :KS*B@#TW_A!/
MAG_T7'2O_!'J'_QJC_A!/AG_ -%QTK_P1ZA_\:KS*B@#TW_A!/AG_P!%QTK_
M ,$>H?\ QJC_ (03X9_]%QTK_P $>H?_ !JO,J* /3?^$$^&?_1<=*_\$>H?
M_&J/^$$^&?\ T7'2O_!'J'_QJO,J* /3?^$$^&?_ $7'2O\ P1ZA_P#&J/\
MA!/AG_T7'2O_  1ZA_\ &J\RHH ]-_X03X9_]%QTK_P1ZA_\:H_X03X9_P#1
M<=*_\$>H?_&J\RHH ]-_X03X9_\ 1<=*_P#!'J'_ ,:H_P"$$^&?_1<=*_\
M!'J'_P :KS*B@#TW_A!/AG_T7'2O_!'J'_QJC_A!/AG_ -%QTK_P1ZA_\:KS
M*B@#TW_A!/AG_P!%QTK_ ,$>H?\ QJC_ (03X9_]%QTK_P $>H?_ !JO,J*
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MH%EX@T.Z^UZ;?1^;;S^6R;U]=K ,.G<"MFO,O@'_ ,F]^"O^P>O_ *$:]-H
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M4?\ GVTK_P %-K_\;H_X274?^?;2O_!3:_\ QN@#%HK:_P"$EU'_ )]M*_\
M!3:__&Z/^$EU'_GVTK_P4VO_ ,;H Q:*VO\ A)=1_P"?;2O_  4VO_QNC_A)
M=1_Y]M*_\%-K_P#&Z ,6BMK_ (274?\ GVTK_P %-K_\;H_X274?^?;2O_!3
M:_\ QN@#%HK:_P"$EU'_ )]M*_\ !3:__&Z/^$EU'_GVTK_P4VO_ ,;H Q:*
MVO\ A)=1_P"?;2O_  4VO_QNC_A)=1_Y]M*_\%-K_P#&Z ,6BMK_ (274?\
MGVTK_P %-K_\;H_X274?^?;2O_!3:_\ QN@#%HK:_P"$EU'_ )]M*_\ !3:_
M_&Z/^$EU'_GVTK_P4VO_ ,;H Q:*VO\ A)=1_P"?;2O_  4VO_QNC_A)=1_Y
M]M*_\%-K_P#&Z ,6BMK_ (274?\ GVTK_P %-K_\;H_X274?^?;2O_!3:_\
MQN@#%HK:_P"$EU'_ )]M*_\ !3:__&Z/^$EU'_GVTK_P4VO_ ,;H Q:*VO\
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M_P"B>Z5_WPW^- 'Y:45^I?\ PH'X-_\ 1/=*_P"^&_QH_P"% _!O_HGNE?\
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M^%9I7_R30!Q=%=I_PK3Q%_T$O"O_ (5FE?\ R31_PK3Q%_T$O"O_ (5FE?\
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M (5FE?\ R30!Q=%=I_PK3Q%_T$O"O_A6:5_\DT?\*T\1?]!+PK_X5FE?_)-
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MPK_X5FE?_)-'_"M/$7_02\*_^%9I7_R30!Q=%=I_PK3Q%_T$O"O_ (5FE?\
MR31_PK3Q%_T$O"O_ (5FE?\ R30!Q=%=I_PK3Q%_T$O"O_A6:5_\DT?\*T\1
M?]!+PK_X5FE?_)- '%T5VG_"M/$7_02\*_\ A6:5_P#)-'_"M/$7_02\*_\
MA6:5_P#)- '%T5VG_"M/$7_02\*_^%9I7_R31_PK3Q%_T$O"O_A6:5_\DT <
M717:?\*T\1?]!+PK_P"%9I7_ ,DT?\*T\1?]!+PK_P"%9I7_ ,DT <717:?\
M*T\1?]!+PK_X5FE?_)-'_"M/$7_02\*_^%9I7_R30!Q=%=I_PK3Q%_T$O"O_
M (5FE?\ R31_PK3Q%_T$O"O_ (5FE?\ R30!Q=?LQ7Y-_P#"M/$7_02\*_\
MA6:5_P#)-?IC_P +8^%G_12_"O\ X.;;_P"+H [.BL31?$.A^);%[_P[KEAK
M%K'(86FL+E+B-7 !*ED) .&4XZX(]:VZ "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@#QC]J/_DV3Q=_VY_\ I9#7YG5^F/[4
M?_)LGB[_ +<__2R&OS.H **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** /O[]BK_DB.L_\ 8P3?^DUO7TU7S+^Q5_R1'6?^
MQ@F_])K>OIJ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH \I^/VH:;I?P'\2WVL:'%KEC']FWV$T\D*39NH@,O&0PP2&X/.,
M'C-?!7_"=_#/_HAVE?\ @\U#_P".U]R?M1_\FR>+O^W/_P!+(:_,Z@#TW_A.
M_AG_ -$.TK_P>:A_\=H_X3OX9_\ 1#M*_P#!YJ'_ ,=KS*B@#TW_ (3OX9_]
M$.TK_P 'FH?_ !VC_A._AG_T0[2O_!YJ'_QVO,J* /3?^$[^&?\ T0[2O_!Y
MJ'_QVC_A._AG_P!$.TK_ ,'FH?\ QVO,J* /3?\ A._AG_T0[2O_  >:A_\
M':/^$[^&?_1#M*_\'FH?_':\RHH ]-_X3OX9_P#1#M*_\'FH?_':/^$[^&?_
M $0[2O\ P>:A_P#':\RHH ]-_P"$[^&?_1#M*_\ !YJ'_P =H_X3OX9_]$.T
MK_P>:A_\=KS*B@#TW_A._AG_ -$.TK_P>:A_\=H_X3OX9_\ 1#M*_P#!YJ'_
M ,=KS*B@#TW_ (3OX9_]$.TK_P 'FH?_ !VC_A._AG_T0[2O_!YJ'_QVO,J*
M /3?^$[^&?\ T0[2O_!YJ'_QVC_A._AG_P!$.TK_ ,'FH?\ QVO,J* /3?\
MA._AG_T0[2O_  >:A_\ ':/^$[^&?_1#M*_\'FH?_':\RHH ]-_X3OX9_P#1
M#M*_\'FH?_':/^$[^&?_ $0[2O\ P>:A_P#':\RHH ]-_P"$[^&?_1#M*_\
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MJ'_QVC_A._AG_P!$.TK_ ,'FH?\ QVO,J* /3?\ A._AG_T0[2O_  >:A_\
M':/^$[^&?_1#M*_\'FH?_':\RHH ]-_X3OX9_P#1#M*_\'FH?_':/^$[^&?_
M $0[2O\ P>:A_P#':\RHH ]-_P"$[^&?_1#M*_\ !YJ'_P =H_X3OX9_]$.T
MK_P>:A_\=KS*B@#TW_A._AG_ -$.TK_P>:A_\=H_X3OX9_\ 1#M*_P#!YJ'_
M ,=KS*B@#TW_ (3OX9_]$.TK_P 'FH?_ !VC_A._AG_T0[2O_!YJ'_QVO,J*
M /3?^$[^&?\ T0[2O_!YJ'_QVC_A._AG_P!$.TK_ ,'FH?\ QVO,J* /3?\
MA._AG_T0[2O_  >:A_\ ':/^$[^&?_1#M*_\'FH?_':\RHH ]-_X3OX9_P#1
M#M*_\'FH?_':/^$[^&?_ $0[2O\ P>:A_P#':\RHH ]-_P"$[^&?_1#M*_\
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M_P#DV3Q=_P!N?_I9#7YG4 >S_P##+GQU_P"A%_\ *G9__'J/^&7/CK_T(O\
MY4[/_P"/5XQ10![/_P ,N?'7_H1?_*G9_P#QZC_AESXZ_P#0B_\ E3L__CU>
M,44 >S_\,N?'7_H1?_*G9_\ QZC_ (9<^.O_ $(O_E3L_P#X]7C%% 'L_P#P
MRY\=?^A%_P#*G9__ !ZC_AESXZ_]"+_Y4[/_ ./5XQ10![/_ ,,N?'7_ *$7
M_P J=G_\>H_X9<^.O_0B_P#E3L__ (]7C%% 'L__  RY\=?^A%_\J=G_ /'J
M/^&7/CK_ -"+_P"5.S_^/5XQ10![/_PRY\=?^A%_\J=G_P#'J/\ AESXZ_\
M0B_^5.S_ /CU>,44 >S_ /#+GQU_Z$7_ ,J=G_\ 'J/^&7/CK_T(O_E3L_\
MX]7C%% 'L_\ PRY\=?\ H1?_ "IV?_QZC_AESXZ_]"+_ .5.S_\ CU>,44 >
MS_\ #+GQU_Z$7_RIV?\ \>H_X9<^.O\ T(O_ )4[/_X]7C%% 'L__#+GQU_Z
M$7_RIV?_ ,>H_P"&7/CK_P!"+_Y4[/\ ^/5XQ10![/\ \,N?'7_H1?\ RIV?
M_P >H_X9<^.O_0B_^5.S_P#CU>,44 >S_P##+GQU_P"A%_\ *G9__'J/^&7/
MCK_T(O\ Y4[/_P"/5XQ10![/_P ,N?'7_H1?_*G9_P#QZC_AESXZ_P#0B_\
ME3L__CU>,44 >S_\,N?'7_H1?_*G9_\ QZC_ (9<^.O_ $(O_E3L_P#X]7C%
M% 'L_P#PRY\=?^A%_P#*G9__ !ZC_AESXZ_]"+_Y4[/_ ./5XQ10![/_ ,,N
M?'7_ *$7_P J=G_\>H_X9<^.O_0B_P#E3L__ (]7C%% 'L__  RY\=?^A%_\
MJ=G_ /'J/^&7/CK_ -"+_P"5.S_^/5XQ10![/_PRY\=?^A%_\J=G_P#'J/\
MAESXZ_\ 0B_^5.S_ /CU>,44 >S_ /#+GQU_Z$7_ ,J=G_\ 'J/^&7/CK_T(
MO_E3L_\ X]7C%% 'L_\ PRY\=?\ H1?_ "IV?_QZC_AESXZ_]"+_ .5.S_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M /&:*]F_XQ:_ZJK_ .4ZC_C%K_JJO_E.H \9HKV;_C%K_JJO_E.H_P",6O\
MJJO_ )3J /&:*]F_XQ:_ZJK_ .4ZC_C%K_JJO_E.H \9HKV;_C%K_JJO_E.H
M_P",6O\ JJO_ )3J /&:*]F_XQ:_ZJK_ .4ZC_C%K_JJO_E.H \9HKV;_C%K
M_JJO_E.H_P",6O\ JJO_ )3J /&:*]F_XQ:_ZJK_ .4ZC_C%K_JJO_E.H \9
MHKV;_C%K_JJO_E.H_P",6O\ JJO_ )3J /&:*]F_XQ:_ZJK_ .4ZC_C%K_JJ
MO_E.H \9HKV;_C%K_JJO_E.H_P",6O\ JJO_ )3J /&:*]F_XQ:_ZJK_ .4Z
MC_C%K_JJO_E.H \9HKV;_C%K_JJO_E.H_P",6O\ JJO_ )3J /&:*]F_XQ:_
MZJK_ .4ZC_C%K_JJO_E.H \9HKV;_C%K_JJO_E.H_P",6O\ JJO_ )3J /&:
M*]F_XQ:_ZJK_ .4ZC_C%K_JJO_E.H \9HKV;_C%K_JJO_E.H_P",6O\ JJO_
M )3J /&:*]F_XQ:_ZJK_ .4ZC_C%K_JJO_E.H \9HKV;_C%K_JJO_E.H_P",
M6O\ JJO_ )3J /&:*]F_XQ:_ZJK_ .4ZC_C%K_JJO_E.H \9HKV;_C%K_JJO
M_E.H_P",6O\ JJO_ )3J /&:*]F_XQ:_ZJK_ .4ZC_C%K_JJO_E.H \9HKV;
M_C%K_JJO_E.H_P",6O\ JJO_ )3J /&:*]F_XQ:_ZJK_ .4ZC_C%K_JJO_E.
MH \9HKV;_C%K_JJO_E.H_P",6O\ JJO_ )3J /&:*]F_XQ:_ZJK_ .4ZC_C%
MK_JJO_E.H \9HKV;_C%K_JJO_E.H_P",6O\ JJO_ )3J /&:*]F_XQ:_ZJK_
M .4ZC_C%K_JJO_E.H \9HKV;_C%K_JJO_E.H_P",6O\ JJO_ )3J /&:*]F_
MXQ:_ZJK_ .4ZC_C%K_JJO_E.H \9HKV;_C%K_JJO_E.KZ$\/_LG?"7Q+X7TK
M7K/6O%T=IJMG#>PI-<6HD5)$#J& A(!PPS@D9[F@#R_]BO\ Y+;K/_8OS?\
MI3;U]_5X[\-?V?\ P;\*?$USXB\.ZEK-U=7-HUDR7TT3Q[&=') 2)3G,:]\8
MSQ7L5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZ%G5?_ .3_XFC_A$_%/_ $+.J_\ @')_\30!B45M_P#")^*?^A9U7_P#D_\
MB:/^$3\4_P#0LZK_ . <G_Q- &)16W_PB?BG_H6=5_\  .3_ .)H_P"$3\4_
M]"SJO_@')_\ $T 8E%;?_")^*?\ H6=5_P# .3_XFC_A$_%/_0LZK_X!R?\
MQ- &)16W_P (GXI_Z%G5?_ .3_XFC_A$_%/_ $+.J_\ @')_\30!B45M_P#"
M)^*?^A9U7_P#D_\ B:/^$3\4_P#0LZK_ . <G_Q- &)16W_PB?BG_H6=5_\
M .3_ .)H_P"$3\4_]"SJO_@')_\ $T 8E%;?_")^*?\ H6=5_P# .3_XFC_A
M$_%/_0LZK_X!R?\ Q- &)16W_P (GXI_Z%G5?_ .3_XFC_A$_%/_ $+.J_\
M@')_\30!B45M_P#")^*?^A9U7_P#D_\ B:/^$3\4_P#0LZK_ . <G_Q- &)1
M6W_PB?BG_H6=5_\  .3_ .)H_P"$3\4_]"SJO_@')_\ $T 8E%;?_")^*?\
MH6=5_P# .3_XFC_A$_%/_0LZK_X!R?\ Q- &)16W_P (GXI_Z%G5?_ .3_XF
MC_A$_%/_ $+.J_\ @')_\30!B45M_P#")^*?^A9U7_P#D_\ B:/^$3\4_P#0
MLZK_ . <G_Q- &)16W_PB?BG_H6=5_\  .3_ .)H_P"$3\4_]"SJO_@')_\
M$T 8E%;?_")^*?\ H6=5_P# .3_XFC_A$_%/_0LZK_X!R?\ Q- &)16W_P (
MGXI_Z%G5?_ .3_XFC_A$_%/_ $+.J_\ @')_\30!B45M_P#")^*?^A9U7_P#
MD_\ B:/^$3\4_P#0LZK_ . <G_Q- &)16W_PB?BG_H6=5_\  .3_ .)H_P"$
M3\4_]"SJO_@')_\ $T 8E?K)\*?^2(> _P#L7[#_ -)DK\MO^$3\4_\ 0LZK
M_P" <G_Q-?J/\+89(?@WX)@FC>*6/0K%'1U*LK"W0$$'H10!VU%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'D7[0^K:IH?[/?
MBC5-'U.ZTR_@^R^7=6<S0RQYNH5.UU((R"0<'H2*_/C_ (6Q\4O^BE^*O_!S
M<_\ Q=??O[4?_)LGB[_MS_\ 2R&OS.H [3_A;'Q2_P"BE^*O_!S<_P#Q='_"
MV/BE_P!%+\5?^#FY_P#BZXNB@#M/^%L?%+_HI?BK_P '-S_\71_PMCXI?]%+
M\5?^#FY_^+KBZ* .T_X6Q\4O^BE^*O\ P<W/_P 71_PMCXI?]%+\5?\ @YN?
M_BZXNB@#M/\ A;'Q2_Z*7XJ_\'-S_P#%T?\ "V/BE_T4OQ5_X.;G_P"+KBZ*
M .T_X6Q\4O\ HI?BK_P<W/\ \71_PMCXI?\ 12_%7_@YN?\ XNN+HH [3_A;
M'Q2_Z*7XJ_\ !S<__%T?\+8^*7_12_%7_@YN?_BZXNB@#M/^%L?%+_HI?BK_
M ,'-S_\ %T?\+8^*7_12_%7_ (.;G_XNN+HH [3_ (6Q\4O^BE^*O_!S<_\
MQ='_  MCXI?]%+\5?^#FY_\ BZXNB@#M/^%L?%+_ **7XJ_\'-S_ /%T?\+8
M^*7_ $4OQ5_X.;G_ .+KBZ* .T_X6Q\4O^BE^*O_  <W/_Q='_"V/BE_T4OQ
M5_X.;G_XNN+HH [3_A;'Q2_Z*7XJ_P#!S<__ !='_"V/BE_T4OQ5_P"#FY_^
M+KBZ* .T_P"%L?%+_HI?BK_P<W/_ ,71_P +8^*7_12_%7_@YN?_ (NN+HH
M[3_A;'Q2_P"BE^*O_!S<_P#Q='_"V/BE_P!%+\5?^#FY_P#BZXNB@#M/^%L?
M%+_HI?BK_P '-S_\71_PMCXI?]%+\5?^#FY_^+KBZ* .T_X6Q\4O^BE^*O\
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M* /H_P#9W^('CS7/VA/"^EZQXVU_4["X%UYEK>:G--%)BUF8;D9B#@@$9'4
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MO_"9MO\ Y/KBZ* .T_L_X6?]#EXJ_P#"9MO_ )/H_L_X6?\ 0Y>*O_"9MO\
MY/KBZ* .T_L_X6?]#EXJ_P#"9MO_ )/H_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* .
MT_L_X6?]#EXJ_P#"9MO_ )/H_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* .T_L_X6?]
M#EXJ_P#"9MO_ )/H_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* .T_L_X6?]#EXJ_P#"
M9MO_ )/H_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* .T_L_X6?]#EXJ_P#"9MO_ )/H
M_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* .T_L_X6?]#EXJ_P#"9MO_ )/H_L_X6?\
M0Y>*O_"9MO\ Y/KBZ* .T_L_X6?]#EXJ_P#"9MO_ )/H_L_X6?\ 0Y>*O_"9
MMO\ Y/KBZ* .T_L_X6?]#EXJ_P#"9MO_ )/H_L_X6?\ 0Y>*O_"9MO\ Y/KB
MZ* .T_L_X6?]#EXJ_P#"9MO_ )/H_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* .T_L_
MX6?]#EXJ_P#"9MO_ )/H_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* .T_L_X6?]#EXJ
M_P#"9MO_ )/H_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* .T_L_X6?]#EXJ_P#"9MO_
M )/H_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* .T_L_X6?]#EXJ_P#"9MO_ )/H_L_X
M6?\ 0Y>*O_"9MO\ Y/KBZ* .T_L_X6?]#EXJ_P#"9MO_ )/H_L_X6?\ 0Y>*
MO_"9MO\ Y/KBZ* .T_L_X6?]#EXJ_P#"9MO_ )/H_L_X6?\ 0Y>*O_"9MO\
MY/KBZ* .T_L_X6?]#EXJ_P#"9MO_ )/H_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* .
MT_L_X6?]#EXJ_P#"9MO_ )/H_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* .T_L_X6?]
M#EXJ_P#"9MO_ )/H_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* .T_L_X6?]#EXJ_P#"
M9MO_ )/H_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* .T_L_X6?]#EXJ_P#"9MO_ )/H
M_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* .T_L_X6?]#EXJ_P#"9MO_ )/H_L_X6?\
M0Y>*O_"9MO\ Y/KBZ* .T_L_X6?]#EXJ_P#"9MO_ )/H_L_X6?\ 0Y>*O_"9
MMO\ Y/KBZ* .T_L_X6?]#EXJ_P#"9MO_ )/H_L_X6?\ 0Y>*O_"9MO\ Y/KB
MZ* .T_L_X6?]#EXJ_P#"9MO_ )/H_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* .T_L_
MX6?]#EXJ_P#"9MO_ )/H_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* .T_L_X6?]#EXJ
M_P#"9MO_ )/H_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* .T_L_X6?]#EXJ_P#"9MO_
M )/H_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* /:?ACXH^%OPW^)VD>,_[<\4ZI_9WG
M?Z)_8-M#YGF0O%]_[:V,;\]#TQ[U]+?\-J_"W_H >*O_  %MO_C]? %% 'Z;
M?#7]H#P;\5O$USX=\.Z;K-K=6UHUZSWT,21[%=$(!25CG,B]L8SS7L5? /[%
M?_);=9_[%^;_ -*;>OOZ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** /&/VH_\ DV3Q=_VY_P#I9#7YG5^G7[1&HW.D_L]^)M0MH[26:'[+
MM6[M8KF(YNX5.Z*561N#QE3@X(Y -?GS_P ++\1?] WPK_X2>E?_ "-0!Q=%
M=I_PLOQ%_P! WPK_ .$GI7_R-1_PLOQ%_P! WPK_ .$GI7_R-0!Q=%=I_P +
M+\1?] WPK_X2>E?_ "-1_P ++\1?] WPK_X2>E?_ "-0!Q=%=I_PLOQ%_P!
MWPK_ .$GI7_R-1_PLOQ%_P! WPK_ .$GI7_R-0!Q=%=I_P ++\1?] WPK_X2
M>E?_ "-1_P ++\1?] WPK_X2>E?_ "-0!Q=%=I_PLOQ%_P! WPK_ .$GI7_R
M-1_PLOQ%_P! WPK_ .$GI7_R-0!Q=%=I_P ++\1?] WPK_X2>E?_ "-1_P +
M+\1?] WPK_X2>E?_ "-0!Q=%=I_PLOQ%_P! WPK_ .$GI7_R-1_PLOQ%_P!
MWPK_ .$GI7_R-0!Q=%=I_P ++\1?] WPK_X2>E?_ "-1_P ++\1?] WPK_X2
M>E?_ "-0!Q=%=I_PLOQ%_P! WPK_ .$GI7_R-1_PLOQ%_P! WPK_ .$GI7_R
M-0!Q=%=I_P ++\1?] WPK_X2>E?_ "-1_P ++\1?] WPK_X2>E?_ "-0!Q=%
M=I_PLOQ%_P! WPK_ .$GI7_R-1_PLOQ%_P! WPK_ .$GI7_R-0!Q=%=I_P +
M+\1?] WPK_X2>E?_ "-1_P ++\1?] WPK_X2>E?_ "-0!Q=%=I_PLOQ%_P!
MWPK_ .$GI7_R-1_PLOQ%_P! WPK_ .$GI7_R-0!Q=%=I_P ++\1?] WPK_X2
M>E?_ "-1_P ++\1?] WPK_X2>E?_ "-0!Q=%=I_PLOQ%_P! WPK_ .$GI7_R
M-1_PLOQ%_P! WPK_ .$GI7_R-0!Q=%=I_P ++\1?] WPK_X2>E?_ "-1_P +
M+\1?] WPK_X2>E?_ "-0!Q=%=I_PLOQ%_P! WPK_ .$GI7_R-1_PLOQ%_P!
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?#__ ,#;K_Y&H_X5/I__ $6#X?\ _@;=?_(U 'F%%>G_ /"I]/\ ^BP?#_\
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M'_\ X&W7_P C4 >845Z?_P *GT__ *+!\/\ _P #;K_Y&H_X5/I__18/A_\
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M44 >,?M1_P#)LGB[_MS_ /2R&OS.K],?VH_^39/%W_;G_P"ED-?F=0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7IWP"_Y.%\%?\
M807_ -!->8UZ=\ O^3A?!7_807_T$T ?J51110 4444 %%%% !1110 4444
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MT4 <9_PJ?X6?]$T\*_\ @FMO_B*/^%3_  L_Z)IX5_\ !-;?_$5V=% '&?\
M"I_A9_T33PK_ .":V_\ B*/^%3_"S_HFGA7_ ,$UM_\ $5V=% '&?\*G^%G_
M $33PK_X)K;_ .(H_P"%3_"S_HFGA7_P36W_ ,179T4 <9_PJ?X6?]$T\*_^
M":V_^(H_X5/\+/\ HFGA7_P36W_Q%=G10!QG_"I_A9_T33PK_P"":V_^(H_X
M5/\ "S_HFGA7_P $UM_\179T4 <9_P *G^%G_1-/"O\ X)K;_P"(H_X5/\+/
M^B:>%?\ P36W_P 179T4 <9_PJ?X6?\ 1-/"O_@FMO\ XBC_ (5/\+/^B:>%
M?_!-;?\ Q%=G10!QG_"I_A9_T33PK_X)K;_XBC_A4_PL_P"B:>%?_!-;?_$5
MV=% '&?\*G^%G_1-/"O_ ()K;_XBC_A4_P +/^B:>%?_  36W_Q%=G10!QG_
M  J?X6?]$T\*_P#@FMO_ (BC_A4_PL_Z)IX5_P#!-;?_ !%=G10!QG_"I_A9
M_P!$T\*_^":V_P#B*/\ A4_PL_Z)IX5_\$UM_P#$5V=% '&?\*G^%G_1-/"O
M_@FMO_B*/^%3_"S_ *)IX5_\$UM_\179T4 <9_PJ?X6?]$T\*_\ @FMO_B*/
M^%3_  L_Z)IX5_\ !-;?_$5V=% '&?\ "I_A9_T33PK_ .":V_\ B*/^%3_"
MS_HFGA7_ ,$UM_\ $5V=% '&?\*G^%G_ $33PK_X)K;_ .(H_P"%3_"S_HFG
MA7_P36W_ ,179T4 <9_PJ?X6?]$T\*_^":V_^(H_X5/\+/\ HFGA7_P36W_Q
M%=G10!QG_"I_A9_T33PK_P"":V_^(H_X5/\ "S_HFGA7_P $UM_\179T4 <9
M_P *G^%G_1-/"O\ X)K;_P"(H_X5/\+/^B:>%?\ P36W_P 179T4 <9_PJ?X
M6?\ 1-/"O_@FMO\ XBC_ (5/\+/^B:>%?_!-;?\ Q%=G10!QG_"I_A9_T33P
MK_X)K;_XBC_A4_PL_P"B:>%?_!-;?_$5V=% '&?\*G^%G_1-/"O_ ()K;_XB
MC_A4_P +/^B:>%?_  36W_Q%=G10!QG_  J?X6?]$T\*_P#@FMO_ (BC_A4_
MPL_Z)IX5_P#!-;?_ !%=G10!QG_"I_A9_P!$T\*_^":V_P#B*/\ A4_PL_Z)
MIX5_\$UM_P#$5V=% '&?\*G^%G_1-/"O_@FMO_B*/^%3_"S_ *)IX5_\$UM_
M\179T4 <9_PJ?X6?]$T\*_\ @FMO_B*/^%3_  L_Z)IX5_\ !-;?_$5V=% '
M&?\ "I_A9_T33PK_ .":V_\ B*ET_P"'/P^TG4(-0TOP)X>L+RW;?%<6VEP1
MR1MZJRJ"#]*ZZB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@#S;XW>$]8\=?!?7_"N@I$^I7WV?R5FDV*=EQ'
M(V3V^5#7QA_PR'\9?^?+2O\ P/7_  K]&** /SG_ .&0_C+_ ,^6E?\ @>O^
M%'_#(?QE_P"?+2O_  /7_"OT8HH _.?_ (9#^,O_ #Y:5_X'K_A1_P ,A_&7
M_GRTK_P/7_"OT8HH _.?_AD/XR_\^6E?^!Z_X4?\,A_&7_GRTK_P/7_"OT8H
MH _.?_AD/XR_\^6E?^!Z_P"%?17[,/PD\9?"O_A+!XL@M8O[4^R?9_L\XESY
M?G;LXZ?ZQ:^CJ* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH X;
MXF>.6^&OPPU?QHVE_P!J_P!G>3_HGG^3YGF3)%]_:V,;\]#TQ[U\V?\ #<__
M %2[_P K?_W/7LO[4?\ R;)XN_[<_P#TLAK\SJ /LS_AN?\ ZI=_Y6__ +GH
M_P"&Y_\ JEW_ )6__N>OC.B@#[,_X;G_ .J7?^5O_P"YZ/\ AN?_ *I=_P"5
MO_[GKXSHH ^S/^&Y_P#JEW_E;_\ N>C_ (;G_P"J7?\ E;_^YZ^,Z* /LS_A
MN?\ ZI=_Y6__ +GH_P"&Y_\ JEW_ )6__N>OC.B@#[,_X;G_ .J7?^5O_P"Y
MZ/\ AN?_ *I=_P"5O_[GKXSHH ^S/^&Y_P#JEW_E;_\ N>C_ (;G_P"J7?\
ME;_^YZ^,Z* /LS_AN?\ ZI=_Y6__ +GH_P"&Y_\ JEW_ )6__N>OC.B@#[,_
MX;G_ .J7?^5O_P"YZ/\ AN?_ *I=_P"5O_[GKXSHH ^S/^&Y_P#JEW_E;_\
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M;_\ N>C_ (;G_P"J7?\ E;_^YZ^,Z* /LS_AN?\ ZI=_Y6__ +GH_P"&Y_\
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M2J* /RU_X4#\9/\ HGNJ_P#?"_XT?\*!^,G_ $3W5?\ OA?\:_4JB@#\M?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 )7F=Q\;/AW;WMC87&
MHZJMUJ#,EG$-!U F[*G#>3B#]Y@]US7IE?./QDPO[3'P2  "BZN< < <QTEN
MD'1GNNAZYI_B+24U327F:U=WC'GV\EO(K(Y1U:.15=2&4C! Z5LUXC\<-:.F
M/I.EV.M:A!?7EO?21:7IDTEK).RQ;OM+W$<B&)(<%B,/OSC:<<>9CX@_$:\^
M!_@#X@-/>ZU:6D5W)KEOIEX;:]*I*T<=T=H.]$"$LK H21N!'(.EPZGTE'XT
M\._\)ZW@9KZ1?$(M?MOV5[650T.0-ZR%=C#)QPQY!'4&NHKY$^(7BI=)^,<7
MB+3XM5U.WE^'2L+FTD,5Q%%).<W)8,K JIWG:<Y';DCZ+\#VNG+\-]'@L]?N
MO$UE-:AEU*]G:>6\#C)=F8D\Y/'\(X[46]VXK^]8K>'_ (H> _%GB:^\-^'?
M$UIJ6J6(+300[N " 2K$;9 "1DJ2!6AXL\<>%_ ND?VQXLUF+2[,MY:O(&9G
M;T5%!9CWX!XKR?P[8?#W5OVF/^$D\/ZYX=M7TS3FTFWTS3KB$37D_P [2R&)
M#D*B?+G')!YPHSW7BC7_  SXDT5O#&C^.-%LM8\06\]MIUUF.ZWC[L@0;@&(
MZ8SU'0XI.]E8:^*SV.LT'7-+\3:'9Z]HMXM[IM[&)8)X\@.OT."#G(((R""#
M3?$/B'3?"VAW.NZY+-#86J[II(;:6X,:]V*Q*S;1W., <G%>(^!=->?X$^%]
M%U+Q8? :Z+K+6,5WIU\L46K-%,Z85G/SK*VX[02&(/&.*]A^(G_)*_%G_8)N
MO_1+4-VN^P+5I,Q=+^+W@/6!I4FGWVH/;ZO,MO8W4FC7L5O<2,=H59GA$?4$
M?>[5Z'7@7[/[:A;?!WPO<:M/;-H(T\?9P(R"D_VM^&R2&;/E[2 #G-<S>6MS
MI'[2LGA76?B'XA3P]K4L=UI^S6;I1!=K\S:>6$FU0XD5L$$[3&!@D&J:L2G=
M/R/I*+4K&;6+K28[A7O+6&.>:$=420L$)[<F-_RK2KY7T_28D\;_ !_O(]3U
MN"ZTVVADMI(M7NHVC/V5Y 21(-V& V[L[1P, D5=F/B.7]E27Q\WC77SJ3^%
MX@JI?.@25) _GAU(?S#C#,3\P)!R, +I?R7XE=;'TU6#XG\5:#X-\/7?B#Q)
MJ"V&F6NWSIV1GV[F"K\J@L<D@< U\V?#G7/%M]XY2UA\6:E-->?#>+4574-1
MEF@2^;8HG*R,54\ D@#J3W.><\3^*/$/_#.OC+2=:N/$>B>,-!FTY+NTNM2G
MF(#R8$R2EB667<Q*%F *C' 4!VW#KJ?9EO<0W5K%=0R"2&9!(CCHRD9!_*K/
M:OE3Q5XP\63S^.[]-7U+1F\$:%IMQI4<%T\<=S+* [3S(#MF!V[-KAE SQDD
MU4U#Q!XDUOQO?7EQK^N:3]M^&C>()+"TU2XBA@O=HPZ)O_=XP#A<=.<Y;(]!
M'U1<S+:V\D[ARD:EF$:,[$#GA5!+'V )->?67QR^&-\LLD'B*XCMX+@6EQ=7
M.EWD%O;2G@)+-)$J1'_?85H?!_7-2\2_!SPMKFL7'VB_N;)3-*>LC E=Q]SC
M)]Z^>O 9M5^$?[1'V[9Y/V_41\_3=LDV_CNQCWQ2U3:?0:U2/KN&:.XB2:&1
M9(W4,KJ<A@>00>XJS7QCX7UKQPW@+X-^ ;>YFL/[9L;^XCF;5)M-\\JS_9T\
MZ)'?"H58(!ALH#Q77R?\)M+\?_ _A7Q9XNN_-N_#LYU6+1-3N(K6YFC,RB10
M-NQ\*I)4*0P.*;LE<2/I^BOBKP%XP\<?VA\&-<OO&^L:F^OZA>Z=>6MS=$P/
M#$RQH"@X=AN9M[9<DC)X%:UU\0O&EK?0>-%UC44U*Z\?MX=?19+AFMH[-5V^
M3Y.=H?(!\P#=D]:=KZ"/K[I25\5^(/$WBSPUH7CC6-,\8>(#-H7C>*RLH[G5
M)YT2WPV8F#L=ZGC(;/0=\Y]5U?Q%XFT/]HBWL]?EU"3PQKEW!9:7?Z;>M]GM
M90F6M)X>5WNX)+\/@C!V[E"Z)KJ4NI[A9ZG87U]?V5I=)-<6$BQ7*+UB=D#A
M3[[64_0BM#TKX[TNQDTWX:?'K6=.UC6[/4=,UZ]CMKB'5[M'01LI4G$GS-P
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *Y/6O OA7Q%KMEKFM:0MWJ5C@VEPTLBO;'.<QD,-AR <
MC!XKK** .=U;PGX;US4++4-8TBVOKNQ22.WFF7<T:2+M=<]PPX(/6LR'X:^!
M[?18='M_#-I%800RV\<*[@%BD;=)'G.=CGEEZ'N#7:T4 <A>> ?".H:NVJ76
M@PO=FQ.F^8'=<6I4J80 0 F"?E QSGK6AHGAC0_#F@CP_H=BMEI:A@MM$S;$
M#<L%Y^7))/&.236_10!P>@?"?X=^%=:CUKP[X/L-.U&-65+B%3N4,,,.3W!(
MJ&X^$/POO--L]/F\"Z1):63O)!$;< 1LY!;\R!D'TKT*B@#E[_P/X1U+1],T
M6_\ #MA/INER)+96IA CMV084HHX& 36EJVBZ?KVD3Z3JUO]HLKA2DT)9E$B
MGJK;2,@]QT-:U%#UW XZR^'G@^QL;"QL]'\JQTZ9;BTM!<2F""16WJRQEMH(
M;GIUIE]\-/ ^I-$VH:&MTT-VU_&99Y6*7#8S*,MPWRCGVKM**/,1R]UX)\,7
ME]JU]-HT)NM8B$-_(A9#<H%V@/M(S\N5SUP2.A(J6S\(^'+/PLWA6WTF,:&\
M30&QD)DB\MA@H Q.%]AQ71T4>0SA]-^&/@32;XW6F^%[.VF>S.GLR!OGMB,>
M4XSADQ@8.>@]!B>_^'_@O4],O=-U+P_;WEM?R1R723,SF<QC$89B<D*/NJ3@
M=@*[&B@#D]0\#^$=4:%M0T*"Z,4"6G[W<PDA1@R1R#/[Q0P! ?(SS3-0^'_A
M/5-9N=8OM'66_NK4V,TXFD5GMSP83AA^[/=>A]*Z^B@#$T;0='\/Z##H.BV@
ML=-@4I%!$[ 1@DDA3G(Y)Z'BL"W^%7P]M;>ZM8?#-M]FO)A<75L[N\-S(#D/
M+&S%9#GG+ UW7:BCS YS6/"'AOQ!_9O]L:/;W;:7*)K)BNUK5QC#1LN"O0=/
M0>E0W/@7PO=^(+;Q!-H\8U6TMS:V]U'(\;PQ$$%%*D;1\S=/6NIHHW X2U^%
M/P_L#IGV/PW;P_V3,UQ8!9),6LC$%FC&[Y22H)QUQ6C_ ,()X//B$Z]_PC]F
M=1^T?:_-*9Q/C;YP7[HDP,;\;O>NJHIW8K'!3?";X?WD%Y;W?AJ*>&^N1>74
M<DTK+/.,XE<%OF?D_,>>:UQX-\,_VK%JC:/!)>17 NA*V3F<)L$I!.&D"_*'
M.6 XS7344AG(3_#_ ,&W$.L02Z! 8M;D\[48T+(MTYY)< @'.!GUP,YJ:^\#
M^%=4\)V_A74]%@OM&MBAAM+C=(L>S[N"Q)&.@YX''3BNHI:D#CA\._!8LM:T
M\>&+'['KCB34(/+^2Z<'(9ATSGG/7/-3?\(-X5_MS3=:_LM?[1TN+R;.X\V3
M= G=1\W0Y.?[V><UU=%4!R>D^ _!VA:L-2T?P]:6=TJ/'')"FWR5<[G$8Z1A
MCR=N,FLVW^$_P^M)[::W\,PQ/:W9OH"LL@\NX.,S#YN'.U<MU.!7?44; %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M ?9G_#<__5+O_*W_ /<]'_#<_P#U2[_RM_\ W/7QG10!]F?\-S_]4N_\K?\
M]ST?\-S_ /5+O_*W_P#<]?&=% 'V9_PW/_U2[_RM_P#W/7O?P9^*G_"WO!-Y
MXF_L'^Q3;:@]B+?[5]HW;8XWW[MB8_UF,8[=>:_+BOO[]BK_ )(CK/\ V,$W
M_I-;T ?35%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+_HFGBK_ ,$US_\ $4?\*G^*7_1-/%7_ ()KG_XBL;_A+/%/_0S:K_X&2?\
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M3_T,VJ_^!DG_ ,51_P )9XI_Z&;5?_ R3_XJ@#9_X5/\4O\ HFGBK_P37/\
M\11_PJ?XI?\ 1-/%7_@FN?\ XBL;_A+/%/\ T,VJ_P#@9)_\51_PEGBG_H9M
M5_\  R3_ .*H V?^%3_%+_HFGBK_ ,$US_\ $4?\*G^*7_1-/%7_ ()KG_XB
ML;_A+/%/_0S:K_X&2?\ Q5'_  EGBG_H9M5_\#)/_BJ -G_A4_Q2_P"B:>*O
M_!-<_P#Q%'_"I_BE_P!$T\5?^":Y_P#B*QO^$L\4_P#0S:K_ .!DG_Q5'_"6
M>*?^AFU7_P #)/\ XJ@#9_X5/\4O^B:>*O\ P37/_P 11_PJ?XI?]$T\5?\
M@FN?_B*QO^$L\4_]#-JO_@9)_P#%4?\ "6>*?^AFU7_P,D_^*H V?^%3_%+_
M *)IXJ_\$US_ /$4?\*G^*7_ $33Q5_X)KG_ .(K&_X2SQ3_ -#-JO\ X&2?
M_%4?\)9XI_Z&;5?_  ,D_P#BJ -G_A4_Q2_Z)IXJ_P#!-<__ !%'_"I_BE_T
M33Q5_P"":Y_^(K&_X2SQ3_T,VJ_^!DG_ ,51_P )9XI_Z&;5?_ R3_XJ@#9_
MX5/\4O\ HFGBK_P37/\ \11_PJ?XI?\ 1-/%7_@FN?\ XBL;_A+/%/\ T,VJ
M_P#@9)_\51_PEGBG_H9M5_\  R3_ .*H V?^%3_%+_HFGBK_ ,$US_\ $4?\
M*G^*7_1-/%7_ ()KG_XBL;_A+/%/_0S:K_X&2?\ Q5'_  EGBG_H9M5_\#)/
M_BJ -G_A4_Q2_P"B:>*O_!-<_P#Q%'_"I_BE_P!$T\5?^":Y_P#B*QO^$L\4
M_P#0S:K_ .!DG_Q5'_"6>*?^AFU7_P #)/\ XJ@#9_X5/\4O^B:>*O\ P37/
M_P 11_PJ?XI?]$T\5?\ @FN?_B*QO^$L\4_]#-JO_@9)_P#%4?\ "6>*?^AF
MU7_P,D_^*H V?^%3_%+_ *)IXJ_\$US_ /$4?\*G^*7_ $33Q5_X)KG_ .(K
M&_X2SQ3_ -#-JO\ X&2?_%4?\)9XI_Z&;5?_  ,D_P#BJ -G_A4_Q2_Z)IXJ
M_P#!-<__ !%'_"I_BE_T33Q5_P"":Y_^(K&_X2SQ3_T,VJ_^!DG_ ,51_P )
M9XI_Z&;5?_ R3_XJ@#9_X5/\4O\ HFGBK_P37/\ \11_PJ?XI?\ 1-/%7_@F
MN?\ XBL;_A+/%/\ T,VJ_P#@9)_\51_PEGBG_H9M5_\  R3_ .*H V?^%3_%
M+_HFGBK_ ,$US_\ $4?\*G^*7_1-/%7_ ()KG_XBL;_A+/%/_0S:K_X&2?\
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M3_T,VJ_^!DG_ ,51_P )9XI_Z&;5?_ R3_XJ@#9_X5/\4O\ HFGBK_P37/\
M\11_PJ?XI?\ 1-/%7_@FN?\ XBL;_A+/%/\ T,VJ_P#@9)_\51_PEGBG_H9M
M5_\  R3_ .*H V?^%3_%+_HFGBK_ ,$US_\ $4?\*G^*7_1-/%7_ ()KG_XB
ML;_A+/%/_0S:K_X&2?\ Q5'_  EGBG_H9M5_\#)/_BJ -G_A4_Q2_P"B:>*O
M_!-<_P#Q%'_"I_BE_P!$T\5?^":Y_P#B*QO^$L\4_P#0S:K_ .!DG_Q5'_"6
M>*?^AFU7_P #)/\ XJ@#9_X5/\4O^B:>*O\ P37/_P 11_PJ?XI?]$T\5?\
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M%'_##'_54?\ RB?_ '10!\9T5]F?\,,?]51_\HG_ -T4?\,,?]51_P#*)_\
M=% 'QG17V9_PPQ_U5'_RB?\ W11_PPQ_U5'_ ,HG_P!T4 ?&=%?9G_##'_54
M?_*)_P#=%'_##'_54?\ RB?_ '10!\9T5]F?\,,?]51_\HG_ -T4?\,,?]51
M_P#*)_\ =% 'QG17V9_PPQ_U5'_RB?\ W11_PPQ_U5'_ ,HG_P!T4 ?&=%?9
MG_##'_54?_*)_P#=%'_##'_54?\ RB?_ '10!\9T5]F?\,,?]51_\HG_ -T4
M?\,,?]51_P#*)_\ =% 'QG17V9_PPQ_U5'_RB?\ W11_PPQ_U5'_ ,HG_P!T
M4 ?&=%?9G_##'_54?_*)_P#=%'_##'_54?\ RB?_ '10!\9T5]F?\,,?]51_
M\HG_ -T4?\,,?]51_P#*)_\ =% 'QG17V9_PPQ_U5'_RB?\ W11_PPQ_U5'_
M ,HG_P!T4 ?&=%?9G_##'_54?_*)_P#=%'_##'_54?\ RB?_ '10!\9T5]F?
M\,,?]51_\HG_ -T4?\,,?]51_P#*)_\ =% 'QG17V9_PPQ_U5'_RB?\ W11_
MPPQ_U5'_ ,HG_P!T4 ?&=%?9G_##'_54?_*)_P#=%'_##'_54?\ RB?_ '10
M!\9T5]F?\,,?]51_\HG_ -T4?\,,?]51_P#*)_\ =% 'QG17V9_PPQ_U5'_R
MB?\ W11_PPQ_U5'_ ,HG_P!T4 ?&=%?9G_##'_54?_*)_P#=%'_##'_54?\
MRB?_ '10!\9T5]F?\,,?]51_\HG_ -T4?\,,?]51_P#*)_\ =% 'QG17V9_P
MPQ_U5'_RB?\ W11_PPQ_U5'_ ,HG_P!T4 ?&=%?9G_##'_54?_*)_P#=%'_#
M#'_54?\ RB?_ '10!\9T5]F?\,,?]51_\HG_ -T4?\,,?]51_P#*)_\ =% '
MQG17V9_PPQ_U5'_RB?\ W11_PPQ_U5'_ ,HG_P!T4 ?&=%?9G_##'_54?_*)
M_P#=%'_##'_54?\ RB?_ '10!\9T5]F?\,,?]51_\HG_ -T4?\,,?]51_P#*
M)_\ =% 'QG17V9_PPQ_U5'_RB?\ W11_PPQ_U5'_ ,HG_P!T4 ?&=%?9G_##
M'_54?_*)_P#=%'_##'_54?\ RB?_ '10!\9T5]F?\,,?]51_\HG_ -T4?\,,
M?]51_P#*)_\ =% 'QG17V9_PPQ_U5'_RB?\ W11_PPQ_U5'_ ,HG_P!T4 ?&
M=%?9G_##'_54?_*)_P#=%'_##'_54?\ RB?_ '10!\9T5]F?\,,?]51_\HG_
M -T4?\,,?]51_P#*)_\ =% 'QG17V9_PPQ_U5'_RB?\ W11_PPQ_U5'_ ,HG
M_P!T4 ?&=%?9G_##'_54?_*)_P#=%'_##'_54?\ RB?_ '10!V7[%7_)$=9_
M[&";_P!)K>OIJO+?@U\*_P#A4/@J\\,_V]_;1N=0>^^T?9?L^W='&FS;O?/^
MKSG/?IQ7J5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110!SOBC7F\,^&+[7Y-+O=2BLHVGFALS%Y@C499AYCHIP 3C.?0
M$\5A:+\2+'4M;TS1]0T#6-!N]7A:XTX:BD)2\55#L$>&610P4[MK%3CM5OXE
M75O9_"GQ7)=7$<*'2KI TC!06,+ #GN37 Z#H%[<Z)HWQ#\0^+EURQT'1)&T
M^ST.Q\@1LT&V23=YLADEV948*@'L*5[1;[!U2[GN-%?+NGSV&DP^*5T75+30
M+._\#K?QR:2PDG\Y?-S/(RE/.N<<LP"GGKWJUX?%K:Z#K^H^"/$GAYM4B\+,
M!I'AK61<O/>*A+W;Q*%'F\@!B&)8C)Z4]E=BOK8^F*X7Q?\ $#3?!KYO]'UJ
M^LXD\V^OK"T\Z#3X_P"_,=P.,98A0Q Y( (SQOPAT_P*NK2^(/ _C34-9&HV
MI^U6&VTA@A<,IWS0V\$02XYQEOF8;NH&1O\ Q(\4^$Q#/X$UWQ3I6D/JUJZ7
M<EY?0V_DVS?*^ [ EV4L%P#CDGH,C5K#33._L;VUU33;;4K&X2XM+J)9H9HS
ME9$895A[$$&KW:N#UJ<)\$=1F^'^TK%HLG]D?90<;5A(B\ON> -OKQ7 V-KX
M+N/'7A^;P=%I_P#PC&JZ1>R>(;9"K6LJ;8_+:Z0Y3S=S,"SC<?G!S@X3:O8%
M>VIW7A?QMJ7B35XG@\,RIX=O%G-GJR7*N&,4AC(ECV@Q[L93#/D==IXJQ)\0
MM'AU:&&ZM;^VTRXO/[.M]7D6/[)/=;RGE AS(#O5E#,BH2,!CD9Y;]G^S\-V
M_P )]/N-#M=.BN)FE^V/9I&KNPFD"^85Y)"],]JYC6O"FIZAK&G?#_PQXFL]
M2T%=>&LW%NEJ"^CPQSB9X7G#L&+2DB-"BMRV6*J:;TE82=TVSZ)HHHH&%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MXV7=N' +-MXXZD'C'M/>J<6MR4[CJ***0PHHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
9HH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>ltbr_ex32img1.jpg
<TEXT>
begin 644 ltbr_ex32img1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" 2D Y8# 2(  A$! Q$!_\0
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MF?QQXJ^(7PNU/6_%VK?VG?Q:Q+:I+Y,4.V(0PL%Q&JCJ['.,\UW/Q*\8ZCX
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MZ^TR-()5C*.RG8F"6^4;CC:<C.*-W8.ESU6BN!^)WQ&L/AGX0N-?N[*34K@
M_9K"%MKSD#+'.#M55R6;!  ]2 >NTR\_M#2[2^V>7]HA2;9G.W<H.,]^M"U^
M0/2WF:5%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@WP;XJ\&^%K'6?A;:V36^F0:B-9FM+<-J,@DP1N0L70KPRR8)#_='!KN])^
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MB77C.Q\7/:[=9L8)+6.Y3@M$^"4;^\ 1D>ASZG,6K>'9M8\0:1JX\1:GI_\
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M:-69=I(R1Z5)2"EH$@HHHH&%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 ,KA=)^*'@W7O&4_@_2[Z^EUNUS]HM)-)NXC ,
M9S(SQ!4!XP6(!R,9R*[EC@U\Z>"66R_;2^(]O>-Y$M[IUM+;JYP9T$<62OKC
M!Z>A]*A?$H^38/1-GI&H_&'P+I>FW>J:E=ZO9V5G-]GN)Y]!U!$BD_NL3!QU
M'YCU%=!;^,/#MUX&3QI;ZHLVA/;_ &I;M(W.Z/V3&_/;;C=GC&>*Y^_CTO7O
M"NJPS^7=:9J>LQ6Y^;*3H98HG /<95AQZ5XG\,4U;2M%\<?!G6(9Y+;PA<S7
MR73_ ''MBC/ GL2^V4>P/I3OH^Z5P2NUVN>N_P#"^OABVB1:_P#VQJ!T>:7R
M([_^Q+_R'DSC8'\C:6SD8SV-;.G_ !4\%ZMJNHZ38ZA>?VIIL'VFXTZ;2[N&
M[$?]Y8'B$DG;A%)Y'K7RM;KYW[#GA2#S5C9_$2(&(W!2;F3DC(SZXR*]/M)I
MM._;)T^V\37D'B77+O16CMKG3HC:PZ6@$C%)("TC98 _.TG\8XZ5=A'H5O\
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MV>FW5W#';,6"RM)#&Z*IVM@DCI6='\9/A_=:>+Z&^U5[5K5KY)1H.H;9+=2
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MS5PZM=F=E_PW/_U2[_RM_P#W/1_PW/\ ]4N_\K?_ -SU\9T4AGV9_P -S_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;7EI'-'$ ,#:K @8  XJ_INEZ;HNGQZ?H^G6NG640Q';VL*Q1H/95  K0HH
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M]L:2VB_VZNJ6ATGR?M/VX3KY'E8SYGF9V[<<[LXQ0!JT5QG_  M3X8>4)/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M 4444 %%%% #>]<3\0?'=K\._#I\0:EHNK:IIT9Q.^FK"[09( ++)*A()/\
M"&Q@YP*[85P7Q$\0>']#T?2SX@UFPTZ*?4[4*+R9(Q(%F0O]X\@#D^@ZUFVU
M;U!$5K\2])U7PEHWBKPQI.I>(]/U:585-AY >W=B%VRB65-I#<'&<8],&O0?
MTKYLA^'^O_"WXS::?!^9/AYXIU&-[NR ++IMROSJR_W5;;M!Z8.T]$-><Z])
M=:7_ ,)5)=R)#\3QXX0Z5)(V+U[1V41B,_?:W(W# ^3L:TTDTMA=_(^VZX"Y
M^)N@VOQ-T_X>M9:J-7OUD>&5[)H[<A$+L1(^-XXQE PR16YH?BS0_$6KZSI>
MDWWVF\T2<6M_'Y4B>3*1G;EE ;IU4D5X?XZ\4^&[?]K[X>>=X@TV,:?:7MO=
ME[J,"WD>-@B2<_(Q)& <$Y'K1]I(+^ZV?2E%%% PHHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH 2BEKS#XS>+O$O@'X8:CXO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MP%C?.599&! /H16+X?\ V?-;T&\\"E?'UI/!X-N)YK5!HC*TXF?=(';[2?<
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQS@J"-Q')>&?"_B.'X.> K.X\&ZO!!H7BR&X\202:;('F@$[,"4V[IDC4G.
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 T\BO"/VJM/L;KX
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M4VX)R"3FJ.J? GPGJG@.7P:VJ:Q;VEQJ)U2]NH98?M%]<DY+RLT3#K@X55'
M[<57Y"7GO:QR'Q UCQ9I_P 6/AO:^)M/\.:C9W^O'^SGMX[I)[-=L8WEA,$9
M_G<<JRD ' S@<#\7?%VJ?$?X1ZUXFDT_2(=$TKQ&NFZ>KV[M>#8ZAIO-+;0&
MS@H$''5CC!^A?%/POL?&&N>%]8U+Q)K4-WX9<36;6S6ZB24%<R2!H3DG:,@8
M7T K#U'X"^#-3L]6TV:\UF'1=5U'^UIM*@N$CMUN>[J0F\ _W=Y4=0!@8C;[
M[C_RL<E\0OC5XP\/:KX[M_#MGHMM;^#[>Q9TU6WEEEU!KAE&8]DJ!57=Z-D^
MF:9>?''Q@/$^I:-I'AUM8G\/PV1OK6UT:\EGOY)@&D$?E,ZVH123B4ON*D"L
MWQQX1\53?%/5-1L]:U?3/L"6\.C"?P>/$(D"0CF*Z9&^SY<D-O8$GYF8]O3/
M#?PWF;5K3Q]JFH:CH/BW5-/@BUVUTR6,6UY(J#.]61RK#&-T;*1V/<U':[$]
M-$5_V@/&&M>"?@EJ>M>'C);W\K16Z3A?FMA(V"_L0.!Z$BCPW\)?!LWPXM%A
MMV35]2L$:7Q!&[#4)))(P3)]HSYAYYV[MN.,8KT37M"TOQ)H%WH.M6*7NG7D
M?ES02@D./KU!S@@CD$9KE=%^&=MH>EQ:);^+O$=UH$(V1Z1<W$+0JG:/S!$)
MR@'&TR$8X((XI+2_F.[TMT//M<^-'BC2YO']_I=AIC:+X$N+6UFMKB.0W%_O
M;:[+*'"Q8[ H^?:K^F_$;X@^)OBEXF\'>&T\/""STZUU/3KF]MIURDP1MDNV
M4Y.UR-R@<C..U=%XH^"_AWQ1>:_+)J6K:7!XA\C^U;73Y(EBO6A(,;-OC=E/
M&#L*Y'7/6M30_A=I.A_$G5/'EGK&J/?:E;I:S6DK0FV6) HC55$08;0HQ\WU
MS1ZB:['E5Q\8/B9;:5\1M8-OX;N+7P3J2VKPK:SH]]%YFUL,9B(V"\YPX)XV
MC'.IJGQI\1WFK>*3X5L]-AT[PSH5OK<RZC#))+>B6(3>6K)(HBPAQN(?GM7-
M>"?A_P#\)GXQ^)^D^)8?%>C:1K&M?;5A^PRVEOJENLA(#22P\#..$9'()Z@<
M>L>(_@_X;\17=]=07FIZ"VHZ:-)OETQXE6ZME&%1A)&^"HX#+M..,D4=$^K2
M'W7F<=I_Q8\:>)_B38^'?#%MHD5IK/A=-?L7O[>8O;2-@>7*5D&]=P(RJJ<$
M=<<UOBA\9O&OP]N;YGT_0_+TZ&SD\@[[B2_$C!9G!24-:HK'"F6-@_8YXKO-
M)^$>@Z+\0=-\8:;K&K1W&G:9'H\%F7A-L+5%VA"/*W]1NSOSN]N*RO%'P$\)
M>+=7\3ZCJ.J:U"WB46_VR.WN(PBF'&QDW1DCIT)(YZ=,/[2ML"ZW['(77BCQ
MU?\ [0/BJRL=<TV*RTOPR+RWM;O3Y)8PDFQRIV3H=Y.T%\G@8"BLKX9?$K58
M_ _PK\'^%M'T?1+GQ,=1;>\=Q<VUFD$DC?+&TWF.6/K+Q].!ZQ/\(]$E\377
MB*'7M;L]1O-)72+F6&6+$\2J KL&B(#C /&%..5/-4](^!_AG1?#^@:3INM:
MS#/X<NI;K2M2\RW-S:>;_K(Q^YV,C9.0Z,>>O3 K+T%NC@[WX]^+I?"?AO4M
M*T[1HK^Y\3-X9U&&XBEDB\P$8EB82*5&.<,&Z]>.?0?A5\0M8\:7_C'1]?M[
M);WPWJTFG">RC>*.X0$@-L=W*GY3GYB.16?)^S_X7;PYHNB0Z]KUM'I.J/K,
M<\<EN99[MFSYDA:$@XZ   8Z@UTO@GX:Z9X%UCQ%JFFZQJE_-X@NOMMV+UH2
MHE)8ED$<:8SN/'(X%"M_7<;\N_X'H-%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MWQ#ID%DUO;:M_9L=B8Q&H1E1U+1YB#;0#R01RN" >AVWQ2M;/Q[XYAU[Q-I
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M]\,-4M?VBGUC4O!T9\*6_AF'1;>62:&>'S$6)<;'D:4IM5U!==Q[]<T =_\
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MP,[58CH:LVOQ)L(_A?H6H:UXFTI=>UC3WFMIK.&62&:1$)>1(R _EKC+%MH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZYXK8H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MSH2(Y+<B//R\9$ID!Q6#X=^+'Q)O- ^%>J77BN26;7?$DNF:BOV.V"W$"RH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MS6R?E3=QN/&:Y;X_3Z/?>)K[3;Z.V>_B\+W%Q:G5G+VX.XG-I"J[FNOE^_O
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MT^VN;?[+)<6[H\YC(VL-TR."6&06(+<Y!!YKI*.]-ZK4%IL<98^!;*W^&[>
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M:HO!NK>(+6W^&GB1O&FMZLVL^(]0TFZM[J^,L#V_F7(0;<8)'EJP8Y;G (7
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MVDQZ)=1-9_:1);QY$;I\Z;)E#, YWC!Y4XK2D\%ZU8>'+3P?X7UK3M*\-PV
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M/( P#GG/%=="DD<*))(\K* "[XRQ]3@ 9^@ JSVHHVT 6BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH HW,LT-K-)%;2W+QJ66*(J'D(&0H+$+D].2!ZD5\^
M>//ASXL^(7PO\076H6?B.PUV[O/M5OX?\W2WA65 $A<2_>"!  3YRG.\A<$
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M!2EX(].A472D[B),+\XSS@YYK6TG1=)T'3UT_0]+M-+LT)9;>S@6&-2>I"J
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MM#\;^!;'0_$.J:C93^#Y;MM)EU![B$7"1QD !B6SD\*20O10HXJK9ZEXFN/
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M>&_BWX9GNO%-YXDU?3/#>HLM\U[+ ;JXAD'DQ,L<F"<[49/^6A'S DU%9_\
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MI_@?P3I&I1:II/@W1+#485V175MIT,4L:[=N%=5! V\8!Z<4UH)JYY?XLO\
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M=T1V8+QN&,D@8/T9>>!?!NH7-I<:AX/T2\GLXUBMI)]/AD:!%.55"5RH!)(
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M[\ ZG?W%]J7@7P_>W=PVZ:XN-,@DDE/JS%26/UI5\ ^!TN]/N/\ A"]#$NG
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M.BR3-]ENK$7D$QD4+OV%U"R( =K_ #8)/!Z4FMK#OJSE-)^-VH:]<>"K71_
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M2T,.T-YK#=E4VLIW'C!![TWQ!I%EXZ^'NI:--'*MKK%DT8^T0O%)'O7Y6*.
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% %%[BW6^CM7N(UGD5G2(L
MSA<;B!U(&Y<^F1ZU<KP/Q'9Z_-^U"(])\5WNG2IX3GNK=7AAG@B;[0BE#&R
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M*+;1[._6WLTND@FMS,0JMY<!D&TJI< 9;D'I3;[Q3\:])O/#NFZQ??V1%?\
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MO$7@R^;Q!>&_OM.U:\TXW9C2-IUBE*JS*@"@XP#@ <4_,'HSTNBBB@ HHHH
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MC%UJMW.@M2NTPE))2K)@_=((Z'J!6]X=\&Z%X73R]'M[E$">4@N;Z>Z\F/\
MN1^<[>6G ^5<#@<<5R^I?&+PWI\D]Q-IVK'0;74/[+N=?2&,V5O<!MI5CO\
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M:59'0*0P*[02S$':#1MJ&Y,WP/\ AX=/.G_V9J9MC>_VB8CKE_@W77SO]?\
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M2 5KF/"_B;7-7_:>OK&Z7Q%IFFOX:6[32-6:)4B<SHHD1(F9>5'5B7!+ XZ
MZI WHV=;<_!GX>7EIJUE<Z9J,UOK%PMSJ$;ZU?$7,J\JS_ON<<?DO]T8V]>\
M#^'?%'A%/"NO6UW>Z0FP&%M0N%:4)]WS)%D#R=C\[') )R0#5:]\>6UOXKO?
M#ECX?U?5[G3XH9;V2QCB9+82YV AY%=B0"?D5L#KBO,K7XB7/@3QA\5]2\27
M6NZ_HVDZCI\44<;1.;))XR?E1FC4('=5^7+?=SG!-):Z#U7J=V_P;\"22ZC-
M-:ZM++J=JME>/)KVH,T\ Z1L3/DKVQZ$CN<V]-^%/@'2KV"ZM-#+2067]G+]
MINIKA6MQN C99'8. '906!(4[00.*@U#XK^'-&\0>(]'UJTU#33X?T]=4GN)
MDC:*:!FVJ8]CLQ);C#*IS69)\</"]BM]%K>CZ_I&H6D$5R;"YL=[O%*0L3"2
M)GA4.Q"C?(OS9!QBGN!U&@_#_P *^&[];W2--E2XCA-O"]Q>3W/V:(G)CA$K
ML(DR!\J;1P..!4?B#X=^#_%6L/JFN:2]Q>/9MI\KI=S0B:W)),<BQNJNN22-
MP.#R,$5KZ'K$^KQ7#W.AZCHTL,@C:#4%CW-E%;*M$[HP^;&0QY!':J/BSQ=:
M>$[;3I+JSO+^ZU.\2QL[.R5#+/,P)"@NRHHPI)+, ,=:3Z7!>1*OA/0XO"=I
MX7CMIQI5GY0@C-W,7C\I@T>)2^_Y2JX^;L!TKGKGX.^ ;V%(;G2[^1H[P:AY
MQU>]$SW  "RO*)M[LH "EB=HSMQDUFQ_'#PO+;:"T&A^(9;K6KR?3X;1+$%X
MKB(L'CD;=Y8;*GHY]3@ D6K7XO:#=:''>6VF:JVIRZI+HT>BF.(WK7<>=\>!
M)Y8 4;BY?:!R33UW#R)9/@W\/9KV[OI=)OFNKN[2^EN#K%[YGGIG9*K>=E&
M) *D'!QTXK@_&'PGAM?'7A$>$?!>JSZ)#J<^IZM-::QY6R26/9OC\RX61'!
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M_$%_<^']3\(_VG!9.^V!&::,*X0 <E><MDC<0"!Q1V7<5U:Y[31113&%%%%
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M=K,,3;XX[^UCN%1L8R X(!QWJ];6]O:6L-K:P)!;PH(XXHU"K&H& H X  X
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M^G/-+H<7VJ25H%-GM1D0L3C=P,@X**."@Q]AJRNBLC J>01R"*?^M'==_P
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M3=&*+[ SYZ^"-QX*\*1>/WNETG0;BT\27D,T\L:6PA@,H$$;2$ *I)^1"?7
MKU3X@>--)\ ^!K_Q)JUW%#Y*E;>.20*;B<@[(USW)'X $G@&N@;4+!=6CTF2
M^@6_>)ITMC(HE:,$ N$SDJ"0"<8R16C2>J2!:-L^2M4;5?AC>?#CXA:W_P (
M]!:I,]MJ6HV.L-<R:K%>-YDLWEFWC#*KL9!L9\ CJ.:Y?Q9??#^\@^-FJ6FN
M:??W(GL+G1;A]0^T.)2H9GMRSDY#EAE?NC*\#BOMS'-*:-OT\@OK=_/S/ESQ
M!I.FZ#XTCU?P[I5C>67Q4T<:9]I@@25$O7*DRY (V.CL[#HQBR<FNY^-6E^&
M_#7[-.MZ+"R:58VEF(+*&*X, :0?<3Y2-Y/)*G.[DD&N\_X1S4K[Q9:ZQK>J
M6UW9:9))-IUE!9M$8G="F^5VD?S&"LX&U4 WG@\8ZSOS0]8V0E[LD]SXWU35
M-/T[Q5K.G?##4[07NH> X))$TVX$DMS<K,&D;Y6W/.+<NW7>1S5F^TNWL?#.
MK>)O OC+3]4T*]CLEUO2?">ERVL<5LDZ>;(X^T2LDQC+!A\K,NXGH2?L''-+
M1N"T/F'Q=9^#=/\ ##:C\-M:M3X3U'6+.;78K:(WFDV4 C=23#"R *S^694#
M@X + #KFR^%])TK0$DL?B1X/U;2H]4EU2ST_4;,P^'WS'MD@1C-*HVEU9?F(
M1FX!.<?5]+1WL/L?(>JZQHK:/H_C@Z'HDZRZ7#:MX-U=Y%O8E>63Y]-E(W%Y
M-Q.%7)4+R.!5#6-:\/O\4;+Q L\&E7$'CA+>_N-2N2-4BB*%65G4(+>TP,(A
M+9Y.X8(K[*HI];ANCY*^&OPO^&_Q*\(^.(9D@U2^@UG4;>POC>O<26L+[1#(
M"7.X';N5FSG#')R:[KX,V\/BB\L]?U3PY;6.I>$+!?#8Q;JACND9A<%, 87;
MY>,<#>X'4U[+JT6K2Z=)'H=Y:65XV-DUY:M<QJ,\YC62,GC_ &ACWZ54\,Z#
M'X?TF2R6=KJ>6>6ZN+AEVF::1R[MCL,G '.  ,G%"$]?F_P/"OB1<>'9OB+X
MYT_XD+$(?[ 0^%A>@^47\MS,8.WVCS-@^7Y\  <5YQH-O;>*M"TW0_%7B33/
M#-H_AVP@T*[US2YF9'12)GLY&GA5)A*!R Q<;,97K]KR2QPQM)(P1%!9F8X"
M@=236=H_B+P_XAMY;CP_KFGZO#"_ER26-TDZHW]TE"<'VI15BFSY_P#$>@Q>
M!_'6C:W%I$.K7'C?1#X>N+BXL IEU%E4I+,ASM$HW>8I_N<YQ6!KW@W2K?QA
MK?@34O$>B^#K:TMK-?#=Q?::\DRQJBEY+*1;B-5F,V\NH5G<MSD'%?4KZGI\
M.J1:5)J%NNH31F2.U:91+(@ZL$SD@=R!6CFD(^1-=UJ_F\1_&2S\-:P;_76T
M[1DE^R.$NI(XEVWA1%)8.JE@RC)4G'6H_'6F^&+A?%EY\+[B&/PD/"<T^J#1
M;AH[3[8C V^[RR!YV,[E/) ^<<\_5MIJ%AJ44DVGWUO=QQRM [02K($D4X9"
M0>&!&".H-8?CWPO>^,? 6K>%;+5(=,.IPFVDN9;4W&R-N&P@=/FQT.<#T-%W
M;S'I?78^6/%W_"&MX;MK[P7?V]O /!]P/$<]E<-"DD_EI]DCG=6&ZX,V1L8[
MR,@@@XK9T%OA>WCWP);SWVARZ;?^#V.KI+=HT5S+&J%?M&YL.RXDP'R1M[;1
MCZ>\+:?>:1X6TW2+^]BOY[&!+=KB& P+(%&T'87?!P!GYCSGITI]QXBT&TBO
MYKK6M/@CTY@EX\MTBBU)4,!(2?D)!!YQP0:K2[L2D[6ZGQIX/O+/Q/X4\,:+
MXI\5:#9:!_8MQ8VMUKMNUY;V]V+F7<H87$2P3K"82A8D[<;>O.O-8^"[7QUX
M@TGQ3XHMM?\ LO@38USJEP4\ZY5B$/DR2-L?RQ&RJ.1D. &;-?7@U72VU4Z2
MFI6[ZAY7GFU693*(\@;]F<[<D<XQS2IJFFMJTNCQZC;OJ,48FDM%E4S(AX#%
M,Y )[XQ2W*O^A\M_#6;PSJ7Q5^&VM:K%87UQ>>#(TCNG@69Y;^*=$R& ),R*
M,%OO*H.2 #7I/QNTO2='O_#/Q0N="@OFT.]6WU#-LLKR64X:)@1@EMK.I [9
M;'4U[8:*):V\B5I<^2?"/A/6K35=:^'MQX5L!J&AO<>*]/"6R>0DUQ;!;>%2
MP_@F+@'C_4CT&*L-KX5G\/?#^ZT2_CLO$Z1NGC*6.[:VN4MO);[6;]PP=#O
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M?S(MMY"T444%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"/W>]V9U8@??4$<\8P;>K?$[QM8#XK+"=#\[P;!;7EFSV,Q6>*6%I3'(!/\
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M"K@5J2?&+QEHS:G;:QX9DOMRVL>DZC_8U]I%M+<S2K%Y$@N@6RI;=N4_,H/
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MRG/.\#G;V*6[[="=;+OU/1X_BEX'G\/VGB"WU>:XLKQY8[=8;"Y>>4Q$B7$
MC,N$P=QVX'>N<F\?:AJ'QA^'UOX=U^UO?"'B.QO9RD-N"TK0ID,9"2<98?*
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M$L&=HEB,J+YR$X ,>X'(QU%7?#OQ(\%^*M5M]-T76&NKBZM/MUN'M9H5GAR
M7C=T57P2 0I)4Y! (->5^*O!_C;Q98:'=/X'NM/NO#6BWMDL/VRT9K^>XMQ;
MJL1$N!$O+EI"C8  4FI_"GAGQQ9^+_A5<7W@F_M;3PYH4NEZA.]W9L(Y71$#
M +.69?W><@9PPXSD"DB==SUKQ)XZ\,^$R@UZ_D@=HWG\N"VFN76)?O2LL2,5
MC'=V 4>M8\_Q@^'MK=W5K)K<V^UT_P#M5VCT^Y>-K3@^<CK&5=/F'*D]_0XY
MGQUX(U*\^*D7B=M#U;Q#HE[I(TNZM-(UE].GMRLC.&(\^%98V#D%2W&,X-<E
MXP^&VOZII^FZ?X?\"/I2>#+5;G02DUM=+>7)D5OLSM--O\E1][=C<P)!^55>
M5M=EM=CTS_A=7PY\RXB77IY9[:W%W<6\6F7<DUO$>=\D:Q%D &"=P& 03@$5
MHZG\4/ ^CZ=;ZA>:X'M;JU%]'+:6\MT%MR<"9_*1O+CSQO?"YXS7D>G^(/&#
M_'S6;R3X=WDFM7/A.WCN-*6^M<6\GG2 %I#*%:(GNI+ $?)G(%;0_@WK7A+[
M!9:MHFJ>+-*O-$BT^]AT;7'L#;RJ\K,C*9X5FA;SB.22,'Y>3E]+BZGJEU\:
M/A;8ZJVES>,;1[F,Q"1H4DECC\T@(6D12B@DC)) &1G&15?3OBY\-X[6PD/C
MW^TAJ]Y/%8M)"3)*RL<QHL<2DJI^56(.[@;F)YY[P+X5U[PQ\5=7U!?!%UI^
M@C0K73;$Q7EO,NZ#<?+4M-YA!R K.!G&6VUQ7A_PC\2+&3P<ES\.=21=&\37
MNL7#B^L"/(GW[0O^D9+#?R, <<$T*WWAM?R/9+?XO?#VZ2&2+790DEW]A9GL
M;E!;W&_8(YRT8\ABW $NW/:KU]\1_!NF^(TT&^UQ8+MKA;3>T$OV=9R-PA:<
M+Y2R$<["P;IQS7B6I>#?B)>>"/&NFKX!U);O6?%Z:W:HUY8X^S^9&YW'[1@,
M!$1CU9<9Y(VM/^&UZ^I:O9^)O VLZQ;WFKOK-C=#Q T5I$TC^:%GMEN@!+&Q
M*Y1'#$#Y@.:.WX@>@67QD^&^I3V\>F^)A=K<7O\ 9T<T-I.\)N.HC\T)L#-_
M#D_-_#FG?#GXDV_CY_$!AT^\LTTS4I;.(7%G-%NC0*,LSJ%W[MV4!W*-NX#J
M?'W\'_$=O!UQIH^'>I_:I?'/_"1A#?6.!:^:),9^T??P,8Z9[UZ)\-]-\6>#
M8/%D&I^$+N>.]\0W5_;-:W=LS313N"&"M(H 4 EMQ!_NAJ%KJ#TV[_@>QT44
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<
MGXL\"^'?'%M9VWB2VN;J&SF%Q L-]<6P60?=?]TZY8=B<XYQC-=910!5AA6.
M%%4N0JA<NQ8X'J3R3[GFK5%% !1110 4444 %%%% !1110 4444 9^H:?8ZM
MIESINI6L5W974;0S02KN21&&"I'<$5@:%X \,^')K>;3+.[)MQMMTN]0N;M+
M48(_<I-(ZQ<$CY .#CI77T&C8 HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@#D;?P'X;M?'$_CB"VNQKUS'Y,MPVH7+
M(\?9/*,ACVCJ!MP#R,'FNM[4M%'2P!1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 4KA9)(7C
M29H692!(N-RGU&01D>X(KY(N?BGXNL=+^(*W7Q>FBU_P_K4EAHVF2V>GO)J2
M*^U5:)8!(Q8\%D( ]*^M[G[1Y#^3&COM.U6;:I/8$X.![X/TKY\A^%OQ4A\*
M>/O#JVWA../QGJ4]Y)</J5Q)]B2; 953[*OF,!T8LO/:IZOT!6LK]SVWPG>:
MQJ'@O1K[Q#8_8-6GM(I;NV'2*4J"R\].>W;I70]Z\W\"^&/&'@VUT#PLVH:7
MJ?AG3=-$$UU,)1?2708D;1DH(@"  26&!7I ZFF]_(E;*YX9\4OB1=>$?B/H
MVCZYKFH>$_"MS9M(NM6-E'<>9=[R!#(9(Y B!1GY5W'<.0,U#XL^+&N^&?!?
MA:UT^_TC7O$GBS4GL=+OX1_H9B,NU)RJL<X5X\KN^\3Z8KO/$&D>*[[5-0-K
M:Z'KVAW5K%"^AZN7B0N"^Z3S1'(,$%1L,9SM!RO?S63]G?=\.-+TFSUJ'3/$
M.E:O+K>GSPQ-);6DCL&^SJK'<8AM09/.5SCG;2CVEW_ M^1Z'_8_CC0[6TO#
MX[EUQUGB;44U"QMXT\@,#*8/)1"AVY^^9...N#7!_#GQ1XX^,FF:]XJL?%UQ
MX2TB.[DL]*L[&SMIV.U0?-G::-RV=P^5=G?GO7I>EK\0KXV\/B:UT'3H8P#<
MMIMU+=FZXY4+)#&(E)Z\R'' P?FKAO!_PY\;?"Z'7-'\!R:+JV@W]P]W9QZO
M<S6TNGR, "O[N*03)P./W9XZ\YI]7Z:>I/16[ZGG]Y\9O&FK? /Q;KB:Q_87
MB_P;?I97;6=O"\-YNE6,,R31OMS\_"D<KGH=M;GAWQQXNUSXGZ?X7\/>/KGQ
M1H5_I'VC4=5MK6S=]&N-I8!98X1"22 NQU8C=Z\TZ_\ @1KUC\#=;\"Z'?:;
MJ.N>);L7FJ:I?RR6T8<2+)^[1(Y"0-N,$KU)_P!FO9--A\46?@6VM9-/TLZ]
M;VPA6!;Z0VK,HV@F7R0X! S_ *LX/'/6D]GWT^\?9+N_N/G_ .$OCKQE\1O"
MDEK<_%ZZM/&DMQ<I:V,5EI[1+%$JD231_9]ZJ2VW(89[ X-?52YP-W7'-?._
MPW^&OQ2^&_@E]%M=)\&ZCJT=S/=6FISZG=*+<RJJLOEBURP^7IO&>/2O?;%9
MH+&VANIO.N$B59)/[[  %OQ-6[60N_J7Z***0PHHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MP+6U]+GTM17S3\+]=TW3_B/HWA#Q-\/9OAYXK2&7RX;(?\2[6<1D-)\IVM(
M"0YWG&X;^<5]+530A:***0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MLC^=&T[^9&%;JKJ3@\=*%J[=1].;H>^4[H*\1B\4?%R\\>^+/"&G:AX3GN]
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MS%%?C/7TU^Q7_P EMUG_ +%^;_TIMZ /OZBBB@ HHHH **** "BBB@ HHHH
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M5]F?\,,?]51_\HG_ -T4?\,,?]51_P#*)_\ =% 'QG17V9_PPQ_U5'_RB?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)+!);S2(C@@!PBY,?IM->IZWH3:%^S;>>'-,\.ZCXB2UTS[-#IE](S7-Q'G
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M77*NH=2,X((#*?<=J^6-:DU36)?C3K%UX@U%X_\ A%[&?[(PA,16:UDD$?\
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M>0,\UXK8Z]XL'PX\(7TWC#69;@^/O[,N'DN!NNX#=,NR0@9P F-JE5P2"",
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M=B77RRLKHK$ J,MNP"HY(+OYCMK9'J5WX4\/WWBG3_%5UIBS:SI\,EO:W1+
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M9W<M@;VW%OY+SQHS,@W2AU&5V[W55+$<X.:H_!_QQK'C[P$?$&L:3/I[O=7
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M&O1$484#Z "KM4[7T)7=[CJ***104444 %%%% !1110 4444 %%%% !1110
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M -I7;CG(()R"<&NQUKP=I/B3P5<>$==:YU&PN(A'++-+^^9@0PDW#&&# ,,
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M#,%WDR,%!+%CP3BO4/"?@NP\*S:M=07UYJ6HZQ<"YOKV],?F3N%"CY8D1%
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M5PR+&-NX<L 372WWPXM[_P 9>&_%5UXHUEKWP_ ;>!/]%$4P<!93(OD9)D
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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3 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>ltbr_ex32img4.jpg
<TEXT>
begin 644 ltbr_ex32img4.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" 2D Y8# 2(  A$! Q$!_\0
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M9T\N".,Y(XY*$_C7#_\ #$/BK_H=]*_\!Y*H1\F45]9_\,0^*O\ H=]*_P#
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MZ[;_ &I84%U)'+*!\[QQE%)]E))'YFK5%)*Q;=PHHHIB"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **_.?_ (:\^,O_ #^Z5_X
M+_C1_P ->?&7_G]TK_P 7_&@#]&**_.?_AKSXR_\_NE?^ "_XT?\->?&7_G]
MTK_P 7_&@#]&**_.?_AKSXR_\_NE?^ "_P"-'_#7GQE_Y_=*_P# !?\ &@#]
M&**_.?\ X:\^,O\ S^Z5_P" "_XT?\->?&7_ )_=*_\  !?\: /T8HK\Y_\
MAKSXR_\ /[I7_@ O^-'_  UY\9?^?W2O_ !?\: /T8HK\Y_^&O/C+_S^Z5_X
M +_C1_PUY\9?^?W2O_ !?\: /T8HK\Y_^&O/C+_S^Z5_X +_ (T?\->?&7_G
M]TK_ , %_P : /T8HK\Y_P#AKSXR_P#/[I7_ ( +_C1_PUY\9?\ G]TK_P
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M?_AKSXR_\_NE?^ "_P"-'_#7GQE_Y_=*_P# !?\ &@#]&**_.?\ X:\^,O\
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M?_AKSXR_\_NE?^ "_P"-'_#7GQE_Y_=*_P# !?\ &@#]&**_.?\ X:\^,O\
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %=K\*?^2W^ _\
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M% !1110 4444 %%%% !1110 445>L[6:^OH+*W7S)[B18HTR!N9C@#)X')H
MHU[/^RW_ ,G-^$?^WS_TCFH_X9<^.O\ T(O_ )4[/_X]7I?P+^!7Q4\%_''P
M[XF\3>%?L&DVGVGSKC[=;2;-]M*B_*DA8Y9E' [T ?<U%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 ?C/1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %;?A/_D=]!_["%O_
M .C%K$K;\)_\COH/_80M_P#T8M 'Z^T444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 ?D#_PDNH_\^VE?^"FU_\ C='_  DNH_\ /MI7_@IM?_C=8M%
M&U_PDNH_\^VE?^"FU_\ C='_  DNH_\ /MI7_@IM?_C=8M% &U_PDNH_\^VE
M?^"FU_\ C='_  DNH_\ /MI7_@IM?_C=8M% &U_PDNH_\^VE?^"FU_\ C='_
M  DNH_\ /MI7_@IM?_C=8M% &U_PDNH_\^VE?^"FU_\ C='_  DNH_\ /MI7
M_@IM?_C=8M% &U_PDNH_\^VE?^"FU_\ C='_  DNH_\ /MI7_@IM?_C=8M%
M&U_PDNH_\^VE?^"FU_\ C='_  DNH_\ /MI7_@IM?_C=8M% &U_PDNH_\^VE
M?^"FU_\ C='_  DNH_\ /MI7_@IM?_C=8M% &U_PDNH_\^VE?^"FU_\ C='_
M  DNH_\ /MI7_@IM?_C=8M% &U_PDNH_\^VE?^"FU_\ C='_  DNH_\ /MI7
M_@IM?_C=8M% &U_PDNH_\^VE?^"FU_\ C='_  DNH_\ /MI7_@IM?_C=8M%
M&U_PDNH_\^VE?^"FU_\ C='_  DNH_\ /MI7_@IM?_C=8M% &U_PDNH_\^VE
M?^"FU_\ C='_  DNH_\ /MI7_@IM?_C=8M% &U_PDNH_\^VE?^"FU_\ C='_
M  DNH_\ /MI7_@IM?_C=8M% &U_PDNH_\^VE?^"FU_\ C='_  DNH_\ /MI7
M_@IM?_C=8M% &U_PDNH_\^VE?^"FU_\ C='_  DNH_\ /MI7_@IM?_C=8M%
M&U_PDNH_\^VE?^"FU_\ C='_  DNH_\ /MI7_@IM?_C=8M% &U_PDNH_\^VE
M?^"FU_\ C='_  DNH_\ /MI7_@IM?_C=8M% &U_PDNH_\^VE?^"FU_\ C='_
M  DNH_\ /MI7_@IM?_C=8M% &U_PDNH_\^VE?^"FU_\ C='_  DNH_\ /MI7
M_@IM?_C=8M% &U_PDNH_\^VE?^"FU_\ C='_  DNH_\ /MI7_@IM?_C=8M%
M&U_PDNH_\^VE?^"FU_\ C='_  DNH_\ /MI7_@IM?_C=8M% &U_PDNH_\^VE
M?^"FU_\ C='_  DNH_\ /MI7_@IM?_C=8M% &U_PDNH_\^VE?^"FU_\ C='_
M  DNH_\ /MI7_@IM?_C=8M% &U_PDNH_\^VE?^"FU_\ C='_  DNH_\ /MI7
M_@IM?_C=8M% &U_PDNH_\^VE?^"FU_\ C='_  DNH_\ /MI7_@IM?_C=8M%
M&U_PDNH_\^VE?^"FU_\ C='_  DNH_\ /MI7_@IM?_C=8M% &U_PDNH_\^VE
M?^"FU_\ C='_  DNH_\ /MI7_@IM?_C=8M% &U_PDNH_\^VE?^"FU_\ C='_
M  DNH_\ /MI7_@IM?_C=8M% &U_PDNH_\^VE?^"FU_\ C='_  DNH_\ /MI7
M_@IM?_C=8M% &U_PDNH_\^VE?^"FU_\ C='_  DNH_\ /MI7_@IM?_C=8M%
M&U_PDNH_\^VE?^"FU_\ C='_  DNH_\ /MI7_@IM?_C=8M% &U_PDNH_\^VE
M?^"FU_\ C='_  DNH_\ /MI7_@IM?_C=8M% &U_PDNH_\^VE?^"FU_\ C='_
M  DNH_\ /MI7_@IM?_C=8M% &U_PDNH_\^VE?^"FU_\ C='_  DNH_\ /MI7
M_@IM?_C=8M% &U_PDNH_\^VE?^"FU_\ C='_  DNH_\ /MI7_@IM?_C=8M%
M&U_PDNH_\^VE?^"FU_\ C='_  DNH_\ /MI7_@IM?_C=8M% 'Z3?!GX?^ -?
M^"?A36-8\ ^&KV_N[(233RZ/;%I&W'D_)7?_ /"I_A9_T33PK_X)K;_XBL7X
M!_\ )O?@K_L'K_Z$:]-H XS_ (5/\+/^B:>%?_!-;?\ Q%,A^%OPSAFCF@^'
MOAF*5&#HZ:1;JRL#D$$)P17;44 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% 'XST444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 ?4W@']K;_A!_A[HOA+_A7W]H?V7;B#[3
M_:WE>;@DYV^2V.O3)K[RK\9Z_9B@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** /QGHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *_67_ (6Q\+/^BE^%?_!S;?\
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M\#V_PKTOX?\ PZ\,_#/P]<:#X7CGCLKBZ:\=;B4R-YC(B'D]L(O% ':4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 ?C/17TU_PQ7\4O\ H/\ A7_P
M*N?_ (Q1_P ,5_%+_H/^%?\ P*N?_C% 'S+17TU_PQ7\4O\ H/\ A7_P*N?_
M (Q1_P ,5_%+_H/^%?\ P*N?_C% 'S+17TU_PQ7\4O\ H/\ A7_P*N?_ (Q1
M_P ,5_%+_H/^%?\ P*N?_C% 'S+17TU_PQ7\4O\ H/\ A7_P*N?_ (Q1_P ,
M5_%+_H/^%?\ P*N?_C% 'S+17TU_PQ7\4O\ H/\ A7_P*N?_ (Q1_P ,5_%+
M_H/^%?\ P*N?_C% 'S+17TU_PQ7\4O\ H/\ A7_P*N?_ (Q1_P ,5_%+_H/^
M%?\ P*N?_C% 'S+17TU_PQ7\4O\ H/\ A7_P*N?_ (Q1_P ,5_%+_H/^%?\
MP*N?_C% 'S+17TU_PQ7\4O\ H/\ A7_P*N?_ (Q1_P ,5_%+_H/^%?\ P*N?
M_C% 'S+17TU_PQ7\4O\ H/\ A7_P*N?_ (Q1_P ,5_%+_H/^%?\ P*N?_C%
M'S+17TU_PQ7\4O\ H/\ A7_P*N?_ (Q1_P ,5_%+_H/^%?\ P*N?_C% 'S+1
M7TU_PQ7\4O\ H/\ A7_P*N?_ (Q1_P ,5_%+_H/^%?\ P*N?_C% 'S+17TU_
MPQ7\4O\ H/\ A7_P*N?_ (Q1_P ,5_%+_H/^%?\ P*N?_C% 'S+17TU_PQ7\
M4O\ H/\ A7_P*N?_ (Q1_P ,5_%+_H/^%?\ P*N?_C% 'S+17TU_PQ7\4O\
MH/\ A7_P*N?_ (Q1_P ,5_%+_H/^%?\ P*N?_C% 'S+17TU_PQ7\4O\ H/\
MA7_P*N?_ (Q1_P ,5_%+_H/^%?\ P*N?_C% 'S+17TU_PQ7\4O\ H/\ A7_P
M*N?_ (Q1_P ,5_%+_H/^%?\ P*N?_C% 'S+17TU_PQ7\4O\ H/\ A7_P*N?_
M (Q1_P ,5_%+_H/^%?\ P*N?_C% 'S+17TU_PQ7\4O\ H/\ A7_P*N?_ (Q1
M_P ,5_%+_H/^%?\ P*N?_C% 'S+17TU_PQ7\4O\ H/\ A7_P*N?_ (Q1_P ,
M5_%+_H/^%?\ P*N?_C% 'S+17TU_PQ7\4O\ H/\ A7_P*N?_ (Q1_P ,5_%+
M_H/^%?\ P*N?_C% 'S+17TU_PQ7\4O\ H/\ A7_P*N?_ (Q1_P ,5_%+_H/^
M%?\ P*N?_C% 'S+17TU_PQ7\4O\ H/\ A7_P*N?_ (Q1_P ,5_%+_H/^%?\
MP*N?_C% 'S+17TU_PQ7\4O\ H/\ A7_P*N?_ (Q1_P ,5_%+_H/^%?\ P*N?
M_C% 'S+17TU_PQ7\4O\ H/\ A7_P*N?_ (Q1_P ,5_%+_H/^%?\ P*N?_C%
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M:R/^&@M0_P"@;\/_ /PX=K_\9KS+]N;_ )I]_P!Q'_VVKXSH _1G_AH+4/\
MH&_#_P#\.':__&:/^&@M0_Z!OP__ /#AVO\ \9K\YJ* /T9_X:"U#_H&_#__
M ,.':_\ QFC_ (:"U#_H&_#_ /\ #AVO_P 9K\YJ* /T9_X:"U#_ *!OP_\
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M[MD!VYVMC/7!]*V_^$J^,O\ T2'2O_"J7_Y&KP#]AG_FH/\ W#O_ &YK[,H
M\>U+XA?%;2[S2;2\^$^FB75KLV=MM\4*09!#)-S_ *-P-D+\^N/6H-=^*GCO
MPO\ 9SXF\%>%M$^T[O(&H^-8;?S=N-VW? -V-RYQTR/6NN\=_P#(T_#?_L9&
M_P#3;?5\V_MS?\T^_P"XC_[;4 >F_P##06H?] WX?_\ AP[7_P",T?\ #06H
M?] WX?\ _AP[7_XS7YS44 ?HS_PT%J'_ $#?A_\ ^'#M?_C-'_#06H?] WX?
M_P#AP[7_ .,U^<U% 'Z,_P##06H?] WX?_\ AP[7_P",T?\ #06H?] WX?\
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M^@ZG82Y\JZM/%T<T4F&*G:ZVY!P00<'J"*_,2OTQ_9<_Y-D\(_\ ;Y_Z634
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M;<TW7?BIX[\+_9SXF\%>%M$^T[O(&H^-8;?S=N-VW? -V-RYQTR/6MOXK_\
M(7^&/_8X6_\ Z2W5> ?MS?\ -/O^XC_[;4 >F_\ #06H?] WX?\ _AP[7_XS
M1_PT%J'_ $#?A_\ ^'#M?_C-?G-10!^C/_#06H?] WX?_P#AP[7_ .,T?\-!
M:A_T#?A__P"'#M?_ (S7YS44 ?HS_P -!:A_T#?A_P#^'#M?_C-'_#06H?\
M0-^'_P#X<.U_^,U^<U% 'Z,_\-!:A_T#?A__ .'#M?\ XS5_1?C!XP\27SV7
MAWPGX0UF[2,S-!8>-X+B14! +%4@) RRC/3)'K7YKU]-?L5_\EMUG_L7YO\
MTIMZ /J/5O'GQ8T?1;[5[[X2Z8MK8V\ES,5\4*2$12S8'V;DX!J*^^(GQ*TO
M1'US5OAOH>FZ8JH[W-YXNCABC#$!=S-;@#)8#D]2!7<?$'_DE?B[_L#WG_HE
MZ\T_:-_Y-(U__KWT_P#]*H* *?\ PT%J'_0-^'__ (<.U_\ C-'_  T%J'_0
M-^'_ /X<.U_^,U^<U% 'Z,_\-!:A_P! WX?_ /AP[7_XS1_PT%J'_0-^'_\
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M_"^A^#_#5IX;\.V/V'2[/?Y-OYKR;-[L[?,Y+'+,QY/>@#D?BO\ \A?X8_\
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M0!T-%%% !1110 5YE\5_^0O\,?\ L<+?_P!);JO3:\R^*_\ R%_AC_V.%O\
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M)ZK_ /(U'_"R_#O_ $#?%7_A)ZK_ /(U '9T5QG_  LOP[_T#?%7_A)ZK_\
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M1J/^%E^'?^@;XJ_\)/5?_D:@"W\0?^25^+O^P/>?^B7K;TG_ ) =A_U[Q_\
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M_P"%L?%+_HI?BK_P<W/_ ,77%T4 =I_PMCXI?]%+\5?^#FY_^+H_X6Q\4O\
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M ,'-S_\ %T?\+8^*7_12_%7_ (.;G_XNN+HH [3_ (6Q\4O^BE^*O_!S<_\
MQ='_  MCXI?]%+\5?^#FY_\ BZXNB@#M/^%L?%+_ **7XJ_\'-S_ /%T?\+8
M^*7_ $4OQ5_X.;G_ .+KBZ* .T_X6Q\4O^BE^*O_  <W/_Q=?H/^SQJVJ:Y^
MSWX7U36-3NM3OY_M7F75Y,TTLF+J91N=B2<  #)Z "OS$K],?V7/^39/"/\
MV^?^EDU 'L]%%% 'F7P;_P"03XR_['#6/_2IJ_.C_A;'Q2_Z*7XJ_P#!S<__
M !=?HO\ !O\ Y!/C+_L<-8_]*FK\M* .T_X6Q\4O^BE^*O\ P<W/_P 71_PM
MCXI?]%+\5?\ @YN?_BZXNB@#]4/@G?7^K? _PGJ.J7UQ?WMQ8J\MQ<RM+)(V
MX\LS$DGZUZ17F7P#_P"3>_!7_8/7_P!"->FT %%%% !7D375U8?LL:C?6-S-
M:W-MX8NI89X9"DD3K;N596'(((!!'(->NUX_??\ )G^M?]BG>_\ I-)0!^??
M_"V/BE_T4OQ5_P"#FY_^+H_X6Q\4O^BE^*O_  <W/_Q=<710!]S?L=^+/%7B
MC_A-_P#A)/$VJZW]F^P^3_:%Y)<>5N^T;MN]CMSM7..N!Z5]95\9_L,_\U!_
M[AW_ +<U]F4 %%%% 'F7Q7_Y"_PQ_P"QPM__ $ENJ\:_;$\6>*O"_P#PA'_"
M-^)M5T3[3]N\[^S[R2W\W;]GV[MC#=C<V,],GUKV7XK_ /(7^&/_ &.%O_Z2
MW5> ?MS?\T^_[B/_ +;4 ?,__"V/BE_T4OQ5_P"#FY_^+H_X6Q\4O^BE^*O_
M  <W/_Q=<710!VG_  MCXI?]%+\5?^#FY_\ BZ/^%L?%+_HI?BK_ ,'-S_\
M%UQ=% ':?\+8^*7_ $4OQ5_X.;G_ .+H_P"%L?%+_HI?BK_P<W/_ ,77%T4
M=I_PMCXI?]%+\5?^#FY_^+K],OAO=75_\)_!E]?7,UU=7.BV4TT\SEY)7:W0
MLS,>22222>2:_)FOUD^%/_)$/ ?_ &+]A_Z3)0!<^(/_ "2OQ=_V![S_ -$O
M7GWQRU;5-#_9@UK5-%U.ZTV^@M[+RKJSF:&6/-Q IVNI!&02#@]"17H/Q!_Y
M)7XN_P"P/>?^B7KS3]HW_DTC7_\ KWT__P!*H* /@[_A;'Q2_P"BE^*O_!S<
M_P#Q='_"V/BE_P!%+\5?^#FY_P#BZXNB@#M/^%L?%+_HI?BK_P '-S_\71_P
MMCXI?]%+\5?^#FY_^+KBZ* .T_X6Q\4O^BE^*O\ P<W/_P 71_PMCXI?]%+\
M5?\ @YN?_BZXNB@#M/\ A;'Q2_Z*7XJ_\'-S_P#%T?\ "V/BE_T4OQ5_X.;G
M_P"+KBZ* .T_X6Q\4O\ HI?BK_P<W/\ \71_PMCXI?\ 12_%7_@YN?\ XNN+
MHH ]D^&_Q,^(U_\ %GP98WOQ \1W5M<ZU90S0S:M</'*C7"!E92^"""00>"*
M_32OR<^%/_);_ ?_ &,%A_Z4I7ZQT %%%% !1110 4444 %>9?!O_D$^,O\
ML<-8_P#2IJ]-KS+X-_\ ()\9?]CAK'_I4U 'IM%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7/77_ "471O\
ML%WW_HVTKH:YZZ_Y*+HW_8+OO_1MI0!Y)\4/V:=#^)WCB7Q5?>)K[3IY((X?
M)@A1E 08!R>:XG_AB'PK_P!#OJO_ (#QU]944 ?+&F_L:^&=,U>RU*/QIJDC
MVDZ3JC6\8#%6#8_2OJ>BB@ KS+XK_P#(7^&/_8X6_P#Z2W5>FUYE\5_^0O\
M#'_L<+?_ -);J@#P#]N;_FGW_<1_]MJ^,Z^S/VYO^:??]Q'_ -MJ^,Z "BBB
M@ HHHH **** "O=/V4[Y[3]H[085C#+>07<#$_P@6[R9'XQ@?C7A=>S_ ++?
M_)S?A'_M\_\ 2.:@#],:\R\&?\EV^*?_ '"O_29J]-KS+P9_R7;XI_\ <*_]
M)FH \O\ $G[(?AOQ+XOUKQ)<>,-2MY=4O9[UXD@C*QM+(SE03V&[%97_  Q#
MX5_Z'?5?_ >.OK*B@#Y-_P"&(?"O_0[ZK_X#QT?\,0^%?^AWU7_P'CKZRHH
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M<;LUZ17)?#7_ ))=X=_Z\TH ^>O^&(?"O_0[ZK_X#QT?\,0^%?\ H=]5_P#
M>.OK*B@#R/X-_!/2O@XVN?V9KEWJ@U?R-_VB-4\ORO,QC;USYA_*O7*** "B
MBB@#S+XK_P#(7^&/_8X6_P#Z2W5> ?MS?\T^_P"XC_[;5[_\5_\ D+_#'_L<
M+?\ ]);JO /VYO\ FGW_ '$?_;:@#XSHHHH **** /I+X%_L[Z/\6O -[XBU
M'Q%>Z9+;:E)8B*WB1U95BB?=D]_WA'X5ZI_PQ#X5_P"AWU7_ ,!XZV/V*O\
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M +'#6/\ TJ:O3:\R^#?_ ""?&7_8X:Q_Z5-0!Z;1110 4444 %%%% !1110
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M_IMOJ[J@#\SO^&7/CK_T(O\ Y4[/_P"/4?\ #+GQU_Z$7_RIV?\ \>K],:*
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M **** "BBB@#S+XK_P#(7^&/_8X6_P#Z2W5> ?MS?\T^_P"XC_[;5[_\5_\
MD+_#'_L<+?\ ]);JO /VYO\ FGW_ '$?_;:@#XSHHHH **** /L+]F7XQ?#K
MX>_"V_T7Q;XB_LR_N-7ENHXOL=Q-NB,,*ALQQL.J,,9SQ7M__#47P*_Z'K_R
MF7G_ ,9K\SJ* /TQ_P"&HO@5_P!#U_Y3+S_XS7J6DZI8ZYHMAK6ES_:+"^MX
M[JVEVLOF1.H9&PP!&00<$ U^/E?K)\*?^2(> _\ L7[#_P!)DH N?$'_ ))7
MXN_[ ]Y_Z)>O-/VC?^32-?\ ^O?3_P#TJ@KTOX@_\DK\7?\ 8'O/_1+UYI^T
M;_R:1K__ %[Z?_Z504 ?FU1110 4444 %%%% !1110 4444 %%%% !1110 5
M]-?LK_%#P+\-_P#A+O\ A-=<_LK^T/L?V;_19IO,\OS]_P#JT;&-Z]<=>.]?
M,M% 'Z8_\-1? K_H>O\ RF7G_P 9KTCPOXHT/QAX:M/$GAV^^W:7=[_)N/*>
M/?L=D;Y7 8896'([5^0U?IC^RY_R;)X1_P"WS_TLFH ]GKS+X-_\@GQE_P!C
MAK'_ *5-7IM>9?!O_D$^,O\ L<-8_P#2IJ /3:*** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N/UK4].TSX@Z)
M)J6H6UDCZ9?JK7$JQACYMIP"2*["O,O%7AW0_$OQ=\+6'B+1;#6+6/1=6F6&
M_MDN(U<7&G ,%<$ X9AGK@GUH [+_A+/"_\ T,VE?^!D?_Q5'_"6>%_^AFTK
M_P #(_\ XJOA7]HC5E\!?&&X\/>%?#OA;3]-2S@E6'_A&M.EPS Y.Z2!F_6O
M(/\ A9?B+_H&^%?_  D]*_\ D:@#]2?^$L\+_P#0S:5_X&1__%4?\)9X7_Z&
M;2O_  ,C_P#BJ_,SP_X\UJ^\3Z39W>E>%I+>XO(8I$_X172QN5G (R+?(X-?
MHW_PJ?X6?]$T\*_^":V_^(H V/\ A+/"_P#T,VE?^!D?_P 57FWQ.\1^';C5
M/ART.O:=,(?%EO)(4NHVV+]EN1N.#P,D<^XKL?\ A4_PL_Z)IX5_\$UM_P#$
M5Y%\:OA[X#TK_A7']E^"- TXWGC;3+2X^S:;#'Y\+^9OB?:HW(<#*G@XH \V
M_;2U;2]4_P"$#_LW4[2]\K[?O^SS+)LS]GQG:3C.#^5?(%?6?[8GA/PKX7_X
M0C_A'/#.E:)]I^W>=_9UG';^;M^S[=VQ1NQN;&>F3ZU\F4 %%%% 'L?[-MW:
MV/[1WA6ZO+F*UMT^U[I9G"(N;28#)/ Y(%?HU_PEGA?_ *&;2O\ P,C_ /BJ
M_)?2]2N-)U2&^M([66:+.U;RTBNHCE2IW12JR-P>,J<'!'(!K?\ ^%E^(O\
MH&^%?_"3TK_Y&H _4G_A+/"__0S:5_X&1_\ Q5'_  EGA?\ Z&;2O_ R/_XJ
MORV_X67XB_Z!OA7_ ,)/2O\ Y&H_X67XB_Z!OA7_ ,)/2O\ Y&H _4G_ (2S
MPO\ ]#-I7_@9'_\ %4?\)9X7_P"AFTK_ ,#(_P#XJORV_P"%E^(O^@;X5_\
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M+Z8_EQ),ZHN6MR3@ #))-<M_PLOQ%_T#?"O_ (2>E?\ R-0!^I/_  EGA?\
MZ&;2O_ R/_XJC_A+/"__ $,VE?\ @9'_ /%5^6W_  LOQ%_T#?"O_A)Z5_\
M(U'_  LOQ%_T#?"O_A)Z5_\ (U 'ZD_\)9X7_P"AFTK_ ,#(_P#XJC_A+/"_
M_0S:5_X&1_\ Q5?EM_PLOQ%_T#?"O_A)Z5_\C4?\++\1?] WPK_X2>E?_(U
M'ZD_\)9X7_Z&;2O_  ,C_P#BJ/\ A+/"_P#T,VE?^!D?_P 57Y;?\++\1?\
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M -J>"- U$V?C;4[2W^TZ;#)Y$*>7LB3<IVH,G"C@9KXK_P"%E^(O^@;X5_\
M"3TK_P"1J /U)_X2SPO_ -#-I7_@9'_\51_PEGA?_H9M*_\  R/_ .*K\MO^
M%E^(O^@;X5_\)/2O_D:C_A9?B+_H&^%?_"3TK_Y&H _4G_A+/"__ $,VE?\
M@9'_ /%4?\)9X7_Z&;2O_ R/_P"*KRKX1^!? ?B?X/\ A?Q%KG@'PM=ZE?68
MEN)O[#M$WMD\[5C"CIV KO?^%3_"S_HFGA7_ ,$UM_\ $4 ;'_"6>%_^AFTK
M_P #(_\ XJC_ (2SPO\ ]#-I7_@9'_\ %5C_ /"I_A9_T33PK_X)K;_XBC_A
M4_PL_P"B:>%?_!-;?_$4 ;'_  EGA?\ Z&;2O_ R/_XJN4^'OBCPU#\-/#\4
MWB'3(Y%M$#(]W&"#[C-:?_"I_A9_T33PK_X)K;_XBO /AOX3\(_\,4R^+9/"
M.@7>O6VD:K=1WUYI5O<2^9%)<&-F,B-NV[5P&R, #I0!]+_\)9X7_P"AFTK_
M ,#(_P#XJC_A+/"__0S:5_X&1_\ Q5?EM_PLOQ%_T#?"O_A)Z5_\C4?\++\1
M?] WPK_X2>E?_(U 'ZD_\)9X7_Z&;2O_  ,C_P#BJ/\ A+/"_P#T,VE?^!D?
M_P 57'^'?AG\-+[POI%]=?#GPM)<7%G#+(_]BVPW,R DX"8')K8_X5/\+/\
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MVRB:%0V8V4]'88SCF@#PFBOTQ_X9<^!?_0C?^5.\_P#CU'_#+GP+_P"A&_\
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MC_6+C&>AZ4 =I\5_^0O\,?\ L<+?_P!);JO /VYO^:??]Q'_ -MJ]_\ BO\
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M/Q]_YI5_V4#2?_:M 'C/[<W_ #3[_N(_^VU?&=?9G[<W_-/O^XC_ .VU?&=
M!1110 4444 %%%% !7TU^Q7_ ,EMUG_L7YO_ $IMZ^9:^FOV*_\ DMNL_P#8
MOS?^E-O0!]_5XS\._P#DYSXW_P#<#_\ 2-Z]FKQGX=_\G.?&_P#[@?\ Z1O0
M![-1110 4444 %%%% !1110 4444 >9?%?\ Y"_PQ_['"W_]);JO /VYO^:?
M?]Q'_P!MJ]_^*_\ R%_AC_V.%O\ ^DMU7@'[<W_-/O\ N(_^VU 'QG1110 5
M]-?L5_\ );=9_P"Q?F_]*;>OF6OIK]BO_DMNL_\ 8OS?^E-O0!]_4444 %%%
M% !1110!XS\ O^:J_P#90-6_]I5[-7C/P"_YJK_V4#5O_:5>S4 %%%% !111
M0 4444 %>,?LN?\ )LGA'_M\_P#2R:O9Z\8_9<_Y-D\(_P#;Y_Z634 >ST44
M4 %%%% !1110!XS\??\ FE7_ &4#2?\ VK7C/[<W_-/O^XC_ .VU>S?'W_FE
M7_90-)_]JUXS^W-_S3[_ +B/_MM0!\9T444 ?IC^RY_R;)X1_P"WS_TLFKV>
MO&/V7/\ DV3PC_V^?^EDU>ST %%%% !1110!Q?Q6_P"2(>//^Q?O_P#TF>O,
M_CM_R97J'_8/TO\ ]*+>O3/BM_R1#QY_V+]__P"DSUYG\=O^3*]0_P"P?I?_
M *46] 'YST444 %%%% !1110 4444 ?<W[$/_(D>+?\ L(1?^BZ^LJ^3?V(?
M^1(\6_\ 80B_]%U]94 %%%% !1110 4444 %%%% !7F7P;_Y!/C+_L<-8_\
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M_2__ $HMZ],^*W_)$/'G_8OW_P#Z3/7F?QV_Y,KU#_L'Z7_Z46] 'YST444
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M_P#()\9?]CAK'_I4U>FUYE\&_P#D$^,O^QPUC_TJ:@#TVBBB@ HHHH ****
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M_P#XS0!]_?\ "V/A9_T4OPK_ .#FV_\ BZ/^%L?"S_HI?A7_ ,'-M_\ %U\
M_P##4?QU_P"AZ_\ *99__&:/^&H_CK_T/7_E,L__ (S0!]_?\+8^%G_12_"O
M_@YMO_BZ/^%L?"S_ **7X5_\'-M_\77P#_PU'\=?^AZ_\IEG_P#&:/\ AJ/X
MZ_\ 0]?^4RS_ /C- 'W]_P +8^%G_12_"O\ X.;;_P"+H_X6Q\+/^BE^%?\
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MTO1/VA/"^J:QJ=KIEA!]J\VYO)EABCS:S*-SL0!DD 9/4@5^@_\ PMCX6?\
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MK_X%7/\ \8H_X8K^*7_0?\*_^!5S_P#&* /F6BOIK_ABOXI?]!_PK_X%7/\
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MK_X%7/\ \8H_X8K^*7_0?\*_^!5S_P#&* /F6BOIK_ABOXI?]!_PK_X%7/\
M\8H_X8K^*7_0?\*_^!5S_P#&* /F6BOIK_ABOXI?]!_PK_X%7/\ \8H_X8K^
M*7_0?\*_^!5S_P#&* /F6BOIK_ABOXI?]!_PK_X%7/\ \8H_X8K^*7_0?\*_
M^!5S_P#&* /F6BOIK_ABOXI?]!_PK_X%7/\ \8H_X8K^*7_0?\*_^!5S_P#&
M* /F6BOIK_ABOXI?]!_PK_X%7/\ \8H_X8K^*7_0?\*_^!5S_P#&* /F6BOI
MK_ABOXI?]!_PK_X%7/\ \8H_X8K^*7_0?\*_^!5S_P#&* /F6BOIK_ABOXI?
M]!_PK_X%7/\ \8H_X8K^*7_0?\*_^!5S_P#&* /F6BOIK_ABOXI?]!_PK_X%
M7/\ \8H_X8K^*7_0?\*_^!5S_P#&* /F6BOIK_ABOXI?]!_PK_X%7/\ \8H_
MX8K^*7_0?\*_^!5S_P#&* /F6BOIK_ABOXI?]!_PK_X%7/\ \8H_X8K^*7_0
M?\*_^!5S_P#&* /F6BOIK_ABOXI?]!_PK_X%7/\ \8H_X8K^*7_0?\*_^!5S
M_P#&* /F6BOIK_ABOXI?]!_PK_X%7/\ \8H_X8K^*7_0?\*_^!5S_P#&* /F
M6BOIK_ABOXI?]!_PK_X%7/\ \8H_X8K^*7_0?\*_^!5S_P#&* /F6BOIK_AB
MOXI?]!_PK_X%7/\ \8H_X8K^*7_0?\*_^!5S_P#&* /F6BOIK_ABOXI?]!_P
MK_X%7/\ \8H_X8K^*7_0?\*_^!5S_P#&* /F6BOIK_ABOXI?]!_PK_X%7/\
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M^?W5?_ !O\:_.:B@#]&?^&O/@W_S^ZK_ . #?XT?\->?!O\ Y_=5_P# !O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJ?X6?]$T\*_^":V_^(H_X5/\+/\ HFGA7_P36W_Q% 'Y-45^LO\ PJ?X6?\
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MJ?X6?]$T\*_^":V_^(H_X5/\+/\ HFGA7_P36W_Q% 'Y-45^LO\ PJ?X6?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MT %%%9L>L:7+J#:;'J5J]ZF=UNLRF1<=<KG- &E1110 4444 %%%% !1110
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ME;M^:..^)GQ0^(WA7XL0>#?#-CX=O+>ZT:758CJ$4\;P^4LA8,R2$/\ ZHD
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQU_Z'K_RF6?_ ,9H _3&BOS._P"&H_CK_P!#U_Y3+/\ ^,T?\-1_'7_H>O\
MRF6?_P 9H _3&BOS._X:C^.O_0]?^4RS_P#C-'_#4?QU_P"AZ_\ *99__&:
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MCK_T/7_E,L__ (S1_P -1_'7_H>O_*99_P#QF@#],:*_,[_AJ/XZ_P#0]?\
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MQU_Z'K_RF6?_ ,9H _3&BOS._P"&H_CK_P!#U_Y3+/\ ^,T?\-1_'7_H>O\
MRF6?_P 9H _3&BOS._X:C^.O_0]?^4RS_P#C-'_#4?QU_P"AZ_\ *99__&:
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MCK_T/7_E,L__ (S1_P -1_'7_H>O_*99_P#QF@#],:*_,[_AJ/XZ_P#0]?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^OWA/
M_D1]!_[!]O\ ^BUK\@:_7[PG_P B/H/_ &#[?_T6M &U1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% 'Y;?\+8T__HC_ ,/_ /P"NO\
MY)H_X6QI_P#T1_X?_P#@%=?_ "37F%% 'I__  MC3_\ HC_P_P#_  "NO_DF
MC_A;&G_]$?\ A_\ ^ 5U_P#)->844 >G_P#"V-/_ .B/_#__ , KK_Y)H_X6
MQI__ $1_X?\ _@%=?_)->844 >G_ /"V-/\ ^B/_  __ / *Z_\ DFC_ (6Q
MI_\ T1_X?_\ @%=?_)->844 >G_\+8T__HC_ ,/_ /P"NO\ Y)H_X6QI_P#T
M1_X?_P#@%=?_ "37F%% 'I__  MC3_\ HC_P_P#_  "NO_DFC_A;&G_]$?\
MA_\ ^ 5U_P#)->844 >G_P#"V-/_ .B/_#__ , KK_Y)H_X6QI__ $1_X?\
M_@%=?_)->844 >G_ /"V-/\ ^B/_  __ / *Z_\ DFC_ (6QI_\ T1_X?_\
M@%=?_)->844 >G_\+8T__HC_ ,/_ /P"NO\ Y)H_X6QI_P#T1_X?_P#@%=?_
M "37F%% 'I__  MC3_\ HC_P_P#_  "NO_DFC_A;&G_]$?\ A_\ ^ 5U_P#)
M->844 >G_P#"V-/_ .B/_#__ , KK_Y)H_X6QI__ $1_X?\ _@%=?_)->844
M >G_ /"V-/\ ^B/_  __ / *Z_\ DFC_ (6QI_\ T1_X?_\ @%=?_)->844
M>G_\+8T__HC_ ,/_ /P"NO\ Y)H_X6QI_P#T1_X?_P#@%=?_ "37F%% 'I__
M  MC3_\ HC_P_P#_  "NO_DFC_A;&G_]$?\ A_\ ^ 5U_P#)->844 >G_P#"
MV-/_ .B/_#__ , KK_Y)H_X6QI__ $1_X?\ _@%=?_)->844 >G_ /"V-/\
M^B/_  __ / *Z_\ DFC_ (6QI_\ T1_X?_\ @%=?_)->844 >G_\+8T__HC_
M ,/_ /P"NO\ Y)H_X6QI_P#T1_X?_P#@%=?_ "37F%% 'I__  MC3_\ HC_P
M_P#_  "NO_DFC_A;&G_]$?\ A_\ ^ 5U_P#)->844 >G_P#"V-/_ .B/_#__
M , KK_Y)H_X6QI__ $1_X?\ _@%=?_)->844 >G_ /"V-/\ ^B/_  __ / *
MZ_\ DFC_ (6QI_\ T1_X?_\ @%=?_)->844 >G_\+8T__HC_ ,/_ /P"NO\
MY)H_X6QI_P#T1_X?_P#@%=?_ "37F%% 'I__  MC3_\ HC_P_P#_  "NO_DF
MC_A;&G_]$?\ A_\ ^ 5U_P#)->844 >G_P#"V-/_ .B/_#__ , KK_Y)H_X6
MQI__ $1_X?\ _@%=?_)->844 >G_ /"V-/\ ^B/_  __ / *Z_\ DFC_ (6Q
MI_\ T1_X?_\ @%=?_)->844 >G_\+8T__HC_ ,/_ /P"NO\ Y)H_X6QI_P#T
M1_X?_P#@%=?_ "37F%% 'I__  MC3_\ HC_P_P#_  "NO_DFC_A;&G_]$?\
MA_\ ^ 5U_P#)->844 >G_P#"V-/_ .B/_#__ , KK_Y)H_X6QI__ $1_X?\
M_@%=?_)->844 >G_ /"V-/\ ^B/_  __ / *Z_\ DFC_ (6QI_\ T1_X?_\
M@%=?_)->844 >G_\+8T__HC_ ,/_ /P"NO\ Y)H_X6QI_P#T1_X?_P#@%=?_
M "37F%% 'I__  MC3_\ HC_P_P#_  "NO_DFC_A;&G_]$?\ A_\ ^ 5U_P#)
M->844 >G_P#"V-/_ .B/_#__ , KK_Y)H_X6QI__ $1_X?\ _@%=?_)->844
M >G_ /"V-/\ ^B/_  __ / *Z_\ DFC_ (6QI_\ T1_X?_\ @%=?_)->844
M>G_\+8T__HC_ ,/_ /P"NO\ Y)H_X6QI_P#T1_X?_P#@%=?_ "37F%% 'I__
M  MC3_\ HC_P_P#_  "NO_DFC_A;&G_]$?\ A_\ ^ 5U_P#)->844 >G_P#"
MV-/_ .B/_#__ , KK_Y)H_X6QI__ $1_X?\ _@%=?_)->844 >G_ /"V-/\
M^B/_  __ / *Z_\ DFC_ (6QI_\ T1_X?_\ @%=?_)->844 >G_\+8T__HC_
M ,/_ /P"NO\ Y)KT:W_;(^)5I:PVMOX=\*1P0H$C06MSA5 P!_K_ $KYJHH
M^JM%_;!^)FI^(=-TV;0_#:175U% [):W 8*SA3C,YYYK[NK\@O"?_([Z#_V$
M+?\ ]&+7Z^T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^
M9W_#+GQU_P"A%_\ *G9__'J/^&7/CK_T(O\ Y4[/_P"/5XQ10![/_P ,N?'7
M_H1?_*G9_P#QZC_AESXZ_P#0B_\ E3L__CU>,44 >S_\,N?'7_H1?_*G9_\
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M7_A36W_R!0!Q=%=I_:'PL_Z$WQ5_X4UM_P#(%']H?"S_ *$WQ5_X4UM_\@4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _&>BNT_X5/\
M%+_HFGBK_P $US_\11_PJ?XI?]$T\5?^":Y_^(H XNBNT_X5/\4O^B:>*O\
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M ,$US_\ $4?\*G^*7_1-/%7_ ()KG_XB@#BZ*[3_ (5/\4O^B:>*O_!-<_\
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M ,56)10!M_\ "6>*?^AFU7_P,D_^*H_X2SQ3_P!#-JO_ (&2?_%5B44 ;?\
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MC/\ X88_ZJC_ .43_P"Z*/\ AAC_ *JC_P"43_[HK[,HH ^,_P#AAC_JJ/\
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MC/\ X88_ZJC_ .43_P"Z*/\ AAC_ *JC_P"43_[HK[,HH ^,_P#AAC_JJ/\
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MC/\ X88_ZJC_ .43_P"Z*/\ AAC_ *JC_P"43_[HK[,HH ^,_P#AAC_JJ/\
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MB,%PN0O7GO71S>-/"-LZK<>*M'@+W)LU$E]$I:<8S$,M]_YA\O7D<<U\L?\
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M..<XK>_L'Q2WB/0=47P-JFB:?8>/I+J73[:SDE2*%E'^E$_,[[R&RR'RQ@
M9YK3H3KKY'TM#XP\*W%R]K;>*-)EGCN19O$E]$S+.3@1$!LAR> O7VJQ!XD\
M/W&J#2;?7=/GU#Y\6L=TC2G:<-\@.>#UXXKQKX/Z5<1_$_XIMK'A_4H+?4-;
M74+"2_TV:**=4=\2(\B!=P8J1SGH1TR.'TGP_P"+/^$S^&VJR>#=5T73;#Q!
MJI?38+"1HM+CD8;&+89F#G<Q<GR^1MV@8I*[:N-Z)M:GTY+XD\.QZF=)D\0:
M:FH#=FU:[C$ORKN;Y,YX7D\<#FN8\$?%/PWXV\,ZEXBM[R"PTVQO)+8S7=PB
M916VK*V<; YS@'_ZU<1\$]'U;PW_ &OX3\;^'+N;7K;6KC5+;5'LFEMIEE4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MPK_X2>E?_(U'_"R_$7_0-\*_^$GI7_R-0!Q=%=I_PLOQ%_T#?"O_ (2>E?\
MR-1_PLOQ%_T#?"O_ (2>E?\ R-0!Q=%=I_PLOQ%_T#?"O_A)Z5_\C4?\++\1
M?] WPK_X2>E?_(U '%T5VG_"R_$7_0-\*_\ A)Z5_P#(U'_"R_$7_0-\*_\
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MOQ%_T#?"O_A)Z5_\C4?\++\1?] WPK_X2>E?_(U '%T5VG_"R_$7_0-\*_\
MA)Z5_P#(U'_"R_$7_0-\*_\ A)Z5_P#(U '%T5VG_"R_$7_0-\*_^$GI7_R-
M1_PLOQ%_T#?"O_A)Z5_\C4 <717:?\++\1?] WPK_P"$GI7_ ,C4?\++\1?]
M WPK_P"$GI7_ ,C4 <717:?\++\1?] WPK_X2>E?_(U'_"R_$7_0-\*_^$GI
M7_R-0!Q=%=I_PLOQ%_T#?"O_ (2>E?\ R-1_PLOQ%_T#?"O_ (2>E?\ R-0!
MQ=%=I_PLOQ%_T#?"O_A)Z5_\C4?\++\1?] WPK_X2>E?_(U '%T5VG_"R_$7
M_0-\*_\ A)Z5_P#(U'_"R_$7_0-\*_\ A)Z5_P#(U '%T5VG_"R_$7_0-\*_
M^$GI7_R-1_PLOQ%_T#?"O_A)Z5_\C4 <717:?\++\1?] WPK_P"$GI7_ ,C4
M?\++\1?] WPK_P"$GI7_ ,C4 <717:?\++\1?] WPK_X2>E?_(U'_"R_$7_0
M-\*_^$GI7_R-0!Q=%=I_PLOQ%_T#?"O_ (2>E?\ R-1_PLOQ%_T#?"O_ (2>
ME?\ R-0!Q=%=I_PLOQ%_T#?"O_A)Z5_\C4?\++\1?] WPK_X2>E?_(U '%U]
M_?L5?\D1UG_L8)O_ $FMZ^-?^%E^(O\ H&^%?_"3TK_Y&K[L_9>U&;5O@I'J
M-Q;Z?!//J%QO%A8064;D;5!*0HBYP ,XR0!Z4 >\4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'C'[4?_)LGB[_MS_\
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M XNBNT_X5IXB_P"@EX5_\*S2O_DFC_A6GB+_ *"7A7_PK-*_^2: .+HKM/\
MA6GB+_H)>%?_  K-*_\ DFC_ (5IXB_Z"7A7_P *S2O_ ))H XNBNT_X5IXB
M_P"@EX5_\*S2O_DFC_A6GB+_ *"7A7_PK-*_^2: .+HKM/\ A6GB+_H)>%?_
M  K-*_\ DFC_ (5IXB_Z"7A7_P *S2O_ ))H XNBNT_X5IXB_P"@EX5_\*S2
MO_DFC_A6GB+_ *"7A7_PK-*_^2: .+HKM/\ A6GB+_H)>%?_  K-*_\ DFC_
M (5IXB_Z"7A7_P *S2O_ ))H XNBNT_X5IXB_P"@EX5_\*S2O_DFC_A6GB+_
M *"7A7_PK-*_^2: .+HKM/\ A6GB+_H)>%?_  K-*_\ DFC_ (5IXB_Z"7A7
M_P *S2O_ ))H XNBNT_X5IXB_P"@EX5_\*S2O_DFC_A6GB+_ *"7A7_PK-*_
M^2: .+HKM/\ A6GB+_H)>%?_  K-*_\ DFC_ (5IXB_Z"7A7_P *S2O_ ))H
M XNBNT_X5IXB_P"@EX5_\*S2O_DFC_A6GB+_ *"7A7_PK-*_^2: .+HKM/\
MA6GB+_H)>%?_  K-*_\ DFC_ (5IXB_Z"7A7_P *S2O_ ))H XNBNT_X5IXB
M_P"@EX5_\*S2O_DFC_A6GB+_ *"7A7_PK-*_^2: .+HKM/\ A6GB+_H)>%?_
M  K-*_\ DFC_ (5IXB_Z"7A7_P *S2O_ ))H XNBNT_X5IXB_P"@EX5_\*S2
MO_DFC_A6GB+_ *"7A7_PK-*_^2: .+HKM/\ A6GB+_H)>%?_  K-*_\ DFC_
M (5IXB_Z"7A7_P *S2O_ ))H XNBNT_X5IXB_P"@EX5_\*S2O_DFC_A6GB+_
M *"7A7_PK-*_^2: .+HKM/\ A6GB+_H)>%?_  K-*_\ DFC_ (5IXB_Z"7A7
M_P *S2O_ ))H XNBNT_X5IXB_P"@EX5_\*S2O_DFC_A6GB+_ *"7A7_PK-*_
M^2: .+HKM/\ A6GB+_H)>%?_  K-*_\ DFC_ (5IXB_Z"7A7_P *S2O_ ))H
M XNBNT_X5IXB_P"@EX5_\*S2O_DFC_A6GB+_ *"7A7_PK-*_^2: .+HKM/\
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M<^.O_0B_^5.S_P#CU>,44 >S_P##+GQU_P"A%_\ *G9__'J/^&7/CK_T(O\
MY4[/_P"/5XQ10![/_P ,N?'7_H1?_*G9_P#QZC_AESXZ_P#0B_\ E3L__CU>
M,44 >S_\,N?'7_H1?_*G9_\ QZC_ (9<^.O_ $(O_E3L_P#X]7C%% 'L_P#P
MRY\=?^A%_P#*G9__ !ZC_AESXZ_]"+_Y4[/_ ./5XQ10![/_ ,,N?'7_ *$7
M_P J=G_\>H_X9<^.O_0B_P#E3L__ (]7C%% 'L__  RY\=?^A%_\J=G_ /'J
M/^&7/CK_ -"+_P"5.S_^/5XQ10![/_PRY\=?^A%_\J=G_P#'J/\ AESXZ_\
M0B_^5.S_ /CU>,44 >S_ /#+GQU_Z$7_ ,J=G_\ 'J/^&7/CK_T(O_E3L_\
MX]7C%% 'L_\ PRY\=?\ H1?_ "IV?_QZC_AESXZ_]"+_ .5.S_\ CU>,44 >
MS_\ #+GQU_Z$7_RIV?\ \>H_X9<^.O\ T(O_ )4[/_X]7C%% 'L__#+GQU_Z
M$7_RIV?_ ,>H_P"&7/CK_P!"+_Y4[/\ ^/5XQ10![/\ \,N?'7_H1?\ RIV?
M_P >H_X9<^.O_0B_^5.S_P#CU>,44 >S_P##+GQU_P"A%_\ *G9__'J/^&7/
MCK_T(O\ Y4[/_P"/5XQ10![/_P ,N?'7_H1?_*G9_P#QZC_AESXZ_P#0B_\
ME3L__CU>,44 >S_\,N?'7_H1?_*G9_\ QZC_ (9<^.O_ $(O_E3L_P#X]7C%
M% 'L_P#PRY\=?^A%_P#*G9__ !ZC_AESXZ_]"+_Y4[/_ ./5XQ10![/_ ,,N
M?'7_ *$7_P J=G_\>H_X9<^.O_0B_P#E3L__ (]7C%% 'L__  RY\=?^A%_\
MJ=G_ /'J/^&7/CK_ -"+_P"5.S_^/5Z9^Q%_R/'BS_L'Q?\ HRON6@#\SO\
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M]F_XQ:_ZJK_Y3J/^,6O^JJ_^4Z@#QFBO9O\ C%K_ *JK_P"4ZC_C%K_JJO\
MY3J /&:*]F_XQ:_ZJK_Y3J/^,6O^JJ_^4Z@#QFBO9O\ C%K_ *JK_P"4ZC_C
M%K_JJO\ Y3J /&:*]F_XQ:_ZJK_Y3J/^,6O^JJ_^4Z@#QFBO9O\ C%K_ *JK
M_P"4ZC_C%K_JJO\ Y3J /&:*]F_XQ:_ZJK_Y3J/^,6O^JJ_^4Z@#QFBO9O\
MC%K_ *JK_P"4ZC_C%K_JJO\ Y3J /&:*]F_XQ:_ZJK_Y3J/^,6O^JJ_^4Z@#
MQFBO9O\ C%K_ *JK_P"4ZC_C%K_JJO\ Y3J /&:*]F_XQ:_ZJK_Y3J/^,6O^
MJJ_^4Z@#QFBO9O\ C%K_ *JK_P"4ZC_C%K_JJO\ Y3J /&:*]F_XQ:_ZJK_Y
M3J/^,6O^JJ_^4Z@#QFBO9O\ C%K_ *JK_P"4ZC_C%K_JJO\ Y3J /&:*]F_X
MQ:_ZJK_Y3J/^,6O^JJ_^4Z@#QFBO9O\ C%K_ *JK_P"4ZC_C%K_JJO\ Y3J
M/&:*]F_XQ:_ZJK_Y3J/^,6O^JJ_^4Z@#QFBO9O\ C%K_ *JK_P"4ZC_C%K_J
MJO\ Y3J /&:*]F_XQ:_ZJK_Y3J/^,6O^JJ_^4Z@#QFBO9O\ C%K_ *JK_P"4
MZC_C%K_JJO\ Y3J /&:*]F_XQ:_ZJK_Y3J/^,6O^JJ_^4Z@#QFBO9O\ C%K_
M *JK_P"4ZC_C%K_JJO\ Y3J /&:*]F_XQ:_ZJK_Y3J/^,6O^JJ_^4Z@#QFBO
M9O\ C%K_ *JK_P"4ZO7_ (9_L_\ P3^*WAJY\1>']2\<VMI;7C63)>S6:2;U
M1') 2)AC$B]\YSQ0!\=45]__ /#%7PM_Z#_BK_P*MO\ XQ1_PQ5\+?\ H/\
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M_P" <G_Q- &)16W_ ,(GXI_Z%G5?_ .3_P")H_X1/Q3_ -"SJO\ X!R?_$T
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M/_B:/^$3\4_]"SJO_@')_P#$T 8E%;?_  B?BG_H6=5_\ Y/_B:/^$3\4_\
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M!R?_ !-?=G[']C?:;\&]7@U&QN+*4Z[,X2XC:-BOV>W&<$#C@_E0!](T444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 >1?M#ZMJFA_L]^*-4T?4[K3+^#[+Y=U9S-#+'FZA4[74@C()!P>A
M(K\^/^%L?%+_ **7XJ_\'-S_ /%U]^_M1_\ )LGB[_MS_P#2R&OS.H [3_A;
M'Q2_Z*7XJ_\ !S<__%T?\+8^*7_12_%7_@YN?_BZXNB@#M/^%L?%+_HI?BK_
M ,'-S_\ %T?\+8^*7_12_%7_ (.;G_XNN+HH [3_ (6Q\4O^BE^*O_!S<_\
MQ='_  MCXI?]%+\5?^#FY_\ BZXNB@#M/^%L?%+_ **7XJ_\'-S_ /%T?\+8
M^*7_ $4OQ5_X.;G_ .+KBZ* .T_X6Q\4O^BE^*O_  <W/_Q='_"V/BE_T4OQ
M5_X.;G_XNN+HH [3_A;'Q2_Z*7XJ_P#!S<__ !='_"V/BE_T4OQ5_P"#FY_^
M+KBZ* .T_P"%L?%+_HI?BK_P<W/_ ,71_P +8^*7_12_%7_@YN?_ (NN+HH
M[3_A;'Q2_P"BE^*O_!S<_P#Q='_"V/BE_P!%+\5?^#FY_P#BZXNB@#M/^%L?
M%+_HI?BK_P '-S_\71_PMCXI?]%+\5?^#FY_^+KBZ* .T_X6Q\4O^BE^*O\
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M_P 71_PMCXI?]%+\5?\ @YN?_BZXNB@#M/\ A;'Q2_Z*7XJ_\'-S_P#%T?\
M"V/BE_T4OQ5_X.;G_P"+KBZ* .T_X6Q\4O\ HI?BK_P<W/\ \71_PMCXI?\
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M .ED-?F=0!VG]G_"S_H<O%7_ (3-M_\ )]']G_"S_H<O%7_A,VW_ ,GUQ=%
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MS_H<O%7_ (3-M_\ )]']G_"S_H<O%7_A,VW_ ,GUQ=% ':?V?\+/^AR\5?\
MA,VW_P GT?V?\+/^AR\5?^$S;?\ R?7%T4 =I_9_PL_Z'+Q5_P"$S;?_ "?1
M_9_PL_Z'+Q5_X3-M_P#)]<710!VG]G_"S_H<O%7_ (3-M_\ )]']G_"S_H<O
M%7_A,VW_ ,GUQ=% ':?V?\+/^AR\5?\ A,VW_P GT?V?\+/^AR\5?^$S;?\
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MB?\ W11_PPQ_U5'_ ,HG_P!T5]F44 ?&?_##'_54?_*)_P#=%'_##'_54?\
MRB?_ '17V910!\9_\,,?]51_\HG_ -T4?\,,?]51_P#*)_\ =%?9E% &!X3T
M(^%_!6A>&?M0NQI&GV]C]HV;/-\J-4W[<G;G;G&3C/4UOT44 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110!XQ^U'_R;)XN_[<__ $LAK\SJ
M_43]H+7M8\,_ 3Q+KF@ZA+I^I6WV;R;B$X=-UU$C8^JL1^-?!/\ PO[XR?\
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ML'P__P# VZ_^1J /,**]/_X5/I__ $6#X?\ _@;=?_(U'_"I]/\ ^BP?#_\
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M_P C4?\ "I]/_P"BP?#_ /\  VZ_^1J /,**]/\ ^%3Z?_T6#X?_ /@;=?\
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M /,**]/_ .%3Z?\ ]%@^'_\ X&W7_P C4?\ "I]/_P"BP?#_ /\  VZ_^1J
M/,**]/\ ^%3Z?_T6#X?_ /@;=?\ R-1_PJ?3_P#HL'P__P# VZ_^1J /,**]
M/_X5/I__ $6#X?\ _@;=?_(U'_"I]/\ ^BP?#_\ \#;K_P"1J /,**]/_P"%
M3Z?_ -%@^'__ (&W7_R-1_PJ?3_^BP?#_P#\#;K_ .1J /,**]/_ .%3Z?\
M]%@^'_\ X&W7_P C4?\ "I]/_P"BP?#_ /\  VZ_^1J /,**]/\ ^%3Z?_T6
M#X?_ /@;=?\ R-1_PJ?3_P#HL'P__P# VZ_^1J /,**]/_X5/I__ $6#X?\
M_@;=?_(U'_"I]/\ ^BP?#_\ \#;K_P"1J /,**]/_P"%3Z?_ -%@^'__ (&W
M7_R-1_PJ?3_^BP?#_P#\#;K_ .1J /,**]/_ .%3Z?\ ]%@^'_\ X&W7_P C
M4?\ "I]/_P"BP?#_ /\  VZ_^1J /,**]/\ ^%3Z?_T6#X?_ /@;=?\ R-1_
MPJ?3_P#HL'P__P# VZ_^1J /,**]/_X5/I__ $6#X?\ _@;=?_(U'_"I]/\
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M %%%% !1110 4444 %%%% !1110!XQ^U'_R;)XN_[<__ $LAK\SJ_3']J/\
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M_JBWPJ_\)S_[97C%% 'M<?Q]DMYDG@^#OPQBEC8.CQ^'BK*P.001+P177_\
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M $$T =E_PR'\9?\ GRTK_P #U_PH_P"&0_C+_P ^6E?^!Z_X5^C%% 'YS_\
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M44 ?G/\ \,A_&7_GRTK_ ,#U_P */^&0_C+_ ,^6E?\ @>O^%?HQ10!^<_\
MPR'\9?\ GRTK_P #U_PH_P"&0_C+_P ^6E?^!Z_X5^C%% 'YS_\ #(?QE_Y\
MM*_\#U_PH_X9#^,O_/EI7_@>O^%?HQ10!^<__#(?QE_Y\M*_\#U_PH_X9#^,
MO_/EI7_@>O\ A7Z,44 ?G/\ \,A_&7_GRTK_ ,#U_P *TM!_93^+6G^)M*O[
MFSTL06UW%-(5OE)VJX)XQZ"OT&HH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%>,?M1_\FR>
M+O\ MS_]+(:_,Z@#]F**_&>B@#]F**_&>B@#]F**_&>B@#]F**_&>B@#]F**
M_&>B@#]F**_&>B@#]F**_&>B@#]F**_&>B@#]F**_&>B@#]F**_&>B@#]F**
M_&>B@#]F**_&>B@#]F**_&>B@#]F**_&>B@#]F**_&>B@#]F**_&>B@#]F**
M_&>B@#]F**_&>B@#]F**_&>B@#]F**_&>B@#]F**_&>B@#]F**_&>B@#]F**
M_&>B@#]F**_,[]EO_DYOPC_V^?\ I'-7Z8T %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!5M_\8H ^ **^_\ _ABKX6_]!_Q5_P"!5M_\8H_X8J^%O_0?\5?^!5M_\8H
M^ **^_\ _ABKX6_]!_Q5_P"!5M_\8H_X8J^%O_0?\5?^!5M_\8H ^ **^_\
M_ABKX6_]!_Q5_P"!5M_\8H_X8J^%O_0?\5?^!5M_\8H ^ **^_\ _ABKX6_]
M!_Q5_P"!5M_\8H_X8J^%O_0?\5?^!5M_\8H ^ **^_O^&*_A;_T'_%7_ (%6
MW_QBE_X8K^%O_0?\5?\ @5;?_&* /@"BOO\ _P"&*OA;_P!!_P 5?^!5M_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(-)U(:=<-*A:X,0EQ&&!<*IXR1D GIG/.,4]@->BO!O ?BSQUXR\:?$G0?\
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M6 *%AU4DXSQ2[OH@ZI=SU2BN=\*ZI=:UX2TK4[ZW>VN+JUBE=6V\ED!+#:S
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M+'-%A2T2Y.W8&+$D%0IYEL_A[XOTGX[Q>-]!T6;1-.F6[EURUL[^-K;5CAA
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M.OH+2*&6V>5)&1D0*<LA*GD=B>,?2NG[FEI*;=W<25D+1110,**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<;+NW#@%FV\<=2#QCVGO5.+6Y*=QU%%%(84444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
544 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>ltbr_ex32img6.jpg
<TEXT>
begin 644 ltbr_ex32img6.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" 2D Y8# 2(  A$! Q$!_\0
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M#U_Y3+/_ .,T ?IC17YG?\-1_'7_ *'K_P IEG_\9H_X:C^.O_0]?^4RS_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M4?(VSS*61/+GCD.0.>0A'XU\K_\ #$/BK_H=]*_\!Y*H1\F45]9_\,0^*O\
MH=]*_P# >2C_ (8A\5?]#OI7_@/)0!\F45]9_P##$/BK_H=]*_\  >2C_AB'
MQ5_T.^E?^ \E 'R917UG_P ,0^*O^AWTK_P'DH_X8A\5?]#OI7_@/)0!X'\*
M/^2V>!/^Q@L/_2E*_0/X]6&H:I\+#IVF6>HW5S+J%DZC3K5[B6-4N$9G 16Q
MM4$Y(QQWZ5XIX._9%\2>&?'?A_Q)<>,-,N(M+U*VO7B2"0-(L4JN5!/<[<5]
MCT[ZI]@>J.*\-^$;/0=2OO$=QJ^JZ[JVHQ(DE]JNPS1PKDK"B1QQK&N26*A
M2QYR<8P_A2MQ'=>.%NM-U"S-SXDN[N$W=C-;B:%P@5U,B@,#@]*]1H]Z5R6K
MV/G>^T/4([S2O'W@'1]=\-^,+J:W&I:#]DECT^[#.!.9P5$8(3<WF!@>!QN-
M>R6%OXOAUB>;5M<TF[TKYS';6NDRPSKS\N93<N&P.N(QD],=*Z:BB^ED4]7<
M\L^&\TME#XVN+RQU.U1M>O+V,3:?.C2PMM*M&I3+YVG 4$GTY%=I_;%G=>&S
MK-J9Y[2:+>GEVTK2$'C'EA=^<]1MR.<]*UV0.C YPPP<'!_,5%#!#:V\=O;Q
M)##$H1(T4*JJ!@  = *4ES*S%'W?O/$=*T+6K/7=(L]-\-W']@>+])MX=<D>
M%X38SVR .71@"#+&3%TR2JGL<YEQH_B*^\$>-[?1=)U2!QXN75/L<EC-;G4+
M)7A+I'O5=P94;Y1G.W&.:^C>:,TQ];GS7\2O#/B[7_$7BOQ)X5TW49-'N=(T
M^WGL?)>VEU*1+P22@1R!6)$ *DD<AMHSR!Z%H;1R_&J\U6UT?4+:SO=!M85G
METV>!#(DTS%&+( K!&3@X[ 5ZC11?9=B6KW\[?@>-?%[POXFU#P=XIO+&\_M
M-[N*W@M=.AT^226&-9D9E3;)R6;+,VWD*H_A!KUVW^U+"@NI(Y90/G>.,HI/
MLI)(_,U:HI)6+;N%%%%,04444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 45@>*/%&A^#_#5WXD\17WV'2[39YUQY3R;-[JB_
M*@+'+,HX'>O-_P#AJ+X%?]#U_P"4R\_^,T >ST5XQ_PU%\"O^AZ_\IEY_P#&
M:/\ AJ+X%?\ 0]?^4R\_^,T >ST5XQ_PU%\"O^AZ_P#*9>?_ !FC_AJ+X%?]
M#U_Y3+S_ .,T >ST5XQ_PU%\"O\ H>O_ "F7G_QFC_AJ+X%?]#U_Y3+S_P",
MT >ST5XQ_P -1? K_H>O_*9>?_&:/^&HO@5_T/7_ )3+S_XS0![/17C'_#47
MP*_Z'K_RF7G_ ,9H_P"&HO@5_P!#U_Y3+S_XS0![/17C'_#47P*_Z'K_ ,IE
MY_\ &:/^&HO@5_T/7_E,O/\ XS0![/17C'_#47P*_P"AZ_\ *9>?_&:/^&HO
M@5_T/7_E,O/_ (S0![/17C'_  U%\"O^AZ_\IEY_\9H_X:B^!7_0]?\ E,O/
M_C- 'L]%>,?\-1? K_H>O_*9>?\ QFC_ (:B^!7_ $/7_E,O/_C- 'L]%>,?
M\-1? K_H>O\ RF7G_P 9H_X:B^!7_0]?^4R\_P#C- 'L]%>,?\-1? K_ *'K
M_P IEY_\9H_X:B^!7_0]?^4R\_\ C- 'L]%>,?\ #47P*_Z'K_RF7G_QFC_A
MJ+X%?]#U_P"4R\_^,T >ST5XQ_PU%\"O^AZ_\IEY_P#&:/\ AJ+X%?\ 0]?^
M4R\_^,T >ST5XQ_PU%\"O^AZ_P#*9>?_ !FC_AJ+X%?]#U_Y3+S_ .,T >ST
M5XQ_PU%\"O\ H>O_ "F7G_QFC_AJ+X%?]#U_Y3+S_P",T >ST5XQ_P -1? K
M_H>O_*9>?_&:/^&HO@5_T/7_ )3+S_XS0![/17C'_#47P*_Z'K_RF7G_ ,9H
M_P"&HO@5_P!#U_Y3+S_XS0![/17C'_#47P*_Z'K_ ,IEY_\ &:/^&HO@5_T/
M7_E,O/\ XS0![/17C'_#47P*_P"AZ_\ *9>?_&:/^&HO@5_T/7_E,O/_ (S0
M![/17C'_  U%\"O^AZ_\IEY_\9H_X:B^!7_0]?\ E,O/_C- 'L]%>,?\-1?
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M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'C'[4?\
MR;)XN_[<_P#TLAK\SJ_3']J/_DV3Q=_VY_\ I9#7YG4 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^OWA/_D1
M]!_[!]O_ .BUK\@:_7[PG_R(^@_]@^W_ /1:T ;5%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 >0_M$:C<Z3^SWXFU"VCM)9H?LNU;N
MUBN8CF[A4[HI59&X/&5.#@CD U^?/_"R_$7_ $#?"O\ X2>E?_(U??O[4?\
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M55 P  .@%?CC7[,4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P#_  -NO_D:C_A4^G_]%@^'_P#X&W7_ ,C5YA10!Z?_ ,*GT_\ Z+!\/_\
MP-NO_D:C_A4^G_\ 18/A_P#^!MU_\C5YA10!Z?\ \*GT_P#Z+!\/_P#P-NO_
M )&H_P"%3Z?_ -%@^'__ (&W7_R-7F%% 'I__"I]/_Z+!\/_ /P-NO\ Y&H_
MX5/I_P#T6#X?_P#@;=?_ "-7F%% 'I__  J?3_\ HL'P_P#_  -NO_D:C_A4
M^G_]%@^'_P#X&W7_ ,C5YA10!Z?_ ,*GT_\ Z+!\/_\ P-NO_D:C_A4^G_\
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M3_\ HL'P_P#_  -NO_D:C_A4^G_]%@^'_P#X&W7_ ,C5YA10!Z?_ ,*GT_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-'_"P_@3_P!&Z_\ EW7G_P 30!XS17LW_"P_@3_T;K_Y=UY_\31_PL/X$_\
M1NO_ )=UY_\ $T >,T5[-_PL/X$_]&Z_^7=>?_$T?\+#^!/_ $;K_P"7=>?_
M !- 'C-%>S?\+#^!/_1NO_EW7G_Q-'_"P_@3_P!&Z_\ EW7G_P 30!XS17LW
M_"P_@3_T;K_Y=UY_\31_PL/X$_\ 1NO_ )=UY_\ $T >,T5[-_PL/X$_]&Z_
M^7=>?_$T?\+#^!/_ $;K_P"7=>?_ !- 'C-%>S?\+#^!/_1NO_EW7G_Q-'_"
MP_@3_P!&Z_\ EW7G_P 30!XS17LW_"P_@3_T;K_Y=UY_\31_PL/X$_\ 1NO_
M )=UY_\ $T >,T5[-_PL/X$_]&Z_^7=>?_$T?\+#^!/_ $;K_P"7=>?_ !-
M'C-%>S?\+#^!/_1NO_EW7G_Q-'_"P_@3_P!&Z_\ EW7G_P 30!XS17LW_"P_
M@3_T;K_Y=UY_\31_PL/X$_\ 1NO_ )=UY_\ $T >,T5[-_PL/X$_]&Z_^7=>
M?_$T?\+#^!/_ $;K_P"7=>?_ !- 'C-%>S?\+#^!/_1NO_EW7G_Q-'_"P_@3
M_P!&Z_\ EW7G_P 30!XS17LW_"P_@3_T;K_Y=UY_\31_PL/X$_\ 1NO_ )=U
MY_\ $T >,T5[-_PL/X$_]&Z_^7=>?_$T?\+#^!/_ $;K_P"7=>?_ !- 'C-%
M>S?\+#^!/_1NO_EW7G_Q-'_"P_@3_P!&Z_\ EW7G_P 30!XS17LW_"P_@3_T
M;K_Y=UY_\31_PL/X$_\ 1NO_ )=UY_\ $T >,T5[-_PL/X$_]&Z_^7=>?_$T
M?\+#^!/_ $;K_P"7=>?_ !- 'C-%>S?\+#^!/_1NO_EW7G_Q-'_"P_@3_P!&
MZ_\ EW7G_P 30!XS17LW_"P_@3_T;K_Y=UY_\31_PL/X$_\ 1NO_ )=UY_\
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M "BBB@ HHHH *^9?VU?^2(Z-_P!C!#_Z37%?35?,O[:O_)$=&_[&"'_TFN*
M/@&BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M/TQ_9<_Y-D\(_P#;Y_Z635[/7C'[+G_)LGA'_M\_]+)J]GH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "OF7]M7_DB.C?\ 8P0_^DUQ7TU7S+^V
MK_R1'1O^Q@A_])KB@#X!HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MS_H<O%7_ (3-M_\ )] '%T5VG]G_  L_Z'+Q5_X3-M_\GT?V?\+/^AR\5?\
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M,7/B#P[9ZA;6EO>-9NE]&B2%U1') 1V&,2+WSG/%>@4 %%%% !1110 4444
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M%_?&3_HH6J_]]K_A1_PO[XR?]%"U7_OM?\*\QHH ]._X7]\9/^BA:K_WVO\
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M_10M5_[[7_"O,:* /3O^%_?&3_HH6J_]]K_A1_PO[XR?]%"U7_OM?\*\QHH
M]._X7]\9/^BA:K_WVO\ A1_PO[XR?]%"U7_OM?\ "O,:* /3O^%_?&3_ **%
MJO\ WVO^%'_"_OC)_P!%"U7_ +[7_"O,:* /3O\ A?WQD_Z*%JO_ 'VO^%'_
M  O[XR?]%"U7_OM?\*\QHH ]._X7]\9/^BA:K_WVO^%'_"_OC)_T4+5?^^U_
MPKS&B@#T[_A?WQD_Z*%JO_?:_P"%'_"_OC)_T4+5?^^U_P *\QHH ]._X7]\
M9/\ HH6J_P#?:_X4?\+^^,G_ $4+5?\ OM?\*\QHH ]._P"%_?&3_HH6J_\
M?:_X4?\ "_OC)_T4+5?^^U_PKS&B@#T[_A?WQD_Z*%JO_?:_X4?\+^^,G_10
MM5_[[7_"O,:* /3O^%_?&3_HH6J_]]K_ (4?\+^^,G_10M5_[[7_  KS&B@#
MT[_A?WQD_P"BA:K_ -]K_A1_PO[XR?\ 10M5_P"^U_PKS&B@#T[_ (7]\9/^
MBA:K_P!]K_A1_P +^^,G_10M5_[[7_"O,:* /3O^%_?&3_HH6J_]]K_A1_PO
M[XR?]%"U7_OM?\*\QHH ]._X7]\9/^BA:K_WVO\ A1_PO[XR?]%"U7_OM?\
M"O,:* /3O^%_?&3_ **%JO\ WVO^%'_"_OC)_P!%"U7_ +[7_"O,:* /3O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Y?\ 'C3]#U3X
M'>(-/\2>(?\ A'-)E^S>?J7V-[OR,7,17]TA#-E@J\=-V>U?#O\ PKSX$_\
M1Q7_ ):-Y_\ %5]E_M1_\FR>+O\ MS_]+(:_,Z@#V;_A7GP)_P"CBO\ RT;S
M_P"*H_X5Y\"?^CBO_+1O/_BJ\9HH ]F_X5Y\"?\ HXK_ ,M&\_\ BJ/^%>?
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MV;_A7GP)_P"CBO\ RT;S_P"*H_X5Y\"?^CBO_+1O/_BJ\9HH ]F_X5Y\"?\
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MBWPJ_P#"<_\ ME'_  OW_JBWPJ_\)S_[90!XQ17L_P#POW_JBWPJ_P#"<_\
MME'_  OW_JBWPJ_\)S_[90!XQ17L_P#POW_JBWPJ_P#"<_\ ME'_  OW_JBW
MPJ_\)S_[90!XQ17L_P#POW_JBWPJ_P#"<_\ ME'_  OW_JBWPJ_\)S_[90!X
MQ17L_P#POW_JBWPJ_P#"<_\ ME'_  OW_JBWPJ_\)S_[90!XQ17L_P#POW_J
MBWPJ_P#"<_\ ME'_  OW_JBWPJ_\)S_[90!XQ17L_P#POW_JBWPJ_P#"<_\
MME'_  OW_JBWPJ_\)S_[90!XQ17L_P#POW_JBWPJ_P#"<_\ ME'_  OW_JBW
MPJ_\)S_[90!XQ17L_P#POW_JBWPJ_P#"<_\ ME'_  OW_JBWPJ_\)S_[90!X
MQ17L_P#POW_JBWPJ_P#"<_\ ME'_  OW_JBWPJ_\)S_[90!XQ17L_P#POW_J
MBWPJ_P#"<_\ ME'_  OW_JBWPJ_\)S_[90!XQ17L_P#POW_JBWPJ_P#"<_\
MME'_  OW_JBWPJ_\)S_[90!XQ17Z?^"? GPW\2?#_P -^(KWX9^$H[O5=,M;
MV9(=%@$:O)$KL%!4D#+'&23CN:Z;_A4_PL_Z)IX5_P#!-;?_ !% 'Y-45^LO
M_"I_A9_T33PK_P"":V_^(H_X5/\ "S_HFGA7_P $UM_\10!^35%?K+_PJ?X6
M?]$T\*_^":V_^(H_X5/\+/\ HFGA7_P36W_Q% 'Y-45^LO\ PJ?X6?\ 1-/"
MO_@FMO\ XBC_ (5/\+/^B:>%?_!-;?\ Q% 'Y-45^LO_  J?X6?]$T\*_P#@
MFMO_ (BC_A4_PL_Z)IX5_P#!-;?_ !% 'Y-45^LO_"I_A9_T33PK_P"":V_^
M(H_X5/\ "S_HFGA7_P $UM_\10!^35%?K+_PJ?X6?]$T\*_^":V_^(H_X5/\
M+/\ HFGA7_P36W_Q% 'Y-45^LO\ PJ?X6?\ 1-/"O_@FMO\ XBC_ (5/\+/^
MB:>%?_!-;?\ Q% 'Y-45^LO_  J?X6?]$T\*_P#@FMO_ (BC_A4_PL_Z)IX5
M_P#!-;?_ !% 'Y-45^LO_"I_A9_T33PK_P"":V_^(H_X5/\ "S_HFGA7_P $
MUM_\10!^35%?K+_PJ?X6?]$T\*_^":V_^(H_X5/\+/\ HFGA7_P36W_Q% 'Y
M-45^LO\ PJ?X6?\ 1-/"O_@FMO\ XBC_ (5/\+/^B:>%?_!-;?\ Q% 'Y-45
M^LO_  J?X6?]$T\*_P#@FMO_ (BC_A4_PL_Z)IX5_P#!-;?_ !% 'Y-45^LO
M_"I_A9_T33PK_P"":V_^(H_X5/\ "S_HFGA7_P $UM_\10!^35%?K+_PJ?X6
M?]$T\*_^":V_^(H_X5/\+/\ HFGA7_P36W_Q% 'Y-45^LO\ PJ?X6?\ 1-/"
MO_@FMO\ XBC_ (5/\+/^B:>%?_!-;?\ Q% 'Y-45^LO_  J?X6?]$T\*_P#@
MFMO_ (BC_A4_PL_Z)IX5_P#!-;?_ !% 'Y-45^LO_"I_A9_T33PK_P"":V_^
M(H_X5/\ "S_HFGA7_P $UM_\10!^35%?K+_PJ?X6?]$T\*_^":V_^(H_X5/\
M+/\ HFGA7_P36W_Q% 'QI^Q7_P EMUG_ +%^;_TIMZ^_JYC1?!'@_P .7SWW
MAWPCHVC73QF%I[#3XK>1D)!*ED4$C*J<=,@>E=/0 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 >,?M1_\FR>+O\ MS_]+(:_
M,ZOU/^-WA/6/'7P7U_PKH*1/J5]]G\E9I-BG9<1R-D]OE0U\8?\ #(?QE_Y\
MM*_\#U_PH ^?Z*^@/^&0_C+_ ,^6E?\ @>O^%'_#(?QE_P"?+2O_  /7_"@#
MY_HKZ _X9#^,O_/EI7_@>O\ A1_PR'\9?^?+2O\ P/7_  H ^?Z*^@/^&0_C
M+_SY:5_X'K_A1_PR'\9?^?+2O_ ]?\* /G^BOH#_ (9#^,O_ #Y:5_X'K_A1
M_P ,A_&7_GRTK_P/7_"@#Y_HKZ _X9#^,O\ SY:5_P"!Z_X4?\,A_&7_ )\M
M*_\  ]?\* /G^BOH#_AD/XR_\^6E?^!Z_P"%'_#(?QE_Y\M*_P# ]?\ "@#Y
M_HKZ _X9#^,O_/EI7_@>O^%'_#(?QE_Y\M*_\#U_PH ^?Z*^@/\ AD/XR_\
M/EI7_@>O^%'_  R'\9?^?+2O_ ]?\* /G^BOH#_AD/XR_P#/EI7_ ('K_A1_
MPR'\9?\ GRTK_P #U_PH ^?Z*^@/^&0_C+_SY:5_X'K_ (4?\,A_&7_GRTK_
M ,#U_P * /G^BOH#_AD/XR_\^6E?^!Z_X4?\,A_&7_GRTK_P/7_"@#Y_HKZ
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45YW\9
M/&6J_#WX0ZWXNT6&VN+^P\CRH[Q&:)M\\<9W!64]'.,$<XKY%_X;4^*7_0 \
M*_\ @+<__'Z /OZBO@'_ (;4^*7_ $ /"O\ X"W/_P ?H_X;4^*7_0 \*_\
M@+<__'Z /OZBO@'_ (;4^*7_ $ /"O\ X"W/_P ?H_X;4^*7_0 \*_\ @+<_
M_'Z /OZBO@'_ (;4^*7_ $ /"O\ X"W/_P ?H_X;4^*7_0 \*_\ @+<__'Z
M/OZBO@'_ (;4^*7_ $ /"O\ X"W/_P ?H_X;4^*7_0 \*_\ @+<__'Z /OZB
MO@'_ (;4^*7_ $ /"O\ X"W/_P ?H_X;4^*7_0 \*_\ @+<__'Z /OZBO@'_
M (;4^*7_ $ /"O\ X"W/_P ?H_X;4^*7_0 \*_\ @+<__'Z /OZBO@'_ (;4
M^*7_ $ /"O\ X"W/_P ?H_X;4^*7_0 \*_\ @+<__'Z /OZBO@'_ (;4^*7_
M $ /"O\ X"W/_P ?H_X;4^*7_0 \*_\ @+<__'Z /OZBO@'_ (;4^*7_ $ /
M"O\ X"W/_P ?H_X;4^*7_0 \*_\ @+<__'Z /OZBO@'_ (;4^*7_ $ /"O\
MX"W/_P ?H_X;4^*7_0 \*_\ @+<__'Z /OZBO@'_ (;4^*7_ $ /"O\ X"W/
M_P ?H_X;4^*7_0 \*_\ @+<__'Z /OZBO@'_ (;4^*7_ $ /"O\ X"W/_P ?
MH_X;4^*7_0 \*_\ @+<__'Z /OZBO@'_ (;4^*7_ $ /"O\ X"W/_P ?H_X;
M4^*7_0 \*_\ @+<__'Z /OZBO@'_ (;4^*7_ $ /"O\ X"W/_P ?H_X;4^*7
M_0 \*_\ @+<__'Z /OZBO@'_ (;4^*7_ $ /"O\ X"W/_P ?H_X;4^*7_0 \
M*_\ @+<__'Z /OZBO@'_ (;4^*7_ $ /"O\ X"W/_P ?H_X;4^*7_0 \*_\
M@+<__'Z /OZBO@'_ (;4^*7_ $ /"O\ X"W/_P ?H_X;4^*7_0 \*_\ @+<_
M_'Z /OZBO@'_ (;4^*7_ $ /"O\ X"W/_P ?H_X;4^*7_0 \*_\ @+<__'Z
M/OZBO@'_ (;4^*7_ $ /"O\ X"W/_P ?H_X;4^*7_0 \*_\ @+<__'Z /OZB
MO@'_ (;4^*7_ $ /"O\ X"W/_P ?H_X;4^*7_0 \*_\ @+<__'Z /OZBO@'_
M (;4^*7_ $ /"O\ X"W/_P ?H_X;4^*7_0 \*_\ @+<__'Z /OZBO@'_ (;4
M^*7_ $ /"O\ X"W/_P ?H_X;4^*7_0 \*_\ @+<__'Z /OZBO@'_ (;4^*7_
M $ /"O\ X"W/_P ?H_X;4^*7_0 \*_\ @+<__'Z /OZBO@'_ (;4^*7_ $ /
M"O\ X"W/_P ?H_X;4^*7_0 \*_\ @+<__'Z /OZBO@'_ (;4^*7_ $ /"O\
MX"W/_P ?H_X;4^*7_0 \*_\ @+<__'Z /OZBO@'_ (;4^*7_ $ /"O\ X"W/
M_P ?H_X;4^*7_0 \*_\ @+<__'Z /OZBO@'_ (;4^*7_ $ /"O\ X"W/_P ?
MH_X;4^*7_0 \*_\ @+<__'Z /OZBO@'_ (;4^*7_ $ /"O\ X"W/_P ?H_X;
M4^*7_0 \*_\ @+<__'Z /OZBO@'_ (;4^*7_ $ /"O\ X"W/_P ?H_X;4^*7
M_0 \*_\ @+<__'Z /OZBO@'_ (;4^*7_ $ /"O\ X"W/_P ?H_X;4^*7_0 \
M*_\ @+<__'Z /OZBO@'_ (;4^*7_ $ /"O\ X"W/_P ?H_X;4^*7_0 \*_\
M@+<__'Z /OZBO@'_ (;4^*7_ $ /"O\ X"W/_P ?H_X;4^*7_0 \*_\ @+<_
M_'Z /OZBO@'_ (;4^*7_ $ /"O\ X"W/_P ?H_X;4^*7_0 \*_\ @+<__'Z
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?:/"O_0'U7_P9Q__ "/6)10!M_:/"O\ T!]5_P#!G'_\CT?:/"O_ $!]5_\
M!G'_ /(]8E% &W]H\*_] ?5?_!G'_P#(]'VCPK_T!]5_\&<?_P CUB44 ;?V
MCPK_ - ?5?\ P9Q__(]'VCPK_P! ?5?_  9Q_P#R/6)10!M_:/"O_0'U7_P9
MQ_\ R/1]H\*_] ?5?_!G'_\ (]8E% &W]H\*_P#0'U7_ ,&<?_R/1]H\*_\
M0'U7_P &<?\ \CUB44 ;?VCPK_T!]5_\&<?_ ,CT?:/"O_0'U7_P9Q__ "/6
M)10!M_:/"O\ T!]5_P#!G'_\CT?:/"O_ $!]5_\ !G'_ /(]8E% &W]H\*_]
M ?5?_!G'_P#(]'VCPK_T!]5_\&<?_P CUB44 ;?VCPK_ - ?5?\ P9Q__(]'
MVCPK_P! ?5?_  9Q_P#R/6)10!M_:/"O_0'U7_P9Q_\ R/1]H\*_] ?5?_!G
M'_\ (]8E% &W]H\*_P#0'U7_ ,&<?_R/1]H\*_\ 0'U7_P &<?\ \CUB44 ;
M?VCPK_T!]5_\&<?_ ,CT?:/"O_0'U7_P9Q__ "/6)10!M_:/"O\ T!]5_P#!
MG'_\CT?:/"O_ $!]5_\ !G'_ /(]8E% &W]H\*_] ?5?_!G'_P#(]'VCPK_T
M!]5_\&<?_P CUB44 ;?VCPK_ - ?5?\ P9Q__(]'VCPK_P! ?5?_  9Q_P#R
M/6)10!M_:/"O_0'U7_P9Q_\ R/1]H\*_] ?5?_!G'_\ (]8E% &W]H\*_P#0
M'U7_ ,&<?_R/1]H\*_\ 0'U7_P &<?\ \CUB44 ;?VCPK_T!]5_\&<?_ ,CT
M?:/"O_0'U7_P9Q__ "/6)10!M_:/"O\ T!]5_P#!G'_\CT?:/"O_ $!]5_\
M!G'_ /(]8E% &W]H\*_] ?5?_!G'_P#(]'VCPK_T!]5_\&<?_P CUB44 ;?V
MCPK_ - ?5?\ P9Q__(]'VCPK_P! ?5?_  9Q_P#R/6)10!M_:/"O_0'U7_P9
MQ_\ R/1]H\*_] ?5?_!G'_\ (]8E% &W]H\*_P#0'U7_ ,&<?_R/1]H\*_\
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M:Y_^(H_X5/\ %+_HFGBK_P $US_\16-_PEGBG_H9M5_\#)/_ (JC_A+/%/\
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M#)/_ (JC_A+/%/\ T,VJ_P#@9)_\50!L_P#"I_BE_P!$T\5?^":Y_P#B*/\
MA4_Q2_Z)IXJ_\$US_P#$5C?\)9XI_P"AFU7_ ,#)/_BJ/^$L\4_]#-JO_@9)
M_P#%4 ;/_"I_BE_T33Q5_P"":Y_^(H_X5/\ %+_HFGBK_P $US_\16-_PEGB
MG_H9M5_\#)/_ (JC_A+/%/\ T,VJ_P#@9)_\50!L_P#"I_BE_P!$T\5?^":Y
M_P#B*/\ A4_Q2_Z)IXJ_\$US_P#$5C?\)9XI_P"AFU7_ ,#)/_BJ/^$L\4_]
M#-JO_@9)_P#%4 ;/_"I_BE_T33Q5_P"":Y_^(H_X5/\ %+_HFGBK_P $US_\
M16-_PEGBG_H9M5_\#)/_ (JC_A+/%/\ T,VJ_P#@9)_\50!L_P#"I_BE_P!$
MT\5?^":Y_P#B*/\ A4_Q2_Z)IXJ_\$US_P#$5C?\)9XI_P"AFU7_ ,#)/_BJ
M/^$L\4_]#-JO_@9)_P#%4 ;/_"I_BE_T33Q5_P"":Y_^(H_X5/\ %+_HFGBK
M_P $US_\16-_PEGBG_H9M5_\#)/_ (JC_A+/%/\ T,VJ_P#@9)_\50!L_P#"
MI_BE_P!$T\5?^":Y_P#B*/\ A4_Q2_Z)IXJ_\$US_P#$5C?\)9XI_P"AFU7_
M ,#)/_BJ/^$L\4_]#-JO_@9)_P#%4 ;/_"I_BE_T33Q5_P"":Y_^(H_X5/\
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MU57_ ,IU 'C-%>S?\8M?]55_\IU'_&+7_55?_*=0!XS17LW_ !BU_P!55_\
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MLZK_ . <G_Q-'_")^*?^A9U7_P  Y/\ XF@#$HK;_P"$3\4_]"SJO_@')_\
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MXI_Z%G5?_ .3_P")H Q**V_^$3\4_P#0LZK_ . <G_Q-'_")^*?^A9U7_P
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M;@,XR/SKZ_H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%MO_ (_1_P -J_"W_H >*O\ P%MO_C] 'TS17S-_PVK\+?\ H >*O_ 6V_\
MC]'_  VK\+?^@!XJ_P# 6V_^/T ?3-%?,W_#:OPM_P"@!XJ_\!;;_P"/T?\
M#:OPM_Z 'BK_ ,!;;_X_0!],T5\S?\-J_"W_ * 'BK_P%MO_ (_1_P -J_"W
M_H >*O\ P%MO_C] 'TS17S-_PVK\+?\ H >*O_ 6V_\ C]'_  VK\+?^@!XJ
M_P# 6V_^/T ?3-%?,W_#:OPM_P"@!XJ_\!;;_P"/T?\ #:OPM_Z 'BK_ ,!;
M;_X_0!],T5\S?\-J_"W_ * 'BK_P%MO_ (_1_P -J_"W_H >*O\ P%MO_C]
M'TS17S-_PVK\+?\ H >*O_ 6V_\ C]'_  VK\+?^@!XJ_P# 6V_^/T ?3-%?
M,W_#:OPM_P"@!XJ_\!;;_P"/T?\ #:OPM_Z 'BK_ ,!;;_X_0!],T5\S?\-J
M_"W_ * 'BK_P%MO_ (_1_P -J_"W_H >*O\ P%MO_C] 'TS17S-_PVK\+?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** /&/VH_\ DV3Q=_VY_P#I9#7YG5^F/[4?_)LGB[_MS_\ 2R&OS.H ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "OU+^ ?_)O?@K_L'K_Z$:_+2OU+^ ?_ ";W
MX*_[!Z_^A&@#TVBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"E=6EKJ%H]K>VT5S;O
MC=%,@=&P<C(/!Y -4?\ A$_"O_0LZ5_X!1__ !-;=% &)_PB?A7_ *%G2O\
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M\*_]"SI7_@%'_P#$UMT4 8G_  B?A7_H6=*_\ H__B:/^$3\*_\ 0LZ5_P"
M4?\ \36W10!B?\(GX5_Z%G2O_ */_P")H_X1/PK_ -"SI7_@%'_\36W10!B?
M\(GX5_Z%G2O_  "C_P#B:/\ A$_"O_0LZ5_X!1__ !-;=% &)_PB?A7_ *%G
M2O\ P"C_ /B:/^$3\*_]"SI7_@%'_P#$UMT4 8G_  B?A7_H6=*_\ H__B:/
M^$3\*_\ 0LZ5_P" 4?\ \36W10!B?\(GX5_Z%G2O_ */_P")H_X1/PK_ -"S
MI7_@%'_\36W10!B?\(GX5_Z%G2O_  "C_P#B:/\ A$_"O_0LZ5_X!1__ !-;
M=% &)_PB?A7_ *%G2O\ P"C_ /B:/^$3\*_]"SI7_@%'_P#$UMT4 8G_  B?
MA7_H6=*_\ H__B:/^$3\*_\ 0LZ5_P" 4?\ \36W10!B?\(GX5_Z%G2O_ */
M_P")H_X1/PK_ -"SI7_@%'_\36W10!B?\(GX5_Z%G2O_  "C_P#B:/\ A$_"
MO_0LZ5_X!1__ !-;=% &)_PB?A7_ *%G2O\ P"C_ /B:/^$3\*_]"SI7_@%'
M_P#$UMT4 8G_  B?A7_H6=*_\ H__B:/^$3\*_\ 0LZ5_P" 4?\ \36W10!B
M?\(GX5_Z%G2O_ */_P")H_X1/PK_ -"SI7_@%'_\36W10!B?\(GX5_Z%G2O_
M  "C_P#B:/\ A$_"O_0LZ5_X!1__ !-;=% &)_PB?A7_ *%G2O\ P"C_ /B:
MT;>WM[6W2WM8(X(8QA(XE"JH] !P*M44 %%%% !1110 4444 %%%% !1110
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M_P#W/7QG10!]F?\ #<__ %2[_P K?_W/1_PW/_U2[_RM_P#W/7QG10!]F?\
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M&U?A;_T /%7_ ("VW_Q^C_AM7X6_] #Q5_X"VW_Q^O@"B@#[_P#^&U?A;_T
M/%7_ ("VW_Q^C_AM7X6_] #Q5_X"VW_Q^O@"B@#[_P#^&U?A;_T /%7_ ("V
MW_Q^OIFOQGK]F* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\9Z
M*_9BB@#\9Z*_9BB@#\9Z*_9BB@#\9Z*_9BB@#\9Z*_9BB@#\9Z*_9BB@#\9Z
M*_9BB@#\9Z*_9BB@#\9Z*_9BB@#\9Z*_9BB@#\9Z*_9BB@#\9Z*_9BB@#\9Z
M*_9BB@#\9Z*_9BB@#\9Z*_9BB@#\9Z^L_P!MW_D>/"?_ &#Y?_1E?<M% 'XS
MT5^S%% 'XST5^S%% 'XST5^S%% 'XST5^S%% 'XST5^S%% 'XST5^S%% 'XS
MT5^S%% 'XST5^S%% 'QG\ O^3(OBK_W%O_3=%7QG7[,44 ?C/17[,44 ?C/1
M7[,44 ?C/17[,44 ?C/17[,44 ?C/17[,44 ?C/17[,44 ?C/17[,44 ?C/1
M7[,44 ?C/17[,44 ?C/17[,44 ?C/17[,44 ?C/17[,44 ?C/17[,44 ?C/7
M[,444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %?G%^TEX@UZQ_:1\56MGKE_;6Z?9-L4-RZ
M*N;2$G !P.237Z.U^9W[4G_)S?B[_MS_ /2.&@#S/_A+/%/_ $,VJ_\ @9)_
M\51_PEGBG_H9M5_\#)/_ (JL2B@#;_X2SQ3_ -#-JO\ X&2?_%4?\)9XI_Z&
M;5?_  ,D_P#BJQ** -O_ (2SQ3_T,VJ_^!DG_P 51_PEGBG_ *&;5?\ P,D_
M^*K$HH V_P#A+/%/_0S:K_X&2?\ Q5'_  EGBG_H9M5_\#)/_BJQ** -O_A+
M/%/_ $,VJ_\ @9)_\51_PEGBG_H9M5_\#)/_ (JL2B@#;_X2SQ3_ -#-JO\
MX&2?_%4?\)9XI_Z&;5?_  ,D_P#BJQ** -O_ (2SQ3_T,VJ_^!DG_P 51_PE
MGBG_ *&;5?\ P,D_^*K$HH V_P#A+/%/_0S:K_X&2?\ Q5'_  EGBG_H9M5_
M\#)/_BJQ** -O_A+/%/_ $,VJ_\ @9)_\51_PEGBG_H9M5_\#)/_ (JL2B@#
M;_X2SQ3_ -#-JO\ X&2?_%4?\)9XI_Z&;5?_  ,D_P#BJQ** -O_ (2SQ3_T
M,VJ_^!DG_P 51_PEGBG_ *&;5?\ P,D_^*K$HH V_P#A+/%/_0S:K_X&2?\
MQ5'_  EGBG_H9M5_\#)/_BJQ** -O_A+/%/_ $,VJ_\ @9)_\51_PEGBG_H9
MM5_\#)/_ (JL2B@#;_X2SQ3_ -#-JO\ X&2?_%4?\)9XI_Z&;5?_  ,D_P#B
MJQ** -O_ (2SQ3_T,VJ_^!DG_P 51_PEGBG_ *&;5?\ P,D_^*K$HH V_P#A
M+/%/_0S:K_X&2?\ Q5'_  EGBG_H9M5_\#)/_BJQ** -O_A+/%/_ $,VJ_\
M@9)_\51_PEGBG_H9M5_\#)/_ (JL2B@#;_X2SQ3_ -#-JO\ X&2?_%4?\)9X
MI_Z&;5?_  ,D_P#BJQ** -O_ (2SQ3_T,VJ_^!DG_P 51_PEGBG_ *&;5?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "O+O$GP'^%/C+Q)=^)/$GA7[?JUYL\ZX^W7
M,>_8BHORI(%&%51P.U>HT4 >,?\ #+GP+_Z$;_RIWG_QZC_AESX%_P#0C?\
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MO_*G>?\ QZMK_A?WP;_Z*%I7_?;?X4?\+^^#?_10M*_[[;_"@#%_X9<^!?\
MT(W_ )4[S_X]1_PRY\"_^A&_\J=Y_P#'JVO^%_?!O_HH6E?]]M_A1_PO[X-_
M]%"TK_OMO\* ,7_AESX%_P#0C?\ E3O/_CU'_#+GP+_Z$;_RIWG_ ,>K:_X7
M]\&_^BA:5_WVW^%'_"_O@W_T4+2O^^V_PH Q?^&7/@7_ -"-_P"5.\_^/4?\
M,N? O_H1O_*G>?\ QZMK_A?OP;_Z*%I7_?;?X4?\+^^#?_10M*_[[;_"@#%_
MX9<^!?\ T(W_ )4[S_X]1_PRY\"_^A&_\J=Y_P#'JVO^%_?!O_HH6E?]]M_A
M1_PO[X-_]%"TK_OMO\* ,7_AESX%_P#0C?\ E3O/_CU'_#+GP+_Z$;_RIWG_
M ,>K:_X7]\&_^BA:5_WVW^%'_"_O@W_T4+2O^^V_PH Q?^&7/@7_ -"-_P"5
M.\_^/4?\,N? O_H1O_*G>?\ QZMK_A?WP;_Z*%I7_?;?X4?\+^^#?_10M*_[
M[;_"@#%_X9<^!?\ T(W_ )4[S_X]1_PRY\"_^A&_\J=Y_P#'JVO^%_?!O_HH
M6E?]]M_A1_PO[X-_]%"TK_OMO\* ,7_AESX%_P#0C?\ E3O/_CU'_#+GP+_Z
M$;_RIWG_ ,>K:_X7]\&_^BA:5_WVW^%'_"_O@W_T4+2O^^V_PH Q?^&7/@7_
M -"-_P"5.\_^/4?\,N? O_H1O_*G>?\ QZMK_A?WP;_Z*%I7_?;?X4?\+^^#
M?_10M*_[[;_"@#%_X9<^!?\ T(W_ )4[S_X]1_PRY\"_^A&_\J=Y_P#'JVO^
M%_?!O_HH6E?]]M_A1_PO[X-_]%"TK_OMO\* ,7_AESX%_P#0C?\ E3O/_CU'
M_#+GP+_Z$;_RIWG_ ,>K:_X7]\&_^BA:5_WVW^%'_"_O@W_T4+2O^^V_PH Q
M?^&7/@7_ -"-_P"5.\_^/4?\,N? O_H1O_*G>?\ QZMK_A?WP;_Z*%I7_?;?
MX4?\+^^#?_10M*_[[;_"@#%_X9<^!?\ T(W_ )4[S_X]1_PRY\"_^A&_\J=Y
M_P#'JVO^%_?!O_HH6E?]]M_A1_POWX-_]%"TK_OMO\* ,7_AESX%_P#0C?\
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M1_PRY\"_^A&_\J=Y_P#'JVO^%_?!O_HH6E?]]M_A1_PO[X-_]%"TK_OMO\*
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M2&%%%% '/>!O^2<>&/\ L%VO_HE:Z&N>\#?\DX\,?]@NU_\ 1*UT- !1110
M4444 %%%% 'SKXPM[KPO=>*?BE\.?%D>RVO'CUKP[?$&VEE#>7)QN&'; ('W
MFSP>=IJ>*KRUNOBI?1ZM*^CQ3^ WO?LHN&A6.YPW.T$ NB@XXR-@/\(Q[_-X
M9\-W&I0:E<>']-FOK=F:&Y>TC:2(L2S%6(R"223CJ2:XW4?ARVK_ !AE\7:M
M;:7J.C2Z4-+?3[J/S=V)/,$A#*5)W<8_'/:E'HO7Y#;U;]/F>5Z/J^M:MIOP
MBL_%5U.ND7>G7TT\LLS#[5*D;^4)#GG"!6&>I)/:LW1=4UK5O!?P=N]<O+M[
MJZ\0-;-<2RL);FV#G:';.67MSUQ7TYJ&@:%J^G1Z;JVBV&H6,1!CMKFV26-,
M# PK @8'2JVI>$/">LO;OK'A?2=1:V01PM=644IB4=%7<IVCV%7_ )W%_E8^
M;?"]]XEO_AOJ@TW6$N[[3/%MPUGI-_.2FHQ)&&-J"6' !9PO3*]*WD\13^)K
M[P+)?1W&F^&[K0=0ODCGNG?S+M0P96<G+[%^9"><'/7FO;X/!'@NUL9["V\(
M:+!:7'^N@CT^)8Y?]Y0N#^-6[WPWX=U+3;?3-2T#3KVQML>1;7%K')%%@8&U
M2"%P.!BI'<^</#>K^(-3M/@M=:]>78O;ZZO;>29Y&26ZMP,1ECD%N#P3ZY[Y
MKWNU\#Z7:C04-Y?W,.AL\EM'<3!P\C9P[L1N8J&.T9 &>A(4B_J7A/PKK-S!
M<:OX9TG49[=1'#+=64<K1*#D*I920 >PK:JKZ/U;(ZKTL?/WPNU_Q!-\69K?
M6I+V]M-0MKZ73]4@O)I;2_C%Q&P8PLQ6)HP=@P%(W;2,X-:?QBFV_%3X3Q0W
M4$%R=2F*&9=P7(0 E=P)&>.HKU;2_"WAC0[N6\T3PYI>F7,R[9)K.SCA>09S
M@E0"1GGFHM2\&^#]<OC?ZUX5T;4[LJ%,]Y8132$#H-S*3@5/\K[.Y71KNFCP
MCP=K&J6$GQ5GU&'ROBGY<LBQ''[^)(SY)MX\9*# XRQ/RDGFH/".J:DLW@T6
M%Y/>G5/"M[<:X7E:3)&2DTF3]_S,IN/.,BOH:3PWX=FU>VUB70-.DU*T01V]
MXUK&9H5&<*CXRH&3P#W--@\,>&K4Z@UMX>TR ZD"MZ8[2-?M0.<B3 ^?.3][
M/4U7;TL4NI\K_#?5M0C\._##0+J>&S\.W]SJ(FEN59H)KG+B*-P&7/4%03RQ
M!YVBOJ7PII]YI/A+3M,O]9.M7%K%Y+7QC,9F"G )!9N<8!.3G&>],_X0WP?_
M &(=#7PKHXTII?.-D+&+R#)TW[-NW=[XS6W'&D4:QQHJ(@"JJC 4#H *70BV
MHZBBBD,**** "BBB@ K&^!W_ "+'BG_L:]6_]*6K9K&^!W_(L>*?^QKU;_TI
M:@#U2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH \0U;Q@NA_$#Q;8GPKXIU/_3H7
M\_2]'FNH>;*VXWHI&?45#_PLA/\ HG_CW_PF;K_XFO5?#_\ R'?%G_843_TB
MMJZ"@#YNL]=T&P\5WOBBV^'?Q#&JWT8AGE?1]1='0'*KY;90 <XPHQDXZG-Z
M?QCI%U;W]O<_#+QE-#J(Q=QR>%[IEG^4)\P*X/R@#Z 5]!T4=+!UN?+EN/!%
MMH&JZ&OPH\>R6.K*D=XLVB:A*\RHH5%\Q\N H "@$!>V*Z33_'&GZ3I=KI>G
M?#GQU;V=I$L$,2^&[O"(HPHY7L!7O]% 'A7_  LA/^B?^/?_  F;K_XFN?\
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M_P 37NM% 'A7_"R$_P"B?^/?_"9NO_B:/^%D)_T3_P >_P#A,W7_ ,37NM%
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M_P"$S=?_ !->ZT4 >%?\+(3_ *)_X]_\)FZ_^)H_X60G_1/_ ![_ .$S=?\
MQ->ZT4 ?-_@_XA+:^ _#]M_P@WC:?RM.MT\R#P]<R1OB)1N5@N&4]B.HK;_X
M60G_ $3_ ,>_^$S=?_$ULZA-)!^R3=3PR/'+'X+=T="596%B2"".A%?F]_PE
MGBG_ *&;5?\ P,D_^*H _0C_ (60G_1/_'O_ (3-U_\ $T?\+(3_ *)_X]_\
M)FZ_^)K\]_\ A+/%/_0S:K_X&2?_ !5'_"6>*?\ H9M5_P# R3_XJ@#]"/\
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M+(3_ *)_X]_\)FZ_^)K\]_\ A+/%/_0S:K_X&2?_ !5'_"6>*?\ H9M5_P#
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M^'_[-:^+M%AM;B_L=/L/*CNT9HFWO#&=P5E/1SC!'.* /7:*^ ?^&U/BE_T
M/"O_ ("W/_Q^C_AM3XI?] #PK_X"W/\ \?H ^_J*^ ?^&U/BE_T /"O_ ("W
M/_Q^C_AM3XI?] #PK_X"W/\ \?H ^_J*^ ?^&U/BE_T /"O_ ("W/_Q^C_AM
M3XI?] #PK_X"W/\ \?H ^_J*^ ?^&U/BE_T /"O_ ("W/_Q^C_AM3XI?] #P
MK_X"W/\ \?H ^_J*^ ?^&U/BE_T /"O_ ("W/_Q^C_AM3XI?] #PK_X"W/\
M\?H ^_J*^ ?^&U/BE_T /"O_ ("W/_Q^C_AM3XI?] #PK_X"W/\ \?H ^_J*
M^ ?^&U/BE_T /"O_ ("W/_Q^C_AM3XI?] #PK_X"W/\ \?H ^_J*^ ?^&U/B
ME_T /"O_ ("W/_Q^C_AM3XI?] #PK_X"W/\ \?H ^_J*^ ?^&U/BE_T /"O_
M ("W/_Q^C_AM3XI?] #PK_X"W/\ \?H ^_J*^ ?^&U/BE_T /"O_ ("W/_Q^
MC_AM3XI?] #PK_X"W/\ \?H ^_J*^ ?^&U/BE_T /"O_ ("W/_Q^C_AM3XI?
M] #PK_X"W/\ \?H ^_J*^ ?^&U/BE_T /"O_ ("W/_Q^C_AM3XI?] #PK_X"
MW/\ \?H ^_J*^ ?^&U/BE_T /"O_ ("W/_Q^C_AM3XI?] #PK_X"W/\ \?H
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MHHH **** "BBB@ HHHH **** "BBB@#G_#__ "'?%G_843_TBMJZ"N?\/_\
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MX\_[%^__ /29Z\S^.W_)E>H?]@_2_P#THMZ /SGHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBOK/PG^QW_P )/X(T'Q+_
M ,+$^R?VMI]O?>1_9&_RO-C5]F[SQNQNQG SCH* /DRBOLS_ (88_P"JH_\
ME$_^Z*/^&&/^JH_^43_[HH ]_P#@'_R;WX*_[!Z_^A&O3:Y/P#X4_P"$'^'V
MB^$OMW]H?V7;B#[3Y7E>;@DYV[FQUZ9-=90!Y-JW_)GM_P#]B/)_Z0&OS K]
M/]6_Y,]O_P#L1Y/_ $@-?F!0 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %?JWH?PB^&WA?7;;7?#_@_3].U.VW>3<PJ0R;E*-CG
MNK$?C7Y25^S% !1110 4444 %>9?!O\ Y!/C+_L<-8_]*FKTVO,O@W_R"?&7
M_8X:Q_Z5-0!Z;1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7(QGD #BFQ+3?8S+7XD>)[.^UF'6]/TZ],'A=/$EG%IT<B-_$&A<LS;^0,,
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M1110 4444 %%%% !1110!Y-JW_)GM_\ ]B/)_P"D!K\P*_3_ %;_ ),]O_\
ML1Y/_2 U^8% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!^LGPI_Y(AX#_[%^P_])DKM*_-G1?VH/BIX>\.Z;H&FWFFK9:;:Q6<
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MBB@ HHHH **** "BBB@ HHHH **** .+^*W_ "1#QY_V+]__ .DSUYG\=O\
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M7/\ \8H ^9:*^FO^&*_BE_T'_"O_ (%7/_QBC_ABOXI?]!_PK_X%7/\ \8H
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M ,)[4/\ XQ1_PG.C?\^/B#_PGM0_^,4 =117+_\ "<Z-_P ^/B#_ ,)[4/\
MXQ1_PG.C?\^/B#_PGM0_^,4 =117+_\ "<Z-_P ^/B#_ ,)[4/\ XQ1_PG.C
M?\^/B#_PGM0_^,4 =117+_\ "<Z-_P ^/B#_ ,)[4/\ XQ1_PG.C?\^/B#_P
MGM0_^,4 =117+_\ "<Z-_P ^/B#_ ,)[4/\ XQ1_PG.C?\^/B#_PGM0_^,4
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M,];7A/\ Y$?0?^P?;_\ HM:Q?BM_R1#QY_V+]_\ ^DSUM>$_^1'T'_L'V_\
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M0 5R7PU_Y)=X=_Z\TKK:Y+X:_P#)+O#O_7FE '6T444 %%%% !1110 4444
M%%%% !1110 4444 <7\5O^2(>//^Q?O_ /TF>MKPG_R(^@_]@^W_ /1:UB_%
M;_DB'CS_ +%^_P#_ $F>L_4O&&E^ ?@?9>+M;M[NXL-/L+,RQVB*TK;_ "XQ
MM#,HZN,Y(XS0!Z)17S-_PVK\+?\ H >*O_ 6V_\ C]'_  VK\+?^@!XJ_P#
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M\+?^@!XJ_P# 6V_^/T ?3-%?,W_#:OPM_P"@!XJ_\!;;_P"/T?\ #:OPM_Z
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#G_  __ ,AWQ9_V%$_](K:N@KG_  __ ,AWQ9_V
M%$_](K:N@H **** "BBB@ KDOAK_ ,DN\._]>:5UM<E\-?\ DEWAW_KS2@#K
M:*** "BBB@ HHHH **** "BBB@ HHHH **** .+^*W_)$/'G_8OW_P#Z3/7F
M?QV_Y,KU#_L'Z7_Z46]>F?%;_DB'CS_L7[__ -)GKS/X[?\ )E>H?]@_2_\
MTHMZ /SGHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** /V8HHHH **** "BBB@#R;5O^3/;_\ [$>3_P!(#7Y@5^G^K?\ )GM_
M_P!B/)_Z0&OS H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH [3_A4_P 4O^B:>*O_  37/_Q%?0W[)G@GQEX:^+>J
MWWB#PCK6CVKZ)-"L]]I\MO&SFX@(4,Z@$X5CCK@'TK[>HH *\R^#?_()\9?]
MCAK'_I4U>FUYE\&_^03XR_['#6/_ $J:@#TVBBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH Y_P_\ \AWQ9_V%$_\ 2*VKH*Y_P_\ \AWQ9_V%$_\ 2*VKH* "BBB@
M HHHH *Y+X:_\DN\._\ 7FE=;7)?#7_DEWAW_KS2@#K:*Y/QOX@U3PMX,U/Q
M%I>DVNJMIL,EU/;W%XUKF)$9FVL(Y,MQP" #GJ*YG5_B1K7@W2HM>\>^&[/3
M_#[M$DE_I6IO??9C(<*94>"(A<E1E=W7I2W=@/4J*Q+CQ'X?M-7L]'N-<T^#
M4[U=]K9RW2)-<+ZHA.YAP>@/2H9/%7AF"_2QG\2Z5%=O<_8U@>\C$C3X!\H*
M6SOPRG;UP1QS3 Z&BL>PU[1=6M[FZTO6+&_AM)&AN)+:X21877EE<J2%([@\
MBJUOXN\*WVB7&N6?B?2;C2+8GSK^*\C>"(CKND#;5QD=30!T-%8EOXC\/WIO
MQ9Z[ITYTTD7OE72/]D."?WF#\G )^;'2L/5?B=X#T73]*U"^\6:4MEJD_P!G
MM;E;R(Q.<$EM^[:% '+9P,@=2 0#MZ*YUO%WA5M2BTV/Q-I+7TI98[87L1E<
MJNY@%W9.%Y/H.:S]1^)7@73?"U]XFD\6:7<:78-Y<TUK=QS 2=H_E)^<]EZT
M =E17&:?XJCUOQ=9QZ)XB\-:CH-SI\DZ"VO!+>2RK*%WH%)1H0,ACU#8%;%C
MXC\.ZG>7MKIOB#3[V?3CMO(K>ZCD:V//$@!)3H>N.E &W16%8>)O#NJ7_P#9
M^E^(--OKOR?M'V>WO(Y)/+W;=^U23MSQGIGBG6-[<76J:KEH_LMG,MO'@'<S
M>6KN2<XQEP.G&TT 8WQ6_P"2(>//^Q?O_P#TF>O,_CM_R97J'_8/TO\ ]*+>
MO3/BM_R1#QY_V+]__P"DSUYG\=O^3*]0_P"P?I?_ *46] 'YST444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?1/[)GA_0?$OQ<U6Q
M\0:+I^L6L>AS3+!?VR7$:N+B !@K@@'#,,]<$^M?.U?37[%?_);=9_[%^;_T
MIMZ /OZBBB@ HHHH **** /)M6_Y,]O_ /L1Y/\ T@-?F!7Z?ZM_R9[?_P#8
MCR?^D!K\P* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** /V8HKXL_9V^-GQ.\>?&*#P_XJ\4?VAIKV<\K1"RMXLLH&
M#NCC5OUK[3H *\R^#?\ R"?&7_8X:Q_Z5-7IM>9?!O\ Y!/C+_L<-8_]*FH
M]-HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** .?\ #_\ R'?%G_843_TBMJZ"N?\
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M:Q_Z5-7IM>9?!O\ Y!/C+_L<-8_]*FH ]-HHHH **** "BBB@ HHHH ****
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MO^AZ_P#*9>?_ !FC_AJ+X%?]#U_Y3+S_ .,U^9U% 'Z8_P##47P*_P"AZ_\
M*9>?_&:/^&HO@5_T/7_E,O/_ (S7YG44 ?J_X&^)W@3XD/J#>"]=.J_V=Y?V
MG_19H?+\S=L_UB+G.QNF>G/:NYKXS_89_P":@_\ <._]N:^S* /)M6_Y,]O_
M /L1Y/\ T@-?F!7Z?ZM_R9[?_P#8CR?^D!K\P* "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#]F*\R^#?_()
M\9?]CAK'_I4U>FUYE\&_^03XR_['#6/_ $J:@#TVBBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH Y_P_\ \AWQ9_V%$_\ 2*VKH*Y_P_\ \AWQ9_V%$_\ 2*VKH* "
MBBB@ HHHH *Y+X:_\DN\._\ 7FE=;7)?#7_DEWAW_KS2@#K:*** &>M>1_&;
M6_&7AW3?#NJ>#]6DMY_[09;JR$,,B7T*6\MP\>71F5B("JE2/OG/8CUSUKB/
M&&FZMJ&L^$KC3]--Y%INJF\NL2HFV/[/-%P&(W',H./13STR=4'?T,/XC>.+
MJT^"]UXK\%7T+7=W8/=V-TP5U1!$96DVG()"J0 01N*@TEW\2=-\#>%-*;Q)
M>:CK5V;%+Z\N56V62*)NLK(#$& .X!8E9L*?E.":YZ[^$M]HOPZ\9>'=!SJ
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M\._]>:5UM<E\-?\ DEWAW_KS2@#K:*** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% '/\ A_\ Y#OBS_L*)_Z16U=!7/\ A_\
MY#OBS_L*)_Z16U=!0 4444 %%%% !7)?#7_DEWAW_KS2NMKDOAK_ ,DN\._]
M>:4 =;1110 4444 %%%% !1110 4444 %%%% !1110!Q?Q6_Y(AX\_[%^_\
M_29Z\S^.W_)E>H?]@_2__2BWKTSXK?\ )$/'G_8OW_\ Z3/7GWQ>TG5-<_9%
MNM+T73+O4KZ>PT[RK6TA::63$T#':B@DX ).!T!- 'YN45VG_"I_BE_T33Q5
M_P"":Y_^(H_X5/\ %+_HFGBK_P $US_\10!Q=%=I_P *G^*7_1-/%7_@FN?_
M (BC_A4_Q2_Z)IXJ_P#!-<__ !% '%T5VG_"I_BE_P!$T\5?^":Y_P#B*/\
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MB30K/?:?+;QLYN("%#.H!.%8XZX!]* /MZBBB@ HHHH **** "BBB@ HHHH
M\FU;_DSV_P#^Q'D_](#7Y@5^G^K?\F>W_P#V(\G_ *0&OS H **** "BBB@
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M4 %%%% !1110 4444 <_X?\ ^0[XL_["B?\ I%;5T%<_X?\ ^0[XL_["B?\
MI%;5T% !1110 4444 %<E\-?^27>'?\ KS2NMKDOAK_R2[P[_P!>:4 =;111
M0 4444 %%%% !1110 4444 %%%% !1110!Q?Q6_Y(AX\_P"Q?O\ _P!)GK:\
M)_\ (CZ#_P!@^W_]%K6+\5O^2(>//^Q?O_\ TF>MKPG_ ,B/H/\ V#[?_P!%
MK0!M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% 'DVK?\F>W_ /V(\G_I :_,"OT_U;_DSV__ .Q'D_\
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M5/\ "S_HFGA7_P $UM_\11_PJ?X6?]$T\*_^":V_^(H _)JBOUE_X5/\+/\
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M_P #$_\ B*/^$+D_Z'+Q+_X&)_\ $4 =;17)?\(7)_T.7B7_ ,#$_P#B*/\
MA"Y/^AR\2_\ @8G_ ,10!UM<E\-?^27>'?\ KS2C_A"Y/^AR\2_^!B?_ !%>
M7? 72]0\4_ KPUK6H>+M>CN)UN$*6]PB1JJ7$L:@#9Q\J"@#WZBN2_X0N3_H
M<O$O_@8G_P 11_PA<G_0Y>)?_ Q/_B* .MHKDO\ A"Y/^AR\2_\ @8G_ ,11
M_P (7)_T.7B7_P #$_\ B* .MHKDO^$+D_Z'+Q+_ .!B?_$4?\(7)_T.7B7_
M ,#$_P#B* .MHKDO^$+D_P"AR\2_^!B?_$4?\(7)_P!#EXE_\#$_^(H ZVBN
M2_X0N3_H<O$O_@8G_P 11_PA<G_0Y>)?_ Q/_B* .MHKDO\ A"Y/^AR\2_\
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M/^AR\2_^!B?_ !%'_"%R?]#EXE_\#$_^(H ZVBN2_P"$+D_Z'+Q+_P"!B?\
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M\\O'/_@U@_\ C= 'V_17Q!_PU3X;_P">7CG_ ,&L'_QNC_AJGPW_ ,\O'/\
MX-8/_C= 'V_17Q!_PU3X;_YY>.?_  :P?_&Z/^&J?#?_ #R\<_\ @U@_^-T
M?;]%?$'_  U3X;_YY>.?_!K!_P#&Z/\ AJGPW_SR\<_^#6#_ .-T ?;]%?$'
M_#5/AO\ YY>.?_!K!_\ &Z/^&J?#?_/+QS_X-8/_ (W0!]OT5\0?\-4^&_\
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MZ;1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% '%^#?^1N^(_P#V,$7_ *:K"NTKB_!O_(W?$?\
M[&"+_P!-5A7:4 %%%% !1110 5XQ^RY_R;)X1_[?/_2R:O9Z\8_9<_Y-D\(_
M]OG_ *634 >ST444 %%%% !1110 4444 %%%% !1110 4444 <7\5O\ DB'C
MS_L7[_\ ])GKQKXE_P#*/.Q_[%_1/_1EK7LOQ6_Y(AX\_P"Q?O\ _P!)GKQK
MXE_\H\['_L7]$_\ 1EK0!\ 4444 %%%% !1110 4444 %%%% !1110 4444
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M5Z;7F7P;_P"03XR_['#6/_2IJ /3:*** "BBB@ HHHH **** "BBB@ HHHH
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ML?"OA^ZOWU.^\SR1-:%$.R-I&R<\?*AKV2OS._9;_P"3F_"/_;Y_Z1S5^F-
M'C'_ #9#_P!T_P#_ ''5^9U?IC_S9#_W3_\ ]QU?F=0 4444 %%%% !1110
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M*2N2=N?E [FM?2_ VL:3J_B+5[7Q)#]NUM+4L/[/'DQ20H$.$WY,;* -FX$
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M ''5^9U?IC_S9#_W3_\ ]QU?F=0 4444 %%%% !1110 4444 %%%% !1110
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M $U6%=I0 4444 %%%% !7C'[+G_)LGA'_M\_]+)J]GKQC]ES_DV3PC_V^?\
MI9-0![/1110 4444 %%%% !1110 4444 %%%% !1110!Q?Q6_P"2(>//^Q?O
M_P#TF>O&OB7_ ,H\['_L7]$_]&6M>R_%;_DB'CS_ +%^_P#_ $F>O&OB7_RC
MSL?^Q?T3_P!&6M 'P!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%?9G[#/_ #4'_N'?^W-?&=?9G[#/_-0?^X=_[<T ?9E%%% !1110 4444 %%
M%% !1110!XQ_S9#_ -T__P#<=7YG5^F/_-D/_=/_ /W'5^9U !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^I?P#_P"3>_!7_8/7
M_P!"->FUYE\ _P#DWOP5_P!@]?\ T(UZ;0 4444 %%%% !7F7P;_ .03XR_[
M'#6/_2IJ]-KS+X-_\@GQE_V.&L?^E34 >FT444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZ.*_\M&S_P#BJ/\ A7GQV_Z.*_\ +1L__BJ]FHH \9_X5Y\=O^CBO_+1L_\
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M_P#+1L__ (JO9J* /&?^%>?';_HXK_RT;/\ ^*H_X5Y\=O\ HXK_ ,M&S_\
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M?\*\^.W_ $<5_P"6C9__ !5>S44 >,_\*\^.W_1Q7_EHV?\ \51_PKSX[?\
M1Q7_ ):-G_\ %5[-10!XS_PKSX[?]'%?^6C9_P#Q5'_"O/CM_P!'%?\ EHV?
M_P 57LU% 'C/_"O/CM_T<5_Y:-G_ /%4?\*\^.W_ $<5_P"6C9__ !5>S44
M>,_\*\^.W_1Q7_EHV?\ \51_PKSX[?\ 1Q7_ ):-G_\ %5[-10!XS_PKSX[?
M]'%?^6C9_P#Q5'_"O/CM_P!'%?\ EHV?_P 57LU% 'C/_"O/CM_T<5_Y:-G_
M /%4?\*\^.W_ $<5_P"6C9__ !5>S44 >,_\*\^.W_1Q7_EHV?\ \51_PKSX
M[?\ 1Q7_ ):-G_\ %5[-10!XS_PKSX[?]'%?^6C9_P#Q5'_"O/CM_P!'%?\
MEHV?_P 57LU% 'C/_"O/CM_T<5_Y:-G_ /%4?\*\^.W_ $<5_P"6C9__ !5>
MS44 >,_\*\^.W_1Q7_EHV?\ \51_PKSX[?\ 1Q7_ ):-G_\ %5[-10!XS_PK
MSX[?]'%?^6C9_P#Q5=9\._!NH>"?#5UIFJ:]_;VH7FH7&I7-]]D6U\V69][_
M +M68#DGIQST%=U10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHJK<6\%U;26]S D\4B[7CD4,K#T(/!H
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
A110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>ltbr_ex32img7.jpg
<TEXT>
begin 644 ltbr_ex32img7.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" 2D Y8# 2(  A$! Q$!_\0
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M#U_Y3+/_ .,T ?IC17YG?\-1_'7_ *'K_P IEG_\9H_X:C^.O_0]?^4RS_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1/+GCD.0.>0A'XU\K_\ #$/BK_H=]*_\!Y*H1\F45]9_\,0^*O\ H=]*_P#
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MZ[;_ &I84%U)'+*!\[QQE%)]E))'YFK5%)*Q;=PHHHIB"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=O\ H(^ _P#P6WG_ ,D4 >S45XS_ &Q\=O\ H(^ _P#P6WG_ ,D4?VQ\=O\
MH(^ _P#P6WG_ ,D4 >S45XS_ &Q\=O\ H(^ _P#P6WG_ ,D4?VQ\=O\ H(^
M_P#P6WG_ ,D4 >S45XS_ &Q\=O\ H(^ _P#P6WG_ ,D4?VQ\=O\ H(^ _P#P
M6WG_ ,D4 >S45XS_ &Q\=O\ H(^ _P#P6WG_ ,D4?VQ\=O\ H(^ _P#P6WG_
M ,D4 >S45XS_ &Q\=O\ H(^ _P#P6WG_ ,D4?VQ\=O\ H(^ _P#P6WG_ ,D4
M >S45XS_ &Q\=O\ H(^ _P#P6WG_ ,D4?VQ\=O\ H(^ _P#P6WG_ ,D4 >S4
M5XS_ &Q\=O\ H(^ _P#P6WG_ ,D4?VQ\=O\ H(^ _P#P6WG_ ,D4 >S45XS_
M &Q\=O\ H(^ _P#P6WG_ ,D4?VQ\=O\ H(^ _P#P6WG_ ,D4 >S45XS_ &Q\
M=O\ H(^ _P#P6WG_ ,D4?VQ\=O\ H(^ _P#P6WG_ ,D4 >S45XS_ &Q\=O\
MH(^ _P#P6WG_ ,D4?VQ\=O\ H(^ _P#P6WG_ ,D4 >S45XS_ &Q\=O\ H(^
M_P#P6WG_ ,D4?VQ\=O\ H(^ _P#P6WG_ ,D4 >S45XS_ &Q\=O\ H(^ _P#P
M6WG_ ,D4?VQ\=O\ H(^ _P#P6WG_ ,D4 >S45X5HWBCXX:SH&G:O%>>!HH[Z
MVCN51M.O"5#J& /^D>]7_P"V/CM_T$? ?_@MO/\ Y(H ]FHKQG^V/CM_T$?
M?_@MO/\ Y(H_MCX[?]!'P'_X+;S_ .2* /9J*\9_MCX[?]!'P'_X+;S_ .2*
M/[8^.W_01\!_^"V\_P#DB@#V:BO&?[8^.W_01\!_^"V\_P#DBC^V/CM_T$?
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M1\!_^"V\_P#DBC^V/CM_T$? ?_@MO/\ Y(H ]FHKQG^V/CM_T$? ?_@MO/\
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M/'-=/X?^*7BJZ^+&F>#_ !#I.G60U*&X+VMNQEFL)8LL$>97:.3* ,0H4KO
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MT/H01V(.01V(-58FYI4444AA1110 4444 %8WP._Y%CQ3_V->K?^E+5LUC?
M[_D6/%/_ &->K?\ I2U 'JE%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!YNG_(X>
M+?\ L(Q?^D5M5VJ2?\CAXM_[",7_ *16U7: /+?&WQ</@+QMIVCZYX?)T6],
M:MJ\-UN%L79E7S(R@ ^XQX8\ ]<8KN;;5[J34=1^U6]E;Z7:*K+>"\+%P5#9
M*E JC!Z[C7,:A9Z/XP\5>)O"NL:-J,EA<Z;! \\UA-' [*\I;RYF7867S$((
M/7IG!QYM/\,?'EK\ ?%W@&.X.I7L5Z@TU]X7[39J8G"9/0\.,$\$8SC%*]HL
M;7O*W]:'O>G:SH^L+(VDZK9Z@(L;S:SK+LR,C.TG&1R*O5XAX9.KV/C?6_':
M>'=;&C6?AZUT\V0L9$NKRXCPQ\N&0*S;02N>AR<$U[-871OM-MKTVL]H9XEE
M\BY7;+%D9VN,G##H1GK56T)O_7W%FN9^'_\ R3G0O^O5:Z:N9^'_ /R3G0O^
MO5:0SIJ*** "BBB@ KR[5/ _BB^^/VB?$"+^RUTK3K%[%XFNI//<,9/G \K;
MGYQQN[=:]1HH6CO_ %V!ZJQY%\1/AWXP\<:GKD#:MISZ%<:7]GTZSN&D MKO
M<"9F55(8X# -DE=W ]:OB3X3ZQK7A_0/L!TW2?%&C6]K;V^NVUU*LL2QJ%D7
M 0>8I^; )'WNW.?9Z*(Z;>OW ]?Z]#PG5/A'XQNO%/C#Q)I^J6-IJ-_>V5_H
M\HO)@L<L'RGSXQ'M8,I;^]@_4FO:]-;4FTVV;5HK:+4/+'GI:R-)$'[[695)
M'U JW126BL@>KY@HHHI@%%%% ')_$S_DD'C/_L"7O_HAZUO#/_(H:+_UXP?^
MBQ63\3/^20>,_P#L"7O_ *(>M;PS_P BAHO_ %XP?^BQ0!K4444 %%%% '#?
M$+QY=>!6T-H=#BU.'5]0BTW<UX8&B=\X;'EMD<>H-,TKX@3W7Q5O_A[J>B+:
M7MM8B_CN;>Z,\4D9*C!RB%&RWOTZUR'Q^M[O4[;PEI]CHNLZB8-:@OKEM,LK
MB7RH%W!F\R)?E;G@ [NXK)\-V&O^$_&GBC36TG5[_1_$]N9M+UUM/GGNH'9=
MJQ74A3S4"YX\W[NW/&3A1>]_,;7;R_,]MM/$6@:A>M8Z?KFG7EXH8F"&Z1W&
M#@Y4$G@]>*Y#X?\ Q0L_&7A_5M8U.SM_#\6FZD^FL9KT.CLH7#;F5,9+8 Q7
ME7PW\)^*+#6/AIIMUX?U#3IO"?\ :CZM<36[+#B9F\M(Y,;9=P(^X6QWKE?#
M?A;QM;:=9:POA_7;:TTKQ=+JEU;#3Y$N7@=8U2:*.1/WA7$G !(SR*8?U_P#
MZEU;Q/I^G^&EUNTEAU&*>2."U$$P*W$LCB-%5AG^(\D9P ?2N,MOB9KUYXG\
M9>'X/"=A]J\+PQS2,^K,J7 ="X"GR/E.!W[U=TOPUIRZCH4=I!J;:9;SW6O%
MKV)T8W4APN5*C:?WTS;, @@<"O&M6\':UX\\>_$=M-L_$.CMJ\=M)I5Q=6-Y
M:6MX8D'F1S!D"%3C \P=<8[@K6_R?RV#I\T>\^#_ !]H_BKP!I_C*3_B3V=W
ME2M[(J;'#E,;C@')'![_ *5MMXB\/QVUO<OKNGK!<JS0RFZ0+*%^\5.<,!WQ
MTKPG7)O%WB;0?A_K$'A76M(/A6_B;6--BTUHY%P%02VT;+B55 ? 0' 8<5H>
M-/"=UI^CZ;KOP_F\06^N027%U )K"6>.^%RX>6WFC"9B#L-WSJJKSNVY!#O[
MS[7%9V7<]>O/&'A+3[Z>QU#Q1I%I=VZ>9-!/?1))$G!W,I;('(Y/J*LWOB#0
M=-M[>XU'6["SAN5W0R7%RD:RC&<J20",<\=J^==<NIX?C]XQ^VZ3=WEW=>#/
ML[6FG6SW3>:XC&T*@)V[N,]!W(J5_!_BSPY>?#K6-6T:^U.UTKP[<Z?<PV4+
M7,EO.\4@1"B M@AE3< 0-O) YH>B;&M6CZ NO%/AFR-D+SQ%I=M]N&ZU\V\C
M3[0/5,GYOPS3HO$WANXTR'5(/$&FRV$[F**Z2[C:*1^?E5P<$\'@'L:^;SX;
M\2^'_#WP7L=2T'5KFXT2\EN]0%I8370M(GE#*&,:L,@?PCGCI3?!_A37/^%&
M0V<UOXC\->(M+UF>^L;B/3+AGB8H -T03>Z.&*G:K=3D8!%#MOV$M3W?5O&I
ML_%ND:'IMOIE^FHVDUT)GU>*&10J%DVPX+RJV#\R@@ $]JJ_#_XEZ3XX\):5
MK%P]GI%]J32K'IKWJR2$I(R_+D*6Z _=XS7E]Q:>+KWXM_"_6-<\-WT=Q;:-
M-'J,EI8R-;V\LD4BJI95*J22,C/RYYP*P?#W@_Q7J7@/X;>$U\.ZE8ZIH&MG
M4[Z2[M7AB@@\UI 1*PVLQ#CY%)8$'(&*%OJ-O9H]4\6?%[_A&?"FO^(H-)L-
M6MM)U".Q5;76(W,P8#+-L1O*8,<;&&>"?3/0#XAZ;#=:T]\]C#INCZ?'?7$\
M6H)-,A8$M&\"C>F !@G[VX8[U\^^+-(U[4/!?Q*T^S\+^(9;G5O$B7UE'_8]
MT#/#N^^,Q].#U]O6NF&EZUK'BCXEQVGA_6$_MKPU%9V,ESIL\$<TR6^UDWR(
M%4YXY(SVIJ[^ZX-=/,]*M_BK9:EHOA/5-)M["5?$%TL#07>K06TMLA/W@K<R
MN,K^[7G+"NX36M&DU0Z5'JUD^H D&U6X0R@@9/R9SP"#T[U\W7VD:]_PA?P5
MME\,ZUYNCZE'+?(NFSLULB.FYG 4E1UQGK@D9'-=/\,/".I6%S<:'XTMM;&K
M:7K<^KVTL<.+.X\Q,>:)PN&)#N"A?//W>#@]/,7F>UV.L:1JC,NFZK9WK(,L
M+>=9"HSCG:3WJ]7CWPGT?Q)X<\4:KH*O?7?@^WMU>QEU6T>"XLY&?)M59P/-
M0#G<A*9Q@C)%>PT/9-"ZM!1112&%%%% '/>!O^2<>&/^P7:_^B5KH:Y[P-_R
M3CPQ_P!@NU_]$K70T %%%% !1110 4444 >6^-/A[J?C?PQJ6CZYIFAW]T\L
M_P#9^IS2NLUE&[DQXQ%DE01D!@&P ?6N,U+1]4'Q[F\.:3);75\? ?V%9;V5
MHU)\PIO8JK'K@D8]>:^A:QSX5\,MKX\0-X<TLZP#N_M V<?VC.W;GS,;NG'7
MIQ227R*;9Y=I/PBUKP];^ [C3;VPN]0\.65W9W*SR/'',)PQW(0C$;68]5Y'
MI6?I?P9\2:'X<\ Z59WFF7;^'M6;5;R26:2(2EF/R1@1MT&.3CITKWFBJOK^
M)'0\)T'X,ZK#X)U[PSXHL=#U6WU75Y]279=2JT&^,!&1_*RKJ1UP002/8W]/
M^%OBG3/^$7U3^U++5-9TS1KG1[MKJ>15D5\F-D?8Q.S.WE1D?E7L]%3;^OE8
MJYX5H_P;\1>';7X<6MC>:;>)X7N;F[O))II(C,TQ^[&!&W ]21G'05[K1157
MZ$V/%OAY\,?$'ACXA/XH+1:1:7EM(-2TV";S8)YVVD21# \L<9(/0\+E3QN_
M$#P7XF\3>.O!NM:7'I9LO#]T]S*EW=2(\^X*"H"Q,!T/4\^U>F44NJ?8?1KN
M>+:3\)=>T.U\9^$[&^L3X-\2QRM!$TL@GTN612&")LVNG*]67A1[Y-&^$_B&
MVF\-MJ5WIS#PUHMSIMH()I#]HFE4IO?,8V+MQP-QR?;GVFBE8=SYS\/_  #U
MS2].\&/JBZ#K%QH,MTMU87;/):74$S$@@M$<.I)."A!('(Q7OVDZ;::1I4.G
MV-A9Z?;Q9V6UE$(XHP23A5  [\G R<G S5ZBJOI876X4444@"BBB@ HHHH *
MQO@=_P BQXI_[&O5O_2EJV:QO@=_R+'BG_L:]6_]*6H ]4HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[P[_ ->:4 <C_P *M\=_]%HU7_P36'_QJC_A5OCO_HM&J_\ @FL/_C5>MT4
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M-5_\$UA_\:KUNB@#R3_A5OCO_HM&J_\ @FL/_C5'_"K?'?\ T6C5?_!-8?\
MQJO6Z* /)/\ A5OCO_HM&J_^":P_^-4?\*M\=_\ 1:-5_P#!-8?_ !JO6Z*
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MV.&L?^E34 >FT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_8X:Q_Z5-0!Z;1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_10M5_[[7_"O,:* /3O^%_?&3_HH6J_]]K_A1_PO[XR?]%"U7_OM?\*\QHH
M]._X7]\9/^BA:K_WVO\ A1_PO[XR?]%"U7_OM?\ "O,:* /3O^%_?&3_ **%
MJO\ WVO^%'_"_OC)_P!%"U7_ +[7_"O,:* /3O\ A?WQD_Z*%JO_ 'VO^%'_
M  O[XR?]%"U7_OM?\*\QHH ]._X7]\9/^BA:K_WVO^%'_"_OC)_T4+5?^^U_
MPKS&B@#T[_A?WQD_Z*%JO_?:_P"%'_"_OC)_T4+5?^^U_P *\QHH ]._X7]\
M9/\ HH6J_P#?:_X4?\+^^,G_ $4+5?\ OM?\*\QHH ]._P"%_?&3_HH6J_\
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MV.&L?^E34 >FT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0K&0P+(VXD$KE?O'U7Q)X937+O2=1AO&T[4]'N3<VEVD8DQN0I)&RGJCJQ!
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MY/\ T@-?F!0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5]O_ +)G@GP;XE^$FJWWB#PCHNL72:W-"L]]I\5Q(J"W@(4,ZD@99CCIDGUK
MX@K[^_8J_P"2(ZS_ -C!-_Z36] 'L_\ PJ?X6?\ 1-/"O_@FMO\ XBC_ (5/
M\+/^B:>%?_!-;?\ Q%=G10!QG_"I_A9_T33PK_X)K;_XBC_A4_PL_P"B:>%?
M_!-;?_$5V=% &)HOA[0_#5D]AX=T.PT>UDD,S0V%LEO&SD %BJ  G"J,]< >
ME;=%% !7F7P;_P"03XR_['#6/_2IJ]-KS+X-_P#()\9?]CAK'_I4U 'IM%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MKG_XQ0!\RT5]-?\ #%?Q2_Z#_A7_ ,"KG_XQ1_PQ7\4O^@_X5_\  JY_^,4
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M%^__ /29Z\S^.W_)E>H?]@_2_P#THMZ /SGK[^_8J_Y(CK/_ &,$W_I-;U\
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M_P"27>'?^O-*ZVN2^&O_ "2[P[_UYI0!UM%%% !1110 4444 %%%% !1110
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y_P_\ \AWQ9_V%$_\
M2*VKH*^?]5T'XS:_\2_'$W@/XC67AW2;;4X+<VEQIL-PQD_L^T=GW-&QP0X&
M,]J7_A!/VG_^BY:5_P"".W_^-4 >_P!%> ?\()^T_P#]%RTK_P $=O\ _&J/
M^$$_:?\ ^BY:5_X([?\ ^-4 >_T5X!_P@G[3_P#T7+2O_!';_P#QJC_A!/VG
M_P#HN6E?^".W_P#C5 'O]<E\-?\ DEWAW_KS2O+?^$$_:?\ ^BY:5_X([?\
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M9K!NKSX\>%?@3I_Q&NOBU;QZ$NFV5REI;:):RSQQS>6L:#<B@E?,7)+=CUH
M^PJ*_.?_ (::^)G_ $5+5?\ PF=/_P#BJ/\ AIKXF?\ 14M5_P#"9T__ .*H
M _1BBOSG_P"&FOB9_P!%2U7_ ,)G3_\ XJC_ (::^)G_ $5+5?\ PF=/_P#B
MJ /T8HK\Y_\ AIKXF?\ 14M5_P#"9T__ .*H_P"&FOB9_P!%2U7_ ,)G3_\
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M?^ \E 'R917UG_PQ#XJ_Z'?2O_ >2C_AB'Q5_P!#OI7_ (#R4 ?)E=K\*?\
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M!Q?@W_D;OB/_ -C!%_Z:K"NTKB_!O_(W?$?_ +&"+_TU6%=I0 4444 %%%%
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M9?!O_D$^,O\ L<-8_P#2IJ]-KS+X-_\ ()\9?]CAK'_I4U 'IM%%% !1110
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M]_\ ^DSUXU\2_P#E'G8_]B_HG_HRUI%'P!1110 4444 %%%% !1110 4444
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MHH **** "BBB@ KS+X-_\@GQE_V.&L?^E35Z;7F7P;_Y!/C+_L<-8_\ 2IJ
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M/$THO;>7#,!@;8Y&;]*^TZ** "BBB@#QC_FR'_NG_P#[CJ_,ZOTQ_P";(?\
MNG__ +CJ_,Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "MOPG_P COH/_ &$+?_T8M8E;?A/_ )'?0?\ L(6__HQ: /U]
MHHHH *\R^#?_ ""?&7_8X:Q_Z5-7IM>9?!O_ )!/C+_L<-8_]*FH ]-HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** .+\&_\ (W?$?_L8(O\ TU6%=I7%^#?^1N^(
M_P#V,$7_ *:K"NTH **** "BBB@ KQC]ES_DV3PC_P!OG_I9-7L]>,?LN?\
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MJOG!5RP< 8SSDG->MT44V[@E8****!G%_%;_ )(AX\_[%^__ /29Z\:^)?\
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MX8J^%O\ T'_%7_@5;?\ QBOIFB@#YF_X8J^%O_0?\5?^!5M_\8H_X8J^%O\
MT'_%7_@5;?\ QBOIFB@#YF_X8J^%O_0?\5?^!5M_\8H_X8J^%O\ T'_%7_@5
M;?\ QBOIFB@#YF_X8J^%O_0?\5?^!5M_\8H_X8J^%O\ T'_%7_@5;?\ QBOI
MFB@#YF_X8J^%O_0?\5?^!5M_\8H_X8J^%O\ T'_%7_@5;?\ QBOIFB@#YF_X
M8J^%O_0?\5?^!5M_\8H_X8J^%O\ T'_%7_@5;?\ QBOIFB@#YF_X8J^%O_0?
M\5?^!5M_\8H_X8J^%O\ T'_%7_@5;?\ QBOIFB@#YF_X8J^%O_0?\5?^!5M_
M\8H_X8J^%O\ T'_%7_@5;?\ QBOIFB@#YF_X8J^%O_0?\5?^!5M_\8H_X8J^
M%O\ T'_%7_@5;?\ QBOIFB@#YF_X8J^%O_0?\5?^!5M_\8KH? _[,O@'X>>-
M].\8:+JVOSW]B9/*CN[B%HFWQM&=P6%3T<XP1SBO>** "O,O@W_R"?&7_8X:
MQ_Z5-7IM>9?!O_D$^,O^QPUC_P!*FH ]-HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** .+\&_\C=\1_\ L8(O_3585VE>1?\ "3ZOX/\ '/C.)OAYXIUJWU/5(;RW
MN],MH)(63[!:0D9>9#D/"X/&.G-:'_"UM2_Z(_\ $#_P"M?_ ))H ]-HKS+_
M (6MJ7_1'_B!_P" 5K_\DT?\+6U+_HC_ ,0/_ *U_P#DF@#TVBO,O^%K:E_T
M1_X@?^ 5K_\ )-'_  M;4O\ HC_Q _\  *U_^2: /3:\8_9<_P"39/"/_;Y_
MZ635M?\ "UM2_P"B/_$#_P  K7_Y)K@/@[XB\2_#WX1:'X/UKX4^,[B_L//\
MV2SM+=HFWSR2#:6G4]'&<@<YH ^C**\R_P"%K:E_T1_X@?\ @%:__)-'_"UM
M2_Z(_P#$#_P"M?\ Y)H ]-HKS+_A:VI?]$?^('_@%:__ "31_P +6U+_ *(_
M\0/_  "M?_DF@#TVBO,O^%K:E_T1_P"('_@%:_\ R31_PM;4O^B/_$#_ , K
M7_Y)H ]-HKS+_A:VI?\ 1'_B!_X!6O\ \DT?\+6U+_HC_P 0/_ *U_\ DF@#
MTVBO,O\ A:VI?]$?^('_ (!6O_R31_PM;4O^B/\ Q _\ K7_ .2: /3:*\R_
MX6MJ7_1'_B!_X!6O_P DT?\ "UM2_P"B/_$#_P  K7_Y)H ]-HKS+_A:VI?]
M$?\ B!_X!6O_ ,DT?\+6U+_HC_Q _P# *U_^2: -GXK?\D0\>?\ 8OW_ /Z3
M/7C7Q+_Y1YV/_8OZ)_Z,M:ZCQMXXUOQ+\/\ Q+X=LOA+XXCN]4TNZLX7FL[8
M1J\D3(I8BX) RPS@$X[&O/?&]]XLU']E6'X;P?"GQG_:\&EZ=9M-]ABDA+P/
M 7(\N5I"#Y9Q\F>F0!G !\-45VG_  J?XI?]$T\5?^":Y_\ B*/^%3_%+_HF
MGBK_ ,$US_\ $4 <717:?\*G^*7_ $33Q5_X)KG_ .(H_P"%3_%+_HFGBK_P
M37/_ ,10!Q=%=I_PJ?XI?]$T\5?^":Y_^(H_X5/\4O\ HFGBK_P37/\ \10!
MQ=%=I_PJ?XI?]$T\5?\ @FN?_B*/^%3_ !2_Z)IXJ_\ !-<__$4 <717:?\
M"I_BE_T33Q5_X)KG_P"(H_X5/\4O^B:>*O\ P37/_P 10!Q=%=I_PJ?XI?\
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M ,0/_ *U_P#DF@#TVBO,O^%K:E_T1_X@?^ 5K_\ )-'_  M;4O\ HC_Q _\
M *U_^2: /3:*\R_X6MJ7_1'_ (@?^ 5K_P#)-'_"UM2_Z(_\0/\ P"M?_DF@
M#TVBO,O^%K:E_P!$?^('_@%:_P#R31_PM;4O^B/_ ! _\ K7_P"2: /3:*\R
M_P"%K:E_T1_X@?\ @%:__)-'_"UM2_Z(_P#$#_P"M?\ Y)H ]-KS+X-_\@GQ
ME_V.&L?^E34?\+6U+_HC_P 0/_ *U_\ DFG?".RU6V\.:Y=:OI-WH\NI^(-1
MU&*UO%59DBFG+IN"D@'!YP3]: /2Z*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKP?QQ^TUX!^
M'GC?4?!^M:3K\]_8F/S9+2WA:)M\:R#:6F4]'&<@<YH ]XHKYF_X;5^%O_0
M\5?^ MM_\?H_X;5^%O\ T /%7_@+;?\ Q^@#Z9HKYF_X;5^%O_0 \5?^ MM_
M\?H_X;5^%O\ T /%7_@+;?\ Q^@#Z9HKYF_X;5^%O_0 \5?^ MM_\?H_X;5^
M%O\ T /%7_@+;?\ Q^@#Z9HKYF_X;5^%O_0 \5?^ MM_\?H_X;5^%O\ T /%
M7_@+;?\ Q^@#Z9HKYF_X;5^%O_0 \5?^ MM_\?H_X;5^%O\ T /%7_@+;?\
MQ^@#Z9HKYF_X;5^%O_0 \5?^ MM_\?H_X;5^%O\ T /%7_@+;?\ Q^@#Z9HK
MYF_X;5^%O_0 \5?^ MM_\?H_X;5^%O\ T /%7_@+;?\ Q^@#Z9HKYF_X;5^%
MO_0 \5?^ MM_\?H_X;5^%O\ T /%7_@+;?\ Q^@#Z9HKYF_X;5^%O_0 \5?^
M MM_\?H_X;5^%O\ T /%7_@+;?\ Q^@#Z9HKYF_X;5^%O_0 \5?^ MM_\?H_
MX;5^%O\ T /%7_@+;?\ Q^@#Z9HKYF_X;5^%O_0 \5?^ MM_\?H_X;5^%O\
MT /%7_@+;?\ Q^@#Z9HKYF_X;5^%O_0 \5?^ MM_\?H_X;5^%O\ T /%7_@+
M;?\ Q^@#Z9HKYF_X;5^%O_0 \5?^ MM_\?H_X;5^%O\ T /%7_@+;?\ Q^@#
MZ9HKYF_X;5^%O_0 \5?^ MM_\?H_X;5^%O\ T /%7_@+;?\ Q^@#Z9HKYF_X
M;5^%O_0 \5?^ MM_\?H_X;5^%O\ T /%7_@+;?\ Q^@#Z9HKYF_X;5^%O_0
M\5?^ MM_\?H_X;5^%O\ T /%7_@+;?\ Q^@#Z9HKYF_X;5^%O_0 \5?^ MM_
M\?H_X;5^%O\ T /%7_@+;?\ Q^@#Z9HKYF_X;5^%O_0 \5?^ MM_\?H_X;5^
M%O\ T /%7_@+;?\ Q^@#Z9HKYF_X;5^%O_0 \5?^ MM_\?H_X;5^%O\ T /%
M7_@+;?\ Q^@#Z9HKYF_X;5^%O_0 \5?^ MM_\?H_X;5^%O\ T /%7_@+;?\
MQ^@#Z9HKYF_X;5^%O_0 \5?^ MM_\?H_X;5^%O\ T /%7_@+;?\ Q^@#Z9HK
MYF_X;5^%O_0 \5?^ MM_\?H_X;5^%O\ T /%7_@+;?\ Q^@#Z9HKYF_X;5^%
MO_0 \5?^ MM_\?KVSP'XRTOQ]X%T_P 8:);W4-AJ!D,<=VBK*NR5HSN"LPZH
M<8)XQ0!UM%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !7YG?M2?\G-^+O^W/\ ](X:_3&O@?\ : ^$7Q*\4?'GQ)KGA_P;
MJ&H:;<_9?)N85!1]MK$C8Y[,I'X4 ?+]%>G?\*!^,G_1/=5_[X7_ !H_X4#\
M9/\ HGNJ_P#?"_XT >8T5Z=_PH'XR?\ 1/=5_P"^%_QH_P"% _&3_HGNJ_\
M?"_XT >8T5Z=_P *!^,G_1/=5_[X7_&C_A0/QD_Z)[JO_?"_XT >8T5Z=_PH
M'XR?]$]U7_OA?\:/^% _&3_HGNJ_]\+_ (T >8T5Z=_PH'XR?]$]U7_OA?\
M&C_A0/QD_P"B>ZK_ -\+_C0!YC17IW_"@?C)_P!$]U7_ +X7_&C_ (4#\9/^
MB>ZK_P!\+_C0!YC17IW_  H'XR?]$]U7_OA?\:/^% _&3_HGNJ_]\+_C0!YC
M17IW_"@?C)_T3W5?^^%_QH_X4#\9/^B>ZK_WPO\ C0!YC17IW_"@?C)_T3W5
M?^^%_P :/^% _&3_ *)[JO\ WPO^- 'F-%>G?\*!^,G_ $3W5?\ OA?\:/\
MA0/QD_Z)[JO_ 'PO^- 'F-%>G?\ "@?C)_T3W5?^^%_QH_X4#\9/^B>ZK_WP
MO^- 'F-%>G?\*!^,G_1/=5_[X7_&C_A0/QD_Z)[JO_?"_P"- 'F-%>G?\*!^
M,G_1/=5_[X7_ !H_X4#\9/\ HGNJ_P#?"_XT >8T5Z=_PH'XR?\ 1/=5_P"^
M%_QH_P"% _&3_HGNJ_\ ?"_XT >8T5Z=_P *!^,G_1/=5_[X7_&C_A0/QD_Z
M)[JO_?"_XT >8T5Z=_PH'XR?]$]U7_OA?\:/^% _&3_HGNJ_]\+_ (T >8T5
MZ=_PH'XR?]$]U7_OA?\ &C_A0/QD_P"B>ZK_ -\+_C0!YC17IW_"@?C)_P!$
M]U7_ +X7_&C_ (4#\9/^B>ZK_P!\+_C0!YC17IW_  H'XR?]$]U7_OA?\:/^
M% _&3_HGNJ_]\+_C0!YC17IW_"@?C)_T3W5?^^%_QH_X4#\9/^B>ZK_WPO\
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MX6_^5&C[5^U#_=^%O_E1H ]MHKQ+[5^U#_=^%O\ Y4:/M7[4/]WX6_\ E1H
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M(EEX#_X1O7-3UF_M#>6HLHX#',@W9&YY5VD;&^]@>_-*^B\Q]6NQW]%>9/\
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M*/,/(=1110 5YO\ %_\ Y!/A#_L;=(_]*EKTBO-_B_\ \@GPA_V-ND?^E2T
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M!ANP0IZ&UWV':[7F>Q45XUHOQHTO2_A[X9N/$LE]K&O76B1ZOJ"Z?;QEX+?
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M;PPR,/E++C+!1V.,GOC!]EC,AB0RJJR;1N"G(![X-.HH6R\@>KO_ %J%%%%
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MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *X3X+_\
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MX4:1H#F-F*C)4_W<]/:FM5<;TLCSC_A,/B=_T1'5/_!WI_\ \=H_X3#XG?\
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M@#])O^%N>)/^B;C_ ,*C2O\ X_1_PMSQ)_T3<?\ A4:5_P#'Z_-FB@#])O\
MA;GB3_HFX_\ "HTK_P"/T?\ "W/$G_1-Q_X5&E?_ !^OS9HH _2;_A;GB3_H
MFX_\*C2O_C]'_"W/$G_1-Q_X5&E?_'Z_-FB@#])O^%N>)/\ HFX_\*C2O_C]
M'_"W/$G_ $3<?^%1I7_Q^OS9HH _2;_A;GB3_HFX_P#"HTK_ ./T?\+<\2?]
M$W'_ (5&E?\ Q^OS9HH _2;_ (6YXD_Z)N/_  J-*_\ C]'_  MSQ)_T3<?^
M%1I7_P ?K\V:* /TF_X6YXD_Z)N/_"HTK_X_1_PMSQ)_T3<?^%1I7_Q^OS9H
MH _2;_A;GB3_ *)N/_"HTK_X_1_PMSQ)_P!$W'_A4:5_\?K\V:* /TF_X6YX
MD_Z)N/\ PJ-*_P#C]'_"W/$G_1-Q_P"%1I7_ ,?K\V:* /TF_P"%N>)/^B;C
M_P *C2O_ (_1_P +<\2?]$W'_A4:5_\ 'Z_-FB@#])O^%N>)/^B;C_PJ-*_^
M/T?\+<\2?]$W'_A4:5_\?K\V:* /TF_X6YXD_P"B;C_PJ-*_^/T?\+<\2?\
M1-Q_X5&E?_'Z_-FB@#])O^%N>)/^B;C_ ,*C2O\ X_1_PMSQ)_T3<?\ A4:5
M_P#'Z_-FB@#])O\ A;GB3_HFX_\ "HTK_P"/T?\ "W/$G_1-Q_X5&E?_ !^O
MS9HH _2;_A;GB3_HFX_\*C2O_C]'_"W/$G_1-Q_X5&E?_'Z_-FB@#])O^%N>
M)/\ HFX_\*C2O_C]'_"W/$G_ $3<?^%1I7_Q^OS9HH _2;_A;GB3_HFX_P#"
MHTK_ ./T?\+<\2?]$W'_ (5&E?\ Q^OS9HH _2;_ (6YXD_Z)N/_  J-*_\
MC]'_  MSQ)_T3<?^%1I7_P ?K\V:* /TF_X6YXD_Z)N/_"HTK_X_1_PMSQ)_
MT3<?^%1I7_Q^OS9HH _2;_A;GB3_ *)N/_"HTK_X_5VQ^(WCC5&D_LSX1W-]
MY6-_V?Q#ILFS.<9VS'&<'\J_,ROLS]AG_FH/_<._]N: /=/^$P^)W_1$=4_\
M'>G_ /QVH_@?-=7'A7Q)<7UBUA=2^*-4>:U9E=H'-PQ9"RDJQ4Y&02#CBO7*
M\R^#?_()\9?]CAK'_I4U 'IM%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!R/@?\
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M_P"%-;?_ "!1_:'PL_Z$WQ5_X4UM_P#(% '%T5VG]H?"S_H3?%7_ (4UM_\
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M!5M_\8H ^ **^_\ _ABKX6_]!_Q5_P"!5M_\8H_X8J^%O_0?\5?^!5M_\8H
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M@W_T4+2O^^V_PH ]-HKS+_A?OP;_ .BA:5_WVW^%'_"_?@W_ -%"TK_OMO\
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M?_10M*_[[;_"O/\ XF_&3X8:QIOA>/2_&VG736OB?2[R81LW[N&.X5G<\=
M2: /HVBO,O\ A?WP;_Z*%I7_ 'VW^%'_  O[X-_]%"TK_OMO\* /@+X^_P#)
MPOC7_L(-_P"@BO,:] ^,FL:;K_QJ\5:SH]U'>:?=WK20SQ\K(N!R*\_H ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "OU^\)_P#(CZ#_ -@^W_\
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M444 %%%% !1110 5YE\9/^03X-_['#1__2I:]-KS+XR?\@GP;_V.&C_^E2T
M>FT444 ?GE\9/C%\4- ^-/BO1]'\:ZC96%I>M'#!$P"QK@<#BN"_X7]\9/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% '(^!_]5XA_[#EY_P"ABNNKD? _^J\0_P#8<O/_ $,5UU !1110
M 4444 %>9?"C_D+_ !._['"X_P#26UKTVO,OA1_R%_B=_P!CA<?^DMK0!Z;1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5YE\9/\
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MV;_A7GP)_P"CBO\ RT;S_P"*H_X5Y\"?^CBO_+1O/_BJ\9HH ]F_X5Y\"?\
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MQ_PRY\"_^A&_\J=Y_P#'J/\ AESX%_\ 0C?^5.\_^/4 >SUYE\*/^0O\3O\
ML<+C_P!);6L7_AESX%_]"-_Y4[S_ ./5PWP_^ 'PDUK4O',.J>$?/32O$4UA
M:#[?=+Y4"V\#A/ED&?FD<Y.3SUX% 'T_2UXQ_P ,N? O_H1O_*G>?_'JP->^
M /P:T>2S@LOA'JVO37(<[-/U*5?*5<99VGNHU'W@ ,DGTXI-V ^A:,5\N>%?
MA5\"_%O]DW%O\%_$6GZ=JZNUKJ%WJ#&$[5)PWE7KNA.TXW*,FN]_X9=^!?\
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MZK_\FT <9179_P#"9>'?^B3^%?\ P)U7_P"3:/\ A,O#O_1)_"O_ ($ZK_\
M)M '&45V?_"9>'?^B3^%?_ G5?\ Y-H_X3+P[_T2?PK_ .!.J_\ R;0!^LM%
M?DU_PF7AW_HD_A7_ ,"=5_\ DVC_ (3+P[_T2?PK_P"!.J__ ";0!^LM%?DU
M_P )EX=_Z)/X5_\  G5?_DVC_A,O#O\ T2?PK_X$ZK_\FT ?K+17Y-?\)EX=
M_P"B3^%?_ G5?_DVC_A,O#O_ $2?PK_X$ZK_ /)M 'ZRT5^37_"9>'?^B3^%
M?_ G5?\ Y-H_X3+P[_T2?PK_ .!.J_\ R;0!^LM%?DU_PF7AW_HD_A7_ ,"=
M5_\ DVC_ (3+P[_T2?PK_P"!.J__ ";0!^LM%?DU_P )EX=_Z)/X5_\  G5?
M_DVC_A,O#O\ T2?PK_X$ZK_\FT ?K+17Y-?\)EX=_P"B3^%?_ G5?_DVC_A,
MO#O_ $2?PK_X$ZK_ /)M 'ZRT5^37_"9>'?^B3^%?_ G5?\ Y-H_X3+P[_T2
M?PK_ .!.J_\ R;0!^LM%?DU_PF7AW_HD_A7_ ,"=5_\ DVC_ (3+P[_T2?PK
M_P"!.J__ ";0!^LM%?DU_P )EX=_Z)/X5_\  G5?_DVC_A,O#O\ T2?PK_X$
MZK_\FT ?K+17Y-?\)EX=_P"B3^%?_ G5?_DVC_A,O#O_ $2?PK_X$ZK_ /)M
M 'ZRT5^37_"9>'?^B3^%?_ G5?\ Y-K[KT/]FWX*:EX<TW4KCP0@EN;6*=PF
MI7H4,R!CC,QXYH ]ZHKQC_AESX%_]"-_Y4[S_P"/4?\ #+GP+_Z$;_RIWG_Q
MZ@#V>BO&/^&7/@7_ -"-_P"5.\_^/4?\,N? O_H1O_*G>?\ QZ@#V>BO&/\
MAESX%_\ 0C?^5.\_^/4?\,N? O\ Z$;_ ,J=Y_\ 'J /9Z\R^#?_ ""?&7_8
MX:Q_Z5-6+_PRY\"_^A&_\J=Y_P#'JN? O3;'1O"&OZ+I=O\ 9[#3_$VJ6MM%
MN9O+B2X947+$DX  R230!ZW1110 4444 %%%% !1110 4444 %%%% !1110
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M/&2Q! ?GRR,\DC@9.*Y?P[:Q?\)#\6?"MCK6D^'=,EBTB6Q2RS+81&088;>
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MGQU_Z$7_ ,J=G_\ 'J /&**]G_X9<^.O_0B_^5.S_P#CU'_#+GQU_P"A%_\
M*G9__'J /&**]G_X9<^.O_0B_P#E3L__ (]1_P ,N?'7_H1?_*G9_P#QZ@#Q
MBBO9_P#AESXZ_P#0B_\ E3L__CU'_#+GQU_Z$7_RIV?_ ,>H \8HKV?_ (9<
M^.O_ $(O_E3L_P#X]1_PRY\=?^A%_P#*G9__ !Z@#QBBO9_^&7/CK_T(O_E3
ML_\ X]1_PRY\=?\ H1?_ "IV?_QZ@#QBBO9_^&7/CK_T(O\ Y4[/_P"/4?\
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M['#6/_2IJ /3:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MH-:1P@8QRL,I8G/ VCH>:3=@.6_X7M\,_P#H*:K_ ."#4/\ XQ1_PO;X9_\
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M7_PG]0_^,4?\+V^&?_04U7_PG]0_^,5Z;10!YE_PO;X9_P#04U7_ ,)_4/\
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M7_12_%7_ (.;G_XNC_A;'Q2_Z*7XJ_\ !S<__%T 8W_")^*?^A9U7_P#D_\
MB:/^$3\4_P#0LZK_ . <G_Q-;/\ PMCXI?\ 12_%7_@YN?\ XNC_ (6Q\4O^
MBE^*O_!S<_\ Q= &-_PB?BG_ *%G5?\ P#D_^)H_X1/Q3_T+.J_^ <G_ ,36
MS_PMCXI?]%+\5?\ @YN?_BZ/^%L?%+_HI?BK_P '-S_\70!C?\(GXI_Z%G5?
M_ .3_P")H_X1/Q3_ -"SJO\ X!R?_$UL_P#"V/BE_P!%+\5?^#FY_P#BZ/\
MA;'Q2_Z*7XJ_\'-S_P#%T ?9GP+^)GA'P7\$/#OAGQ--J=AJUG]I\^W_ +%O
M9-F^YE=?F2$J<JRG@]Z]+_X7M\,_^@IJO_A/ZA_\8K\Z/^%L?%+_ **7XJ_\
M'-S_ /%T?\+8^*7_ $4OQ5_X.;G_ .+H _1?_A>WPS_Z"FJ_^$_J'_QBC_A>
MWPS_ .@IJO\ X3^H?_&*_.C_ (6Q\4O^BE^*O_!S<_\ Q='_  MCXI?]%+\5
M?^#FY_\ BZ /T7_X7M\,_P#H*:K_ .$_J'_QBC_A>WPS_P"@IJO_ (3^H?\
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M_P"%L?%+_HI?BK_P<W/_ ,71_P +8^*7_12_%7_@YN?_ (N@#]%_^%[?#/\
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MN(]934/MD4$MN8L(JPW "H1*L9'EA>-Q.:]5[4M%'2P!1110 5YE\*/^0O\
M$[_L<+C_ -);6O3:\R^%'_(7^)W_ &.%Q_Z2VM 'IM5+JXCM;5[B5961!DB*
M)I6/T502?P%6Z*5@/"M!M[R/]E(Z7=>$[_4KVWTU[>;1KJTN()9B6.5VX5V&
M#GY.3C .:Q=+\,:A=^-?BDFL0Z[#8:S#HSV>H6.D208>,8W11LIXB;9N5MS;
M5.<U]'453=[ON$=#Y[\36OC;6M/T#3O.N[?5;?Q!+Y>NV.@SQ!XCI\B+<RQ8
M/EGS)!&3D9V[EP,8]5\#:Q_:WA.T:30[O0KN&,1W-C<6DL BE'#!"ZCS%R"0
MPSD$$]:ZZEJ5HF)ZM,\0U/P+#\0+/Q19LNHZ+K-GKC:CH^IM:2V[0RB")5=&
M=0'0LI# $Y ]@:HZ GCA?"/AC7O%WANY2_M?$UQ<ZOIUI;-*0CI-&LR(NXNB
MNZ.-N[CD=*]\ZT=J.H^C7<\R\%V4FD^+_&^M?V;=V>CZSJEJ;*$6<BEY# B2
MS>6%W(&<_,[ #Y2Q..:ZGQ-H^I:Q9V]G8ZI'81"X26Y5[<RBYC7GRCATPI(&
M[KE<KWKI:*5M$AW/+_A;IFO:;-XS.LQ^4EQXBNIX@;1X#*"(_P!ZI9CE#CC&
M>AY->G=C3J6A*R2[ W=W"BBBJ$%%%% !1110 4444 %>9?&3_D$^#?\ L<-'
M_P#2I:]-KS+XR?\ ()\&_P#8X:/_ .E2T >FT444 ?EK\??^3A?&O_80;_T$
M5YC7T9\8O!_@*^^-7BJ\U/XL:?I5Y+>LTMG+I-[*T#8'REDC*GZ@D5P'_""?
M#/\ Z+CI7_@CU#_XU0!YE17IO_""?#/_ *+CI7_@CU#_ .-4?\()\,_^BXZ5
M_P""/4/_ (U0!YE17IO_  @GPS_Z+CI7_@CU#_XU1_P@GPS_ .BXZ5_X(]0_
M^-4 >945Z;_P@GPS_P"BXZ5_X(]0_P#C5'_""?#/_HN.E?\ @CU#_P"-4 >9
M45Z;_P ()\,_^BXZ5_X(]0_^-4?\()\,_P#HN.E?^"/4/_C5 'F5%>F_\()\
M,_\ HN.E?^"/4/\ XU1_P@GPS_Z+CI7_ ((]0_\ C5 'F5%>F_\ ""?#/_HN
M.E?^"/4/_C5'_""?#/\ Z+CI7_@CU#_XU0!YE17IO_""?#/_ *+CI7_@CU#_
M .-4?\()\,_^BXZ5_P""/4/_ (U0!YE17TUX9_9/O/&7ANU\2>&_B)I5[I-W
MO\B?[%/'OV.R-\K@,,,K#D=JV?\ AB'Q5_T.^E?^ \E 'R917UG_ ,,0^*O^
MAWTK_P !Y*/^&(?%7_0[Z5_X#R4 ?)E%?6?_  Q#XJ_Z'?2O_ >2C_AB'Q5_
MT.^E?^ \E 'R917UG_PQ#XJ_Z'?2O_ >2C_AB'Q5_P!#OI7_ (#R4 ?)E%?6
M?_#$/BK_ *'?2O\ P'DH_P"&(?%7_0[Z5_X#R4 ?)E%?6?\ PQ#XJ_Z'?2O_
M  'DH_X8A\5?]#OI7_@/)0!\F45]9_\ #$/BK_H=]*_\!Y*/^&(?%7_0[Z5_
MX#R4 ?)E%?6?_#$/BK_H=]*_\!Y*/^&(?%7_ $.^E?\ @/)0!\F45]9_\,0^
M*O\ H=]*_P# >2C_ (8A\5?]#OI7_@/)0!\F45]9_P##$/BK_H=]*_\  >2C
M_AB'Q5_T.^E?^ \E 'R917UG_P ,0^*O^AWTK_P'DH_X8A\5?]#OI7_@/)0!
M\F45]9_\,0^*O^AWTK_P'DH_X8A\5?\ 0[Z5_P" \E 'R917UG_PQ#XJ_P"A
MWTK_ ,!Y*/\ AB'Q5_T.^E?^ \E 'R917UG_ ,,0^*O^AWTK_P !Y*/^&(?%
M7_0[Z5_X#R4 ?)E%?6?_  Q#XJ_Z'?2O_ >2C_AB'Q5_T.^E?^ \E 'R97[,
M5\-?\,0^*O\ H=]*_P# >2ON6@ KS+X-_P#()\9?]CAK'_I4U>FUYE\&_P#D
M$^,O^QPUC_TJ:@#TVBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y'P/_ *KQ#_V'
M+S_T,5UU<CX'_P!5XA_[#EY_Z&*ZZ@ HHHH **** "O,OA1_R%_B=_V.%Q_Z
M2VM>FUYE\*/^0O\ $[_L<+C_ -);6@#TVBBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ KS+XR?\@GP;_V.&C_^E2UZ;7F7QD_Y!/@W
M_L<-'_\ 2I: /3:*** /RU^/O_)POC7_ +"#?^@BO,:].^/O_)POC7_L(-_Z
M"*\QH **** "BBB@ HHHH **** "BBB@ HHHH **** /TQ_9<_Y-D\(_]OG_
M *635[/7C'[+G_)LGA'_ +?/_2R:O9Z "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O,O@W_R
M"?&7_8X:Q_Z5-7IM>9?!O_D$^,O^QPUC_P!*FH ]-HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** /GWX?_"OX=^+'\9ZSXE\)6.I:@WBS5HS/.I+%5NGP.#VKM?\
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MB>4*P+[R2L;8PI'')' .[)\"?A$D3.OPYTZ5@"0BJ<M[#+ ?F17!:Q=>)8=
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M .B/_#__ , KK_Y)KS"B@#T__A;&G_\ 1'_A_P#^ 5U_\DT?\+8T_P#Z(_\
M#_\ \ KK_P"2:\PHH ]/_P"%L:?_ -$?^'__ (!77_R31_PMC3_^B/\ P_\
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MM8+6;/F0QPJJ29&#N4#!X]:(]'TF%=L6FVJJR",A8% *#D+TZ#L*U:* ,?\
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M?]!+PK_X5FE?_)-<710!VG_"M/$7_02\*_\ A6:5_P#)-'_"M/$7_02\*_\
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M+5-$\-6NIV$X/EW5IK%C-%)ABIVNLQ!P00<'J"*G_P"&7/CK_P!"+_Y4[/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P#C5 'IM%>9?\()\3/^BXZK_P""/3__ (U1_P ()\3/^BXZK_X(]/\ _C5
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M>NU0%'X 5E_\,0^%?^AWU7_P'CH ^&:*^YO^&(?"O_0[ZK_X#QT?\,0^%?\
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MQT?\,0^%?^AWU7_P'CH ^&:*^YO^&(?"O_0[ZK_X#QT?\,0^%?\ H=]5_P#
M>.@#X9HK[F_X8A\*_P#0[ZK_ . \='_#$/A7_H=]5_\  >.@#X9HK[F_X8A\
M*_\ 0[ZK_P" \='_  Q#X5_Z'?5?_ >.@#X9HK[F_P"&(?"O_0[ZK_X#QT?\
M,0^%?^AWU7_P'CH ]+_9<_Y-D\(_]OG_ *635[/7B_A?X/\ B[P?X9M/#OAK
MXO:K8:79[_(M_P"R+*39N=G;YGC+'+,QY/>MO_A!/B9_T7'5?_!'I_\ \:H
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M>G__ !J@#TVBO,O^$$^)G_1<=5_\$>G_ /QJC_A!/B9_T7'5?_!'I_\ \:H
M]-KS+X-_\@GQE_V.&L?^E34?\()\3/\ HN.J_P#@CT__ .-5O>!O";^#="NM
M/DU2;5I[N_N-0N+R>-(FDEF?>YVH H^8G@ "@#KZ*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M# !))) P*W:\]^+'P]A^*7PXN_"<FI-ISS21S0W(C\P(Z-D97(W C(Z]\]J
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M/_BJ/^$L\4_]#-JO_@9)_P#%5B44 ;?_  EGBG_H9M5_\#)/_BJ/^$L\4_\
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MGAOQ)X:\(>)H/$?A_4M&EFOHGB2_M)+=I%$>"5#@9'TKZ=HH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH[5RGCJ
MZURQ\!:UJ&@W\-A?VEG+<1S2V_G@;$+8"[@,G'4Y ]#2N!U-+WKGO"=Y=ZAX
M)T34+Z3S;JZL8)IGP%W.T:EC@8 Y)Z5T/>G:S:)3NDQ:*^9?VU?^2(Z-_P!C
M!#_Z37%? -!1^S%%?C/10!^S%%?C/10!^S%%?C/10!^S%%?C/10!^S%%?C/1
M0!^S%%?C/10!^S%%?C/10!^S%%?C/10!^S%%?C/10!^S%%?C/10!^S%%?C/1
M0!^S%%?C/10!^S%%?C/10!^S%%?C/10!^S%%?C/10!^S%%?C/10!^S%%?C/1
M0!^S%%?C/10!^S%%?C/10!^S%%?C/10!^S%%?C/10!^S%%?C/10!^S%%?C/1
M0!^S%%?C/10!^S%%?C/10!^S%%?C/10!^S%%?C/10!^S%%?C/10!^S%%?C/1
M0!^S%%?C/10!^S%%?C/10!^S%%?C/10!^S%%?C/10!^S%%?C/10!^S%%?C/1
M0!^S%%?C/10!^S%%?C/10!^S%%?C/10!^S%%?C/10!^S%%?C/7V9^PS_ ,U!
M_P"X=_[<T ?9E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 ':N:\76E]?>!];TO3[5[FZO+*:VB
M565?F="H)+$  $Y/MT!Z5TM%*P''>'TUS2?!7AW3_P"Q=]W;1V]G=QR7*IY2
M*@5Y5*[@^,9"\$^U=?US12T]VV2E9)'S-^VK_P D1T;_ +&"'_TFN*^ :^_O
MVU?^2(Z-_P!C!#_Z37%? -!04444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5]F?L,_\
MU!_[AW_MS7QG7KOP;^-FJ_!Q=<_LS0[35#J_D;_M$C)Y?E>9C&WKGS#^5 'Z
M=T5\-?\ #;WBK_H2-*_\")*/^&WO%7_0D:5_X$24 ?<M%?&W@W]KOQ)XF\>>
M'_#=QX/TRWBU74K:R>5)Y"T:RRJA8 ]QNS7V30 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\
MR_MJ_P#)$=&_[&"'_P!)KBO@&OO[]M7_ )(CHW_8P0_^DUQ7P#0 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% ':_"G_ )+?X#_[&"P_]*4K]8Z_)CX9
MW4-C\7O!E]=2>7!;ZU92R/@G:JSH2<#D\"OUGH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^
M9?VU?^2(Z-_V,$/_ *37%? -??W[:O\ R1'1O^Q@A_\ 2:XKX!H **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@#;\)_\COH/_80M_P#T8M?K[7Y!>$_^
M1WT'_L(6_P#Z,6OU]H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^9?VU?^2(Z-_V,$/_ *37
M%? -??W[:O\ R1'1O^Q@A_\ 2:XKX!H **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "O7OV>-)TO6_P!H3POI>L:9:ZG83_:O-MKR%9HI,6LS#<C @X(!&1U
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M7_#$/BK_ *'?2O\ P'DH_P"&(?%7_0[Z5_X#R5]RT4 ?#7_#$/BK_H=]*_\
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MPNKOYD$D8P3QP7!_"OJVB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^=_VL_#^O>)?
MA'I5CX?T74-8NX]<AF:"PMGN)%06\X+%4!(&649Z9(]:^(_^%3_%+_HFGBK_
M ,$US_\ $5^LE% 'Y-_\*G^*7_1-/%7_ ()KG_XBC_A4_P 4O^B:>*O_  37
M/_Q%?K)10!^3?_"I_BE_T33Q5_X)KG_XBC_A4_Q2_P"B:>*O_!-<_P#Q%?K)
M10!^3?\ PJ?XI?\ 1-/%7_@FN?\ XBC_ (5/\4O^B:>*O_!-<_\ Q%?K)10!
MA>&(9(?!^C031/%+'90(\;J59&$:@@@]"*W:** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HKR_P"/'B37
M/!_P.\0>)?#E]]AU6S^S>1<>6DFS?<Q(WRN"IRK,.1WKX>_X:C^.O_0]?^4R
MS_\ C- 'Z8T5^9W_  U'\=?^AZ_\IEG_ /&:/^&H_CK_ -#U_P"4RS_^,T ?
MIC17YG?\-1_'7_H>O_*99_\ QFC_ (:C^.O_ $/7_E,L_P#XS0!^F-%?F=_P
MU'\=?^AZ_P#*99__ !FC_AJ/XZ_]#U_Y3+/_ .,T ?IC17YG?\-1_'7_ *'K
M_P IEG_\9H_X:C^.O_0]?^4RS_\ C- 'Z8T5^9W_  U'\=?^AZ_\IEG_ /&:
M/^&H_CK_ -#U_P"4RS_^,T ?IC17YG?\-1_'7_H>O_*99_\ QFC_ (:C^.O_
M $/7_E,L_P#XS0!^F-%?F=_PU'\=?^AZ_P#*99__ !FC_AJ/XZ_]#U_Y3+/_
M .,T ?IC17YG?\-1_'7_ *'K_P IEG_\9H_X:C^.O_0]?^4RS_\ C- 'Z8T5
M^9W_  U'\=?^AZ_\IEG_ /&:/^&H_CK_ -#U_P"4RS_^,T ?IC17YG?\-1_'
M7_H>O_*99_\ QFC_ (:C^.O_ $/7_E,L_P#XS0!^F-%?F=_PU'\=?^AZ_P#*
M99__ !FC_AJ/XZ_]#U_Y3+/_ .,T ?IC17YG?\-1_'7_ *'K_P IEG_\9H_X
M:C^.O_0]?^4RS_\ C- 'Z8T5^9W_  U'\=?^AZ_\IEG_ /&:/^&H_CK_ -#U
M_P"4RS_^,T ?IC17YG?\-1_'7_H>O_*99_\ QFC_ (:C^.O_ $/7_E,L_P#X
MS0!^F-%?F=_PU'\=?^AZ_P#*99__ !FC_AJ/XZ_]#U_Y3+/_ .,T ?IC17YG
M?\-1_'7_ *'K_P IEG_\9H_X:C^.O_0]?^4RS_\ C- 'Z8T5^9W_  U'\=?^
MAZ_\IEG_ /&:/^&H_CK_ -#U_P"4RS_^,T ?IC17YG?\-1_'7_H>O_*99_\
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MX7ZGK?B[5CJ=_%K$MJDODQ0[8A#"P7$:J.KL<XSS7NM !1110 4444 %%%%
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MN?\ Z60U^9U !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !7[,5^,]?LQ0 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% 'C'[4?_)LGB[_ +<__2R&OS.K],?VH_\ DV3Q
M=_VY_P#I9#7YG4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!]_?L5?\D1UG_L8)O\ TFMZ^FJ^9?V*O^2(ZS_V
M,$W_ *36]?35 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% 'C'[4?_ ";)XN_[<_\ TLAK\SJ_3']J/_DV3Q=_VY_^ED-?F=0 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%=G\-[6UO_ (L>#+&^M8;JVN=;LH9H)D#QRHUP
M@964\$$$@@\$5^F7_"I_A9_T33PK_P"":V_^(H _)JBOUE_X5/\ "S_HFGA7
M_P $UM_\11_PJ?X6?]$T\*_^":V_^(H _)JBOUE_X5/\+/\ HFGA7_P36W_Q
M%'_"I_A9_P!$T\*_^":V_P#B* /R:HK]9?\ A4_PL_Z)IX5_\$UM_P#$4?\
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M_P#!-;?_ !%'_"I_A9_T33PK_P"":V_^(H _)JOV8KC/^%3_  L_Z)IX5_\
M!-;?_$5V= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% 'C'[4?_)LGB[_MS_\ 2R&OS.K]7_B9X&;XE?##5_!;:I_97]H^3_I?D>=Y
M?ES)+]S<N<[,=1US[5\V?\,,?]51_P#*)_\ =% 'QG17V9_PPQ_U5'_RB?\
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M%'_##'_54?\ RB?_ '10!\9T5]F?\,,?]51_\HG_ -T4?\,,?]51_P#*)_\
M=% 'QG17V9_PPQ_U5'_RB?\ W11_PPQ_U5'_ ,HG_P!T4 ?&=%?9G_##'_54
M?_*)_P#=%'_##'_54?\ RB?_ '10!\9T5]F?\,,?]51_\HG_ -T4?\,,?]51
M_P#*)_\ =% 'QG17V9_PPQ_U5'_RB?\ W11_PPQ_U5'_ ,HG_P!T4 ?&=%?9
MG_##'_54?_*)_P#=%'_##'_54?\ RB?_ '10!\9T5]F?\,,?]51_\HG_ -T4
M?\,,?]51_P#*)_\ =% 'QG17V9_PPQ_U5'_RB?\ W11_PPQ_U5'_ ,HG_P!T
M4 ?&=%?9G_##'_54?_*)_P#=%'_##'_54?\ RB?_ '10!\9T5]F?\,,?]51_
M\HG_ -T4?\,,?]51_P#*)_\ =% 'QG17V9_PPQ_U5'_RB?\ W11_PPQ_U5'_
M ,HG_P!T4 ?&=%?9G_##'_54?_*)_P#=%'_##'_54?\ RB?_ '10!\9T5]F?
M\,,?]51_\HG_ -T4?\,,?]51_P#*)_\ =% 'QG17V9_PPQ_U5'_RB?\ W11_
MPPQ_U5'_ ,HG_P!T4 ?-'PI_Y+?X#_[&"P_]*4K]8Z^3?"?['?\ PC'C?0?$
MG_"Q/M?]DZA;WWD?V1L\WRI%?9N\\[<[<9P<9Z&OK*@ HHHH **** "BBB@
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I%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>ltbr_ex32img8.jpg
<TEXT>
begin 644 ltbr_ex32img8.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" 2D Y8# 2(  A$! Q$!_\0
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M9T\N".,Y(XY*$_C7#_\ #$/BK_H=]*_\!Y*H1\F45]9_\,0^*O\ H=]*_P#
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MZ[;_ &I84%U)'+*!\[QQE%)]E))'YFK5%)*Q;=PHHHIB"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M (NC_A;'PL_Z*7X5_P#!S;?_ != '9T5QG_"V/A9_P!%+\*_^#FV_P#BZ/\
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M (.;;_XNC_A;'PL_Z*7X5_\ !S;?_%T =G17&?\ "V/A9_T4OPK_ .#FV_\
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M%G_12_"O_@YMO_BZ/^%L?"S_ **7X5_\'-M_\70!V=%<9_PMCX6?]%+\*_\
M@YMO_BZ/^%L?"S_HI?A7_P '-M_\70!V=%<9_P +8^%G_12_"O\ X.;;_P"+
MH_X6Q\+/^BE^%?\ P<VW_P 70!V=%<9_PMCX6?\ 12_"O_@YMO\ XNC_ (6Q
M\+/^BE^%?_!S;?\ Q= '9T5QG_"V/A9_T4OPK_X.;;_XNC_A;'PL_P"BE^%?
M_!S;?_%T =G17&?\+8^%G_12_"O_ (.;;_XNC_A;'PL_Z*7X5_\ !S;?_%T
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M60U^9U?IC^U'_P FR>+O^W/_ -+(:_,Z@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH ^S/V&?^:@_P#<._\ ;FOLROC/
M]AG_ )J#_P!P[_VYK[,H **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** /&/VH_^39/%W_;G_Z60U^9U?IC^U'_ ,FR>+O^W/\
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MBC_AAC_JJ/\ Y1/_ +HK[,HH ^,_^&&/^JH_^43_ .Z*/^&&/^JH_P#E$_\
MNBOLRB@#XS_X88_ZJC_Y1/\ [HH_X88_ZJC_ .43_P"Z*^S** /C/_AAC_JJ
M/_E$_P#NBC_AAC_JJ/\ Y1/_ +HK[,HH ^,_^&&/^JH_^43_ .Z*/^&&/^JH
M_P#E$_\ NBOLRB@#XS_X88_ZJC_Y1/\ [HH_X88_ZJC_ .43_P"Z*^S** /C
M/_AAC_JJ/_E$_P#NBC_AAC_JJ/\ Y1/_ +HK[,HH ^&+?]C?6I=7>RG\17=O
M"'P+PZ; T)7GG N]_IQL[]JV_P#AAC_JJ/\ Y1/_ +HK[,HH ^,_^&&/^JH_
M^43_ .Z*/^&&/^JH_P#E$_\ NBOLRB@#XS_X88_ZJC_Y1/\ [HH_X88X_P"2
MH_\ E$_^Z*^S** /A?3_ -C?5KK4/LUYXEN["$%LW3Z; \9 '& MV7R3Q@J*
MW/\ AAC_ *JC_P"43_[HK[,HH ^,_P#AAC_JJ/\ Y1/_ +HH_P"&&/\ JJ/_
M )1/_NBOLRB@#XS_ .&&/^JH_P#E$_\ NBC_ (88_P"JH_\ E$_^Z*^S** /
MC/\ X88_ZJC_ .43_P"Z*/\ AAC_ *JC_P"43_[HK[,HH ^,_P#AAC_JJ/\
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M\,A_!O\ Y\M5_P# ]O\ "@#\YJ*_1G_AD/X-_P#/EJO_ ('M_A1_PR'\&_\
MGRU7_P #V_PH _.:BOT9_P"&0_@W_P ^6J_^![?X4?\ #(?P;_Y\M5_\#V_P
MH _.:OUD^%/_ "1#P'_V+]A_Z3)7FG_#(?P;_P"?+5?_  /;_"O:=#T>S\/^
M'=,T'35=;+3;6*S@#MN81QH$7)[G '- &M1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 45@>*/%&A^#_#5WXD\17WV'2[39YUQY3R;-[JB_*@+'+,HX'>
MO-_^&HO@5_T/7_E,O/\ XS0![/17C'_#47P*_P"AZ_\ *9>?_&:/^&HO@5_T
M/7_E,O/_ (S0![/17C'_  U%\"O^AZ_\IEY_\9H_X:B^!7_0]?\ E,O/_C-
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% '[,4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !7Y:_'W_DX7QK_ -A!O_017ZE5^6OQ]_Y.
M%\:_]A!O_010!YC1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'C'[4?_
M ";)XN_[<_\ TLAK\SJ_7GQ1X7T/QAX:N_#?B*Q^W:7>;/.M_->/?L=77YD(
M8895/![5YO\ \,N? O\ Z$;_ ,J=Y_\ 'J /S.HK],?^&7/@7_T(W_E3O/\
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M_P J=Y_\>H _,ZBOTQ_X9<^!?_0C?^5.\_\ CU'_  RY\"_^A&_\J=Y_\>H
M_,ZBOTQ_X9<^!?\ T(W_ )4[S_X]1_PRY\"_^A&_\J=Y_P#'J /S.HK],?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 1D?RKX_\
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MZ36C7<2>S[,\&^&_@>7Q1\"_!/@[Q]&SP:E8WK0H7'FQ0,4D@8'LP&UAUP,
M^E;7P7G\8>&?&]]\)_%T/G1>'+%WTC40NW[79/*@3/8E=H''3D'ID^UW&@Z'
M>:E::I=Z+87&H60(M;J2V1I;<>B.1E?P(JWY,/VI;IXE,RJ460J-P4D$@'K@
MD#CV%#WOWW!(^?\ 4/\ D_W2/^Q7;_T*6O0/BAI]SXNTT> ;>PN[FTU2&1]1
MDM6C5X(0I$>"[J-QFV''.51ZZV7P?X2GUX>()O"^DRZN,$7[V,1N!C_IH5W?
MK5A=!T5-<?6H])LTU210CWHMT$S* 0 7QN(Y/?O3>JL/9W/G/X?:]KEU^S3X
MW^'<<9@\8>#[.[TR6(8)*[9-A4J2"<!U&#U4'O7??LVW&FR_LZ>&&L&58XHY
MEF[;91,Y?/X\_0BO1;'PEX5TC59M6TKPQI5AJ%P");NULXXI9 >NYU4$_B:<
MOA+PHL\LZ^&=*$TIW22"RCW.?4G;R:._G;\!6V\CR3]I9;5?V8-86QV_9 +,
M0[#E=GGQ[<'TQBMKQIX=T'Q=\*?#GA_6M<FT6:]>U72[V!L&.]$1:$^A&5/'
M&3@ @X->BZSX;\.^(K9+;Q!H.G:O!'RL5]:QSJOT#@@=!^5#>'M ;3;;2SH=
M@=/M2#!:&W3RH2 0-J8PO!(X'<TDM&GU=QO=/L>.?#7Q!\0;?XOWG@'XH6^F
MZGKUMHYO;37-.&T26S3*I210%'+ $?*I&T]<YKWVLNPT71]*,KZ7I5I8M+CS
M#;0+&7QTSM S6IWJF]A6U8M%%% PHHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MBC_AAC_JJ/\ Y1/_ +HH ^,Z*^S/^&&/^JH_^43_ .Z*/^&&/^JH_P#E$_\
MNB@#XSHK[,_X88_ZJC_Y1/\ [HH_X88_ZJC_ .43_P"Z* /C.BOLS_AAC_JJ
M/_E$_P#NBC_AAC_JJ/\ Y1/_ +HH ^,Z*^S/^&&/^JH_^43_ .Z*/^&&/^JH
M_P#E$_\ NB@#QK]EO_DYOPC_ -OG_I'-7Z8U\S?"_P#98_X5S\3=(\;?\)U_
M:?\ 9WG?Z)_9GD^9YD+Q??\ .;&-^>AZ8]Z^F: "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M#\F_^%L?%+_HI?BK_P '-S_\71_PMCXI?]%+\5?^#FY_^+KBZ* .T_X6Q\4O
M^BE^*O\ P<W/_P 71_PMCXI?]%+\5?\ @YN?_BZXNB@#M/\ A;'Q2_Z*7XJ_
M\'-S_P#%T?\ "V/BE_T4OQ5_X.;G_P"+KBZ* .T_X6Q\4O\ HI?BK_P<W/\
M\71_PMCXI?\ 12_%7_@YN?\ XNN+HH [3_A;'Q2_Z*7XJ_\ !S<__%T?\+8^
M*7_12_%7_@YN?_BZXNB@#M/^%L?%+_HI?BK_ ,'-S_\ %T?\+8^*7_12_%7_
M (.;G_XNN+HH [3_ (6Q\4O^BE^*O_!S<_\ Q='_  MCXI?]%+\5?^#FY_\
MBZXNB@#M/^%L?%+_ **7XJ_\'-S_ /%T?\+8^*7_ $4OQ5_X.;G_ .+KBZ*
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MO_!C9?\ Q=?)E% 'UG_PSU\ ?^C@M*_\&-E_\71_PSU\ ?\ HX+2O_!C9?\
MQ=?)E% 'UG_PSU\ ?^C@M*_\&-E_\71_PSU\ ?\ HX+2O_!C9?\ Q=?)E% '
MUG_PSU\ ?^C@M*_\&-E_\71_PSU\ ?\ HX+2O_!C9?\ Q=?)E% 'UG_PSU\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]%"TK_OMO\* /3:*\R_X7]\&_P#HH6E?]]M_A1_PO[X-_P#10M*_[[;_  H
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _&>BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** /UD^%/_)$/ ?\ V+]A_P"DR5VE<7\*?^2(> _^Q?L/_29*[2@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#R+4M'_9VT/4'TW7=
M)^'>EWT8!>VO8+"&501D$JP!&1S5[1/!WP-\302W'AWPKX&UB&%@DDEA8V=P
ML;8S@E%.#CL:X+XE?:(_VN/A;-8PPS77V.^"K+(8U?$,G!8*Q'4]C6MXJ\6Z
MEX>7P-I]GI:Z'XE\>WT%OJ-[%'&S6A7;YAPRE'E ?:I92.,D' %2G>*?=@_B
MY?*YZ%_PJ?X6?]$U\*_^":V_^(H_X5/\+/\ HFGA7_P36W_Q%>!^*_C!XUT_
MP9JL.GZU)#J_AKQ>NA3W_P!G@8:E;L9,%U,95'PHSL"C/(QG ^D-#M->LDU!
M=>UE-5:6[:6U:.W$ AA*KB+ ZX8/R23@C)J@.0D\(? F/7'T*3POX#75D3S&
ML6LK(3JO]XQ[=V/?%;8^$_PM_P"B:^%?_!-;?_$5X#=G7_@^U[8^./#D'B[P
M#K&M?VO%XBL%!FTV5Y@PDFRIRP.TAB>^ Q^Z-+5/&WQ(D\>_%^RTWQQ-:6'@
MZQ35-/M_L-JZM^Z\TQ.QBW%"-PZ[ONG=P=RZ7%UL>U_\*G^%O_1-?"O_ ()K
M;_XBE_X5/\+?^B:>%?\ P36W_P 17C.H?&#Q7XMURQTGPW=?\(NJ^$&\433^
M3'.TLNS*P_O%(\H$\D ,>Q7%4M2^*?CK7O$7PQ;1?$4WA^T\6:-<W%Y;1VEO
M,(YHHG.]#)&S<L. 3C ''7)M>_0I:VMU/<_^%3_"W_HFGA7_ ,$UM_\ $4?\
M*G^%G_1-?"O_ ()K;_XBO#?^%M^/O^&?_A_X\N)+^6&ZNIDU^_TRSAEE2.-I
M$1_+9"BJ2@+$!>F 5+ U-KWQ8\6:AK-WH?A7Q5;1PZ#X-/B2;5(+2-UU6=50
M[=LBD)$=W1<,#D9&,4WU?82U:2ZGM?\ PJ?X6_\ 1-?"O_@FMO\ XBE_X5/\
M+?\ HFOA7_P36W_Q%>/7GQ&\=>(/B-\---\/Z]_8=KXR\.2WDEL]I#,EO<^1
M(ZR LN\@, <;L':,CD@^NZ/I?CZUUO19]7\5V=[IUOI8@U"V2P"/=7G&9U<'
MY1U^4#')XY!5V:W E_X5/\+/^B:>%?\ P36W_P 11_PJ?X6?]$T\*_\ @FMO
M_B*[.BD!QG_"I_A9_P!$T\*_^":V_P#B*/\ A4_PL_Z)IX5_\$UM_P#$5V=%
M '&?\*G^%G_1-/"O_@FMO_B*/^%3_"S_ *)IX5_\$UM_\179T4 <9_PJ?X6?
M]$T\*_\ @FMO_B*/^%3_  L_Z)IX5_\ !-;?_$5V=% '&?\ "I_A9_T33PK_
M .":V_\ B*/^%3_"S_HFGA7_ ,$UM_\ $5V=% '&?\*G^%G_ $33PK_X)K;_
M .(H_P"%3_"S_HFGA7_P36W_ ,179T4 <9_PJ?X6?]$T\*_^":V_^(H_X5/\
M+/\ HFGA7_P36W_Q%=G10!QG_"I_A9_T33PK_P"":V_^(H_X5/\ "S_HFGA7
M_P $UM_\179T4 <9_P *G^%G_1-/"O\ X)K;_P"(H_X5/\+/^B:>%?\ P36W
M_P 179T4 9]G:6]A9VUC8VL=K:6\:PPP0H$CB11A551P    !P!6A110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110!P>M_#71->\=Z7XTNKS4
M8=9TA&CLI()E5( P(;"E2&SDYW9ZUK^)/"ND^*8K"/58V,FGW<=]9SQG;);3
MH<K(IZ9[8((()!!KY8_X;G_ZI=_Y6_\ [GH_X;G_ .J7?^5O_P"YZ.E@ZW/H
M#5/@[X/UCPP?#MU#=K:-J;:Q-)'/MEN;MB299&QR?F/' Z#& *]#ACDCA16F
M:5@ "[8RWN< #\@*^//^&Y_^J7?^5O\ ^YZ/^&Y_^J7?^5O_ .YZ /I.+X;>
M'X=,BT=9M0?1H[A;HZ;-=M+"\BOO&=^6V;P&\L,$S_#7F&F_"G6=7^.'Q.U#
MQ/IM_9^&/$L$%O%-;WD2B[C55#HRJY=0=O7 .,C(R0?._P#AN;_JE_\ Y6__
M +GH_P"&YO\ JEW_ )6__N>BVH'T9KGPK\'Z[<0W,EE+87$>F-HWFV$IA+63
M#!@/;;Z<9'8BJ^I_"7PGJ6K^']247EC-X=LS8::+64*L$10H1AE.3M.,G/3U
MKY[_ .&Y?^J7_P#E;_\ N>C_ (;F_P"J7_\ E;_^YZ35]P6A]%Z+\+?#_A_P
M=;^%=*NM2@TZTCN(81]IRRQSG,J'C# G)&X$C/!'&*&H?!7X?W-O###IL^G+
M%I?]B'['<O&9;+=N,+GG()&2WWNO->!_\-S_ /5+O_*W_P#<]'_#<_\ U2[_
M ,K?_P!STWKN"TV/HZ3X8^&6\8>'/$ZK=0W_ (<M?L6G)%(!%%#M*%2I!SE6
M(Y/TQ6U)X0T>7QW;>-)!=?VO;V;6"$7+B+RF;<08\[2<]\>GH,?+'_#<W_5+
MO_*W_P#<]'_#<W_5+_\ RM__ '/0!]ET5\9_\-S_ /5+O_*W_P#<]>W_  3^
M,7_"XM&U;4_^$=_L/^S[A(/+^V?:?,W+NSGRTQ].: /7:*** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH _&>BNT_X5/\ %+_HFGBK_P $US_\11_PJ?XI?]$T\5?^
M":Y_^(H XNBNT_X5/\4O^B:>*O\ P37/_P 11_PJ?XI?]$T\5?\ @FN?_B*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'PU_PV]XJ_Z$C2O_ B
M2C_AM[Q5_P!"1I7_ ($25\F44 ?6?_#;WBK_ *$C2O\ P(DH_P"&WO%7_0D:
M5_X$25\F44 ?6?\ PV]XJ_Z$C2O_  (DH_X;>\5?]"1I7_@1)7R910!]9_\
M#;WBK_H2-*_\")*/^&WO%7_0D:5_X$25\F44 ?6?_#;WBK_H2-*_\")*/^&W
MO%7_ $)&E?\ @1)7R910!]9_\-O>*O\ H2-*_P# B2C_ (;>\5?]"1I7_@1)
M7R910!]9_P##;WBK_H2-*_\  B2C_AM[Q5_T)&E?^!$E?)E% 'UG_P -O>*O
M^A(TK_P(DH_X;>\5?]"1I7_@1)7R910!]9_\-O>*O^A(TK_P(DH_X;>\5?\
M0D:5_P"!$E?)E% 'UG_PV]XJ_P"A(TK_ ,")*/\ AM[Q5_T)&E?^!$E?)E%
M'UG_ ,-O>*O^A(TK_P ")*/^&WO%7_0D:5_X$25\F44 ?6?_  V]XJ_Z$C2O
M_ B2C_AM[Q5_T)&E?^!$E?)E% 'UG_PV]XJ_Z$C2O_ B2OM+1KY]3T#3M1DC
M$;W5M'.R+R%+*&Q^M?CU7Z_>$_\ D1]!_P"P?;_^BUH VJ*** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MH_CK_P!#U_Y3+/\ ^,T?\-1_'7_H>O\ RF6?_P 9H /^&7/CK_T(O_E3L_\
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MESXZ_P#0B_\ E3L__CU'_#+GQU_Z$7_RIV?_ ,>H_P"&H_CK_P!#U_Y3+/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _&>BOIK_ (8K^*7_ $'_
M  K_ .!5S_\ &*/^&*_BE_T'_"O_ (%7/_QB@#YEHKZ:_P"&*_BE_P!!_P *
M_P#@5<__ !BC_ABOXI?]!_PK_P"!5S_\8H ^9:*^FO\ ABOXI?\ 0?\ "O\
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M?9G[#/\ S4'_ +AW_MS0!]F4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% 'QG_P ,,?\ 54?_ "B?_=%'_##'_54?_*)_]T5]F44
M?&?_  PQ_P!51_\ *)_]T4?\,,?]51_\HG_W17V910!\9_\ ##'_ %5'_P H
MG_W11_PPQ_U5'_RB?_=%?9E% 'QG_P ,,?\ 54?_ "B?_=%'_##'_54?_*)_
M]T5]F44 ?&?_  PQ_P!51_\ *)_]T4?\,,?]51_\HG_W17V910!\9_\ ##'_
M %5'_P HG_W11_PPQ_U5'_RB?_=%?9E% 'QG_P ,,?\ 54?_ "B?_=%'_##'
M_54?_*)_]T5]F44 ?&?_  PQ_P!51_\ *)_]T4?\,,?]51_\HG_W17V910!\
M9_\ ##'_ %5'_P HG_W11_PPQ_U5'_RB?_=%?9E% 'QG_P ,,?\ 54?_ "B?
M_=%'_##'_54?_*)_]T5]F44 ?&?_  PQ_P!51_\ *)_]T4?\,,?]51_\HG_W
M17V910!\9_\ ##'_ %5'_P HG_W11_PPQ_U5'_RB?_=%?9E% 'QG_P ,,?\
M54?_ "B?_=%'_##'_54?_*)_]T5]F44 ?&?_  PQ_P!51_\ *)_]T5[)\#?@
M;_PIAM?_ .*H_MW^U_L__+E]F\GRO-_Z:/NSYOMC'?/'M%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MI7_@9'_\51_PEGA?_H9M*_\  R/_ .*K\@J* /U]_P"$L\+?]#-I7_@9'_\
M%4?\)9X7_P"AFTK_ ,#(_P#XJOR"HH _7W_A+/"__0S:5_X&1_\ Q5'_  EG
MA;_H9M*_\#(__BJ_(*B@#]??^$L\+_\ 0S:5_P"!D?\ \51_PEGA?_H9M*_\
M#(__ (JOR"HH _8Z&:*Z@CN+>198I%#HZ,&5E(R"".H-6JXOX4_\D0\!_P#8
MOV'_ *3)7:4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'XST5]F?\8*
M?Y_MBC_C!3_/]L4 ?&=%?9G_ !@I_G^V*/\ C!3_ #_;% 'QG17V9_Q@I_G^
MV*/^,%/\_P!L4 ?&=%?9G_&"G^?[8H_XP4_S_;% 'QG17V9_Q@I_G^V*/^,%
M/\_VQ0!],?"G_DB'@/\ [%^P_P#29*[2O"-)_:(^ &A:-8Z+I?C#R+"PMX[:
MVB_L^^;RXD4*BY:(DX  R236A_PU%\"O^AZ_\IEY_P#&: /9Z*\8_P"&HO@5
M_P!#U_Y3+S_XS1_PU%\"O^AZ_P#*9>?_ !F@#V>BO&/^&HO@5_T/7_E,O/\
MXS1_PU%\"O\ H>O_ "F7G_QF@#V>BO&/^&HO@5_T/7_E,O/_ (S1_P -1? K
M_H>O_*9>?_&: /9Z*\8_X:B^!7_0]?\ E,O/_C-'_#47P*_Z'K_RF7G_ ,9H
M ]GHKQC_ (:B^!7_ $/7_E,O/_C-'_#47P*_Z'K_ ,IEY_\ &: /9Z*\8_X:
MB^!7_0]?^4R\_P#C-'_#47P*_P"AZ_\ *9>?_&: /9Z*\8_X:B^!7_0]?^4R
M\_\ C-'_  U%\"O^AZ_\IEY_\9H ]GHKQC_AJ+X%?]#U_P"4R\_^,T?\-1?
MK_H>O_*9>?\ QF@#V>BO&/\ AJ+X%?\ 0]?^4R\_^,T?\-1? K_H>O\ RF7G
M_P 9H ]GHKQC_AJ+X%?]#U_Y3+S_ .,T?\-1? K_ *'K_P IEY_\9H ]GHKQ
MC_AJ+X%?]#U_Y3+S_P",T?\ #47P*_Z'K_RF7G_QF@#V>BO&/^&HO@5_T/7_
M )3+S_XS1_PU%\"O^AZ_\IEY_P#&: /9Z*\8_P"&HO@5_P!#U_Y3+S_XS1_P
MU%\"O^AZ_P#*9>?_ !F@#V>BO&/^&HO@5_T/7_E,O/\ XS1_PU%\"O\ H>O_
M "F7G_QF@#V>BO&/^&HO@5_T/7_E,O/_ (S1_P -1? K_H>O_*9>?_&: /9Z
M*\8_X:B^!7_0]?\ E,O/_C-'_#47P*_Z'K_RF7G_ ,9H ]GHKQC_ (:B^!7_
M $/7_E,O/_C-'_#47P*_Z'K_ ,IEY_\ &: /9Z*\8_X:B^!7_0]?^4R\_P#C
M-'_#47P*_P"AZ_\ *9>?_&: /9Z*\8_X:B^!7_0]?^4R\_\ C->I:3JECKFB
MV&M:7/\ :+"^MX[JVEVLOF1.H9&PP!&00<$ T :M%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 ?C/1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7ZR?"G_DB'@/\
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M%G_1-/"O_@FMO_B*/^%3_"S_ *)IX5_\$UM_\179T4 <9_PJ?X6?]$T\*_\
M@FMO_B*/^%3_  L_Z)IX5_\ !-;?_$5V=% '&?\ "I_A9_T33PK_ .":V_\
MB*/^%3_"S_HFGA7_ ,$UM_\ $5V=% '&?\*G^%G_ $33PK_X)K;_ .(H_P"%
M3_"S_HFGA7_P36W_ ,179T4 <9_PJ?X6?]$T\*_^":V_^(KH[.TM["SMK&QM
M8[6TMXUAA@A0)'$BC"JJC@    #@"M"B@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@#\9Z*^S/^&Y_P#JEW_E;_\ N>C_ (;G
M_P"J7?\ E;_^YZ /C.BOLS_AN?\ ZI=_Y6__ +GH_P"&Y_\ JEW_ )6__N>@
M#XSHK[,_X;G_ .J7?^5O_P"YZ/\ AN?_ *I=_P"5O_[GH ^,Z*^S/^&Y_P#J
MEW_E;_\ N>C_ (;G_P"J7?\ E;_^YZ /C.BOLS_AN?\ ZI=_Y6__ +GH_P"&
MY_\ JEW_ )6__N>@#XSHK[,_X;G_ .J7?^5O_P"YZ/\ AN?_ *I=_P"5O_[G
MH ^,Z*^S/^&Y_P#JEW_E;_\ N>C_ (;G_P"J7?\ E;_^YZ /C.BOLS_AN?\
MZI=_Y6__ +GH_P"&Y_\ JEW_ )6__N>@#XSHK[,_X;G_ .J7?^5O_P"YZ/\
MAN?_ *I=_P"5O_[GH ^,Z_3']ES_ )-D\(_]OG_I9-7C7_#<_P#U2[_RM_\
MW/1_PW/_ -4N_P#*W_\ <] 'V917QG_PW/\ ]4N_\K?_ -ST?\-S_P#5+O\
MRM__ '/0!]F45\9_\-S_ /5+O_*W_P#<]=G\+_VJ/^%C?$W2/!7_  @O]E_V
MCYW^E_VGYWE^7"\OW/)7.=F.HZY]J /IFBBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\9Z*]._P"% _&3_HGNJ_\
M?"_XT?\ "@?C)_T3W5?^^%_QH \QHKT[_A0/QD_Z)[JO_?"_XT?\*!^,G_1/
M=5_[X7_&@#S&BO3O^% _&3_HGNJ_]\+_ (T?\*!^,G_1/=5_[X7_ !H \QHK
MT[_A0/QD_P"B>ZK_ -\+_C1_PH'XR?\ 1/=5_P"^%_QH \QHKT[_ (4#\9/^
MB>ZK_P!\+_C1_P *!^,G_1/=5_[X7_&@#S&BO3O^% _&3_HGNJ_]\+_C1_PH
M'XR?]$]U7_OA?\: /,:*]._X4#\9/^B>ZK_WPO\ C1_PH'XR?]$]U7_OA?\
M&@#S&BO3O^% _&3_ *)[JO\ WPO^-'_"@?C)_P!$]U7_ +X7_&@#S&BO3O\
MA0/QD_Z)[JO_ 'PO^-'_  H'XR?]$]U7_OA?\: /,:*]._X4#\9/^B>ZK_WP
MO^-'_"@?C)_T3W5?^^%_QH \QHKT[_A0/QD_Z)[JO_?"_P"-'_"@?C)_T3W5
M?^^%_P : /,:]G_9;_Y.;\(_]OG_ *1S5C?\*!^,G_1/=5_[X7_&O4OV?_A%
M\2O"_P >?#>N>(/!NH:?IMM]J\ZYF4!$W6LJ+GGNS ?C0!]\4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /Q
MGHHHH **** "BBB@ HHHH **** "BBB@#Z9\8_\ */3X<?\ 8P2_^C+^OF:O
MIGQC_P H]/AQ_P!C!+_Z,OZ^9J "BBB@ HHHH **** "BBB@ HHHH *_7[PG
M_P B/H/_ &#[?_T6M?D#7Z_>$_\ D1]!_P"P?;_^BUH VJ*** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MTCQM_P )U_9G]H^=_HG]F>=Y?ES/%]_SESG9GH.N/>OF6OTQ_9<_Y-D\(_\
M;Y_Z634 >-?\,,?]51_\HG_W11_PPQ_U5'_RB?\ W17V910!\9_\,,?]51_\
MHG_W11_PPQ_U5'_RB?\ W17V910!\9_\,,?]51_\HG_W17UQI-C_ &7HEEIC
M2^=]DMXX/,V[=^U0N<9.,XZ5J44 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** /QGHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH *^S/V&?^:@_]P[_ -N:^,Z^S/V&?^:@_P#<._\ ;F@#
M[,HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,3_A
M$_"O_0LZ5_X!1_\ Q-'_  B?A7_H6=*_\ H__B:VZ* ,3_A$_"O_ $+.E?\
M@%'_ /$T?\(GX5_Z%G2O_ */_P")K;HH Q/^$3\*_P#0LZ5_X!1__$T?\(GX
M5_Z%G2O_  "C_P#B:VZ* ,3_ (1/PK_T+.E?^ 4?_P 31_PB?A7_ *%G2O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** ,;7M/O-4\/WVFV-Y%9W%W
M\*330&9(]PP24#(6X)XW"L?X>^%KSP;\/])\*WFJ1:I_9L(MX[F*U-OOC'W<
MH7?G'4YY]!78>E'K2VOYAN+1113 **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KB]2\.^)&\7/X@T#Q1'9B>".VN+*_LC=PA48G=#MEC,;G<<DE
M@<+E>*[2BI R=)TFVT>P%G9\(7:5V( ,DCL6=S@ 99B2< #G@"M:BBJ ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_#^DZ(FMZIKFG6.ER;=E[<W4<4#[N5P[$*<]N>:T89HKB%9X9%DC=0R.ARK
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M+<EL*_/*DY'I5'0K6_NO@)I^GM9W,>HGP^ELUO<0M%*)A;["I5P"#NXYKBO
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M8 ]_[TVK$IW'4444B@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M**XCXC>)I_"?@N;6+;Y)?M%M:B5U!6#SIDB,ASQA0Y/ID#/%)NPTKG;45YEX
MJU#Q'X573XSXG>YBUO6K+3H9Y[6%9+%'SYF&50CEBN%W)P6[]JLVJ^-K/6_%
M>AV-U=:XVG#3KZW=8K>.Z^SS/()XDRJQ,X$+%=P'WL$YYH>FHEJSU)W52 S
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M7<IV2JK8(Y# 8/8FO$_BYK&L3_"_XM>&;[4;FZBT>.RF@O'CB1I8Y]I,+[$
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M<8Y; &:6_P"!5K'TMVHKS[XCZUJNDVOAZ/2=:BTV6_U>"TD40>=<7,9#%HH
M591(<#YG 50&)(KB?#/B[QAJ^F^&)+W7KF.2?Q5?Z+= V]MOF@B2Y9-^U"H<
M&% 2F >>#1>[L+979[O17@'A_P <>,+[1O$5Y=>()99-#\=)H$8,, 6XM6NX
M(L28C'S;96Y7;T'OG777/B9XFUW4IO"FH:-9Z?I.N/9W2W=[D^3$^'1H1:$J
MS+\P;S^X/ X##9V/9ZQ=8\0:3H*V;:M?I:"\N8[.W# DR2R,%10 ">20,]!G
MFO&M/\=^+K;28-2NM<FO2OCMO#S));P!9+4S&(9V1J=P&#D$<^HXJ6ZUC6O&
M'@6/Q)=:L4MAXRM;6/3TBC$:01:K'$@8[2_F?*&)W8YQC%):I2Z,3=FXO='O
M=%?/>M>-_&FGZ!X^U.'Q)/YN@^*+:PM$-M;[#;R-;@QM^[R>)6YR&Z<U>\4?
M$;Q+X7U_Q=I::A'=16EQHT5I-?&. 6_VN1EDW2)$0% 7ABC[2<D,.*:5] Z7
M/=C36954LQP!R2>U>,:M>?%+0=!O+_7M>L[=GUC3(K)+*2.[=()KB.&:.5FM
M8@0=Q*D(".Y.*Y7Q=XG\27Q^*OA>XUZ[$&@:EHPM9HDCCD,5RT?F1N54!ER3
MVSC@DCBEO?R'UL?2E%5H(Y(H$CDN'N&48,L@4,_N=H _("K-, HHHH ****
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MG='(J.%D7DD!@<'D8/-=915/4%H><0?!_P "VSS-;6&I1F:P72FQK5\/]%4
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M,D"N[S0#1N):'"K\,?!O]HZ1?QV-]!<:,A2R,.JW<8BSG<=JR@,S X9F!+#
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M..,U/AU\,?%WPW^*_A>62REUK2XO")T>YU)9T"6]P;MKAEPQWE ,(F%YRHX
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M/(KM&,\!BI*[L8S@D \ GK3U!V-2BBBJ$%%%% !1110 4444 %%%% !1110
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MQDDFK:7%?6WG8^F>U<[XL\3:?X-\'ZEXHU:.YFL=.A\Z5+2$RR%<XX7\>22
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M/^$4^%-YXZ\)^*M4O8=5BLW\_4+J2]@MXI)462[2-B&3"2$E$9$&!@+BNI\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MYA?GYYYSS5__ (1_P_\ VW_;G]A:?_:WD_9_MWV5//\ *_N>9C=M]LXK7HH
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M#3 [FBO-+'XT?#G4/['^PZ_<7!UH2-IRII=V3=^6Q5P@\K)((.1U[]*OZ?\
M%3P+JFG:;J&G^(%NH-2NGL;5([>4RRSH,O'Y6S>"!R<J,#'K0!WE%<P?&6@K
MK.CZ.]Y*M]K,<LEE']EF'FB+_69.W"8R.&(-=/2\P"BBBF 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MV/X<\5]+T4+1W#I8S[B::WM)YHK.6[:.-F6"(J'E(&0JERJ@GH,D#U(KQ?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M ^S/^&Y_^J7?^5O_ .YZ/^&Y_P#JEW_E;_\ N>OC.B@#[,_X;G_ZI=_Y6_\
M[GH_X;G_ .J7?^5O_P"YZ^,Z* /LS_AN?_JEW_E;_P#N>C_AN?\ ZI=_Y6__
M +GKXSHH ^S/^&Y_^J7?^5O_ .YZ/^&Y_P#JEW_E;_\ N>OC.B@#[,_X;G_Z
MI=_Y6_\ [GH_X;G_ .J7?^5O_P"YZ^,Z* /LS_AN?_JEW_E;_P#N>C_AN?\
MZI=_Y6__ +GKXSHH ^S/^&Y_^J7?^5O_ .YZ/^&Y_P#JEW_E;_\ N>OC.B@#
M[,_X;G_ZI=_Y6_\ [GH_X;G_ .J7?^5O_P"YZ^,Z* /LS_AN?_JEW_E;_P#N
M>C_AN?\ ZI=_Y6__ +GKXSHH ^S/^&Y_^J7?^5O_ .YZ/^&Y_P#JEW_E;_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^LGPI_P"2(> _^Q?L
M/_29*_+;PG_R.^@_]A"W_P#1BU^OM !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5B^+
M/^1'U[_L'W'_ *+:MJJ5]9PZAIUS87()@N8FAD"G!VL"#S]#0!^.E%?HS_PR
M'\&_^?+5?_ ]O\*/^&0_@W_SY:K_ .![?X4 ?G-17Z,_\,A_!O\ Y\M5_P#
M]O\ "C_AD/X-_P#/EJO_ ('M_A0!^<U%?HS_ ,,A_!O_ )\M5_\  ]O\*/\
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MD/X-_P#/EJO_ ('M_A0!^<U%?HS_ ,,A_!O_ )\M5_\  ]O\*/\ AD/X-_\
M/EJO_@>W^% 'YS45^C/_  R'\&_^?+5?_ ]O\*/^&0_@W_SY:K_X'M_A0!^<
MU%?HS_PR'\&_^?+5?_ ]O\*/^&0_@W_SY:K_ .![?X4 ?G-17Z,_\,A_!O\
MY\M5_P# ]O\ "C_AD/X-_P#/EJO_ ('M_A0!^<U%?HS_ ,,A_!O_ )\M5_\
M ]O\*/\ AD/X-_\ /EJO_@>W^% 'YS45^C/_  R'\&_^?+5?_ ]O\*/^&0_@
MW_SY:K_X'M_A0!^<U%?HS_PR'\&_^?+5?_ ]O\*/^&0_@W_SY:K_ .![?X4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
H0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>ltbr_ex32img9.jpg
<TEXT>
begin 644 ltbr_ex32img9.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" 2D Y8# 2(  A$! Q$!_\0
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M#U_Y3+/_ .,T ?IC17YG?\-1_'7_ *'K_P IEG_\9H_X:C^.O_0]?^4RS_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1/+GCD.0.>0A'XU\K_\ #$/BK_H=]*_\!Y*H1\F45]9_\,0^*O\ H=]*_P#
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MZ[;_ &I84%U)'+*!\[QQE%)]E))'YFK5%)*Q;=PHHHIB"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BOF;_AM7X6_] #Q5_X"VW_Q^C_AM7X6
M_P#0 \5?^ MM_P#'Z /IFBOF;_AM7X6_] #Q5_X"VW_Q^C_AM7X6_P#0 \5?
M^ MM_P#'Z /IFBOF;_AM7X6_] #Q5_X"VW_Q^C_AM7X6_P#0 \5?^ MM_P#'
MZ /IFBOF;_AM7X6_] #Q5_X"VW_Q^C_AM7X6_P#0 \5?^ MM_P#'Z /IFBOF
M;_AM7X6_] #Q5_X"VW_Q^C_AM7X6_P#0 \5?^ MM_P#'Z /IFBOF;_AM7X6_
M] #Q5_X"VW_Q^C_AM7X6_P#0 \5?^ MM_P#'Z /IFBOF;_AM7X6_] #Q5_X"
MVW_Q^C_AM7X6_P#0 \5?^ MM_P#'Z /IFBOF;_AM7X6_] #Q5_X"VW_Q^C_A
MM7X6_P#0 \5?^ MM_P#'Z /IFBOF;_AM7X6_] #Q5_X"VW_Q^C_AM7X6_P#0
M \5?^ MM_P#'Z /IFBOF;_AM7X6_] #Q5_X"VW_Q^C_AM7X6_P#0 \5?^ MM
M_P#'Z /IFBOF;_AM7X6_] #Q5_X"VW_Q^C_AM7X6_P#0 \5?^ MM_P#'Z /I
MFBOF;_AM7X6_] #Q5_X"VW_Q^C_AM7X6_P#0 \5?^ MM_P#'Z /IFBOF;_AM
M7X6_] #Q5_X"VW_Q^C_AM7X6_P#0 \5?^ MM_P#'Z /IFBOF;_AM7X6_] #Q
M5_X"VW_Q^C_AM7X6_P#0 \5?^ MM_P#'Z /IFBOF;_AM7X6_] #Q5_X"VW_Q
M^C_AM7X6_P#0 \5?^ MM_P#'Z /IFBOF;_AM7X6_] #Q5_X"VW_Q^C_AM7X6
M_P#0 \5?^ MM_P#'Z /IFBOF;_AM7X6_] #Q5_X"VW_Q^C_AM7X6_P#0 \5?
M^ MM_P#'Z /IFBOF;_AM7X6_] #Q5_X"VW_Q^C_AM7X6_P#0 \5?^ MM_P#'
MZ /IFBOF;_AM7X6_] #Q5_X"VW_Q^C_AM7X6_P#0 \5?^ MM_P#'Z /IFBOF
M;_AM7X6_] #Q5_X"VW_Q^C_AM7X6_P#0 \5?^ MM_P#'Z /IFBOF;_AM7X6_
M] #Q5_X"VW_Q^C_AM7X6_P#0 \5?^ MM_P#'Z /IFBOF;_AM7X6_] #Q5_X"
MVW_Q^C_AM7X6_P#0 \5?^ MM_P#'Z /IFBOF;_AM7X6_] #Q5_X"VW_Q^C_A
MM7X6_P#0 \5?^ MM_P#'Z /IFBOF;_AM7X6_] #Q5_X"VW_Q^C_AM7X6_P#0
M \5?^ MM_P#'Z /IFBOF;_AM7X6_] #Q5_X"VW_Q^C_AM7X6_P#0 \5?^ MM
M_P#'Z /IFBOF;_AM7X6_] #Q5_X"VW_Q^C_AM7X6_P#0 \5?^ MM_P#'Z /I
MFBOF;_AM7X6_] #Q5_X"VW_Q^C_AM7X6_P#0 \5?^ MM_P#'Z /IFBOF;_AM
M7X6_] #Q5_X"VW_Q^C_AM7X6_P#0 \5?^ MM_P#'Z /IFBOF;_AM7X6_] #Q
M5_X"VW_Q^C_AM7X6_P#0 \5?^ MM_P#'Z /IFBOF;_AM7X6_] #Q5_X"VW_Q
M^C_AM7X6_P#0 \5?^ MM_P#'Z /IFBOF;_AM7X6_] #Q5_X"VW_Q^C_AM7X6
M_P#0 \5?^ MM_P#'Z /IFBOF;_AM7X6_] #Q5_X"VW_Q^C_AM7X6_P#0 \5?
M^ MM_P#'Z /IFBOF;_AM7X6_] #Q5_X"VW_Q^C_AM7X6_P#0 \5?^ MM_P#'
MZ /IFBOF;_AM7X6_] #Q5_X"VW_Q^C_AM7X6_P#0 \5?^ MM_P#'Z /IFBOF
M;_AM7X6_] #Q5_X"VW_Q^C_AM7X6_P#0 \5?^ MM_P#'Z /IFBOF;_AM7X6_
M] #Q5_X"VW_Q^C_AM7X6_P#0 \5?^ MM_P#'Z /IFBOF;_AM7X6_] #Q5_X"
MVW_Q^C_AM7X6_P#0 \5?^ MM_P#'Z /IFBOF;_AM7X6_] #Q5_X"VW_Q^C_A
MM7X6_P#0 \5?^ MM_P#'Z /IFBOF;_AM7X6_] #Q5_X"VW_Q^C_AM7X6_P#0
M \5?^ MM_P#'Z /IFBOF;_AM7X6_] #Q5_X"VW_Q^C_AM7X6_P#0 \5?^ MM
M_P#'Z /IFBOF;_AM7X6_] #Q5_X"VW_Q^OIF@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** /QGHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_9BOQGK]F* "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3_"S_HFGA7_P36W_ ,11_P *G^%G_1-/"O\ X)K;_P"(KLZ* .,_X5/\+/\
MHFGA7_P36W_Q%'_"I_A9_P!$T\*_^":V_P#B*[.B@#C/^%3_  L_Z)IX5_\
M!-;?_$4?\*G^%G_1-/"O_@FMO_B*[.B@#C/^%3_"S_HFGA7_ ,$UM_\ $4?\
M*G^%G_1-/"O_ ()K;_XBNSHH XS_ (5/\+/^B:>%?_!-;?\ Q%'_  J?X6?]
M$T\*_P#@FMO_ (BNSHH XS_A4_PL_P"B:>%?_!-;?_$4?\*G^%G_ $33PK_X
M)K;_ .(KLZ* .,_X5/\ "S_HFGA7_P $UM_\11_PJ?X6?]$T\*_^":V_^(KL
MZ* .,_X5/\+/^B:>%?\ P36W_P 11_PJ?X6?]$T\*_\ @FMO_B*[.B@#C/\
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M5_\ !-;?_$4?\*G^%G_1-/"O_@FMO_B*[.B@#C/^%3_"S_HFGA7_ ,$UM_\
M$4?\*G^%G_1-/"O_ ()K;_XBNSHH XS_ (5/\+/^B:>%?_!-;?\ Q%'_  J?
MX6?]$T\*_P#@FMO_ (BNSHH XS_A4_PL_P"B:>%?_!-;?_$4?\*G^%G_ $33
MPK_X)K;_ .(KLZ* .,_X5/\ "S_HFGA7_P $UM_\11_PJ?X6?]$T\*_^":V_
M^(KLZ* .,_X5/\+/^B:>%?\ P36W_P 11_PJ?X6?]$T\*_\ @FMO_B*[.B@#
MC/\ A4_PL_Z)IX5_\$UM_P#$5V=%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M ?)O_#$/A7_H=]5_\!XZ/^&(?"O_ $.^J_\ @/'7UE10!\F_\,0^%?\ H=]5
M_P# >.C_ (8A\*_]#OJO_@/'7UE10!\F_P##$/A7_H=]5_\  >.C_AB'PK_T
M.^J_^ \=?65% 'R;_P ,0^%?^AWU7_P'CH_X8A\*_P#0[ZK_ . \=?65% 'R
M;_PQ#X5_Z'?5?_ >.O:OA'\+[#X2^$;OPWINJ7&IQ7-\]\9;A%1E9HXTVX';
M]V#^->D44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!X_\:M6\
M5>$?ASJWBCP_XFN;.Y2YM(X(EM[=XXT>6.-_OQL23ECDGC(]*C\?2>(-!\1^
M")[?Q1J]W;WOB&WM9+7,,0D0QRLRG8B;@2B<,?7L:UOC+X1\2>//AU/X8\._
MV:DUS<0222W]Q)$L:QR+)P$C<L25 QQC.<GI1XW\.^+O$EUX(NK&STF-M'U2
M+5+Y)[^50&5&4QQ$0'>/G8[F"?=''/$RUBK;W_#0%HWZ%FX^+7A2QTZ:]U.9
M],\K4Y-(>*^EA@*W$:EV!D>018VC(._G('7BMCP9XVT/QYH<^LZ#(\D$-U)9
MR;F1]LB'G#1LR,,$$,K$$$<UYDOPU^(DE_?:U;WFAZ7K%MXBFU[3=ES-<0SB
M6+RI+:<&%"@*@?.NX\GY> 3Z_H/]O'2XF\1?85U)N94L-YA3_95GPS>N2!UZ
M5>G02N>5^%?'E]J7BRZ\*^)/$ESH/C"'469-(NK6&*WNK03DK]G8INE!A!Y#
M[MV3C KIIOBEI-O=>*X?[!UF1/"DJKJ<L:0E8T9-_FJ/-W,H3YC@;L=L\52\
M2>#?$WB:QLM$UJUT2Y@@EBF77EDD2^M2CJ_[J(QL-_RA=_FKG).W^$\-HNFZ
M]K_Q0^,WAW25TX6.JW5O9WUU<3.)+:-[3:6CC5")&P6X9D (')Z4TKQ?=(-G
MY-GJVL>/M-T>UUB^DTO4+^QT3:;^YLTC=;?,:R'Y2X=L1NC':IX/U I:E\4]
M'TV/Q!.VDZG-;:!9P:A<SQ+"5>WE#E)$S*"1B-C@@'CI6=J7@7Q$LOBG1=#F
MTM?#WBN(BX>Y>03Z?(;=;=VC15*S I&IVEX\'/)'%<[J_P -O'%UIWCG1],M
M=!2QUK1K;1;"2;4IO,C6 .BR2*+; )24G"DX*@9(.X9ZE*UM=ST6R\>Z7J>M
M7FF:39WVHR62VK7#P(@$(N &C)5G#D;6W$A2  >X(JG_ ,+*\/F&WOA;WC:+
M<:B=+350J?9_M'F&+!^?>%,@*;MFW/?!S7)W'PS\3:E9>%X[JUT+3M3T<V:_
MVSI]W.MU#'"L>^/_ %:_:%D*N-KE%4$'#$46OPCU&W\*Q_#=I+-_!T&I#4H+
MKSG^V!!/YXMC$8]F-^1YGF9V_P &>:NRYK="?LWZG9>%?B%:^,-5U.TTK0=5
M2/2M0GTN\N;@0+'#/$%+# E+,#NP"JGD'.!@F\WBZQD\4:CX=L[&\O;[38X9
MKL0*F(EEW;.&<,W"D_*#CZ\5S/PK\&^)O!\GC%O$"Z9C7-=GUBW^PW4DQ02X
MS&^^),;=HY&<Y/ QR>.O >J>*-;L[RTMM+MI[:ZADM]8CGE@OK)$*LP^52)P
MQW#RV9% P>3TF72WS^XI6N_P,S1?'!\+OXQN/$EQJNHZ?#XJ73XKMF246PEB
MMPB[=P(0/)T13C=G'6NA7XH:&_B :6EAJ9C_ +:.@&],2+"+P)OV8+AR,?Q!
M",]\<UPNO?#KXC:QX;\3:;':>'89M6\16^MPNVJW#*B1^5E&_P!&'/[A>G'S
MG^Z-UYOAKXXO?$*ZQJU]I%Y<VWB6/6K6YEFEDDCM=A4V@!0"-8\DC;Q(>2$)
M)I+X5WZAI=G*ZYX@\36W@GQS=1^*-66XL/'4-G#(MP0RP,]NIB&!\J8=OE7
MR:]K\=^-M+^'_A"Y\5:Q9W=S8VSQI(MFJ-(-[!%.&901N8#KWKRC5/AE\2[_
M ,/>*=)2U\-(=:\21Z]'*VJW'[I5>-O+(^R\G]RHS_M'TYU_VDFF_P"&<->^
MT*D<IDLMRJVY0WVJ+(!(&1[X'T%&]O5(1VM]\0-/TV75K74M*U*UO-/A@N!;
ME(W>ZCFD,4;1;)"#^\&T[BI'!. 0:H7?Q4TFTLM:N&T/6';0[Z*QU&"-8-]J
M9 I20DRA3'AUR58D<Y Q5'5/!_B[7DU;7)FT_3M;N;*WTZV@M+Z8Q&W2?S9
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3/7Y-T ??_\ PVK\+?\ H >*O_ 6V_\ C]'_  VK\+?^@!XJ_P# 6V_^/U\
M44 ??_\ PVK\+?\ H >*O_ 6V_\ C]'_  VK\+?^@!XJ_P# 6V_^/U\ 44 ?
M?_\ PVK\+?\ H >*O_ 6V_\ C]'_  VK\+?^@!XJ_P# 6V_^/U\ 44 ??_\
MPVK\+?\ H >*O_ 6V_\ C]'_  VK\+?^@!XJ_P# 6V_^/U\ 44 ??_\ PVK\
M+?\ H >*O_ 6V_\ C]'_  VK\+?^@!XJ_P# 6V_^/U\ 44 ??_\ PVK\+?\
MH >*O_ 6V_\ C]'_  VK\+?^@!XJ_P# 6V_^/U\ 44 ??_\ PVK\+?\ H >*
MO_ 6V_\ C]'_  VK\+?^@!XJ_P# 6V_^/U\ 44 ??_\ PVK\+?\ H >*O_ 6
MV_\ C]'_  VK\+?^@!XJ_P# 6V_^/U\ 44 ??_\ PVK\+?\ H >*O_ 6V_\
MC]'_  VK\+?^@!XJ_P# 6V_^/U\ 44 ??_\ PVK\+?\ H >*O_ 6V_\ C]'_
M  VK\+?^@!XJ_P# 6V_^/U\ 44 ??_\ PVK\+?\ H >*O_ 6V_\ C]'_  VK
M\+?^@!XJ_P# 6V_^/U\ 44 ??_\ PVK\+?\ H >*O_ 6V_\ C]'_  VK\+?^
M@!XJ_P# 6V_^/U\ 44 ??_\ PVK\+?\ H >*O_ 6V_\ C]'_  VK\+?^@!XJ
M_P# 6V_^/U\ 44 ??_\ PVK\+?\ H >*O_ 6V_\ C]'_  VK\+?^@!XJ_P#
M6V_^/U\ 44 ??_\ PVK\+?\ H >*O_ 6V_\ C]'_  VK\+?^@!XJ_P# 6V_^
M/U\ 44 ??_\ PVK\+?\ H >*O_ 6V_\ C]'_  VK\+?^@!XJ_P# 6V_^/U\
M44 ??_\ PVK\+?\ H >*O_ 6V_\ C]'_  VK\+?^@!XJ_P# 6V_^/U\ 44 ?
M?_\ PVK\+?\ H >*O_ 6V_\ C]'_  VK\+?^@!XJ_P# 6V_^/U\ 44 ??_\
MPVK\+?\ H >*O_ 6V_\ C]'_  VK\+?^@!XJ_P# 6V_^/U\ 44 ??_\ PVK\
M+?\ H >*O_ 6V_\ C]'_  VK\+?^@!XJ_P# 6V_^/U\ 44 ??_\ PVK\+?\
MH >*O_ 6V_\ C]'_  VK\+?^@!XJ_P# 6V_^/U\ 44 ??_\ PVK\+?\ H >*
MO_ 6V_\ C]'_  VK\+?^@!XJ_P# 6V_^/U\ 44 ??_\ PVK\+?\ H >*O_ 6
MV_\ C]'_  VK\+?^@!XJ_P# 6V_^/U\ 44 ??_\ PVK\+?\ H >*O_ 6V_\
MC]'_  VK\+?^@!XJ_P# 6V_^/U\ 44 ??_\ PVK\+?\ H >*O_ 6V_\ C]'_
M  VK\+?^@!XJ_P# 6V_^/U\ 44 ??_\ PVK\+?\ H >*O_ 6V_\ C]'_  VK
M\+?^@!XJ_P# 6V_^/U\ 44 ??_\ PVK\+?\ H >*O_ 6V_\ C]'_  VK\+?^
M@!XJ_P# 6V_^/U\ 44 ??_\ PVK\+?\ H >*O_ 6V_\ C]'_  VK\+?^@!XJ
M_P# 6V_^/U\ 44 ??_\ PVK\+?\ H >*O_ 6V_\ C]'_  VK\+?^@!XJ_P#
M6V_^/U\ 44 ??_\ PVK\+?\ H >*O_ 6V_\ C]?3-?C/7[,4 %%%% !1110
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MTJ[H"49@JYQA3CI7Q5_PEGBC_H9M5_\  R3_ .*H_P"$K\4?]#-JO_@9)_\
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M** "BBB@ HHHH *_9BOR#\+*K>,]#21=RM?P*RGD$>8O%?KY0 4444 %%%%
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M]1_PRY\=?^A%_P#*G9__ !Z@#QBBO9_^&7/CK_T(O_E3L_\ X]1_PRY\=?\
MH1?_ "IV?_QZ@#QBBO9_^&7/CK_T(O\ Y4[/_P"/4?\ #+GQU_Z$7_RIV?\
M\>H \8HKV?\ X9<^.O\ T(O_ )4[/_X]1_PRY\=?^A%_\J=G_P#'J /&**]G
M_P"&7/CK_P!"+_Y4[/\ ^/4?\,N?'7_H1?\ RIV?_P >H \8HKV?_AESXZ_]
M"+_Y4[/_ ./4?\,N?'7_ *$7_P J=G_\>H \8HKV?_AESXZ_]"+_ .5.S_\
MCU'_  RY\=?^A%_\J=G_ /'J /&**]G_ .&7/CK_ -"+_P"5.S_^/4?\,N?'
M7_H1?_*G9_\ QZ@#QBOV8K\SO^&7/CK_ -"+_P"5.S_^/5^F- !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !7P#^VI_R6W1O^Q?A_]*;BOOZO@']M3_DM
MNC?]B_#_ .E-Q0!\RT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110![/^RW_R<WX1_P"WS_TC
MFK],:_,[]EO_ ).;\(_]OG_I'-7Z8T %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P"^&_QKTVB@#S+_ (4#\&_^B>Z5_P!\-_C1_P *!^#?_1/=*_[X;_&O3:*
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M'6L+>*XF_P"$9N_DGF:)<>?'SD(W/MBH/@NL]EXI^)FDZDB)KRZ]]NO5MO\
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M ?9G_#<__5+O_*W_ /<]'_#<_P#U2[_RM_\ W/7QG10!]F?\-S_]4N_\K?\
M]ST?\-S_ /5+O_*W_P#<]?&=% 'V9_PW/_U2[_RM_P#W/1_PW/\ ]4N_\K?_
M -SU\9T4 ?9G_#<__5+O_*W_ /<]'_#<_P#U2[_RM_\ W/7QG10!]F?\-S_]
M4N_\K?\ ]ST?\-S_ /5+O_*W_P#<]?&=% 'V9_PW/_U2[_RM_P#W/1_PW/\
M]4N_\K?_ -SU\9T4 ?9G_#<__5+O_*W_ /<]'_#<_P#U2[_RM_\ W/7QG10!
M]F?\-S_]4N_\K?\ ]ST?\-S_ /5+O_*W_P#<]?&=% 'V9_PW/_U2[_RM_P#W
M/1_PW/\ ]4N_\K?_ -SU\9T4 ?;.D_MH_P!I:W8:9_PK;R?M=Q'!YG]L;MFY
M@N<?9QG&>E?7]?D%X3_Y'?0?^PA;_P#HQ:_7V@ HHHH **** "BBB@ HHHH
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M?&U%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ K]F*_'[0;.'4/$VE6%P#Y%S=Q0R!3@[6< \_0U^P- !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !7P#^VI_R6W1O^Q?A_]*;BOOZO
M@']M3_DMNC?]B_#_ .E-Q0!\RT444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &WX3_ .1WT'_L
M(6__ *,6OU]K\@O"?_([Z#_V$+?_ -&+7Z^T %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %? /[:G_);=&_[%^'_TIN*^_J^ ?VU/^2VZ-_V+\/\ Z4W%
M 'S+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 ;?A/\ Y'?0?^PA;_\ HQ:_7VOR"\)_\COH
M/_80M_\ T8M?K[0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\ _MJ?\
MEMT;_L7X?_2FXK[^KX!_;4_Y+;HW_8OP_P#I3<4 ?,M%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 5^S%?C/7[,4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %? /[:G
M_);=&_[%^'_TIN*^_J^ ?VU/^2VZ-_V+\/\ Z4W% 'S+1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 :>C6*ZGK^GZ?)(8TNKB.!G7DJ&8+G]:_86OR"\)_\ ([Z#_P!A"W_]
M&+7Z^T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %? /[:G_);=&_[%^'
M_P!*;BOOZO@']M3_ )+;HW_8OP_^E-Q0!\RT444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &UX
M>NH+'Q1I-[=2>7!;WD,LCX)VJK@DX')X%?K]7XSU^S% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !7P#^VI_R6W1O^Q?A_\ 2FXK[^KX!_;4_P"2VZ-_
MV+\/_I3<4 ?,M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MHK[,_P"&&/\ JJ/_ )1/_NBC_AAC_JJ/_E$_^Z* /C.BOLS_ (88_P"JH_\
ME$_^Z*/^&&/^JH_^43_[HH ^,Z*^S/\ AAC_ *JC_P"43_[HH_X88_ZJC_Y1
M/_NB@#XSHK[,_P"&&/\ JJ/_ )1/_NBC_AAC_JJ/_E$_^Z* /C.BOLS_ (88
M_P"JH_\ E$_^Z*/^&&/^JH_^43_[HH ^,Z*^S/\ AAC_ *JC_P"43_[HH_X8
M8_ZJC_Y1/_NB@#XSHK[,_P"&&/\ JJ/_ )1/_NBC_AAC_JJ/_E$_^Z* /C.B
MOLS_ (88_P"JH_\ E$_^Z*/^&&/^JH_^43_[HH ^,Z*^S/\ AAC_ *JC_P"4
M3_[HH_X88_ZJC_Y1/_NB@#XSHK[,_P"&&/\ JJ/_ )1/_NBC_AAC_JJ/_E$_
M^Z* /C.BOLS_ (88_P"JH_\ E$_^Z*/^&&/^JH_^43_[HH ^,Z*^S/\ AAC_
M *JC_P"43_[HH_X88_ZJC_Y1/_NB@#XSHK[,_P"&&/\ JJ/_ )1/_NBC_AAC
M_JJ/_E$_^Z* /C.BOLS_ (88_P"JH_\ E$_^Z*/^&&/^JH_^43_[HH ^,Z*^
MS/\ AAC_ *JC_P"43_[HH_X88_ZJC_Y1/_NB@#XSHK[,_P"&&/\ JJ/_ )1/
M_NBC_AAC_JJ/_E$_^Z* /C.BOLS_ (88_P"JH_\ E$_^Z*/^&&/^JH_^43_[
MHH ^,Z*^S/\ AAC_ *JC_P"43_[HH_X88_ZJC_Y1/_NB@#XSHK[,_P"&&/\
MJJ/_ )1/_NBC_AAC_JJ/_E$_^Z* /C.BOLS_ (88_P"JH_\ E$_^Z*/^&&/^
MJH_^43_[HH ^,Z*^S/\ AAC_ *JC_P"43_[HH_X88_ZJC_Y1/_NB@#XSHK[,
M_P"&&/\ JJ/_ )1/_NBC_AAC_JJ/_E$_^Z* /C.BOLS_ (88_P"JH_\ E$_^
MZ*/^&&/^JH_^43_[HH ^,Z*^S/\ AAC_ *JC_P"43_[HH_X88_ZJC_Y1/_NB
M@#XSHK[,_P"&&/\ JJ/_ )1/_NBC_AAC_JJ/_E$_^Z* /C.BOLS_ (88_P"J
MH_\ E$_^Z*/^&&/^JH_^43_[HH ^,Z_9BOC/_AAC_JJ/_E$_^Z*^S* "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "O@']M3_DMNC?]B_#_P"E-Q7W]7Q#
M^UGX)\9>)?BWI5]X?\(ZUK%JFB0PM/8Z?+<1JXN)R5+(I .&4XZX(]: /D6B
MNT_X5/\ %+_HFGBK_P $US_\11_PJ?XI?]$T\5?^":Y_^(H XNBNT_X5/\4O
M^B:>*O\ P37/_P 11_PJ?XI?]$T\5?\ @FN?_B* .+HKM/\ A4_Q2_Z)IXJ_
M\$US_P#$4?\ "I_BE_T33Q5_X)KG_P"(H XNBNT_X5/\4O\ HFGBK_P37/\
M\11_PJ?XI?\ 1-/%7_@FN?\ XB@#BZ*[3_A4_P 4O^B:>*O_  37/_Q%'_"I
M_BE_T33Q5_X)KG_XB@#BZ*[3_A4_Q2_Z)IXJ_P#!-<__ !%'_"I_BE_T33Q5
M_P"":Y_^(H XNBNT_P"%3_%+_HFGBK_P37/_ ,11_P *G^*7_1-/%7_@FN?_
M (B@#V;]BO\ Y+;K/_8OS?\ I3;U]_5\0_LF>"?&7AKXMZK?>(/".M:/:OHD
MT*SWVGRV\;.;B A0SJ 3A6..N ?2OMZ@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** $/6J-]/<6ME-<6MC+?3(I*6\3*K2'T!<A1^)%7CUJM/<0VUN]Q<3)#%&I
M9Y)&"JH'4DGH*0'/^!?$C>-/ ^G>)6L#IQO5<FV,HE,>UV3&X  _=]*T/$5U
M<6/A;5KZUD\N>WLYI8WP#M94)!P>#R*X#X4ZOI^C_ [3+N_D:..Q\U;A4B>2
M2(M.^ 44%LD,IZ=#GI7>^+/^1'U[_L'W'_HMJ;5FR8NZ5S\ZO^&H_CK_ -#U
M_P"4RS_^,T?\-1_'7_H>O_*99_\ QFO&**"CV?\ X:C^.O\ T/7_ )3+/_XS
M1_PU'\=?^AZ_\IEG_P#&:\8HH ]G_P"&H_CK_P!#U_Y3+/\ ^,T?\-1_'7_H
M>O\ RF6?_P 9KQBB@#V?_AJ/XZ_]#U_Y3+/_ .,T?\-1_'7_ *'K_P IEG_\
M9KQBB@#V?_AJ/XZ_]#U_Y3+/_P",T?\ #4?QU_Z'K_RF6?\ \9KQBB@#V?\
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M9KQBB@#V?_AJ/XZ_]#U_Y3+/_P",T?\ #4?QU_Z'K_RF6?\ \9KQBB@#V?\
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M9KQBB@#V?_AJ/XZ_]#U_Y3+/_P",T?\ #4?QU_Z'K_RF6?\ \9KQBB@#V?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5D:Y93:EX<U'38=BR
MW5K+ A<D*&9"HSC/'-:]% 'P#_PQ7\4O^@_X5_\  JY_^,4?\,5_%+_H/^%?
M_ JY_P#C%??U% 'P#_PQ7\4O^@_X5_\  JY_^,4?\,5_%+_H/^%?_ JY_P#C
M%??U% 'P#_PQ7\4O^@_X5_\  JY_^,4?\,5_%+_H/^%?_ JY_P#C%??U% 'P
M#_PQ7\4O^@_X5_\  JY_^,4?\,5_%+_H/^%?_ JY_P#C%??U% 'P#_PQ7\4O
M^@_X5_\  JY_^,4?\,5_%+_H/^%?_ JY_P#C%??U% 'P#_PQ7\4O^@_X5_\
M JY_^,4?\,5_%+_H/^%?_ JY_P#C%??U% 'P#_PQ7\4O^@_X5_\  JY_^,4?
M\,5_%+_H/^%?_ JY_P#C%??U% 'P#_PQ7\4O^@_X5_\  JY_^,4?\,5_%+_H
M/^%?_ JY_P#C%??U% 'P#_PQ7\4O^@_X5_\  JY_^,4?\,5_%+_H/^%?_ JY
M_P#C%??U% 'P#_PQ7\4O^@_X5_\  JY_^,4?\,5_%+_H/^%?_ JY_P#C%??U
M% 'P#_PQ7\4O^@_X5_\  JY_^,4?\,5_%+_H/^%?_ JY_P#C%??U% 'P#_PQ
M7\4O^@_X5_\  JY_^,4?\,5_%+_H/^%?_ JY_P#C%??U% 'P#_PQ7\4O^@_X
M5_\  JY_^,4?\,5_%+_H/^%?_ JY_P#C%??U% 'P#_PQ7\4O^@_X5_\  JY_
M^,4?\,5_%+_H/^%?_ JY_P#C%??U% 'P#_PQ7\4O^@_X5_\  JY_^,4?\,5_
M%+_H/^%?_ JY_P#C%??U% 'P#_PQ7\4O^@_X5_\  JY_^,4?\,5_%+_H/^%?
M_ JY_P#C%??U% 'P#_PQ7\4O^@_X5_\  JY_^,4?\,5_%+_H/^%?_ JY_P#C
M%??U% 'P#_PQ7\4O^@_X5_\  JY_^,4?\,5_%+_H/^%?_ JY_P#C%??U% 'P
M#_PQ7\4O^@_X5_\  JY_^,4?\,5_%+_H/^%?_ JY_P#C%??U% 'P#_PQ7\4O
M^@_X5_\  JY_^,4?\,5_%+_H/^%?_ JY_P#C%??U% 'P#_PQ7\4O^@_X5_\
M JY_^,4?\,5_%+_H/^%?_ JY_P#C%??U% 'P#_PQ7\4O^@_X5_\  JY_^,4?
M\,5_%+_H/^%?_ JY_P#C%??U% 'P#_PQ7\4O^@_X5_\  JY_^,4?\,5_%+_H
M/^%?_ JY_P#C%??U% 'P#_PQ7\4O^@_X5_\  JY_^,4?\,5_%+_H/^%?_ JY
M_P#C%??U% 'P#_PQ7\4O^@_X5_\  JY_^,4?\,5_%+_H/^%?_ JY_P#C%??U
M% 'P#_PQ7\4O^@_X5_\  JY_^,4?\,5_%+_H/^%?_ JY_P#C%??U% 'P#_PQ
M7\4O^@_X5_\  JY_^,4?\,5_%+_H/^%?_ JY_P#C%??U% 'P#_PQ7\4O^@_X
M5_\  JY_^,4?\,5_%+_H/^%?_ JY_P#C%??U% 'P#_PQ7\4O^@_X5_\  JY_
M^,4?\,5_%+_H/^%?_ JY_P#C%??U% 'P#_PQ7\4O^@_X5_\  JY_^,4?\,5_
M%+_H/^%?_ JY_P#C%??U% 'P#_PQ7\4O^@_X5_\  JY_^,4?\,5_%+_H/^%?
M_ JY_P#C%??U% 'P#_PQ7\4O^@_X5_\  JY_^,4?\,5_%+_H/^%?_ JY_P#C
M%??U% 'P#_PQ7\4O^@_X5_\  JY_^,4?\,5_%+_H/^%?_ JY_P#C%??U% 'Q
M]\'_ -F7Q[\/?B[H?C#6M6T&XL+#S_-CL[B9I6WP21C:&A4=7&<D<9K[!HHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ J&218T:21@J*,L6. !ZU-6+XL_Y$?7O^P?<?^BVH 3_A+/"__0S:5_X&
M1_\ Q5'_  EGA?\ Z&;2O_ R/_XJOR"HH _7W_A+/"__ $,VE?\ @9'_ /%4
M?\)9X7_Z&;2O_ R/_P"*K\@J* /U]_X2SPO_ -#-I7_@9'_\51_PEGA?_H9M
M*_\  R/_ .*K\@J* /U]_P"$L\+_ /0S:5_X&1__ !5'_"6>%_\ H9M*_P#
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M_P"*O_ JV_\ C%'_  Q5\+?^@_XJ_P# JV_^,4 ? %%??_\ PQ5\+?\ H/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\#:%H6AR1^(+$+>-K5E9+%'+<SS)B%HWG= $0A0?F#'KM.<!/9V[:#72_?\
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M8\'&3O:Y\,[KXF_!FST/7]'E\)^)M.?=87,LD4\EM*K9#*\+M\C#@C((QG'
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MA4B1/,#2#/\ K!YB!,+UW9!P* .CHHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** / ?&4UM-^TYH5O_P )<_AN6+PY=;[FVDM?,7,T9",+B.11
MN'/W<\<'K7"S7$.G_!?XW:;/J-MJR+<ED\1AMIU>65 Q4_,4+QX"8CPO PH.
M<_6_>BE'W58INYY7H>M:;H5UITUY\2KGQ&MW#Y,=E-)8_NCA7:7]Q%%A$1'+
M,Y. ..3@\9XZO]2\1?#74OB5X8%A&UC>QZOIU[)??.8[;*"/:$VXD0S$+O\
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M)*D?PYP1;M_AS:V_C'6_$DGB36;PZW +:\L)S;_9WB565$&V$2#:';!WY/\
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M"[#<>!Z4_P >:#XAC\9'Q3X*BU6+Q #;6QM699-+U:'>-WGJ?]6T:LY#Y4\
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MUJQMI5,*:LEI&5EB!; !R01G&2HQFN^\57WB#7/#FD>*]+^&NHW!T_5?.NM
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M#X6:IXROM/UG2?MHM+*+2K5[*6"[EB(2217DF\V,*#G:T>"0<'&#W6EL;?\
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MWR*ZE*'XM>#;A+M[=?$$ZVLC0W!B\-:DP@=1EE?%O\I ()!Y&:ZR\UK3-/\
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MYI["3N%%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MND.J7:/)"T9D9]\SN4CC&W:HW'JH'<@ [V7PEX5GLUL9O#.E2VJR"80O91E
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MVB$@1&19%93)E67?SD $X"[BPH [S_A%_#:FX9?#^FAIV#2D6D>9"!@%N.<
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MDQN/'O5'P?XJA\7:)<WT.GW&GW5E>3V%W8W#(TD$\389"R,5/8@@D8(KA_\
MA>^EQ.;B_P#!_B#3])AU=M$NM3G2 PVET)#&5?;*25##EU#*,CDGB@#T&#P;
MX2M[*2QMO"ND06<LXN9(([&)8WE!R)"H7!;_ &NM'_"'^$_+N83X9TDQW;B6
MXC^Q18F<'(9QM^8@DX)]:\^\/^*;W2?$7Q+DO&U+5X;'7K2SLK-93*8_.B@
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MDW1-;.,R8B4L,,P\S)SC/'1R?#7Q9HVI:C'X5UVP?3_$5A#::Q+JB2//'-'
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MT)YXS6=)J-]'XCBA\FT_L:2RDG:]-R XE#H%4)W0JQ)?/! '<4 >0?$+X/\
MCKQ!I/BSPSX8\0Z1%X<\3W$5_<1:G%*UQ;W"R0EO+D7(*$0AOF!.>.,[AZ7X
ML\+WGBCX>2^'3JBV6H%;>6.^CA#)'<02)*C^6Q.5\R-<J3TXSWKITO+23RO+
MN8G\W(CVR [\=<>N*R=3UZWM]"UC4M)EM-1N-,@DD>!;D !T4G8[*&*=#V/T
MH \GO/A'XX\4:EKFI>,/$FE1W>I:7:6\$FDV\B?9[NVG::*0!R<H&P2#G=N(
M&S )WO\ A%?B=JG@:2S\5:MX<US5KF18I[*:T<::]L,Y4KC<TC':=_ 7:-HX
M._J_!OC"#Q)\.M!\6:@+?2SJ]O'*(7F&U7?H@8XW'^==!=ZE8V()OKZWM0%W
MDS2JF%R!GD],D#/J10!XCI/P,\4>$X-%U3P7XRBL-:T]KJ-K6]B>ZL1:7$BN
M;5 6#A(RH93G+,,G;GCMK7POXPMOB7HOB"[O-.U*SL]+GTVXG>1XIYGFEBE>
M18PA555H0JIN/RGEN*W[[Q=I4?B@^$;&\MIO$LFGR:A!9RR[%**RHN]@"5#,
MXQP3@,0#BK'A?Q%;^)-*EN%C\B[M)WL[ZT9P[6MPGWXV(X/4$'NK*>] '@OQ
MQTSQ%I7PG\=7FKG2X8=;U^PO+5K>XDD9"OV: (ZLB@_+;AR0>I(QQFNWUKX?
M^,/%6@>)[K6M1T:#Q%JD-G;V*VBRM:6\=M.;B,.S89RTC-N( P,8'!ST/Q<\
M8M\/_AO>^+VT"#7K?3I(O.M9KGR#AY%C#*?+<$AG'&!QGGL8_#OC_4+KQ]_P
M@OB3P_;Z+JTFGC4[(V5\;V"X@W;&^8Q1E&4XX*X(/!H P-3^&/B;Q5XMUS4?
M%EUI:V6K^&4T&1M/DE$D4@D:7S51EQ@.Y !;HH)ZD5-<>"?B%KL*ZAXKU'0;
MO6M.T^[L=-6R6:&!WN%"/<3$AB"$ PBC&=WS<C;ZG%>6<US-:PW44D\./,B5
MP7CSTW#J,^],M]0L[J1H[>\AG?!.V.16( 8J3P?[P(^H([4 >,#X:_$BVO?"
M.I:9>Z!:7WAOPQ/HD<QGE<&=HMD<X!AQM!2-BISU8<X!+/#WP3U2P\5R:U>R
M:5I]GJ%[:7FJ:9H_FQV]S);&25) KY"EIS"Q084",C+;B:]O6[M9+R2UCN(G
MN(U#/$K@NH/0D=0*Q=?\8>&?"UB]_KFN6EG$A"D/*-[L6*A57J265A@=P?0T
M 4_B-X-M?B!\/]4\)WEY-8K>JACN8>6AD1U=&QW 91D<9&>1U'*-X$^(6O>"
MF@\8>*M/E\36MQ!>:9/86K);6TT#AT>12<REB &X  )"@=3V\6K:Q)X[;2S8
MV8T$Z>+J&_%X#-)-YFUD\K&=@4@[\XR0.<\;$%]9W4CI;W4,[1A681R!BH89
M4G'3(Z>M 'C7B#X9^/?$NC:YJ&I7V@-XMUBPMM()@\Z.SM;6*4S,1E6=Y'=F
MZ[0 1UV_-T^H>%/%6I_%_P *>-&;2H;'2=/GM;BW%Q(TIDF"[RA\L!E4HN,[
M2><XZ5Z!;W5K=>9]GN(I_+<QOY;AMC#JIQT/M4=]=+9P-(TD2,QV1^?+Y:NY
M^ZN[!QD\< GV- 'F'A3X=^./#.O7VC0^++23P%)=2WD-DUH?MJ>;(TCP>8"%
M";V)W?,2"1A<YI? OP[\;>&=_AK4/%T,_@K3_,CTFU@AQ=M$P8+'<2$ %4#<
M!1EB 20!M/3^ O&0\7?#S2?%FI6T&EO?LZF#SMRHPE:,*&(&2=OH,YK7;Q)H
M(\5CPO\ VI;'6?LYN6M!(#(D>Y5!8=LEA@'K@XZ4 >4^&?AK\0/"_@;P3X9^
MW>'[[_A%]8>^6<R30^=;[95"$;&^<B=R6Z+A1AN6KKF^'-N_QK'CQ;C9:/;1
MR36:DXFOHUDACN&&,?+!+(F,]2IQE0:[B.^M;EYX[&Y@N9H"5=$E!V-_=;&2
MOY5YU<?$;7-.\:?#GPSJGA^SCG\60W+7#P7QE%G)!")&1<)AQEE&[=Z\< D
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MNB6SG1=%76()3=L/M.XN-C?N_P!W]P]-W:@#AO#/P?\ &7A;PAH#Z?J&B?\
M"7>';R]>UDD:5[.ZM[I@TL4N%#J<XP0#C:.NX@7I_A)XBBU[0]<M+S3;C4!X
MD;Q'J[RO)$CN8_*$,"A&PJH3RQR2,]\#O_#/BN^\1_"C3/&$>FP+=WVFI??9
M'G*Q@E=Q7?M8X]]IJ_X.\21^*/!FAZXRQ07.HZ;:W\MJDF\P>=$' ]<<D D#
M.* ,3X>^&?$/AF;Q2NM?V>T6K:U/JMN;*9W:,2XS&^Y%Y&T?,.N[H,9/E7A'
MPOJGQ$TWQ;X?NKS3'\'/XVU&[N'AD?[6WEW1D6)<#9M9@C;]V=I( Z,/?+;Q
M!H%]K5UH=GK>GW6J6B[KFQBN4>> ''+Q@[E'(ZCN*K7^O>$?##F/4M9TG1OW
M?G,MQ<16_P @.-YW$<9(&?>@#S*]^&?CB\_X3K;?:'#_ ,)#K%IJ4-O,9)X)
M8HMBO;W"[%)1UC7.T\Y*G@G.%=?!7Q\T44:ZQX=GBB\90>*PBP36HW1Q*AB
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M)A6.!B,C#?,8R3@C(YKZ4UCQ9X7\.SB/Q!X@T_26*>9F]N4A4*3@99B ,G.
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MG6/&=YC)W!<<YQBK&GZGI^I37<=C=++)93&WN(^0T4@YVL#R."".Q!!&00:
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MN)M0^*?C#4Q;W)BNO \,:RRV[Q[Y092R?,!\WS XZX(/2OH%6#*&7D$9%.H
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M$4D3QN,-'B5\*1V^7''IBO3Z*!K06BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@#R;Q=XJUCP]X^3^V+^_T/PJ8H%@U..UBGLGF:0K)'<D@R1,?E",
M"J9;YL]#Y[_;'B[P[X8^,/B/3?%U_+=Z=K_V>!;V*&=(U(M^5&P$$!]H&2@
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MNXO(7M8/*:XCC1DF&U%8'+G*A@I ' YSZG)X9T236+;5I+-S>06AL5;SY,/
M2"4==V)!D9^8$]?4UDP_#7PC;QZ7#;Z?<PII$<D5B(]0N5^S)( '5,2<*0 ,
M= !@4+L(\N\(^-?B#JGPC\*>)KCQ-!=:MXMN1I\:72PV4-I(#<-O218)/F98
ME0!T<;L<<UZKX)A\<6NB7%OX\N]-O=0CG;[/+82EV: _=\T^5$IDSD$JBJ<#
M@<U7/PN\#_\ ""0^!6T,OX>@?S8;1[J9C$P;<&20OO4@DD888R?6NDTK1;#0
M[(V=BMPR,VYGN;J6YE<X RTDK,[< #DG@4W9WL-7LKG&^%=+M?%'@/Q#_:4.
MV7Q!>ZE!>%E!?:)Y;=%.?[L:* /:O%O^$VU+2_#_ (.U;4M,BEUOX<W#6GB&
MXVDR16YD^Q@9ZGS(V,W<9B![U]%:-HM]H^L:JL=U%-H]Y.UY! 5*R6LSG,J@
M]&1F+/S@@LPY!&'3>#?#-Q'X@AN-&@>/Q%C^U <_Z5B,1C=SQA0!QCUZDFHV
MM?4??H>8?$)9K_X ?$?Q-<!3_;$$DEJ!R!:1X2 @]PRJ9?;S35#Q)J&K6OQ&
M^&NH^.M+M/#]@EV;>SO](O6O&N;F2/;';S%HHFCC89)PK@D ''4>OZMX/\/Z
MWX1/A'4+-WT3R5MS:Q7$L0,:C 0LC!B, <9JO-X#\+W.H:;?7FGSW\VER":S
M%[>3W"6\@Z.J2.5##LV,CM5II?>2SR'7FOOA_I6JMJFEP^,/AGJ.H37UUJ<#
M!K_29GF^9F5LB58Y!PP^9<<_=&>X\2:S<:5\=_ 4.GMN@\06=_:7:#HR1(DT
M4A]U.X#/02-ZUT<OP^\*S6,NFS:;++I\\S7$MFUY.;>1VD\QBT6_807)8@C!
M/:K$?A\W/C8>)M2AA\VQMWL]/5&+F*-VS(YRHPS[8Q@9P$ZG<:%H/>[[G*^/
MKS[!\6_A_?;"_P!GM=8EV#JVVW0X_2L'P7>_%CQK::?XFF\2Z38>'M=L&D7[
M#<QW,MI*5RA@1[-0"I!5TEDE_BP1BO3]4\*Z/J_B'3M?OK>>34-+#BUD6ZFC
M6,.,/\BL%;( !R#D<51\-_#_ ,*^$[EI/#VGSZ?$6:1;5+V=K:-F^\R0,YC0
MG)Y50>3ZT:-:ALSRS0_&_BRZ\-Z=>'Q)J-[J'AA-2F\4P&WM%\U[8$+ 0L(V
M;W *;2IV;\EC@B?2]6^)&O\ @34/%6M:AI#^'-:\/W%Q':Q7@E>&1H"Z"%1:
MQ$ #<&5Y)3QPW!SZWI_AK1=+UC5]4T_2XK:\UITDOY%S^_95V@L"<=/0#/.>
M:Q]-^&O@W2;&]TW3=/NK:PO(Y(7LX]1N?(C1SEQ%'YFV'.3GRPO7%3_7S&^@
MGPSD6'X)^#Y6=45-#M6+N<*N(%Y/M7 :7XP\>-J^I:/I=]+XDOKGPNVLV+75
MM%;P/=APNRV(2-C 2PVF4$G .X@DUZ[IOA_2=)\+P>&[&U8:5!!]E2WEE>;$
M6-NS<Y+$8XY/2LBW^'GA.SN;6XM[&Z66UL?[-A;^T+DE+?<&$?,G0%5([C'%
M-N\F^C(LU%+JK&=\.O$S:Y%>V=WK.H3ZKIZQ+>:=JUG';7EF[!F_>>6JHX;^
M%D&W:HZG)KG]1\7>(++XBZ<+77);_3[K7AI$MG;V\7V.WC,!;#RL@D-P'!)"
M.R <%0:]&TWPWI&CZG?:E8V[+>Z@(Q<W,LTDTDH0$("SL3@9.!T&3ZUFO\/_
M  J]SYO]GS1N=1_M;$5Y/&HNL$&4*K@ G)S@8.3D<TOM+L4]M-S@+7Q-\2-0
M\6ZCY,LD3VOB(Z7'IR:>+BP^P?*?M+S* PE"L6(,J@$!=F344?CCQ9IWAGQU
MXJU#6H[P:#K-SI=O9&WC@MR"T*1N[A6<!"Y).3P6SNP,6+'P3J37^KV[:/XC
MT;4KZ\N;R/5]/\0R+IT;O(61_LXN%+'&TE6@(8@Y.#QWMGX#\,V6FZUIL.GO
M)9:Z\DFHPW-S-.MP\@P[$.QP2.N,=O2GT#KY7//=4\2?%+P#X;O;GQ-?Z!=_
M:[NUMM.FN=0W/;F658Y&F>.SA01KN!#"(E2?FW"K UCXD>';:RT/Q9JUG)=^
M(-8BT_3K^TE2XGLXGC=Y&D/V:&)F'ED)^ZQEOF#;>>RB^&?@M?"UUX9FT>2]
MTFZC2&2WO[N>[^1#E$5I79D53R I !Y%6(_A_P"%X]$71VM;RXM8Y8YHFN=1
MN9YH7C.8S',\ADCVY.-K#&3ZFD_(:.#^%-K=6?Q7^+-K>7\NHS1W]BK7,JHK
MR_Z*,,P157=C&=J@9Z 5D>._%GC3PW\//'NH:?XJNWO=!\16EM:7$MK:EC;R
MQVI:%@(@I -P^&P&X7YCSGUK1?"&@Z#J^J:QI-K-%?:JR/>RRW4TQG9%"J2'
M<C( QD51USX<^#O$4.JPZUI<US#JLL5Q>0B\GCCGDCV!'*(X7<!&@R!DA1G-
M#?O*72Q-M+>9YKJGC+QQ;GXHZHGB;RU\&7"3V=HEG"(;F/R%F,,I92Y!SMRC
M*W?/:K<7CKQ7XFTOQAX@TW5FT ^%(UE32?(CE%U_HJW#"X+J7"L254QE" "?
MFJQX1\"WUWX[\?3^*O#.HVVD:K>6\UHMUJ"/%<QQQ+&1)'%.V[)3/[Q3D'GG
M(KT*Y\#^&;K6=0U:33/+N]3C6&^,,\L2WB*-JK*B,%DPI*_,#P<=*%\.N[M\
MAOXM-E^)Y)XA\?>-Y)/B'>Z=KTFDP:)H%CK5C:K9PLT;O'([Q2%U8L#M ;H>
M!M*\Y]&\7>(=5L_@AJ_BW29EM-3AT5]1A=HPZHXA\S[IX/ISG\:MZE\-?!VL
M7NM7FH:=<2S:[;K:Z@5O[E%N(ESM0JL@  R>@'4^M:EQX9TB^\(R^$KNU>31
MY+7[&\'VB4,T.W;L,@;?TXSNR13>NV@XZ-7/+=)\4>--9/AFWD\3-:+J?@DZ
MO++;V</FBZ7R,R NK+R9&XV[<'&,X(Z_X=^(-2\?_!?1M>O+J33]1U2Q)EN+
M1%#1R E2Z!PR@Y&1D$>U7[3X=^$[.:SDL[2\B>RT\Z5!C4KHB.U(4&, R=/E
M7GKE0<Y%:WAKPOHOA'P];>']!M6M=,M 5A@::2;8"22 TC,V,D\9H>J:[BZW
M['SI;V.JS>*OV?1-XHU.YNK[3[^9;R=+=I;7=81\1XB"MCD@R!SD_,6Z5W"^
M,O&U]X=\,:#INI6AU[5+K5+4W]W/'9O*+.=HQLQ;S1^8R@,1Y6WY6QCBNY7X
M:^#UU'0KQ-/NA-X?1X]-8:C<_P"B*Z[&51YF,%0!@] !BFW7PM\$WFC6^CW6
MDSS6EK>/J%N6O[GS;>X9B[21R^9O0EF8_*PY-&X^B)-#_P"$YM_A[+#XJU#2
MF\301RAKJP5I8>,E&*LJ?-MQD8 SR!CBN TOQ=XVA3X77\_B!;]?&ED(KJUF
MM(PMO-]D,PGBV!6ZCYE9B#GC;7I]Y9_V'X2N[71=*O=4D6,A+9;@23SLW!)D
MN)!N/.27?.!WX%<G\.?!-O9^ _#7_"2>'[^PU_2-/6PQ>7YG:W;RU21X#',Z
MQAL8!0JV.,#I4[M_(-K'%V?Q \96_P /_!_B"_\ $#7-UXJU=-#;=:PI#IY:
MXF4W"83)?8@4*Y9<X)'4%WC;Q[XU\(>%_B)I-KK4MYJ/ANSL[^SUFZM83(R3
MN5,<B(BQEE*G#! ".HR,GU.'P!X1MO"7_"*QZ4SZ0DOG);RW,TIBDW[PZ.SE
MT8-\P*D$'D5R7Q(\%ZEKGA;5?!'AS092/$,*+=:Y/>"06[(Z8\T2.97&Q3MV
MAL'CC)-/9-=1Z.2?0S[OQ)\2O$7C#6K'P3<:;91>&Y;:*9-0O1&ER7A29FEC
M%I*Y0ABJE)8CD$G-=#HNH>(/&&JWFI:7XN33(=(UB73Y]+CLXKB&6*(X8.QQ
M('8?,K*RJ 5RC=]N\^'_ (5U#7$UVZL)O[2^SI:RS6]Y/;BYB7HDR1NJS+UX
M<,,<=*DC^'OA6W\577B>VL;BUU.[97NFMKZXABNF48!EA1Q')Q_>4TT2[Z6.
M9^&%GJT-[XPN+[Q5JVL+'K=Q;K#>^057:L>&!2)6!Q\N,[  ,*.M4O\ A-=?
MT/QIJMOXPFO--A-U-_9-JMFDMGJ5LD3NJQS*-R7!P2RR-SM 5>2:](T_0M-T
MN\OKJPMW@DOYC<7&)G*/(0H+["=H)"C. /U-4V\(Z"U];WLEI++);73WL*2W
M4SQ1S/NW.(RQ0'YW[<;CC%39VT>I=U=Z;G#:+?Z]XG^%LWC:X\2-/8ZUH,UQ
M)I/V>(PVKM%D"&1563Y?F5O,+Y/3;C%<3X/\8:YX/\/> T:\DU'1[GP3/J+:
M:88U$4EK%$R^6X7?E@Q!W,PSR .E>P6'PY\)Z5!>66G6-U:V5VLB/9IJ%R+>
M,29W^5%YFR$G<W,84\GUI-/^&WA#2[S1[NQTVX271;5[&QWW]Q(L,# !H]K2
M%6! 'W@>@]!5.]FNY.E[O4\Y_P"$N^*'AOPA?^/-:NM%U#1+G2Q>6L!OO.=)
MW :/R]EK!^ZPV65FD8!<A^N5\16WB;1?'&HW3>++B?48?!M_>6]^MI;K)"Z3
MP.4"^64,>0  RLV"<L3AJ]!TWX9>!]*TN[TFUT=FTNZBD@>RN;R>X@2-^76.
M.1V6('N$"]!Z59C^'OA2&>&;['=2O#9/IJ^?J%S*#;/C=$0\A#*<#@YZ#TI-
M+2W0$[7.*T/Q5XINOBCX2TNZUJ2;3M6\)?VE<6S01*OVE3$#(K*@<9WG*[L>
M@%<GX7\0>*O^$%^'7@GPC=6EA?ZCH#WWVFXNU@D/EE $B+6]PK'YB6!CSM'!
M&*]:M?ASX1M=1T_4;>QO$N].LFT^UG.I73/%;GK&"9,XX'7D8&*BD^%/@6;2
MM&TUM'G6'1"3ILL>H7*7%GD $1SK()%! ' ;'%5=?(E)Z%VSN/$VF_#AK[Q'
M?Z0NOVEC*US<HS?8A*BM\Y)56"\ MP,?-@5Y*_CWQMIR^/M+37;B\ETCPW'K
MEG?:GIL<,GF8?>JQJL?[HE,+YB[QSG<,9]PDT/3YO#LWAZXLVGTVY@>WFCFE
M=S*C@APSDEB3DY8G)SG.:Y^X^%_@N\N+R2ZL;R62^T\:7<NVIW6Z:V!)$;'S
M<D?,>>O/6I?7S'U1YW>?$KQ'X12[N]0OGUQ9/!@\1)#/%%&L-PK*A13&JGRV
M+@G=N(QP0.*Z/2[77(?C#X:N=6UTZN]WX?U"8,8(XA"QFLBR)L S'R-N[<PY
MRS5TA^&_@V2[BN9-'DG>+33I"QSWD\L9M",&%D9RK*<#J"> :LZ;X&\.Z7>:
M9>65M=QS:5 UK9EM0N7$43;<QX:0@K\B?*00-H]*?NZ:;"M+N<[J^NZQKGQ1
MO_A_H_B!O#4MEI,6J)=0PPS37#O(Z8VRJRF)=J[L ,2P^9<<T=8USQ5?:EXL
ML=,\02:5=>$;*";Y+2)H=2F>%I2TBR*S"([=H$;JP.[YC@8[#7/ ?AGQ!KEM
MK6I6<Z:I:QF*&^LKR>SN%C)R4\R%T8KG^$DCGI4U_P""_#VI7C7=U:S>;):B
MQE\JZFB$\ SB.0(X$@&YL;LXW-ZFIU:TT9>B\SS/3/B1XDOCX?\ $GB#[7X=
M\-ZOI=G/;W=K:+=6GVF;B2.Y.TR18)3RVRJ?-\Q;I70_#&SU:&_\8W%]XJU;
M6$37+BV6&]\@JNU8\,"D2L#CY<9V  84=:ZN?P3X=N8#;R6+I;'R@;6*XEC@
M(C"A 8E8(0 BC&,<5>T[0M.TN\OKJPMWADOYC<7&)G*/(0H+["=H)"C. /U-
M'VK] Z6/+I_$WQ&\4>-_$4/A"XTK3]/\+ZBEE/#?WPC6X4(DCO*GV21\$,P5
MDFCQC)!QS;F\1:TOBG6M#U[6M9T"YN3<QZ6C6MN;2YC6)RC6LX0L)0NUV64L
M<J=JXS79WG@7PS>>)9/$TVGS1ZI,B1W$EO>3P)=*OW5FCC<), .,.K<<=*LR
M>$M#FU.#4+FT>YFADDFA$]Q+(D3R!@[(C,54D.PR .&([TUV8GOH>0^ M4\2
M:3\,?A')'X@N;N+6[V.*\6[AB=S&]M+)L5PH(4-'G)W.=QR_:JVC^-/'5U87
M.KW7BAW>R\=-X=^S+8P"":V:=(1N&W>"N[<"''/WMPZ>K0?#GPI;Z;HFF1V-
MW'::'-Y^GQ+J%R!;N%*@C]YSA68 '( ) JM#\*?!-O:S6MO8WD<4NI?VQ(HU
M2[^:[W!O.SYOWMR@^F1TH>K;[O\  A75C@6\;>*+?6?%_A63Q;;0/INO6-C;
M:C>6Z&[DAN(A(\4,<4>R2<<B/,9&/O9QFLV36?%7BGP7H<>H^(]5T^]M/&XT
MIYXX[:.>6-)#L,RA'B+K@'"C9D9(.*]0NOA5X'NM9NM8N-)G>_NKV'49)VU"
MYW?:(E*QR+^\^4JI(^7'''2KP\ >$UM);9=.G$<FH#56Q>SAA= Y\U6WY4YZ
MX(![YIZ7172QYYH?BCXC^+O%5[>:)J.FV^AZ!KDFD7MO=WBJ\\4+A9'DC%H2
M)6!W*5F1/N@KUSVGCSQ!J.EZEX6\.Z5<"RN?$>H-9&^90[6L:PO(S(&RID.P
M!=P(R<D'&#H0^ ?"MOXFF\16MA/:ZE<.DMPUO?7$45RZ?=>6)7$<K#U=2:T/
M$'AG1/$T%K;ZY8BZ6SN%N[9U=XY()E^[(CH0RL,GD$=:-+!WL>10ZEXGT/4?
M$F@Z7J4%QK>L>+%L4O[J5+0X&E0R[MP@E02D1@8\HJ23@#C%^^D^+&@:1H6L
M>*?%]E!#IVLQ0:M'IJPS+/82.JI)*\ENA2168!S&J*4RP"GIV>H?"_P7JUI?
MVVI:9/=1ZA<QWD_F:A<DF=%"I*I\S*.%51N4@X'6M23PGX?F\*WWABZL9+K2
M]01H[I+JYEFDG#*%)>5V,A. !N+9&!@\"DE9+R&>;ZUXA\:6NI6^GZ3XCBN9
M/%.JW4&F_;9(;5+&"!6^6*1;63<[L"09$D!4 =<DR&/Q9#JWPRM_'%W8WFM1
M:[=J\UBY9'3[!<E"V8XQOVD9PB@]0!G%=UJGP_\ !^M>&]-\.ZEHZRZ=I;1O
M8QQRR1/:M&,(T<B,'5@.X;-*W@GP])+I4UQ%?RS:3*9[6235+IG60J4+LQDS
M(2K%<OG@XZ4WKH+OZ'!:?XL\5WOAKP]\08==$EGJNJ1:?/HGV6,PPQRW7V<%
M7 $HE0D%MSE20PVK5&;QAXYT_P )R^+I/$B7;:9XHETB;3C9Q)%>0&^^S 9
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %"^L;/4].GT_4;
M2&\M9T,<L$\8>.53P593P0?0UGVGA?PSI^A3>'['P[IEKH\^X2V$-G&EO(&X
M;=&!M.>^1S6_14@8FB>'= \-6KV7AW1;#1K620RO#86J6Z,Y &XJ@ )P ,^P
MK;HHJ@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/6+'2=8.F:Y,L-G=F!"K%LX+ .61?E/+*!^8KP76+B3PC^Q7X4\-V4@75O&
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M>LZ9IMQ'>NL@CCA#--*SXR\DF\%V)S@[?NX +-[=["NOPN?2RZSI_P#PC_\
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M;\JCC+ G%9VH?'K0M+O->6^TB[MK32M'@UB":1QNO5F ,:*B@E22<$GI@D\
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M\OOOA)I5UX=\*^&_[1F?2M"U*'4;A;Q?M$NI-$C!5D<D #)4G@C"A0  ,7_
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M4DM[>5I'C(&>6(#$9(SV-7/BU\/=4^)7@Q_"=KXB@T:PN75[IGT\W4DFQU=
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M;WP_XUN#K8O_ )II%C\E8G_A,*9;R]O;)8_WBU<K<?";6/$NCZ9X9\=>-O\
MA(/#6GR"7[(NG_9KB]*?ZL7$XD(=5_V$0MP2:->_5?</33T/+O%VO:79_M!^
M O$6OPO;Z)J/AB75-3M(H9)HRWDS.7:) =Q7CYL9&T$GC-=!\/;/5+[X*>.]
M<O-0>[\+ZF+R\\.6MQ<&XEL;=5DVY<EMA!"X7.4*GH2:Z[6/A+K6K_&31?B
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MSPGF,0.F37O7PQ^&NO\ PS^']QX0L_%ECJ6UGEL;F72G3R&<DMYBBX_>#/0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_0 \5?\ @+;?_'Z/^&U?A;_T /%7_@+;?_'Z^ ** /O_ /X;5^%O_0 \5?\
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M0!\B?L@ZIINC_%_6;S5]0M=.MO[!F7SKJ98DS]HM^,L0,\'\J^X?^%A^ ?\
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M ,51_P *\\ _]"/X?_\ !9#_ /$T?\*\\ _]"/X?_P#!9#_\35 '_"P_ /\
MT/'A_P#\&</_ ,51_P +#\ _]#QX?_\ !G#_ /%4?\*\\ _]"/X?_P#!9#_\
M31_PKSP#_P!"/X?_ /!9#_\ $T '_"P_ /\ T/'A_P#\&</_ ,51_P +#\ _
M]#QX?_\ !G#_ /%4?\*\\ _]"/X?_P#!9#_\31_PKSP#_P!"/X?_ /!9#_\
M$T '_"P_ /\ T/'A_P#\&</_ ,51_P +#\ _]#QX?_\ !G#_ /%4?\*\\ _]
M"/X?_P#!9#_\31_PKSP#_P!"/X?_ /!9#_\ $T '_"P_ /\ T/'A_P#\&</_
M ,51_P +#\ _]#QX?_\ !G#_ /%4?\*\\ _]"/X?_P#!9#_\31_PKSP#_P!"
M/X?_ /!9#_\ $T '_"P_ /\ T/'A_P#\&</_ ,51_P +#\ _]#QX?_\ !G#_
M /%4?\*\\ _]"/X?_P#!9#_\31_PKSP#_P!"/X?_ /!9#_\ $T '_"P_ /\
MT/'A_P#\&</_ ,51_P +#\ _]#QX?_\ !G#_ /%4?\*\\ _]"/X?_P#!9#_\
M31_PKSP#_P!"/X?_ /!9#_\ $T %KXX\%WUW':V/C#1;FYE8)'##J$+N['H
M V2?:NGKF+7P/X+L;N.ZL?!^BVUS$P>.:'3X4=&'0@A<@^]=/0 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 455GF
MAM8)+BXD6**-2[R.P554#)))Z 5RW_"V/A9_T4OPK_X.;;_XN@#LZ*YZS\6>
M&]1GL(-.URSO3J<<DUFUM,LJ7"1D!V1ERI"D@'FIM;\2:#X=2T?7-7MM.^V3
M+;6XN) IFE;HBCJQ]A0!MT444 %%%% !1110 4444 %%?&?_  W/_P!4N_\
M*W_]ST?\-S_]4N_\K?\ ]ST ?9E%?&?_  W/_P!4N_\ *W_]ST?\-S_]4N_\
MK?\ ]ST ?9E%?&?_  W/_P!4N_\ *W_]ST?\-S_]4N_\K?\ ]ST ?9E%?&?_
M  W/_P!4N_\ *W_]ST?\-S_]4N_\K?\ ]ST ?9E%?&?_  W/_P!4N_\ *W_]
MST?\-S_]4N_\K?\ ]ST ?9E%?&?_  W/_P!4N_\ *W_]ST?\-S_]4N_\K?\
M]ST ?9E%?&?_  W/_P!4N_\ *W_]ST?\-S_]4N_\K?\ ]ST ?9E%?&?_  W/
M_P!4N_\ *W_]ST?\-S_]4N_\K?\ ]ST ?9E%?&?_  W/_P!4N_\ *W_]ST?\
M-S_]4N_\K?\ ]ST ?9E%?&?_  W/_P!4N_\ *W_]ST?\-S_]4N_\K?\ ]ST
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MK%_WP*/L=K_SZQ?]\"IZ* (/L=K_ ,^L7_? H^QVO_/K%_WP*GHH @^QVO\
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MDOTM46X=?0R ;B/;-;%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MD2.5.6P%( KS'X1ZUK7AGX1> =1L=2D-IJ/B:32;C33%%Y+I-/-F3=L\P.I
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MVB\Q7W\CZ8I:05Y_\0/!N@^)+2XU+Q3K&IV.G6%FY3['?RVJV[<EISY;#>P
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MY*X\>>%K.[FM+K494G@<QR*+29L,#@C(3!Y':NMK\SO^&H_CK_T/7_E,L_\
MXS0!]SKK_P .UUN?6O[2U!KN>,12;_MS1,@W87RC\F!O;C;WK(OH?@]J'A_3
M/#<T<\6DZ5,L]I:6JWUND4BMN5OW>W)#<C.<&OB__AJ/XZ_]#U_Y3+/_ .,T
M?\-1_'7_ *'K_P IEG_\9I6'<^SM6B^$.NVVK6NJ_;;F#64B2_C+:@JW/EA0
MC,!@%@$4;OO':,DUH:?J7PPTSQ!-KUI>:@NI3PI;R2R-?R!XTW;%*-E<#>V.
M.]?$7_#47QT_Z'K_ ,IEG_\ &:/^&HOCK_T/7_E,L_\ XS3%Y'VA8#X2Z5J-
MU>::U];&ZF:YDMXWU!;;S6.3(L'^J5\\[E4$'D<U3MM)^"UCHNG:+9IJ$.G:
M;>_VA:PI-J0$-QDGS <YSDD\G')]:^.O^&H_CK_T/7_E,L__ (S1_P -1_'7
M_H>O_*99_P#QFA:; ]=S[[F\?>#9[=[=]5N0CKM)2WN4;'LRJ"#[@YK"TO4O
MA;HWABX\+V<EPVC7"R)+:7,=Y<*RR%BX_>!CABS$\]Z^(?\ AJ/XZ_\ 0]?^
M4RS_ /C-'_#4?QU_Z'K_ ,IEG_\ &: /N&SUKX:Z?>07UO>7TUW;0/;P2W9O
MKAHD;&X*9-Q7.U<D<\"I_#OC+PQH^A1Z?=>(+R]=))&5YH;N9T1G9D3S)%+O
MM4A=S')QGCH/A?\ X:C^.O\ T/7_ )3+/_XS1_PU'\=?^AZ_\IEG_P#&: /L
MT0_"E;J6:/5/$.99FG>(ZKJYAD=FW-NB\S8P)ZJ1@]",5>U2\^%.L7-W+J:R
M72WDD<MU \-WY%R\>-C21 ;'(VKRRG[J^@Q\2?\ #4?QU_Z'K_RF6?\ \9H_
MX:C^.O\ T/7_ )3+/_XS0!]K:I<?#+5M8EU:ZUCQ!%>3*L;M9:AJUHI5<[1L
MA=5 &YNW<^M7(M<^'D$%G#!JFK116</D1HDVH %<Y)< _O&)_C?+')YY-?#O
M_#4?QU_Z'K_RF6?_ ,9H_P"&H_CK_P!#U_Y3+/\ ^,T ??-IXX\"V%E#96-V
M;:V@01Q0Q6,RHB@8  "8 JW_ ,+'\'?]!.7_ , I_P#XBOS[_P"&H_CK_P!#
MU_Y3+/\ ^,T?\-1_'7_H>O\ RF6?_P 9H _03_A8_@[_ *"<O_@%/_\ $4?\
M+'\'?]!.7_P"G_\ B*_/O_AJ/XZ_]#U_Y3+/_P",T?\ #4?QU_Z'K_RF6?\
M\9H _03_ (6/X._Z"<O_ (!3_P#Q%'_"Q_!W_03E_P# *?\ ^(K\^_\ AJ/X
MZ_\ 0]?^4RS_ /C-'_#4?QU_Z'K_ ,IEG_\ &: /T$_X6/X._P"@G+_X!3__
M !%'_"Q_!W_03E_\ I__ (BOS[_X:C^.O_0]?^4RS_\ C-'_  U'\=?^AZ_\
MIEG_ /&: /T$_P"%C^#O^@G+_P" 4_\ \11_PL?P=_T$Y?\ P"G_ /B*_/O_
M (:C^.O_ $/7_E,L_P#XS1_PU'\=?^AZ_P#*99__ !F@#]!/^%C^#O\ H)R_
M^ 4__P 11_PL?P=_T$Y?_ *?_P"(K\^_^&H_CK_T/7_E,L__ (S1_P -1_'7
M_H>O_*99_P#QF@#]!/\ A8_@[_H)R_\ @%/_ /$4?\+'\'?]!.7_ , I_P#X
MBOS[_P"&H_CK_P!#U_Y3+/\ ^,T?\-1_'7_H>O\ RF6?_P 9H _03_A8_@[_
M *"<O_@%/_\ $4?\+'\'?]!.7_P"G_\ B*_/O_AJ/XZ_]#U_Y3+/_P",T?\
M#4?QU_Z'K_RF6?\ \9H _03_ (6/X._Z"<O_ (!3_P#Q%'_"Q_!W_03E_P#
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M *"<O_@%/_\ $4?\+'\'?]!.7_P"G_\ B*_)2B@#]:_^%C^#O^@G+_X!3_\
MQ%'_  L?P=_T$Y?_  "G_P#B*_)2B@#]:_\ A8_@[_H)R_\ @%/_ /$4?\+'
M\'?]!.7_ , I_P#XBOR4HH _6O\ X6/X._Z"<O\ X!3_ /Q%'_"Q_!W_ $$Y
M?_ *?_XBOR4HH _6O_A8_@[_ *"<O_@%/_\ $4?\+'\'?]!.7_P"G_\ B*_)
M2B@#]:_^%C^#O^@G+_X!3_\ Q%'_  L?P=_T$Y?_  "G_P#B*_)2B@#]:_\
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MMK8A)I),ZBOQGK]EL_*3_+FOQIH*"BBB@ HHHH **** "BBB@ HHHH ****
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MI:***!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% ':_"G_ )+?X#_[&"P_]*4K]8Z_)SX4_P#)
M;_ ?_8P6'_I2E?K'0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7XSU^S%> ?\
M,A_!O_GRU7_P/;_"@#\YJ*_1G_AD/X-_\^6J_P#@>W^%'_#(?P;_ .?+5?\
MP/;_  H _.:BOT9_X9#^#?\ SY:K_P"![?X4?\,A_!O_ )\M5_\  ]O\* /S
MFHK]&?\ AD/X-_\ /EJO_@>W^%'_  R'\&_^?+5?_ ]O\* /SFHK]&?^&0_@
MW_SY:K_X'M_A1_PR'\&_^?+5?_ ]O\* /SFHK]&?^&0_@W_SY:K_ .![?X4?
M\,A_!O\ Y\M5_P# ]O\ "@#\YJ*_1G_AD/X-_P#/EJO_ ('M_A1_PR'\&_\
MGRU7_P #V_PH _.:BOT9_P"&0_@W_P ^6J_^![?X4?\ #(?P;_Y\M5_\#V_P
MH _.:BOT9_X9#^#?_/EJO_@>W^%'_#(?P;_Y\M5_\#V_PH _.:BOT9_X9#^#
M?_/EJO\ X'M_A1_PR'\&_P#GRU7_ ,#V_P * /SFHK]&?^&0_@W_ ,^6J_\
M@>W^%'_#(?P;_P"?+5?_  /;_"@#\YJ*_1G_ (9#^#?_ #Y:K_X'M_A1_P ,
MA_!O_GRU7_P/;_"@#\YJ*_1G_AD/X-_\^6J_^![?X4?\,A_!O_GRU7_P/;_"
M@#\YJ*_1G_AD/X-_\^6J_P#@>W^%'_#(?P;_ .?+5?\ P/;_  H _.:BOT9_
MX9#^#?\ SY:K_P"![?X4?\,A_!O_ )\M5_\  ]O\* /SFHK]&?\ AD/X-_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *PO$^B1^)/!^L^'9)GMXM6LI
M[%Y4&6C66-D+ 'N-V:W:* /DW_AB'PK_ -#OJO\ X#QT?\,0^%?^AWU7_P !
MXZ^LJ* /DW_AB'PK_P!#OJO_ (#QT?\ #$/A7_H=]5_\!XZ^LJ* /DW_ (8A
M\*_]#OJO_@/'1_PQ#X5_Z'?5?_ >.OK*B@#Y-_X8A\*_]#OJO_@/'1_PQ#X5
M_P"AWU7_ ,!XZ^LJ* /DW_AB'PK_ -#OJO\ X#QT?\,0^%?^AWU7_P !XZ^L
MJ* /DW_AB'PK_P!#OJO_ (#QT?\ #$/A7_H=]5_\!XZ^LJ* /DW_ (8A\*_]
M#OJO_@/'1_PQ#X5_Z'?5?_ >.OK*B@#Y-_X8A\*_]#OJO_@/'1_PQ#X5_P"A
MWU7_ ,!XZ^LJ* /DW_AB'PK_ -#OJO\ X#QT?\,0^%?^AWU7_P !XZ^LJ* /
MDW_AB'PK_P!#OJO_ (#QT?\ #$/A7_H=]5_\!XZ^LJ* /DW_ (8A\*_]#OJO
M_@/'1_PQ#X5_Z'?5?_ >.OK*B@#Y-_X8A\*_]#OJO_@/'1_PQ#X5_P"AWU7_
M ,!XZ^LJ* /DW_AB'PK_ -#OJO\ X#QT?\,0^%?^AWU7_P !XZ^LJ* /DW_A
MB'PK_P!#OJO_ (#QT?\ #$/A7_H=]5_\!XZ^LJ* /DW_ (8A\*_]#OJO_@/'
M1_PQ#X5_Z'?5?_ >.OK*B@#Y-_X8A\*_]#OJO_@/'1_PQ#X5_P"AWU7_ ,!X
MZ^LJ* /F+PW^R'X;\->+]%\26_C#4KB72[V"]2)X(PLC12*X4D=CMQ7T[110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 <[XHUYO#/AB^U^32[W4HK*-IYH;,Q>8(U&68>8Z*< $XSGT!/%
M86B_$BQU+6],T?4- UC0;O5X6N-.&HI"4O%50[!'AED4,%.[:Q4X[5;^)5U;
MV?PI\5R75Q'"ATJZ0-(P4%C"P Y[DUP.@Z!>W.B:-\0_$/BY=<L=!T21M/L]
M#L?($;-!MDDW>;(9)=F5&"H!["E>T6^P=4NY[C17R[I\]AI,/BE=%U2TT"SO
M_ ZW\<FDL))_.7S<SR,I3SKG'+, IYZ]ZM>'Q:VN@Z_J/@CQ)X>;5(O"S :1
MX:UD7+SWBH2]V\2A1YO( 8AB6(R>E/978KZV/IBN0U[QI9Z#>36ZZ3J.I_98
M1=7TEC'&XL83NQ)(&=6;.QSMC#OA3\O3/!?"'3? BZK-X@\#^-K_ %D:C:G[
M58%;2&"%PRG?-#;P1!+CG&6^9ANZ@9$_Q&AO=+UO4M4\)^(+6/6]:T]-/DT)
MK5;B6_?++#*GS@Q;?,;<Y5TV DCY:3NMBE9[GJVF:C8ZQI5IJVG7*75E=Q+/
M!-&<K(C#*L/J#5^O,ET#7?!?[.,GAW1[@SZYI.@/!#)!D%IUA/,?&<[ON^^*
MY*QM?!MSXX\/S>#HM/\ ^$8U72;V3Q#;(5:UE3;'Y;72'*>;N9@6<;C\X.<'
M!]JR%T.Z\+^-M1\2:O$\'AF5/#MXLYL]62Y5PQBD,9$L>T&/=C*89\CKM/%6
M)/B%H\.K0PW5K?VVF7%Y_9UOJ\BQ_9)[K>4\H$.9 =ZLH9D5"1@,<C/+_L_V
M?ANW^$^GS:%:Z=%<3-+]L>S2-7=A-(%\PKR2%Z9[5R^M>%-3U#6-.^'_ (8\
M36>I:"NO#6;BW2U!?1X8YQ,\+SAV#%I21&A16Y;+%5--Z2L).Z;9]$T444#"
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHJK<6\%U;26]S D\4B[7CD4,K#T(/!H L4=Z^9
M_#<%[=>$?AAJ'A.PU7_A(8]03[?<+!<06T]IN<3?:)=OER#&W:26;.-N>:[F
MW^*&LV_A&7Q%KVEZ=:G^TI]$@L[:YDD:6]6Z^SQ .47]V2'))4$!<X.<!/1M
M!T3[GL%%>.>*OB-?:3_PFGA?5-$TW5=2TG11K4<,S-%;:C8G*S!E*R;64AEV
MG(;*\@$XT[[QUJL.E>5X;T5+S4;;1[?4?[/CMYG$IE#;(%9%VQ9\M@&;(''&
M,D%QV/4**\ML_'GBCQ$^KQ^&?"\8GT7[(EW97\XCEDGE19)8%(.U#&CCYCD,
MV1@ 9.[X8OM<N_%GB^WO[ZUFL].U%+>"*.V9&53:P2CYC(1UD;/')YXZ4;/4
MDV_$&EMK7A^]TE;I[0W49C\Y%5BN?56X(/0CN"15#3=#U?S;:Z\3:AI^J75B
MS-:/9:>UH(]R%"6#329.TD<%1R>.F.+^(WAW2[&'3=16#SKO4O$^F_:)I<,Q
MC>XCC:(>D948*]#DYSDUH^(+M/AR&DT:&TL;#59Y;B:>]EVV]M*L*+'#'&""
M6E91A5[[C@]*(O?R&UJCTL"@"O%+7XU/?:/X=U#^S[+1QKFD?;K9]5N&BM[B
MZW%19I/C:K\%LMR05PO)(@TG6H='^.OCS0-+>R@U[5SITEK:2KA'"PLT\A"D
M9P&+'G))[TW?FY02NKGN=%<SXGM=?O/ FKZ?I%U''KDUA-';SQ@Q*)BA"D?,
M2G.,')QU[5YMX&US1]0\36E@]C?^!/&EMI\JR^';QI9+>=.,7  *I.00?W@.
M\Y<$]#4WW\AGM]%>)+\0O%^D_#GPOK5Y%IMU_:>CMJ$U]/NAB240H\=L$WLT
MDDC%@"O0 G:<8K1TWQ]K&L'PEX@6:VTW1]4\.7.M75H\#3.AC-L64.'4'B5L
M';QW!S@4+MYGKG:DKR>U\>>--0$-QIOA*"[L[W2WOHIY&N+:*VE&"L,DCQ?O
M R$D.B]1C !#5!IWQ.UZ]UKP'I4NDV$+^,])DU"%UDD<6;)&DA## \P%7Z#;
M@C&3UI6U:ZH5]+GL%%>6Z;\1M0U71=(V6D,&L7L5[)(B6\]U&OV:?R&VK&N[
M#.1@DC /<\'-TOXD>,K_ ,8^&?#M]X3MO#MQK>EW%[(M[.\LMK)"P5E,:JH*
MG((.[)!R<8P1.ZT*::/9**\5T/X@:YXJ\;_#[['-#8:;J^D7E_=VGELY,L3Q
MQLN[<. 6;;QQU(/&/:>]4XM;DIW'4444AA1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 50OUU"33YX],N(+:\9"(9
MKB$S1HW8L@="P]@P^M7Z*6X'"^!?"FN>#? T/AF]UZTU9[162TNDT]H JG)
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M^'8[NU_=Z:8A<V\[JY0YF;:X=?OC.0<;01NKV'BCBEIMM[DI6"BBB@84444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
6444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>May 01, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LIGHTBRIDGE CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001084554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,538,160<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-34487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">NV<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">91-1975651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address Address Line 1</a></td>
<td class="text">11710 Plaza America Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address Address Line 2</a></td>
<td class="text">Suite 2000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address City Or Town</a></td>
<td class="text">Reston<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address State Or Province</a></td>
<td class="text">VA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address Postal Zip Code</a></td>
<td class="text">20190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">730-1200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LTBR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 56,929,988<span></span>
</td>
<td class="nump">$ 39,990,827<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">546,267<span></span>
</td>
<td class="nump">324,378<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">57,476,255<span></span>
</td>
<td class="nump">40,315,205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>Other Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssets', window );">Prepaid project costs and other long-term assets</a></td>
<td class="nump">702,562<span></span>
</td>
<td class="nump">528,805<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Trademarks</a></td>
<td class="nump">108,865<span></span>
</td>
<td class="nump">108,865<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">58,287,682<span></span>
</td>
<td class="nump">40,952,875<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">966,209<span></span>
</td>
<td class="nump">424,585<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">966,209<span></span>
</td>
<td class="nump">424,585<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value, 10,000,000 authorized shares, 1 share and 0 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value, 25,000,000 authorized, 21,557,343 shares and 18,783,912 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively</a></td>
<td class="nump">21,557<span></span>
</td>
<td class="nump">18,784<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">226,255,770<span></span>
</td>
<td class="nump">204,694,348<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(168,955,854)<span></span>
</td>
<td class="num">(164,184,842)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders' Equity</a></td>
<td class="nump">57,321,473<span></span>
</td>
<td class="nump">40,528,290<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders' Equity</a></td>
<td class="nump">$ 58,287,682<span></span>
</td>
<td class="nump">$ 40,952,875<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>CONSOLIDATED BALANCE SHEETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Shares Par Value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares issued</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Shares Par Value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">25,000,000<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares Issued</a></td>
<td class="nump">21,557,343<span></span>
</td>
<td class="nump">21,557,343<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares Outstanding</a></td>
<td class="nump">18,783,912<span></span>
</td>
<td class="nump">18,783,912<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">3,480,010<span></span>
</td>
<td class="nump">2,157,745<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">1,665,913<span></span>
</td>
<td class="nump">1,023,823<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total Operating Expenses</a></td>
<td class="nump">5,145,923<span></span>
</td>
<td class="nump">3,181,568<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Loss</a></td>
<td class="num">(5,145,923)<span></span>
</td>
<td class="num">(3,181,568)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other Income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeOther', window );">Interest income</a></td>
<td class="nump">374,911<span></span>
</td>
<td class="nump">361,984<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Total Other Income</a></td>
<td class="nump">374,911<span></span>
</td>
<td class="nump">361,984<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net Loss Before Income Taxes</a></td>
<td class="num">(4,771,012)<span></span>
</td>
<td class="num">(2,819,584)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="num">$ (4,771,012)<span></span>
</td>
<td class="num">$ (2,819,584)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net Loss Per Common Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Basic and diluted</a></td>
<td class="num">$ (0.24)<span></span>
</td>
<td class="num">$ (0.21)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Number of Common Shares Outstanding</a></td>
<td class="nump">19,547,312<span></span>
</td>
<td class="nump">13,491,954<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income earned from interest bearing assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY - USD ($)<br></strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, shares at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,698,274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, amount at Dec. 31, 2023</a></td>
<td class="nump">$ 28,911,047<span></span>
</td>
<td class="nump">$ 13,698<span></span>
</td>
<td class="nump">$ 181,295,125<span></span>
</td>
<td class="num">$ (152,397,776)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares', window );">Shares issued - registered offerings - net of offering costs of $155,686, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">427,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount', window );">Shares issued - registered offerings - net of offering costs of $155,686, amount</a></td>
<td class="nump">1,221,982<span></span>
</td>
<td class="nump">$ 428<span></span>
</td>
<td class="nump">1,221,554<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Shares issued to consultant &amp; directors for services, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Shares issued to consultant &amp; directors for services, amount</a></td>
<td class="nump">255,000<span></span>
</td>
<td class="nump">$ 64<span></span>
</td>
<td class="nump">254,936<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">456,904<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">456,904<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the three months ended March 31, 2024</a></td>
<td class="num">(2,819,584)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,819,584)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, shares at Mar. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,189,780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, amount at Mar. 31, 2024</a></td>
<td class="nump">28,025,349<span></span>
</td>
<td class="nump">$ 14,190<span></span>
</td>
<td class="nump">183,228,519<span></span>
</td>
<td class="num">(155,217,360)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, shares at Dec. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,783,912<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, amount at Dec. 31, 2024</a></td>
<td class="nump">40,528,290<span></span>
</td>
<td class="nump">$ 18,784<span></span>
</td>
<td class="nump">204,694,348<span></span>
</td>
<td class="num">(164,184,842)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares', window );">Shares issued - registered offerings - net of offering costs of $155,686, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,605,619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount', window );">Shares issued - registered offerings - net of offering costs of $155,686, amount</a></td>
<td class="nump">20,213,195<span></span>
</td>
<td class="nump">$ 2,605<span></span>
</td>
<td class="nump">20,210,590<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Shares issued to consultant &amp; directors for services, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Shares issued to consultant &amp; directors for services, amount</a></td>
<td class="nump">30,000<span></span>
</td>
<td class="nump">$ 89<span></span>
</td>
<td class="nump">29,911<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">1,295,181<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,295,181<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the three months ended March 31, 2024</a></td>
<td class="num">(4,771,012)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,771,012)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_RestrictedSharesAwardsIssuedShares', window );">Restricted shares awards issued, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_RestrictedSharesAwardsIssuedAmount', window );">Restricted shares awards issued, amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 58<span></span>
</td>
<td class="num">(58)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares', window );">Share settlement for withholding taxes paid upon vesting of restricted stock awards, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25,148)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount', window );">Share settlement for withholding taxes paid upon vesting of restricted stock awards, amount</a></td>
<td class="num">(194,878)<span></span>
</td>
<td class="num">$ (25)<span></span>
</td>
<td class="nump">194,853<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares issued through the exercise of options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Shares issued through the exercise of options, amount</a></td>
<td class="nump">220,697<span></span>
</td>
<td class="nump">$ 46<span></span>
</td>
<td class="nump">220,651<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, shares at Mar. 31, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,557,343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, amount at Mar. 31, 2025</a></td>
<td class="nump">$ 57,321,473<span></span>
</td>
<td class="nump">$ 21,557<span></span>
</td>
<td class="nump">$ 226,255,770<span></span>
</td>
<td class="num">$ (168,955,854)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_RestrictedSharesAwardsIssuedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_RestrictedSharesAwardsIssuedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_RestrictedSharesAwardsIssuedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_RestrictedSharesAwardsIssuedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Loss</a></td>
<td class="num">$ (4,771,012)<span></span>
</td>
<td class="num">$ (2,819,584)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">1,355,181<span></span>
</td>
<td class="nump">456,904<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(266,889)<span></span>
</td>
<td class="num">(194,796)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets', window );">Prepaid project costs and other long-term assets</a></td>
<td class="num">(173,757)<span></span>
</td>
<td class="nump">3,375<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">556,624<span></span>
</td>
<td class="nump">676,095<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net Cash Used in Operating Activities</a></td>
<td class="num">(3,299,853)<span></span>
</td>
<td class="num">(1,878,006)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net Cash Used in Investing Activities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from the issuances of common stock</a></td>
<td class="nump">20,213,195<span></span>
</td>
<td class="nump">1,221,982<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Net proceeds from the exercise of stock options</a></td>
<td class="nump">220,697<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payments for taxes related to net share settlement of equity awards</a></td>
<td class="num">(194,878)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net Cash Provided by Financing Activities</a></td>
<td class="nump">20,239,014<span></span>
</td>
<td class="nump">1,221,982<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net Increase (Decrease) in Cash and Cash Equivalents</a></td>
<td class="nump">16,939,161<span></span>
</td>
<td class="num">(656,024)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and Cash Equivalents, Beginning of Period</a></td>
<td class="nump">39,990,827<span></span>
</td>
<td class="nump">28,598,445<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and Cash Equivalents, End of Period</a></td>
<td class="nump">56,929,988<span></span>
</td>
<td class="nump">27,942,421<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_CashPaidDuringThePeriodAbstract', window );"><strong>Cash paid during the period:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Non-Cash Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_PaymentOfAccruedLiabilitiesWithCommonStock', window );">Payment of accrued liabilities with common stock</a></td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_CashPaidDuringThePeriodAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_CashPaidDuringThePeriodAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_PaymentOfAccruedLiabilitiesWithCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_PaymentOfAccruedLiabilitiesWithCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpensesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2025 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingArrLineItems', window );"><strong>Insider Trading Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arragement Adopted [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arragement Terminated [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non Rule 10b5-1 Arragement Adopted [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non Rule 10b5-1 Arragement Terminated [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_TrdArrIndNameOne', window );">First Individual Name</a></td>
<td class="text">Jesse Funches<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_TrdArrIndNameTwo', window );">Second Individual Name</a></td>
<td class="text">Mark Tobin<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_TrdArrIndNameThird', window );">Third Individual Name</a></td>
<td class="text">Sherri Goodman<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_TrdArrIndNameFourth', window );">Fourth Individual Name</a></td>
<td class="text">Larry Goldman<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_TrdArrIndTitleOne', window );">First Individual Title</a></td>
<td class="text">Director<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_TrdArrIndTitleTwo', window );">Second Individual Title</a></td>
<td class="text">Director<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_TrdArrIndTitleThree', window );">Third Individual Title</a></td>
<td class="text">Director<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_TrdArrIndTitleFour', window );">Fourth Individual Title</a></td>
<td class="text">Chief Financial Officer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_Rule10b51ArrAdoptedOneFlag', window );">Rule 10b5-1 Arrangement Adopted One [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_Rule10b51ArrAdoptedTwoFlag', window );">Rule 10b5-1 Arrangement Adopted Two [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_Rule10b51ArrAdoptedThreeFlag', window );">Rule 10b5-1 Arrangement Adopted Three [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_Rule10b51ArrAdoptedFourFlag', window );">Rule 10b5-1 Arrangement Adopted Four [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_TrdArrAdoptionDateFirst', window );">Trading Arrangement Adoption Date, First</a></td>
<td class="text">1/9/2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_TrdArrAdoptionDateSecond', window );">Trading Arrangement Adoption Date, Second</a></td>
<td class="text">1/13/2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_TrdArrAdoptionDateThird', window );">Trading Arrangement Adoption Date, Third</a></td>
<td class="text">1/24/2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_TrdArrAdoptionDateFourth', window );">Trading Arrangement Adoption Date, Fourth</a></td>
<td class="text">3/7/2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_TrdArrExpirationDateOne', window );">Trading Arrangement Expiration Date, First</a></td>
<td class="text">4/9/2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_TrdArrExpirationDateTwo', window );">Trading Arrangement Expiration Date, Second</a></td>
<td class="text">6/1/2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_TrdArrExpirationDateThree', window );">Trading Arrangement Expiration Date, Third</a></td>
<td class="text">4/24/2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_TrdArrExpirationDateFour', window );">Trading Arrangement Expiration Date, Fourth</a></td>
<td class="text">6/8/2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_TrdArrSecuritiesAggAvailAmtOne', window );">Trading Arrangement, Securities Aggregate Available Amount, First</a></td>
<td class="nump">6,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_TrdArrSecuritiesAggAvailAmtTwo', window );">Trading Arrangement, Securities Aggregate Available Amount, Second</a></td>
<td class="nump">6,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_TrdArrSecuritiesAggAvailAmtThree', window );">Trading Arrangement, Securities Aggregate Available Amount, Third</a></td>
<td class="nump">7,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingArrLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingArrLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_Rule10b51ArrAdoptedFourFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_Rule10b51ArrAdoptedFourFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_Rule10b51ArrAdoptedOneFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_Rule10b51ArrAdoptedOneFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_Rule10b51ArrAdoptedThreeFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_Rule10b51ArrAdoptedThreeFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_Rule10b51ArrAdoptedTwoFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_Rule10b51ArrAdoptedTwoFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_TrdArrAdoptionDateFirst">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_TrdArrAdoptionDateFirst</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_TrdArrAdoptionDateFourth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_TrdArrAdoptionDateFourth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_TrdArrAdoptionDateSecond">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_TrdArrAdoptionDateSecond</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_TrdArrAdoptionDateThird">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_TrdArrAdoptionDateThird</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_TrdArrExpirationDateFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_TrdArrExpirationDateFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_TrdArrExpirationDateOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_TrdArrExpirationDateOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_TrdArrExpirationDateThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_TrdArrExpirationDateThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_TrdArrExpirationDateTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_TrdArrExpirationDateTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_TrdArrIndNameFourth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_TrdArrIndNameFourth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_TrdArrIndNameOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_TrdArrIndNameOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_TrdArrIndNameThird">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_TrdArrIndNameThird</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_TrdArrIndNameTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_TrdArrIndNameTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_TrdArrIndTitleFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_TrdArrIndTitleFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_TrdArrIndTitleOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_TrdArrIndTitleOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_TrdArrIndTitleThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_TrdArrIndTitleThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_TrdArrIndTitleTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_TrdArrIndTitleTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_TrdArrSecuritiesAggAvailAmtOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_TrdArrSecuritiesAggAvailAmtOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_TrdArrSecuritiesAggAvailAmtThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_TrdArrSecuritiesAggAvailAmtThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_TrdArrSecuritiesAggAvailAmtTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_TrdArrSecuritiesAggAvailAmtTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock', window );">Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 1. Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Nature of Operations and Basis of Presentation</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">When used in these notes, the terms &#8220;Lightbridge,&#8221; &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221; mean Lightbridge Corporation and all entities included in the condensed consolidated financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company was formed on October 6, 2006, when Thorium Power, Ltd., which was incorporated in the state of Nevada on February 2, 1999, merged with Thorium Power, Inc. (TPI), which was incorporated in the state of Delaware on January 8, 1992. On September 29, 2009, the Company changed its name from Thorium Power, Ltd. to Lightbridge Corporation and began its focus on developing and commercializing metallic nuclear fuels. The Company is a nuclear fuel technology company developing its nuclear fuel. The Company views its operations and manages its business as one business segment, which is the development and commercialization of its nuclear fuel. These unaudited condensed consolidated financial statements include the accounts of the Company, and the Company&#8217;s wholly-owned subsidiaries, TPI, a Delaware corporation, and Lightbridge International Holding LLC, a Delaware limited liability company. These wholly-owned subsidiaries are inactive, and all significant intercompany transactions and balances have been eliminated in consolidation.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The accompanying unaudited condensed consolidated financial statements of Lightbridge Corporation and its subsidiaries have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission, or the SEC, including the instructions to Form 10-Q and Regulation S-X. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America (GAAP), including a summary of the Company&#8217;s significant accounting policies, have been condensed or omitted from these statements pursuant to such rules and regulations and, accordingly, they do not include all the information and footnotes necessary for comprehensive condensed consolidated financial statements and should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2024, included in the Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on March 3, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In the opinion of the management of the Company, all adjustments, which are of a normal recurring nature, necessary for a fair statement of the results for the three-month period have been made. Results for the interim period presented are not necessarily indicative of the results that might be expected for the entire fiscal year.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Summary of Significant Accounting Policies</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Fair Value of Financial Instruments</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company determined fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between unaffiliated market participants at the measurement date.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounting Standards Codification (ASC), <em>Fair Value Measurement</em> (ASC 820), established a fair value hierarchy that prioritizes the inputs used to measure fair value. Assets and liabilities measured at fair value were categorized based on whether the inputs are observable in the market and the degree that the inputs are observable. The hierarchy gives the highest priority to active markets for identical assets and liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). The categorization of financial instruments within the valuation hierarchy was based on the lowest level of input that is significant to the fair value measurement. At the end of the reporting period, the Company reviews U.S. treasury instruments held to determine whether the securities are of the most recent issuance of that security with the same maturity (referred to as &#8220;on-the-run&#8221;, which is the most liquid version of the maturity band). If a U.S. treasury instrument held at the end of the reporting period was from the most recent issuance it is classified as level 1, otherwise it is referred to as &#8220;off-the-run&#8221; and is classified as level 2. The three levels of the fair value hierarchy were as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 1 - Observable inputs such as quoted prices in active markets for identical assets or liabilities;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 2 - Inputs other than quoted prices that were observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that were not active and inputs other than quoted prices that were observable for the asset or liability; and</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 3 - Unobservable inputs that reflect management&#8217;s assumptions.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For disclosure purposes, assets and liabilities were classified in their entirety in the fair value hierarchy level based on the lowest level of input that was significant to the overall fair value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement required judgment and may have affected the placement within the fair value hierarchy levels.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company&#8217;s financial instruments consisted principally of cash and cash equivalents, accounts payable and accrued liabilities. The carrying amounts of cash, accounts payable and accrued liabilities are considered to be Level 1 measurements, because of the short-term nature of those instruments. Cash equivalents are primarily composed of US Treasury instruments having maturity dates of 30 to 90 days. The Company purchased $37 million of US Treasury instruments for the three months ended March 31, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following table summarized the valuation of the Company&#8217;s financial instruments that fell within the fair value hierarchy (in millions) at March 31, 2025: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level I</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level II</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level III</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash and cash equivalents</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">19.9</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">37.0</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounts payable and accrued liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.0</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following table summarized the valuation of the Company&#8217;s financial instruments that fell within the fair value hierarchy (in millions) at December 31, 2024: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level I</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level II</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level III</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash and cash equivalents</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">40.0</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounts payable and accrued liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.4</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Certain Risks and Uncertainties</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company will need additional funding and/or in-kind support via a combination of strategic alliances, government grants, commercial loans, further offerings of equity securities, or an offering of debt securities in order to support its future research and development (R&amp;D) activities required to further enhance and complete the development and commercialization of its fuel products.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">There can be no assurance that the Company will be able to successfully continue to conduct its operations if there is a lack of financial resources available in the future to continue its fuel development activities, and a failure to do so would have a material adverse effect on the Company&#8217;s future R&amp;D activities, financial position, results of operations, and cash flows. Also, the success of the Company&#8217;s operations will be subject to other numerous contingencies, some of which are beyond management&#8217;s control. These contingencies include general and regional economic conditions, contingent liabilities, potential competition with other nuclear fuel developers, including those entities developing accident tolerant fuels (ATFs), changes in government regulations, risks related to the R&amp;D of the Lightbridge Fuel&#8482;, regulatory approval of the Company&#8217;s fuel, support for nuclear power, changes in accounting and taxation standards, inability to achieve overall short-term and long-term R&amp;D milestones toward commercialization, future impairment charges to the Company&#8217;s assets, and global or regional catastrophic events. The Company may also be subject to various additional political, economic, and other uncertainties.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company is engaged in significant research and development (R&amp;D) activities to advance its nuclear fuel technology at Idaho National Laboratory (INL). For the three months ended March 31, 2025, R&amp;D expenses associated with activities conducted at the INL accounted for approximately 47% of the Company&#8217;s total R&amp;D expenditure. The Company currently relies on INL for developing, testing and evaluating its nuclear fuel. Any disruption in access to INL&#8217;s resources, including changes in government policies, facility downtime, regulatory constraints, or unforeseen operational challenges could have a material adverse effect on the Company&#8217;s current ability to advance its R&amp;D activities. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Recent Accounting Pronouncements</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">ASU No. 2023-09, <em>Income Taxes (Topic 740): Improvements to Income Tax Disclosures</em>, was issued by the FASB in December 2023. This guidance enhances income tax disclosure requirements by mandating the disclosure of (1) specific categories in the rate reconciliation, (2) income or loss from continuing operations before income taxes, disaggregated between domestic and foreign, and (3) income tax expense or benefit from continuing operations, disaggregated by federal, state, and foreign. The ASU also requires disclosure of income tax payments to federal, state, local, and foreign jurisdictions, among other changes. The standard is effective for annual periods beginning after December 15, 2024, and will be adopted by the Company as permitted. The Company will apply the guidance on a prospective basis and the adoption is not expected to have a material impact on its condensed consolidated financial statements or related disclosures.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In November 2024, the FASB issued ASU No. 2024-03, <em>Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures</em> (Subtopic 220-40): <em>Disaggregation of Income Statement Expenses</em> (&#8220;ASU 2024-03&#8221;), which required disclosure of certain costs and expenses on an interim and annual basis in the notes to the consolidated financial statements. The guidance is effective for annual reporting periods beginning after December 15, 2026 and interim periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The guidance is to be applied either (1) prospectively to financial statements issued for reporting periods after the effective date or (2) retrospectively to any or all prior periods presented in the financial statements. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has evaluated other recently issued, but not yet effective, accounting standards that have been issued or proposed by the FASB or other standards-setting bodies through the filing date of these unaudited condensed consolidated financial statements and does not believe the future adoption of any such standards will have a material impact on the consolidated financial statements and related disclosures.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/275/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 250<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/250/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net Loss Per Common Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 2. Net Loss Per Share</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Basic net loss per share is computed using the weighted-average number of common shares outstanding during the reporting period, except that it does not include unvested common shares subject to repurchase or cancellation. Diluted net loss per share is computed using the weighted-average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The outstanding securities noted below have been excluded from the computation of diluted weighted shares outstanding for the three months ended March 31, 2025 and 2024, as they would have been anti-dilutive due to the Company&#8217;s losses at March 31, 2025 and 2024 and also because the exercise price of certain of these outstanding securities was greater than the average closing price of the Company&#8217;s common stock.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three Months Ended</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Stock options outstanding</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">429,454</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">555,582</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Restricted stock awards outstanding</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">743,702</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">557,688</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">1,173,156</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">1,113,270</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid Project Costs and Other Longterm Assets<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_PrepaidExpensesCurrentAndLongTermAssetsAbstract', window );"><strong>Prepaid Project Costs and Other Longterm Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_PrepaidProjectCostsDisclosureTextBlock', window );">Prepaid Project Costs and Other Long-term Assets</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 3. Prepaid Project Costs and Other Long-term Assets</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In 2022, the Company entered into two agreements with Idaho National Laboratory (INL), in collaboration with the Department of Energy (DOE), to support the development of Lightbridge Fuel&#8482;. At the time of signing, the Company made advance payments for future project work totaling $0.4 million to Battelle Energy Alliance, LLC (BEA), the DOE&#8217;s operating contractor for INL. In May 2023, the Company and INL modified the agreements to extend the contract term to May 2029, aligning it with the duration of the irradiation testing, and increasing the advance payments by $0.1 million to $0.5 million. During the quarter ended March 31, 2025, the Company made additional advance payments of $0.6 million which subsequently offset $0.4 million in project costs. As of March 31, 2025, and December 31, 2024, the Company&#8217;s prepaid project costs were $0.7 million and $0.5 million, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_PrepaidExpensesCurrentAndLongTermAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_PrepaidExpensesCurrentAndLongTermAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_PrepaidProjectCostsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_PrepaidProjectCostsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable and Accrued Liabilities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accounts Payable and Accrued Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accounts Payable and Accrued Liabilities</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 4. Accounts Payable and Accrued Liabilities</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounts payable and accrued liabilities consist of the following (rounded in millions):</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Trade payables</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.3</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accrued research and development expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accrued bonus</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.3</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accrued payroll taxes and professional fees </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.3</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">1.0</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">0.4</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 720<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_CommitmentsAndContingenciesAbstract', window );"><strong>Commitments and Contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 5. Commitments and Contingencies</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Operating Leases</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company leased office space for a 12-month term from January 1, 2025 through December 31, 2025 with a monthly payment of approximately $8,000. The future minimum lease payments required under the non-cancellable operating leases for 2025 total approximately $0.1 million. Total rent expense for the three months ended March 31, 2025 and 2024 was approximately $25,000 and $24,000, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_CommitmentsAndContingenciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_CommitmentsAndContingenciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research and Development Costs<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development Costs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock', window );">Research and Development Costs</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 6. Research and Development Costs</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">INL Project</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In 2022, Lightbridge entered into agreements with BEA, to support the development of Lightbridge Fuel&#8482;. These framework agreements use an innovative structure that consists of an &#8220;umbrella&#8221; Strategic Partnership Project Agreement (SPPA) and an &#8220;umbrella&#8221; Cooperative Research and Development Agreement (CRADA), with an initial duration of seven years. Throughout the duration of these umbrella agreements, all R&amp;D work contracted with BEA is through the issuance of Project Task Statements (PTS). The initial phase of work under the two agreements is expected to culminate in future irradiation testing in the INL Advanced Test Reactor of fuel samples using enriched uranium supplied by the DOE. The initial phase of work aims to generate irradiation performance data for Lightbridge&#8217;s delta-phase uranium-zirconium alloy relating to various thermophysical properties. Data gathered during future post-irradiation examination work are expected to support fuel performance modeling and regulatory licensing efforts for the commercial deployment of Lightbridge Fuel&#8482;. For the three months ended March 31, 2025 and 2024, the Company recorded $0.8 million and $0.4 million in R&amp;D expenses associated with INL, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">INL Modifications to the CRADA and SPPA Project Task Statements</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On January 16, 2025, the Company and BEA entered into Modification No. 3 to the PTS No. 1 under the CRADA, dated September 27, 2022, as amended on May 22, 2023 and May 30, 2023, by and between the Company and BEA. Pursuant to the terms of Modification No. 3, the potential amounts payable by the Company to reimburse BEA for its expenses and employee time associated with R&amp;D activities were increased by approximately $1.6 million, bringing the total estimated cost for the work to be performed under the &#8220;umbrella&#8221; CRADA to $4.2 million. This modification also required that a $600,000 advance payment be made, which was due and paid on January 16, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 18, 2025, the Company and BEA entered into Modification No. 4 to the PTS No. 1 under the SPPA, dated December 9, 2022, as amended on May 23, 2023, March 26, 2024 and October 24, 2024, by and between the Company and BEA. Pursuant to the terms of Modification No. 4, the potential amounts payable by the Company to reimburse BEA for its expenses and employee time were increased by approximately $0.6 million, bringing the total estimated cost for the work to be performed under the &#8220;umbrella&#8221; SPPA to $2.6 million.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">After accounting for Modification No. 4, cash payments from Lightbridge to BEA under both CRADA and SPPA are estimated at approximately $6.8 million on a cost reimbursable basis over the performance periods. These obligations are generally cancellable with 30 days&#8217; notice and, therefore, are not considered firm commitments. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline"></span></em>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Romania Feasibility Study</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On October 16, 2023, the Company engaged RATEN ICN in Romania to perform an engineering study to assess the compatibility and suitability of Lightbridge Fuel&#8482; for use in Canada Deuterium Uranium (CANDU) reactors. The total price of approximately $0.2 million was payable in three installments, including an advance payment of $0.1 million and an interim milestone payment and final payment totaling approximately $0.1 million. The Company made its final payment in December 2024 when the study was completed. The Company has no further obligations under the agreement. For the three months ended March 31, 2025 and 2024, the Company recorded $0 million and $0.1 million, respectively in R&amp;D expenses associated with RATEN ICN feasibility study.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">FEED Study with Centrus Energy for a Lightbridge Pilot Fuel Fabrication Facility</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On December 5, 2023, the Company entered into an agreement with Centrus Energy to conduct a front-end engineering and design (FEED) study to evaluate deployment of a Lightbridge Pilot Fuel Fabrication Facility (LPFFF) at the American Centrifuge Plant in Piketon, Ohio. The Company made its final payment in December 2024 for the study was completed in 2024 and has no further obligations under the agreement. For the three months ended March 31, 2025 and 2024, the Company recorded $0 million and $0.2 million, respectively, in R&amp;D expenses associated with this FEED study.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/985-20/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483041/730-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders Equity and StockBased Compensation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Stockholders Equity and StockBased Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity and Stock-Based Compensation</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 7. Stockholders&#8217; Equity and Stock-Based Compensation</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At March 31, 2025, the Company had 21,557,343 common shares outstanding (including outstanding restricted stock awards (RSAs) totaling 743,702 shares). Also outstanding were stock options relating to 429,454 shares of common stock (of which 409,789 stock options were vested), all totaling 21,986,797 shares of common stock and all common stock equivalents, outstanding as of March 31, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At December 31, 2024, the Company had 18,783,912 common shares outstanding (including outstanding RSAs totaling 781,864 shares). Also outstanding were stock options relating to 464,940 shares of common stock (of which 445,275 stock options were vested), all totaling 19,248,852 shares of common stock and all common stock equivalents, outstanding as of December 31, 2024.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Issuance of Series X Preferred Stock&#160;</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On February 27, 2025, the Company entered into a Subscription and Investment Representation Agreement with the chair of the Audit Committee and an independent member of the Board (the &#8220;Purchaser&#8221;), pursuant to which the Company agreed to issue and sell one (1) share of the Company&#8217;s Series X Preferred Stock, par value $0.001 per share (the &#8220;Series X Preferred Stock&#8221;), to the Purchaser for $100 in cash. The sale closed on February 27, 2025 and the $100 was fully paid-up and recorded under current liabilities. The Company will redeem the Series X Preferred Stock for $100 cash after the Company&#8217;s annual 2025 shareholder meeting (the &#8220;Annual Meeting&#8221;).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Series X Preferred Stock does not have any voting rights except with respect to any proposal to increase the number of authorized shares of common stock of the Company. Each share of Series X Preferred Stock will be entitled to 25,000,000 votes on such proposal, voting together with the holders of the Company&#8217;s common stock. The votes by the holder of Series X Preferred Stock will be cast at the Annual Meeting automatically in the same &#8220;mirrored&#8221; proportion as the aggregate votes cast &#8220;for&#8221; and &#8220;against&#8221; the proposal by the holders of the common stock who vote on such proposal (excluding abstentions, broker non-votes and shares of common stock that are not voted &#8220;for&#8221; or &#8220;against&#8221; such proposal). The voting power attributable to the Series X Preferred Stock will be disregarded for purposes of determining whether a quorum is present at the Annual Meeting.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Pursuant to the terms of issuance, the Series X Preferred Stock will be redeemed at its original issuance price of $100 upon the earlier of (i) the order of the Board of Directors in its sole discretion, automatically and effective at such date and time as determined and specified by the Board of Directors in its sole discretion and (ii) automatically and effective immediately after the publishing or other public announcement by the Company of the final results of any stockholder vote on a proposal to increase the authorized common stock. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Common Stock Equity Offerings</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Increase in Authorized Common Shares </em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On February 26, 2025, the Company&#8217;s Board of Directors approved increasing the authorized common shares from 25,000,000 shares to 100,000,000 shares. This change will take effect upon receiving majority shareholder approval at the 2025 shareholder annual meeting on May 8, 2025 and filing the amendment to the Company&#8217;s Articles of Incorporation with the Nevada Secretary of State (note 9).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>At-the-Market (ATM) Offerings</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On May 28, 2019, the Company entered into an at-the-market equity offering sales agreement with Stifel, Nicolaus &amp; Company, Incorporated (Stifel), which was amended on April 9, 2021 and May 8, 2024 (the ATM Agreement), pursuant to which the Company may issue and sell shares of its common stock from time to time through Stifel as the Company&#8217;s sales agent. Under this amended agreement, the Company pays Stifel a commission equal to 3.0% of the aggregate gross proceeds of any sales of common stock under the agreement. The offering of common stock pursuant to this agreement can be terminated with 10 days written notice by either party. Sales of the Company&#8217;s common stock through Stifel, if any, will be made by any method that is deemed to be an &#8220;at-the-market&#8221; equity offering as defined in Rule 415 promulgated under the Securities Act of 1933.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company filed a shelf registration statement on Form S-3 with the Securities and Exchange Commission (SEC) on March 29, 2024, registering the sale of up to $75.0 million of the Company&#8217;s securities that was declared effective on April 19, 2024. On May 10, 2024, the Company filed a prospectus supplement, which was further supplemented on July 19, 2024 and August 9, 2024 (collectively, the &#8220;First Prospectus Supplement&#8221;), pursuant to which the Company may offer and sell shares of common stock having an aggregate offering price of up to $12.6 million from time to time through the ATM. The Company exhausted all sales under the First Prospectus Supplement. On November 22, 2024, the Company filed a prospectus supplement pursuant to which the Company may offer and sell shares of common stock having an aggregate offering price of up to $45.0 million from time to time through the ATM.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company records its ATM sales on a settlement date basis. The Company sold 2,605,619 shares under the ATM for the three months ended March 31, 2025 resulting in net proceeds of $20.2 million (stock issuance costs were approximately $0.7 million). The Company records its ATM sales on a settlement date basis. The Company sold 427,300 shares under the ATM for the three months ended March 31, 2024 resulting in net proceeds of $1.2 million (stock issuance costs were approximately $0.2 million).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Stock-Based Compensation</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>&#160;2020 Omnibus Incentive Plan </em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 9, 2020, the Board of Directors adopted the Company&#8217;s 2020 Omnibus Incentive Plan (as subsequently amended, the &#8220;2020 Plan&#8221;). On September 3, 2020, the shareholders approved the 2020 Plan to authorize grants of the following types of awards: (a) Options, (b) Stock Appreciation Rights, (c) Restricted Stock Awards and Restricted Stock Units, and (d) Other Stock-Based and Cash-Based Awards. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On February 27, 2024, the Board of Directors approved an increase of 700,000 shares to the authorized number of shares under the 2020 Plan, increasing the total authorized number of shares from 1,800,000 shares to 2,500,000 shares. This increase was approved by the stockholders at the shareholders&#8217; annual meeting on April 19, 2024. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The total number of shares of common stock available for issuance under the 2020 Plan was 2,500,000 shares with 1,009,389 shares available for future issuance at March 31, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On February 26, 2025, the Company&#8217;s Board of Directors approved an increase of 2,500,000 shares to the authorized number of shares under the 2020 Plan, increasing the total authorized number of shares from 2,500,000 to 5,000,000. This change will take effect if approved by shareholders at the Company&#8217;s 2025 shareholder annual meeting on May 8, 2025 (note 9).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Stock Options</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Stock options issued to the Company&#8217;s employees, directors and consultants are summarized as follows for the three months ended March 31, 2025 and 2024:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Options </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted Average Exercise Price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted-Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Remaining</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Contractual</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Term (Years)</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Aggregate</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Intrinsic</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Outstanding, December 31, 2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">464,940</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">16.24</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.07</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">184,818</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">10,448</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">9.42</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(45,934 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4.80</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">310,093</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt">Forfeited</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt">Expired</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Outstanding, March 31, 2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">429,454</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">17.29</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">2.53</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">469,719</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Vested and expected to vest, end of the period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">429,454</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">17.29</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">2.53</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">469,719</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Options exercisable, end of the period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">409,789</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">17.97</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">2.22</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">387,153</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In the three months ended March 31, 2025 and 2024, the Company issued 10,448 and 58,309 stock options, respectively, to one consultant. The 10,448 stock options and the 58,309 stock options were assigned a fair value of $5.74 per share and $1.03 per share, respectively (total fair value of $60,000 for each grant). The weighted-average grant-date exercise price per share of the stock options granted for the three months ended March 31, 2025 and 2024, was $9.42 and $2.62, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The fair value was determined using the Black-Scholes pricing model. For expected volatility, the Company concluded that the historical volatility over the option&#8217;s expected holding term provided the most reasonable basis for this estimate. For the risk-free interest rate, the Company used U.S. Treasury Note rates, which mature at approximately the same time as the option&#8217;s expected holding term or option life determined by using the simplified method. The Company recognized forfeitures of equity-based awards as a reduction to compensation costs in the period in which they occur. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following assumptions were used in the Black-Scholes pricing model to determine the fair value of stock options granted for the three months ended March 31, 2025 and 2024:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected volatility</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">117.44</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">75.36</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Risk free interest rate </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.95</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4.54</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Dividend yield rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected life</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2 years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2 years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Closing price per share - common stock </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">9.42</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.62</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The intrinsic value is calculated as the difference between the fair value of the Company&#8217;s common stock and the exercise price of the stock options. The fair value of the Company&#8217;s common stock was $7.46 per share and $2.95 per share at March 31, 2025 and 2024, respectively. As of March 31, 2025, total unrecognized compensation cost related to option awards was $35,388, which is expected to be recognized over a remaining weighted-average vesting period of 1.9 years. As of March 31, 2024, total unrecognized compensation cost related to option awards was $35,384, which is expected to be recognized over a remaining weighted-average vesting period of 1.9 years.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Exercise of Options</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For the three months ended March 31, 2025, the Company received approximately $0.2 million of net proceeds from the exercise of 45,934 stock options from employees and consultants. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Common Stock</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Consultants&#8217; Stock Issuances</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For the three months ended March 31, 2025 and 2024, the Company issued 3,171 shares (with stock prices of $4.73 per share) and 3,750 shares (with stock prices of $4.00 per share) of common stock, respectively, to its investor relations firm for services provided during the period, recorded to general and administrative expenses. These shares vested immediately upon issuance. The expense recorded for these share issuances was $15,000 for each quarter. The shares were valued based on the closing market price of the Company&#8217;s common stock on the date of grant. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On August 19, 2024, the Board of Directors approved an equity grant valued at $180,000 to a consulting and investment research firm, for corporate advisory services to be provided over a twelve-month period, and preparation and dissemination of a report regarding the Company, which resulted in issuing the consultant 71,713 shares of common stock on the grant date, valued at $2.51 per share. These shares vested immediately upon issuance and are not forfeitable. The compensation cost of $180,000 began to be recognized on a straight-line basis over the requisite service period. Approximately $45,000 and $0 were recorded as consulting expenses for the three months ended March 31, 2025, and 2024, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of March 31, 2025, the unrecognized compensation cost of approximately $69,000 was recorded under prepaid expenses and other current assets on the accompanying condensed consolidated balance sheet, which is expected to be recognized over a remaining service period of 0.4 years.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Director Compensation - Equity-Settled Awards</span></em>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On December 4, 2024, the Board of Directors approved an equity grant valued at $500,000 in total to its five directors for the service period and year ended December 31, 2024, which resulted in granting a total of 85,915 shares of common stock, valued on the grant date at $5.82 per share on December 4, 2024, which shares vested on January 2, 2025. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On November 20, 2023, the Board of Directors approved an equity grant valued at $240,000 in total to its six directors for the service period and year ended December 31, 2023, which resulted in granting a total of 60,456 shares of common stock, valued on the grant date at $3.97 per share on November 20, 2023, which shares vested on January 2, 2024.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As a result, the fair value of the stock awards was measured on the grant date and recorded as an increase to stock-based compensation expense and additional paid-in capital in 2025 and 2024. The fair value of the shares granted was determined based on the closing market price of the Company&#8217;s common stock on the grant date. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Restricted Stock Awards</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following summarizes the Company&#8217;s restricted stock award activity and the RSA outstanding: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted- </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Grant Date</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Fair Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Aggregate </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Fair</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Outstanding, December 31, 2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">781,864</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.19</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,698,217</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Awards granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">57,940</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">8.63</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">500,022</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Awards vested</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(96,102</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.67</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">737,535</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Awards forfeited</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Outstanding, March 31, 2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">743,702</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">5.40</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;">$</td><td style="BORDER-BOTTOM: black 3px double;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;5,548,017 </p></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 12, 2025, the Board of Directors approved a grant of restricted stock awards (RSAs) totaling $0.5 million to its five directors for the service year ending December 31, 2025. This grant comprised 57,940 RSAs, valued at $8.63 per share on the grant date, with vesting scheduled in four quarterly installments. The first installment, consisting of 14,485 RSAs, vested on March 31, 2025. This resulted in the recognition of $0.1 million in stock-based compensation expense for the quarter ended March 31, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The aggregate fair value was calculated as the fair value of the Company&#8217;s common stock. The fair value of the Company&#8217;s common stock was $7.46 and $2.95 per share at March 31, 2025 and 2024, respectively. The fair value of the RSAs vested for the three months ended March 31, 2025 and 2024 was $0.7 million and $0 million, respectively. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of March 31, 2025, all the outstanding shares of RSAs are unvested. As of March 31, 2025, total unrecognized compensation cost related to RSAs was $3.5 million, which is expected to be recognized over a remaining weighted-average vesting period of 2.14 years.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><em><span style="text-decoration:underline"></span></em>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><em><span style="text-decoration:underline">Restricted Stock Awards Modification and Net Share Settlements for Payments of Withholding Taxes</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On March 24, 2025, the Company entered into a separation agreement with a former employee. As part of the agreement, the Board of Directors approved the accelerated vesting of 70,710 RSAs, which would have otherwise been forfeited upon termination. In accordance with ASC 718, this was treated as a modification, leading to the recognition of $0.5 million in stock-based compensation expense for the quarter ended March 31, 2025. This expense included $0.2 million of previously unrecognized compensation cost and $0.3 million of incremental fair value from the modification of the RSAs awarded.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">To satisfy approximately $0.2 million in payroll withholding taxes associated with the accelerated RSAs vesting, the Company withheld 21,285 shares, resulting in the issuance of 49,425 net shares to the former employee. These withheld shares were returned to the 2020 Plan share reserve for potential future issuance.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On March 14, 2025, 10,907 RSAs vested to the former employee based on his service to the Company. To satisfy approximately $36,000 in payroll withholding taxes, the Company withheld 3,863 shares, resulting in the issuance of 7,044 net shares to the former employee. These withheld shares were returned to the 2020 Plan share reserve for potential future issuance.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">RSA Summary - 2025 and 2024</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of March 31, 2025 and December 31, 2024, there were 743,702 shares and 781,864 shares of RSAs included in the total issued and outstanding common stock, respectively. Compensation expense for RSAs issued to employees and consultants are generally recognized straight line over the three-year vesting period. A total of $1.3 million (including the $0.5 million accelerated RSAs vesting for the former employee) and $0.4 million of stock-based compensation expense was recorded for the three months ended March 31, 2025 and 2024, respectively, for the RSAs.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Stock-Based Compensation Expense</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Total non-cash stock-based compensation expense recorded related to options granted and restricted stock awards included in the Company&#8217;s unaudited condensed consolidated statements of operations for the three months ended March 31, 2025 and 2024 are as follows (rounded in millions):</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Research and development expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">General and administrative expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1.1</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.4</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total stock-based compensation expense </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">1.3</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">0.5</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 8. Segment Reporting</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Operating segments are defined as components of an enterprise about which separate discrete information is available for evaluation by the chief operating decision maker, or decision-making group, in deciding how to allocate resources in assessing performance. The Company has one reportable business segment: nuclear fuel technology. This segment consists of the research and development and commercialization of its nuclear fuel. The Company&#8217;s chief operating decision maker (&#8220;CODM&#8221;) is the chief executive officer.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The accounting policies of the segment are the same as those described in the summary of significant accounting policies. The CODM assesses performance for the segment based on net loss as reported on the condensed consolidated statement of operations. The Company expects to continue to incur significant expenses and operating losses for the foreseeable future as it advances its nuclear fuel through all the stages of its development and commercialization. In addition, the measure of segment assets is reported on the condensed consolidated balance sheet as total assets.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The CODM uses segment net loss to allocate resources predominantly in the annual budget and forecasting process and uses that measure as a basis for evaluating progress toward R&amp;D milestones. The CODM uses cash forecast models in deciding how to invest into the segment. Research and development expenses, general and administrative expenses are included in segment net loss and used to monitor budget versus actual results. Monitoring budgeted versus actual results is used in assessing performance of the segment, while research and development milestones scorecard results and scorecard general and administrative budgeted results are used in establishing management&#8217;s incentive compensation.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The table below summarizes the significant expense categories regularly provided to the CODM for the three months ended March 31, 2025 and 2024 (rounded in millions):</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">General and administrative </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">3.5</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2.2</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Research and development:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 11.25pt; text-align:justify;">INL Project</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.8</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.4</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 11.25pt; text-align:justify;">Romania feasibility study</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 11.25pt; text-align:justify;">Centrus Energy FEED study</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Allocated employee compensation and stock-based compensation </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.8</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 11.25pt; text-align:justify;">Other outside R&amp;D expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Total research and development</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1.7</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1.0</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Other segments items<sup style="vertical-align:super">(1)</sup></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(0.4 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(0.4 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Net loss</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(4.8 </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(2.8 </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; text-align:justify;">(1) Other segment items include interest income.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 9. Subsequent Events</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>ATM Sales</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Sales of common stock under the Company&#8217;s ATM from April 1, 2025 to May 12, 2025 amounted to 677,300 shares, which resulted in total net proceeds of approximately $5.0 million. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Issuance of Performance-Based RSAs</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On April 3, 2025, the Company&#8217;s Compensation Committee and Board approved the grant of performance-based RSAs to certain executives, key employees and certain consultants under the 2020 Plan. The awards are subject to both service and performance-based vesting conditions, including achievement of one specific R&amp;D fuel milestone, the insertion of the Company&#8217;s coupon fuel samples into the ATR reactor at INL for irradiation testing by December 31, 2026. The service requirement for vesting is a three-year period from the grant date.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company will recognize stock-based compensation expense for these awards beginning on the grant date, with the amount and timing of expense recognition dependent on the probability of achieving the above performance condition. These 300,000 performance-based restricted stock awards were valued at $2.1 million, based on the April 7, 2025 closing stock price of $6.99 per share</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>2025 Annual Shareholder Meeting Voting Results</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At the Company&#8217;s Annual Meeting of Shareholders held on May 8, 2025, shareholders approved the following proposals:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">1.</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Amendment to the Articles of Incorporation to increase the number of authorized shares of common stock from 25,000,000 shares to 100,000,000 shares.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2.</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Amendment to the 2020 Plan to increase the number of shares authorized for issuance under the plan from 2,500,000 shares to 5,000,000 shares.</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The approved proposal to the Amendment to the Articles of Incorporation became effective upon the filing of the Amended and Restated Certificate of Incorporation with the Secretary of State of Nevada.The Series X Preferred Stock (note 7) was redeemed and the Certificate of Withdrawal was filed with the Secretary of State of Nevada. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span class="atag" id="forward" style="display: inline">FORWARD-LOOKING STATEMENTS </span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In addition to historical information, this Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. We use words such as &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;project,&#8221; &#8220;target,&#8221; &#8220;plan,&#8221; &#8220;optimistic,&#8221; &#8220;intend,&#8221; &#8220;aim,&#8221; &#8220;will,&#8221; &#8220;may,&#8221; or similar expressions, which are intended to identify forward-looking statements. Such statements include, among others:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">those concerning market and business segment growth, demand, and acceptance of our nuclear fuel technology and other steps toward the commercialization of Lightbridge Fuel&#8482;;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">any projections of sales, earnings, revenue, margins, or other financial items;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">any statements of the plans, strategies, and objectives of management for future operations and the timing and outcome of the development of our nuclear fuel technology;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">any statements regarding future economic conditions or performance;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">any statements about future financings and liquidity;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">the Company&#8217;s anticipated financial resources and position; and</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">all assumptions, expectations, predictions, intentions, or beliefs about future events and other statements that are not historical facts.</td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">You are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, as well as assumptions that if they were to ever materialize or prove incorrect, could cause the results of the Company to differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties, among others, include:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">our ability to commercialize our nuclear fuel technology, including risks related to the design and testing of nuclear fuel incorporating our technology and the degree of market adoption of the Company&#8217;s product and service offerings;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">dependence on strategic partners;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">any adverse changes to our agreements or relationship with the U.S. government and its national laboratories;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">our ability to fund our future operations, including general corporate overhead and outside research and development (R&amp;D) expenses, and continue as a going concern;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">the future market and demand for our fuel for nuclear reactors and our ability to attract customers;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">our ability to manage the business effectively in a rapidly evolving market;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">our ability to employ and retain qualified employees and consultants that have experience in the nuclear industry;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">competition and competitive factors in the markets in which we compete, including from accident tolerant fuels (ATFs);</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">access to and availability of nuclear test reactors and the risks associated with unexpected changes in our nuclear fuel development timeline;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">access to and availability of adequate resources and manufacturing capabilities at national laboratories that affect our nuclear fuel development timeline and project costs;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">the increased costs associated with metallization of our nuclear fuel;</td></tr></tbody></table><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">uncertainties related to conducting business in foreign countries;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">public perception of nuclear energy generally;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">changes in laws, rules, and regulations governing our business;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">changes in the political environment;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">development and utilization of, and challenges to, our intellectual property domestically and abroad;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">the trading price of our securities is likely to be volatile, and purchasers of our securities could incur substantial losses; and</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">the other risks and uncertainties identified in Item 1A. Risk Factors included in our Annual Report on Form 10-K for the year ended December 31, 2024.</td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Most of these factors are beyond our ability to predict or control and you should not put undue reliance on any forward-looking statement. Future events and actual results could differ materially from those set forth in, contemplated by or underlying the forward-looking statements. Forward-looking statements speak only as of the date on which they are made. The Company assumes no obligation and does not intend to update these forward-looking statements for any reason after the date of the filing of this report, to conform these statements to actual results or to changes in our expectations, except as required by law.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation Summary of Significant Accounting Policies and Nature of Operations (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations', window );"><strong>Basis of Presentation Summary of Significant Accounting Policies and Nature of Operations (Policies)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company determined fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between unaffiliated market participants at the measurement date.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounting Standards Codification (ASC), <em>Fair Value Measurement</em> (ASC 820), established a fair value hierarchy that prioritizes the inputs used to measure fair value. Assets and liabilities measured at fair value were categorized based on whether the inputs are observable in the market and the degree that the inputs are observable. The hierarchy gives the highest priority to active markets for identical assets and liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). The categorization of financial instruments within the valuation hierarchy was based on the lowest level of input that is significant to the fair value measurement. At the end of the reporting period, the Company reviews U.S. treasury instruments held to determine whether the securities are of the most recent issuance of that security with the same maturity (referred to as &#8220;on-the-run&#8221;, which is the most liquid version of the maturity band). If a U.S. treasury instrument held at the end of the reporting period was from the most recent issuance it is classified as level 1, otherwise it is referred to as &#8220;off-the-run&#8221; and is classified as level 2. The three levels of the fair value hierarchy were as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 1 - Observable inputs such as quoted prices in active markets for identical assets or liabilities;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 2 - Inputs other than quoted prices that were observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that were not active and inputs other than quoted prices that were observable for the asset or liability; and</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 3 - Unobservable inputs that reflect management&#8217;s assumptions.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For disclosure purposes, assets and liabilities were classified in their entirety in the fair value hierarchy level based on the lowest level of input that was significant to the overall fair value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement required judgment and may have affected the placement within the fair value hierarchy levels.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company&#8217;s financial instruments consisted principally of cash and cash equivalents, accounts payable and accrued liabilities. The carrying amounts of cash, accounts payable and accrued liabilities are considered to be Level 1 measurements, because of the short-term nature of those instruments. Cash equivalents are primarily composed of US Treasury instruments having maturity dates of 30 to 90 days. The Company purchased $37 million of US Treasury instruments for the three months ended March 31, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following table summarized the valuation of the Company&#8217;s financial instruments that fell within the fair value hierarchy (in millions) at March 31, 2025: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level I</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level II</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level III</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash and cash equivalents</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">19.9</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">37.0</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounts payable and accrued liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.0</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following table summarized the valuation of the Company&#8217;s financial instruments that fell within the fair value hierarchy (in millions) at December 31, 2024: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level I</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level II</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level III</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash and cash equivalents</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">40.0</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounts payable and accrued liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.4</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Certain Risks and Uncertainties</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company will need additional funding and/or in-kind support via a combination of strategic alliances, government grants, commercial loans, further offerings of equity securities, or an offering of debt securities in order to support its future research and development (R&amp;D) activities required to further enhance and complete the development and commercialization of its fuel products.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">There can be no assurance that the Company will be able to successfully continue to conduct its operations if there is a lack of financial resources available in the future to continue its fuel development activities, and a failure to do so would have a material adverse effect on the Company&#8217;s future R&amp;D activities, financial position, results of operations, and cash flows. Also, the success of the Company&#8217;s operations will be subject to other numerous contingencies, some of which are beyond management&#8217;s control. These contingencies include general and regional economic conditions, contingent liabilities, potential competition with other nuclear fuel developers, including those entities developing accident tolerant fuels (ATFs), changes in government regulations, risks related to the R&amp;D of the Lightbridge Fuel&#8482;, regulatory approval of the Company&#8217;s fuel, support for nuclear power, changes in accounting and taxation standards, inability to achieve overall short-term and long-term R&amp;D milestones toward commercialization, future impairment charges to the Company&#8217;s assets, and global or regional catastrophic events. The Company may also be subject to various additional political, economic, and other uncertainties.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company is engaged in significant research and development (R&amp;D) activities to advance its nuclear fuel technology at Idaho National Laboratory (INL). For the three months ended March 31, 2025, R&amp;D expenses associated with activities conducted at the INL accounted for approximately 47% of the Company&#8217;s total R&amp;D expenditure. The Company currently relies on INL for developing, testing and evaluating its nuclear fuel. Any disruption in access to INL&#8217;s resources, including changes in government policies, facility downtime, regulatory constraints, or unforeseen operational challenges could have a material adverse effect on the Company&#8217;s current ability to advance its R&amp;D activities. </p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Adopted Pronouncements</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">ASU No. 2023-09, <em>Income Taxes (Topic 740): Improvements to Income Tax Disclosures</em>, was issued by the FASB in December 2023. This guidance enhances income tax disclosure requirements by mandating the disclosure of (1) specific categories in the rate reconciliation, (2) income or loss from continuing operations before income taxes, disaggregated between domestic and foreign, and (3) income tax expense or benefit from continuing operations, disaggregated by federal, state, and foreign. The ASU also requires disclosure of income tax payments to federal, state, local, and foreign jurisdictions, among other changes. The standard is effective for annual periods beginning after December 15, 2024, and will be adopted by the Company as permitted. The Company will apply the guidance on a prospective basis and the adoption is not expected to have a material impact on its condensed consolidated financial statements or related disclosures.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In November 2024, the FASB issued ASU No. 2024-03, <em>Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures</em> (Subtopic 220-40): <em>Disaggregation of Income Statement Expenses</em> (&#8220;ASU 2024-03&#8221;), which required disclosure of certain costs and expenses on an interim and annual basis in the notes to the consolidated financial statements. The guidance is effective for annual reporting periods beginning after December 15, 2026 and interim periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The guidance is to be applied either (1) prospectively to financial statements issued for reporting periods after the effective date or (2) retrospectively to any or all prior periods presented in the financial statements. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has evaluated other recently issued, but not yet effective, accounting standards that have been issued or proposed by the FASB or other standards-setting bodies through the filing date of these unaudited condensed consolidated financial statements and does not believe the future adoption of any such standards will have a material impact on the consolidated financial statements and related disclosures.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478898/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation Summary of Significant Accounting Policies and Nature of Operations (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations', window );"><strong>Basis of Presentation Summary of Significant Accounting Policies and Nature of Operations (Policies)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of fair value of financial instruments</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level I</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level II</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level III</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash and cash equivalents</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">19.9</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">37.0</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounts payable and accrued liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.0</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level I</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level II</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level III</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash and cash equivalents</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">40.0</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounts payable and accrued liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.4</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net Loss Per Common Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Summary of outstanding securities excluded from diluted weighted shares outstanding</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three Months Ended</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Stock options outstanding</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">429,454</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">555,582</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Restricted stock awards outstanding</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">743,702</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">557,688</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">1,173,156</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">1,113,270</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable and Accrued Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accounts Payable and Accrued Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of accounts payable and accrued liabilities</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Trade payables</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.3</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accrued research and development expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accrued bonus</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.3</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accrued payroll taxes and professional fees </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.3</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">1.0</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">0.4</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders Equity and StockBased Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Stockholders Equity and StockBased Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock', window );">Schedule Of stock option</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Options </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted Average Exercise Price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted-Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Remaining</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Contractual</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Term (Years)</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Aggregate</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Intrinsic</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Outstanding, December 31, 2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">464,940</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">16.24</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.07</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">184,818</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">10,448</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">9.42</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(45,934 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4.80</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">310,093</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt">Forfeited</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt">Expired</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Outstanding, March 31, 2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">429,454</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">17.29</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">2.53</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">469,719</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Vested and expected to vest, end of the period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">429,454</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">17.29</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">2.53</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">469,719</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Options exercisable, end of the period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">409,789</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">17.97</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">2.22</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">387,153</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule Of Share-based Compensation, Stock Options, Activity</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected volatility</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">117.44</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">75.36</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Risk free interest rate </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.95</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4.54</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Dividend yield rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected life</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2 years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2 years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Closing price per share - common stock </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">9.42</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.62</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ScheduleOfOutstandingRSATableTextBlock', window );">Schedule Of outstanding RSA</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted- </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Grant Date</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Fair Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Aggregate </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Fair</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Outstanding, December 31, 2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">781,864</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.19</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,698,217</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Awards granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">57,940</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">8.63</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">500,022</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Awards vested</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(96,102</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.67</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">737,535</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Awards forfeited</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Outstanding, March 31, 2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">743,702</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">5.40</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;">$</td><td style="BORDER-BOTTOM: black 3px double;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;5,548,017 </p></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Schedule of stock based compensation expense</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Research and development expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">General and administrative expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1.1</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.4</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total stock-based compensation expense </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">1.3</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">0.5</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_ScheduleOfOutstandingRSATableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_ScheduleOfOutstandingRSATableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of summarizes the expense categories Segment Reporting</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">General and administrative </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">3.5</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2.2</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Research and development:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 11.25pt; text-align:justify;">INL Project</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.8</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.4</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 11.25pt; text-align:justify;">Romania feasibility study</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 11.25pt; text-align:justify;">Centrus Energy FEED study</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Allocated employee compensation and stock-based compensation </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.8</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 11.25pt; text-align:justify;">Other outside R&amp;D expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Total research and development</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1.7</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1.0</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Other segments items<sup style="vertical-align:super">(1)</sup></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(0.4 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(0.4 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Net loss</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(4.8 </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(2.8 </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 56,929,988<span></span>
</td>
<td class="nump">$ 39,990,827<span></span>
</td>
<td class="nump">$ 27,942,421<span></span>
</td>
<td class="nump">$ 28,598,445<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Accounts Payable and Accrued Liabilities</a></td>
<td class="nump">1,000,000.0<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ltbr_TreasuryBillsLevelTwoMember', window );">Level II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">37,000,000.0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Accounts Payable and Accrued Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ltbr_TreasuryBillsLevelThreeMember', window );">Level III</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Accounts Payable and Accrued Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ltbr_TreasuryBillsLevelOneMember', window );">Level I</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">19,900,000<span></span>
</td>
<td class="nump">40,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Accounts Payable and Accrued Liabilities</a></td>
<td class="nump">$ 1,000,000.0<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ltbr_TreasuryBillsLevelTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ltbr_TreasuryBillsLevelTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ltbr_TreasuryBillsLevelThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ltbr_TreasuryBillsLevelThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ltbr_TreasuryBillsLevelOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ltbr_TreasuryBillsLevelOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details Narrative)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_InvestmentsInDebtSecuritiesPurchased', window );">US Treasury instruments purchased</a></td>
<td class="nump">$ 37<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ltbr_INLMember', window );">Idaho National Laboratory (INL)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ResearchAndDevelopmentPercentage', window );">Percentage of research and development expense</a></td>
<td class="nump">47.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_InvestmentsInDebtSecuritiesPurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_InvestmentsInDebtSecuritiesPurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_ResearchAndDevelopmentPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_ResearchAndDevelopmentPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ltbr_INLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ltbr_INLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net Loss Per Common Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease', window );">Stock options outstanding</a></td>
<td class="nump">429,454<span></span>
</td>
<td class="nump">555,582<span></span>
</td>
<td class="nump">464,940<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Restricted stock awards outstanding</a></td>
<td class="nump">743,702<span></span>
</td>
<td class="nump">557,688<span></span>
</td>
<td class="nump">781,864<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Total</a></td>
<td class="nump">1,173,156<span></span>
</td>
<td class="nump">1,113,270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase or decrease in number of shares reserved for issuance under stock option agreements awarded under the plan that validly exist and are outstanding, including vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid Project Costs and Other Long-term Assets (Details Narrative) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>May 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_AdditionalPrepaidExpenseAndOtherAssetsCurrent', window );">Aditional advance payments</a></td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_OffsetOfProjectCosts', window );">Offset of Project Costs</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid Expenses And Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseNoncurrent', window );">Prepaid project costs</a></td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid Expenses And Other Current Assets [Member] | Maxiimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_PrepaidProjectCostsAddition', window );">Prepaid project costs- addition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid Expenses And Other Current Assets [Member] | Miniimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseNoncurrent', window );">Prepaid project costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ltbr_BattelleEnergyAllianceLLCMember', window );">Battelle Energy Alliance, LLC (BEA) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseNoncurrent', window );">Prepaid project costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_AdditionalPrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_AdditionalPrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_OffsetOfProjectCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_OffsetOfProjectCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_PrepaidProjectCostsAddition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_PrepaidProjectCostsAddition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ltbr_MaxiimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ltbr_MaxiimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ltbr_MiniimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ltbr_MiniimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ltbr_BattelleEnergyAllianceLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ltbr_BattelleEnergyAllianceLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accounts Payable and Accrued Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accounts Payable and Accrued Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrentAndNoncurrent', window );">Trade payables</a></td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_AccruedResearchAndDevelopmentExpensesCurrent', window );">Accrued research and development expenses</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedBonusesCurrentAndNoncurrent', window );">Accrued bonus</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Accrued payroll taxes and professional fees</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Total</a></td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_AccruedResearchAndDevelopmentExpensesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_AccruedResearchAndDevelopmentExpensesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedBonusesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedBonusesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_CommitmentsAndContingenciesAbstract', window );"><strong>Commitments and Contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Total Rent Expense</a></td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="nump">$ 24,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating Lease Monthly Payment</a></td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_LeasePaymentUnderNonCancellableOperatingLeases', window );">Future minimum lease payments required under the non-cancellable operating leases</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_LesseeOperatingLeaseTerm', window );">Operating Lease Term</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_CommitmentsAndContingenciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_CommitmentsAndContingenciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_LeasePaymentUnderNonCancellableOperatingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_LeasePaymentUnderNonCancellableOperatingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_LesseeOperatingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_LesseeOperatingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research and Development Cost (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Jan. 16, 2025</div></th>
<th class="th"><div>Oct. 16, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherResearchAndDevelopmentExpense', window );">Other research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Advance Payment Made</a></td>
<td class="nump">$ 324,378<span></span>
</td>
<td class="nump">546,267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,665,913<span></span>
</td>
<td class="nump">$ 1,023,823<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ltbr_StrategicPartnershipProjectAgreementMember', window );">Strategic Partnership Project Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ltbr_BattelleEnergyAllianceLLCMember', window );">Battelle Energy Alliance, LLC (BEA) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ResearchAndDevelopmentArrangementExpense', window );">Increase in Estimated Cost Under R&amp;D Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ltbr_INLMember', window );">Idaho National Laboratory (INL)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ltbr_CRADAMember', window );">CRADA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ltbr_CANDUMember', window );">Canada Deuterium Uranium (CANDU)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Advance Payment Made</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ResearchAndDevelopmentExpensePayable', window );">Payable amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_PaymentsToResearchAndDevelopmentCost', window );">Final payment</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ltbr_FEEdMember', window );">Front-end engineering and design (FEED)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_PaymentsToResearchAndDevelopmentCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_PaymentsToResearchAndDevelopmentCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_ResearchAndDevelopmentArrangementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_ResearchAndDevelopmentArrangementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_ResearchAndDevelopmentExpensePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_ResearchAndDevelopmentExpensePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other research and development expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ltbr_StrategicPartnershipProjectAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ltbr_StrategicPartnershipProjectAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ltbr_BattelleEnergyAllianceLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ltbr_BattelleEnergyAllianceLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ltbr_INLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ltbr_INLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ltbr_CRADAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ltbr_CRADAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ltbr_CANDUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ltbr_CANDUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ltbr_FEEdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ltbr_FEEdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders Equity and StockBased Compensation (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Stockholders Equity and StockBased Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding, Beginning of the period</a></td>
<td class="nump">464,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Options outstanding, Granted</a></td>
<td class="nump">10,448<span></span>
</td>
<td class="nump">58,309<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options outstanding, Exercised</a></td>
<td class="num">(45,934)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Options outstanding, Forfeited</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Options outstanding, Expired</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding, End of the period</a></td>
<td class="nump">429,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Options vested and expected to vest, End of the period</a></td>
<td class="nump">429,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options outstanding options, exercisable</a></td>
<td class="nump">409,789<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Beginning of the period</a></td>
<td class="nump">$ 16.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Stock Options, Granted</a></td>
<td class="nump">9.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Stock Options, Exercised</a></td>
<td class="nump">4.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Stock Options, Forfeited</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Stock Options, Expired</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, End of the period</a></td>
<td class="nump">17.29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, vested and expected to vest, End of the period</a></td>
<td class="nump">17.29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Options, exercisable</a></td>
<td class="nump">$ 17.97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm', window );">Weighted Average Remaining Contractual Life - Years Beginning</a></td>
<td class="text">3 years 25 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermEndingFF', window );">Weighted Average Remaining Contractual Life - Years Ending</a></td>
<td class="text">2 years 6 months 10 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermVested', window );">Weighted Average Remaining Contractual Life - (Years) Vested and expected to vest</a></td>
<td class="text">2 years 6 months 10 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermOptionsExercisable', window );">Weighted Average Remaining Contractual Life - (Years) exercisable</a></td>
<td class="text">2 years 2 months 19 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding', window );">Options aggregate intrinsic value, Outstanding beginning</a></td>
<td class="nump">$ 184,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueExercised', window );">Options aggregate intrinsic value, Outstanding exercised</a></td>
<td class="nump">310,093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding', window );">Options aggregate intrinsic value, Outstanding ending</a></td>
<td class="nump">469,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVestedAndExpectedToVest', window );">Options aggregate intrinsic value, Vested and expected to vest</a></td>
<td class="nump">469,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOptionsExercisable', window );">Options aggregate intrinsic value, Options exercisable</a></td>
<td class="nump">$ 387,153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermEndingFF">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermEndingFF</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermOptionsExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermOptionsExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOptionsExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOptionsExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVestedAndExpectedToVest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVestedAndExpectedToVest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders Equity and StockBased Compensation (Details 1) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Stockholders Equity and StockBased Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">117.44%<span></span>
</td>
<td class="nump">75.36%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="nump">3.95%<span></span>
</td>
<td class="nump">4.54%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing price per share - common stock</a></td>
<td class="nump">$ 9.42<span></span>
</td>
<td class="nump">$ 2.62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected Life</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders Equity and StockBased Compensation (Details 2) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted average fair value grant date, vested</a></td>
<td class="nump">$ 9.42<span></span>
</td>
<td class="nump">$ 2.62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding', window );">Options aggregate intrinsic value, Outstanding beginning</a></td>
<td class="nump">$ 184,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ltbr_RestrictedStockAwardMember', window );">Restricted Stock Award [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding', window );">Outstanding at beginning of period</a></td>
<td class="nump">781,864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Shares, Granted</a></td>
<td class="nump">57,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Shares, vested</a></td>
<td class="num">(96,102)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares', window );">Shares, forfieted</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94', window );">Outstanding at end of period</a></td>
<td class="nump">743,702<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average fair value grant date, beginning</a></td>
<td class="nump">$ 5.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value grant date, granted</a></td>
<td class="nump">8.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted average fair value grant date, vested</a></td>
<td class="nump">5.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue', window );">Weighted average fair value grant date, forfeited</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average fair value grant date, ending</a></td>
<td class="nump">$ 5.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding', window );">Options aggregate intrinsic value, Outstanding beginning</a></td>
<td class="nump">$ 3,698,217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted', window );">Options aggregate intrinsic value, granted</a></td>
<td class="nump">500,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVested', window );">Options aggregate intrinsic value, vested</a></td>
<td class="nump">737,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited', window );">Options aggregate intrinsic value, forfeited</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings', window );">Options aggregate intrinsic value, Outstanding ending</a></td>
<td class="nump">$ 5,548,017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ltbr_RestrictedStockAwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ltbr_RestrictedStockAwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders Equity and StockBased Compensation (Details 3) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 1.3<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research And Development Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General And Administrative Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders Equity and StockBased Compensation (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="9">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 14, 2025</div></th>
<th class="th"><div>Mar. 12, 2025</div></th>
<th class="th"><div>Dec. 04, 2024</div></th>
<th class="th"><div>Mar. 24, 2025</div></th>
<th class="th"><div>Feb. 27, 2025</div></th>
<th class="th"><div>Feb. 26, 2025</div></th>
<th class="th"><div>Nov. 22, 2024</div></th>
<th class="th"><div>Aug. 19, 2024</div></th>
<th class="th"><div>Mar. 29, 2024</div></th>
<th class="th"><div>Feb. 27, 2024</div></th>
<th class="th"><div>Nov. 20, 2023</div></th>
<th class="th"><div>May 28, 2019</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Options outstanding, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,448<span></span>
</td>
<td class="nump">58,309<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price lower range limit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.74<span></span>
</td>
<td class="nump">$ 1.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Total fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000<span></span>
</td>
<td class="nump">$ 60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,355,181<span></span>
</td>
<td class="nump">$ 456,904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Outstanding restricted stock awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">743,702<span></span>
</td>
<td class="nump">557,688<span></span>
</td>
<td class="nump">781,864<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,557,343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,557,343<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Stock options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">409,789<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">445,275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from stock option exercise</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 220,697<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation cost related to option awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,388<span></span>
</td>
<td class="nump">$ 35,384<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Unrecognized compensation cost related to option awards vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 10 months 24 days<span></span>
</td>
<td class="text">1 year 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_CommonStockShareOutstanding', window );">Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,557,343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,783,912<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntercompanyAgreementsDescription', window );">ATM Agreement amendment, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Under this amended agreement, the Company pays Stifel a commission equal to 3.0% of the aggregate gross proceeds of any sales of common stock under the agreement. The offering of common stock pursuant to this agreement can be terminated with 10 days written notice by either party<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Consulting expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,145,923<span></span>
</td>
<td class="nump">$ 3,181,568<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.42<span></span>
</td>
<td class="nump">$ 2.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Fair value of the Company's common stock per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.46<span></span>
</td>
<td class="nump">$ 2.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Fair value of the Company's common stock per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_CommonStockEquivalentsOutstandingShares', window );">Outstanding shares of common stock and ommon stock equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,986,797<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,248,852<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease', window );">Stock options outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">429,454<span></span>
</td>
<td class="nump">555,582<span></span>
</td>
<td class="nump">464,940<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfInitialPublicOffering', window );">Offering price, ATM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_MarketOfferingsDisclosureDescription', window );">Description related to ATM offerings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Company filed a shelf registration statement on Form S-3 with the Securities and Exchange Commission (SEC) on March 29, 2024, registering the sale of up to $75.0 million of the Company&#8217;s securities that was declared effective on April 19, 2024. On May 10, 2024, the Company filed a prospectus supplement, which was further supplemented on July 19, 2024 and August 9, 2024 (collectively, the &#8220;First Prospectus Supplement&#8221;), pursuant to which the Company may offer and sell shares of common stock having an aggregate offering price of up to $12.6 million from time to time through the ATM. The Company exhausted all sales under the First Prospectus Supplement<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ltbr_SeriesXPreferredStockMember', window );">Series X Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockRedemptionAmount', window );">Redemption Price of Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_DescriptionOfSubscriptionAndInvestmentRepresentationAgreement', window );">Description of subscription and investment representation agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">(1) share of the Company&#8217;s Series X Preferred Stock, par value $0.001 per share (the &#8220;Series X Preferred Stock&#8221;), to the Purchaser for $100 in cash. The sale closed on February 27, 2025 and the $100 was fully paid-up and recorded under current liabilities. The Company will redeem the Series X Preferred Stock for $100 cash after the Company&#8217;s annual 2025 shareholder meeting (the &#8220;Annual Meeting&#8221;).<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_PreferredStockVotingRightsShares', window );">Preferred stock voting rights shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=ltbr_PrepaidExpenseAndOtherCurrentAssetMember', window );">Prepaid Expenses And Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation cost related to option awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Unrecognized compensation cost related to option awards vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VestingAxis=ltbr_CommonShareIssuancesMember', window );">Common Share Issuances [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Shares of common stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,171<span></span>
</td>
<td class="nump">3,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.73<span></span>
</td>
<td class="nump">$ 4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ltbr_TwoThousandTwentyEquityIncentivePlanMember', window );">2020 Equity Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_FutureIssuanceOfShare', window );">Common stock available for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,009,389<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total number of common stock available for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_DescriptionOfEquityIncentivePlan', window );">Description of Equity incentive plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">the Company&#8217;s Board of Directors approved an increase of 2,500,000 shares to the authorized number of shares under the 2020 Plan, increasing the total authorized number of shares from 2,500,000 to 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">the Board of Directors approved an increase of 700,000 shares to the authorized number of shares under the 2020 Plan, increasing the total authorized number of shares from 1,800,000 shares to 2,500,000 shares<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ltbr_TwentyTwentyFiveTransactionsMember', window );">2025 Transactions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Total fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Shares, vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation cost related to option awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_DescriptionOfRSAsModificationAndNetShareSettlementsForPaymentsOfWithholdingTaxes', window );">RSAs Modification and Net Share Settlements for Payments of Withholding Taxes, Description</a></td>
<td class="text">10,907 RSAs vested to the former employee based on his service to the Company. To satisfy approximately $36,000 in payroll withholding taxes, the Company withheld 3,863 shares, resulting in the issuance of 7,044 net shares to the former employee<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">approximately $0.2 million in payroll withholding taxes associated with the accelerated RSAs vesting, the Company withheld 21,285 shares, resulting in the issuance of 49,425 net shares to the former employee<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ltbr_RestrictedStockAwardsSummaryMember', window );">RSA Summary 2025 and 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">743,702<span></span>
</td>
<td class="nump">781,864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_CommonStockShareOutstanding', window );">Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">743,702<span></span>
</td>
<td class="nump">781,864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_RSAFairValue', window );">Fair value of the RSAs vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ltbr_AvailableForSaleSecuritiesMember', window );">Available for sale Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Proceeds from sale of common stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,605,619<span></span>
</td>
<td class="nump">427,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ProceedsFromStockIssuances', window );">Net proceeds from stock issuance under ATM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,200,000<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock issuence cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ltbr_OptionsMember', window );">Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from stock option exercise</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Proceeds from Stock options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_BoardOfDirectorsChairmanMember', window );">Board of Directors Chairman [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_CommonSharesIssuancesEquityGrant', window );">Common shares issuances equity grant value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 180,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 240,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_CommonSharesEquityGrantPricePerShares', window );">Common shares equity grant price per shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted', window );">Number of shares granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,915<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense', window );">Compensation cost recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 180,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Consulting expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_CommonStockValuedGrantDatePricePerShare', window );">Common stock, valued grant date price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_BoardOfDirectorsChairmanMember', window );">Board of Directors Chairman [Member] | Restricted Stock Units R S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Shares, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value grant date, granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_EquityGrantValue', window );">Equity grant approved by board of directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Stock options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation cost related to option awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Unrecognized compensation cost related to option awards vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 1 month 20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Fair value of the Company's common stock per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.46<span></span>
</td>
<td class="nump">$ 2.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ltbr_BoardOfDirectorsMember', window );">Board of Directors [Member] | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ltbr_BoardOfDirectorsMember', window );">Board of Directors [Member] | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_CommonSharesEquityGrantPricePerShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_CommonSharesEquityGrantPricePerShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_CommonSharesIssuancesEquityGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_CommonSharesIssuancesEquityGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_CommonStockEquivalentsOutstandingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_CommonStockEquivalentsOutstandingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_CommonStockShareOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_CommonStockShareOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_CommonStockValuedGrantDatePricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_CommonStockValuedGrantDatePricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_DescriptionOfEquityIncentivePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_DescriptionOfEquityIncentivePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_DescriptionOfRSAsModificationAndNetShareSettlementsForPaymentsOfWithholdingTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_DescriptionOfRSAsModificationAndNetShareSettlementsForPaymentsOfWithholdingTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_DescriptionOfSubscriptionAndInvestmentRepresentationAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_DescriptionOfSubscriptionAndInvestmentRepresentationAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_EquityGrantValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_EquityGrantValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_FutureIssuanceOfShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_FutureIssuanceOfShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_MarketOfferingsDisclosureDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_MarketOfferingsDisclosureDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_PreferredStockVotingRightsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_PreferredStockVotingRightsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_ProceedsFromStockIssuances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_ProceedsFromStockIssuances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_RSAFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_RSAFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-21<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of plan compensation cost recognized during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480489/718-40-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntercompanyAgreementsDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of product support, consulting, business, or other advisory service agreements entered into between the managing member or general partner and the LLC or LP, affiliate of the managing member or general partner, or affiliate of the LLC or LP. Includes a description of the key provisions of such agreements and the amount of compensation for such services during the accounting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntercompanyAgreementsDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the repurchase of amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockRedemptionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The redemption (or callable) amount of currently redeemable preferred stock. Includes amounts representing dividends not currently declared or paid but which will be payable under the redemption features or for which ultimate payment is solely within the control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockRedemptionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase or decrease in number of shares reserved for issuance under stock option agreements awarded under the plan that validly exist and are outstanding, including vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ltbr_SeriesXPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ltbr_SeriesXPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=ltbr_PrepaidExpenseAndOtherCurrentAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=ltbr_PrepaidExpenseAndOtherCurrentAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=ltbr_CommonShareIssuancesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=ltbr_CommonShareIssuancesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ltbr_TwoThousandTwentyEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ltbr_TwoThousandTwentyEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ltbr_TwentyTwentyFiveTransactionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ltbr_TwentyTwentyFiveTransactionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ltbr_RestrictedStockAwardsSummaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ltbr_RestrictedStockAwardsSummaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ltbr_AvailableForSaleSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ltbr_AvailableForSaleSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ltbr_OptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ltbr_OptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_BoardOfDirectorsChairmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_BoardOfDirectorsChairmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ltbr_RestrictedStockUnitsRSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ltbr_RestrictedStockUnitsRSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ltbr_BoardOfDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ltbr_BoardOfDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ltbr_TopMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ltbr_TopMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ltbr_BottomMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ltbr_BottomMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Allocated employee compensation and stock-based compensation</a></td>
<td class="nump">1,300,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=ltbr_CODMMember', window );">CODM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherGeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">3,500,000<span></span>
</td>
<td class="nump">2,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_InlProject', window );">INL Project</a></td>
<td class="nump">800,000<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_RomaniaFeasibilityStudy', window );">Romania feasibility study</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_CentrusEnergyFeedStudy', window );">Centrus Energy FEED study</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Allocated employee compensation and stock-based compensation</a></td>
<td class="nump">800,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherExpenses', window );">Other outside R&amp;D expenses</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ResearchAndDevelopmentExpenseNet', window );">Total research and development</a></td>
<td class="nump">1,700,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_OtherSegmentsItem', window );">Other segments item (1)</a></td>
<td class="num">(400,000)<span></span>
</td>
<td class="num">(400,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_OperatingNetIncomeLossFromSegmentsToConsolidated', window );">Net loss</a></td>
<td class="num">$ (4,800,000)<span></span>
</td>
<td class="num">$ (2,800,000)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_CentrusEnergyFeedStudy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_CentrusEnergyFeedStudy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_InlProject">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_InlProject</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_OperatingNetIncomeLossFromSegmentsToConsolidated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_OperatingNetIncomeLossFromSegmentsToConsolidated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_OtherSegmentsItem">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_OtherSegmentsItem</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_ResearchAndDevelopmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_ResearchAndDevelopmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_RomaniaFeasibilityStudy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_RomaniaFeasibilityStudy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of general and administrative expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=ltbr_CODMMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=ltbr_CODMMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details Narrative) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 03, 2025</div></th>
<th class="th"><div>May 12, 2025</div></th>
<th class="th"><div>May 08, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Proceeds from sale of common stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">677,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ProceedsFromStockIssuances', window );">Net proceeds from stock issuance under ATM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted stock awards shares</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Restricted stock awards shares value</a></td>
<td class="nump">$ 2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Stock price per share</a></td>
<td class="nump">$ 6.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Bottom | Articles of Incorporation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Bottom | 2020 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Top | Articles of Incorporation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Top | 2020 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_ProceedsFromStockIssuances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_ProceedsFromStockIssuances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of stock related to Restricted Stock Awards issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ltbr_BottomMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ltbr_BottomMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ltbr_ArticlesOfIncorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ltbr_ArticlesOfIncorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ltbr_TwentyTwentyPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ltbr_TwentyTwentyPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ltbr_TopMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ltbr_TopMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>59
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    (  J K%I&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    (  J K%HPLN5D\0   "L"   1
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M:L16<,FY;&[>)M<??A=AWUNW<__+6/!OQF=!U<*ONU"?4$L#!!0    (  J
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M;"]W;W)K<VAE971S+W-H965T,2YX;6RUF5USXC88A?^*AG9ZM<26#"'9$F;
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M5R].UL$AANUYOMMU]WB/**SQVM:_A<LZG?BV?>:6EK57J._WW8'M['$?4UF
MFSN+K]KYR'5N13*.$EA*J=7QI0<K-A-%0]"U7H\?J)"KNSZ-Y08,F"J0UY>4
MBN>&6N*K+5WP%U!+ P04    "  *@*Q:>3.RYA$$  "V#P  &    'AL+W=O
M<FMS:&5E=',O<VAE970T+GAM;*U7:X_B-A3]*U9:5:VT.XGS9@I(P+!;I)T!
M#6SWLX<8B#:)J6U@^N_W.LD$",8[5?E"'MQ[?.[#/KG= ^/?Q892B5[SK! ]
M:R/E]MZVQ7)#<R+NV)86\,^*\9Q(>.1K6VPY)4GIE&>VZSBAG9.TL/K=\MV,
M][ML)[.TH#..Q"[/"?]W2#-VZ%G8>GOQG*XW4KVP^]TM6=,YE5^W,PY/=H.2
MI#DM1,H*Q.FJ9PWP_0C'RJ&T^#NE!W%RCU0H+XQ]5P^3I&<YBA'-Z%(J" *7
M/1W1+%-(P..?&M1JUE2.I_=OZ)_*X"&8%R+HB&7?TD1N>E9LH82NR"Z3S^SP
M%ZT#"A3>DF6B_$6'RC;P++3<"<GRVAD8Y&E17<EKG8@3!\#1.[BU@]MV\*\X
M>+6#5P9:,2O#>B"2]+N<'1!7UH"F;LK<E-X035JH,LXEAW]3\)/]T?1I/OTR
M>1@LQ@]HOH#+X_AI,4?33V@Z&S\/%A,P0!_1U_D#^OW7/[JVA$65J[VL%QA6
M"[A7%O#0(ROD1J!QD=#DW-\&L@UC]XWQT#4"/A)^ASS\ ;F.&VCXC-[O[AOH
M>$T"O1+/^S\)U*6M@O7UL&KWWHLM6=*>!=M34+ZG5O^W7W#H_*F+^49@9QGP
MFPSX)O3^,]W38D=U,5:.8>FH#I1]W^G:^U/B)HLS-D'#)C#68[JEG,BT6*/Q
M*YQU@@H=L>"6R;\1V%FX81-N:$S^9UI O!DB18)( @=$*J2*?Z^M1X45G&3;
M\V/'P>VJ7-JY.(@B/]#7)FK(1C_I%$$)7VY*M@FT3<:V( E21S6ZH(##,.A@
MKT558^>X7NQZ>JIQ0S4V4ETP"5E]7S/%%Q0"[ <=MTWUTL[#,0["6$^UTU#M
M&*D>27YA0DNP<['P1SU#C:&1(G:.,N.8MZ7<4(XFQ9+EVLZLW6^T(V^%=A[L
MB:9B8T4FA:2 *U%Z/5Y\V0R1W\&X51&=78@[L7^E(.Z1H_N>!O]96=QWTM38
MF6@>U14;I:O_!%^RJJW1D,(W*ZVIH@5YU>_%&NZLA?THP@YVVY0UEFZ,.\%5
MTD=!Q&9%K$G*JR3]BZ7;)[#1Y)S641FQ48F:7&HI!1="?"UO&DMSWHY:AD/C
M(=$4>P9-.6)Y#M_Y\PWA^M8T"N-_/C%NA'8>^5$8L5D9AT2DRTH6TVPGVQ_*
M=<051GR:>>?.]=L%TIOA*]4Y*B(V2^*W<B2B"1KL07#6%#WM\A<H%%N=U4J@
MZ4X*";& )&G#N-1!Z!X_\BY;36/IP>D#UJU@[),)**=\70Z& BW9KI#5:-&\
MK8;/H1H^U035>@]#Z: <Q>PC3#71PN"P3@N!,KH"2.<N EJ\&A*K!\FVY9SU
MPB1,;>7M!@9KRI4!_+]B3+X]J 6:4;W_ U!+ P04    "  *@*Q:.I@Q,[ &
M  !>)0  &    'AL+W=O<FMS:&5E=',O<VAE970U+GAM;,5:;7.;.!#^*QI?
MIW,W4\=((%Y:QS.I3:^9:Y-<G-[-?51!CID"\H$<Y_[]2?@%(\G8GM+T0V*#
M=Q^QSR[+/L!PQ8IOY9Q2#IZS-"\O>W/.%V\'@S*:TXR4%VQ!<_'+C!49X6*S
M>!R4BX*2N'+*T@&R+'>0D23OC8;5OKMB-&1+GB8YO2M N<PR4OSWGJ9L==F#
MO>V.^^1QSN6.P6BX((]T2OF7Q5TAM@8[E#C):%XF+ <%G5WVKN#;$'G2H;+X
M*Z&K<N\[D*%\9>R;W+B.+WN6/"*:THA+""(^GNB8IJE$$L?Q[P:TMUM3.NY_
MWZ)_J((7P7PE)1VS].\DYO/+GM\#,9V19<KOV>HCW02$)5[$TK+Z#U8;6ZL'
MHF7)6;9Q%D>0)?GZDSQOB-AS@/8!![1Q0*<ZV!L'6W$05)H=G(V#HSH<B@%O
M'*K0!^O8*^(FA)/1L& K4$AK@2:_5.Q7WH*O))>%,N6%^#41?GPTOKV9WGZZ
MGEP]A!,P?1 ?G\.;ARFX_0#&'Z]N?@^GX/I&_' [_N/C[:=)>#\%X9]?KA_^
M 7WP93H!O[[Z;3C@XD DW"#:+/I^O2@ZL.@#XR0UN(W;W<8LRT1M33F+OAF\
M)^W>5W&<R-HD*;@C2=R_SL&8+!+SD81'L*)HF2U3PFD,)G261 EO@@Q$&G:Y
M0+M<H K5.8#ZGJ0DC^@;4,Y)04M N "/+H -WP!D(=M$="NB[#)ORP6)Z&5/
MM)&2%D^T-WK]"W2M=R;ZUV"X I,=YFD$;3?PD><,!T_[3'>Y:M@16(-R>T>Y
M?1KE)&/+G)]$^1K1W6,)^0&$EN,U61KKAA6="I<&*Q^B $.$FY:A;MF'&-F!
MYWGNSK1!@[.CP6FE8;HNN*0LEZ*B^^(*\)B4G!9B@\UFM$CRQU+LSL6%B\UV
MNT#$2E[*/:\@QF]<W]V6KHFVUB,XMU(=K5(=Y-F6I7#;Y9IA1V"-!.%=@O +
M)6A=Z*8$8?WL1PB*TU\I:ZR5H8/4HC9C8:PTDE"WL\R5[.Z(<L\@BC-!05Z*
MH8&(D_LUR1;O0)P48DAA10G$F 5DHI*(EFV5V[KBN97K:A&[#K)<A;\NEPP[
M FODP]OEP_M!^3A<J)Y&(<+84D_^L:?5J:M>QTQ(3F KV0AULP-5ZN]8\=M9
MD2-,7PZXL2 D$U-_2>1L8HK6UUL==@-+"66LFZG-\#2@L VH$6RP"S9H#?9&
M-*64E>O\\CD5?P6E0(QR?%X"FL>"A,^DB.;;JZYCHB'0#JN/?!A@7R4BT-*N
M$J%#*1;A"8LUJ(!6/6Y;Y\YX(O:+UM#;(<]M0!NT1F]VH!]XOLI3I^N&7:$U
MB=_3.?#<2>\X\5#O#[Z%L.T$2M%M+-TFJ8'&J X(?1LA'T,%,328BFD/(^C9
M[H$3$M9" WZ7TC"3T:G4@ :MX7N^'4"D<M:IV.@*K4E\+3?@=^D-,_&VWK@M
MC'RDEM<8FK2$IW;(B0$068X;.+;CJU6HF_:A*]J%XSOH0!76H@/^?-71?@AG
M5ZVN.Y!K85<]>R>=+AMVA=;,4ZT]X,\7'U!7 N)\@+:XZ*I%KNL/F0,U 68\
M"ZLG36BP/-1?:Q$"7UZ%M"]Y=B7K.L0/+%_5(9TN&G:%ULQ*+47@RVL1J&L#
MV]*U"-3%B*_U#(,:"0((U7H]68W 6H[ [O0(U 5"=;O*AVK,QR7)J5AA*U8S
MZ%J6P)?0)="@%1S/@Y8ZR(SA<65B -/:U0GK->\^U]H$M6N3>UKR(HGD3>WM
M7+@B1;P]8]J:4SORV?>A=8F"O<!1V>ITT; KM";YM3Y![?KD*/F'>Q#2I8+:
M?Y"N3[!ZS\X TU>-PM:UFJ'O/?9H5R-57Q;=EO.49E0T8WE"KA(^G[,TEI,$
M)\^"CP5)8K!<L!P\":[D?C%;%'NTR2:V8:VU5KM]9J(+F3["4)VD)YVN&G:%
MULQ8+6-0NXSY(1EK*7"3"@D<(6W4,C<\(E$?HTP,:!(,VVJIZW:'2KV6/.@<
MR2,N.&SY.*\N/O29%E%2TFJ$7LB+;WL1=ZIKD.%Y"@YL[;%?IZJF*[1F*FI5
M@\Y1-4=3T5*=!JF!+#=0'P<BPX,3==X^@(75><A@=Z@V:]&"VD7+D5N3V!A[
MIZ($Z:)$/C3R;,=6>>I4EW2%UB2^UB6H79<<N35I)EX7%((G!!W/5LM.MZQ(
M51DUF"$7"4-/'4$-IGWH^@'&/E9OD _V7DV1;QZ)P!Z3O 0IG0EGZ\(3R2[6
M+_.L-SA;5&^K?&6<LZSZ.J<DIH4T$+_/&./;#?D"S.Z5JM'_4$L#!!0    (
M  J K%KS/&V3H@4  &@6   8    >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL
MK5C;;MLX$/T5PKM8M$!3B]0]FQAPG 0-D!OJ=OO,2(RM5A)=DHZ3O]^AI$BV
M13$IX!=;DF=&Y\R0<\8\V7#Q2RX94^BYR$MY.EHJM3H>CV6R9 65G_F*E?#+
M(Q<%57 K%F.Y$HRFE5.1CXGC!.."9N5H<E(]NQ>3$[Y6>5:R>X'DNBBH>#EC
M.=^<CO#H]<'7;+%4^L%X<K*B"S9GZOOJ7L#=N(V29@4K9<9+)-CCZ6B*CV?$
MUPZ5Q7\9V\BM:Z2I/'#^2]]<I:<C1R-B.4N4#D'AZXG-6)[K2(#C=Q-TU+Y3
M.VY?OT:_K,@#F0<JV8SG/[)4+4]'T0BE[)&N<_65;[ZPAE %,.&YK#[1IK8-
M@Q%*UE+QHG$&!$56UM_TN4G$E@/$,3N0QH'L.W@##F[CX%9$:V05K7.JZ.1$
M\ T2VAJBZ8LJ-Y4WL,E*7<:Y$O!K!GYJ,KN[G=]=7YU/OUV<H_DW^+JYN/TV
M1W>7:#:=?T&7UW<_YN@(?9^?HP]_?SP9*WBI=ATGS0O.ZA>0@1>XZ(:7:BG1
M19FR=-=_#&!;Q.05\1FQ!KRAXC-R\2=$'.(;\,S>[^Y9X+AM MTJGCL0[V[%
M!%59N4!3O2(SE3%IRE(=Q3-'T9OU6*YHPDY'L!LE$T]L-/GG+QPX_YHH'BC8
M#F&O)>S9HD]NH;=<<VDD67L&E:=N($^3(R\,L8/)R?AIFX#!D$0X]B.O-=P!
MY[?@?&LUINE/V#/09I1$BD.?27B99#E#):#. ;5^JJ\3*I=H+5F*LA+QMH:T
MK>&QB9]_R"(>*-A.GH(V3X&UB'/%DU]'NO^E*.$%B(*DNJV:2->1_*U:8=?W
M<83W:MJW\_P@=@8J&K9(0VM%9TM:+IC<*Y.4#"I,RQ3E&7W(\N&2A8<LV8&"
M[20B:A,164MV+]B*9BEBS[I:K&;/U9()T DA8,DW:3%E(>K5YH@$013%>S4T
MV.'8"^/ 7,2XQ1Z_"_M*\)^@W[#DI-HFD/-R<:28*"P48@.TT W]<(]"W\X%
M*S-^['0RZ5@93).$KW576=$7^@ -18.G22+6;&<-&@72Z4'R_2 @WAYR@UT0
M!DX\!'Y+X_&;+7NF&][WIN&]5[2:N#M)=TD<1[Z[C]U@B:,P@FER #WIT),_
M0W]5/C'Y'O2DA\G9AVTSV<7;#038/A%<9B4%T7D;WD%'@D-%VR7=#07X[:D
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MP<7$#"VK?;VJH<6NW$M;"ZU%5AXFP"*0MH.YOA5"OS3L /7NZOP_4$L#!!0
M   (  J K%I\(TU,=@T  -XF   8    >&PO=V]R:W-H965T<R]S:&5E=#@N
M>&ULU5IM<]LV$OXK&+?7269D69;=)HZ3S#A.<O6=F^3BI+VO$ E)2$B  4 I
M[J^_9Q<@"<ERXK0W<[TOMD02^[[/OE"/U]9]]$NE@OA<5\8_V5N&T#PZ./#%
M4M72CVVC#.[,K:MEP%>W./"-4[+D0W5U,)U,?CJHI39[3Q_SM3?NZ6/;ADH;
M]<8)W]:U=-?/5&773_8.][H+;_5B&>C"P=/'C5RH*Q7>-V\<OAWT5$I=*^.U
M-<*I^9.]L\-'SX[I>7[@5ZW6/OLL2).9M1_IRT7Y9&]" JE*%8$H2/Q;J7-5
M540(8GQ*-/=ZEG0P_]Q1?\FZ0Y>9].K<5K_I,BR?[#W<$Z6:R[8*;^WZ9Y7T
M^9'H%;;R_%>LT[.3/5&T/M@Z'88$M3;QO_R<['"7 ]-T8,IR1T8LY7,9Y-/'
MSJZ%HZ=!C3ZPJGP:PFE#3KD*#G<USH6GKV1HG1)V+EXWRDFRE!^)9])K3Q??
M..65"7Q])*ZBY^C&E5X8/=>%-$&<%85M3=!F(=[82A=:>2%-*=ZJ0FW==M;@
M<Z'@UN ?'P1H0'(<%$G:9U':Z2W2'HE?K E++UZ84I6;YP^@>:_^M%/_V?2+
M!'^1;BR.#D=B.IG^^ 5Z1[TYCYC>T?^).:.TQ[NEI81_Y!M9J"=[#4GF5FKO
MZ0_?'?XT.?V"+8Y[6QQ_B?I?SA9?D=8&)0['XG\I]4[F?'(G?_';4AG1>E4*
M;418XHXP4 /RXHL(RM5>_/#=P^ET<GI)Z#1SNERH$5\Z/.UNG=NZD>9Z^_+Z
MQH.M[RY8UUVSK>LNUDH:D?$1Y]8U-FK!2LBJ$I!=![*'-D75EKWHHK!(:4.Z
MX).'U4H9\&6NC32%EI7P4#J::2S>+8DZBRW6T@LJ3G@8?%X7P<Z4$S]12D_P
M=TTV>K>T3K<UO+%6;B0N0SFF.[I8\G'(DD0=Y&%V9/%7:B5+2;1?JIEKR=W3
MD3@\.3D9066WP)&U#LMM'A>F&(M[[]Y<W+\SI^>JDFM)_C?B'](PJX?,:CH6
MKXVX4@TL0-I-3UB]D^CHSA+%4AH21R.2C*R5F#M;[])=!/M%1\W4 JXD,G.+
M&D3RE&J% MY0S-(3A:VA._E%_T[7:A7@75T(TQ:5DD[,6U5M.0H!+#?N(T*+
MI;&575P307XHX\-J9(]O4EM1?>9G[&:JU-*@FXBW9JU'FGO<("74\-VK!852
MYQJ(1H9,S.G.#2VC=>"EG6(A\UHCVU*'&,!W#>4N#9B]C+C >9[Y=<2R9!<H
MX0X?G'H(;ZOJ>M^N#<C[=N9UJ:73!  (/)P;0JH87!SIY?Z_,, *PS<AW<^V
M*LG^EY?G&R0J7;-ZE98S7>G0.ZVSP*WB"#H.[;D#&_58X#/(U"1"%P3!2>-E
M,?AT)BN8#H26<@4O*J2T(G%,ET>#H7$F!@I9D\F1+G_,.?##E]*$(F%#S4$Z
ME-,&2K-L)(@K2?X(%.1)UU:I)CBU:*L4OLGO5ZIH741)>N+%YYC8Y/Y:>\\N
M! +SHR_@HQA#I"9=TL8'UR;C(=&I>16'D_U_I1+4L1-7^_\>BW/E EIWG(H-
M?J?;W-I M424VA>5]2A+"'MZ!"[> .^=EON2_@MED+!$!G<(TLHN\DF%QH&X
M;BHN$:S0>\..NR+J;*,S)"6B1MS[^]G9F_NY_K(;+K92J,^8/.1RIJE*CS(7
M#H$"6UN$/H<)(6JLM+FVK?,MD82Y?0L\V>U>?!\E:X!I=<WH#<BS5+5[)*#,
MB'[<[1&X 6V$]Z0EGN D=&I)<]+JF\HH4_5+VU:$^()&NI1*']"1,-\^7K/L
M^0K1>8K,:\)'16TZ$*2(92LUVL>C&]7_S*#<58A.)%C@6INB]I]W(@A1JJX.
MI[0@(NCNX8RCV-V/ 7-\DZI+PG+Z&NL%8_X-W(4K9/D!4QCKUE4+&5LTF?(!
MED.^.HHCP_W;:,M#4LRE=H.1.CY(*<R.@\G"TBFU7].$(U#3M"VS<*QEJ<8P
MT.81ADU==X\WL3NDC'+<"_:2:,[:$I%/&+PM05C*@.D24$>1H#XWF)G)P8D+
M-6V@-P<40%URQ/A;6M^7I/VOLFJ9[\L^:BX8J6+8Y*6]5-2Z:JHB;+@5'Y6Q
M1@,?"A4%7@^A6RAH57+^*7(:4L9[%2AU&ZGY!A>5N2)W#!6,X F1X$KEJHVZ
M [)A379'Y9@CNC1'/#3^"*J M@#5("QE48AAI"2!)/N7TF.<FP+894KI2@\=
M2S85\[AW=G4._,KL\TM&Y9*Z$7$H]L7K&<UF<E:1PYN6RP[%H1>?6DMRL5%\
M!%OV;Q0TQHDNR7_D.;:))Z-T%H![3A.C*1A=1.H6"I'G89I-!M'LBN)_$*F+
MDM[BO7E'0FDF52)\B@ +DSBF^];U#1WR;?(BLAXUOD+:[Q3\IKJC'20&[>]"
MK[/;H"@E4>+"-?^_:Z'3V(NQ X[@@/?&WO UDW1J3HNL#*WZF@:J;=UPB1D3
M;F8EFRI38ST5MJ0RL<MU9E&+"G<1ECT>:Y=R/J8(R9YEXE*C?@-9KT7%@M-6
MC(<O>J["F.%#ND/M,BF1S"(W"S E)>'QBMN!G$.63!M=?ZXS8"T'TX%PD= Y
M9FE+_DY"V&U-\J1UZE.KJ67YT):+?@2HY74$8:! !$4&H4K&D9U+SE<MY'<K
M,=1/G2$AE5CM4TA1*\2M$C0JI%_&L80^D+1@%NM2/SDT\II#AUOLHG"MVG!W
ME*.0SG%7+.M^WB":=Z<CXD@!00&<$7<!PQU@95:%;#-5R-;W)0<-APO[!/"I
M6L8;UJO<"FA,MY1DEK!('6L9=3V6PVXNWE^)=XYY7F]8$G[CV938$-B770-Y
M-"&)3R:X<KTUI")AT&T3X>^/'J D8JB-K<)M3#:*MZCC>C*V*:G]..SZ#^(S
MQXADU]RKLX%COZI_3X%%X=-/FKL:V-TQP^DUI\KWM7B\1R 7M?+WJ79M"ODH
M.?&B^S]\N(@NV16 XGMQ>#(^P;^C!^,)_K&XT].N!'X]GD!@X^#PZ2]IM!L-
MZ!^VV_'D%KV_P723\?%.$MUL]U;[CQ'YWP,<^1J?W-BB03TTB]0YEFCUXR9@
MWIHR;7P.N'+O?]0T,[0-M^DK+0&SR,29-KW]85^DV4(7U#UKGMI'8D$8;Q@P
M%TXR+ R[%90,23O6>>NXJEH@+773G*ID+:2N[T=B'GVI9TM/T4.EFH7L$2I9
MW-+%>2P*R]NLE@&'FF2.>C))OO.Y]_8'63>GS^_'BA^)]74!Q#H1E5ERG4E+
M(DRK07W;!HGW7XVS)2;U"$&$J)+Z3K0<7-,=L^ H#=N>PE,<%''@I!9_WE8,
MB]1PMGR#1D%0W]Z1:<X16LC0/@Z%["/)-*0(K&,!@@3R*XEN*78B,3FB_2+M
MR*?794/SWGIIV4-I5:6C&'>]3;U[K*R$T/ E-:@EX@250'&Q[5J*&^D<Q4C.
MVN VJ('JH..VJQMRH*7-5OI]0LZ!+7#!6>5MW*<FB]Z&)IDM.U_X=O:!!(9Z
ML3,TP!AG6Y\,M5 FKA>\K;G@#8/D3%W;?FNYT=?146?[_>(&I;YG3LN4;M<0
M\U;A65LC!2D$=-*W/Q]R^!C!4(%Z/1RC2%9!#Y-_ITNVLDUNAI<V]TY4O_O=
M?KXL+@KNP&&:2E'JQ\TP1I]W+SUFG[C:XI3-0"+;FL!_#%].53R"I2:N<W[R
M4;ZF>PD&,.+QP^GIJ*-D4;5E@WQ;R>K6*H%SHQXOJ*YWFC=Q=9[)FNV.>#DK
M/\?L]MV@1];IADR(+ M4D]70ZV9=$'?DUBSBMTXOE!NTT=;02&'7H'@32D9=
M(FCHH1T;#B*Z!9_9J6(< F+L+RH[BU-1'S<82R7PVS:(3@%Q;[QKH6Y8(D^V
M8GZ%8DS!GI4.VJCQV#7JHS&RC3'5YH7HQFL"919R$8>1?%[X-MPFJY<KQM#M
ME7W^X@'H>E'*I:5W;U'T2SFC+2^%S+V+5Y?WXU!UIQYOU/N/=BC&*S:Y+>+V
M@',JDS !--7<"/'@UD56VKYPS'[6!)! ]^,'?[LM>(,-M#_+N<,7B(Y-X]*B
M"A8#+>03R8"8):[$:\A:P"""KPMNE?JKG:]DSFA?H[UK>0!-J4'@"?.#<"]?
M7U5RV-B=_,,R=BZ+F$&E72-2:K61SS1_H-G0W$Y8BBEH@1!19H!H"NHE$DXQ
MG^)/%)UD.9$G=19>-XO1^.NO>\^NWHM7=DRA<[1/;_,N3$$%XIW\#&GOO8,S
M"O'@>'+_D;BH";S2.;)M_Z1XGFWH+PP(KM)+0MZTDBXOSZZ>(:\\M8X9S^/]
MR5'/\ZK?3NZG-2P)?+ZQ7$Z/[HL7,;J)M5PLX).(?KDD6[<0MC<8O>AR)(]0
M#%]=Q*D.+1P;DC:8K -F2DSSM)BY5B&Y+;Y8&BS= W%LH(8]:C(#+08!=#Q"
MSJX'*]&NGWGV!/8!F4QR9DO&E24*^R+NF6DQB#ME>H$;_L2+0,8TRR]9: E;
M<;G(FBY9VJ:S)-F)-X"#EMR);$<V%88AHN\F0U=GL_<^XUT_!CG(?G/$K\'I
MEU6<8B;$GQ_U5_L?;YW%WRP-C\=??@%#%QC,1*7F.#H9/_AQ#T6??TT5OP3;
M\"^89C8$6_/'I9)H\.D!W*=7(]T78M#_I.WI?P!02P,$%     @ "H"L6J0D
MG*2X P  ]@@  !@   !X;"]W;W)K<VAE971S+W-H965T.2YX;6RM5MN.VS80
M_96! N1)L6SYVHUM(-ZT:($D,';3]IDFQQ:[$JF2U&KW[SM#V:[=V,8^],7F
M[1S.G.',:-Y:]^0+Q  O56G\(BE"J.^RS,L"*^%[MD9#.UOK*A%HZG:9KQT*
M%4%5F>7]_B2KA#;)<A[7UFXYMTTHM<&U ]]4E7"O*RQMNT@&R6'A0>^*P O9
M<EZ+'3YB^+U>.YIE1Q:E*S1>6P,.MXODT^!N->+S\< ?&EM_,@;V9&/M$T]^
M4XNDSP9AB3(P@Z"_9[S'LF0B,N/O/6=RO)*!I^,#^R_1=_)E(SS>V_)/K4*Q
M2&8)*-R*I@P/MOT5]_Z,F4_:TL=?:+NS^20!V?A@JSV8+*BTZ?[%RUZ'$\"L
M?P60[P%YM+N[*%KY602QG#O;@N/3Q,:#Z&I$DW':<% >@Z-=3;BP_$9Q_V*]
MAS4Z>"R$PWD6B)=W,[GG6'4<^16.(7RU)A0>?C8*U3D^(WN.1N4'HU;Y3<*O
MPO5@.$@A[^?C&WS#HY/#R#=\BY/WMJKH.5SUM:,:7:;B'+GSM9"X2"@)/+IG
M3);OWPTF_8\W#!T=#1W=8G]C-&YR7+;PFPT(>0]^O !6PFL)AC9*WJAIP\<-
M[4':JFX"*FB\-CL(!4(;WSFJ#^(9':4MF*;:$,9N^30K&]$>J +X((QBH&K<
M >^PMB[PC&[25J6 +Q+K0)LB@ Z@+(&-I;&19:,0&O.,GHTXY_?-YB]*;0B6
M.1LG"TI.L ZD,)*R7'#6]^"S+J,'_[^#Y%L*>@N*;Z#2DD)-*IN@1?DV*3H!
M>K"^ I.6:I\/?#,?)ST<4CT,/QS4WC=B4Y)4-2WR67Q!)S7KL06J(?();,UZ
M^!Y\I^U3@SQ*,BGH3G628L.5&@IRGX9H.#X<!P5;9ZO(WJD6!>8+U%[B@W*7
MW*;V$:&A<(A0=?4"N5X 9;LLCNG.LO)@E(+P#'FENMZ4ZL0@06)].*A.@B*_
M 2:GU*Z%>7W_;I8/IA]]C#<'*ER[(PY$Z2T12]%X/!>O=EI&"26Z0 UN'PE_
M5<"63-Y1;PS(WHHN%H=W),F<^.X/K)=,/@268\:Q8K5.J^M_/8E>/)Y&^,RV
M4?Y3.AJ/8#P>I^-9#@^4271]#%($B58X=8Z9CH;IM)\39II.9C/X;OG%#=+!
M=)@.QA,>#89I/NW#I8J7G?2B"MTN=ESVJS&A:TO'U6-3_]3ULG^/=U\$Y.I.
MDT,E;@G:[TW'";BNRW:38.O8V38V4)^,PX(^3-#Q =K?6GK0^PE?</S46?X#
M4$L#!!0    (  J K%HM>*4<N0,  )\(   9    >&PO=V]R:W-H965T<R]S
M:&5E=#$P+GAM;+5646_;. S^*X0W#!N0BQ,G[;HV"9 T'58@[8(-MWM6;,;6
MS99<2:Z;?W^D['C)UN6VASTDMB22WT=2)#VIM?EJ,T0'3T6N[#3(G"LOP]#&
M&1;"]G6)BDZVVA3"T=*DH2T-BL0K%7D8#0;G82&D"F83O[<VLXFN7"X5K@W8
MJBB$V2TPU_4T& ;[C4\RS1QOA+-)*5+\C.[O<FUH%796$EF@LE(K,+B=!O/A
MY6+,\E[@B\3:'KP#>[+1^BLO;I-I,&!"F&/LV(*@QR->8YZS(:+QT-H,.DA6
M/'S?6W_O?2=?-L+BM<[_D8G+IL%%  EN196[3[K^@*T_9VPOUKGU_U WLN-W
M <25=;IHE8E!(57S%$]M' X4+@8_48A:A<CS;H \RZ5P8C8QN@;#TF2-7[RK
M7IO(2<5)^>P,G4K2<[.UP5+(!-9&_TN!@FMMG06A$OCH,C2PTBIU: J86XO.
M3D)'H*P:QBW H@&(?@(P@CNM7&;A1B68'.N'1+9C'.T9+Z*3!N^$Z<-HV(-H
M$)V=L#?J(C#R]D9_+@(-P/AY "ZK2UN*&*<!U8U%\XC![-6+X?G@Z@3]<4=_
M?,KZ+]'_ZW_XGT:XUPYAU(??18);Q3F*>D#')%V40NT %8E@ E(Y#:[6(%*#
M2&5."K5T&=PF(M-P+[AH10XKL=%&.&UV\/KV?O6F1YI MSYO]KFRO1IC+(F@
M<6P+])8N')J4M)8?;TB+T&Q5EMHX+YK@(S6D<B^[XN+=&)FD".\KS%^]N!A?
M1%=]F#?BCAH1RUF9*JG28Y<*D2"(Y%&H&*$4N\89:IBPK5QE:*^-&#<H(N($
MA3B%EX/^F$HZS]D'HK<0SE%WPCWQ.9VPR1ZL5M?P>G$S?]/@DD/$+QJ^O;)
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M=@&T7ROZ\,/$)1C_)_+?4$L#!!0    (  J K%I#8,3CSP(  &H&   9
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M=N1-85C3QP"-#Z#]2M,KZR:^0/]YF?\!4$L#!!0    (  J K%HZOQD=_0<
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MWC[)/7KT_+U[O^4:QU&!E<(ZA/-MG>&=:UFN[5>>*^QKHR:'M>3$0<U.6];
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M1\'^GI'?]3H5T64(WZ'$F^"7:1),HZGX!V(TD KY<Y),Q2Q,8@H.4?S<DPW
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M]'$-J8DJ\ &XOS0 ?_8++N!_2.?5OP!02P,$%     @ "H"L6G?EI0[5!0
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M2UT$]M#XL5OD9.-:CXY?QL<+7]=PHJ8;_K ZO(_>IV?!/7EZ7"%A2F6\T+0
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MBDJ62U285Q:)KU(Q)0/F;(!TPF-1976B<"4]BK_.4S%18(I$H=!3X8U ]>>
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M\&3#1Z7PPYN*/^1,C/>FX,M,29PH: &>3PV&IOB#%+1?]L[^ U!+ P04
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M&E[-,P_DT/E#HD7KNFTGM.E=%];FL41I"\QZ)80^)':#Z?G-_P)02P,$%
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M<P=X#4P9R/D-I>*YHRXSZNNQZ?]02P,$%     @ "H"L6BR7 O"? @  NP4
M !D   !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL?51M3]LP$/XKIPQ-(*$F
M35O86!J)CDU# E;1L7UVDTMBX=B9[;3LW^_LI%F'2K\D]MGW^+GG7I*MTL^F
M0K3P4@MIYD%E;7,5AB:KL&9FI!J4=%(H73-+6UV&IM'(<N]4BS".HHNP9EP&
M:>)M2YTFJK6"2UQJ,&U=,_UG@4)MY\$XV!D>>5E99PC3I&$EKM ^-4M-NW!
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MUP'J>\Z8/$QTP^[OY^0/4$L#!!0    (  J K%IZ,=,]U (  &((   9
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M\A.!%_NKBA/!-OE^H"43@L7YX1KDQRG/"LC[3XR)UY.L@FJ7V_0_4$L#!!0
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MNL,<3\>,[@!+GQ;6T@N9&]E;T 1Q.HPOG(E? ]&/3U\X]=Y6-/0)2\#]KTW
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M/2CK@.=+*<UN8U_0_'](_@)02P,$%     @ "H"L6AX8I44G'   F8,! !D
M  !X;"]W;W)K<VAE971S+W-H965T,S0N>&ULQ=UKCZ/&GL?QMX+F9,\F4J?'
MX&LG,R-UQMPO1NG)9J75/F!LNHUB&P?PS/1J7_P"QHW!N-R.OMDS#Y*^P*>P
MW?X9BOI7O?L:)W^DRS#,I&_KU29]_V:99=N?WKY-Y\MP':2W\3;<Y+]YC)-U
MD.7?)D]OTVT2!HMRI_7JK=+KC=ZN@VCSYL.[\F=^\N%=O,M6T2;T$RG=K==!
M\OQ+N(J_OG\COSG\X-?H:9D5/WC[X=TV> H?PNRWK9_DW[U]41;1.MRD4;R1
MDO#Q_9M[^2=_?%?L4&[Q'U'X-3WZ6BH>RN<X_J/XQER\?],KCBA<A?.L((+\
M?U_"C^%J54CY<?Q9H6]>VBQV//[ZH&OE@\\?S.<@#3_&J]^C1;9\_V;R1EJ$
MC\%NE?T:?S7"Z@$-"V\>K]+RO]+7:MO>&VF^2[-X7>V<'\$ZVNS_'WRKGHC7
M[*!4.RBM'>3!F1WZU0[]U^XPJ'88O/:0AM4.P]?N,*IV&+UVAW&UP[C]&(9G
M=IA4.TQ>^Z#OJAWN7GM(<N_PRO5>O<O+B]U^M<\>EGQXN>7VZWV^E<,++K=?
M<>7<LR4?7G*Y_9J?W^7PHLOM5UT>G=OE\+++Y>O^=O\F*=]ATR +/KQ+XJ]2
M4FR?>\47Y=NTW#]_8T6;(E$>LB3_;93OEWUXR.+Y'\MXM0B35%+_W$79LQ1L
M%E+Y\U_RM^I"^ABO\_Q*@S(!OI^&61"M4LD+DB0HTN 'Z4?IMX>I]/UW/[Q[
MF^6'5,!OYU7SZKYYY4SSLN3&FVR9-[U9A(N._3WQ_OU+^_L7VE<$P-O\N7QY
M0I7#$_J+(A3=(+F5Y,&-I/248<<!?7S-[LK9W:?BW:?A_%;J[5L?=+T<KVA=
M.7_PFGAW+?R<[SX^N[O^FMU'9W<WQ+M[\9=\=^7L8S?%N]_OGO)G_N[L[M9K
MGKKSN]NO?^JZ=G=>\]A[Y>[]CMW=2P?_+"F38F_YKNM-^(J'WI?/OFZSU^_>
M]=#]5_S)=^_>> /W7Q*Q7WJ#,]YL6P1=*N6G7VF61V&T>;J1]"389)T!\XM0
M*TX(?TJWP3Q\_R8_XTO#Y$OXYL,__R&/>C]WA0.)34E,)3&-Q'02,TC,)#&+
MQ&P2<TC,)3%OCPU+K+BV^O)![@T&DW=OOQS'T^E6PTF_=]?<RH<.K)%)@Y=,
M&@@S2?T6)O,H#:5M$LU#*;\,#!,ICZ2G_.MH'65=N204K\TE$IN2F$IB&HGI
M)&:0F$EB%HG9).:0F$MBWAZ;'"?.[7C0BJ73C>3;7K^52M!A-5)I^))*0V$J
M?8JS8"4]!E$B?0E6N[ KA83"M2E$8E,24TE,(S&=Q P2,TG,(C&;Q!P2<TG,
MVV.CHX 9]?)_K1AZU58^=&"-'!J]Y-!(F$-E7]6/G\O.JOEQ9U7XK?BZ,Y>$
MXK6Y1&)3$E-)3",QG<0,$C-)S"(QF\0<$G-)S!N=)([<'P[EB=Q*IM/M!L/1
M7:]U'N5#Q]:(IO%+-(W%G4EU)Y*4ZUE^^9;E*946B24%7X-DD7:EDQ"]-IU(
M;$IB*HEI)*:3F$%B)HE9)&:3F$-B+HEYXY/>HO&@/^XIK7 ZW6PX'(\FK;XG
MOT.;R)-1G6&-V)F\Q,Y$&#M^$CZ&21)6]_%NI&T@N$836M>F#8E-24PE,8W$
M=!(S2,PD,8O$;!)S2,PE,6^/C8_RH7?;Z[7/A,@F_4M--A+I[B61[H2)]#%>
MK_,KLBJ.'I9!?B"2F::[[IMJ0NS:2"*Q*8FI)*:1F$YB!HF9)&:1F$UB#HFY
M).;=G9RR*')^;M,?M/JF9V2K_BM:;023W'M)IF*4V:7N(RFN;OM_R:_2NC-)
MS%P;2J@V1345U314TU'-0#43U2Q4LU'-0347U;Q*.XZ*0>]N/&G=T)^AK?I=
MK0Z&RGAX)IZ.!FC*%Z[EXGD8+E+I,8G75<_1/JRDL!H6T)E60O7JM"*U*:JI
MJ*:AFHYJ!JJ9J&:AFHUJ#JJYJ.95VG$OMJ+T1G?C=EJ=;M>^!T<=6#.HE#JH
M%&%0_;9)PGG\M(G^IWT?;AZGF92$JZ#H^\[B0WR=[_\6MW1U>)':%-545--0
M34<U ]5,5+-0S48U!]5<5/,J[3B4^L-^NY-[=F:S]HTZZMB:^56/^Y;% [__
M8GZ55XS%_;UMF$1Q]Y4C.D8<U::HIJ*:AFHZJAFH9J*:A6HVJCFHYJ*:=R$@
M9.DY#!))[DGK?<V8,I 6P7/7&<R,HWSJ,39CL1YZ7A0N7MMS?S2NH3/PA.35
M@4=J4U1344U#-1W5#%0S4<U"-1O5'%1S4<VKM%?TY:/M^AWMRI/QI'\G*V>Z
MR^HQZ;)X4'IG7-WOLF6<%"=VG6F%#E)'M2FJJ:BFH9J.:@:JF:AFH9J-:@ZJ
MN:CF55HCK8:]7L>8=;1=_S7M-M.J'KDNBX>NWW]RI?NG) S7X2:3@OR_B^*K
M&VD1IO,D*J\S.R,+';^.:E-44U%-0S4=U0Q4,U'-0C4;U1Q4<R^\87_;+,)$
MRI91NG^WA@LI.+Q_;_*?A^5T*<'F6=KFEW/Y:4CT&*ZDH.A/6D=I.0]3^.<N
M6!7=2/W;WK])\6.Y5_"4*T]!%DI/29RFTO9PUR__?:&EP2HLOYGOSV_V]P%W
MU=&$]4'<2I_R;^/'QS I.J7:>VQW2;H+\JS)V]\_BI?TF0<;Z7,H96&RCC9E
M5]?7*%L6UZC%E:GT-8FR+-Q(FS@K:I _/TMA_NN\^6V09,^=>4V^,#-4\RFM
MF?MU68 LK@OX&&_2W:KL-A04*8F1JU,>+01 -175-%334<U -1/5+%2S4<U!
M-1?5O$H[OK\QE ?#.^7D*OITP[X\D8>C=ED =7S->*K+!V1Q_<#OY41\Q6?;
MES )GHH/I>(S8U%\/HGKO<7PU9&%5A.@FHIJ&JKIJ&:@FHEJ%JK9J.:@FHMJ
M7J4=SRYQ=SMH%S%U;*7<CI1V6$%'U@RKNK) %I<6:"^!=#B9KD[!_SUMG?OF
M)ZMIT2'8&5QHR0&J35%-134-U714,U#-1#4+U6Q4<U#-136OTF3E*)/&MX-1
M.[GN.I+K;MA.+NC0FC.%UI4'BKCR@$DN<2/7)A>J35%-134-U714,U#-1#4+
MU6Q4<U#-136OTAH3>HUOE799 MJHW]7HZ%8Y4U^NU%4)BK@JX7ABBW1_D[7=
MU5A,(WW\??CG+LK#+MQDG6-^Q0U>'6-HP0*JJ:BFH9J.:@:JF:AFH9J-:@ZJ
MN:CF55ISS,C=9#0^*5E V_4[VI7OE,%D,CPS9D11ZC 35RXT*T!C\=@VL75U
M3J&U":BFHIJ&:CJJ&:AFHIJ%:C:J.:CFHII7:8V"3.5N,&Q/L]JQW3#_-VGW
M<G5YH\'=X,P8$*6N.U N3#A_N%=;3NY\(]U_<CMS!RTB0+4IJJFHIJ&:CFI&
MI36GL.L:T62B[5JH9J.:@VHNJGFH-D,UG]*:*5:7">1?BE)L6@]8.RZ5*@:X
M'0:C=%_V"=FK8XW4IJBFHIJ&:CJJ&:AFHIIUX<_XT]$(KL=H5=P"E])EN'K,
M_ZB?HC1+]A6!^05"MA\UE7]3+&TG/?S8WX^7*KIQ'\+Y+HFR*$S+7A#UVWQ9
M+M;PL1X%]OV#^O&'8F\W2.;+EY6#;JIV]F<$A56,_"KZ5G;;XOWTW7AXVY/6
MT6I5(,U>XW_^8Z+(XY]3*:V;SY9!)GT-4FD1SE=!,2-@F+\;RV7\BL;O\W..
MU<NJ1[?2K#B>9TGN'8XFZW@^MDF<;G-CE[>TVVY7U>"WK\LH?R!%6X^[I!P9
M5O\VWR]OS=JMGE\:*Y^9^]W3+LVDPX^^G\>KU?[H5L_[QHL'I?1^UJ(DW\ZO
M6WYXL<LMY)]_N&D,;ML?S?'AK_,'5D91V7(:KE;G>JZ6P9?BV0\V1\/RXL99
MVM$+(BNWHY<7I)RC(XO683F^KOS_,HEW3_LCR<-P/SSO<$CAMV6P2\N!%L71
ME&/\ZC%]@L?<^3%,OD\<5'-1S4.U&:KYE-;\&*[+7Q1Q^<M#_D>:_Q']9_YG
MTY@"5/HO-UQ_#I/_[OP,1@M@4&V*:BJJ::BFHYJ!:B:J6:AFHYJ#:BZJ>:@V
M0S6?TIJY5Q?2*.)Q^;^&BW"]O_KP#Q_0K0CL3#ZTC@;5IJBFHIJF=,S1W^ZS
MT-$F#50S4<U"-1O5'%1S4<U#M1FJ^936#+2Z0D015XCX5TWA+L:NSC&T4@35
M5%33*NW"_-HZVJB!:B:J6:AFHYJ#:BZJ>:@V0S6?TII)5A>3*.)BDH]!NNS,
M++14!-6FJ*:BFE9I%\Z]T H05#-1S4(U&]4<5'-1S4.U&:KYE-9,K+JB1!%7
ME!S?R\JO(]/=Y_K[HN\XVA1S_I7=_TE8'L$FV]\7>*FF[@P\M,0$U::HIJ*:
M=N'5^E[^8=^1?^YVR+D^T:-S:NF[\K2O'F@O?7]T\^$<4-]Y**OI0\G?)?-E
MD#\@Z3%.I._R6,[_5J1Y_@&X[_<O[^7,5W&ZOQ^BA9^379 \2\JXO $R+/^Z
M"JC<=7\K9;4JYA*(%C_NMN6OBTDJDV+>@?V-@ODN/Y[\#W$5!9^C57G3IWF/
MX6NT6N4[+?*_R^K>U)D>XI=#+HY7"AZSZC9$^^D,-IMB H/R>,OG:AFOBB-9
MAV%9T'[\S-WOMW7WOSH\7[>=W9]HZ0^JF:AFH9J-:@ZJN:CFH=H,U7Q*:WQB
M]>M*HKZXDJA^+^_O8'Z)R[=B4I1QI]5MSJZ/)#%[[4<2JDU1344UK7^ZVD/W
M5%0ZVJZ!:B:J6:AFHYJ#:BZJ>:@V0S6?TIJQ5E<9]2^M?1(6ISZ2NI\C)Y7N
M\Q.@63FVY&-UWG.?IF$><:+;V^)&K@XYM+((U514TU!-1S4#U4Q4LU#-1C4'
MU5Q4\U!MAFH^I36#4*F#\/]M;15Q2U>G(5J_A&HJJFFHIJ.:@6HFJEFH9J.:
M@VHNJGG]TT531G>G4]VBC?J4UHRYNA2J_Z]:@D7<\-6IAU9/H9J*:AJJZ:AF
MH)J):A:JV:CFH)J+:MZ%@!B\8ND5](!\2FLF8EU6E7\IO'E>+6=0WI,HUDL/
M-O/PPN6N4+PZZDAMBFHJJFFHIJ.:@6HFJEFH9J.:@VHNJGFH-D,UG]*:J5=7
ML?0O5+$4-S%^_!RD[=- P6398O+JV$.+6%!-134-U714,U#-1#4+U6Q4<U#-
M136OTAK#UX8=U[6OVLRGCJT95'7925]<=O+074 :Y2=JW6M-B;VK4PHM.$$U
M%=4T5--1S4 U$]4L5+-1S4$U%]6\2CN^P=^7QW([I#JV&@]/,NKOJ"3IUY4D
M?7$ER5^?S%\,7QU6:%4)JJFHIJ&:CFH&JIFH9J&:C6H.JKFHYE7:\22O@]MQ
M>_&1_NGB(^T5V*G#:B9572G2%U>**#VE)ZE_[J+L63(W\W!33E/BKX*-N,,+
M+21!M2FJJ:BFH9J.:@:JF:AFH9J-:@ZJN:CFH=H,U7Q*:R9?77'2%]<P?&Q,
MG/TEB%;!YU58#LE_W&6[)"PO*8N^_\X 1 M+4&V*:BJJ::BFHYJ!:B:J6:AF
MHYJ#:BZJ>976F,*ZU[OK3]IK *#-^I36R+9!79LP$-<F?(JS8"5M=L7YV^DB
M ==FG;BQ:[,.U::HIJ*:AFHZJAFH9J*:A6HVJCFHYJ*:-SA;(=/*.K19G]*:
M65<7+ S$!0NMRN'J6C9ZN9;=YM>RG:F&EBB@VA355%334$V_\.)V%</^$@?)
MHGBIIU$2SK,X2:5@NTWB+T5_ZZ9XY9,P2,O29.4F__N_R=\ AVE'JZ+A8)<M
MXZ0<\EA_2%:;U).!EGTC15?(S0$]3!";E9^O(J6<E;1N/F]W6'QQ4[X9.^(8
MK:U -0O5[%>\X%>\P.-_Y<LKWTQ.FF__Q75^AJ %(:CFH=H,U7Q*:W[0*/4'
MC;@@I*R^_Y0$FS28[Y>M$?60BK&K/U[0F@]44U%-0S4=U0Q4,U'-0C4;U1Q4
M<U'-0[49JOF4U@R\NC1D(![YO>]%$-^O%A-7QQQ:Y(%J*JIIJ*:CFH%J)JI9
MJ&:CFH-J+JIY@]-EC_J=70-H)0>E-0.LKN3(OQ0.%?P+8YK%Y-6!1FI35%-1
M34,U'=4,5#-1S4(U&]4<5'-1S:NTXT#K[NLD6_4IK1EH=9'&X$*11MFG<%,6
MWW8/=A8#5\<76I*!:BJJ::BFHYJ!:B:J6:AFHYJ#:BZJ>95V?*]FW!O+)^F%
M+AA":<WTJBLW!N+*#7!&%7%+5\<<6M.!:BJJ::BFHYJ!:B:J6:AFHYJ#:BZJ
M>8/316N4SK,T=!T12FOF7%W],1!7?_SZ<)]*;KR('J-Y\#*#M1=FU9P"#V&6
M[=<43,LA.'[PO/\F?I1^C[)E,;EO<2OJ4_"M.-D[NL'=&87B@Y%[-W>]L50>
MT_ZT\7"7+&]Z'292N-ZNXN<PE/;7R?G1+J-B/<OD2[&F4[5M=0_V5OH42T5F
MIX_/^WMRWZ)U'MJK9^F[_JB\[15MI&WPG,2K5;DVY^&Q9/O'DC5F2<Y_':X6
M4O]F,NI7]\N*Q3C3W:J<6B:GBNT/0Y/*^WTWO<% VN1/9?..7^NQ=(8\6@N#
M:NJ%U[#U3/=NE9?5+T5/MQ2D:3R/R@_5EW52@_D\7(5)^<.7/XI\ES.OC2+?
M*)/AZUZ<P=W-0!G^I5='0Y]/'=4,5#-1S4(U&]4<5'-1S4.U&:KYE-;\^*I+
M@@;BDJ \%:2'W7I=SI)_F"&_7"M8>+\;K0A"M2FJJ:BFH9J.:@:JF:AFH9J-
M:@ZJN:CFH=H,U7Q*:P9?71$T$%<$_:7;16@=$*I-44U%-0W5=%0S4,U$-0O5
M;%1S4,U%-:_2&G/;=-\ /]UPT+&=3QU>(ZN&=87/4%SA<YBD<+^H4C4GCGEV
M#ARQ=FU,H=H4U514TU!-1S4#U4Q4LU#-1C4'U5Q4\X:G)3SC07_<4UHIU;7=
M1)Z,VK-+4$?73*FZ-F<H'LW?F5*S799F^35EM'GJC"JT+@?5IJBFHIJ&:CJJ
M&:AFHIJ%:C:J.:CFHII7:9>CJF.[SJCZ.ZH[ADH=5>+J#NUEF/-A3<NC6R:=
M.846>*#:%-545--034<U ]5,5+-0S48U!]5<5/.&IXMZ= X41%OU*:V99G7I
MQE!<NG'?F..A7 /W(9SODG*Q6F$_OAB^.M;0@@Y44U%-0S4=U0Q4,U'-0C4;
MU1Q4<U'-0[49JOF4U@R_NNPC_U(4?GX2S\-P455IE^'7F@/G1K ^KQB_.@!)
M;8IJ*JIIJ*:CFH%J)JI9J&:CFH-J+JIYE=:8[6;4&X[D]LQ>'1L.E''_I$>?
M.KQF:M6U'4-Q;4<Q/G#;3*Z7B>W+$5;[F2ON/[F=J876?:#:%-545--034<U
M ]5,5+-0S48U!]5<5/.&IVML%//0=%V/=JS&T;6A3QU@,[?JJH[AA?4XZN4W
MBI0J2CDZ PJMV$"U*:JIJ*:AFHYJ!JJ9J&:AFHUJ#JJYJ.8-3]?7&'?&T^EV
MW>GT=]1B#.M:C*%XZ/QL>WFJ)C%Q=32A=0:HIJ*:AFHZJAFH9J*:A6HVJCFH
MYJ*:AVHS5/,IK1ES]9C]H7C,OM]QX5@5T8;?PF0>=8]>%:M7)Q\Z:!_55%33
M4$U'-0/53%2S4,U&-0?57%3S*NUB&2W:JD]IS4RKA^,/Q</QFYGV<)1IJ;#_
M'AV1CVI35%-134,U'=4,5#-1S4(U&]4<5'-1S1N>KLPQ&-[U!^U(0]?EH+1&
MI(WJ4?LC\:C]CIFM/RZ#*%E?6&Y-S%Z;::@V1345U314TU'-0#43U2Q4LU'-
M0347U3Q4FZ&:3VG-Z*M+ 4:O*@6H)H8XW-1,I7"_7L=^@=RSTPR+\:L#$"T*
MJ+1+ PQ5M%4-U714,U#-['A^Y<GI\VNAK=JHYG0\!F5P^AA<M%4/U6:HYE-:
M,XZ4.H[$P_V;<=0(H6U23'RT#1/!1:98OSJ/T,'_E7:\-/'P=J*TTP@=U(]J
M.JH9J&:BFH5J-JHY'7]'_=N[<3NQT,'ZJ#9#-9_2FHE5#^D?B8?T>^TUB,JT
MZJY-$E-7QQ,ZB+_2CJ_[)\,[>=C.)W1T/JKIJ&:@FMGQ]([EL=QOGRRAP^Y1
MS>EX"*/>8#AJ)P\ZGA[59JCF4UHS>>KQ]/F7%\Z53J;J/<SCVYD^0N[J]"&U
M*:JIJ*:AFHYJ!JJ9E7;YDHYLU48U!]5<5/-0;89J/J4UPZP>9C\2#[/_&&\.
M4Y@*IO42(U='&#J<'M545--034<U ]5,5+-0S48U!]5<5/-&IX/D!\/3<1$=
MF[7'J5+'U8RE>A3]2#R*_F.C.K'L!U]4_5&+( O;G5*=F86.L$>U*:JIJ*:A
MFHYJ!JJ9E7;<HZ/<#N7V21<Z<A[5'%1S4<U#M1FJ^9363+=Z%/Y(/ K_->,>
MI/^5?@W3+,^Y8FKZ_7"OWS91EDJ_2@_2O7A\!#J"']6FJ*:BFH9J.JH9J&:B
MFH5J-JHYJ.:BFH=J,U3S*:T9D?4(_I%X!/]A:3]=T*N/CM:OM.->5GDPF+3Z
MX:=HHRJJ::BFHYJ!:B:J6:AFHYJ#:BZJ>1UOF>'X;G!RM8F.PJ>T9B[5H_!'
M_*3X8O+JH$*'X*.:BFH:JNFH9J":B6H6JMFHYJ":BVK>J&-2_*ZR(K15G](:
M@3:NQ^"/Q6/P?P^CIV5QB1E\"9/@*90>ZYE?ZPZW&]'P"G$+U^8;JDU1344U
M#=5T5#-0S40U"]5L5'-0S44UK]*.^SLGMZ/]LA_5OU;GYPP] )_2FE%7C[D?
MB\?<J\?#6LM%)+_DN??Y6?I\Z(];'/KC.F,.'70_?MTP^2G:JHIJ&JKIJ&:@
MFHEJ%JK9J.:@FHMJ'JK-4,VGM&:V*76VB0?P-^K!!=/TBYFK0PP=J8]J*JII
MJ*:CFH%J)JI9J&:CFH-J+JIYE79QWC&T5;^CU;K!9C+5 _7'XH'ZOVWJX;'-
M+K-J[.PJJ%9AKV;H";[F9V/=9V#H.'Y4FZ*:BFH:JNFH9J":B6H6JMFHYJ":
MBVI>I1U?V_0[%QE!F_4IK1ET=5U _N7?$'3ER5HQ_G8;)E'<?=(F;/CJW".U
M*:JIJ*:AFHYJ!JJ9J&:AFHUJ#JJYJ.9=" A%>@Z#))5D:1UOLJ6D]*1%\-QU
MIC-#C\NGM&8PUC4&8W&-P>E:<D4)5;!Y_O>TL0R)>#RON)&K0Q"M04 U%=4T
M5--1S4 U$]4L5+-1S4$U%]6\2CN^RS"^'8S:9WZG6RFW=ZW15CYU9,W@JJL0
MQN(JA(YQND?#<]W@6[3>K3NS"JT]0+4IJJFHIJ&:CFH&JIFH9J&:C6H.JKFH
MYJ':#-5\2FMF7UVC,!;7*'2N57Z_RY9Q<J[072Q>G7IHV0&JJ:BFH9I>:8V!
MS(?;^\V/5P-MV$0U"]5L5'-0S44U#]5FJ.936C/2ZIJ"L;BFX,+I7+0Y>SJ'
M5AJ@VA355%334$U'-0/53%2S4,U&-0?57%3S4&V&:CZE-;.OKEL8B^L6_LKI
M'%JV@&I35%-134,U?7PZ+[PR[#Z;0TL24,U"-1O5'%1S4<U#M1FJ^92V3[2W
MZ3(,LVF0!1_>K</D*?P8KE;%_8'=)N>+T28O/Y62\#%_;N2?9O*;MR<_5^6?
MW*Z?W\L_W2O%S]_6_(=WV^ I=(/D*=JDTBI\S)OJW1:]CDE1%7'X)HNW[]_(
M;Z3/<9;%Z_++91@LPJ38(/_]8QQGAV^*!K[&R1_EP_GP?U!+ P04    "  *
M@*Q:Z>4"<Z$#  #A#   &0   'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6R]
MEVUOVS80@/\*H0U%"BS1BU^3V@82.]T*+&W@K-UG1CI;7"A1(VD[_O<[2HIL
M10P]%$7]P1:IN^-SY/'N/-D)^:12 $V>,YZKJ9=J75SYOHI3R*BZ$ 7D^&8E
M9$8U#N7:5X4$FI1*&?>C(!CZ&66Y-YN4<_=R-A$;S5D.]Y*H3991N;\!+G93
M+_1>)I9LG6HSX<\F!5W# ^BOQ;W$D=]825@&N6(B)Q)64^\ZO)J' Z-02GQC
ML%-'S\2X\BC$DQE\2J9>8(B 0ZR-"8H_6Y@#Y\82<OQ;&_6:-8WB\?.+]8^E
M\^C,(U4P%_QOENATZHT]DL"*;KA>BMT?4#M4 L:"J_*;["K9(:X8;Y066:V,
MXXSEU2]]KC?B2 'MV!6B6B%ZK=!_0Z%7*_1*1RNRTJT%U70VD6)'I)%&:^:A
MW)M2&[UAN3G&!RWQ+4,]/7N -1Z*)DLHA-0L7Y.S!6C*N'I/SLG7AP4Y^_7]
MQ->XE%'PX]KL364V>L-LC]R)7*>*W.8))&U]'Q$;SNB%\R9R&KRC\H+TPM](
M%$0#"\_\_ZOW'3B]9MMZI;W^&_:6L(5\ [:-J12'I:*Y1-M9,/&WQZ@NB19-
MOZ'I.VFN.1<QU9 0R HN]@ D%AG>=$6KNY(G!",I?CHW$9^T7MI<J%8;' &&
MO<!\7CG2E1NTQ5K>#!IO!DYOYE\6=S8JIY9)=U>JH#%,/<QG"N06O-F[7\)A
M\,$6+C_(6,O!8>/@\'N#9]C9T==[[I)HT8P:FI&3YG?(05)>!@E-,,4PI24U
MR=4&..HLWQO80J,K%T6.V!@WL&,G[*?/?Y)[*?[!(F"C&W=6'=O@NF)]!]ME
MPW;I/E:1T9Q1L@*JV"/C3._QUFV2O8WT\N1!=R5"!V08'!)^X+Y>F.[EQF1F
MD.L]^7A[NW@;L[;EXK2(N$XZ/*I,X4_-:O5R)Z/#(N=T*#HX%#D=^J)3D 1[
M*<42(,MW-"L^+ @\&VI05N3H5!#4R"?EVLB',A>ZZ]Q?0F-J,"F0RC@MMSS!
M[,5%8;H&*W*OBS*R,EL$ Q?TH1J&[G)8[;.J.AM%F(:,G(7V+J9;PL[[5MK3
M@FW:0[4+W>7N,_;J7"C[^0\ZK<)YWQZT%LEH; /TCYK%#%- V4,KO#V;7%?]
M6#-;]>DWID\WS>:K>>S?K\NNU3^8J9I_[+;6+%>$PPI-!A<CA)-5/UT-M"C*
MEO11:&QPR\<4_X. - +X?B6$?AF8!9I_-;/_ %!+ P04    "  *@*Q:3MTA
MQZ\$  ##(   &0   'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6RMFEUOXC@4
MAO^*E1VM9J0N^8! VP4D2A+M7#"JRG3W8K47;CB4J$F<L1V86>V/7^>C@5#B
MEL[I!20A[^./UR=VCCO>,?XD-@"2?$_B5$R,C939M6F*< ,)%3V60:I^63.>
M4*E.^:,I,@YT58J2V'0L:V@F-$J-Z;B\=LNG8Y;+.$KAEA.1)PGE/VX@9KN)
M81O/%^ZBQXTL+IC3<48?80GR/KOEZLQL**LH@51$+"4<UA-C9E\']J@0E'?\
M&<%.'!R3HBD/C#T5)Y]7$\,J:@0QA+) 4/6UA3G$<4%2]?A60XVFS$)X>/Q,
M#\K&J\8\4 %S%O\5K>1F8EP:9 5KFL?RCNW^@+I!;L$+62S*3[*K[[4,$N9"
MLJ06JQHD45I]T^]U1QP([$&'P*D%SK' [1#T:T'_6-#O$ QJP>"M57)K@?M6
MP; 6#,N^KSJK[&F/2CH=<[8CO+A;T8J#TJY2K3HX2HN1M91<_1HIG9PN\P<!
MWW)()?&WZE.0CQY(&L6"?*&<T\+W3^0W<K_TR,</G\@'8A*QH1P$B5)RGT92
M7*B+ZG@1Q;$:*V)L2E6O@FZ&=1WF51V<CCK89,%2N1'$3U>P:NM-U9ZF4<YS
MHVX<+7"6\1ZQ^A?$L1SW5'WT\@7]06RG4^V]KK8N.]7^:VI5];[=*0_T<@_"
M1C[0]&2_&1[]DC?HX,U9DJCX7TH6/EV0967\+)<;QJ-_C[VJK-$"BP?EM<AH
M"!-#/0D%\"T8TU]_L8?6[Z>,PH1YF#"_@KDEK'A\;Z>.:Y5_8W-[:-@;;FQ9
M,VBL&6BM.8Y<\O<"D@?@_YPR18LZUQ1,F(<)\S%A 1*L9:[;F.MJS;WE+ 18
M";+F+"&"QD#8FH15-(HJ&JO'\"FWM>QSW79?C-_A:-0_'N8>9ID^)BQ @K5\
M'#8^#K4^?E%KPZSM96$>B83(:1H"R=64Q\GLZ^*4CUKVN3Y6L.&!C^Z1A9C%
M^9BP  G6LG#46#C26G@'0O(HE+"JO:,[RI6;W>$W>A$Q_1,3PUQ;[+F/44R8
MCPD+D& M[RX;[RY_PCNRI7$.IQRLJ+9U.&GW["/_M$6?ZQ\FS,>$!4BPEG]7
MC7]7^C5.:5JF+ 22J>=DZ=LIPRK,Y>$DU;NZ.C),6]:YAF'"?$Q8@ 1K&69;
M^_=)ZWW+4O(?N6%2O<^J@QF741BK"%2+FL]IR'C&BE=-M;;1+6+U)9\['Z+2
M/%2:CTH+L&CM$7&08;"QWR'UQ+.=QJ1Y->WU-S\?M=P B]9VT=F[Z/Q\7#N6
M8Y';F+X2Q]J2SG87D^:ATGQ46H!%:X^ ?2K(1L\%Z8EG.XV:#;([$S/'88Q9
M;(!%:YNX3QK9[\P:J>C]RK+WS\VH&294FH=*\U%I 1:M/1SV:29;GV=Z3TRC
M9I=0:9[],EEE6];IR1DUQX1%:]NXSS+9^C33ZU']QID9->.$2O-0:3XJ+<"B
MM>W?9ZAL?8KJ/5&,F>.9H](\^V4"K6.!C9JHPJ)5)IH'>[()\,=R]UR0D.6I
MK+9GFZO-#OVLW)<V][=7V_L+RA^C5) 8UDIJ]4:J9WBU8UZ=2):5.[P/Y3J\
M/-P 70$O;E"_KQF3SR=% <W_+4S_!U!+ P04    "  *@*Q:FDV)0$0#  #*
M%   #0   'AL+W-T>6QE<RYX;6S=6%UOVC 4_2M1NDZM-#5 VD!60-J0*DW:
MIDKMP]XJ0QRPY-B98SK8KY^O'<)'?1GKPP8+*K'O\3GWV+YIW/8KO>3T84:I
M#A8%%]4@G&E=OH^B:C*C!:FN9$F%07*I"J)-5TVCJE249!60"AYU6JTD*@@3
MX; OYL5=H:M@(N="#\)N$PK<[5,V"-O)=1@XN9',Z"!\NGC[?2[U[9O W<_>
MG9VUGBYO=^,7%K@,(Z_HS0&B5ZT6+@P@)IX<)KY/&Y/N;DO;X>=&R!'/,5KO
M($=[#&'"J<>/%?H-L=OR$C?F AU+CNHR&?9S*=;5$H<N8-1)08-GP@?AB' V
M5@Q8.2D87[IP!P(3R:4*M"E3DZX-D>JG@]NN!Q5<ZQ1,2&5SNPSN>UP/WP%6
M/3#(.&\,=D(7&/9+HC55XLYT[& ;? $%=?MQ61J'4T66[<Y-N";8FTDREBJC
MJDG3#E>A89_3'.PH-IW!7<LR E!K69A&QLA4"F(]K!AUP\A.*.</\'A_R[>T
M%_G&OME=$TW3&*J;3L9U0']3S6EOREZ_2C<HV;/4'^=F.L+VH4+IO:(Y6]C^
M(F\,8.IM7)V4)5]^X&PJ"NHF?W#"89^L>,%,*O;39(-2F9@ 56'P3)5FD\W(
M#T7*1[K0JW):Y+CGS@EZ_KOK/*6"*L(W39O:/^95?K7CN/NO+-O?*KN&O1[K
M=_:QF[PY!9/)*9@\B9KLG8+)]/A-QB?@L3Y?'IW)J#X);1RWM@Y;332 0^T@
M_ I'9+Y.&HSGC&LFZMZ,91D5+\Y<1EZ3L?E#;4O?C,]H3N9</S;@(%RWO]",
MS8NT&74/"U&/6K<_P_3:27.B-KF8R.B"9J.ZJZ9CVPQ,PV2M+R#L(G?V\B,8
MQV%^!# L#^8 XS@6EN=_FD\/G8_#,&\]+])#.3V4XU@^9&0_6!X_)S67?Z9I
M&L=)@JWH:.1U,,+6+4G@QZ^&>0,&E@<R_=E:X[N-5\C^.L#V=%^%8#/%*Q&;
M*;[6@/C7#1AIZM]M+ \PL%W :@?R^_- 3?DY<0R[BGG#GF <25,,@5KTUVB2
M(*N3P,>_/]A3$L=IZD< \SN(8PR!IQ%', ?@ 4/BV+X'=]Y'T>H]%:W_>SG\
M!5!+ P04    "  *@*Q:EXJ[',     3 @  "P   %]R96QS+RYR96QSG9*Y
M;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI
M0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:W
MO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:
M>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%B
MM/XU@LD/['X 4$L#!!0    (  J K%IQ[GBF?0,  *08   /    >&PO=V]R
M:V)O;VLN>&ULQ9E=;]HP%$#_BI6G3IH6D@#]4*E$(1U(#!!!?:U,<B%>DSBS
M';KVU\])1&?6ZFHOAJ>0Z^"<7)-[;'/[PL7SAO-G\CO/"CEP4J7*&]>5<0HY
ME=]X"85NV7*14Z5/Q<Z5I0":R!1 Y9GK=SI]-Z>L<.YN#WTMA6N>< 6Q8KS0
MP3KPR.!%_FVO3\F>2;9A&5.O Z?YG(%#<E:PG+U!,G Z#I$I?YEPP=YXH6@6
MQ8)GV<#QVH9'$(K%'\)1#;FF&]E$%-VLJ 89./V.[G#+A%3-%4W_5#/N05_<
MGE6*/[!,@1A3!=\%KTI6[.IN]%.XQF,T>3@<VR3>B/])(]]N60QC'E<Y%*K-
MHX"L!BQDRDKID(+F,'!&? ^B?AY]@VG2/IO24$:FQ W3#6*:-'@641;S:#&;
MCH?K<$SNA[/A?!22:!*&Z\@ ]!% _VR Y&))#<@ @0Q."!FM]>%'.-> BP>R
M6(8K [*+0';/!CF:#.<&9 ^![)T/<AA-#,@^ MFW"SDM)$M D+6@B:XA9"@$
M+790?TL:A)<(X:5=PCE5E0#"MV11@FC;OY)[*IFL@P;D%0)Y91E2]SOC4I*E
MSF644@$&US7"=6V7:RF@I"PAVG,_M>?(B$LE"2T2LE#I<>'N8)6[8Q=S&,>\
MTK\XLJ2O5-^Z(=1!44%"9LS$1 5CVS \SYEJWHV&<*1MKU\:*&(&YMOB89+Q
M+%MF!1*HB-.&< Q[R'A9?Z4=>Y,2LXQG63.1XO%SRC-=>R0)?U5Z<M4 -_%[
MTX4>YAG/LF@BV#6Y6T')13W6)ACF%L^R7*)J(^%75;.%^W^*M8?YQ+,LE/?"
MK$N/U)<V5Y"HRG,J7@DW,3&I>):M@F(^^28FIA7OY%XA%^NZ0LHO)B)F&,^R
M8M#:?91)'U.,;UDQ:,$YQL04XUM6S(>"\]EX^^@BQK)?T/G8<2(QP?B6!8-C
M!B8F)AC?LF ^>\''H"C+CD<<<XUOV37H)/)XQ#'S^);-@Q>BHQ''S.-;-@\Z
MB207)B9F'M^R>=!IY#$F9A_?LGWPLFX.>H#9)SBK?;HF)F:?P+9]4,R>B8DI
M*+"L(!RS;V*B.VGG7.,\79J8F(*"4Z]Q/C50@!DH./5JYQV1S*DPMS$"S$!!
M8R#WL"N>P)85D,SU+:2.QS2+EX+4AW81W^W5$^MME64C'5L4,TZ3PR;[X0^"
MNS]02P,$%     @ "H"L6M;Z^;%X 0   Q8  !H   !X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<\W836[",!"&X:M$/@#.S/!; :MNV%9<( J&(/*GV%7A
M]HW"(GQ1%]T@SRIRHHS?31Y%WGZY,@O7IO;%M?7)O2IKOS-%".V'M3XO7)7Y
M6=.ZNG]R;KHJ"_VRN]@VRV_9Q5E.TZ7M7F>8_?9U9G)\M.X_$YOS^9J[SR;_
MKEP=_AAL?YKNY@OG@DF.67=Q86?LO1QO>SM<:-9/-LGAM#/=X43&Q@YB".+X
M00)!$C]H#D'S^$$+"%K$#UI"T#)^T J"5O&#UA"TCA^T@:!-_"!*4<940=($
M:P5:$W)-"KPF!)L4B$U(-BDPFQ!M4J V(=NDP&U"N$F!W(1TDP*["?$F!7HS
MZLT*]&;4FQ7HS9.?;05Z,^K-"O1FU)L5Z,VH-RO0FU%O5J WH]ZL0&]&O5F!
MWHQZLP*]!?46!7H+ZBT*]!;46Q3H+9/#$@5Z"^HM"O06U%L4Z"VHM[Q3;Q\>
MI?-CSW.-^[^3ZM"_Z\;MA^7SYN0;'W"V<.:[_P502P,$%     @ "H"L6NN(
MNN65 0  @A8  !,   !;0V]N=&5N=%]4>7!E<UTN>&ULS9C-;L(P$(1?)<H5
M$6.[I3\"+FVO+8>^@)ML2$026[:A\/9UPH_4BD8@*G4NL1+OSHR]TG?(Y'UK
MR$6;NFK<-"Z\-X^,N;2@6KE$&VK"3JYMK7QXM0MF5+I4"V)B-!JS5#>>&C_T
MK48\FSQ3KE:5CUXVX;,K=3.-+54NCIYVA:W7-%;&5&6J?-AGZR;[X3+<.R2A
MLZMQ16G<(!3$[*1#N_.[P;[O;4W6EAE%<V7]JZI#%=M4S/EM12[IESB14>=Y
MF5*FTU4=6A)G+*G,%42^KI*=Z*#?V8<;IMV37^W?R?09ALJYU<:%B5FZW.XP
MDK9[:((065_V'_'H&*2O/A^UT\XH.],[7.^GMLMN'HYUR_5W_'W&1_T+<PB0
M'!(DQPU(CEN0'&.0''<@.>Y!<CR Y. CE" H1.4H2.4H3.4H4.4H5.4H6.4H
M7.4H8.4H9!4H9!4H9!4H9!4H9!4H9!4H9!4H9!4H9!4H9!4H9)4H9)4H9)4H
M9)4H9)4H9)4H9)7_2=8/K9=__5>T79-:E<W!GW6_GF=?4$L! A0#%     @
M"H"L6D;'34B5    S0   !               ( !     &1O8U!R;W!S+V%P
M<"YX;6Q02P$"% ,4    "  *@*Q:,++E9/$    K @  $0
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M965T-"YX;6Q02P$"% ,4    "  *@*Q:.I@Q,[ &  !>)0  &
M    @(%W&@  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @
M"H"L6O,\;9.B!0  :!8  !@              ("!72$  'AL+W=O<FMS:&5E
M=',O<VAE970V+GAM;%!+ 0(4 Q0    (  J K%H%"+;85 0  &D5   8
M          " @34G  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4
M    "  *@*Q:?"--3'8-  #>)@  &               @(&_*P  >&PO=V]R
M:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ "H"L6J0DG*2X P  ]@@
M !@              ("!:SD  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+
M 0(4 Q0    (  J K%HM>*4<N0,  )\(   9              " @5D]  !X
M;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ "H"L6D?)>MB6
M @  ,P8  !D              ("!24$  'AL+W=O<FMS:&5E=',O<VAE970Q
M,2YX;6Q02P$"% ,4    "  *@*Q:0V#$X\\"  !J!@  &0
M@($61   >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    (  J
MK%HZOQD=_0<  +05   9              " @1Q'  !X;"]W;W)K<VAE971S
M+W-H965T,3,N>&UL4$L! A0#%     @ "H"L6J]8??=)%0  5$<  !D
M         ("!4$\  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4
M    "  *@*Q:=^6E#M4%  !!#@  &0              @('09   >&PO=V]R
M:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    (  J K%JC]G[-] L  *(>
M   9              " @=QJ  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL
M4$L! A0#%     @ "H"L6DEC!R)'"@  Y1L  !D              ("!!W<
M 'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    "  *@*Q:$[('
M9X\"  !\!@  &0              @(&%@0  >&PO=V]R:W-H965T<R]S:&5E
M=#$X+GAM;%!+ 0(4 Q0    (  J K%K*T[Y;=P(  (H%   9
M  " @4N$  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @
M"H"L6K& <0I] @  OP4  !D              ("!^88  'AL+W=O<FMS:&5E
M=',O<VAE970R,"YX;6Q02P$"% ,4    "  *@*Q:'B+*NYP$  #="P  &0
M            @(&MB0  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4
M Q0    (  J K%I/[PBV\0(  ((&   9              " @8".  !X;"]W
M;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @ "H"L6DHH]@6? P
M*A,  !D              ("!J)$  'AL+W=O<FMS:&5E=',O<VAE970R,RYX
M;6Q02P$"% ,4    "  *@*Q:+)<"\)\"  "[!0  &0              @(%^
ME0  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    (  J K%J:
M>$>$Q@(  'L(   9              " @528  !X;"]W;W)K<VAE971S+W-H
M965T,C4N>&UL4$L! A0#%     @ "H"L6@]!UM## P  #A0  !D
M     ("!49L  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    (  J K%JO$M86Z (  (0(   9              "
M@2NP  !X;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @ "H"L
M6O0Z].(^!   WQ,  !D              ("!2K,  'AL+W=O<FMS:&5E=',O
M<VAE970S,BYX;6Q02P$"% ,4    "  *@*Q:_R$+TLD"  !+"   &0
M        @(&_MP  >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0
M   (  J K%H>&*5%)QP  )F# 0 9              " @;^Z  !X;"]W;W)K
M<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @ "H"L6NGE G.A P  X0P
M !D              ("!'=<  'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q0
M2P$"% ,4    "  *@*Q:3MTAQZ\$  ##(   &0              @('UV@
M>&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    (  J K%J:38E
M1 ,  ,H4   -              "  =O?  !X;"]S='EL97,N>&UL4$L! A0#
M%     @ "H"L6I>*NQS     $P(   L              ( !2N,  %]R96QS
M+RYR96QS4$L! A0#%     @ "H"L6G'N>*9] P  I!@   \
M ( !,^0  'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (  J K%K6^OFQ> $
M  ,6   :              "  =WG  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN
M<F5L<U!+ 0(4 Q0    (  J K%KKB+KEE0$  ((6   3              "
M 8WI  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     L "P ZPL  %/K
!  $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>104</ContextCount>
  <ElementCount>243</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>35</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>110200 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>110201 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>124100 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/ConsolidatedStatementsOfOperations</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>148600 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>170000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>995446 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements</Role>
      <ShortName>Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Net Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/NetLossPerShare</Role>
      <ShortName>Net Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>995448 - Disclosure - Prepaid Project Costs and Other Longterm Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/PrepaidProjectCostsAndOtherLongtermAssets</Role>
      <ShortName>Prepaid Project Costs and Other Longterm Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>995449 - Disclosure - Accounts Payable and Accrued Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/AccountsPayableAndAccruedLiabilities</Role>
      <ShortName>Accounts Payable and Accrued Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>995450 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>995451 - Disclosure - Research and Development Costs</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/ResearchAndDevelopmentCosts</Role>
      <ShortName>Research and Development Costs</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>995452 - Disclosure - Stockholders Equity and StockBased Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/StockholdersEquityAndStockbasedCompensation</Role>
      <ShortName>Stockholders Equity and StockBased Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>995453 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>995454 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>995455 - Disclosure - Basis of Presentation Summary of Significant Accounting Policies and Nature of Operations (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperationsPolicies</Role>
      <ShortName>Basis of Presentation Summary of Significant Accounting Policies and Nature of Operations (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>995456 - Disclosure - Basis of Presentation Summary of Significant Accounting Policies and Nature of Operations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperationsTables</Role>
      <ShortName>Basis of Presentation Summary of Significant Accounting Policies and Nature of Operations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>995457 - Disclosure - Net Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/NetLossPerShareTables</Role>
      <ShortName>Net Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://ltbr.com/role/NetLossPerShare</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>995458 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesTables</Role>
      <ShortName>Accounts Payable and Accrued Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://ltbr.com/role/AccountsPayableAndAccruedLiabilities</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>995459 - Disclosure - Stockholders Equity and StockBased Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables</Role>
      <ShortName>Stockholders Equity and StockBased Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://ltbr.com/role/StockholdersEquityAndStockbasedCompensation</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>995460 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://ltbr.com/role/SegmentReporting</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>995461 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails</Role>
      <ShortName>Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>995462 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative</Role>
      <ShortName>Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>995463 - Disclosure - Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/NetLossPerShareDetails</Role>
      <ShortName>Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://ltbr.com/role/NetLossPerShareTables</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>995464 - Disclosure - Prepaid Project Costs and Other Long-term Assets (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative</Role>
      <ShortName>Prepaid Project Costs and Other Long-term Assets (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>995465 - Disclosure - Accounts Payable and Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails</Role>
      <ShortName>Accounts Payable and Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesTables</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>995466 - Disclosure - Commitments and Contingencies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>Commitments and Contingencies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://ltbr.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>995467 - Disclosure - Research and Development Cost (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/ResearchAndDevelopmentCostDetailsNarrative</Role>
      <ShortName>Research and Development Cost (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://ltbr.com/role/ResearchAndDevelopmentCosts</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>995468 - Disclosure - Stockholders Equity and StockBased Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails</Role>
      <ShortName>Stockholders Equity and StockBased Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>995469 - Disclosure - Stockholders Equity and StockBased Compensation (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1</Role>
      <ShortName>Stockholders Equity and StockBased Compensation (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>995470 - Disclosure - Stockholders Equity and StockBased Compensation (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2</Role>
      <ShortName>Stockholders Equity and StockBased Compensation (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>995471 - Disclosure - Stockholders Equity and StockBased Compensation (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails3</Role>
      <ShortName>Stockholders Equity and StockBased Compensation (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>995472 - Disclosure - Stockholders Equity and StockBased Compensation (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative</Role>
      <ShortName>Stockholders Equity and StockBased Compensation (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>995473 - Disclosure - Segment Reporting (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/SegmentReportingDetails</Role>
      <ShortName>Segment Reporting (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://ltbr.com/role/SegmentReportingTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>995474 - Disclosure - Subsequent Events (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>Subsequent Events (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://ltbr.com/role/SubsequentEvents</ParentRole>
      <Position>36</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>ltbr-20250331.xsd</File>
    <File>ltbr-20250331_cal.xml</File>
    <File>ltbr-20250331_def.xml</File>
    <File>ltbr-20250331_lab.xml</File>
    <File>ltbr-20250331_pre.xml</File>
    <File doctype="10-Q" isDefinitelyFs="true" isUsgaap="true" original="ltbr_10q.htm">ltbr_10q.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="328">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="31">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>66
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ltbr_10q.htm": {
   "nsprefix": "ltbr",
   "nsuri": "http://ltbr.com/20250331",
   "dts": {
    "schema": {
     "local": [
      "ltbr-20250331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/currency/2024/currency-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/exch/2024/exch-2024.xsd",
      "https://xbrl.sec.gov/naics/2024/naics-2024.xsd",
      "https://xbrl.sec.gov/sic/2024/sic-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "ltbr-20250331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "ltbr-20250331_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "ltbr-20250331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ltbr-20250331_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "ltbr_10q.htm"
     ]
    }
   },
   "keyStandard": 161,
   "keyCustom": 82,
   "axisStandard": 13,
   "axisCustom": 0,
   "memberStandard": 8,
   "memberCustom": 27,
   "hidden": {
    "total": 25,
    "http://fasb.org/us-gaap/2024": 16,
    "http://xbrl.sec.gov/dei/2024": 5,
    "http://xbrl.sec.gov/ecd/2024": 4
   },
   "contextCount": 104,
   "entityCount": 1,
   "segmentCount": 35,
   "elementCount": 338,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 328,
    "http://xbrl.sec.gov/dei/2024": 31,
    "http://xbrl.sec.gov/ecd/2024": 4
   },
   "report": {
    "R1": {
     "role": "http://ltbr.com/role/Cover",
     "longName": "000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "strong",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "strong",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://ltbr.com/role/ConsolidatedBalanceSheets",
     "longName": "110200 - Statement - CONSOLIDATED BALANCE SHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "AsOf2025-03-31",
      "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-03-31",
      "name": "us-gaap:AssetsCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://ltbr.com/role/ConsolidatedBalanceSheetsParenthetical",
     "longName": "110201 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "AsOf2025-03-31",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-03-31",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://ltbr.com/role/ConsolidatedStatementsOfOperations",
     "longName": "124100 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:GeneralAndAdministrativeExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://ltbr.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity",
     "longName": "148600 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY",
     "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31_us-gaap_CommonStockMember",
      "name": "us-gaap:SharesIssued",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31_us-gaap_CommonStockMember",
      "name": "us-gaap:SharesIssued",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://ltbr.com/role/ConsolidatedStatementsOfCashFlows",
     "longName": "170000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "ltbr:TrdArrIndNameOne",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "ltbr:TrdArrIndNameOne",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements",
     "longName": "995446 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements",
     "shortName": "Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://ltbr.com/role/NetLossPerShare",
     "longName": "995447 - Disclosure - Net Loss Per Share",
     "shortName": "Net Loss Per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongtermAssets",
     "longName": "995448 - Disclosure - Prepaid Project Costs and Other Longterm Assets",
     "shortName": "Prepaid Project Costs and Other Longterm Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "ltbr:PrepaidProjectCostsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "ltbr:PrepaidProjectCostsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://ltbr.com/role/AccountsPayableAndAccruedLiabilities",
     "longName": "995449 - Disclosure - Accounts Payable and Accrued Liabilities",
     "shortName": "Accounts Payable and Accrued Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://ltbr.com/role/CommitmentsAndContingencies",
     "longName": "995450 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://ltbr.com/role/ResearchAndDevelopmentCosts",
     "longName": "995451 - Disclosure - Research and Development Costs",
     "shortName": "Research and Development Costs",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensation",
     "longName": "995452 - Disclosure - Stockholders Equity and StockBased Compensation",
     "shortName": "Stockholders Equity and StockBased Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://ltbr.com/role/SegmentReporting",
     "longName": "995453 - Disclosure - Segment Reporting",
     "shortName": "Segment Reporting",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://ltbr.com/role/SubsequentEvents",
     "longName": "995454 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://ltbr.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperationsPolicies",
     "longName": "995455 - Disclosure - Basis of Presentation Summary of Significant Accounting Policies and Nature of Operations (Policies)",
     "shortName": "Basis of Presentation Summary of Significant Accounting Policies and Nature of Operations (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "17",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:FairValueOfFinancialInstrumentsPolicy",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:FairValueOfFinancialInstrumentsPolicy",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://ltbr.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperationsTables",
     "longName": "995456 - Disclosure - Basis of Presentation Summary of Significant Accounting Policies and Nature of Operations (Tables)",
     "shortName": "Basis of Presentation Summary of Significant Accounting Policies and Nature of Operations (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "18",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://ltbr.com/role/NetLossPerShareTables",
     "longName": "995457 - Disclosure - Net Loss Per Share (Tables)",
     "shortName": "Net Loss Per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "19",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesTables",
     "longName": "995458 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)",
     "shortName": "Accounts Payable and Accrued Liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "20",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables",
     "longName": "995459 - Disclosure - Stockholders Equity and StockBased Compensation (Tables)",
     "shortName": "Stockholders Equity and StockBased Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "21",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://ltbr.com/role/SegmentReportingTables",
     "longName": "995460 - Disclosure - Segment Reporting (Tables)",
     "shortName": "Segment Reporting (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "22",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails",
     "longName": "995461 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details)",
     "shortName": "Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "23",
     "firstAnchor": {
      "contextRef": "AsOf2025-03-31",
      "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-03-31_ltbr_TreasuryBillsLevelTwoMember",
      "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "unique": true
     }
    },
    "R24": {
     "role": "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative",
     "longName": "995462 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details Narrative)",
     "shortName": "Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "24",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "ltbr:InvestmentsInDebtSecuritiesPurchased",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "ltbr:InvestmentsInDebtSecuritiesPurchased",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://ltbr.com/role/NetLossPerShareDetails",
     "longName": "995463 - Disclosure - Net Loss Per Share (Details)",
     "shortName": "Net Loss Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "25",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "unique": true
     }
    },
    "R26": {
     "role": "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative",
     "longName": "995464 - Disclosure - Prepaid Project Costs and Other Long-term Assets (Details Narrative)",
     "shortName": "Prepaid Project Costs and Other Long-term Assets (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "26",
     "firstAnchor": {
      "contextRef": "AsOf2025-03-31",
      "name": "ltbr:AdditionalPrepaidExpenseAndOtherAssetsCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "ltbr:PrepaidProjectCostsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-03-31",
      "name": "ltbr:AdditionalPrepaidExpenseAndOtherAssetsCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "ltbr:PrepaidProjectCostsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails",
     "longName": "995465 - Disclosure - Accounts Payable and Accrued Liabilities (Details)",
     "shortName": "Accounts Payable and Accrued Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "27",
     "firstAnchor": {
      "contextRef": "AsOf2025-03-31",
      "name": "us-gaap:AccountsPayableTradeCurrentAndNoncurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-03-31",
      "name": "us-gaap:AccountsPayableTradeCurrentAndNoncurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative",
     "longName": "995466 - Disclosure - Commitments and Contingencies (Details Narrative)",
     "shortName": "Commitments and Contingencies (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "28",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:OperatingLeaseExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:OperatingLeaseExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://ltbr.com/role/ResearchAndDevelopmentCostDetailsNarrative",
     "longName": "995467 - Disclosure - Research and Development Cost (Details Narrative)",
     "shortName": "Research and Development Cost (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "29",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:OtherResearchAndDevelopmentExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:OtherResearchAndDevelopmentExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails",
     "longName": "995468 - Disclosure - Stockholders Equity and StockBased Compensation (Details)",
     "shortName": "Stockholders Equity and StockBased Compensation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "30",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1",
     "longName": "995469 - Disclosure - Stockholders Equity and StockBased Compensation (Details 1)",
     "shortName": "Stockholders Equity and StockBased Compensation (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "31",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2",
     "longName": "995470 - Disclosure - Stockholders Equity and StockBased Compensation (Details 2)",
     "shortName": "Stockholders Equity and StockBased Compensation (Details 2)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "32",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-31_ltbr_RestrictedStockAwardMember",
      "name": "ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ltbr:ScheduleOfOutstandingRSATableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "unique": true
     }
    },
    "R33": {
     "role": "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails3",
     "longName": "995471 - Disclosure - Stockholders Equity and StockBased Compensation (Details 3)",
     "shortName": "Stockholders Equity and StockBased Compensation (Details 3)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "33",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31_us-gaap_ResearchAndDevelopmentExpenseMember",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "unique": true
     }
    },
    "R34": {
     "role": "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative",
     "longName": "995472 - Disclosure - Stockholders Equity and StockBased Compensation (Details Narrative)",
     "shortName": "Stockholders Equity and StockBased Compensation (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "unique": true
     }
    },
    "R35": {
     "role": "http://ltbr.com/role/SegmentReportingDetails",
     "longName": "995473 - Disclosure - Segment Reporting (Details)",
     "shortName": "Segment Reporting (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31_ltbr_CODMMember",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "unique": true
     }
    },
    "R36": {
     "role": "http://ltbr.com/role/SubsequentEventsDetailsNarrative",
     "longName": "995474 - Disclosure - Subsequent Events (Details Narrative)",
     "shortName": "Subsequent Events (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "AsOf2025-03-31",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-05-12_us-gaap_SubsequentEventMember",
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable and accrued liabilities",
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r27"
     ]
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails",
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts Payable and Accrued Liabilities",
        "label": "[Accounts Payable and Accrued Liabilities]",
        "terseLabel": "Total",
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r60"
     ]
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable and Accrued Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "presentation": [
      "http://ltbr.com/role/AccountsPayableAndAccruedLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts Payable and Accrued Liabilities",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r27",
      "r29",
      "r577"
     ]
    },
    "us-gaap_AccountsPayableTradeCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableTradeCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade payables",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "us-gaap_AccruedBonusesCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedBonusesCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued bonus",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "us-gaap_AccruedLiabilitiesAndOtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedLiabilitiesAndOtherLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued payroll taxes and professional fees",
        "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_AccruedResearchAndDevelopmentExpensesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "AccruedResearchAndDevelopmentExpensesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued research and development expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional paid-in capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r485",
      "r625"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-In Capital",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r383",
      "r525",
      "r526",
      "r527",
      "r528",
      "r579",
      "r627"
     ]
    },
    "ltbr_AdditionalPrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "AdditionalPrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aditional advance payments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock-based compensation",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r18",
      "r228"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/SegmentReportingDetails",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total stock-based compensation expense",
        "verboseLabel": "Allocated employee compensation and stock-based compensation",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r255",
      "r256"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_ArticlesOfIncorporationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "ArticlesOfIncorporationMember",
     "presentation": [
      "http://ltbr.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Articles of Incorporation [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://ltbr.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Assets",
        "label": "[Assets]",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r67",
      "r77",
      "r98",
      "r125",
      "r133",
      "r141",
      "r144",
      "r182",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r274",
      "r278",
      "r295",
      "r347",
      "r415",
      "r463",
      "r464",
      "r485",
      "r502",
      "r547",
      "r548",
      "r589"
     ]
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Current Assets",
        "label": "[Assets, Current]",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r81",
      "r98",
      "r182",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r274",
      "r278",
      "r295",
      "r485",
      "r547",
      "r548",
      "r589"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Assets"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_AvailableForSaleSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "AvailableForSaleSecuritiesMember",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Available for sale Securities [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative",
      "http://ltbr.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type Axis",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254"
     ]
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BalanceSheetLocationAxis",
     "presentation": [
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Location Axis",
        "documentation": "Information by location in statement of financial position where disaggregated cumulative balance has been reported."
       }
      }
     },
     "auth_ref": [
      "r197",
      "r593",
      "r594"
     ]
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BalanceSheetLocationDomain",
     "presentation": [
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in statement of financial position where disaggregated cumulative balance has been reported."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r22",
      "r197",
      "r593",
      "r594"
     ]
    },
    "ltbr_BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations",
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Presentation Summary of Significant Accounting Policies and Nature of Operations (Policies)"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_BattelleEnergyAllianceLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "BattelleEnergyAllianceLLCMember",
     "presentation": [
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative",
      "http://ltbr.com/role/ResearchAndDevelopmentCostDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Battelle Energy Alliance, LLC (BEA) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_BoardOfDirectorsChairmanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "BoardOfDirectorsChairmanMember",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Board of Directors Chairman [Member]"
       }
      }
     },
     "auth_ref": [
      "r536"
     ]
    },
    "ltbr_BoardOfDirectorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "BoardOfDirectorsMember",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Board of Directors [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_BottomMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "BottomMember",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative",
      "http://ltbr.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum",
        "verboseLabel": "Bottom"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_CANDUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "CANDUMember",
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCostDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Canada Deuterium Uranium (CANDU)"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_CODMMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "CODMMember",
     "presentation": [
      "http://ltbr.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CODM"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_CRADAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "CRADAMember",
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCostDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CRADA"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Cash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Cash",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r349",
      "r394",
      "r410",
      "r485",
      "r502",
      "r519"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/ConsolidatedBalanceSheets",
      "http://ltbr.com/role/ConsolidatedStatementsOfCashFlows",
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "periodStartLabel": "Cash and Cash Equivalents, Beginning of Period",
        "periodEndLabel": "Cash and Cash Equivalents, End of Period",
        "verboseLabel": "Cash and cash equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r44",
      "r96"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Increase (Decrease) in Cash and Cash Equivalents",
        "label": "[Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect]",
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r44"
     ]
    },
    "ltbr_CashPaidDuringThePeriodAbstract": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "CashPaidDuringThePeriodAbstract",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash paid during the period:"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_CentrusEnergyFeedStudy": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "CentrusEnergyFeedStudy",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Centrus Energy FEED study"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r78",
      "r79",
      "r80",
      "r98",
      "r115",
      "r116",
      "r118",
      "r120",
      "r127",
      "r128",
      "r182",
      "r201",
      "r203",
      "r204",
      "r205",
      "r208",
      "r209",
      "r212",
      "r213",
      "r215",
      "r218",
      "r225",
      "r295",
      "r377",
      "r378",
      "r379",
      "r380",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r395",
      "r402",
      "r424",
      "r442",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r511",
      "r523",
      "r529"
     ]
    },
    "ltbr_CommitmentsAndContingenciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "CommitmentsAndContingenciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and contingencies - Note 5"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://ltbr.com/role/CommitmentsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r199",
      "r200",
      "r454",
      "r543",
      "r544"
     ]
    },
    "ltbr_CommonShareIssuancesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "CommonShareIssuancesMember",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Share Issuances [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_CommonSharesEquityGrantPricePerShares": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "CommonSharesEquityGrantPricePerShares",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common shares equity grant price per shares"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_CommonSharesIssuancesEquityGrant": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "CommonSharesIssuancesEquityGrant",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common shares issuances equity grant value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total number of common stock available for future issuance",
        "documentation": "Aggregate number of common shares reserved for future issuance."
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "ltbr_CommonStockEquivalentsOutstandingShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "CommonStockEquivalentsOutstandingShares",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding shares of common stock and ommon stock equivalents"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r492",
      "r493",
      "r494",
      "r496",
      "r497",
      "r498",
      "r499",
      "r525",
      "r526",
      "r528",
      "r579",
      "r624",
      "r627"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares Par Value",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "ltbr_CommonStockShareOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "CommonStockShareOutstanding",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common Stock, Shares Outstanding",
        "label": "[Common Stock, Shares Outstanding]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative",
      "http://ltbr.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares Authorized",
        "verboseLabel": "Common Stock, Shares Authorized",
        "terseLabel": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r402"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares Issued",
        "verboseLabel": "Common Stock, Shares Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r32",
      "r402",
      "r421",
      "r627",
      "r628"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, $0.001 par value, 25,000,000 authorized, 21,557,343 shares and 18,783,912 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r351",
      "r485"
     ]
    },
    "ltbr_CommonStockValuedGrantDatePricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "CommonStockValuedGrantDatePricePerShare",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, valued grant date price per share"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://ltbr.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperationsPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Certain Risks and Uncertainties",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r70"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_DescriptionOfEquityIncentivePlan": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "DescriptionOfEquityIncentivePlan",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of Equity incentive plan"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_DescriptionOfRSAsModificationAndNetShareSettlementsForPaymentsOfWithholdingTaxes": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "DescriptionOfRSAsModificationAndNetShareSettlementsForPaymentsOfWithholdingTaxes",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RSAs Modification and Net Share Settlements for Payments of Withholding Taxes, Description"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_DescriptionOfSubscriptionAndInvestmentRepresentationAgreement": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "DescriptionOfSubscriptionAndInvestmentRepresentationAgreement",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of subscription and investment representation agreement"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r506"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r507"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Loss Per Common Share"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic and diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r104",
      "r105",
      "r106",
      "r107",
      "r108",
      "r109",
      "r115",
      "r118",
      "r119",
      "r120",
      "r124",
      "r269",
      "r272",
      "r289",
      "r290",
      "r345",
      "r360",
      "r458"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://ltbr.com/role/NetLossPerShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net Loss Per Share",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r121",
      "r122",
      "r123"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized compensation cost related to option awards",
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r576"
     ]
    },
    "us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOwnershipPlanESOPCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation cost recognized",
        "documentation": "The amount of plan compensation cost recognized during the period."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Address Line 1",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Address Line 2",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address City Or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address State Or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r504"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r504"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r504"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r510"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r504"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r504"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r504"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r504"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders Equity and StockBased Compensation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r73",
      "r84",
      "r85",
      "r86",
      "r99",
      "r100",
      "r101",
      "r103",
      "r108",
      "r110",
      "r112",
      "r126",
      "r183",
      "r184",
      "r195",
      "r226",
      "r263",
      "r264",
      "r266",
      "r267",
      "r268",
      "r270",
      "r271",
      "r272",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r288",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r303",
      "r304",
      "r307",
      "r358",
      "r371",
      "r372",
      "r373",
      "r383",
      "r442"
     ]
    },
    "ltbr_EquityGrantValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "EquityGrantValue",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity grant approved by board of directors"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityInterestIssuedOrIssuableByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityInterestIssuedOrIssuableByTypeAxis",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Interest Type [Axis]",
        "documentation": "Information by type of equity interests that are issued or issuable in a business combination."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityInterestIssuedOrIssuableTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityInterestIssuedOrIssuableTypeDomain",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of equity interest issued or issuable to acquire an entity in a business combination."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "ltbr_FEEdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "FEEdMember",
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCostDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Front-end engineering and design (FEED)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://ltbr.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperationsPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value of Financial Instruments",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instrument Axis",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r210",
      "r223",
      "r286",
      "r294",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r359",
      "r468",
      "r475",
      "r476",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r486",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r537",
      "r538",
      "r539",
      "r540",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trademarks",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r344",
      "r542"
     ]
    },
    "ltbr_FutureIssuanceOfShare": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "FutureIssuanceOfShare",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock available for future issuance"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and administrative",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r426"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General And Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "ltbr_INLMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "INLMember",
     "presentation": [
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative",
      "http://ltbr.com/role/ResearchAndDevelopmentCostDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Idaho National Laboratory (INL)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Loss Before Income Taxes",
        "label": "[Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest]",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r62",
      "r66",
      "r346",
      "r355",
      "r459",
      "r463",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "CONSOLIDATED STATEMENTS OF OPERATIONS"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement Location Axis",
        "documentation": "Information by location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r196",
      "r197",
      "r198",
      "r291",
      "r292",
      "r293",
      "r369",
      "r370",
      "r427",
      "r456",
      "r477",
      "r595"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r197",
      "r198",
      "r291",
      "r292",
      "r293",
      "r369",
      "r370",
      "r427",
      "r456",
      "r477",
      "r595"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income taxes",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r71",
      "r111",
      "r112",
      "r125",
      "r136",
      "r144",
      "r259",
      "r260",
      "r265",
      "r361",
      "r472"
     ]
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxesPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income taxes paid",
        "documentation": "Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r95",
      "r261",
      "r262"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable and accrued liabilities",
        "label": "[Increase (Decrease) in Accounts Payable and Accrued Liabilities]",
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in operating assets and liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpensesOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInPrepaidExpensesOther",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses and other current assets",
        "label": "[Increase (Decrease) in Prepaid Expenses, Other]",
        "documentation": "Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid project costs and other long-term assets",
        "label": "[Prepaid project costs and other long-term assets]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_InlProject": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "InlProject",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "INL Project"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r508"
     ]
    },
    "us-gaap_IntercompanyAgreementsDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntercompanyAgreementsDescription",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ATM Agreement amendment, description",
        "documentation": "Description of product support, consulting, business, or other advisory service agreements entered into between the managing member or general partner and the LLC or LP, affiliate of the managing member or general partner, or affiliate of the LLC or LP. Includes a description of the key provisions of such agreements and the amount of compensation for such services during the accounting period."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "us-gaap_InterestIncomeOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestIncomeOther",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest income",
        "documentation": "Amount of interest income earned from interest bearing assets classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest paid",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r93",
      "r94"
     ]
    },
    "ltbr_InvestmentsInDebtSecuritiesPurchased": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "InvestmentsInDebtSecuritiesPurchased",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "US Treasury instruments purchased"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_LeasePaymentUnderNonCancellableOperatingLeases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "LeasePaymentUnderNonCancellableOperatingLeases",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Future minimum lease payments required under the non-cancellable operating leases"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_LesseeOperatingLeaseTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "LesseeOperatingLeaseTerm",
     "presentation": [
      "http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease Term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://ltbr.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities and Stockholders' Equity",
        "label": "[Liabilities and Equity]",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r61",
      "r353",
      "r485",
      "r524",
      "r541",
      "r586"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Current Liabilities",
        "label": "[Liabilities, Current]",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r76",
      "r98",
      "r182",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r275",
      "r278",
      "r279",
      "r295",
      "r485",
      "r547",
      "r589",
      "r590"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_MarketOfferingsDisclosureDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "MarketOfferingsDisclosureDescription",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description related to ATM offerings"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_MaxiimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "MaxiimumMember",
     "presentation": [
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maxiimum [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_MiniimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "MiniimumMember",
     "presentation": [
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Miniimum [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Cash Provided by Financing Activities",
        "label": "[Net Cash Provided by (Used in) Financing Activities]",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Used in Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://ltbr.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Cash Used in Operating Activities",
        "label": "[Net Cash Provided by (Used in) Operating Activities]",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r45",
      "r46"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity",
      "http://ltbr.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Loss",
        "label": "[Net Income (Loss) Attributable to Parent]",
        "verboseLabel": "Net loss for the three months ended March 31, 2024",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r46",
      "r63",
      "r74",
      "r82",
      "r83",
      "r86",
      "r98",
      "r102",
      "r104",
      "r105",
      "r106",
      "r107",
      "r108",
      "r111",
      "r112",
      "r117",
      "r182",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r269",
      "r272",
      "r290",
      "r295",
      "r357",
      "r423",
      "r440",
      "r441",
      "r500",
      "r547"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://ltbr.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperationsPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recent Adopted Pronouncements",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Rule 10b5-1 Arragement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r509"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ASSETS",
        "verboseLabel": "Non Rule 10b5-1 Arragement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r509"
     ]
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Cash Financing Activities:"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_OffsetOfProjectCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "OffsetOfProjectCosts",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset of Project Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfOperations",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Operating Expenses",
        "label": "[Operating Expenses]",
        "verboseLabel": "Consulting expense",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating Loss",
        "label": "[Operating Income (Loss)]",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r459",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535"
     ]
    },
    "us-gaap_OperatingLeaseExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseExpense",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Rent Expense",
        "documentation": "Amount of operating lease expense. Excludes sublease income."
       }
      }
     },
     "auth_ref": [
      "r587"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease Monthly Payment",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r305",
      "r306"
     ]
    },
    "ltbr_OperatingNetIncomeLossFromSegmentsToConsolidated": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "OperatingNetIncomeLossFromSegmentsToConsolidated",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net loss"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_OptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "OptionsMember",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
     "presentation": [
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements",
        "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r48",
      "r49",
      "r57"
     ]
    },
    "us-gaap_OtherAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsAbstract",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherExpenses",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other outside R&amp;D expenses",
        "documentation": "Amount of expense classified as other."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r41"
     ]
    },
    "us-gaap_OtherGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "General and administrative",
        "label": "[Other General and Administrative Expense]",
        "documentation": "Amount of general and administrative expense classified as other."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r626"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Other Income",
        "label": "[Other Nonoperating Income (Expense)]",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherResearchAndDevelopmentExpense",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCostDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other research and development expenses",
        "documentation": "Amount of other research and development expense."
       }
      }
     },
     "auth_ref": [
      "r578"
     ]
    },
    "ltbr_OtherSegmentsItem": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "OtherSegmentsItem",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other segments item (1)"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_PaymentOfAccruedLiabilitiesWithCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "PaymentOfAccruedLiabilitiesWithCommonStock",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payment of accrued liabilities with common stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForRepurchaseOfInitialPublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForRepurchaseOfInitialPublicOffering",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering price, ATM",
        "documentation": "The cash outflow associated with the repurchase of amount received from entity's first offering of stock to the public."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments for taxes related to net share settlement of equity awards",
        "label": "[Payment, Tax Withholding, Share-Based Payment Arrangement]",
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "ltbr_PaymentsToResearchAndDevelopmentCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "PaymentsToResearchAndDevelopmentCost",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCostDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final payment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative",
      "http://ltbr.com/role/ResearchAndDevelopmentCostDetailsNarrative",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative",
      "http://ltbr.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative",
      "http://ltbr.com/role/ResearchAndDevelopmentCostDetailsNarrative",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative",
      "http://ltbr.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Par Value",
        "verboseLabel": "Preferred Stock, par value",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r212"
     ]
    },
    "us-gaap_PreferredStockRedemptionAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockRedemptionAmount",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Redemption Price of Preferred Stock",
        "documentation": "The redemption (or callable) amount of currently redeemable preferred stock. Includes amounts representing dividends not currently declared or paid but which will be payable under the redemption features or for which ultimate payment is solely within the control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r30"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r402"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r212"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r402",
      "r421",
      "r627",
      "r628"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, $0.001 par value, 10,000,000 authorized shares, 1 share and 0 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r350",
      "r485"
     ]
    },
    "ltbr_PreferredStockVotingRightsShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "PreferredStockVotingRightsShares",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock voting rights shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssets",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid project costs and other long-term assets",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/ConsolidatedBalanceSheets",
      "http://ltbr.com/role/ResearchAndDevelopmentCostDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses and other current assets",
        "verboseLabel": "Advance Payment Made",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r521"
     ]
    },
    "ltbr_PrepaidExpenseAndOtherCurrentAssetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "PrepaidExpenseAndOtherCurrentAssetMember",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Prepaid Expenses And Other Current Assets [Member]",
        "label": "[Prepaid Expenses And Other Current Assets [Member]]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseNoncurrent",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid project costs",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r520"
     ]
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "presentation": [
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expenses And Other Current Assets [Member]",
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets."
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_PrepaidExpensesCurrentAndLongTermAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "PrepaidExpensesCurrentAndLongTermAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Project Costs and Other Longterm Assets"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_PrepaidProjectCostsAddition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "PrepaidProjectCostsAddition",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid project costs- addition"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_PrepaidProjectCostsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "PrepaidProjectCostsDisclosureTextBlock",
     "presentation": [
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongtermAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Project Costs and Other Long-term Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net proceeds from the issuances of common stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ltbr_ProceedsFromStockIssuances": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "ProceedsFromStockIssuances",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative",
      "http://ltbr.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net proceeds from stock issuance under ATM",
        "verboseLabel": "Net proceeds from stock issuance under ATM"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfCashFlows",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net proceeds from the exercise of stock options",
        "verboseLabel": "Proceeds from stock option exercise",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r7"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative",
      "http://ltbr.com/role/ResearchAndDevelopmentCostDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product Or Service Axis"
       }
      }
     },
     "auth_ref": [
      "r147",
      "r343",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r457",
      "r470",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r545",
      "r546",
      "r549",
      "r592",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative",
      "http://ltbr.com/role/ResearchAndDevelopmentCostDetailsNarrative"
     ],
     "auth_ref": [
      "r147",
      "r343",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r457",
      "r470",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r545",
      "r546",
      "r549",
      "r592",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623"
     ]
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net Loss",
        "label": "[Net Income (Loss), Including Portion Attributable to Noncontrolling Interest]",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r82",
      "r83",
      "r91",
      "r98",
      "r102",
      "r108",
      "r111",
      "r112",
      "r182",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r269",
      "r272",
      "r273",
      "r276",
      "r277",
      "r290",
      "r295",
      "r346",
      "r356",
      "r382",
      "r423",
      "r440",
      "r441",
      "r473",
      "r474",
      "r501",
      "r522",
      "r547"
     ]
    },
    "ltbr_RSAFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "RSAFairValue",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of the RSAs vested"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative",
      "http://ltbr.com/role/ResearchAndDevelopmentCostDetailsNarrative",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r227",
      "r308",
      "r309",
      "r348",
      "r354",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r420",
      "r422",
      "r447"
     ]
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative",
      "http://ltbr.com/role/ResearchAndDevelopmentCostDetailsNarrative",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions By Related Party Axis",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r227",
      "r308",
      "r309",
      "r348",
      "r354",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r420",
      "r422",
      "r447",
      "r588"
     ]
    },
    "us-gaap_ReportingUnitAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReportingUnitAxis",
     "presentation": [
      "http://ltbr.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Unit Axis",
        "documentation": "Information by reporting unit."
       }
      }
     },
     "auth_ref": [
      "r193",
      "r194",
      "r469"
     ]
    },
    "us-gaap_ReportingUnitDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReportingUnitDomain",
     "presentation": [
      "http://ltbr.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Level of reporting at which goodwill is tested for impairment."
       }
      }
     },
     "auth_ref": [
      "r193",
      "r194",
      "r469"
     ]
    },
    "us-gaap_ResearchAndDevelopmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Costs"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_ResearchAndDevelopmentArrangementExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "ResearchAndDevelopmentArrangementExpense",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCostDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase in Estimated Cost Under R&amp;D Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_ResearchAndDevelopmentCostAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "ResearchAndDevelopmentCostAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Cost (Details Narrative)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfOperations",
      "http://ltbr.com/role/ResearchAndDevelopmentCostDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development",
        "verboseLabel": "Research and development expenses",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r257",
      "r456",
      "r463",
      "r591"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research And Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_ResearchAndDevelopmentExpenseNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "ResearchAndDevelopmentExpenseNet",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total research and development"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_ResearchAndDevelopmentExpensePayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "ResearchAndDevelopmentExpensePayable",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCostDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payable amount"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_ResearchAndDevelopmentPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "ResearchAndDevelopmentPercentage",
     "presentation": [
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of research and development expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCosts"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Research and Development Costs",
        "label": "Research, Development, and Computer Software Disclosure [Text Block]",
        "documentation": "The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r455"
     ]
    },
    "ltbr_RestrictedSharesAwardsIssuedAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "RestrictedSharesAwardsIssuedAmount",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted shares awards issued, amount"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_RestrictedSharesAwardsIssuedShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "RestrictedSharesAwardsIssuedShares",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted shares awards issued, shares"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_RestrictedStockAwardMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "RestrictedStockAwardMember",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock Award [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_RestrictedStockAwardsSummaryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "RestrictedStockAwardsSummaryMember",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RSA Summary 2025 and 2024 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings",
     "presentation": [
      "http://ltbr.com/role/NetLossPerShareDetails",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted stock awards outstanding",
        "verboseLabel": "Outstanding restricted stock awards",
        "documentation": "Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation."
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_RestrictedStockUnitsRSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "RestrictedStockUnitsRSAMember",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock Units R S A [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated deficit",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r53",
      "r352",
      "r374",
      "r375",
      "r381",
      "r403",
      "r485"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Deficit",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r99",
      "r100",
      "r101",
      "r103",
      "r108",
      "r110",
      "r112",
      "r183",
      "r184",
      "r195",
      "r263",
      "r264",
      "r266",
      "r267",
      "r268",
      "r270",
      "r271",
      "r272",
      "r280",
      "r282",
      "r283",
      "r285",
      "r288",
      "r303",
      "r304",
      "r371",
      "r373",
      "r383",
      "r627"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfOperations",
      "http://ltbr.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue",
        "verboseLabel": "Revenue",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r65",
      "r87",
      "r98",
      "r125",
      "r134",
      "r135",
      "r140",
      "r144",
      "r147",
      "r149",
      "r150",
      "r182",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r295",
      "r346",
      "r463",
      "r547"
     ]
    },
    "ltbr_RomaniaFeasibilityStudy": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "RomaniaFeasibilityStudy",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Romania feasibility study"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arragement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r509"
     ]
    },
    "ltbr_Rule10b51ArrAdoptedFourFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "Rule10b51ArrAdoptedFourFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted Four [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_Rule10b51ArrAdoptedOneFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "Rule10b51ArrAdoptedOneFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted One [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_Rule10b51ArrAdoptedThreeFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "Rule10b51ArrAdoptedThreeFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted Three [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_Rule10b51ArrAdoptedTwoFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "Rule10b51ArrAdoptedTwoFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted Two [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arragement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r509"
     ]
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative",
      "http://ltbr.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from sale of common stock, shares",
        "verboseLabel": "Proceeds from sale of common stock, shares",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://ltbr.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock price per share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of accounts payable and accrued liabilities",
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://ltbr.com/role/NetLossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of outstanding securities excluded from diluted weighted shares outstanding",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "presentation": [
      "http://ltbr.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperationsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of fair value of financial instruments",
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "ltbr_ScheduleOfOutstandingRSATableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "ScheduleOfOutstandingRSATableTextBlock",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of outstanding RSA"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://ltbr.com/role/SegmentReportingTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of summarizes the expense categories Segment Reporting",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r12",
      "r13"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of stock based compensation expense",
        "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r6",
      "r55"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Share-based Compensation, Stock Options, Activity",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r6",
      "r54"
     ]
    },
    "us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfStockOptionsRollForwardTableTextBlock",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of stock option",
        "documentation": "Tabular disclosure of the change in stock options."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r503"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r505"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://ltbr.com/role/SegmentReporting"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Segment Reporting",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r125",
      "r129",
      "r130",
      "r131",
      "r132",
      "r133",
      "r137",
      "r138",
      "r139",
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r150",
      "r460",
      "r461",
      "r462",
      "r463",
      "r465",
      "r466",
      "r467"
     ]
    },
    "ltbr_SeriesXPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "SeriesXPreferredStockMember",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series X Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfCashFlows",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock-based compensation",
        "label": "[Share-Based Payment Arrangement, Noncash Expense]",
        "terseLabel": "Stock-based compensation expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized compensation cost related to option awards vesting period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r471"
     ]
    },
    "ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding at beginning of period",
        "label": "[Outstanding at beginning of period]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Outstanding at end of period",
        "label": "[Outstanding at end of period]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock options vested",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r244"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend yield rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r252"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected volatility",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r251"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk free interest rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r253"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Options outstanding options, exercisable",
        "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number]",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r234"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Weighted Average Exercise Price Options, exercisable",
        "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price]",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r234"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options outstanding, Expired",
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements."
       }
      }
     },
     "auth_ref": [
      "r239"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options outstanding, Forfeited",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r238"
     ]
    },
    "ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares granted"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options outstanding, Granted",
        "verboseLabel": "Options outstanding, Granted",
        "documentation": "Net number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r557"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares, Granted",
        "verboseLabel": "Shares, Granted",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r236"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average fair value grant date, granted",
        "verboseLabel": "Weighted average fair value grant date, granted",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r246"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Options outstanding, Beginning of the period",
        "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number]",
        "periodEndLabel": "Options outstanding, End of the period",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r232",
      "r233"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease",
     "presentation": [
      "http://ltbr.com/role/NetLossPerShareDetails",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock options outstanding",
        "verboseLabel": "Stock options outstanding",
        "documentation": "The increase or decrease in number of shares reserved for issuance under stock option agreements awarded under the plan that validly exist and are outstanding, including vested options."
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted Average Exercise Price, Beginning of the period",
        "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price]",
        "periodEndLabel": "Weighted Average Exercise Price, End of the period",
        "verboseLabel": "Fair value of the Company's common stock per share",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r232",
      "r233"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Options vested and expected to vest, End of the period",
        "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number]",
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r249"
     ]
    },
    "ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Weighted Average Exercise Price, vested and expected to vest, End of the period",
        "label": "[Weighted Average Exercise Price, vested and expected to vest, End of the period]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of the Company's common stock per share"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative",
      "http://ltbr.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price Stock Options, Exercised",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r237"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price Stock Options, Expired",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired."
       }
      }
     },
     "auth_ref": [
      "r239"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price Stock Options, Forfeited",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r238"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price Stock Options, Granted",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r236"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise price lower range limit",
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharePrice",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Closing price per share - common stock",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected Life",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r250"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares, forfieted",
        "documentation": "Number of non-vested options forfeited."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average fair value grant date, forfeited",
        "documentation": "Weighted average grant-date fair value of non-vested options forfeited."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted average fair value grant date, beginning",
        "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price]",
        "periodEndLabel": "Weighted average fair value grant date, ending",
        "documentation": "Weighted average grant-date fair value of non-vested options outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total fair value",
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock."
       }
      }
     },
     "auth_ref": [
      "r247"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Shares, vested",
        "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares]",
        "verboseLabel": "Shares, vested",
        "documentation": "Number of options vested."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average fair value grant date, vested",
        "verboseLabel": "Weighted average grant date fair value",
        "documentation": "Weighted average grant-date fair value of options vested."
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life - Years Beginning"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermEndingFF": {
     "xbrltype": "durationItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermEndingFF",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life - Years Ending"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermOptionsExercisable": {
     "xbrltype": "durationItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermOptionsExercisable",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life - (Years) exercisable"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermVested": {
     "xbrltype": "durationItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermVested",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life - (Years) Vested and expected to vest"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "SharebasedCompensationSharesOptionsAggregateIntrinsicValueExercised",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options aggregate intrinsic value, Outstanding exercised"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "SharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options aggregate intrinsic value, forfeited"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "SharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options aggregate intrinsic value, granted"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOptionsExercisable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "SharebasedCompensationSharesOptionsAggregateIntrinsicValueOptionsExercisable",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options aggregate intrinsic value, Options exercisable"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Options aggregate intrinsic value, Outstanding beginning",
        "label": "[Options aggregate intrinsic value, Outstanding beginning]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Options aggregate intrinsic value, Outstanding ending",
        "label": "[Options aggregate intrinsic value, Outstanding ending 1]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVested": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "SharebasedCompensationSharesOptionsAggregateIntrinsicValueVested",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options aggregate intrinsic value, vested"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVestedAndExpectedToVest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "SharebasedCompensationSharesOptionsAggregateIntrinsicValueVestedAndExpectedToVest",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options aggregate intrinsic value, Vested and expected to vest"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "SharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Options aggregate intrinsic value, Outstanding ending",
        "label": "[Options aggregate intrinsic value, Outstanding ending]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesIssued",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance, shares",
        "label": "[Shares, Issued]",
        "periodEndLabel": "Balance, shares",
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share settlement for withholding taxes paid upon vesting of restricted stock awards, amount"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share settlement for withholding taxes paid upon vesting of restricted stock awards, shares"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued - registered offerings - net of offering costs of $155,686, amount"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued - registered offerings - net of offering costs of $155,686, shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Class Of Stock Axis",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r78",
      "r79",
      "r80",
      "r98",
      "r115",
      "r116",
      "r118",
      "r120",
      "r127",
      "r128",
      "r182",
      "r201",
      "r203",
      "r204",
      "r205",
      "r208",
      "r209",
      "r212",
      "r213",
      "r215",
      "r218",
      "r225",
      "r295",
      "r377",
      "r378",
      "r379",
      "r380",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r395",
      "r402",
      "r424",
      "r442",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r511",
      "r523",
      "r529"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r32",
      "r35",
      "r36",
      "r73",
      "r84",
      "r85",
      "r86",
      "r99",
      "r100",
      "r101",
      "r103",
      "r108",
      "r110",
      "r112",
      "r126",
      "r183",
      "r184",
      "r195",
      "r226",
      "r263",
      "r264",
      "r266",
      "r267",
      "r268",
      "r270",
      "r271",
      "r272",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r288",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r303",
      "r304",
      "r307",
      "r358",
      "r371",
      "r372",
      "r373",
      "r383",
      "r442"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity",
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails",
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative",
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative",
      "http://ltbr.com/role/ResearchAndDevelopmentCostDetailsNarrative",
      "http://ltbr.com/role/SegmentReportingDetails",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails3",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative",
      "http://ltbr.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r100",
      "r101",
      "r126",
      "r304",
      "r343",
      "r376",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r411",
      "r412",
      "r413",
      "r414",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r422",
      "r425",
      "r426",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r442",
      "r495"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "CONSOLIDATED STATEMENTS OF CASH FLOWS"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "CONSOLIDATED BALANCE SHEETS"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity",
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails",
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative",
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative",
      "http://ltbr.com/role/ResearchAndDevelopmentCostDetailsNarrative",
      "http://ltbr.com/role/SegmentReportingDetails",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails3",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative",
      "http://ltbr.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r100",
      "r101",
      "r126",
      "r151",
      "r304",
      "r343",
      "r376",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r411",
      "r412",
      "r413",
      "r414",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r422",
      "r425",
      "r426",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r442",
      "r495"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued to consultant &amp; directors for services, shares",
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesOther": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesOther",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares of common stock issued",
        "documentation": "Number of shares of stock issued attributable to transactions classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "presentation": [
      "http://ltbr.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted stock awards shares",
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r53"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued through the exercise of options, shares",
        "verboseLabel": "Proceeds from Stock options, shares",
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r31",
      "r32",
      "r53"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Options outstanding, Exercised",
        "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period]",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r31",
      "r32",
      "r53",
      "r237"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueIssuedForServices",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued to consultant &amp; directors for services, amount",
        "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock issuence cost",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r31",
      "r32",
      "r53",
      "r383",
      "r442",
      "r449",
      "r501"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted stock awards shares value",
        "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r31",
      "r32",
      "r53"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued through the exercise of options, amount",
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r31",
      "r32",
      "r53"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/ConsolidatedBalanceSheets",
      "http://ltbr.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Stockholders' Equity",
        "label": "[Equity, Attributable to Parent]",
        "periodStartLabel": "Balance, amount",
        "periodEndLabel": "Balance, amount",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r35",
      "r36",
      "r50",
      "r404",
      "r421",
      "r443",
      "r444",
      "r485",
      "r502",
      "r524",
      "r541",
      "r586",
      "r627"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity and Stock-Based Compensation",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r97",
      "r211",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r224",
      "r226",
      "r287",
      "r445",
      "r446",
      "r453"
     ]
    },
    "ltbr_StrategicPartnershipProjectAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "StrategicPartnershipProjectAgreementMember",
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCostDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Strategic Partnership Project Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://ltbr.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r302",
      "r311"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://ltbr.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type Axis",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r302",
      "r311"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://ltbr.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r302",
      "r311"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://ltbr.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Subsequent Events",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r310",
      "r312"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Disclosure of Cash Flow Information"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_TopMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "TopMember",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative",
      "http://ltbr.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum",
        "verboseLabel": "Top"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r210",
      "r223",
      "r286",
      "r294",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r359",
      "r475",
      "r476",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r486",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r537",
      "r538",
      "r539",
      "r540",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585"
     ]
    },
    "ltbr_TrdArrAdoptionDateFirst": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "TrdArrAdoptionDateFirst",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date, First"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_TrdArrAdoptionDateFourth": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "TrdArrAdoptionDateFourth",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date, Fourth"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_TrdArrAdoptionDateSecond": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "TrdArrAdoptionDateSecond",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date, Second"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_TrdArrAdoptionDateThird": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "TrdArrAdoptionDateThird",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date, Third"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_TrdArrExpirationDateFour": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "TrdArrExpirationDateFour",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date, Fourth"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_TrdArrExpirationDateOne": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "TrdArrExpirationDateOne",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date, First"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_TrdArrExpirationDateThree": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "TrdArrExpirationDateThree",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date, Third"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_TrdArrExpirationDateTwo": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "TrdArrExpirationDateTwo",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date, Second"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_TrdArrIndNameFourth": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "TrdArrIndNameFourth",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fourth Individual Name"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_TrdArrIndNameOne": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "TrdArrIndNameOne",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "First Individual Name"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_TrdArrIndNameThird": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "TrdArrIndNameThird",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Third Individual Name"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_TrdArrIndNameTwo": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "TrdArrIndNameTwo",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Second Individual Name"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_TrdArrIndTitleFour": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "TrdArrIndTitleFour",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fourth Individual Title"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_TrdArrIndTitleOne": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "TrdArrIndTitleOne",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "First Individual Title"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_TrdArrIndTitleThree": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "TrdArrIndTitleThree",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Third Individual Title"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_TrdArrIndTitleTwo": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "TrdArrIndTitleTwo",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Second Individual Title"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_TrdArrSecuritiesAggAvailAmtOne": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "TrdArrSecuritiesAggAvailAmtOne",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount, First"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_TrdArrSecuritiesAggAvailAmtThree": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "TrdArrSecuritiesAggAvailAmtThree",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount, Third"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_TrdArrSecuritiesAggAvailAmtTwo": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "TrdArrSecuritiesAggAvailAmtTwo",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount, Second"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_TreasuryBillsLevelOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "TreasuryBillsLevelOneMember",
     "presentation": [
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Level I"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_TreasuryBillsLevelThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "TreasuryBillsLevelThreeMember",
     "presentation": [
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Level III"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_TreasuryBillsLevelTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "TreasuryBillsLevelTwoMember",
     "presentation": [
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Level II"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_TwentyTwentyFiveTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "TwentyTwentyFiveTransactionsMember",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2025 Transactions [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_TwentyTwentyPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "TwentyTwentyPlanMember",
     "presentation": [
      "http://ltbr.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2020 Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_TwoThousandTwentyEquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250331",
     "localname": "TwoThousandTwentyEquityIncentivePlanMember",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2020 Equity Incentive Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VestingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VestingAxis",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting [Axis]",
        "documentation": "Information by vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575"
     ]
    },
    "us-gaap_VestingDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VestingDomain",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575"
     ]
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "presentation": [
      "http://ltbr.com/role/NetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total",
        "label": "[Weighted Average Number of Shares Outstanding, Diluted, Adjustment]",
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation."
       }
      }
     },
     "auth_ref": [
      "r530"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://ltbr.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Common Shares Outstanding",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r120"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-11"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-12"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-13"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "40",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480489/718-40-50-1"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "250",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/250/tableOfContent"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/275/tableOfContent"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/810/tableOfContent"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "210",
   "Topic": "946",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-20"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-2"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1A"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483041/730-20-50-1"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481444/860-30-45-1"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-21"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/985-20/tableOfContent"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479081/326-30-55-8"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "101",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r512": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r513": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r514": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r515": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r516": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r517": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r518": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r519": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r520": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r521": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r522": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r523": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r524": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r525": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r526": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r527": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r528": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r529": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r530": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r531": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r532": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r533": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r534": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r535": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r536": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r537": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r538": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r539": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r540": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r541": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r542": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r543": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r544": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r545": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r546": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r548": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r549": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r550": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r551": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r552": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r553": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r554": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r555": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r556": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r557": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r558": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r559": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r560": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r561": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r562": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r563": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r564": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r565": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r566": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r567": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r568": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r569": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r570": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r571": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r572": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r573": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r574": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r575": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r576": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r577": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "720",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483384/720-30-45-1"
  },
  "r578": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r579": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r580": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r581": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r582": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r583": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r584": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r585": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r586": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r587": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4"
  },
  "r588": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r589": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r590": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r591": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r593": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r594": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r595": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r596": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r597": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r598": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r599": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r600": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r601": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r602": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r603": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r604": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r605": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r606": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r607": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r608": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r609": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r610": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r611": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r612": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r613": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r614": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r615": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r616": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r617": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r618": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r619": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r620": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r621": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r622": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r623": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r624": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r625": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r628": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>67
<FILENAME>0001477932-25-003550-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001477932-25-003550-xbrl.zip
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M?^4!]"%GADRAV1-M7C5:[4:[V;[:#YHX,_YBN!@9KKD@')M\[1HVLC C<XH
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MOV=M#H4/-0@H?11O;6:@U)U\08^#T:]:>D,0BH+(D^ML"-CC[O4;$R\O["?
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M%:NH(G5H?NFVRO&28/,"KXB6U_:KLBV3YJ *O(BJY01>O]E_?7UU>?E!',M
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M\<6\'Q3Y!Q/"(;#>+/W'(QLX.'SB#/\#6\>SB(/ ^8.,.WJ 86!:8=*3:SX
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M84>'9\O>\W0SVB NYTHU-S]'.R%?\96J_AHTH/M&55JD+G=D6;USKD>8!S"
M<TJ'LR%WV&1RH9-LE4+"6'1%^]BQA_#=$@80M]%\97J3#0GPF6Q#&*)M+E44
M-']EU<_8 ] >J5-N3^Q06Z&@-I$Q*;^@ACB?:%26_9? A[S321>#Z:!.7=*O
MUG5/\"T<QXLD/3!(^H8,++#OMIC!DP5I*E*@UD?338-:9X#:VX2F--WY)+$Q
M2/Z^\8,%<'K4*FD$OB-%D^9)%W<EO:S<YV<JMU'G!88-4YUZ94BC2Y_AV+'?
M@+-<H=^C1Q"82T!6_2O$Z!O3";Z9[I;G3^T1!QW43P%;\M=>.N_GFVIBGXCH
MIHY]\B;)KJ>G8?RFVBI*(Z";#O;!DR3'H)ZZQ]S'#F&1KH'3=Z2A3=@4*^UY
MZZ>2 CW1.2A&<;1<!F")4!E[8>!XT+$(/I*NV^9]ZZ =+9*;N%[;]^#7PHTH
M(K,850O]OG[QIJ0FHFWU055]O*+5LG7))MV^?L$FE"9R;?>Q5VVTTC6E==%2
M/;]^Z5+$)@)NWR'8=+U@Y=%LJ_/7+^8LO8FD4W?=4 .$3\NB2H];BRH]W4>5
M[J-*7T-4Z=A#DPSLB):JC<0%TBKBE$N)XOA3!FZB,$ !V" B0B6T3DY0 PGT
M[$)4 PJ];%E<.N2>XKY8$Y72D )6OW64TMHJKRC;B;)L++M?@ <"T\6YK>TU
MXBH,HXS&DM*3!-=3?I+$)1)4%*$V<DF_P"Z_=1.^6I:%5R]#Z>VF+$GYT-2A
M'M!XR<L_G+1V4-NG,]\?V%[5@6V?-;C=K,&M)DFO*<=]UN"2K,%ZIG,>T*FM
MXZS!0TVKOG\G/;3PQ<&_<AV(-=V_D]96@P9D]E_Q.^G&BG;C>*9G.::[>Y_
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MF\$D()39Q%H@HT(T2U90;'AM!<8F27%2JTL3KCC!F>1;C;@>(=Q)Q9DK *W
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MKBH#$MK]QOGDLOD3HAOEL4>E7>;L%ROUHH/P:A&6R++5V)]"Y'?Z^HDQ>W@
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MP7/=4ER6;=TE1=#G<_$]"S<IB"2JLV@*^4B#%/)Y98ER=_02R&5R+X27-%B
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M\"OYPDMR(<BK_!X'6QF!JQQ%1GJ'TYJ98QV21'00F>T()/<W,"1Q'*9B-#[
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MG$^7LN**8Q@>]S18)NVQ3X/E_W"#?D)_3/^$_L'A(?_Q_P%02P,$%     @
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ML<YME:V$Q8.]+]CWZ7D9!HV[V'$[)N8:_)A; 8H#;Z\V.'HF9_R?HO!K\L+
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ML+XLO;8EO@A[0.0<(5>DJRU"KMP6(.1*RU()6U[ESSLSOU6()S Y"^L+]&&
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M1_E=A=?C<CQ9X,)-4'CUH>'4VV$48"(X/YD. 9J+>-0\UE)^R#YWLV:NU7<
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MGULZ;=]P6M8@O0JY@U%F4U5=J6BE*Y7]((MLE/V5RF(_$)_+E1-T#)<K-3V
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MX_'Q5DZ@;GY+>_4Z3TH,!1Y0L18][XA?(G*2;A'%KNI_4W_H^M23O)##5]5
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M0W4(7B7FWP,/D6DV2JC$3PF0M9#XA3,%;,,HMB]!@,_3F6K.%13(\#J08GA
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M)O</S/K608KCQ6?$-'Q@^/_&+6%8V%/)(>V!Y;FB2 )YT9T_S@3GY2.PIR6
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M_ALI79';+@*^=W^'?^MU'SMW[3[\(R1AKP\??(,]T8N03I!R!XL[2$?*]-I
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M=SVT\/10NC S2Q **<Z?#A>.H9J Y)&9&6Q@# +@3#@U];A)CMMY$N5]=):
M U?H<BW4_F@P,A.>F0_QF(Y->:#C^U7O"H0 >]4\MI0)-1CJ M$4PX@3<<3L
MP.*86K 8FT>^_5Y^_#M8D/C)/+1%'0PF3=&JPH\O;0JRRN985X,@J646X-F"
M[9DBIKD07&%C&OJ?'LB\5VH[,>-/O'H 2 !.=M"L2ULQ7[#Z+AUY8% X.\DK
MUAGWV'D4L ]WH2-8#$:YA31\P]97_+&458]&"\OF?G7R:\L<I<S$Y!\%'G.B
MM&%R@,4W#4"@R-T\<L'M2X "Z2[M;.9YPGK_]"S4:4RA.MP!?U_6P&<14;/K
M9>R15F6@58<3R!(;&RR#.(VXU4'CJL#W' *#([ N0-?I[%4:N!1#%PP,I*CI
M_\N/Z/D.?7PL?*VC3W4#O-E$VB]S3$EX1<C +._S61\N%!TK,0K;<MNE$-O'
MIX.A"F#H>X(N950!T68 WR-.>!!M L)X4]ZZBYN-GV.>P/*_\V2972?+-/)D
M&=\E%?Z@&F0N1C,4$KS%5J54*34O5OQV#_[D7G;]@V5'XMX8WIU9#D:'4PQS
M[G&$)@LWCG5;1)VX/YIJIW#K)JO%C(99@LELO;*8>JKI'/'#H^*).DXTG!>^
M>"CB@]PE]E"[B$FL,M%!&(*)BG;>[YXV#HX"I^J<AP%55@R9<H=E!AN8_RKB
M4*13Z.0.WP,^)'M9&&K7':&#\4B$'9E@RW"_$B7["XU6H@P.06?JG D8=EJX
M?&7 ]_=LFYV.J=/@Z!3?F?T]A)^.PD1!B7#K?D!)@IL*<QO0H>HY@1?E3,#A
M**#7)4+._ O+H5$J7/&"1Y%%LB&!(E,>$,;3#XOMG!'YWB/]1"=/?67'[+ZC
MI/D'294BSKA5A$_F"^?ML.>'$[8E_YJ6Y%VN;79QH&.^4A&.[YAW=."&YWW/
M_J@9T[L+]:6"X6 2PD @A"O+E8P): A#N(YIQ(I%\@F+Y#OBV$4<IY1.Z#P%
M6<[]0W9\RBTC%D=GD:-XB"/E3#%Y^S)A/<*@Y7O2[1(-=,X8YQ/ZYG$Z7Y.#
M!ZI+R8T',P2J>\,)U3R#=D=W\,I7=G(3"51WS)Y_HA2)9#];CHX$#Z+<:R18
M5BLU3:,7[UFY$4(8=.3NS.K=Z1V8?=\(G&C;KJ[MF^7AA8GR+B]%!(G<3$%U
MXB=!62IA[_V:4\[BC[$XY_$9\%A:)LMXNSA2R7[1?\BO>*YQQ;-<K:TJ0_\;
MFOJ_^1;V5S#O' ;7KDF_L=RE0U3_+M32W852ZZHEW;50J4:6%8>-37#8?[/D
MQ&&E<27?]62I1I85A\E-GM[#(889=H[$I#I)JV(G9UHR:5=Y1N_&$?.=MLY.
MJR6W%=G4\O"9],QYQ*^X+E2?N/5L&[85?/=DF4/^CVT8';FL/TX$EK=J<VP'
M@:<BY*4:658 5K9L;.007+(S%K,/#I*L<F9'/TLWF_9\^I.<UY$?JN31V/Q0
M)6=Q?JAR/CR6ELGYH<H)V_75>DK'5-9-^^@.5:K%/,!QG#A,[NK^#@[W<:AR
M*BZF5"-+BL):<J?S]U"8'ZGD1RJYW;'>3JMNU>XXX)%*\:HJW1Z3:F19$9B<
M3K2IQ9''LW, K@G C5RO_$CEHT<JT9![TB='?LSBQY7\0H,ONO,'OT'YW1SR
MS[BY(DU5IHTON]P"A &_O$(DKO/6IAJ@%/ZV<'%E;^5]89_"K[&*AJ;IHD3I
M" Q:48KV,RM<4/A#QTJ WHP5WWO55:+BO;J!;@:'7PZNBHZ!3EBIEI435<@8
M+YV:[ ;GV%;9);^PZ"LQ+!4+C8\\FQ45L$8CB@7FV,4[C(^Y\TA]%5;0$BLV
MB:?P(8T.W&@)%ET4=.)5%OED69E=CUT?Q+IQ[.(48BM:C/;RY;_4Z>S+W2=>
M\("_++BH"B_SITC-";OX*JK7S@SJTO5*V[+"O#,06-[P=(I%LVI*6#@+I",K
M:6 S*@75D&)@@Z>85\(K86+AOI%GL'N:_*86?H$U*H% B_6'=7;&BL5NL=8Q
MN]T?*T$$#+8\&ZM1J*^J;D3K-0D(\'?S<0)VQ)@7 $ 4TL5C64/\5(,I6Z+X
M&+^MC%=& 8Y8)47#JCN44':!V;^FO70<S*<A\!8;+5S&3-QN4X+2A;!**U*:
M/X@BC[!LS15I&X[%ZQH)BJ:=1D=HZ?/"\0:_XX1A>;RVAXGBSO(<0:@Q-7G=
M4P=[P\)[P_*0 SJW@HK0L;(6^%/;"FHWQ]X45#T155[](JA<]%!XUIJ"%$$(
MZ&*]P>_=J/^J *&P, *2##<C=?6P)*F_ED@Y;,%FX%*\("Y>* Y*OT<+<0^'
MK(8*D,:@*+UXU6URV>X_.)\440^<29V(G(N4<P7^,55F4X/5D!,7XWWF"QY%
MZP<_P ! Q&JS_$7QWV39<Z+.0&2\JD9JE@'\3@E$'E[0]5<^XV7)(W.-%+5E
MA<'4'UQ .7Z9-Z2.7R6/U2&;Z/0UK!\0N9;-JAR 2N;_\M<%A@]U7,O$HC#6
M&[QQ61HJ_D;081VZS0@'4[3'[#>)2^2%%3CVQX8UX'5M MP,55=%^V &Z"0P
M778S/*KHL,( F(;6 N9?55M'L$>T'Y;Z99:R$J"1#\LQY46-DE.1X-$J\M0<
MJV->HR):1F(][8G T5Y%&3 GM2X]*(B.IDXL[$'"J?^H#K""-J+^LO/T^.D*
M"_UFNV^N!!#$XJZF0QEJK"&OX,C$0F2&0L?0H-@9C.9O#E$6EFV['SK*>%!0
MZ7Y1<O?>!'N0^T@P4-P?8I?^7P1]P=.Y"ZG[#/L&FX2,:=2]Z3P]1/R;9]A)
M@8-3*%_<5)<O]O\M372XEHMEE:.$@YT ;XQO'^%Y&5@RST#R 0&08$BF4&:"
M$H*M[XL6*K*C$IL-M+'<I^[8WHP3DPDF5%V ''AQ,+] IT>%=K+H#6MTC]0A
MEU^:]6;BCHA)4RQ' =:JSNQ1"W<TK *H3\U00:)(F8"XHVR<X0=4OJ <B8K4
MR,Y8-@6N2&HEJ /X?6=="ZJ9UX):G?<75'PZ<A48K9+]?LNJP]3&3BN]L7&-
MZ"?Z%FE5%ELCKP_-_YM66V.G9UB][^3)ND*U7BE@(QYD#.]U3UBS>W+9!XTS
M)(UJ\=,UZ4S1/A;]!5"!!$^2N[ [!6.<PAL%@9.*=7_G3&0_M'M?49<$N;4X
M+.H_L(;&GLX[4PC?GS<9@I>#X1PM 2;"!7P* [0W38WK/A8?"!^$77Q9^D2<
M&6CS$3HZHJ8N#=I98" %BZE:YI"5GV8&\V7YDS\RUE&T'%%]5>Q+%A$)O;L!
M1946F2IJ19B$.AZ#(F3VD%_F6H,G@.Q#T4+"!G$D>MA<5CY%%RN,*AQ^ *[;
M2'=7S&!IM#D940T]"(6P'@%*=#QN:R#3F8DN:.DLD"TREQEO@\N8O?A>@"K^
M*_)Z\KL'GIBF#WW_&8S(L3#GA2G!9^#[0,P,9EH=RU\R4Y"WG^"U;Y&^("9-
M9NB@F ^14ZKY#2QP_"#@H5DS-\2;;U0!$&=85!@;A\3-+?9#,#\-_H, A-CI
M \-'B!XVMP'K)N=7>&;C, 'ML/J=09,#(-.B]8*N%[=:=%Y++'O3&SMP:2.]
M7T["%>J8('9> R%052+R@8N,B&3"_LPQR124*B(%T:@$$7(;:[\B'BV0>[&=
M[L)]@IQ;E%?DLN<-7";KRN5B@8D[''+A9[ ]EB8A1O#?(THJXP+$Y$5)Y:"%
M6A#RC.\[X>\",AQ1VC#PKUCGF:!!!PN8\8W"<2D$&F]*(QS[]UOHL9T00#YM
M*RX6I'Y_4]9%(=MH-Y&@5OG&;VU<D7L5>PA$-]_"MHXNAE? P[V-A2!%G6#4
M")%M;3 W(;FC&8?AB&W"Q;GR&;+*W0')--;^SF8*Q*;NXB H;9"HAL$+PP?O
M"MNL^"'41%Z=PJZ/2MX)"&7AN%(_Y,,+FV-S&49\A0P\E\G7.75#2BO1T%H0
M3>-1\+#%C> ?$MJV>&'"J!6"G:38F,$+"@YUV2O!NF>1E8EM>>.)8(F!WVBB
MPZ'[@4YY+*IC4:XW!NCCO])HY#Q -Q;]!#JQ6N+A*IG"2E<QF3:^B 2G:!9)
M_.&T?L,;6^$@/%"Z.,_4[DU4.[64W=XZ I>OR!/@^A%-3)@48;,ZJ5Y V()W
M"#]QN1T]P^TV4?FY$IXD> A [&7)C?<WYJ%3K:!B"'Q,\8ADP XL660;8^?X
M:]"&GLMV!-N3GNW_?KD%!?V!;>U$@PLWW'?^T8C'"H!2;>']D;@UO%-4 D61
MP<KQ&OS8X0I,"(.M8/L+9/WI]!%L3AB!B;S8$<S[I. $N"+/*3\3)6W]8"70
M@[M42P^R)A,8%/%F0KS0'WC$P,O'.JZ%9X.BL/K)Z*@H42/'WJ;%_3G#>HMV
M\/PA&N@%33HXYP-[41,P\;F?Q+K,M5Z9[!:.C\.[%D;.2=F$5&!XP4<.@(*F
M'?4@9JFS7.<T&$.T.&6'.;QD< P O%%4Q' -5&,* 3$B *:TZOJM#9@O)?8"
M:B'1=G)(TZ+H/C@1=WMTA-)"0M6/5V-M [=\9H7EA^\%J/"-MR&<NJ/L6BR_
M(7R45PMW4;1_Z6HARQ4DW[B8N4<QLUN[8VD"@<!9>;?QX!</<@A+>SL69:NL
M%V-S_FZ%OU59^2OGQ>=>U!B/FF"29M_O?6_L+F._7MS8$$0C[BLVFD SCYH.
ML_/:MHVG)>B1?9V'CSSSTY@V)GMU.9^[(9N?F<_705<.'KZC_,^,%YF*D3P7
M-J!S<5,MMY1J+;_$),G(NT=Q<KY]-8+BZO&AN%:K*;5F63H4[_BZZX:S#.\<
MB^".^L;BSM*JDW<L' EVZ!9LL/>W;FE3!10RG-D/?-=TV.')$W6[(_[!@V7W
MU1__U-W)Q#(0!%EK<B3MR$:UHC2*[^_(1 OOG"1^#O$HQ).#;1FTTP$@7JLU
ME'JS>100E].;Z6.^M-3[L (HURQO8%!I-^+2%+>S$S<^@_VG. )I\YC_$SO^
M$L=H?.M$+,&VAK'X:?9B#$D;L:24&A6E5*NOO14KN;8Y;Y37-M4W!T%YJ:*4
M&^^7.),!Y9EJ&A^DQG%:TLG:%]'93:-GF\Y477NV+<PFN,6LOC#K\.#I)Y4K
M(B9(Q S);9!XV&6Y48_!G<,VNQ5X4LDI'1//N,M*+%.81:%9*AZ>F;]91!W;
M5&1-L8MM[]RBP\M3&"@W^.?!-5D<XXYB"V>_R?.]2>TQ_.JN>P^_BERD7[SF
M#L^F7%V](FW^.*Z>I6/@-4)V.RQV(5.CP4VH()\;$PY$QME,</_-LO_@U]3P
M&#Z]V6X]N3Q).5J>Y*OJNB"Q*5]E6U0J>'R\32Y0(H H$FEW7H4IZ+X+9/=G
MZC/$GZM"8+;D\NM]^Q.G)S!J\7XWWI##&]CP6B0G_ \P<$4 6=_4.;O<$&<%
M[BR\S#>U--Z>G.4_A B#Z0!1J4@R]U]-V Z$[\1+6PIA6.;W_4)\:9X=*Y&N
MV[:J\6L-_G5!163FLJ":GRNTA(W!?!7WD^LQ5@K%&G)?</2W.$>=MJDQD>)7
MF6'BA&.! ^:;;NKZU)L> !^EE?A808GD-DL?IH3Z(X$2:0JE+>Y3;X42M51*
M7)&[,+GL3P_D&*O2D70W.$'V!%>^EZ &4$TG<&-E=YT89=K!&'%R^]3F9+[=
M(FJ6'8H -3S)W_$&#OW3XPG-UF@$$UBUUK5]*K;N+GMO=Q2%Q*Z%)F@X7V6P
MFPJ@AA@C%X& HF:IBX*2F-8U$X9([+WD#4N0K"!9<DU._PKX^OMOKU)G14]X
M)-P*L9/<9="O#B;YLM-%#*O"$ER92,Y%SV]B)_URFS>Q6_E-[)6>X,89GUEJ
M\$GD'5:O2%#?]CE2WU9,FCQ&Z]N>D%>8M:CO8@9]V+_HDL7+^76NH*/0]>%S
ME9/#6>OE*F? ,-NX>5;R 5+^(OEYZR>'A/EWYY7[F_,M,]^BMKP,K,O3MH\S
MK3=/VSYM_N9IV^LE.M@8)!/F9MXL8JTSVL;*YK/ON&",\#OK_5"1+N%4JI%E
M!51R3%\$UPX*J#R#.=LL_0A%:AU5&I3KD7)G'#JY9IN[*;F73^(!#N=:<G%6
M/XB]S?.;Y5,_"3ARCB/O'H4K.PCF*#P&(]D7Z@/+]'+!O?LMD]P"*]VN1N9\
M1=[LL)M:;E%+,O+.X==<V6WSH_ [J3Y6TIK?,W5N6X;!:^(R&WQF6R/J.*+U
M$85/)<%S?LTJ*OJ3TTM6B_[(^9^?:!+Y:$_27X:[5#F.9<%Q,SEY<+4.V0..
MW[?X9<"QG%[ <=X)W&:H<R\WGQK)"?X?2&S:D4]0NCJ."T\Y4'<#U&;Y ]%Z
MV5J!RP#4X[N9MW%6VZTUG>KL-A:J>LPR#3HG2I2&6;LBD8DR-RHVU9/*O61I
MP)BKX(_ GH(=)J[276->I6WH)C"@&]S >L3Z0$@(^*&?(7S\M(B6RC=PA1K>
M(<'*N$P(\ 8-)"W9LYFY4UXL_/T([CFE 6D99?O4GL8D8,&APVO-LUF18M#!
MY46!4&#?\%MKK";R_ZBFI]ISXI<7]BOK+UX.J8G>@;S^L3'WKPFQ4OBQ%H'I
MMR.:&PN$^+)%D:I-:H"@[+]I*L7BLG'"NU2(>Y=3W<1[7IR]X96HH#D(0[OH
MZV$6_-+C+"T^ #_[+;_-R4G+N@QF)E9]0YB$!/J.DP1=>1M.+T[(77E-X<TT
MYA40.W*TNT$Y;5:;.C/=-KX%$*>-.%':%&/E6B+(WKD_U-RXRMMV)U]-G+PT
MMX#2#(ZUMTRD"A$[5(R<*#+#@W4)L'O6R'U3;?J^[1$TUM;:KN@.J!6UBE;9
MGU52OR(OT>R*R))X#8&S-4OP=K>XBWEJ%DE0+R%:C2!6+V&Q5L+7^_;&E0UX
M0_.1#5N(U26(O!O[$+!F6*;UJK(>!P V;\C[SF.G#W$UQ^$M=(CHQ^5-!S9J
M*-&,B_1<[/\WALW]K-JN26UGHL^"4AAM?SQRV7M^;G\2/;?27G9K"9T,LTG=
M&I%WWKZT[["P #=X<#$ZZ](1O</O8'MM,H=WL59=S&:R/#?IKC]V(Q(SBE!*
M8=VF_,:WC(Q^30&_3S.PB/7*BO0Z8AT_3-Z"P:=&7W7^"!N>.>3RN=_[Q(T9
M?^8SWB-EQ,<);9>%(AK892S2+&_H&6 &85LEW0QZE2_7+?!;8^'V:O,[Y!KI
MPW= ;%Y\ 09F/:\=6*Q!'=%TA9H@O"=H2]FJJ8.MA5!D_<!$+ZB[[OVJ9:CZ
ME%5E &^+LFZ1T;D!PYGJ0UIIJJLRJR,"Z.!VLT8-5RWP-XN)%/ZCV\ +G!+P
MR)KS=DSL@GW8*QW#SU-K-ID[&"9A?:PP9()-%.]PO+&*3V /)WXWWZ_G 1*X
M$)TH_:$R(K.[Z6Q9-HUQ(6AHCQ2,+FMJP=S]-M.1SLX&."(FI_ ('A;U1$3O
M$]&"'I8]@Y6]N],SMQV/M#Z)UAC !IXV/KW"Y&EE5=HIC<,7=7AB8M!6#-WE
MDH$9KX6WDDM0)YAU!U_CZMH"[_:6AYDG68E'KE[7M3*^L1HR0]&'UN_P@VJ%
M 0655IKX/C7+I&N&(89Z4AD2) AJNIBU$B4@ZS1:\:D(RHU]4(JH,499A?"F
M>CTZ<T7OTH8BK")T'Z=<;%FB_D^9?5=AP^,'E:(BB@(-^)S\UL )<[TBSYZ-
MBMCU9X7Q%%YG8VGB?+5ABS!U&K_#O- .E[4UTZ<#&( RNJ#PQN:TX9;#WJ-3
M%-]45)=:W(3^+L4-_"JZ.U&;^K6%N(;-ZD^W,E<O7JNZ% M6)(NS2&GR[4FV
MTHJB,,!SU-%^"1T>IT'C9JKR_G-@R_@Z5!3BPO:E0AG'HD%I)BC;^RLK%F5O
MGLCIS%YY&"U13;CO$ GY8,?P:70?1/M9:]P-4%=1(O7B4*E0JJ^NB/*1FD)+
M89!ZL9@2Q(F72D(P8#4EOX4PAJNPM1M+K,+2.=:R$#P)O=@UA1E8:FXNVJNK
M1#NJ2E^R!R'IU@JY7O'%.)]8F9.;=\OK@C?"%$/5KW>T75E?W8.L_X @SQQ]
MWZA,X.Y-TT,*<&:RK9;?F>/.G+Q!B",2X1 V81"+. RERRLH?1)BJ\TZA$<:
M52,VDG;S4'4FD;*<>%X6=96Q0B7L6@Z>@066UX*-SWSY (:H]K(>8C0W/L1
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M96<G@5 7,=0T*13E!]^A? 217BXV419NP/YT@P.EV 9#) !>61$P?CS+#H.
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MX#N&67W&V+8:C?6=?S2-ES6\O/AHILQ[THQG0"!]5)M!:'Q"R*<G$*PHY&^
M*LWZX2Q5LE)>B@&_*(>&FD)A<$0,#J.+=V&B1]?^BB[&WNU@%'BP! HE_F4<
M.,*K6Q<HW:HHYS[PX$P]-W[,FF_ +P,O05&,1W( [<@%,0[1/S&^907W<I N
M2W<ZTE&M@--I:5\XD@A'W+K\5)3X*+9PXF[@TTA"X")7#7.$'X!WX.!CP3O&
M+X1N]&-OB,K"Q;DP K\.'\CN/ %6M+[7;T%KX;/!2[8N<?0M?A+L3? 00+/
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MK&VX]F]A$#VGXDU?!$>UD_9LLK0 1_P>5]Z\P9-?L50XMMZ\!71</YSMDB@
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M^IS.\Z-X&7X@*".ES9C0Z<1RSIS<"1\,#P]4K^$!J"')%@U)UN.1*>&Z1R6
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M_]$H:T"C<?2G*)G,V0_\!<[^RTYC]T\?X>?\_MQ*J+<AU#OSI7H]V1=B#8D
M$76!,9Y_1<&^X?=/SJ-<2:!7Z<?:K7BT:#RZGK1,^7CTK3DTEQ):K- WP5N"
M.%X@,R_N,6:941"*<'1=?Q",Q5<X/WR8$J1><&H@$JY3I-HY&98G1:I5/K5?
M$H9\<8OQJS-D\S48<BF$[;<"X9;^MW[@^G.6!(?!RK@:[&DHL$I$Q!0A0V/B
M^:<(BP7"&'_^(.6D'XG_).@2WQ,W+X\LWAPV!W9C>\CB)W4KW:W%VRT5LKAZ
M6T1U[/2^6;>@""()W5BBUZ370H1*1"T&E<U3U!'#,,P=G(ZD&,+3K<XD=#U+
M 2#&@?7-?K0:306(.$98:<93G#N*87^NF=(V!.5@K]'44WRF)"0_Q8'O=#6\
MQ3<!X80/R,'D43>*0&:Z?B^T_8AWL^05L6_<$/RL#U\.CXYJK?W]V5LAH@_4
M)+ \P\E*)&X*ZB/(+D$."X=!Z2?PKY^P4BR\1^N7^?2:._CK>?2B._5:;H1N
M4209$HEPL-<0:#ZHYY!'XF+6K3+(CZDF%.7P3*]3..,]JO2P;FX[)=0?5[[4
M!"V6_%JNUC#+7/ ?8S>.A:"DUJ\!XC*3"-RCOH!OWX4V(\(;F-"R- ^)2$#P
M8$O9B,NLH/]!W'Z(1UW@Q[C/ZE,(FPXR:&/@,E5ML-U]Z]JS?0;IMA'"FU&?
MHZ2/K5JX$%AI.!LBO'<'O-_9/2%2-\)"(TP[0;Q'-6FNX&]MG%%PGX+<^_#X
M"0C/$$P&545"(/,:Q9I)Z/H1VHL\2"&/IH,@F<!?Z;L1/,>C&1$2O[;3NP'%
M Q(7A)8=6]BRBFBV;AC:CLO'$,MM]Q^M,S$@Q:  ;0^9(NJU0] @;LBO@$]1
M+XQ#,1@<=^\1L?*!-&[@\/60GB-:XN5!HY<S"1Y AP%=!L&=#[[?_.I1!3HL
MH80CS69] ;Z@CU24(/\IL>#B<('I"+:>KE'B.]@P?7JHGRF7IW4<,4%@8N0Q
M?AR(4]^6?6QXQ1 7X@/HL7V0M0SBNN9=.GF<E3;W$II;K6E>0NC-K7AIJ[M'
M.&<)HLA?$S?Q97L#' <V-I;.X<<Z2,/?0O#]7G!]P]5=V\^[OF<E/-3+2_M(
M'N(#N"(6C@/ 43/QHIM[[ERTC1#M'[BEE])L,0;*;)I-W>NU="((:2*Z'8ZD
M78@CDVA:#Y$1_L2WY0+*315Q=:*KX;.IE=J%U[@R$(N884F"="\OLA2YUI9@
M_>0DEX_8%"R#\C/M'#K)#D_4(!*, @\OU6]"T+WPCX#^WPW/42B?S=.)\UTC
MIHBB K"U09S(&@F/A +]I&-E+$7F)S)&T##PO.!!3AF9!!&PX!9QY(L!UYZ-
MQK:W@H/2G@G4K0E?M5'/6W0S:W7 5G/(7E/V(*XB/7V,G(:3()1F($U2 ELQ
MXCE2/GG,9#,D\2C 60J.]&AGP@1DZ<U7W<?S5#?\WS$'>G^E("BKZ\7*G#^O
MWN-JF'F+?'U_2GLE?<^:NJ/?Z 5V XCM_CS30=)I8=#CY&FJ](+)FR))@^FQ
MB";U92I?-H:7_M)GLL9SR<+^U-K0(H5"EM^,7FJ^I@[4_OX"G2<%V%!]Y#:K
MP$X:/)C@<Q;KO\;^^O5?[P%^\<C_BZ^R5<57.WB!WFLTUJSW7I,43UX!T^IN
M,S.>-AU!I;"8,DJ5&:I-BN5MC+X8X'1*,1R* 6$-4^2*K%S7D[:R?B3ZTKZ#
MWD-,/;NGJ!UPAE,L9I^L(R6W H>VR@F7M['\\*6XMQV[WJ,/T,BG?UK7H1B*
M,(0G$U=8.S[FLXYVK0>:6^D(,99;(",_N_KOL)X3@OOOT<=A^_#9Y39A5</@
M7F<8W.&JE^E[&P8G<\<Y6>4#<3(\&FXTJ[REZ 5XZHH?[=B^T_4OCAO!5?[X
M"0P"T$3B U]808C1L@]?+JYN?N_<G.U]O;KZ6_?R-^NVU^F=?P-VNP5IQF>6
M(IYA3*=%73YR(YSC"0:9.0(;LQ)N9/T]L4,0">]1#A3'B,8%? :VLO=WXB#;
M]6E0*E)PSPN"'QSODX-^(]*6<BKK6-B^"I4(MA>:1QUU&\"ODA!V!:_3&5#R
MI''2:M5H'BM?%#52T_JKC?.<KY[_'(QL_TX8SVB;SZA;'<\S]Q=0]4D,7\K\
M=FC290BW/6>*TD_0S-A!D'@.W'>6O$;FTZ%N_4[C1:V' $/)48)-7I$EAUWW
MA8=9HYH<>*U^S:.0IW]K@]@.W FF#J;^,F',P>E?PQ5U)V9^BR;M].^"">8=
M@%$&TW_!0AS?F=F*.Y[^%:9*IG\WMA_UKP(<X@QZS XQLX'C=#F%QMES'E0;
MLUV =CNZ8,"V"RE[B\0TCD86#]4PGX+LAB=<1=/>=#2--;KY#/FEZ''<#SS:
MV7'KLZFEE_$Z>7HZJ+&!"'V>]1O^D!.C^TD$-T24#J*^"X.'>%0#68?=265D
M#P9B$JLJ@" )IR:)B\'(#[S@[I&'E'.E6RPF>H8T#_R>FB".S_J*I]D/70=T
MV04\"^2G?=S\O)Q%5055RAM4V9 H8)I;WA^HD"DZ@L5B-0NX&64#?@IYX$_-
MXOW ;T";,U,/<0([LC 7<%9L6K'IQM@T:Z>I\!QP(TW_$'<N<BWI6ZKKP7(A
M_.!8SW&G*-\PB1.P-@(N,D>65T$ 67M!3TABK#M6ZYACZ!?K^TH *@'8A@"$
MX@[,"&17R<\"K)E@[ Z,^C34TD:52\6:%6MN@S7M/FA/Q9;2/@ S@O2JY_XG
M<8$]*SU9,>.F7+O9DITT<N(8!FLH(KC(![*(>!)$I#4_X[\JYJR8<R.:TO,L
M.XJ2\406D'.DSY;_FH3"<0>ZMARS!_PS7.04*AQ.:5=QSQK7B#%D Y485_.#
M>#JHB8G+-YZT_%>0T-L-[ 2)1.5T^,)X%V%<<$%H6A'E+K&Q&ENPFR!):I9+
M(UU=_S[P[H45NM$/IG3BRX:#F!T.+!"F<S6/EG?CDOOPR!7$<8#G%5K8 !12
MT$>0A89Y5^IS#$,,XLK@,KR7+%O@SJ)HJD$ '^>XPZ'Q0.]1%>5C=$M&6;%$
M-[3<\038Q\$N@">H(\.J\U_7B*VJ!@A1!5FK(.O,OM!+5KT)V,MC1#O%(A?:
M;*MA-@R%9\LN0_;&L7&;W7;9HP*RD7F:FY8/X%]AL:F0+#_G+A2"0P0<_G6"
MR:)>'!!5)QEPF%AUS00H@FC?5A9M931L1(Y4TP\RFZ]C70-K8H>Q#UJX8KR*
M\3;FU]L._ ES991=I]H_TNNH.64H-F3]C%;/R)VD95+?Z[=UZPZ,F]"GP"E9
M4_ %GSX+EJ@'MBPP<X 56Q435TR\#2MDF%!T/R<-8)H==SQ>W%)&!'P.'CX2
MMJ.R P0//P^VU]J1+;^[&CF>$Q.J](J<!9 -V4^,6>A* "H!V%A 3#*[4>7
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MX,F$GBO/9_Z6D%WQX1A\QZ=A1-;8UG &_]/%@!BR?4T&Q+#=3JYCMB\&T\>
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M<&]3O@VLB&1 H2^9%TGKK.&#*J$X!LL.=(C*'=SJB3#7<B(,CN&XELA[FFG
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MCF,P&V/DH(3;6$PB$'!\24+%(D$_FVK_[,G0,T+OJ"D$LL[-N.?QZ\K(H,>
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M\]?SP8 :?]PBVTLN' Z?MBFW@(.TU5>OB%X1O2)Z1?3M7C:?^_;@QQTEL/:
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MJ144.PM.T8CV'RF5>/0YDGT!+KUK39FMLF6,V@A V\H_6W#Q^=3C$8Q)$4U
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MQPY-1S UN>.<**)I)H+F&IKY$4J2T6:DVPCO[+A>$LL;'5](_)111WK"*/"
MS)&B&B9R^&XV]L,^N;J?IS<^"068HNC"R"WQJR.),&E"(0BJ':&$@P 5(:'K
MV.].?P,?3#R'C7*J)8GPV_QX0:HJ$KX;A'RC!)$V'3.&,RMF?!!J"YN Q.Z%
M3]<_'2U&64-7IF(,!37%13W2H4@/=*J#^5:S-<5CID>O:>"(?JQ,%XS,J  1
M HA-XC15Q <:8^U!*>R/WP6?YY3I>)AFU>$,\<(T[55;\[Z#%B[]C,E?4/A2
M5=&_I7T@?DHG%STE[7TY<\(X>1&AC!^G;9T<=S -LQM\0[_K!Q+::=$EXSLY
M2$(LJ(PD)$UY'>3)&.XS7OHOX%SOSU0G3.?-KZ:SOI%,YNI5V(V3(86L]:X3
MZ&1@I_>O[=PK3G[";@3#>ZR$R4PA&YE569:"'C90FDAAFE-II'(V0*9$4!ZS
MD^.RHLZE:["/]P%< !@> R)150AH.K6<8KXT?I9Y5M;\,+:7 YG%%MD5Z4?:
MN,F6!M@7T@-U MHQCJ6OT6G3)?L%RF'2FZ(E+H/)4U_)G/,//WCPZ9;B$T_=
M=GLJ78_6(JROP[ORJ9JX,X^GRSFD3:L(J'K_*<:6C]8B16R%^24CTD*RE=''
M*N9*-D&5'=]6=KQ=9<<WS&I7AJ_$EK)V<Z=K1_(OK9IE6!JDF^:'G4'ZX \U
M] <IDYRZ@](0)LF3MHJR["+,.../L<8ZS40AE6DCPY 4Q(Q2744A&7M,L=L:
M.[2W\.ZH%R[=0>#9\&:D391Y6Z,:@' 2$)@J:6ZX[U%?@CDLO"&HDSMYE9*I
M!Y\:RR*?BR <6[=[+5X&MWJ;VI1(DO.?@Q'%N$XQU440L=;.[?GI+GZ; \O-
MDQ2W$]?AES*CL\F$0F)'YIT[QT(W3%J^I8 6C@#A1B4*3@L7!.+BG4GH>E;C
M1$'N7N%^'H')U&X>4C+ 94JUA$E$KHHGZ<R>!2ZA5''Z5T[=_34!1:O68 3N
MY Y8T5*_VH$#\525(D<[\%V:^Y\OW! ^=YVN?*N?39]H?-[-\(G<#-^ZQ!M<
M3H:QN3F)A!'5*F!>P[X#[KECBT]R%9!G8%*_868F.)@'PD<<ZF)-A>FC='K?
M.)PDCP>NK1&P'=W!N!UB6,K;T\<7O"J=RR681I2+:3:7/9RMDJ:=,0:G23-+
MF3)X%QT/_$!\*\.X0<\ XT&:4%-QH[Z025&L_WLTM.^T%Z(4KV(?KIP^,*)K
MLUXA'!6NG3IZ=DC1=>(&[2].:?@IF_56"& V..HC^-EPT:5ZL<Y9\Q)Z+)4^
M_THY^M,I\&I\)#XF4G[_=Y\ U^FC6"#)7_+),B#+]$)'UF^5>E6@LFQ97]MA
M;'7K5A?^:#6 A> FSOM2C>YH[;?]/8'O"4H""8JP*)W=V-_[.Y'9+!!%/@]U
M^0(<4Z!C"9JLY8C-*]_8#S@\ "^J@ZG@CA$XOLSBT>=D>-.9=D"Q_H!3FZF(
MJUN+:9@)T.CDD](S=;AS?%LRJ:S^D#?7).E[[H##,&!0P"+*3-!9I(@46H:M
M,PS]V1H%#_#$L(9>(_"QF"VW)6MF)I+#&HY<G)!3"?>!EZ":-](]TF7B0+X,
M_!@!3F Z%\37#:?K<#C(I60]Z^K)V#ZK#.G8Y/FZ]:VPR=;GEMR.0$CW>E@*
M@Y3XBH4Q]*^TE.N6H[OEFV=BY!WR;PFCR"N2(28NN-"A(?/R*86>ZH#UZD:#
M),+7I.Q-&O.F6#<^+;WRS-!]GVY@N./,Z+;,#)##0^)7DT7[*C)J1&-F*_-S
M8KY/!FLYTKQP#_IV'MN.J<L61&HQ(\Z16C(S%:^D_E5FE6B4UG3E& $8J4$;
MGL#(HW<'[IUMN&UO911I>Z:G=4U=XIE*8?-+T>.X'WBTL^/69[/:?6J#N?N:
MRB88A1RRK"'-ONG2")1&HYYDN6C2)DC_TF<R)[K4V?.IM:%%"H4/_:9X$R,(
M7-6 -CP%8E(]"*<&F@=5HTP;?T;#HF+%BA4WP8IIE8*A(66NWZCR4L%/3-CK
MS#\F.\:VZYM5!IG&=9D)F4X&S4D"85@(*X0X##D.J*H>?&>:"674_U$A9'WC
M0>U-QWRZOB:E)$):5*]+]TDWR+9H%9H@6AE#K=2'.6L%@F;?<]H?LY2Q,"L"
M/4^6,1E%4]1+SX&/I8^6PS=FMLM(;@E_1,:D])SS:SISSSW_I%5>LF^6J& (
MA M4\EYOKAUJF*%E<#:JZ-<[B7Z9$8=3](XNP/$I7T A?\(4%>-C4BBV*8&0
MZ9#OZV(YU321;45XSN0HX-]J<M1&7,EJ<E0U.>IM<,SZL .KR5$5!ZV;@XHQ
M,2H7^O*=3Y%Z6^>[>'K4*Y[O:RJ,5\>M-=A@QEHI*8)G1?1B@@5O#?K\$MPW
M\FR_RY[W*]WSWM&!IR*0KW"#PW:PL7\M>]NM:#M-VT;]9*VT+292]XSP=35
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MDO+]+=F#R6B1D770KITTFNHIAK<V3&)$CE13;KE'$3X3P]-B_99RP(.:-J'
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M5I/5U)FF#U:3U=29IH]6TVN>9_N7;? =4$L#!!0    (  J K%H<XQ2#;Q(
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M'0;,K2H$[M*1DC,1[\B,8&T:8A0$*-Q SZ6((5[[TKJZ;&AW6%Y;+&\CL<L
M9.6D!TP"LC#YP=ULN5(4NHPPP>"9 +N0LX064R(2F.)MSZUJHY$"YF!QS=1?
M+%56+I8F3"ZEPD9?"DLHS2$)6?7]HWK@GZWM+2<XO&.[PX5MGI2)59YD&P&.
M'=LV9P=%HLNDX,;$GB/_,:0/^'_?P@3"",J8%JS3;" :T;0U]MHJ(@=]0G)[
M[+6M&/E])F/L"R#;<5;.;/:(C(4!,<WJ3!>\ &V27+,4!+C)Z>% O5:?'1.B
MN+W9R0+OJ&30"4(LA$=90)R=LXB76FQM?1=8D/418&5<:PT&D9!Z;3H#_LGE
M.;@0-=T8GQ?61$*AU$$HP19#1@TWP.J)6(@TUF;YMGS_XW:^IZ[K#-=90<*-
M>^P64(XM,9$ LP=<XPD)$P77LB=;\4VM>>OQ2R""_0#S5*U&(#4J%7@XW(%Y
M1XE_EV"32)SVL:[9?,TS>!J?P!O %R.H%V&+9Y\SR7Q$^ ]33V&8,OO/,@5>
MW]4YCT":@SYU? :MT[RUC(LE7.K_L <1-TER'F-8_WFOOX>K*K?D4F 7?G#P
M$AM#< %P5 (Y'R[DLZ6J:"EBR#"%^L"S]L+Y[>1R-.F>WTZGMV\&;);PZ!T[
MR-^#F28R;L@"I=,VV#EXY*;54/*/.5^([DP)_JY+QC]@/%GSC?XC%;:/7:_)
M,OR#2O@M-MX^ 5.\ 'A895ZJ,TV\"4K=<97E? 2JXE*N)(;5;"NTF+R?8O7'
M-<ZH;/3]C](TIEF*FHU,O U=9\*DUL2F%"#$8<SZS;:F8?AWU2OWT8!FTA#)
M<"4[1['0U,Y5+.ME:@*P"TC<%QZ"JT2:(AX_QB@;_#N4NZI=HDCH!.(F?%28
MP_?-C0P7"FHJ531Q!D*G#*#;O%0$-C %(;+PN^)-D"/H3Q/'(1_YFG,WQ/L@
MN"/0!N3E-B;_!SCO28#[ESUV+3"- ]_#F:9F2>6"B%SR4F%-Y<W*6;-SQ#@3
MQC>\DP)V%![+0-%KAHB<89TPRU+.YJ!"4R]XG)(X(K@APCCCV@SP%*;Q9C>#
MK(@-YW.92-P4E+K&E)LN""!OS3K-#M: R'XL7D:3MKQ$  3M$G"=V'C@)NP\
MV<Q.U 7Y'Y)^C_V2K=$[*E&Y]DQA#]$ =]XN8;F?^N")&VTADY/?FGH6!E=Z
M61 S6)PF0NOVV&'@>E&JE.*0@3;K3+U#LA<E-\\0X;8T1A:(7X1OO0H!5L&7
M0L_&]E%(/-M4,<).=<J87*U :+!&LK%$Z8 J'_L?.,I0Q6GJ5P%VQ3PNL.0'
MA9A896H6HD*'MA1E4,63R@DH6HLVL8VX:&&5 @RHRYM_O=9Y$L'AQUY5YX.:
MK@TN#N(#ZBMH*4) )DE#395@<+58&[N1KNP)H//NKJ/O*'+0@87COG>#L<88
M!Q7R@+\UUC82GMC89J$'^NC_O[^9TL> =%.N@AZT"$[-:!HS8_$>E"?M353T
M@<<U:KE/II]P9B5LLX9GA5PQI,1"XC%"[!.M4X]:*J[V0?_HO/@?7,[A3A%!
MB#%'/APX>A8 EFIS>(S?<YE0:)[3$P007/9'J )%N(+T;Q%@!FDE,%B!(2;H
M5P0<]&Q+X'NV,A</CB$>8&HAE$E>O,P2B(K!+*OJ^U7M/M\MV^K[=4@;.F-)
M1L=[JGRA'[**'8B:VA$$2CV1W)B/(7,+'(9+01Z@Z&)!+I#E "_F&]N/['AS
MH8:DA<AV.UCP/BM$&.+0%A'F4I_);%N/@;R@A+H2@J*E._IFZ-4G8:/1WAI+
M.LZ%!]X<R3F7)-N(ZV7'^CX"-X7][V+S#'(GE-.*SMC%YNX&EFH*IAWK W*A
MAX-9(<Z/$&WY3!HVRJDC%G: @[;-,2#[_8,:N*?NDEO8!BMM*CDCX"5U_C4>
M".,;>SHL:V043$'*--F(*3\6VJ[5R.A ?,9LJFT>939-">V8'Y!@=FW<*!5=
M;Q77^;-;_M*K6XG$P$2X-9#RDP BKWKL+=^L[/1NRM\3WR[FW(!$N>DR0D5P
M5$/1]6YT901H02O^3E#C.+%&8MJ&!2P?.W"!/55*90;^.7-Z=;0_\\9[D<6
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M>9,%:B"$SB".%INO"H&>[BCL\/]'85\"V_[48R,Z.DDO#ZAL*6=TU,4=GPJ
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M^5;>\+V..5Y\6='2KR.>_1]02P,$%     @ "H"L6E!$B3KM!@  ]"    X
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M6A//]X+*/48\D6K:NA_,CQ3/]&\0W;\ 4$L#!!0    (  J K%J:/5WV' 0
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MU8<_)F+)$LO46 =C_O#%3EO4/N[X/L\2I?_[^9D/O.YOH/Q/I_8W4$L#!!0
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M4=C;R.LH"@0:0/:4EUU7*QS8PZ,X=3/VY)M072*1:5N ,\Z91,M0/'I2"/-
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M<-.D?-+D=(Y;J,^I#W^+&PMII[H<XZT=W/8L_IM'Z%U290>ND@DB<SP\RJ
MQEN_;UGHU,_P:/C-CDA4GE>DL,OICSM#MFI;DS-%LGP\.FBF:P(6#ZIX9KLE
M^O0$O^Q_>+=Y\/;ZYOSB9O#V^N[N^L-8Q+F$_T>HY@ZZ+MU@&\&S[41]],1)
MNZ^-OJM0W >Q5?)^(#-8&2,E+>32?<??,3S5WN:6\8N<L/D]1=]/&X_(+0.'
M[,6^82\-,HFJL!QO^JEOY7>+ZA^ZJ'[;9NCS-D-O!'6AJ(2OPG!JT!24U*^%
MW-Z5%%I^*K[]\^N]O>'1RAI?CXY":@7VMM4$:]&84Q,';5!RW?Y^] (/&BG'
M=S,-]RHJL <OGF^R/>S<<JEEK',=SNQ68#**UZQMU_QT958%EEN#,**!F(75
MZBPP7QE&YMLLQ'B7VFJN>G381'ZG7CR5!2(M?*9P"YHBTVF-G@\M8EK#'DGE
M;<N@4P%/CIX1:TA-Z#87*RJ^I$%H>.C7:4EY?_-;;=)*QN)P=R1.VW:H@/CA
M(DZ4P@Q38U*126B)(PS<VS(P:")=SDT^I_,6*+GF2 )#FH/KB XO:CZQG&N3
MR_;( _*#S.YO,8NY.XRXC#7KIU 8'1ZYWCY6MQA!LFN6,G^R<V@)K[8L@;5:
M]]7$-@#QNIZSGA:Z" <X'4EB5:I,@^1XX7#W0'SL3LNZSA3[W(3D^8;FZRXT
M)V6JBG*E)S<UT">"0S?CEU'KU:PF[M.YN>^4C&H.'<D+" 3^WPR\&40-L'7]
MKK1,>^=CLJIR+(9T XV+>L<SL)ER</D9_[]'J=*F;^4'W'T$MH$',FEY!CXD
M2I%^Z,X3(;TI5O-()*  _L@4U^@9:+-SG@2AI #8E&]$I-(QJ0OLX'U+$ES4
M <Y"7V?%XK&LL54^&NXT FW;W;-\J"P?E#]FJ^DYJ8/' K>9/@JG GQFV1ZP
M]IS<N%+FCL'K(=ZX5#VHI*84O89+F[*;)@D DDK-T1OG6 PU-%A] U_38M J
MMFPAM%/PRUR'$&_W<*N2W@*I*52J6'E9KLZ,<.475$(WTPJ?+<O^K+SB!KG%
MS 3(.=YY=5#YD*.4\#TOF0*,D@V!T5^1YE=4EO%72"UEL>WFZZG"I!V^V[=#
MJ5RR@?#NZD2Y=^Q%&\(T#Z%[#5TU@*U:<4^@>BXQ&1-P\X7FJ#F0/\(64836
M0@#9G/Z] PA*%YIK@)(WA.< $G5ERLY]Z],%SZ%>J:DA:^TF'N-8HX@:-ZJ'
M)*]=CR"!2HT1["]D^7!FN"6(K"!4MS*N.42@HN=)N4G>RJK-?YQKSS?+O^G]
M$P"2BO(U8+L@IM!AP5JFW]K8ME*K>5/UWGRFB(V&O59B.;A$_<&-%B=B_J<-
M!F4&]4!<=/FR=_(34E'!_RH1,IA,346YHVB^86Z2!]&SF6Q;+O^<:#\5A_]W
M]O^FL]_[77MK_C?6DW\!4$L! A0#%     @ "H"L6D"<KXAB$0  $[P  !$
M             ( !     &QT8G(M,C R-3 S,S$N>'-D4$L! A0#%     @
M"H"L6J?M@=0-"P  W7<  !4              ( !D1$  &QT8G(M,C R-3 S
M,S%?8V%L+GAM;%!+ 0(4 Q0    (  J K%HHJ!&4\!L  !.[ 0 5
M      "  =$<  !L=&)R+3(P,C4P,S,Q7V1E9BYX;6Q02P$"% ,4    "  *
M@*Q:Y2.!FRQ+   V^@, %0              @ 'T.   ;'1B<BTR,#(U,#,S
M,5]L86(N>&UL4$L! A0#%     @ "H"L6JRQ8&QF.@  ;S4# !4
M     ( !4X0  &QT8G(M,C R-3 S,S%?<')E+GAM;%!+ 0(4 Q0    (  J
MK%JRN2W_&MD  +,6"@ ,              "  >R^  !L=&)R7S$P<2YH=&U0
M2P$"% ,4    "  *@*Q:5[CK'P("   2%@  #@              @ $PF $
M;'1B<E]E>#$P,BYH=&U02P$"% ,4    "  *@*Q:'.,4@V\2  !]40  #@
M            @ %>F@$ ;'1B<E]E>#$P-"YH=&U02P$"% ,4    "  *@*Q:
M4$2).NT&  #T(   #@              @ 'YK $ ;'1B<E]E>#,Q,2YH=&U0
M2P$"% ,4    "  *@*Q:^R%%-/\&  !F(0  #@              @ $2M $
M;'1B<E]E>#,Q,BYH=&U02P$"% ,4    "  *@*Q:FCU=]AP$  #3$@  #0
M            @ $]NP$ ;'1B<E]E>#,R+FAT;5!+ 0(4 Q0    (  J K%KX
MX.6]HPH  "4K   -              "  82_ 0!L=&)R7V5X,S,N:'1M4$L%
3!@     ,  P ZP(  %+* 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>ltbr_10q_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:ltbr="http://ltbr.com/20250331"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ltbr-20250331.xsd" xlink:type="simple"/>
    <context id="From2025-01-01to2025-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-05-08_ltbr_TopMember_us-gaap_SubsequentEventMember_ltbr_TwentyTwentyPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:TwentyTwentyPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TopMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-08</instant>
        </period>
    </context>
    <context id="AsOf2025-05-08_ltbr_BottomMember_us-gaap_SubsequentEventMember_ltbr_TwentyTwentyPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:TwentyTwentyPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:BottomMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-08</instant>
        </period>
    </context>
    <context id="AsOf2025-05-08_ltbr_TopMember_us-gaap_SubsequentEventMember_ltbr_ArticlesOfIncorporationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:ArticlesOfIncorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TopMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-08</instant>
        </period>
    </context>
    <context id="AsOf2025-05-08_ltbr_BottomMember_us-gaap_SubsequentEventMember_ltbr_ArticlesOfIncorporationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:ArticlesOfIncorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:BottomMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-08</instant>
        </period>
    </context>
    <context id="AsOf2025-04-03_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-03</instant>
        </period>
    </context>
    <context id="From2025-04-01to2025-04-03_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-04-03</endDate>
        </period>
    </context>
    <context id="From2025-04-01to2025-05-12_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-05-12</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_ltbr_CODMMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">ltbr:CODMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_ltbr_CODMMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">ltbr:CODMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-02-01to2025-02-26_ltbr_TwoThousandTwentyEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-01</startDate>
            <endDate>2025-02-26</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_ltbr_AvailableForSaleSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ltbr:AvailableForSaleSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_ltbr_AvailableForSaleSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ltbr:AvailableForSaleSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2024-02-01to2024-02-27_ltbr_TwoThousandTwentyEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-01</startDate>
            <endDate>2024-02-27</endDate>
        </period>
    </context>
    <context id="AsOf2025-03-31_ltbr_TwoThousandTwentyEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_ltbr_TwoThousandTwentyEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-04_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-04</instant>
        </period>
    </context>
    <context id="From2024-03-01to2024-03-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-03-29</endDate>
        </period>
    </context>
    <context id="From2024-11-01to2024-11-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
        </entity>
        <period>
            <startDate>2024-11-01</startDate>
            <endDate>2024-11-22</endDate>
        </period>
    </context>
    <context id="From2025-03-01to2025-03-24_ltbr_TwentyTwentyFiveTransactionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TwentyTwentyFiveTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-01</startDate>
            <endDate>2025-03-24</endDate>
        </period>
    </context>
    <context id="From2025-03-01to2025-03-14_ltbr_TwentyTwentyFiveTransactionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TwentyTwentyFiveTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-01</startDate>
            <endDate>2025-03-14</endDate>
        </period>
    </context>
    <context id="AsOf2024-03-31_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockUnitsRSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_ltbr_RestrictedStockAwardsSummaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:RestrictedStockAwardsSummaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-11-20_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-20</instant>
        </period>
    </context>
    <context id="AsOf2024-08-19_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-19</instant>
        </period>
    </context>
    <context id="From2024-08-01to2024-08-19_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-01</startDate>
            <endDate>2024-08-19</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_ltbr_CommonShareIssuancesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">ltbr:CommonShareIssuancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_ltbr_CommonShareIssuancesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">ltbr:CommonShareIssuancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2019-05-01to2019-05-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
        </entity>
        <period>
            <startDate>2019-05-01</startDate>
            <endDate>2019-05-28</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_ltbr_RestrictedStockAwardsSummaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:RestrictedStockAwardsSummaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-02-26_ltbr_BoardOfDirectorsMember_ltbr_BottomMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:BottomMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ltbr:BoardOfDirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-26</instant>
        </period>
    </context>
    <context id="AsOf2025-02-26_ltbr_BoardOfDirectorsMember_ltbr_TopMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TopMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ltbr:BoardOfDirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-26</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_ltbr_TwentyTwentyFiveTransactionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TwentyTwentyFiveTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockUnitsRSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2024-01-01to2024-12-31_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockUnitsRSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-03-31_ltbr_PrepaidExpenseAndOtherCurrentAssetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">ltbr:PrepaidExpenseAndOtherCurrentAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_ltbr_PrepaidExpenseAndOtherCurrentAssetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">ltbr:PrepaidExpenseAndOtherCurrentAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_ltbr_OptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:OptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-03-31_ltbr_RestrictedStockAwardsSummaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:RestrictedStockAwardsSummaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_ltbr_RestrictedStockAwardsSummaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:RestrictedStockAwardsSummaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="From2024-12-01to2024-12-04_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2024-12-04</endDate>
        </period>
    </context>
    <context id="From2023-11-01to2023-11-20_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2023-11-20</endDate>
        </period>
    </context>
    <context id="From2025-02-03to2025-02-27_ltbr_SeriesXPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ltbr:SeriesXPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-03</startDate>
            <endDate>2025-02-27</endDate>
        </period>
    </context>
    <context id="AsOf2025-02-27_ltbr_SeriesXPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ltbr:SeriesXPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-27</instant>
        </period>
    </context>
    <context id="From2024-01-01to2024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_ltbr_TwentyTwentyFiveTransactionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TwentyTwentyFiveTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-03-01to2025-03-12_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockUnitsRSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-01</startDate>
            <endDate>2025-03-12</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockUnitsRSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_us-gaap_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_us-gaap_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-03-31_ltbr_RestrictedStockAwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockAwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_ltbr_RestrictedStockAwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockAwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_ltbr_RestrictedStockAwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockAwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_ltbr_FEEdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:FEEdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_ltbr_FEEdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:FEEdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2024-12-01to2024-12-31_ltbr_CANDUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:CANDUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-10-16_ltbr_CANDUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:CANDUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-16</instant>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_ltbr_CANDUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:CANDUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_ltbr_CANDUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:CANDUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_ltbr_StrategicPartnershipProjectAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:StrategicPartnershipProjectAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_ltbr_CRADAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:CRADAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_ltbr_INLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:INLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-01-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
        </entity>
        <period>
            <instant>2025-01-16</instant>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_ltbr_BattelleEnergyAllianceLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ltbr:BattelleEnergyAllianceLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-05-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_ltbr_MaxiimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:MaxiimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-05-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_ltbr_MiniimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:MiniimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ltbr_BattelleEnergyAllianceLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ltbr:BattelleEnergyAllianceLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_ltbr_INLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:INLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-03-31_ltbr_TreasuryBillsLevelThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ltbr:TreasuryBillsLevelThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ltbr_TreasuryBillsLevelThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ltbr:TreasuryBillsLevelThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_ltbr_TreasuryBillsLevelTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ltbr:TreasuryBillsLevelTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ltbr_TreasuryBillsLevelTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ltbr:TreasuryBillsLevelTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_ltbr_TreasuryBillsLevelOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ltbr:TreasuryBillsLevelOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ltbr_TreasuryBillsLevelOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ltbr:TreasuryBillsLevelOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-05-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
        </entity>
        <period>
            <instant>2025-05-01</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2025-01-01to2025-03-31" id="ixv-6861">0001084554</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2025-01-01to2025-03-31" id="ixv-6862">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2025-01-01to2025-03-31" id="ixv-6863">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus contextRef="From2025-01-01to2025-03-31" id="ixv-6864">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="From2025-01-01to2025-03-31" id="ixv-6865">2025</dei:DocumentFiscalYearFocus>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="ixv-6866"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="ixv-6867"
      unitRef="Shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="ixv-6868"
      unitRef="Shares">1</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="ixv-6869"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="ixv-6870"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="ixv-6871"
      unitRef="Shares">25000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="ixv-6872"
      unitRef="Shares">21557343</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="ixv-6873"
      unitRef="Shares">18783912</us-gaap:CommonStockSharesOutstanding>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="From2025-01-01to2025-03-31" id="ixv-6874">true</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="From2025-01-01to2025-03-31" id="ixv-6875">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="From2025-01-01to2025-03-31" id="ixv-6876">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="From2025-01-01to2025-03-31" id="ixv-6877">false</ecd:NonRule10b51ArrTrmntdFlag>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2025-01-01to2025-03-31"
      decimals="INF"
      id="ixv-6878"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2024-01-01to2024-03-31"
      decimals="INF"
      id="ixv-6879"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="ixv-6880"
      unitRef="USD">60000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-02-27_ltbr_SeriesXPreferredStockMember"
      decimals="INF"
      id="ixv-6881"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:Cash
      contextRef="AsOf2025-02-27_ltbr_SeriesXPreferredStockMember"
      decimals="0"
      id="ixv-6882"
      unitRef="USD">100</us-gaap:Cash>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-03-31_ltbr_RestrictedStockAwardsSummaryMember"
      decimals="0"
      id="ixv-6883"
      unitRef="Shares">781864</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2025-03-31_ltbr_RestrictedStockAwardsSummaryMember"
      decimals="0"
      id="ixv-6884"
      unitRef="Shares">743702</us-gaap:CommonStockSharesIssued>
    <us-gaap:ShareBasedCompensation
      contextRef="From2024-01-01to2024-03-31_ltbr_CommonShareIssuancesMember"
      decimals="0"
      id="ixv-6885"
      unitRef="USD">15000</us-gaap:ShareBasedCompensation>
    <dei:DocumentType contextRef="From2025-01-01to2025-03-31" id="ixv-7676">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="From2025-01-01to2025-03-31" id="ixv-7677">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="From2025-01-01to2025-03-31" id="ixv-7678">2025-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="From2025-01-01to2025-03-31" id="ixv-7679">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2025-01-01to2025-03-31" id="ixv-7680">001-34487</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2025-01-01to2025-03-31" id="ixv-7681">LIGHTBRIDGE CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2025-01-01to2025-03-31" id="ixv-7682">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2025-01-01to2025-03-31" id="ixv-7683">91-1975651</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2025-01-01to2025-03-31" id="ixv-7684">11710 Plaza America Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2025-01-01to2025-03-31" id="ixv-7685">Suite 2000</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2025-01-01to2025-03-31" id="ixv-7686">Reston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2025-01-01to2025-03-31" id="ixv-7687">VA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2025-01-01to2025-03-31" id="ixv-7688">20190</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2025-01-01to2025-03-31" id="ixv-7689">571</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2025-01-01to2025-03-31" id="ixv-7690">730-1200</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="From2025-01-01to2025-03-31" id="ixv-7691">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2025-01-01to2025-03-31" id="ixv-7692">LTBR</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2025-01-01to2025-03-31" id="ixv-7693">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="From2025-01-01to2025-03-31" id="ixv-7694">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2025-01-01to2025-03-31" id="ixv-7695">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2025-01-01to2025-03-31" id="ixv-7696">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2025-01-01to2025-03-31" id="ixv-7697">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2025-01-01to2025-03-31" id="ixv-7698">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="From2025-01-01to2025-03-31" id="ixv-7699">false</dei:EntityShellCompany>
    <dei:Security12bTitle contextRef="From2025-01-01to2025-03-31" id="ixv-7700">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2025-05-01"
      decimals="INF"
      id="ixv-7701"
      unitRef="Shares">22538160</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_2"
      unitRef="USD">56929988</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_3"
      unitRef="USD">39990827</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_4"
      unitRef="USD">546267</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_5"
      unitRef="USD">324378</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_6"
      unitRef="USD">57476255</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_7"
      unitRef="USD">40315205</us-gaap:AssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssets
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_9"
      unitRef="USD">702562</us-gaap:PrepaidExpenseAndOtherAssets>
    <us-gaap:PrepaidExpenseAndOtherAssets
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_10"
      unitRef="USD">528805</us-gaap:PrepaidExpenseAndOtherAssets>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_11"
      unitRef="USD">108865</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_12"
      unitRef="USD">108865</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:Assets
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_13"
      unitRef="USD">58287682</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_14"
      unitRef="USD">40952875</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_17"
      unitRef="USD">966209</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_18"
      unitRef="USD">424585</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_19"
      unitRef="USD">966209</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_20"
      unitRef="USD">424585</us-gaap:LiabilitiesCurrent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-03-31"
      decimals="INF"
      id="fid_35"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_37"
      unitRef="Shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_39"
      unitRef="Shares">1</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_41"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_23"
      unitRef="USD">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_24"
      unitRef="USD">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2025-03-31"
      decimals="INF"
      id="fid_43"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_45"
      unitRef="Shares">25000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_47"
      unitRef="Shares">21557343</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_49"
      unitRef="Shares">18783912</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_25"
      unitRef="USD">21557</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_26"
      unitRef="USD">18784</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_27"
      unitRef="USD">226255770</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_28"
      unitRef="USD">204694348</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_29"
      unitRef="USD">-168955854</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_30"
      unitRef="USD">-164184842</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_31"
      unitRef="USD">57321473</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_32"
      unitRef="USD">40528290</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_33"
      unitRef="USD">58287682</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_34"
      unitRef="USD">40952875</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_51"
      unitRef="USD">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_52"
      unitRef="USD">0</us-gaap:Revenues>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_54"
      unitRef="USD">3480010</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_55"
      unitRef="USD">2157745</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_56"
      unitRef="USD">1665913</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_57"
      unitRef="USD">1023823</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_58"
      unitRef="USD">5145923</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_59"
      unitRef="USD">3181568</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_60"
      unitRef="USD">-5145923</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_61"
      unitRef="USD">-3181568</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeOther
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_63"
      unitRef="USD">374911</us-gaap:InterestIncomeOther>
    <us-gaap:InterestIncomeOther
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_64"
      unitRef="USD">361984</us-gaap:InterestIncomeOther>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_65"
      unitRef="USD">374911</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_66"
      unitRef="USD">361984</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_67"
      unitRef="USD">-4771012</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_68"
      unitRef="USD">-2819584</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_69"
      unitRef="USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_70"
      unitRef="USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_71"
      unitRef="USD">-4771012</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_72"
      unitRef="USD">-2819584</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2025-01-01to2025-03-31"
      decimals="INF"
      id="fid_74"
      unitRef="USDPShares">-0.24</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-01-01to2024-03-31"
      decimals="INF"
      id="fid_75"
      unitRef="USDPShares">-0.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_76"
      unitRef="Shares">19547312</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_77"
      unitRef="Shares">13491954</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:SharesIssued
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_149"
      unitRef="Shares">13698274</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_79"
      unitRef="USD">13698</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_80"
      unitRef="USD">181295125</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_81"
      unitRef="USD">-152397776</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="fid_82"
      unitRef="USD">28911047</us-gaap:StockholdersEquity>
    <ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares
      contextRef="From2024-01-01to2024-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_83"
      unitRef="Shares">427300</ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares>
    <ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount
      contextRef="From2024-01-01to2024-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_84"
      unitRef="USD">428</ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount>
    <ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount
      contextRef="From2024-01-01to2024-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_85"
      unitRef="USD">1221554</ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount>
    <ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount
      contextRef="From2024-01-01to2024-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_86"
      unitRef="USD">0</ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount>
    <ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_87"
      unitRef="USD">1221982</ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2024-01-01to2024-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_88"
      unitRef="Shares">64206</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-01-01to2024-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_89"
      unitRef="USD">64</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-01-01to2024-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_90"
      unitRef="USD">254936</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-01-01to2024-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_91"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_92"
      unitRef="USD">255000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-01-01to2024-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_93"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-01-01to2024-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_94"
      unitRef="USD">456904</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-01-01to2024-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_95"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_96"
      unitRef="USD">456904</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_97"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_98"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_99"
      unitRef="USD">-2819584</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_100"
      unitRef="USD">-2819584</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="AsOf2024-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_101"
      unitRef="Shares">14189780</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_102"
      unitRef="USD">14190</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_103"
      unitRef="USD">183228519</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_104"
      unitRef="USD">-155217360</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="fid_105"
      unitRef="USD">28025349</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_106"
      unitRef="Shares">18783912</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_107"
      unitRef="USD">18784</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_108"
      unitRef="USD">204694348</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_109"
      unitRef="USD">-164184842</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_110"
      unitRef="USD">40528290</us-gaap:StockholdersEquity>
    <ltbr:RestrictedSharesAwardsIssuedShares
      contextRef="From2025-01-01to2025-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_111"
      unitRef="Shares">57940</ltbr:RestrictedSharesAwardsIssuedShares>
    <ltbr:RestrictedSharesAwardsIssuedAmount
      contextRef="From2025-01-01to2025-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_112"
      unitRef="USD">58</ltbr:RestrictedSharesAwardsIssuedAmount>
    <ltbr:RestrictedSharesAwardsIssuedAmount
      contextRef="From2025-01-01to2025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_113"
      unitRef="USD">-58</ltbr:RestrictedSharesAwardsIssuedAmount>
    <ltbr:RestrictedSharesAwardsIssuedAmount
      contextRef="From2025-01-01to2025-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_114"
      unitRef="USD">0</ltbr:RestrictedSharesAwardsIssuedAmount>
    <ltbr:RestrictedSharesAwardsIssuedAmount
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_115"
      unitRef="USD">0</ltbr:RestrictedSharesAwardsIssuedAmount>
    <ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares
      contextRef="From2025-01-01to2025-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_116"
      unitRef="Shares">-25148</ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares>
    <ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount
      contextRef="From2025-01-01to2025-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_117"
      unitRef="USD">-25</ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount>
    <ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount
      contextRef="From2025-01-01to2025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_118"
      unitRef="USD">194853</ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount>
    <ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount
      contextRef="From2025-01-01to2025-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_119"
      unitRef="USD">0</ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount>
    <ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_120"
      unitRef="USD">-194878</ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount>
    <ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares
      contextRef="From2025-01-01to2025-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_121"
      unitRef="Shares">2605619</ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares>
    <ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount
      contextRef="From2025-01-01to2025-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_122"
      unitRef="USD">2605</ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount>
    <ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount
      contextRef="From2025-01-01to2025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_123"
      unitRef="USD">20210590</ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount>
    <ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount
      contextRef="From2025-01-01to2025-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_124"
      unitRef="USD">0</ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount>
    <ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_125"
      unitRef="USD">20213195</ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2025-01-01to2025-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_126"
      unitRef="Shares">89086</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2025-01-01to2025-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_127"
      unitRef="USD">89</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2025-01-01to2025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_128"
      unitRef="USD">29911</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2025-01-01to2025-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_129"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_130"
      unitRef="USD">30000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="From2025-01-01to2025-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_131"
      unitRef="Shares">45934</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2025-01-01to2025-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_132"
      unitRef="USD">46</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2025-01-01to2025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_133"
      unitRef="USD">220651</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2025-01-01to2025-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_134"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_135"
      unitRef="USD">220697</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2025-01-01to2025-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_136"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2025-01-01to2025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_137"
      unitRef="USD">1295181</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2025-01-01to2025-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_138"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_139"
      unitRef="USD">1295181</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-01-01to2025-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_140"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-01-01to2025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_141"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-01-01to2025-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_142"
      unitRef="USD">-4771012</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_143"
      unitRef="USD">-4771012</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="AsOf2025-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_144"
      unitRef="Shares">21557343</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_145"
      unitRef="USD">21557</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_146"
      unitRef="USD">226255770</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_147"
      unitRef="USD">-168955854</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_148"
      unitRef="USD">57321473</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_151"
      unitRef="USD">-4771012</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_152"
      unitRef="USD">-2819584</us-gaap:ProfitLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_154"
      unitRef="USD">1355181</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_155"
      unitRef="USD">456904</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_157"
      unitRef="USD">266889</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_158"
      unitRef="USD">194796</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <ltbr:IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_159"
      unitRef="USD">173757</ltbr:IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets>
    <ltbr:IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_160"
      unitRef="USD">-3375</ltbr:IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_161"
      unitRef="USD">556624</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_162"
      unitRef="USD">676095</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_163"
      unitRef="USD">-3299853</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_164"
      unitRef="USD">-1878006</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_165"
      unitRef="USD">0</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_166"
      unitRef="USD">0</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_168"
      unitRef="USD">20213195</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_169"
      unitRef="USD">1221982</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_170"
      unitRef="USD">220697</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_171"
      unitRef="USD">0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_172"
      unitRef="USD">194878</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_173"
      unitRef="USD">0</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_174"
      unitRef="USD">20239014</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_175"
      unitRef="USD">1221982</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_176"
      unitRef="USD">16939161</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_177"
      unitRef="USD">-656024</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_178"
      unitRef="USD">39990827</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="fid_179"
      unitRef="USD">28598445</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_180"
      unitRef="USD">56929988</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="fid_181"
      unitRef="USD">27942421</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_184"
      unitRef="USD">0</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_185"
      unitRef="USD">0</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_186"
      unitRef="USD">0</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_187"
      unitRef="USD">0</us-gaap:IncomeTaxesPaidNet>
    <ltbr:PaymentOfAccruedLiabilitiesWithCommonStock
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_189"
      unitRef="USD">15000</ltbr:PaymentOfAccruedLiabilitiesWithCommonStock>
    <ltbr:PaymentOfAccruedLiabilitiesWithCommonStock
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_190"
      unitRef="USD">15000</ltbr:PaymentOfAccruedLiabilitiesWithCommonStock>
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_191">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Note 1. Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;&lt;em&gt;Nature of Operations and Basis of Presentation&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;When used in these notes, the terms &#x201c;Lightbridge,&#x201d; &#x201c;Company,&#x201d; &#x201c;we,&#x201d; &#x201c;us&#x201d; or &#x201c;our&#x201d; mean Lightbridge Corporation and all entities included in the condensed consolidated financial statements.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company was formed on October 6, 2006, when Thorium Power, Ltd., which was incorporated in the state of Nevada on February 2, 1999, merged with Thorium Power, Inc. (TPI), which was incorporated in the state of Delaware on January 8, 1992. On September 29, 2009, the Company changed its name from Thorium Power, Ltd. to Lightbridge Corporation and began its focus on developing and commercializing metallic nuclear fuels. The Company is a nuclear fuel technology company developing its nuclear fuel. The Company views its operations and manages its business as one business segment, which is the development and commercialization of its nuclear fuel. These unaudited condensed consolidated financial statements include the accounts of the Company, and the Company&#x2019;s wholly-owned subsidiaries, TPI, a Delaware corporation, and Lightbridge International Holding LLC, a Delaware limited liability company. These wholly-owned subsidiaries are inactive, and all significant intercompany transactions and balances have been eliminated in consolidation.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The accompanying unaudited condensed consolidated financial statements of Lightbridge Corporation and its subsidiaries have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission, or the SEC, including the instructions to Form 10-Q and Regulation S-X. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America (GAAP), including a summary of the Company&#x2019;s significant accounting policies, have been condensed or omitted from these statements pursuant to such rules and regulations and, accordingly, they do not include all the information and footnotes necessary for comprehensive condensed consolidated financial statements and should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2024, included in the Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on March 3, 2025.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;In the opinion of the management of the Company, all adjustments, which are of a normal recurring nature, necessary for a fair statement of the results for the three-month period have been made. Results for the interim period presented are not necessarily indicative of the results that might be expected for the entire fiscal year.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;&lt;em&gt;Summary of Significant Accounting Policies&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Fair Value of Financial Instruments&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company determined fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between unaffiliated market participants at the measurement date.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Accounting Standards Codification (ASC), &lt;em&gt;Fair Value Measurement&lt;/em&gt; (ASC 820), established a fair value hierarchy that prioritizes the inputs used to measure fair value. Assets and liabilities measured at fair value were categorized based on whether the inputs are observable in the market and the degree that the inputs are observable. The hierarchy gives the highest priority to active markets for identical assets and liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). The categorization of financial instruments within the valuation hierarchy was based on the lowest level of input that is significant to the fair value measurement. At the end of the reporting period, the Company reviews U.S. treasury instruments held to determine whether the securities are of the most recent issuance of that security with the same maturity (referred to as &#x201c;on-the-run&#x201d;, which is the most liquid version of the maturity band). If a U.S. treasury instrument held at the end of the reporting period was from the most recent issuance it is classified as level 1, otherwise it is referred to as &#x201c;off-the-run&#x201d; and is classified as level 2. The three levels of the fair value hierarchy were as follows:&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Level 1 - Observable inputs such as quoted prices in active markets for identical assets or liabilities;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Level 2 - Inputs other than quoted prices that were observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that were not active and inputs other than quoted prices that were observable for the asset or liability; and&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Level 3 - Unobservable inputs that reflect management&#x2019;s assumptions.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;For disclosure purposes, assets and liabilities were classified in their entirety in the fair value hierarchy level based on the lowest level of input that was significant to the overall fair value measurement. The Company&#x2019;s assessment of the significance of a particular input to the fair value measurement required judgment and may have affected the placement within the fair value hierarchy levels.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company&#x2019;s financial instruments consisted principally of cash and cash equivalents, accounts payable and accrued liabilities. The carrying amounts of cash, accounts payable and accrued liabilities are considered to be Level 1 measurements, because of the short-term nature of those instruments. Cash equivalents are primarily composed of US Treasury instruments having maturity dates of 30 to 90 days. The Company purchased $37 million of US Treasury instruments for the three months ended March 31, 2025.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The following table summarized the valuation of the Company&#x2019;s financial instruments that fell within the fair value hierarchy (in millions) at March 31, 2025: &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level I&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level II&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level III&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Cash and cash equivalents&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;19.9&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;37.0&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Accounts payable and accrued liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1.0&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The following table summarized the valuation of the Company&#x2019;s financial instruments that fell within the fair value hierarchy (in millions) at December 31, 2024: &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level I&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level II&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level III&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Cash and cash equivalents&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;40.0&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Accounts payable and accrued liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.4&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Certain Risks and Uncertainties&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company will need additional funding and/or in-kind support via a combination of strategic alliances, government grants, commercial loans, further offerings of equity securities, or an offering of debt securities in order to support its future research and development (R&amp;amp;D) activities required to further enhance and complete the development and commercialization of its fuel products.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;There can be no assurance that the Company will be able to successfully continue to conduct its operations if there is a lack of financial resources available in the future to continue its fuel development activities, and a failure to do so would have a material adverse effect on the Company&#x2019;s future R&amp;amp;D activities, financial position, results of operations, and cash flows. Also, the success of the Company&#x2019;s operations will be subject to other numerous contingencies, some of which are beyond management&#x2019;s control. These contingencies include general and regional economic conditions, contingent liabilities, potential competition with other nuclear fuel developers, including those entities developing accident tolerant fuels (ATFs), changes in government regulations, risks related to the R&amp;amp;D of the Lightbridge Fuel&#x2122;, regulatory approval of the Company&#x2019;s fuel, support for nuclear power, changes in accounting and taxation standards, inability to achieve overall short-term and long-term R&amp;amp;D milestones toward commercialization, future impairment charges to the Company&#x2019;s assets, and global or regional catastrophic events. The Company may also be subject to various additional political, economic, and other uncertainties.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company is engaged in significant research and development (R&amp;amp;D) activities to advance its nuclear fuel technology at Idaho National Laboratory (INL). For the three months ended March 31, 2025, R&amp;amp;D expenses associated with activities conducted at the INL accounted for approximately 47% of the Company&#x2019;s total R&amp;amp;D expenditure. The Company currently relies on INL for developing, testing and evaluating its nuclear fuel. Any disruption in access to INL&#x2019;s resources, including changes in government policies, facility downtime, regulatory constraints, or unforeseen operational challenges could have a material adverse effect on the Company&#x2019;s current ability to advance its R&amp;amp;D activities. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;&lt;em&gt;Recent Accounting Pronouncements&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;ASU No. 2023-09, &lt;em&gt;Income Taxes (Topic 740): Improvements to Income Tax Disclosures&lt;/em&gt;, was issued by the FASB in December 2023. This guidance enhances income tax disclosure requirements by mandating the disclosure of (1) specific categories in the rate reconciliation, (2) income or loss from continuing operations before income taxes, disaggregated between domestic and foreign, and (3) income tax expense or benefit from continuing operations, disaggregated by federal, state, and foreign. The ASU also requires disclosure of income tax payments to federal, state, local, and foreign jurisdictions, among other changes. The standard is effective for annual periods beginning after December 15, 2024, and will be adopted by the Company as permitted. The Company will apply the guidance on a prospective basis and the adoption is not expected to have a material impact on its condensed consolidated financial statements or related disclosures.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;In November 2024, the FASB issued ASU No. 2024-03, &lt;em&gt;Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures&lt;/em&gt; (Subtopic 220-40): &lt;em&gt;Disaggregation of Income Statement Expenses&lt;/em&gt; (&#x201c;ASU 2024-03&#x201d;), which required disclosure of certain costs and expenses on an interim and annual basis in the notes to the consolidated financial statements. The guidance is effective for annual reporting periods beginning after December 15, 2026 and interim periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The guidance is to be applied either (1) prospectively to financial statements issued for reporting periods after the effective date or (2) retrospectively to any or all prior periods presented in the financial statements. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company has evaluated other recently issued, but not yet effective, accounting standards that have been issued or proposed by the FASB or other standards-setting bodies through the filing date of these unaudited condensed consolidated financial statements and does not believe the future adoption of any such standards will have a material impact on the consolidated financial statements and related disclosures.&lt;/p&gt;</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2025-01-01to2025-03-31" id="fid_202">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company determined fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between unaffiliated market participants at the measurement date.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Accounting Standards Codification (ASC), &lt;em&gt;Fair Value Measurement&lt;/em&gt; (ASC 820), established a fair value hierarchy that prioritizes the inputs used to measure fair value. Assets and liabilities measured at fair value were categorized based on whether the inputs are observable in the market and the degree that the inputs are observable. The hierarchy gives the highest priority to active markets for identical assets and liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). The categorization of financial instruments within the valuation hierarchy was based on the lowest level of input that is significant to the fair value measurement. At the end of the reporting period, the Company reviews U.S. treasury instruments held to determine whether the securities are of the most recent issuance of that security with the same maturity (referred to as &#x201c;on-the-run&#x201d;, which is the most liquid version of the maturity band). If a U.S. treasury instrument held at the end of the reporting period was from the most recent issuance it is classified as level 1, otherwise it is referred to as &#x201c;off-the-run&#x201d; and is classified as level 2. The three levels of the fair value hierarchy were as follows:&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Level 1 - Observable inputs such as quoted prices in active markets for identical assets or liabilities;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Level 2 - Inputs other than quoted prices that were observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that were not active and inputs other than quoted prices that were observable for the asset or liability; and&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Level 3 - Unobservable inputs that reflect management&#x2019;s assumptions.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;For disclosure purposes, assets and liabilities were classified in their entirety in the fair value hierarchy level based on the lowest level of input that was significant to the overall fair value measurement. The Company&#x2019;s assessment of the significance of a particular input to the fair value measurement required judgment and may have affected the placement within the fair value hierarchy levels.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company&#x2019;s financial instruments consisted principally of cash and cash equivalents, accounts payable and accrued liabilities. The carrying amounts of cash, accounts payable and accrued liabilities are considered to be Level 1 measurements, because of the short-term nature of those instruments. Cash equivalents are primarily composed of US Treasury instruments having maturity dates of 30 to 90 days. The Company purchased $37 million of US Treasury instruments for the three months ended March 31, 2025.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The following table summarized the valuation of the Company&#x2019;s financial instruments that fell within the fair value hierarchy (in millions) at March 31, 2025: &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level I&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level II&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level III&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Cash and cash equivalents&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;19.9&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;37.0&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Accounts payable and accrued liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1.0&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The following table summarized the valuation of the Company&#x2019;s financial instruments that fell within the fair value hierarchy (in millions) at December 31, 2024: &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level I&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level II&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level III&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Cash and cash equivalents&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;40.0&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Accounts payable and accrued liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.4&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <ltbr:InvestmentsInDebtSecuritiesPurchased
      contextRef="From2025-01-01to2025-03-31"
      decimals="-6"
      id="fid_259"
      unitRef="USD">37000000</ltbr:InvestmentsInDebtSecuritiesPurchased>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_213">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level I&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level II&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level III&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Cash and cash equivalents&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;19.9&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;37.0&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Accounts payable and accrued liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1.0&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level I&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level II&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level III&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Cash and cash equivalents&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;40.0&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Accounts payable and accrued liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.4&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2025-03-31_ltbr_TreasuryBillsLevelOneMember"
      decimals="-5"
      id="fid_245"
      unitRef="USD">19900000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2025-03-31_ltbr_TreasuryBillsLevelTwoMember"
      decimals="-5"
      id="fid_247"
      unitRef="USD">37000000.0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2025-03-31_ltbr_TreasuryBillsLevelThreeMember"
      decimals="-6"
      id="fid_248"
      unitRef="USD">0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2025-03-31_ltbr_TreasuryBillsLevelOneMember"
      decimals="-5"
      id="fid_251"
      unitRef="USD">1000000.0</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2025-03-31_ltbr_TreasuryBillsLevelTwoMember"
      decimals="-6"
      id="fid_252"
      unitRef="USD">0</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2025-03-31_ltbr_TreasuryBillsLevelThreeMember"
      decimals="-6"
      id="fid_253"
      unitRef="USD">0</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-12-31_ltbr_TreasuryBillsLevelOneMember"
      decimals="-5"
      id="fid_246"
      unitRef="USD">40000000.0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-12-31_ltbr_TreasuryBillsLevelTwoMember"
      decimals="-6"
      id="fid_249"
      unitRef="USD">0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-12-31_ltbr_TreasuryBillsLevelThreeMember"
      decimals="-6"
      id="fid_250"
      unitRef="USD">0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2024-12-31_ltbr_TreasuryBillsLevelOneMember"
      decimals="-5"
      id="fid_254"
      unitRef="USD">400000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2024-12-31_ltbr_TreasuryBillsLevelTwoMember"
      decimals="-6"
      id="fid_255"
      unitRef="USD">0</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2024-12-31_ltbr_TreasuryBillsLevelThreeMember"
      decimals="-6"
      id="fid_256"
      unitRef="USD">0</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2025-01-01to2025-03-31" id="fid_203">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company will need additional funding and/or in-kind support via a combination of strategic alliances, government grants, commercial loans, further offerings of equity securities, or an offering of debt securities in order to support its future research and development (R&amp;amp;D) activities required to further enhance and complete the development and commercialization of its fuel products.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;There can be no assurance that the Company will be able to successfully continue to conduct its operations if there is a lack of financial resources available in the future to continue its fuel development activities, and a failure to do so would have a material adverse effect on the Company&#x2019;s future R&amp;amp;D activities, financial position, results of operations, and cash flows. Also, the success of the Company&#x2019;s operations will be subject to other numerous contingencies, some of which are beyond management&#x2019;s control. These contingencies include general and regional economic conditions, contingent liabilities, potential competition with other nuclear fuel developers, including those entities developing accident tolerant fuels (ATFs), changes in government regulations, risks related to the R&amp;amp;D of the Lightbridge Fuel&#x2122;, regulatory approval of the Company&#x2019;s fuel, support for nuclear power, changes in accounting and taxation standards, inability to achieve overall short-term and long-term R&amp;amp;D milestones toward commercialization, future impairment charges to the Company&#x2019;s assets, and global or regional catastrophic events. The Company may also be subject to various additional political, economic, and other uncertainties.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company is engaged in significant research and development (R&amp;amp;D) activities to advance its nuclear fuel technology at Idaho National Laboratory (INL). For the three months ended March 31, 2025, R&amp;amp;D expenses associated with activities conducted at the INL accounted for approximately 47% of the Company&#x2019;s total R&amp;amp;D expenditure. The Company currently relies on INL for developing, testing and evaluating its nuclear fuel. Any disruption in access to INL&#x2019;s resources, including changes in government policies, facility downtime, regulatory constraints, or unforeseen operational challenges could have a material adverse effect on the Company&#x2019;s current ability to advance its R&amp;amp;D activities. &lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <ltbr:ResearchAndDevelopmentPercentage
      contextRef="From2025-01-01to2025-03-31_ltbr_INLMember"
      decimals="INF"
      id="fid_257"
      unitRef="Pure">0.47</ltbr:ResearchAndDevelopmentPercentage>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_212">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;ASU No. 2023-09, &lt;em&gt;Income Taxes (Topic 740): Improvements to Income Tax Disclosures&lt;/em&gt;, was issued by the FASB in December 2023. This guidance enhances income tax disclosure requirements by mandating the disclosure of (1) specific categories in the rate reconciliation, (2) income or loss from continuing operations before income taxes, disaggregated between domestic and foreign, and (3) income tax expense or benefit from continuing operations, disaggregated by federal, state, and foreign. The ASU also requires disclosure of income tax payments to federal, state, local, and foreign jurisdictions, among other changes. The standard is effective for annual periods beginning after December 15, 2024, and will be adopted by the Company as permitted. The Company will apply the guidance on a prospective basis and the adoption is not expected to have a material impact on its condensed consolidated financial statements or related disclosures.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;In November 2024, the FASB issued ASU No. 2024-03, &lt;em&gt;Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures&lt;/em&gt; (Subtopic 220-40): &lt;em&gt;Disaggregation of Income Statement Expenses&lt;/em&gt; (&#x201c;ASU 2024-03&#x201d;), which required disclosure of certain costs and expenses on an interim and annual basis in the notes to the consolidated financial statements. The guidance is effective for annual reporting periods beginning after December 15, 2026 and interim periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The guidance is to be applied either (1) prospectively to financial statements issued for reporting periods after the effective date or (2) retrospectively to any or all prior periods presented in the financial statements. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company has evaluated other recently issued, but not yet effective, accounting standards that have been issued or proposed by the FASB or other standards-setting bodies through the filing date of these unaudited condensed consolidated financial statements and does not believe the future adoption of any such standards will have a material impact on the consolidated financial statements and related disclosures.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:EarningsPerShareTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_192">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Note 2. Net Loss Per Share&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Basic net loss per share is computed using the weighted-average number of common shares outstanding during the reporting period, except that it does not include unvested common shares subject to repurchase or cancellation. Diluted net loss per share is computed using the weighted-average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The outstanding securities noted below have been excluded from the computation of diluted weighted shares outstanding for the three months ended March 31, 2025 and 2024, as they would have been anti-dilutive due to the Company&#x2019;s losses at March 31, 2025 and 2024 and also because the exercise price of certain of these outstanding securities was greater than the average closing price of the Company&#x2019;s common stock.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Three Months Ended&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;March 31,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Stock options outstanding&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;429,454&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;555,582&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Restricted stock awards outstanding&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;743,702&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;557,688&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;1,173,156&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;1,113,270&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_214">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Three Months Ended&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;March 31,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Stock options outstanding&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;429,454&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;555,582&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Restricted stock awards outstanding&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;743,702&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;557,688&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;1,173,156&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;1,113,270&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_260"
      unitRef="Shares">429454</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_263"
      unitRef="Shares">555582</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_261"
      unitRef="Shares">743702</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_264"
      unitRef="Shares">557688</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_262"
      unitRef="Shares">1173156</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_265"
      unitRef="Shares">1113270</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <ltbr:PrepaidProjectCostsDisclosureTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_193">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Note 3. Prepaid Project Costs and Other Long-term Assets&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;In 2022, the Company entered into two agreements with Idaho National Laboratory (INL), in collaboration with the Department of Energy (DOE), to support the development of Lightbridge Fuel&#x2122;. At the time of signing, the Company made advance payments for future project work totaling $0.4 million to Battelle Energy Alliance, LLC (BEA), the DOE&#x2019;s operating contractor for INL. In May 2023, the Company and INL modified the agreements to extend the contract term to May 2029, aligning it with the duration of the irradiation testing, and increasing the advance payments by $0.1 million to $0.5 million. During the quarter ended March 31, 2025, the Company made additional advance payments of $0.6 million which subsequently offset $0.4 million in project costs. As of March 31, 2025, and December 31, 2024, the Company&#x2019;s prepaid project costs were $0.7 million and $0.5 million, respectively.&lt;/p&gt;</ltbr:PrepaidProjectCostsDisclosureTextBlock>
    <us-gaap:PrepaidExpenseNoncurrent
      contextRef="AsOf2022-12-31_ltbr_BattelleEnergyAllianceLLCMember"
      decimals="-5"
      id="fid_266"
      unitRef="USD">400000</us-gaap:PrepaidExpenseNoncurrent>
    <us-gaap:PrepaidExpenseNoncurrent
      contextRef="AsOf2023-05-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_ltbr_MiniimumMember"
      decimals="-5"
      id="fid_269"
      unitRef="USD">100000</us-gaap:PrepaidExpenseNoncurrent>
    <ltbr:PrepaidProjectCostsAddition
      contextRef="AsOf2023-05-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_ltbr_MaxiimumMember"
      decimals="-5"
      id="fid_268"
      unitRef="USD">500000</ltbr:PrepaidProjectCostsAddition>
    <ltbr:AdditionalPrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2025-03-31"
      decimals="-5"
      id="fid_271"
      unitRef="USD">600000</ltbr:AdditionalPrepaidExpenseAndOtherAssetsCurrent>
    <ltbr:OffsetOfProjectCosts
      contextRef="From2025-01-01to2025-03-31"
      decimals="-5"
      id="fid_272"
      unitRef="USD">400000</ltbr:OffsetOfProjectCosts>
    <us-gaap:PrepaidExpenseNoncurrent
      contextRef="AsOf2025-03-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"
      decimals="-5"
      id="fid_270"
      unitRef="USD">700000</us-gaap:PrepaidExpenseNoncurrent>
    <us-gaap:PrepaidExpenseNoncurrent
      contextRef="AsOf2024-12-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"
      decimals="-5"
      id="fid_267"
      unitRef="USD">500000</us-gaap:PrepaidExpenseNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_194">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Note 4. Accounts Payable and Accrued Liabilities&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Accounts payable and accrued liabilities consist of the following (rounded in millions):&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;March 31,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;December 31,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Trade payables&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.3&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.2&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Accrued research and development expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.1&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.1&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Accrued bonus&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.3&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Accrued payroll taxes and professional fees &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.3&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.1&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;1.0&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;0.4&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_215">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;March 31,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;December 31,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Trade payables&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.3&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.2&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Accrued research and development expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.1&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.1&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Accrued bonus&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.3&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Accrued payroll taxes and professional fees &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.3&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.1&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;1.0&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;0.4&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccountsPayableTradeCurrentAndNoncurrent
      contextRef="AsOf2025-03-31"
      decimals="-5"
      id="fid_273"
      unitRef="USD">300000</us-gaap:AccountsPayableTradeCurrentAndNoncurrent>
    <us-gaap:AccountsPayableTradeCurrentAndNoncurrent
      contextRef="AsOf2024-12-31"
      decimals="-5"
      id="fid_278"
      unitRef="USD">200000</us-gaap:AccountsPayableTradeCurrentAndNoncurrent>
    <ltbr:AccruedResearchAndDevelopmentExpensesCurrent
      contextRef="AsOf2025-03-31"
      decimals="-5"
      id="fid_274"
      unitRef="USD">100000</ltbr:AccruedResearchAndDevelopmentExpensesCurrent>
    <ltbr:AccruedResearchAndDevelopmentExpensesCurrent
      contextRef="AsOf2024-12-31"
      decimals="-5"
      id="fid_279"
      unitRef="USD">100000</ltbr:AccruedResearchAndDevelopmentExpensesCurrent>
    <us-gaap:AccruedBonusesCurrentAndNoncurrent
      contextRef="AsOf2025-03-31"
      decimals="-5"
      id="fid_275"
      unitRef="USD">300000</us-gaap:AccruedBonusesCurrentAndNoncurrent>
    <us-gaap:AccruedBonusesCurrentAndNoncurrent
      contextRef="AsOf2024-12-31"
      decimals="-6"
      id="fid_280"
      unitRef="USD">0</us-gaap:AccruedBonusesCurrentAndNoncurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="AsOf2025-03-31"
      decimals="-5"
      id="fid_277"
      unitRef="USD">300000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="AsOf2024-12-31"
      decimals="-5"
      id="fid_281"
      unitRef="USD">100000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2025-03-31"
      decimals="-5"
      id="fid_276"
      unitRef="USD">1000000.0</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2024-12-31"
      decimals="-5"
      id="fid_282"
      unitRef="USD">400000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_195">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Note 5. Commitments and Contingencies&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;em&gt;&lt;span style="text-decoration:underline"&gt;Operating Leases&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company leased office space for a 12-month term from January 1, 2025 through December 31, 2025 with a monthly payment of approximately $8,000. The future minimum lease payments required under the non-cancellable operating leases for 2025 total approximately $0.1 million. Total rent expense for the three months ended March 31, 2025 and 2024 was approximately $25,000 and $24,000, respectively.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <ltbr:LesseeOperatingLeaseTerm contextRef="From2025-01-01to2025-03-31" id="fid_287">P12M</ltbr:LesseeOperatingLeaseTerm>
    <us-gaap:OperatingLeasePayments
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_285"
      unitRef="USD">8000</us-gaap:OperatingLeasePayments>
    <ltbr:LeasePaymentUnderNonCancellableOperatingLeases
      contextRef="From2025-01-01to2025-03-31"
      decimals="-5"
      id="fid_286"
      unitRef="USD">100000</ltbr:LeasePaymentUnderNonCancellableOperatingLeases>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_284"
      unitRef="USD">25000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_283"
      unitRef="USD">24000</us-gaap:OperatingLeaseExpense>
    <us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_196">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Note 6. Research and Development Costs&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;em&gt;&lt;span style="text-decoration:underline"&gt;INL Project&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;In 2022, Lightbridge entered into agreements with BEA, to support the development of Lightbridge Fuel&#x2122;. These framework agreements use an innovative structure that consists of an &#x201c;umbrella&#x201d; Strategic Partnership Project Agreement (SPPA) and an &#x201c;umbrella&#x201d; Cooperative Research and Development Agreement (CRADA), with an initial duration of seven years. Throughout the duration of these umbrella agreements, all R&amp;amp;D work contracted with BEA is through the issuance of Project Task Statements (PTS). The initial phase of work under the two agreements is expected to culminate in future irradiation testing in the INL Advanced Test Reactor of fuel samples using enriched uranium supplied by the DOE. The initial phase of work aims to generate irradiation performance data for Lightbridge&#x2019;s delta-phase uranium-zirconium alloy relating to various thermophysical properties. Data gathered during future post-irradiation examination work are expected to support fuel performance modeling and regulatory licensing efforts for the commercial deployment of Lightbridge Fuel&#x2122;. For the three months ended March 31, 2025 and 2024, the Company recorded $0.8 million and $0.4 million in R&amp;amp;D expenses associated with INL, respectively.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;em&gt;&lt;span style="text-decoration:underline"&gt;INL Modifications to the CRADA and SPPA Project Task Statements&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On January 16, 2025, the Company and BEA entered into Modification No. 3 to the PTS No. 1 under the CRADA, dated September 27, 2022, as amended on May 22, 2023 and May 30, 2023, by and between the Company and BEA. Pursuant to the terms of Modification No. 3, the potential amounts payable by the Company to reimburse BEA for its expenses and employee time associated with R&amp;amp;D activities were increased by approximately $1.6 million, bringing the total estimated cost for the work to be performed under the &#x201c;umbrella&#x201d; CRADA to $4.2 million. This modification also required that a $600,000 advance payment be made, which was due and paid on January 16, 2025.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On March 18, 2025, the Company and BEA entered into Modification No. 4 to the PTS No. 1 under the SPPA, dated December 9, 2022, as amended on May 23, 2023, March 26, 2024 and October 24, 2024, by and between the Company and BEA. Pursuant to the terms of Modification No. 4, the potential amounts payable by the Company to reimburse BEA for its expenses and employee time were increased by approximately $0.6 million, bringing the total estimated cost for the work to be performed under the &#x201c;umbrella&#x201d; SPPA to $2.6 million.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;After accounting for Modification No. 4, cash payments from Lightbridge to BEA under both CRADA and SPPA are estimated at approximately $6.8 million on a cost reimbursable basis over the performance periods. These obligations are generally cancellable with 30 days&#x2019; notice and, therefore, are not considered firm commitments. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;em&gt;&lt;span style="text-decoration:underline"&gt;&lt;/span&gt;&lt;/em&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;em&gt;&lt;span style="text-decoration:underline"&gt;Romania Feasibility Study&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On October 16, 2023, the Company engaged RATEN ICN in Romania to perform an engineering study to assess the compatibility and suitability of Lightbridge Fuel&#x2122; for use in Canada Deuterium Uranium (CANDU) reactors. The total price of approximately $0.2 million was payable in three installments, including an advance payment of $0.1 million and an interim milestone payment and final payment totaling approximately $0.1 million. The Company made its final payment in December 2024 when the study was completed. The Company has no further obligations under the agreement. For the three months ended March 31, 2025 and 2024, the Company recorded $0 million and $0.1 million, respectively in R&amp;amp;D expenses associated with RATEN ICN feasibility study.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;em&gt;&lt;span style="text-decoration:underline"&gt;FEED Study with Centrus Energy for a Lightbridge Pilot Fuel Fabrication Facility&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On December 5, 2023, the Company entered into an agreement with Centrus Energy to conduct a front-end engineering and design (FEED) study to evaluate deployment of a Lightbridge Pilot Fuel Fabrication Facility (LPFFF) at the American Centrifuge Plant in Piketon, Ohio. The Company made its final payment in December 2024 for the study was completed in 2024 and has no further obligations under the agreement. For the three months ended March 31, 2025 and 2024, the Company recorded $0 million and $0.2 million, respectively, in R&amp;amp;D expenses associated with this FEED study.&lt;/p&gt;</us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2025-01-01to2025-03-31_ltbr_INLMember"
      decimals="-5"
      id="fid_289"
      unitRef="USD">800000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-01-01to2024-03-31_ltbr_INLMember"
      decimals="-5"
      id="fid_290"
      unitRef="USD">400000</us-gaap:ResearchAndDevelopmentExpense>
    <ltbr:ResearchAndDevelopmentArrangementExpense
      contextRef="From2025-01-01to2025-03-31_ltbr_BattelleEnergyAllianceLLCMember"
      decimals="-5"
      id="fid_291"
      unitRef="USD">1600000</ltbr:ResearchAndDevelopmentArrangementExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2025-01-01to2025-03-31_ltbr_CRADAMember"
      decimals="-5"
      id="fid_292"
      unitRef="USD">4200000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2025-01-16"
      decimals="0"
      id="fid_293"
      unitRef="USD">600000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2025-01-01to2025-03-31_ltbr_BattelleEnergyAllianceLLCMember"
      decimals="-5"
      id="fid_295"
      unitRef="USD">600000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2025-01-01to2025-03-31_ltbr_StrategicPartnershipProjectAgreementMember"
      decimals="-5"
      id="fid_294"
      unitRef="USD">2600000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OtherResearchAndDevelopmentExpense
      contextRef="From2025-01-01to2025-03-31"
      decimals="-5"
      id="fid_288"
      unitRef="USD">6800000</us-gaap:OtherResearchAndDevelopmentExpense>
    <ltbr:ResearchAndDevelopmentExpensePayable
      contextRef="AsOf2023-10-16_ltbr_CANDUMember"
      decimals="-5"
      id="fid_298"
      unitRef="USD">200000</ltbr:ResearchAndDevelopmentExpensePayable>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2023-10-16_ltbr_CANDUMember"
      decimals="-5"
      id="fid_299"
      unitRef="USD">100000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <ltbr:PaymentsToResearchAndDevelopmentCost
      contextRef="From2024-12-01to2024-12-31_ltbr_CANDUMember"
      decimals="-5"
      id="fid_300"
      unitRef="USD">100000</ltbr:PaymentsToResearchAndDevelopmentCost>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2025-01-01to2025-03-31_ltbr_CANDUMember"
      decimals="-6"
      id="fid_296"
      unitRef="USD">0</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-01-01to2024-03-31_ltbr_CANDUMember"
      decimals="-5"
      id="fid_297"
      unitRef="USD">100000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2025-01-01to2025-03-31_ltbr_FEEdMember"
      decimals="-6"
      id="fid_301"
      unitRef="USD">0</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-01-01to2024-03-31_ltbr_FEEdMember"
      decimals="-5"
      id="fid_302"
      unitRef="USD">200000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_197">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Note 7. Stockholders&#x2019; Equity and Stock-Based Compensation&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;At March 31, 2025, the Company had 21,557,343 common shares outstanding (including outstanding restricted stock awards (RSAs) totaling 743,702 shares). Also outstanding were stock options relating to 429,454 shares of common stock (of which 409,789 stock options were vested), all totaling 21,986,797 shares of common stock and all common stock equivalents, outstanding as of March 31, 2025.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;At December 31, 2024, the Company had 18,783,912 common shares outstanding (including outstanding RSAs totaling 781,864 shares). Also outstanding were stock options relating to 464,940 shares of common stock (of which 445,275 stock options were vested), all totaling 19,248,852 shares of common stock and all common stock equivalents, outstanding as of December 31, 2024.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Issuance of Series X Preferred Stock&#160;&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On February 27, 2025, the Company entered into a Subscription and Investment Representation Agreement with the chair of the Audit Committee and an independent member of the Board (the &#x201c;Purchaser&#x201d;), pursuant to which the Company agreed to issue and sell one (1) share of the Company&#x2019;s Series X Preferred Stock, par value $0.001 per share (the &#x201c;Series X Preferred Stock&#x201d;), to the Purchaser for $100 in cash. The sale closed on February 27, 2025 and the $100 was fully paid-up and recorded under current liabilities. The Company will redeem the Series X Preferred Stock for $100 cash after the Company&#x2019;s annual 2025 shareholder meeting (the &#x201c;Annual Meeting&#x201d;).&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Series X Preferred Stock does not have any voting rights except with respect to any proposal to increase the number of authorized shares of common stock of the Company. Each share of Series X Preferred Stock will be entitled to 25,000,000 votes on such proposal, voting together with the holders of the Company&#x2019;s common stock. The votes by the holder of Series X Preferred Stock will be cast at the Annual Meeting automatically in the same &#x201c;mirrored&#x201d; proportion as the aggregate votes cast &#x201c;for&#x201d; and &#x201c;against&#x201d; the proposal by the holders of the common stock who vote on such proposal (excluding abstentions, broker non-votes and shares of common stock that are not voted &#x201c;for&#x201d; or &#x201c;against&#x201d; such proposal). The voting power attributable to the Series X Preferred Stock will be disregarded for purposes of determining whether a quorum is present at the Annual Meeting.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Pursuant to the terms of issuance, the Series X Preferred Stock will be redeemed at its original issuance price of $100 upon the earlier of (i) the order of the Board of Directors in its sole discretion, automatically and effective at such date and time as determined and specified by the Board of Directors in its sole discretion and (ii) automatically and effective immediately after the publishing or other public announcement by the Company of the final results of any stockholder vote on a proposal to increase the authorized common stock. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Common Stock Equity Offerings&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;&lt;em&gt;Increase in Authorized Common Shares &lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On February 26, 2025, the Company&#x2019;s Board of Directors approved increasing the authorized common shares from 25,000,000 shares to 100,000,000 shares. This change will take effect upon receiving majority shareholder approval at the 2025 shareholder annual meeting on May 8, 2025 and filing the amendment to the Company&#x2019;s Articles of Incorporation with the Nevada Secretary of State (note 9).&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;&lt;em&gt;At-the-Market (ATM) Offerings&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On May 28, 2019, the Company entered into an at-the-market equity offering sales agreement with Stifel, Nicolaus &amp;amp; Company, Incorporated (Stifel), which was amended on April 9, 2021 and May 8, 2024 (the ATM Agreement), pursuant to which the Company may issue and sell shares of its common stock from time to time through Stifel as the Company&#x2019;s sales agent. Under this amended agreement, the Company pays Stifel a commission equal to 3.0% of the aggregate gross proceeds of any sales of common stock under the agreement. The offering of common stock pursuant to this agreement can be terminated with 10 days written notice by either party. Sales of the Company&#x2019;s common stock through Stifel, if any, will be made by any method that is deemed to be an &#x201c;at-the-market&#x201d; equity offering as defined in Rule 415 promulgated under the Securities Act of 1933.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company filed a shelf registration statement on Form S-3 with the Securities and Exchange Commission (SEC) on March 29, 2024, registering the sale of up to $75.0 million of the Company&#x2019;s securities that was declared effective on April 19, 2024. On May 10, 2024, the Company filed a prospectus supplement, which was further supplemented on July 19, 2024 and August 9, 2024 (collectively, the &#x201c;First Prospectus Supplement&#x201d;), pursuant to which the Company may offer and sell shares of common stock having an aggregate offering price of up to $12.6 million from time to time through the ATM. The Company exhausted all sales under the First Prospectus Supplement. On November 22, 2024, the Company filed a prospectus supplement pursuant to which the Company may offer and sell shares of common stock having an aggregate offering price of up to $45.0 million from time to time through the ATM.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company records its ATM sales on a settlement date basis. The Company sold 2,605,619 shares under the ATM for the three months ended March 31, 2025 resulting in net proceeds of $20.2 million (stock issuance costs were approximately $0.7 million). The Company records its ATM sales on a settlement date basis. The Company sold 427,300 shares under the ATM for the three months ended March 31, 2024 resulting in net proceeds of $1.2 million (stock issuance costs were approximately $0.2 million).&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Stock-Based Compensation&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;&lt;em&gt;&#160;2020 Omnibus Incentive Plan &lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On March 9, 2020, the Board of Directors adopted the Company&#x2019;s 2020 Omnibus Incentive Plan (as subsequently amended, the &#x201c;2020 Plan&#x201d;). On September 3, 2020, the shareholders approved the 2020 Plan to authorize grants of the following types of awards: (a) Options, (b) Stock Appreciation Rights, (c) Restricted Stock Awards and Restricted Stock Units, and (d) Other Stock-Based and Cash-Based Awards. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On February 27, 2024, the Board of Directors approved an increase of 700,000 shares to the authorized number of shares under the 2020 Plan, increasing the total authorized number of shares from 1,800,000 shares to 2,500,000 shares. This increase was approved by the stockholders at the shareholders&#x2019; annual meeting on April 19, 2024. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The total number of shares of common stock available for issuance under the 2020 Plan was 2,500,000 shares with 1,009,389 shares available for future issuance at March 31, 2025.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On February 26, 2025, the Company&#x2019;s Board of Directors approved an increase of 2,500,000 shares to the authorized number of shares under the 2020 Plan, increasing the total authorized number of shares from 2,500,000 to 5,000,000. This change will take effect if approved by shareholders at the Company&#x2019;s 2025 shareholder annual meeting on May 8, 2025 (note 9).&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;&lt;em&gt;Stock Options&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Stock options issued to the Company&#x2019;s employees, directors and consultants are summarized as follows for the three months ended March 31, 2025 and 2024:&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Number of&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Options &lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Weighted Average Exercise Price&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Weighted-Average&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Remaining&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Contractual&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Term (Years)&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Aggregate&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Intrinsic&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Value&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Outstanding, December 31, 2024&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;464,940&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;16.24&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;3.07&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;184,818&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt"&gt;Granted&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;10,448&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;9.42&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt"&gt;Exercised&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;(45,934 &lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;4.80&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;310,093&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt"&gt;Forfeited&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt"&gt;Expired&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Outstanding, March 31, 2025&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;429,454&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;17.29&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;2.53&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;469,719&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Vested and expected to vest, end of the period&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;429,454&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;17.29&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;2.53&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;469,719&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Options exercisable, end of the period&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;409,789&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;17.97&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;2.22&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;387,153&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;In the three months ended March 31, 2025 and 2024, the Company issued 10,448 and 58,309 stock options, respectively, to one consultant. The 10,448 stock options and the 58,309 stock options were assigned a fair value of $5.74 per share and $1.03 per share, respectively (total fair value of $60,000 for each grant). The weighted-average grant-date exercise price per share of the stock options granted for the three months ended March 31, 2025 and 2024, was $9.42 and $2.62, respectively.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The fair value was determined using the Black-Scholes pricing model. For expected volatility, the Company concluded that the historical volatility over the option&#x2019;s expected holding term provided the most reasonable basis for this estimate. For the risk-free interest rate, the Company used U.S. Treasury Note rates, which mature at approximately the same time as the option&#x2019;s expected holding term or option life determined by using the simplified method. The Company recognized forfeitures of equity-based awards as a reduction to compensation costs in the period in which they occur. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The following assumptions were used in the Black-Scholes pricing model to determine the fair value of stock options granted for the three months ended March 31, 2025 and 2024:&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Three Months Ended&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;March 31,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Expected volatility&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;117.44&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;75.36&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Risk free interest rate &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;3.95&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;4.54&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Dividend yield rate&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Expected life&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"&gt;2 years&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"&gt;2 years&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Closing price per share - common stock &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;9.42&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;2.62&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The intrinsic value is calculated as the difference between the fair value of the Company&#x2019;s common stock and the exercise price of the stock options. The fair value of the Company&#x2019;s common stock was $7.46 per share and $2.95 per share at March 31, 2025 and 2024, respectively. As of March 31, 2025, total unrecognized compensation cost related to option awards was $35,388, which is expected to be recognized over a remaining weighted-average vesting period of 1.9 years. As of March 31, 2024, total unrecognized compensation cost related to option awards was $35,384, which is expected to be recognized over a remaining weighted-average vesting period of 1.9 years.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;&lt;em&gt;Exercise of Options&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;For the three months ended March 31, 2025, the Company received approximately $0.2 million of net proceeds from the exercise of 45,934 stock options from employees and consultants. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;&lt;em&gt;Common Stock&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;em&gt;&lt;span style="text-decoration:underline"&gt;Consultants&#x2019; Stock Issuances&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;For the three months ended March 31, 2025 and 2024, the Company issued 3,171 shares (with stock prices of $4.73 per share) and 3,750 shares (with stock prices of $4.00 per share) of common stock, respectively, to its investor relations firm for services provided during the period, recorded to general and administrative expenses. These shares vested immediately upon issuance. The expense recorded for these share issuances was $15,000 for each quarter. The shares were valued based on the closing market price of the Company&#x2019;s common stock on the date of grant. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On August 19, 2024, the Board of Directors approved an equity grant valued at $180,000 to a consulting and investment research firm, for corporate advisory services to be provided over a twelve-month period, and preparation and dissemination of a report regarding the Company, which resulted in issuing the consultant 71,713 shares of common stock on the grant date, valued at $2.51 per share. These shares vested immediately upon issuance and are not forfeitable. The compensation cost of $180,000 began to be recognized on a straight-line basis over the requisite service period. Approximately $45,000 and $0 were recorded as consulting expenses for the three months ended March 31, 2025, and 2024, respectively.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;As of March 31, 2025, the unrecognized compensation cost of approximately $69,000 was recorded under prepaid expenses and other current assets on the accompanying condensed consolidated balance sheet, which is expected to be recognized over a remaining service period of 0.4 years.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;em&gt;&lt;span style="text-decoration:underline"&gt;Director Compensation - Equity-Settled Awards&lt;/span&gt;&lt;/em&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On December 4, 2024, the Board of Directors approved an equity grant valued at $500,000 in total to its five directors for the service period and year ended December 31, 2024, which resulted in granting a total of 85,915 shares of common stock, valued on the grant date at $5.82 per share on December 4, 2024, which shares vested on January 2, 2025. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On November 20, 2023, the Board of Directors approved an equity grant valued at $240,000 in total to its six directors for the service period and year ended December 31, 2023, which resulted in granting a total of 60,456 shares of common stock, valued on the grant date at $3.97 per share on November 20, 2023, which shares vested on January 2, 2024.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;As a result, the fair value of the stock awards was measured on the grant date and recorded as an increase to stock-based compensation expense and additional paid-in capital in 2025 and 2024. The fair value of the shares granted was determined based on the closing market price of the Company&#x2019;s common stock on the grant date. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;&lt;em&gt;Restricted Stock Awards&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The following summarizes the Company&#x2019;s restricted stock award activity and the RSA outstanding: &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Number of &lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Shares&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Weighted- &lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Average&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Grant Date&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Fair Value&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Aggregate &lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Fair&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Value&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Outstanding, December 31, 2024&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;781,864&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;5.19&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;3,698,217&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Awards granted&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;57,940&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;8.63&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;500,022&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Awards vested&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;(96,102&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;5.67&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;737,535&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Awards forfeited&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Outstanding, March 31, 2025&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;743,702&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;5.40&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;"&gt;$&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"&gt;&#160;5,548,017 &lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On March 12, 2025, the Board of Directors approved a grant of restricted stock awards (RSAs) totaling $0.5 million to its five directors for the service year ending December 31, 2025. This grant comprised 57,940 RSAs, valued at $8.63 per share on the grant date, with vesting scheduled in four quarterly installments. The first installment, consisting of 14,485 RSAs, vested on March 31, 2025. This resulted in the recognition of $0.1 million in stock-based compensation expense for the quarter ended March 31, 2025.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The aggregate fair value was calculated as the fair value of the Company&#x2019;s common stock. The fair value of the Company&#x2019;s common stock was $7.46 and $2.95 per share at March 31, 2025 and 2024, respectively. The fair value of the RSAs vested for the three months ended March 31, 2025 and 2024 was $0.7 million and $0 million, respectively. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;As of March 31, 2025, all the outstanding shares of RSAs are unvested. As of March 31, 2025, total unrecognized compensation cost related to RSAs was $3.5 million, which is expected to be recognized over a remaining weighted-average vesting period of 2.14 years.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"&gt;&lt;em&gt;&lt;span style="text-decoration:underline"&gt;&lt;/span&gt;&lt;/em&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"&gt;&lt;em&gt;&lt;span style="text-decoration:underline"&gt;Restricted Stock Awards Modification and Net Share Settlements for Payments of Withholding Taxes&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"&gt;On March 24, 2025, the Company entered into a separation agreement with a former employee. As part of the agreement, the Board of Directors approved the accelerated vesting of 70,710 RSAs, which would have otherwise been forfeited upon termination. In accordance with ASC 718, this was treated as a modification, leading to the recognition of $0.5 million in stock-based compensation expense for the quarter ended March 31, 2025. This expense included $0.2 million of previously unrecognized compensation cost and $0.3 million of incremental fair value from the modification of the RSAs awarded.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;To satisfy approximately $0.2 million in payroll withholding taxes associated with the accelerated RSAs vesting, the Company withheld 21,285 shares, resulting in the issuance of 49,425 net shares to the former employee. These withheld shares were returned to the 2020 Plan share reserve for potential future issuance.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"&gt;On March 14, 2025, 10,907 RSAs vested to the former employee based on his service to the Company. To satisfy approximately $36,000 in payroll withholding taxes, the Company withheld 3,863 shares, resulting in the issuance of 7,044 net shares to the former employee. These withheld shares were returned to the 2020 Plan share reserve for potential future issuance.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;em&gt;&lt;span style="text-decoration:underline"&gt;RSA Summary - 2025 and 2024&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;As of March 31, 2025 and December 31, 2024, there were 743,702 shares and 781,864 shares of RSAs included in the total issued and outstanding common stock, respectively. Compensation expense for RSAs issued to employees and consultants are generally recognized straight line over the three-year vesting period. A total of $1.3 million (including the $0.5 million accelerated RSAs vesting for the former employee) and $0.4 million of stock-based compensation expense was recorded for the three months ended March 31, 2025 and 2024, respectively, for the RSAs.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Stock-Based Compensation Expense&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Total non-cash stock-based compensation expense recorded related to options granted and restricted stock awards included in the Company&#x2019;s unaudited condensed consolidated statements of operations for the three months ended March 31, 2025 and 2024 are as follows (rounded in millions):&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Three Months Ended&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;March 31,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Research and development expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.2&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.1&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;General and administrative expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1.1&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.4&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Total stock-based compensation expense &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;1.3&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;0.5&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <ltbr:CommonStockShareOutstanding
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_370"
      unitRef="Shares">21557343</ltbr:CommonStockShareOutstanding>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_397"
      unitRef="Shares">743702</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_400"
      unitRef="Shares">429454</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_401"
      unitRef="Shares">409789</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <ltbr:CommonStockEquivalentsOutstandingShares
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_402"
      unitRef="Shares">21986797</ltbr:CommonStockEquivalentsOutstandingShares>
    <ltbr:CommonStockShareOutstanding
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_371"
      unitRef="Shares">18783912</ltbr:CommonStockShareOutstanding>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="fid_396"
      unitRef="Shares">781864</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="fid_373"
      unitRef="Shares">464940</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="fid_379"
      unitRef="Shares">445275</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <ltbr:CommonStockEquivalentsOutstandingShares
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_372"
      unitRef="Shares">19248852</ltbr:CommonStockEquivalentsOutstandingShares>
    <ltbr:DescriptionOfSubscriptionAndInvestmentRepresentationAgreement
      contextRef="From2025-02-03to2025-02-27_ltbr_SeriesXPreferredStockMember"
      id="fid_461">(1) share of the Company&#x2019;s Series X Preferred Stock, par value $0.001 per share (the &#x201c;Series X Preferred Stock&#x201d;), to the Purchaser for $100 in cash. The sale closed on February 27, 2025 and the $100 was fully paid-up and recorded under current liabilities. The Company will redeem the Series X Preferred Stock for $100 cash after the Company&#x2019;s annual 2025 shareholder meeting (the &#x201c;Annual Meeting&#x201d;).</ltbr:DescriptionOfSubscriptionAndInvestmentRepresentationAgreement>
    <ltbr:PreferredStockVotingRightsShares
      contextRef="From2025-02-03to2025-02-27_ltbr_SeriesXPreferredStockMember"
      decimals="0"
      id="fid_462"
      unitRef="Shares">25000000</ltbr:PreferredStockVotingRightsShares>
    <us-gaap:PreferredStockRedemptionAmount
      contextRef="AsOf2025-02-27_ltbr_SeriesXPreferredStockMember"
      decimals="0"
      id="fid_453"
      unitRef="USD">100</us-gaap:PreferredStockRedemptionAmount>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-02-26_ltbr_BoardOfDirectorsMember_ltbr_BottomMember"
      decimals="0"
      id="fid_452"
      unitRef="Shares">25000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-02-26_ltbr_BoardOfDirectorsMember_ltbr_TopMember"
      decimals="0"
      id="fid_451"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:IntercompanyAgreementsDescription contextRef="From2019-05-01to2019-05-28" id="fid_386">Under this amended agreement, the Company pays Stifel a commission equal to 3.0% of the aggregate gross proceeds of any sales of common stock under the agreement. The offering of common stock pursuant to this agreement can be terminated with 10 days written notice by either party</us-gaap:IntercompanyAgreementsDescription>
    <ltbr:MarketOfferingsDisclosureDescription contextRef="From2024-03-01to2024-03-29" id="fid_374">The Company filed a shelf registration statement on Form S-3 with the Securities and Exchange Commission (SEC) on March 29, 2024, registering the sale of up to $75.0 million of the Company&#x2019;s securities that was declared effective on April 19, 2024. On May 10, 2024, the Company filed a prospectus supplement, which was further supplemented on July 19, 2024 and August 9, 2024 (collectively, the &#x201c;First Prospectus Supplement&#x201d;), pursuant to which the Company may offer and sell shares of common stock having an aggregate offering price of up to $12.6 million from time to time through the ATM. The Company exhausted all sales under the First Prospectus Supplement</ltbr:MarketOfferingsDisclosureDescription>
    <us-gaap:PaymentsForRepurchaseOfInitialPublicOffering
      contextRef="From2024-11-01to2024-11-22"
      decimals="-5"
      id="fid_403"
      unitRef="USD">45000000.0</us-gaap:PaymentsForRepurchaseOfInitialPublicOffering>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2025-01-01to2025-03-31_ltbr_AvailableForSaleSecuritiesMember"
      decimals="0"
      id="fid_398"
      unitRef="Shares">2605619</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <ltbr:ProceedsFromStockIssuances
      contextRef="From2025-01-01to2025-03-31_ltbr_AvailableForSaleSecuritiesMember"
      decimals="-5"
      id="fid_376"
      unitRef="USD">20200000</ltbr:ProceedsFromStockIssuances>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-01-01to2025-03-31_ltbr_AvailableForSaleSecuritiesMember"
      decimals="-5"
      id="fid_378"
      unitRef="USD">700000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-01-01to2024-03-31_ltbr_AvailableForSaleSecuritiesMember"
      decimals="0"
      id="fid_399"
      unitRef="Shares">427300</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <ltbr:ProceedsFromStockIssuances
      contextRef="From2024-01-01to2024-03-31_ltbr_AvailableForSaleSecuritiesMember"
      decimals="-5"
      id="fid_375"
      unitRef="USD">1200000</ltbr:ProceedsFromStockIssuances>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-01-01to2024-03-31_ltbr_AvailableForSaleSecuritiesMember"
      decimals="-5"
      id="fid_377"
      unitRef="USD">200000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <ltbr:DescriptionOfEquityIncentivePlan
      contextRef="From2024-02-01to2024-02-27_ltbr_TwoThousandTwentyEquityIncentivePlanMember"
      id="fid_383">the Board of Directors approved an increase of 700,000 shares to the authorized number of shares under the 2020 Plan, increasing the total authorized number of shares from 1,800,000 shares to 2,500,000 shares</ltbr:DescriptionOfEquityIncentivePlan>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="AsOf2025-03-31_ltbr_TwoThousandTwentyEquityIncentivePlanMember"
      decimals="0"
      id="fid_385"
      unitRef="Shares">2500000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <ltbr:FutureIssuanceOfShare
      contextRef="From2025-01-01to2025-03-31_ltbr_TwoThousandTwentyEquityIncentivePlanMember"
      decimals="0"
      id="fid_384"
      unitRef="Shares">1009389</ltbr:FutureIssuanceOfShare>
    <ltbr:DescriptionOfEquityIncentivePlan
      contextRef="From2025-02-01to2025-02-26_ltbr_TwoThousandTwentyEquityIncentivePlanMember"
      id="fid_404">the Company&#x2019;s Board of Directors approved an increase of 2,500,000 shares to the authorized number of shares under the 2020 Plan, increasing the total authorized number of shares from 2,500,000 to 5,000,000</ltbr:DescriptionOfEquityIncentivePlan>
    <us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_216">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Number of&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Options &lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Weighted Average Exercise Price&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Weighted-Average&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Remaining&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Contractual&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Term (Years)&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Aggregate&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Intrinsic&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Value&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Outstanding, December 31, 2024&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;464,940&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;16.24&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;3.07&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;184,818&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt"&gt;Granted&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;10,448&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;9.42&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt"&gt;Exercised&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;(45,934 &lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;4.80&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;310,093&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt"&gt;Forfeited&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt"&gt;Expired&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Outstanding, March 31, 2025&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;429,454&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;17.29&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;2.53&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;469,719&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Vested and expected to vest, end of the period&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;429,454&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;17.29&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;2.53&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;469,719&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Options exercisable, end of the period&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;409,789&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;17.97&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;2.22&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;387,153&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_312"
      unitRef="Shares">464940</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="fid_317"
      unitRef="USDPShares">16.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm contextRef="From2025-01-01to2025-03-31" id="fid_322">P3Y25D</ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm>
    <ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_330"
      unitRef="USD">184818</ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_313"
      unitRef="Shares">10448</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2025-01-01to2025-03-31"
      decimals="INF"
      id="fid_318"
      unitRef="USDPShares">9.42</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_314"
      unitRef="Shares">45934</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2025-01-01to2025-03-31"
      decimals="INF"
      id="fid_319"
      unitRef="USDPShares">4.80</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueExercised
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_336"
      unitRef="USD">310093</ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_315"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="From2025-01-01to2025-03-31"
      decimals="INF"
      id="fid_320"
      unitRef="USDPShares">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_316"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2025-01-01to2025-03-31"
      decimals="INF"
      id="fid_321"
      unitRef="USDPShares">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_335"
      unitRef="Shares">429454</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2025-03-31"
      decimals="INF"
      id="fid_334"
      unitRef="USDPShares">17.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermEndingFF contextRef="From2025-01-01to2025-03-31" id="fid_323">P2Y6M10D</ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermEndingFF>
    <ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_333"
      unitRef="USD">469719</ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_326"
      unitRef="Shares">429454</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice
      contextRef="AsOf2025-03-31"
      decimals="INF"
      id="fid_328"
      unitRef="USDPShares">17.29</ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice>
    <ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermVested contextRef="From2025-01-01to2025-03-31" id="fid_324">P2Y6M10D</ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermVested>
    <ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueVestedAndExpectedToVest
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_331"
      unitRef="USD">469719</ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueVestedAndExpectedToVest>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_327"
      unitRef="Shares">409789</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2025-03-31"
      decimals="INF"
      id="fid_329"
      unitRef="USDPShares">17.97</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermOptionsExercisable contextRef="From2025-01-01to2025-03-31" id="fid_325">P2Y2M19D</ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermOptionsExercisable>
    <ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueOptionsExercisable
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_332"
      unitRef="USD">387153</ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueOptionsExercisable>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_405"
      unitRef="Shares">10448</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_406"
      unitRef="Shares">58309</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="From2025-01-01to2025-03-31"
      decimals="INF"
      id="fid_407"
      unitRef="USDPShares">5.74</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="From2024-01-01to2024-03-31"
      decimals="INF"
      id="fid_408"
      unitRef="USDPShares">1.03</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_409"
      unitRef="USD">60000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="From2025-01-01to2025-03-31"
      decimals="INF"
      id="fid_411"
      unitRef="USDPShares">9.42</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="From2024-01-01to2024-03-31"
      decimals="INF"
      id="fid_412"
      unitRef="USDPShares">2.62</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_217">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Three Months Ended&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;March 31,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Expected volatility&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;117.44&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;75.36&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Risk free interest rate &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;3.95&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;4.54&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Dividend yield rate&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Expected life&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"&gt;2 years&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"&gt;2 years&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Closing price per share - common stock &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;9.42&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;2.62&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2025-01-01to2025-03-31"
      decimals="INF"
      id="fid_339"
      unitRef="Pure">1.1744</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2024-01-01to2024-03-31"
      decimals="INF"
      id="fid_340"
      unitRef="Pure">0.7536</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2025-01-01to2025-03-31"
      decimals="INF"
      id="fid_341"
      unitRef="Pure">0.0395</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2024-01-01to2024-03-31"
      decimals="INF"
      id="fid_342"
      unitRef="Pure">0.0454</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2025-01-01to2025-03-31" id="fid_345">P2Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2024-01-01to2024-03-31" id="fid_346">P2Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharePrice
      contextRef="AsOf2025-03-31"
      decimals="INF"
      id="fid_343"
      unitRef="USDPShares">9.42</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2024-03-31"
      decimals="INF"
      id="fid_344"
      unitRef="USDPShares">2.62</us-gaap:SharePrice>
    <ltbr:ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2025-03-31"
      decimals="INF"
      id="fid_414"
      unitRef="USDPShares">7.46</ltbr:ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice>
    <ltbr:ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-03-31"
      decimals="INF"
      id="fid_413"
      unitRef="USDPShares">2.95</ltbr:ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_415"
      unitRef="USD">35388</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="From2025-01-01to2025-03-31" id="fid_416">P1Y10M24D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="fid_417"
      unitRef="USD">35384</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="From2024-01-01to2024-03-31" id="fid_418">P1Y10M24D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2025-01-01to2025-03-31_ltbr_OptionsMember"
      decimals="-5"
      id="fid_394"
      unitRef="USD">200000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="From2025-01-01to2025-03-31_ltbr_OptionsMember"
      decimals="0"
      id="fid_395"
      unitRef="Shares">45934</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2025-01-01to2025-03-31_ltbr_CommonShareIssuancesMember"
      decimals="0"
      id="fid_419"
      unitRef="Shares">3171</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="From2025-01-01to2025-03-31_ltbr_CommonShareIssuancesMember"
      decimals="INF"
      id="fid_421"
      unitRef="USDPShares">4.73</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2024-01-01to2024-03-31_ltbr_CommonShareIssuancesMember"
      decimals="0"
      id="fid_420"
      unitRef="Shares">3750</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="From2024-01-01to2024-03-31_ltbr_CommonShareIssuancesMember"
      decimals="INF"
      id="fid_422"
      unitRef="USDPShares">4.00</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensation
      contextRef="From2025-01-01to2025-03-31_ltbr_CommonShareIssuancesMember"
      decimals="0"
      id="fid_423"
      unitRef="USD">15000</us-gaap:ShareBasedCompensation>
    <ltbr:CommonSharesIssuancesEquityGrant
      contextRef="From2024-08-01to2024-08-19_srt_BoardOfDirectorsChairmanMember"
      decimals="0"
      id="fid_392"
      unitRef="USD">180000</ltbr:CommonSharesIssuancesEquityGrant>
    <ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted
      contextRef="AsOf2024-08-19_srt_BoardOfDirectorsChairmanMember"
      decimals="0"
      id="fid_389"
      unitRef="Shares">71713</ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted>
    <ltbr:CommonStockValuedGrantDatePricePerShare
      contextRef="From2024-08-01to2024-08-19_srt_BoardOfDirectorsChairmanMember"
      decimals="INF"
      id="fid_387"
      unitRef="USDPShares">2.51</ltbr:CommonStockValuedGrantDatePricePerShare>
    <us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense
      contextRef="From2024-08-01to2024-08-19_srt_BoardOfDirectorsChairmanMember"
      decimals="0"
      id="fid_388"
      unitRef="USD">180000</us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2025-01-01to2025-03-31_srt_BoardOfDirectorsChairmanMember"
      decimals="0"
      id="fid_425"
      unitRef="USD">45000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2024-01-01to2024-03-31_srt_BoardOfDirectorsChairmanMember"
      decimals="0"
      id="fid_426"
      unitRef="USD">0</us-gaap:OperatingExpenses>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="AsOf2025-03-31_ltbr_PrepaidExpenseAndOtherCurrentAssetMember"
      decimals="0"
      id="fid_428"
      unitRef="USD">69000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="From2025-01-01to2025-03-31_ltbr_PrepaidExpenseAndOtherCurrentAssetMember"
      id="fid_427">P0Y4M24D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <ltbr:CommonSharesIssuancesEquityGrant
      contextRef="From2024-12-01to2024-12-04_srt_BoardOfDirectorsChairmanMember"
      decimals="0"
      id="fid_380"
      unitRef="USD">500000</ltbr:CommonSharesIssuancesEquityGrant>
    <ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted
      contextRef="AsOf2024-12-04_srt_BoardOfDirectorsChairmanMember"
      decimals="0"
      id="fid_382"
      unitRef="Shares">85915</ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted>
    <ltbr:CommonSharesEquityGrantPricePerShares
      contextRef="From2024-12-01to2024-12-04_srt_BoardOfDirectorsChairmanMember"
      decimals="INF"
      id="fid_381"
      unitRef="USDPShares">5.82</ltbr:CommonSharesEquityGrantPricePerShares>
    <ltbr:CommonSharesIssuancesEquityGrant
      contextRef="From2023-11-01to2023-11-20_srt_BoardOfDirectorsChairmanMember"
      decimals="0"
      id="fid_368"
      unitRef="USD">240000</ltbr:CommonSharesIssuancesEquityGrant>
    <ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted
      contextRef="AsOf2023-11-20_srt_BoardOfDirectorsChairmanMember"
      decimals="0"
      id="fid_390"
      unitRef="Shares">60456</ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted>
    <ltbr:CommonSharesEquityGrantPricePerShares
      contextRef="From2023-11-01to2023-11-20_srt_BoardOfDirectorsChairmanMember"
      decimals="INF"
      id="fid_391"
      unitRef="USDPShares">3.97</ltbr:CommonSharesEquityGrantPricePerShares>
    <ltbr:ScheduleOfOutstandingRSATableTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_218">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Number of &lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Shares&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Weighted- &lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Average&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Grant Date&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Fair Value&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Aggregate &lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Fair&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Value&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Outstanding, December 31, 2024&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;781,864&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;5.19&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;3,698,217&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Awards granted&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;57,940&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;8.63&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;500,022&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Awards vested&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;(96,102&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;5.67&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;737,535&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Awards forfeited&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Outstanding, March 31, 2025&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;743,702&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;5.40&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;"&gt;$&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"&gt;&#160;5,548,017 &lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</ltbr:ScheduleOfOutstandingRSATableTextBlock>
    <ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding
      contextRef="AsOf2024-12-31_ltbr_RestrictedStockAwardMember"
      decimals="0"
      id="fid_358"
      unitRef="Shares">781864</ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2024-12-31_ltbr_RestrictedStockAwardMember"
      decimals="INF"
      id="fid_359"
      unitRef="USDPShares">5.19</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding
      contextRef="AsOf2024-12-31_ltbr_RestrictedStockAwardMember"
      decimals="0"
      id="fid_360"
      unitRef="USD">3698217</ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2025-01-01to2025-03-31_ltbr_RestrictedStockAwardMember"
      decimals="0"
      id="fid_347"
      unitRef="Shares">57940</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2025-01-01to2025-03-31_ltbr_RestrictedStockAwardMember"
      decimals="INF"
      id="fid_350"
      unitRef="USDPShares">8.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted
      contextRef="From2025-01-01to2025-03-31_ltbr_RestrictedStockAwardMember"
      decimals="0"
      id="fid_354"
      unitRef="USD">500022</ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="From2025-01-01to2025-03-31_ltbr_RestrictedStockAwardMember"
      decimals="0"
      id="fid_348"
      unitRef="Shares">96102</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="From2025-01-01to2025-03-31_ltbr_RestrictedStockAwardMember"
      decimals="INF"
      id="fid_351"
      unitRef="USDPShares">5.67</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueVested
      contextRef="From2025-01-01to2025-03-31_ltbr_RestrictedStockAwardMember"
      decimals="0"
      id="fid_355"
      unitRef="USD">737535</ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueVested>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
      contextRef="From2025-01-01to2025-03-31_ltbr_RestrictedStockAwardMember"
      decimals="0"
      id="fid_349"
      unitRef="Shares">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
      contextRef="From2025-01-01to2025-03-31_ltbr_RestrictedStockAwardMember"
      decimals="INF"
      id="fid_352"
      unitRef="USDPShares">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue>
    <ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited
      contextRef="From2025-01-01to2025-03-31_ltbr_RestrictedStockAwardMember"
      decimals="0"
      id="fid_356"
      unitRef="USD">0</ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited>
    <ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94
      contextRef="AsOf2025-03-31_ltbr_RestrictedStockAwardMember"
      decimals="0"
      id="fid_361"
      unitRef="Shares">743702</ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2025-03-31_ltbr_RestrictedStockAwardMember"
      decimals="INF"
      id="fid_353"
      unitRef="USDPShares">5.40</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings
      contextRef="AsOf2025-03-31_ltbr_RestrictedStockAwardMember"
      decimals="0"
      id="fid_357"
      unitRef="USD">5548017</ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings>
    <ltbr:EquityGrantValue
      contextRef="From2025-03-01to2025-03-12_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember"
      decimals="-5"
      id="fid_369"
      unitRef="USD">500000</ltbr:EquityGrantValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2025-01-01to2025-03-31_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember"
      decimals="0"
      id="fid_430"
      unitRef="Shares">57940</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2025-01-01to2025-03-31_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember"
      decimals="INF"
      id="fid_429"
      unitRef="USDPShares">8.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2025-03-01to2025-03-12_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember"
      decimals="0"
      id="fid_432"
      unitRef="Shares">14485</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensation
      contextRef="From2025-01-01to2025-03-31_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember"
      decimals="-5"
      id="fid_431"
      unitRef="USD">100000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2025-03-31_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember"
      decimals="INF"
      id="fid_435"
      unitRef="USDPShares">7.46</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-03-31_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember"
      decimals="INF"
      id="fid_436"
      unitRef="USDPShares">2.95</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="From2025-01-01to2025-03-31_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember"
      decimals="-5"
      id="fid_433"
      unitRef="Shares">700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="From2024-01-01to2024-12-31_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember"
      decimals="-6"
      id="fid_434"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="AsOf2025-03-31_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember"
      decimals="-5"
      id="fid_437"
      unitRef="USD">3500000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="From2025-01-01to2025-03-31_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember"
      id="fid_438">P2Y1M20D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="From2025-01-01to2025-03-31_ltbr_TwentyTwentyFiveTransactionsMember"
      decimals="0"
      id="fid_443"
      unitRef="Shares">70710</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:ShareBasedCompensation
      contextRef="From2025-01-01to2025-03-31_ltbr_TwentyTwentyFiveTransactionsMember"
      decimals="-5"
      id="fid_440"
      unitRef="USD">500000</us-gaap:ShareBasedCompensation>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="AsOf2025-03-31_ltbr_TwentyTwentyFiveTransactionsMember"
      decimals="-5"
      id="fid_441"
      unitRef="USD">200000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="From2025-01-01to2025-03-31_ltbr_TwentyTwentyFiveTransactionsMember"
      decimals="-5"
      id="fid_442"
      unitRef="USD">300000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <ltbr:DescriptionOfRSAsModificationAndNetShareSettlementsForPaymentsOfWithholdingTaxes
      contextRef="From2025-03-01to2025-03-24_ltbr_TwentyTwentyFiveTransactionsMember"
      id="fid_439">approximately $0.2 million in payroll withholding taxes associated with the accelerated RSAs vesting, the Company withheld 21,285 shares, resulting in the issuance of 49,425 net shares to the former employee</ltbr:DescriptionOfRSAsModificationAndNetShareSettlementsForPaymentsOfWithholdingTaxes>
    <ltbr:DescriptionOfRSAsModificationAndNetShareSettlementsForPaymentsOfWithholdingTaxes
      contextRef="From2025-03-01to2025-03-14_ltbr_TwentyTwentyFiveTransactionsMember"
      id="fid_393">10,907 RSAs vested to the former employee based on his service to the Company. To satisfy approximately $36,000 in payroll withholding taxes, the Company withheld 3,863 shares, resulting in the issuance of 7,044 net shares to the former employee</ltbr:DescriptionOfRSAsModificationAndNetShareSettlementsForPaymentsOfWithholdingTaxes>
    <ltbr:CommonStockShareOutstanding
      contextRef="AsOf2025-03-31_ltbr_RestrictedStockAwardsSummaryMember"
      decimals="0"
      id="fid_444"
      unitRef="Shares">743702</ltbr:CommonStockShareOutstanding>
    <ltbr:CommonStockShareOutstanding
      contextRef="AsOf2024-03-31_ltbr_RestrictedStockAwardsSummaryMember"
      decimals="0"
      id="fid_445"
      unitRef="Shares">781864</ltbr:CommonStockShareOutstanding>
    <us-gaap:ShareBasedCompensation
      contextRef="From2025-01-01to2025-03-31_ltbr_RestrictedStockAwardsSummaryMember"
      decimals="-5"
      id="fid_448"
      unitRef="USD">1300000</us-gaap:ShareBasedCompensation>
    <ltbr:RSAFairValue
      contextRef="From2025-01-01to2025-03-31_ltbr_RestrictedStockAwardsSummaryMember"
      decimals="-5"
      id="fid_450"
      unitRef="USD">500000</ltbr:RSAFairValue>
    <us-gaap:ShareBasedCompensation
      contextRef="From2024-01-01to2024-03-31_ltbr_RestrictedStockAwardsSummaryMember"
      decimals="-5"
      id="fid_449"
      unitRef="USD">400000</us-gaap:ShareBasedCompensation>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_219">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Three Months Ended&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;March 31,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Research and development expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.2&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.1&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;General and administrative expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1.1&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.4&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Total stock-based compensation expense &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;1.3&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;0.5&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2025-01-01to2025-03-31_us-gaap_ResearchAndDevelopmentExpenseMember"
      decimals="-5"
      id="fid_362"
      unitRef="USD">200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-01-01to2024-03-31_us-gaap_ResearchAndDevelopmentExpenseMember"
      decimals="-5"
      id="fid_363"
      unitRef="USD">100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2025-01-01to2025-03-31_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="-5"
      id="fid_364"
      unitRef="USD">1100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-01-01to2024-03-31_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="-5"
      id="fid_365"
      unitRef="USD">400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2025-01-01to2025-03-31"
      decimals="-5"
      id="fid_366"
      unitRef="USD">1300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-01-01to2024-03-31"
      decimals="-5"
      id="fid_367"
      unitRef="USD">500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_198">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Note 8. Segment Reporting&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Operating segments are defined as components of an enterprise about which separate discrete information is available for evaluation by the chief operating decision maker, or decision-making group, in deciding how to allocate resources in assessing performance. The Company has one reportable business segment: nuclear fuel technology. This segment consists of the research and development and commercialization of its nuclear fuel. The Company&#x2019;s chief operating decision maker (&#x201c;CODM&#x201d;) is the chief executive officer.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The accounting policies of the segment are the same as those described in the summary of significant accounting policies. The CODM assesses performance for the segment based on net loss as reported on the condensed consolidated statement of operations. The Company expects to continue to incur significant expenses and operating losses for the foreseeable future as it advances its nuclear fuel through all the stages of its development and commercialization. In addition, the measure of segment assets is reported on the condensed consolidated balance sheet as total assets.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The CODM uses segment net loss to allocate resources predominantly in the annual budget and forecasting process and uses that measure as a basis for evaluating progress toward R&amp;amp;D milestones. The CODM uses cash forecast models in deciding how to invest into the segment. Research and development expenses, general and administrative expenses are included in segment net loss and used to monitor budget versus actual results. Monitoring budgeted versus actual results is used in assessing performance of the segment, while research and development milestones scorecard results and scorecard general and administrative budgeted results are used in establishing management&#x2019;s incentive compensation.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The table below summarizes the significant expense categories regularly provided to the CODM for the three months ended March 31, 2025 and 2024 (rounded in millions):&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Three Months Ended&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;March 31,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Revenue&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;General and administrative &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;3.5&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;2.2&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Research and development:&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 11.25pt; text-align:justify;"&gt;INL Project&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.8&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.4&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 11.25pt; text-align:justify;"&gt;Romania feasibility study&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.1&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 11.25pt; text-align:justify;"&gt;Centrus Energy FEED study&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.2&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt"&gt;Allocated employee compensation and stock-based compensation &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.8&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.2&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 11.25pt; text-align:justify;"&gt;Other outside R&amp;amp;D expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.1&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.1&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Total research and development&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1.7&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1.0&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Other segments items&lt;sup style="vertical-align:super"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(0.4 &lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(0.4 &lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Net loss&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;(4.8 &lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;(2.8 &lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; text-align:justify;"&gt;(1) Other segment items include interest income.&lt;/p&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_220">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Three Months Ended&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;March 31,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Revenue&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;General and administrative &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;3.5&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;2.2&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Research and development:&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 11.25pt; text-align:justify;"&gt;INL Project&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.8&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.4&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 11.25pt; text-align:justify;"&gt;Romania feasibility study&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.1&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 11.25pt; text-align:justify;"&gt;Centrus Energy FEED study&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.2&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt"&gt;Allocated employee compensation and stock-based compensation &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.8&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.2&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 11.25pt; text-align:justify;"&gt;Other outside R&amp;amp;D expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.1&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.1&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Total research and development&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1.7&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1.0&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Other segments items&lt;sup style="vertical-align:super"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(0.4 &lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(0.4 &lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Net loss&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;(4.8 &lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;(2.8 &lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="From2025-01-01to2025-03-31_ltbr_CODMMember"
      decimals="-6"
      id="fid_223"
      unitRef="USD">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-01-01to2024-03-31_ltbr_CODMMember"
      decimals="-6"
      id="fid_224"
      unitRef="USD">0</us-gaap:Revenues>
    <us-gaap:OtherGeneralAndAdministrativeExpense
      contextRef="From2025-01-01to2025-03-31_ltbr_CODMMember"
      decimals="-5"
      id="fid_225"
      unitRef="USD">3500000</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense
      contextRef="From2024-01-01to2024-03-31_ltbr_CODMMember"
      decimals="-5"
      id="fid_226"
      unitRef="USD">2200000</us-gaap:OtherGeneralAndAdministrativeExpense>
    <ltbr:InlProject
      contextRef="From2025-01-01to2025-03-31_ltbr_CODMMember"
      decimals="-5"
      id="fid_227"
      unitRef="USD">800000</ltbr:InlProject>
    <ltbr:InlProject
      contextRef="From2024-01-01to2024-03-31_ltbr_CODMMember"
      decimals="-5"
      id="fid_228"
      unitRef="USD">400000</ltbr:InlProject>
    <ltbr:RomaniaFeasibilityStudy
      contextRef="From2025-01-01to2025-03-31_ltbr_CODMMember"
      decimals="-6"
      id="fid_229"
      unitRef="USD">0</ltbr:RomaniaFeasibilityStudy>
    <ltbr:RomaniaFeasibilityStudy
      contextRef="From2024-01-01to2024-03-31_ltbr_CODMMember"
      decimals="-5"
      id="fid_230"
      unitRef="USD">100000</ltbr:RomaniaFeasibilityStudy>
    <ltbr:CentrusEnergyFeedStudy
      contextRef="From2025-01-01to2025-03-31_ltbr_CODMMember"
      decimals="-6"
      id="fid_231"
      unitRef="USD">0</ltbr:CentrusEnergyFeedStudy>
    <ltbr:CentrusEnergyFeedStudy
      contextRef="From2024-01-01to2024-03-31_ltbr_CODMMember"
      decimals="-5"
      id="fid_232"
      unitRef="USD">200000</ltbr:CentrusEnergyFeedStudy>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2025-01-01to2025-03-31_ltbr_CODMMember"
      decimals="-5"
      id="fid_235"
      unitRef="USD">800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-01-01to2024-03-31_ltbr_CODMMember"
      decimals="-5"
      id="fid_236"
      unitRef="USD">200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:OtherExpenses
      contextRef="From2025-01-01to2025-03-31_ltbr_CODMMember"
      decimals="-5"
      id="fid_237"
      unitRef="USD">100000</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses
      contextRef="From2024-01-01to2024-03-31_ltbr_CODMMember"
      decimals="-5"
      id="fid_238"
      unitRef="USD">100000</us-gaap:OtherExpenses>
    <ltbr:ResearchAndDevelopmentExpenseNet
      contextRef="From2025-01-01to2025-03-31_ltbr_CODMMember"
      decimals="-5"
      id="fid_239"
      unitRef="USD">1700000</ltbr:ResearchAndDevelopmentExpenseNet>
    <ltbr:ResearchAndDevelopmentExpenseNet
      contextRef="From2024-01-01to2024-03-31_ltbr_CODMMember"
      decimals="-6"
      id="fid_240"
      unitRef="USD">1000000</ltbr:ResearchAndDevelopmentExpenseNet>
    <ltbr:OtherSegmentsItem
      contextRef="From2025-01-01to2025-03-31_ltbr_CODMMember"
      decimals="-5"
      id="fid_241"
      unitRef="USD">-400000</ltbr:OtherSegmentsItem>
    <ltbr:OtherSegmentsItem
      contextRef="From2024-01-01to2024-03-31_ltbr_CODMMember"
      decimals="-5"
      id="fid_242"
      unitRef="USD">-400000</ltbr:OtherSegmentsItem>
    <ltbr:OperatingNetIncomeLossFromSegmentsToConsolidated
      contextRef="From2025-01-01to2025-03-31_ltbr_CODMMember"
      decimals="-5"
      id="fid_243"
      unitRef="USD">-4800000</ltbr:OperatingNetIncomeLossFromSegmentsToConsolidated>
    <ltbr:OperatingNetIncomeLossFromSegmentsToConsolidated
      contextRef="From2024-01-01to2024-03-31_ltbr_CODMMember"
      decimals="-5"
      id="fid_244"
      unitRef="USD">-2800000</ltbr:OperatingNetIncomeLossFromSegmentsToConsolidated>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_199">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Note 9. Subsequent Events&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;&lt;em&gt;ATM Sales&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Sales of common stock under the Company&#x2019;s ATM from April 1, 2025 to May 12, 2025 amounted to 677,300 shares, which resulted in total net proceeds of approximately $5.0 million. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;&lt;em&gt;Issuance of Performance-Based RSAs&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On April 3, 2025, the Company&#x2019;s Compensation Committee and Board approved the grant of performance-based RSAs to certain executives, key employees and certain consultants under the 2020 Plan. The awards are subject to both service and performance-based vesting conditions, including achievement of one specific R&amp;amp;D fuel milestone, the insertion of the Company&#x2019;s coupon fuel samples into the ATR reactor at INL for irradiation testing by December 31, 2026. The service requirement for vesting is a three-year period from the grant date.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company will recognize stock-based compensation expense for these awards beginning on the grant date, with the amount and timing of expense recognition dependent on the probability of achieving the above performance condition. These 300,000 performance-based restricted stock awards were valued at $2.1 million, based on the April 7, 2025 closing stock price of $6.99 per share&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;&lt;em&gt;2025 Annual Shareholder Meeting Voting Results&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;At the Company&#x2019;s Annual Meeting of Shareholders held on May 8, 2025, shareholders approved the following proposals:&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td style="width:4%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:4%;vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;1.&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Amendment to the Articles of Incorporation to increase the number of authorized shares of common stock from 25,000,000 shares to 100,000,000 shares.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;2.&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Amendment to the 2020 Plan to increase the number of shares authorized for issuance under the plan from 2,500,000 shares to 5,000,000 shares.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160; &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The approved proposal to the Amendment to the Articles of Incorporation became effective upon the filing of the Amended and Restated Certificate of Incorporation with the Secretary of State of Nevada.The Series X Preferred Stock (note 7) was redeemed and the Certificate of Withdrawal was filed with the Secretary of State of Nevada. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;span class="atag" id="forward" style="display: inline"&gt;FORWARD-LOOKING STATEMENTS &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;In addition to historical information, this Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. We use words such as &#x201c;believe,&#x201d; &#x201c;expect,&#x201d; &#x201c;anticipate,&#x201d; &#x201c;project,&#x201d; &#x201c;target,&#x201d; &#x201c;plan,&#x201d; &#x201c;optimistic,&#x201d; &#x201c;intend,&#x201d; &#x201c;aim,&#x201d; &#x201c;will,&#x201d; &#x201c;may,&#x201d; or similar expressions, which are intended to identify forward-looking statements. Such statements include, among others:&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td style="width:4%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:4%;vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;span style="font-family:symbol"&gt;&#xb7;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;those concerning market and business segment growth, demand, and acceptance of our nuclear fuel technology and other steps toward the commercialization of Lightbridge Fuel&#x2122;;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;span style="font-family:symbol"&gt;&#xb7;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;any projections of sales, earnings, revenue, margins, or other financial items;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;span style="font-family:symbol"&gt;&#xb7;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;any statements of the plans, strategies, and objectives of management for future operations and the timing and outcome of the development of our nuclear fuel technology;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;span style="font-family:symbol"&gt;&#xb7;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;any statements regarding future economic conditions or performance;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;span style="font-family:symbol"&gt;&#xb7;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;any statements about future financings and liquidity;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;span style="font-family:symbol"&gt;&#xb7;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;the Company&#x2019;s anticipated financial resources and position; and&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;span style="font-family:symbol"&gt;&#xb7;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;all assumptions, expectations, predictions, intentions, or beliefs about future events and other statements that are not historical facts.&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160; &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;You are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, as well as assumptions that if they were to ever materialize or prove incorrect, could cause the results of the Company to differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties, among others, include:&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td style="width:4%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:4%;vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;span style="font-family:symbol"&gt;&#xb7;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;our ability to commercialize our nuclear fuel technology, including risks related to the design and testing of nuclear fuel incorporating our technology and the degree of market adoption of the Company&#x2019;s product and service offerings;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;span style="font-family:symbol"&gt;&#xb7;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;dependence on strategic partners;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;span style="font-family:symbol"&gt;&#xb7;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;any adverse changes to our agreements or relationship with the U.S. government and its national laboratories;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;span style="font-family:symbol"&gt;&#xb7;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;our ability to fund our future operations, including general corporate overhead and outside research and development (R&amp;amp;D) expenses, and continue as a going concern;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;span style="font-family:symbol"&gt;&#xb7;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;the future market and demand for our fuel for nuclear reactors and our ability to attract customers;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;span style="font-family:symbol"&gt;&#xb7;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;our ability to manage the business effectively in a rapidly evolving market;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;span style="font-family:symbol"&gt;&#xb7;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;our ability to employ and retain qualified employees and consultants that have experience in the nuclear industry;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;span style="font-family:symbol"&gt;&#xb7;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;competition and competitive factors in the markets in which we compete, including from accident tolerant fuels (ATFs);&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;span style="font-family:symbol"&gt;&#xb7;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;access to and availability of nuclear test reactors and the risks associated with unexpected changes in our nuclear fuel development timeline;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;span style="font-family:symbol"&gt;&#xb7;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;access to and availability of adequate resources and manufacturing capabilities at national laboratories that affect our nuclear fuel development timeline and project costs;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;span style="font-family:symbol"&gt;&#xb7;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;the increased costs associated with metallization of our nuclear fuel;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td style="width:4%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:4%;vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;span style="font-family:symbol"&gt;&#xb7;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;uncertainties related to conducting business in foreign countries;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;span style="font-family:symbol"&gt;&#xb7;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;public perception of nuclear energy generally;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;span style="font-family:symbol"&gt;&#xb7;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;changes in laws, rules, and regulations governing our business;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;span style="font-family:symbol"&gt;&#xb7;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;changes in the political environment;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;span style="font-family:symbol"&gt;&#xb7;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;development and utilization of, and challenges to, our intellectual property domestically and abroad;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;span style="font-family:symbol"&gt;&#xb7;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;the trading price of our securities is likely to be volatile, and purchasers of our securities could incur substantial losses; and&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;span style="font-family:symbol"&gt;&#xb7;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;the other risks and uncertainties identified in Item 1A. Risk Factors included in our Annual Report on Form 10-K for the year ended December 31, 2024.&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160; &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Most of these factors are beyond our ability to predict or control and you should not put undue reliance on any forward-looking statement. Future events and actual results could differ materially from those set forth in, contemplated by or underlying the forward-looking statements. Forward-looking statements speak only as of the date on which they are made. The Company assumes no obligation and does not intend to update these forward-looking statements for any reason after the date of the filing of this report, to conform these statements to actual results or to changes in our expectations, except as required by law.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2025-04-01to2025-05-12_us-gaap_SubsequentEventMember"
      decimals="0"
      id="fid_303"
      unitRef="Shares">677300</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <ltbr:ProceedsFromStockIssuances
      contextRef="From2025-04-01to2025-05-12_us-gaap_SubsequentEventMember"
      decimals="-5"
      id="fid_304"
      unitRef="USD">5000000.0</ltbr:ProceedsFromStockIssuances>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2025-04-01to2025-04-03_us-gaap_SubsequentEventMember"
      decimals="0"
      id="fid_305"
      unitRef="Shares">300000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2025-04-01to2025-04-03_us-gaap_SubsequentEventMember"
      decimals="-5"
      id="fid_306"
      unitRef="USD">2100000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2025-04-03_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="fid_307"
      unitRef="USDPShares">6.99</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-05-08_ltbr_BottomMember_us-gaap_SubsequentEventMember_ltbr_ArticlesOfIncorporationMember"
      decimals="0"
      id="fid_308"
      unitRef="Shares">25000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-05-08_ltbr_TopMember_us-gaap_SubsequentEventMember_ltbr_ArticlesOfIncorporationMember"
      decimals="0"
      id="fid_309"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-05-08_ltbr_BottomMember_us-gaap_SubsequentEventMember_ltbr_TwentyTwentyPlanMember"
      decimals="0"
      id="fid_310"
      unitRef="Shares">2500000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-05-08_ltbr_TopMember_us-gaap_SubsequentEventMember_ltbr_TwentyTwentyPlanMember"
      decimals="0"
      id="fid_311"
      unitRef="Shares">5000000</us-gaap:CommonStockSharesAuthorized>
    <ltbr:TrdArrIndNameOne contextRef="From2025-01-01to2025-03-31" id="fid_463">Jesse Funches</ltbr:TrdArrIndNameOne>
    <ltbr:TrdArrIndTitleOne contextRef="From2025-01-01to2025-03-31" id="fid_467">Director</ltbr:TrdArrIndTitleOne>
    <ltbr:Rule10b51ArrAdoptedOneFlag contextRef="From2025-01-01to2025-03-31" id="fid_471">true</ltbr:Rule10b51ArrAdoptedOneFlag>
    <ltbr:TrdArrAdoptionDateFirst contextRef="From2025-01-01to2025-03-31" id="fid_475">1/9/2025</ltbr:TrdArrAdoptionDateFirst>
    <ltbr:TrdArrExpirationDateOne contextRef="From2025-01-01to2025-03-31" id="fid_479">4/9/2026</ltbr:TrdArrExpirationDateOne>
    <ltbr:TrdArrSecuritiesAggAvailAmtOne
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_483"
      unitRef="Shares">6250</ltbr:TrdArrSecuritiesAggAvailAmtOne>
    <ltbr:TrdArrIndNameTwo contextRef="From2025-01-01to2025-03-31" id="fid_464">Mark Tobin</ltbr:TrdArrIndNameTwo>
    <ltbr:TrdArrIndTitleTwo contextRef="From2025-01-01to2025-03-31" id="fid_468">Director</ltbr:TrdArrIndTitleTwo>
    <ltbr:Rule10b51ArrAdoptedTwoFlag contextRef="From2025-01-01to2025-03-31" id="fid_472">true</ltbr:Rule10b51ArrAdoptedTwoFlag>
    <ltbr:TrdArrAdoptionDateSecond contextRef="From2025-01-01to2025-03-31" id="fid_476">1/13/2025</ltbr:TrdArrAdoptionDateSecond>
    <ltbr:TrdArrExpirationDateTwo contextRef="From2025-01-01to2025-03-31" id="fid_480">6/1/2026</ltbr:TrdArrExpirationDateTwo>
    <ltbr:TrdArrSecuritiesAggAvailAmtTwo
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_484"
      unitRef="Shares">6000</ltbr:TrdArrSecuritiesAggAvailAmtTwo>
    <ltbr:TrdArrIndNameThird contextRef="From2025-01-01to2025-03-31" id="fid_465">Sherri Goodman</ltbr:TrdArrIndNameThird>
    <ltbr:TrdArrIndTitleThree contextRef="From2025-01-01to2025-03-31" id="fid_469">Director</ltbr:TrdArrIndTitleThree>
    <ltbr:Rule10b51ArrAdoptedThreeFlag contextRef="From2025-01-01to2025-03-31" id="fid_473">true</ltbr:Rule10b51ArrAdoptedThreeFlag>
    <ltbr:TrdArrAdoptionDateThird contextRef="From2025-01-01to2025-03-31" id="fid_477">1/24/2025</ltbr:TrdArrAdoptionDateThird>
    <ltbr:TrdArrExpirationDateThree contextRef="From2025-01-01to2025-03-31" id="fid_481">4/24/2026</ltbr:TrdArrExpirationDateThree>
    <ltbr:TrdArrSecuritiesAggAvailAmtThree
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_485"
      unitRef="Shares">7000</ltbr:TrdArrSecuritiesAggAvailAmtThree>
    <ltbr:TrdArrIndNameFourth contextRef="From2025-01-01to2025-03-31" id="fid_466">Larry Goldman</ltbr:TrdArrIndNameFourth>
    <ltbr:TrdArrIndTitleFour contextRef="From2025-01-01to2025-03-31" id="fid_470">Chief Financial Officer</ltbr:TrdArrIndTitleFour>
    <ltbr:Rule10b51ArrAdoptedFourFlag contextRef="From2025-01-01to2025-03-31" id="fid_474">true</ltbr:Rule10b51ArrAdoptedFourFlag>
    <ltbr:TrdArrAdoptionDateFourth contextRef="From2025-01-01to2025-03-31" id="fid_478">3/7/2025</ltbr:TrdArrAdoptionDateFourth>
    <ltbr:TrdArrExpirationDateFour contextRef="From2025-01-01to2025-03-31" id="fid_482">6/8/2026</ltbr:TrdArrExpirationDateFour>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
